data_1cye_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1cye _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 91.4 mttt . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 117.367 2.358 . . . . 0.0 117.367 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.92 89.86 3.21 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.548 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 tt -144.26 128.57 17.83 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 112.28 -2.236 . . . . 0.0 107.687 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -82.06 112.86 19.5 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -104.32 132.97 50.0 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.47 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -111.95 99.76 8.35 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.103 0.954 . . . . 0.0 110.06 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.9 t -78.94 103.61 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 112.03 -2.35 . . . . 0.0 108.467 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 t -100.85 90.05 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 113.555 -1.657 . . . . 0.0 107.785 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -132.34 121.59 23.75 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.818 1.294 . . . . 0.0 112.275 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.84 -29.9 70.48 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 111.979 -2.373 . . . . 0.0 115.345 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -98.4 121.31 40.18 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.7 0.625 . . . . 0.0 109.452 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.1 p -50.04 -50.67 46.91 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 m -59.45 -50.12 75.16 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.046 0.538 . . . . 0.0 111.137 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -40.35 94.58 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.135 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.526 HH21 ' NH1' ' A' ' 19' ' ' ARG . 37.1 ttp180 -58.88 -48.33 81.78 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.315 1.046 . . . . 0.0 111.147 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.526 ' NH1' HH21 ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.74 -46.47 89.04 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.387 1.054 . . . . 0.0 111.994 177.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.2 mt -53.97 -50.92 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.828 0.851 . . . . 0.0 110.932 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.8 t -57.23 -48.45 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 122.506 0.323 . . . . 0.0 110.732 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -56.39 -50.77 70.63 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.86 0.725 . . . . 0.0 110.946 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -55.83 -43.33 76.89 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.268 1.027 . . . . 0.0 110.769 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.9 mt -59.97 -51.82 68.03 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.718 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.7 mt -57.11 -43.19 82.06 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.718 0.807 . . . . 0.0 112.81 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -58.2 -48.9 78.88 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.383 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -60.69 -33.99 73.68 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.748 1.619 . . . . 0.0 113.008 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.5 mt -76.2 -13.7 60.17 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.06 -14.44 26.17 Favored Glycine 0 N--CA 1.482 1.755 0 C-N-CA 124.359 0.98 . . . . 0.0 113.741 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -81.23 85.41 6.38 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 122.384 1.088 . . . . 0.0 111.999 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -81.37 13.55 2.91 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -121.83 85.9 2.49 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 123.461 1.601 . . . . 0.0 110.756 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p -136.78 127.63 41.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 113.562 -1.653 . . . . 0.0 111.374 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -119.43 155.29 32.29 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -127.8 139.7 52.49 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.79 167.15 17.72 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 111.175 -2.738 . . . . 0.0 109.748 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -104.35 -53.78 2.65 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -125.0 171.33 10.32 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.199 0.599 . . . . 0.0 110.989 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -45.58 -53.77 8.12 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.992 1.282 . . . . 0.0 115.662 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.5 t -58.25 -55.06 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.671 0.788 . . . . 0.0 111.27 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -54.49 -41.51 69.67 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.672 1.189 . . . . 0.0 111.318 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.1 -49.45 74.41 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.501 1.121 . . . . 0.0 112.146 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.0 mt -52.25 -53.91 37.83 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 124.332 1.02 . . . . 0.0 110.706 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -52.11 -52.2 52.99 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.39 1.056 . . . . 0.0 112.426 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -57.93 -52.8 63.99 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.634 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.1 mt -59.56 -33.09 70.98 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -62.29 -26.27 68.32 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.87 -25.84 68.07 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.79 -168.37 15.96 Favored Glycine 0 N--CA 1.478 1.449 0 O-C-N 124.585 1.178 . . . . 0.0 110.588 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.61 -41.73 2.15 Favored Glycine 0 CA--C 1.541 1.71 0 N-CA-C 116.17 1.228 . . . . 0.0 116.17 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -66.77 135.42 53.95 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.83 19.87 7.34 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 113.801 -1.545 . . . . 0.0 113.62 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -174.29 144.06 0.91 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.762 1.225 . . . . 0.0 111.776 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 t -125.64 124.66 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.886 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.0 mt -115.92 99.99 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.8 t -116.93 137.5 52.17 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 -176.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -77.37 129.49 35.87 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 113.456 -1.702 . . . . 0.0 110.236 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -56.58 -50.4 72.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.101 0.96 . . . . 0.0 112.534 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -87.92 77.28 8.52 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.146 1.379 . . . . 0.0 113.338 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.4 mtm -117.66 133.23 23.32 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-N 113.576 -1.647 . . . . 0.0 113.706 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -61.68 147.02 96.28 Favored 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 123.982 3.122 . . . . 0.0 112.505 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 68.9 -64.08 0.34 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.565 1.946 . . . . 0.0 112.208 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 60.4 ttm -126.69 104.31 8.02 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 124.779 1.231 . . . . 0.0 107.887 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -69.71 168.61 14.57 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 113.614 -1.63 . . . . 0.0 113.178 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.3 -54.57 12.37 Favored Glycine 0 N--CA 1.476 1.314 0 C-N-CA 125.046 1.308 . . . . 0.0 114.393 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.8 tp -59.99 -41.5 92.21 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.66 0.784 . . . . 0.0 112.846 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.5 -43.91 88.65 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.627 0.371 . . . . 0.0 111.228 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.1 tp -58.73 -40.82 84.87 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.091 0.956 . . . . 0.0 110.736 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.0 tp -56.0 -45.64 78.99 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.178 0.991 . . . . 0.0 110.675 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.75 -45.42 89.94 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.018 0.927 . . . . 0.0 112.083 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.251 67.8 p -59.84 -38.31 81.71 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.109 0.964 . . . . 0.0 110.54 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.8 mt -68.98 -54.28 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.637 0.775 . . . . 0.0 109.473 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -52.92 -28.59 24.07 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 126.925 2.09 . . . . 0.0 114.231 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.5 -12.75 15.86 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -80.37 60.39 3.78 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.992 0.917 . . . . 0.0 113.437 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 32.98 -89.5 0.01 OUTLIER Glycine 0 N--CA 1.485 1.964 0 C-N-CA 127.856 2.646 . . . . 0.0 115.036 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.36 -38.58 80.78 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.072 0.949 . . . . 0.0 113.137 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 87.0 mtp -78.17 -11.17 59.9 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.6 m -57.68 -17.6 15.91 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.64 8.31 41.77 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.1 mt -85.11 112.42 43.3 Favored Pre-proline 0 N--CA 1.484 1.247 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.86 139.52 49.95 Favored 'Trans proline' 0 N--CA 1.477 0.547 0 C-N-CA 123.872 3.048 . . . . 0.0 113.365 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.0 t -122.53 127.42 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.457 -1.247 . . . . 0.0 113.684 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.2 tp -114.66 102.2 9.81 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.534 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.4 mmt -78.96 108.31 12.35 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.361 -1.745 . . . . 0.0 113.162 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -85.93 104.89 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.5 p -94.64 139.74 30.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.703 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.93 -45.39 74.47 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.13 -1.396 . . . . 0.0 110.72 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -136.45 128.39 29.39 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.649 -1.614 . . . . 0.0 107.226 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.16 113.46 26.75 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.715 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.4 153.01 51.22 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 113.171 -1.832 . . . . 0.0 108.277 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -41.25 -43.54 2.42 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -53.37 -61.14 2.49 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.463 1.105 . . . . 0.0 112.933 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -69.94 -28.94 65.98 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 88.1 mt -61.55 -52.7 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.739 0.816 . . . . 0.0 110.102 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.6 mt -62.56 -44.33 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.98 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.54 -47.54 69.89 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.187 0.995 . . . . 0.0 112.104 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.71 -53.4 58.65 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.782 1.233 . . . . 0.0 111.75 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.67 90.72 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.204 1.002 . . . . 0.0 112.279 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -57.61 -38.37 74.81 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.64 1.176 . . . . 0.0 113.325 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.96 5.57 32.59 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.06 -5.56 30.5 Favored Glycine 0 CA--C 1.541 1.718 0 N-CA-C 116.825 1.49 . . . . 0.0 116.825 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.55 117.13 5.81 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 119.454 1.627 . . . . 0.0 113.906 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.3 m -62.59 -28.58 69.98 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 112.109 -2.314 . . . . 0.0 113.142 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.1 170.8 43.14 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.982 1.277 . . . . 0.0 110.706 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -143.81 142.16 30.73 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.18 -1.01 . . . . 0.0 111.738 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.0 p -128.92 126.97 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.198 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.4 p -84.47 142.56 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.755 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -90.4 137.85 27.3 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.692 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -86.87 135.63 17.02 Favored 'Cis proline' 0 CA--C 1.539 0.729 0 CA-C-O 122.722 1.051 . . . . 0.0 113.624 -0.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -116.09 151.29 35.88 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 113.467 -1.697 . . . . 0.0 109.558 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.5 p -105.7 177.9 4.72 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.35 0.595 . . . . 0.0 111.384 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.6 -45.1 69.93 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.027 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.33 -48.72 76.85 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.624 0.77 . . . . 0.0 111.221 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.65 -47.97 78.6 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.43 0.692 . . . . 0.0 110.291 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -51.44 70.02 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.445 1.098 . . . . 0.0 109.095 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -55.7 -46.28 77.7 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.644 1.178 . . . . 0.0 112.685 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.03 -48.09 70.88 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.249 0.62 . . . . 0.0 111.352 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -61.94 -47.28 85.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.817 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.5 mt -55.3 -51.1 67.78 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.037 0.835 . . . . 0.0 112.534 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -53.34 -50.51 64.86 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.558 1.143 . . . . 0.0 111.882 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -56.07 -49.01 74.99 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.817 1.647 . . . . 0.0 112.035 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.4 mt -59.47 -48.64 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.278 1.031 . . . . 0.0 110.53 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 . . . . . 0 N--CA 1.479 0.987 0 O-C-N 124.03 0.831 . . . . 0.0 112.83 179.653 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.4 tptt . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -118.8 73.29 0.92 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.899 0.857 . . . . 0.0 108.884 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.3 tp -102.27 128.6 48.74 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 112.534 -2.121 . . . . 0.0 109.572 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -74.48 113.42 11.71 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.53 -1.214 . . . . 0.0 114.017 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -107.84 142.53 37.75 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.106 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -123.23 103.76 8.73 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.221 175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 77.1 t -81.28 101.15 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 111.889 -2.414 . . . . 0.0 109.333 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.7 t -100.39 94.65 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 113.685 -1.598 . . . . 0.0 107.149 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -139.23 124.75 19.33 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.779 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.6 p-10 -61.92 -30.7 71.07 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.16 121.56 38.06 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.092 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.3 p -47.0 -50.6 18.88 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 113.2 -1.818 . . . . 0.0 113.025 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 m -60.56 -55.27 35.43 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.1 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -62.69 -35.8 80.85 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -58.55 -47.59 83.69 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.3 1.04 . . . . 0.0 110.395 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.747 ' CZ ' HD22 ' A' ' 23' ' ' ASN . 28.4 tpt180 -60.71 -45.53 93.89 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.286 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 45.5 mm -52.98 -54.73 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.274 1.03 . . . . 0.0 110.41 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.94 -49.05 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 123.562 0.539 . . . . 0.0 111.345 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.601 HH11 HH12 ' A' ' 19' ' ' ARG . 3.3 tmt_? -54.69 -46.3 74.09 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 124.088 0.867 . . . . 0.0 110.592 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.747 HD22 ' CZ ' ' A' ' 19' ' ' ARG . 12.0 m120 -63.81 -47.49 80.62 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.56 1.144 . . . . 0.0 112.158 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.0 mt -52.97 -53.77 45.02 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.284 1.034 . . . . 0.0 112.313 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.7 mt -55.61 -48.0 75.6 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.192 0.997 . . . . 0.0 113.372 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -55.89 -46.56 78.29 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 113.215 -1.811 . . . . 0.0 110.476 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -62.4 -31.1 71.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.073 1.749 . . . . 0.0 113.706 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 73.4 mt -77.15 -10.06 59.15 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.835 1.254 . . . . 0.0 113.904 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.76 -12.83 20.43 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 125.302 1.43 . . . . 0.0 114.53 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -85.57 81.29 8.73 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 122.48 1.133 . . . . 0.0 113.629 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -85.42 29.24 0.69 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 113.168 -1.833 . . . . 0.0 114.431 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -127.62 53.38 1.76 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 123.789 1.757 . . . . 0.0 109.788 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.95 126.19 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.602 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -117.49 165.03 14.01 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.33 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -127.41 141.4 51.69 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 119.508 3.151 . . . . 0.0 119.508 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -132.46 148.96 52.41 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 111.301 -2.681 . . . . 0.0 109.098 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -85.81 -53.77 4.92 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.526 -1.215 . . . . 0.0 112.777 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -130.72 171.06 13.52 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.899 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -45.14 -44.11 9.45 Favored Glycine 0 N--CA 1.477 1.426 0 O-C-N 125.11 1.506 . . . . 0.0 116.524 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.3 t -61.76 -55.76 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 118.18 -0.914 . . . . 0.0 109.908 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -54.54 -40.01 68.25 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 123.596 0.56 . . . . 0.0 110.726 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.41 -54.46 45.37 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.453 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.3 mt -54.65 -51.26 66.01 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.31 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -46.08 -48.65 17.0 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.961 0.904 . . . . 0.0 112.733 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -69.0 -49.83 54.25 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.917 2.087 . . . . 0.0 113.591 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.4 mt -59.44 -36.66 76.34 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -55.43 -25.66 37.44 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.26 -28.1 68.45 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.95 -170.42 23.82 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.538 1.065 . . . . 0.0 111.405 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.05 -46.06 3.1 Favored Glycine 0 N--CA 1.483 1.817 0 CA-C-N 113.814 -1.193 . . . . 0.0 113.748 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -62.21 109.57 1.36 Allowed 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.134 0.969 . . . . 0.0 111.961 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.3 29.56 11.36 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-N 113.2 -1.818 . . . . 0.0 113.363 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -178.72 129.49 0.12 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.053 1.341 . . . . 0.0 112.404 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 t -116.35 116.4 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 113.536 -1.665 . . . . 0.0 107.384 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 77.4 mt -107.2 98.77 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.5 t -118.28 127.11 53.4 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 117.895 2.554 . . . . 0.0 117.895 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.88 128.55 35.83 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.228 -2.26 . . . . 0.0 111.0 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -49.33 -47.32 47.31 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -92.8 106.76 18.68 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.972 0.891 . . . . 0.0 109.125 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.9 mtp -145.98 133.53 10.33 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.687 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.08 146.8 78.08 Favored 'Trans proline' 0 N--CA 1.48 0.691 0 C-N-CA 123.299 2.666 . . . . 0.0 111.969 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 m120 70.31 -72.92 0.1 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.106 1.762 . . . . 0.0 111.069 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.1 ttm -116.88 97.74 6.12 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -64.48 168.75 5.47 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 113.006 -1.906 . . . . 0.0 113.64 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.22 -56.6 10.25 Favored Glycine 0 N--CA 1.479 1.563 0 C-N-CA 124.664 1.126 . . . . 0.0 114.242 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.7 tp -61.03 -37.85 84.05 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.099 0.959 . . . . 0.0 112.96 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -68.53 -38.85 81.2 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.368 0.667 . . . . 0.0 111.151 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 65.4 tp -64.9 -38.93 92.62 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.861 0.864 . . . . 0.0 110.648 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.8 tt -50.63 -49.44 56.79 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.027 0.931 . . . . 0.0 109.254 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -60.43 -42.86 96.93 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.936 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 47.8 p -69.22 -14.92 63.24 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.4 1.08 . . . . 0.0 113.014 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.5 mt -92.51 -54.34 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.156 1.382 . . . . 0.0 107.679 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -50.8 -52.81 37.51 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.688 1.995 . . . . 0.0 112.761 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.0 -14.7 59.42 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -86.85 75.75 9.55 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.664 0.745 . . . . 0.0 111.847 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 30.99 -100.0 0.01 OUTLIER Glycine 0 N--CA 1.483 1.818 0 C-N-CA 126.828 2.156 . . . . 0.0 115.151 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.84 -31.19 72.15 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 95.5 mtp -62.98 -18.0 62.75 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.7 p -53.17 -26.85 18.62 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.82 -16.43 36.21 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.6 mt -76.56 111.41 15.63 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 123.153 0.581 . . . . 0.0 111.51 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -52.49 130.57 36.94 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.389 2.726 . . . . 0.0 115.367 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.61 117.78 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 112.462 -2.154 . . . . 0.0 110.754 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.0 tp -110.37 114.77 28.48 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 113.207 -1.815 . . . . 0.0 108.863 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 28.4 mmt -87.92 104.42 16.59 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 122.91 1.338 . . . . 0.0 114.441 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.02 99.38 7.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 122.91 1.338 . . . . 0.0 107.82 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.2 t -123.1 129.1 51.02 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 113.256 -1.793 . . . . 0.0 112.546 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.75 -32.02 73.33 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.109 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -107.47 106.5 16.93 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.128 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.05 66.15 4.91 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 123.767 1.746 . . . . 0.0 107.098 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -115.99 150.88 36.49 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 111.868 -2.424 . . . . 0.0 111.056 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -33.61 -57.91 0.43 Allowed 'General case' 0 N--CA 1.476 0.826 0 O-C-N 125.488 1.743 . . . . 0.0 114.725 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -51.69 -52.34 48.95 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -61.72 -49.05 77.99 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.317 0.647 . . . . 0.0 111.53 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.0 mt -56.47 -54.89 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.539 1.136 . . . . 0.0 111.629 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.0 mm -57.86 -54.77 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.548 1.139 . . . . 0.0 111.056 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.83 -45.22 67.21 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.05 0.94 . . . . 0.0 112.47 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.17 -53.14 49.35 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.973 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.97 -46.16 85.6 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -57.72 -39.68 77.84 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.371 1.068 . . . . 0.0 113.579 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.51 -26.93 46.02 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 129.22 13.78 2.32 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 116.651 1.42 . . . . 0.0 116.651 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.43 121.37 13.64 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 118.79 1.295 . . . . 0.0 112.295 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.9 m -67.29 -25.78 66.22 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 112.988 -1.914 . . . . 0.0 112.482 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.0 173.11 40.52 Favored Glycine 0 N--CA 1.482 1.705 0 C-N-CA 125.686 1.613 . . . . 0.0 109.66 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -143.35 130.97 21.24 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.25 1.8 p -113.09 123.57 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 122.195 0.998 . . . . 0.0 111.97 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.2 t -72.41 128.36 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 111.609 -2.541 . . . . 0.0 108.963 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -99.93 134.89 20.63 Favored Pre-proline 0 N--CA 1.472 0.638 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.431 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.68 144.28 79.64 Favored 'Cis proline' 0 N--CA 1.482 0.815 0 N-CA-C 115.123 1.163 . . . . 0.0 115.123 0.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -129.77 150.88 50.88 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 112.384 -2.189 . . . . 0.0 107.517 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.3 t -102.34 172.05 7.11 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.773 0.671 . . . . 0.0 110.29 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.34 -43.9 61.89 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.93 0.892 . . . . 0.0 111.698 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.32 -46.64 87.84 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.134 0.974 . . . . 0.0 112.412 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.79 -48.31 81.7 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.456 1.103 . . . . 0.0 109.181 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 48.8 tp -57.67 -51.32 70.01 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.201 1.4 . . . . 0.0 110.329 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -55.53 -47.36 76.42 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.685 0.794 . . . . 0.0 111.54 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.79 -46.43 74.46 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.429 0.692 . . . . 0.0 112.025 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.9 mmmt -63.95 -48.4 76.66 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 124.2 0.937 . . . . 0.0 112.328 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 48.5 mt -53.18 -48.41 68.04 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.498 1.119 . . . . 0.0 110.961 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -55.95 -58.46 7.79 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.534 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -51.32 -44.06 61.86 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.894 1.278 . . . . 0.0 112.37 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 79.3 mt -57.2 -52.06 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.164 1.386 . . . . 0.0 112.307 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 . . . . . 0 N--CA 1.49 1.562 0 O-C-N 123.885 0.74 . . . . 0.0 112.19 -179.667 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 85.2 mttt . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.83 71.15 10.69 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.591 0.71 . . . . 0.0 109.172 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 tt -121.28 132.77 55.0 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.154 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -77.06 105.51 8.18 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.162 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -109.43 144.9 37.02 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.139 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.71 110.91 16.52 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.64 -1.163 . . . . 0.0 112.012 174.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.5 t -89.84 106.03 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.22 90.06 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 112.864 -1.971 . . . . 0.0 108.888 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -137.88 124.17 20.55 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.184 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -59.88 -25.85 65.41 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -97.88 119.45 36.51 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.248 0.546 . . . . 0.0 110.347 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.9 p -46.05 -48.39 16.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 113.926 -1.488 . . . . 0.0 113.517 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -60.85 -55.06 37.52 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.682 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.2 mmm -59.95 -38.95 83.95 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.492 ' NH1' HH22 ' A' ' 19' ' ' ARG . 15.5 ttm180 -57.1 -53.08 62.16 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.813 0.845 . . . . 0.0 110.153 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.492 HH22 ' NH1' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -58.64 -41.72 86.68 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.142 1.377 . . . . 0.0 113.477 177.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.9 mm -57.1 -58.63 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.261 1.024 . . . . 0.0 110.724 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 t -55.99 -44.56 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.231 0.613 . . . . 0.0 111.537 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 28.6 mtp-105 -54.25 -55.45 28.04 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.96 0.904 . . . . 0.0 112.376 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -59.92 -39.83 86.79 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.9 mt -55.38 -52.38 63.74 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.553 0.692 . . . . 0.0 111.358 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.0 mt -54.66 -48.97 71.71 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.47 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -56.45 -44.89 80.94 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.287 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -58.06 -40.48 81.12 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.434 1.894 . . . . 0.0 112.308 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.2 mt -73.47 -13.95 61.15 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.069 1.347 . . . . 0.0 113.605 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.34 -11.4 24.04 Favored Glycine 0 CA--C 1.544 1.901 0 C-N-CA 124.816 1.198 . . . . 0.0 113.757 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -85.7 76.5 9.95 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 123.23 1.49 . . . . 0.0 111.537 -177.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -72.32 -24.72 61.35 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 118.04 2.607 . . . . 0.0 118.04 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.22 71.68 10.02 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.505 1.145 . . . . 0.0 112.178 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.2 p -120.04 128.6 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -110.79 167.18 10.43 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.573 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -126.75 126.15 42.96 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 -176.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.29 150.97 41.61 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.093 -1.867 . . . . 0.0 108.893 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -92.05 -43.67 9.27 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -141.49 173.34 11.59 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.241 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -43.15 -56.6 4.54 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.065 1.317 . . . . 0.0 115.852 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.1 t -56.16 -54.61 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 123.429 0.691 . . . . 0.0 110.997 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -56.94 -34.27 67.85 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.941 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.41 -48.89 71.24 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.347 1.059 . . . . 0.0 110.971 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.5 mt -57.46 -45.47 84.71 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -55.42 -54.79 39.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.541 1.136 . . . . 0.0 110.927 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -59.66 -45.03 93.27 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 114.399 -1.273 . . . . 0.0 113.641 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.2 mt -55.42 -42.83 74.66 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.327 1.051 . . . . 0.0 112.433 177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -52.92 -35.57 58.47 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.758 1.223 . . . . 0.0 111.493 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.73 59.17 3.55 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.07 -19.63 4.61 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 118.466 2.147 . . . . 0.0 118.466 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.86 56.37 21.39 Favored Glycine 0 CA--C 1.548 2.138 0 CA-C-N 118.23 1.015 . . . . 0.0 112.296 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -50.71 135.63 23.14 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.063 2.145 . . . . 0.0 113.427 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.47 22.18 9.29 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -178.13 129.26 0.13 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.698 1.237 . . . . 0.0 112.237 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.4 t -117.82 113.58 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 112.907 -1.951 . . . . 0.0 107.537 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt -107.94 97.52 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 t -119.04 136.62 54.04 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -71.13 130.18 40.83 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 112.258 -2.246 . . . . 0.0 109.195 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.7 t-105 -58.29 -44.7 88.62 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.706 0.802 . . . . 0.0 111.428 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -94.53 96.17 9.29 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.747 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.6 mtm -134.71 132.76 20.78 Favored Pre-proline 0 N--CA 1.486 1.33 0 CA-C-N 113.651 -1.613 . . . . 0.0 110.362 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -59.34 144.06 99.52 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.763 2.975 . . . . 0.0 112.517 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.8 m120 69.69 -65.02 0.32 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.543 1.937 . . . . 0.0 113.062 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.0 ttm -123.3 96.77 5.12 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -68.34 167.12 15.18 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.034 -1.894 . . . . 0.0 112.548 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -47.0 -55.04 8.8 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.645 1.593 . . . . 0.0 116.152 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.9 tp -56.71 -48.88 76.71 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . 0.268 7.1 pm0 -67.98 -33.76 75.25 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 177.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.11 -43.96 95.22 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.855 0.722 . . . . 0.0 110.079 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.2 tp -54.09 -44.41 71.17 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.416 1.086 . . . . 0.0 110.865 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -64.15 -43.68 94.48 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.55 0.74 . . . . 0.0 111.785 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.263 33.0 p -58.6 -29.86 66.78 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 123.682 0.793 . . . . 0.0 111.99 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.6 mt -80.02 -56.61 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.855 1.262 . . . . 0.0 109.217 177.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -53.94 -47.48 71.23 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.539 1.536 . . . . 0.0 114.076 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.31 -26.32 67.72 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.284 1.033 . . . . 0.0 113.557 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -85.11 108.17 17.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.294 1.038 . . . . 0.0 108.827 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -29.14 -61.78 0.15 Allowed Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.046 1.784 . . . . 0.0 114.95 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.38 -47.9 80.12 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.4 mtm -68.31 -22.19 64.73 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.8 p -46.45 -35.73 5.9 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.31 -13.11 59.45 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 77.4 mt -79.31 111.87 23.96 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 122.857 0.463 . . . . 0.0 111.388 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -51.31 136.42 46.99 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.685 2.923 . . . . 0.0 115.919 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.2 t -120.08 123.34 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 112.843 -1.98 . . . . 0.0 112.686 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.45 110.15 20.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 112.887 -1.96 . . . . 0.0 107.864 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 30.1 mmt -85.22 105.3 15.81 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 113.628 -1.624 . . . . 0.0 111.991 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.52 103.51 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.34 138.38 42.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 112.068 -2.333 . . . . 0.0 115.851 -174.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.17 -27.92 69.4 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.045 -1.889 . . . . 0.0 113.157 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -151.97 110.99 3.86 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 124.171 0.92 . . . . 0.0 110.21 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.43 86.42 4.48 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.494 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -118.85 147.22 44.19 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.956 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -33.53 -55.66 0.44 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -53.24 -49.5 66.7 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.613 0.765 . . . . 0.0 112.33 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.68 -49.07 79.0 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.006 1.323 . . . . 0.0 110.811 177.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 79.4 mt -58.73 -53.21 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 124.508 1.13 . . . . 0.0 111.411 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.0 mt -55.39 -54.49 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.642 1.177 . . . . 0.0 110.537 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.58 -47.2 73.6 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.812 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.52 -58.0 10.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.3 1.04 . . . . 0.0 112.84 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.16 -49.01 78.49 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.518 0.727 . . . . 0.0 112.619 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -65.91 -25.37 67.12 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.4 1.45 54.67 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.75 -4.84 24.38 Favored Glycine 0 CA--C 1.545 1.95 0 N-CA-C 116.829 1.492 . . . . 0.0 116.829 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.63 119.81 9.96 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.098 1.449 . . . . 0.0 114.686 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.5 m -63.48 -30.45 71.57 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 110.823 -2.899 . . . . 0.0 113.691 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -174.58 167.07 39.21 Favored Glycine 0 N--CA 1.476 1.32 0 C-N-CA 124.501 1.048 . . . . 0.0 110.761 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -142.5 138.42 30.93 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.625 -0.788 . . . . 0.0 112.065 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.98 131.17 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 124.243 0.964 . . . . 0.0 112.277 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.5 p -79.26 134.79 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 113.417 -1.72 . . . . 0.0 110.803 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.13 136.73 37.84 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.022 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -87.22 153.34 42.85 Favored 'Cis proline' 0 CA--C 1.541 0.873 0 CA-C-O 122.451 0.938 . . . . 0.0 112.771 -1.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -131.42 150.61 52.08 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 113.468 -1.696 . . . . 0.0 108.949 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.7 t -101.92 169.71 8.6 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 123.776 0.673 . . . . 0.0 111.829 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.33 37.38 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.427 1.091 . . . . 0.0 112.187 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.22 -52.02 66.54 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.877 0.871 . . . . 0.0 112.31 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -57.09 -48.96 77.32 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.249 1.02 . . . . 0.0 110.081 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.1 tp -56.49 -52.82 63.3 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.919 1.387 . . . . 0.0 110.349 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -55.24 -48.97 73.17 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.497 1.119 . . . . 0.0 112.573 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -50.91 -46.68 60.8 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.978 0.911 . . . . 0.0 112.107 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -67.78 -52.38 37.85 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.233 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.2 mt -48.04 -51.36 24.53 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.68 0.792 . . . . 0.0 112.238 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -52.25 -55.92 18.1 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.846 1.258 . . . . 0.0 112.32 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -61.57 -39.71 92.13 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.193 1.397 . . . . 0.0 113.096 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 31.6 mm -57.56 -49.18 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.962 0.905 . . . . 0.0 111.045 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 . . . . . 0 N--CA 1.478 0.942 0 C-N-CA 123.357 0.663 . . . . 0.0 112.364 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.13 27.82 0.65 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 tt -77.91 132.59 37.99 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.618 0.767 . . . . 0.0 109.932 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -84.04 104.51 14.17 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 125.032 1.458 . . . . 0.0 112.762 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -104.28 142.29 34.81 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 113.081 -1.872 . . . . 0.0 114.165 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.71 112.14 18.91 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.447 173.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 83.1 t -84.26 94.0 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 t -98.21 85.8 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 123.832 1.777 . . . . 0.0 106.284 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -126.97 121.08 30.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 111.908 -2.405 . . . . 0.0 113.488 -175.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -60.04 -28.15 67.52 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 112.233 -2.258 . . . . 0.0 115.702 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -99.03 103.88 15.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.211 -1.404 . . . . 0.0 107.211 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -41.79 -42.82 2.76 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.975 1.31 . . . . 0.0 113.735 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -51.75 62.98 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.801 1.24 . . . . 0.0 111.41 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 13.4 ttt -64.27 -36.19 83.28 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.87 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -52.71 -50.27 63.7 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.633 1.173 . . . . 0.0 110.533 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -58.6 -51.08 71.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.771 1.228 . . . . 0.0 110.211 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.0 mt -55.11 -51.8 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.047 0.939 . . . . 0.0 112.162 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 t -57.09 -44.48 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 118.461 0.573 . . . . 0.0 110.992 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -50.26 71.73 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.205 1.402 . . . . 0.0 109.615 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -60.3 -41.59 93.73 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.6 1.16 . . . . 0.0 112.302 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.2 mt -56.87 -51.13 70.28 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.252 1.021 . . . . 0.0 110.685 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.8 mt -55.88 -45.71 78.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.018 0.927 . . . . 0.0 111.857 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -56.36 -46.73 79.89 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.678 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -59.83 -38.7 82.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.358 1.463 . . . . 0.0 112.602 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.8 mt -71.2 -13.17 61.83 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.507 1.123 . . . . 0.0 113.836 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.3 -1.17 32.95 Favored Glycine 0 CA--C 1.541 1.676 0 C-N-CA 124.808 1.194 . . . . 0.0 114.806 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -79.2 108.93 13.06 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 123.322 1.534 . . . . 0.0 114.385 -177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -67.87 -51.34 49.32 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 110.726 -2.943 . . . . 0.0 117.42 -176.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -97.45 97.24 8.93 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -174.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -133.21 118.39 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.971 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -106.28 161.49 14.5 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.31 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.89 119.37 21.07 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.61 165.45 16.44 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 113.299 -1.773 . . . . 0.0 109.597 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -109.69 -38.71 5.33 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 118.017 2.599 . . . . 0.0 118.017 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -128.67 167.62 16.94 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.867 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -44.24 -57.71 4.81 Favored Glycine 0 N--CA 1.478 1.477 0 C-N-CA 125.831 1.681 . . . . 0.0 114.529 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.7 t -55.3 -58.45 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.549 0.739 . . . . 0.0 111.702 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.38 -32.83 57.93 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.74 -50.57 64.31 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.51 1.124 . . . . 0.0 111.249 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.4 mt -58.55 -43.38 89.27 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.873 0.733 . . . . 0.0 110.679 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -54.3 -58.49 7.21 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.492 0.717 . . . . 0.0 110.641 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -61.69 -39.66 92.22 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 tp -54.66 -37.26 65.51 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.914 1.286 . . . . 0.0 113.669 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -68.63 -10.17 54.39 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.81 15.85 0.34 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.82 94.3 1.98 Allowed Glycine 0 N--CA 1.481 1.661 0 N-CA-C 115.443 0.937 . . . . 0.0 115.443 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 17.84 88.46 0.01 OUTLIER Glycine 0 CA--C 1.546 2.021 0 C-N-CA 128.683 3.039 . . . . 0.0 120.248 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -88.63 104.32 16.75 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.894 -1.153 . . . . 0.0 109.89 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.64 27.22 1.9 Allowed Glycine 0 N--CA 1.478 1.458 0 CA-C-N 114.039 -1.437 . . . . 0.0 114.919 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -178.71 131.52 0.12 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.49 1.516 . . . . 0.0 113.062 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.1 t -126.55 115.0 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 113.188 -1.823 . . . . 0.0 107.744 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 94.9 mt -106.2 101.17 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.6 t -120.0 133.42 55.55 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 117.623 2.453 . . . . 0.0 117.623 -175.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -73.67 136.39 43.8 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.185 -1.371 . . . . 0.0 111.059 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -56.73 -49.31 75.59 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.016 0.822 . . . . 0.0 111.324 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -92.29 101.38 13.86 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.11 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 30.0 mtm -133.85 125.28 18.19 Favored Pre-proline 0 N--CA 1.482 1.131 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.363 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -55.52 150.55 42.37 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 124.009 3.139 . . . . 0.0 111.635 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 70.47 -69.51 0.17 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.461 1.904 . . . . 0.0 111.5 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 18.6 ttp -127.04 109.21 11.65 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -64.94 167.29 7.93 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.327 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.56 -48.82 63.54 Favored Glycine 0 N--CA 1.48 1.619 0 C-N-CA 124.273 0.939 . . . . 0.0 114.602 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.45 -40.07 93.13 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.826 0.45 . . . . 0.0 112.183 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -63.37 -41.82 98.84 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.83 -49.83 75.89 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.949 0.9 . . . . 0.0 110.964 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 tt -46.75 -50.79 17.56 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.28 1.432 . . . . 0.0 109.274 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.69 -46.57 84.92 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.266 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 47.2 p -59.24 -25.31 63.92 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.094 0.958 . . . . 0.0 112.982 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.4 mt -84.02 -58.04 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -49.74 -46.77 50.74 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.875 1.67 . . . . 0.0 113.122 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.37 -18.79 57.05 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -82.57 94.82 7.58 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.736 -0.602 . . . . 0.0 110.178 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -21.18 -62.48 0.02 OUTLIER Glycine 0 CA--C 1.547 2.062 0 C-N-CA 126.88 2.181 . . . . 0.0 116.232 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.16 89.07 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.1 mtm -87.26 -34.67 18.85 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.4 t 2.57 -61.03 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 121.385 3.846 . . . . 0.0 121.385 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.24 25.03 0.62 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 118.855 2.909 . . . . 0.0 118.855 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.2 mt -83.05 118.94 73.25 Favored Pre-proline 0 N--CA 1.483 1.19 0 O-C-N 121.306 -0.872 . . . . 0.0 112.794 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.36 128.34 28.85 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 123.53 2.82 . . . . 0.0 113.675 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 t -116.57 119.89 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 113.13 -1.85 . . . . 0.0 112.645 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.2 tp -108.55 109.45 20.69 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.384 -1.734 . . . . 0.0 108.766 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 82.9 mmm -87.32 112.44 22.08 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 113.89 -1.505 . . . . 0.0 114.597 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.56 102.62 13.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 123.901 1.81 . . . . 0.0 108.319 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.9 t -115.71 130.26 56.79 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 111.593 -2.549 . . . . 0.0 109.426 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -46.42 -40.99 13.07 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -141.78 148.55 39.1 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.41 83.3 3.85 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 122.97 1.366 . . . . 0.0 107.718 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -92.68 112.36 24.29 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 111.011 -2.813 . . . . 0.0 109.139 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -34.57 -56.03 0.54 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 117.431 2.382 . . . . 0.0 117.431 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . 0.258 0.0 OUTLIER -55.58 -42.86 75.35 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 177.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -62.63 -47.59 83.07 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.672 1.189 . . . . 0.0 110.335 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.1 mm -58.08 -49.71 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.1 1.36 . . . . 0.0 112.537 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.7 mt -60.1 -50.66 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.284 0.634 . . . . 0.0 110.271 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.89 -46.43 81.92 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.777 0.831 . . . . 0.0 111.908 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.71 -56.24 19.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.427 1.491 . . . . 0.0 112.241 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.38 -48.35 82.13 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.071 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -56.53 -37.72 70.88 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.84 -16.45 55.41 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.65 12.65 7.15 Favored Glycine 0 CA--C 1.545 1.916 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.34 106.1 3.25 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.981 1.372 . . . . 0.0 111.36 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.9 m -56.89 -27.22 60.33 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 112.234 -2.257 . . . . 0.0 113.25 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -173.6 169.08 42.14 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.209 0.909 . . . . 0.0 111.406 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -142.62 142.27 32.08 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.643 -0.778 . . . . 0.0 110.948 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.61 131.47 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 124.742 1.276 . . . . 0.0 111.491 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -79.79 126.0 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 112.34 -2.209 . . . . 0.0 110.301 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -91.52 130.6 38.76 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 112.843 -1.98 . . . . 0.0 110.511 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.41 148.39 77.07 Favored 'Cis proline' 0 N--CA 1.484 0.937 0 O-C-N 123.233 1.123 . . . . 0.0 114.953 0.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -130.31 156.53 44.51 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.002 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 69.9 p -108.96 174.83 5.69 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.693 0.797 . . . . 0.0 111.013 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.99 -39.0 68.56 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.142 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.71 -47.39 72.5 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.039 0.936 . . . . 0.0 111.263 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.0 m -61.32 -46.0 92.12 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 50.6 tp -56.24 -50.67 70.65 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.925 1.29 . . . . 0.0 109.529 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -55.42 -48.77 73.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.293 1.037 . . . . 0.0 111.488 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -55.93 -46.89 78.37 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.361 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.3 mptp? -63.92 -42.18 97.45 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.114 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.8 mt -53.87 -51.02 64.97 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.219 0.608 . . . . 0.0 111.101 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -50.05 -52.29 35.59 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.333 1.053 . . . . 0.0 113.137 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -53.59 -47.05 70.52 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.478 1.511 . . . . 0.0 112.386 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 57.8 mt -57.46 -51.52 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.872 1.269 . . . . 0.0 111.925 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 179.244 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.9 mttt . . . . . 0 CA--C 1.544 0.745 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -100.07 41.1 1.18 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 123.206 1.479 . . . . 0.0 113.791 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 tt -86.25 124.72 32.94 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.277 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -75.96 107.92 8.5 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 125.095 1.497 . . . . 0.0 113.393 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -102.88 132.83 48.82 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 112.402 -2.181 . . . . 0.0 111.8 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.46 102.7 11.77 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.069 -1.053 . . . . 0.0 109.288 173.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.14 98.72 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 113.481 -1.69 . . . . 0.0 106.777 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.3 t -108.24 60.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 112.241 -2.254 . . . . 0.0 107.138 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -109.56 90.38 3.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 113.359 -1.746 . . . . 0.0 108.638 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -13.58 -42.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 121.58 3.919 . . . . 0.0 121.58 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.532 ' C ' ' H ' ' A' ' 16' ' ' THR . 2.6 t80 -87.57 109.6 19.76 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.487 ' HG ' ' CZ ' ' A' ' 18' ' ' ARG . 3.3 t -65.98 27.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 124.167 1.937 . . . . 0.0 115.697 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -123.72 -58.52 1.58 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.062 2.545 . . . . 0.0 105.448 177.031 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -35.82 75.96 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.696 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.487 ' CZ ' ' HG ' ' A' ' 15' ' ' SER . 8.8 ttp180 -53.76 -50.93 64.94 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.521 1.529 . . . . 0.0 112.139 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.617 ' CZ ' HD22 ' A' ' 23' ' ' ASN . 3.0 tmt_? -65.24 -38.37 90.15 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.809 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 71.6 mt -57.73 -46.3 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.7 t -58.26 -42.52 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.462 0.705 . . . . 0.0 110.049 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.437 ' NH2' ' HE ' ' A' ' 19' ' ' ARG . 46.9 ttp180 -53.01 -52.57 57.97 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.187 0.995 . . . . 0.0 110.575 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.617 HD22 ' CZ ' ' A' ' 19' ' ' ARG . 80.9 m-20 -57.71 -41.02 80.88 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.355 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -59.62 -51.44 69.79 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.135 0.974 . . . . 0.0 110.774 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.9 mt -56.56 -44.51 81.01 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.015 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -58.59 -42.26 87.69 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.981 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -59.78 -38.55 82.16 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.627 1.171 . . . . 0.0 110.48 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 mp -74.94 -11.9 60.22 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.29 2.236 . . . . 0.0 115.17 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.82 -0.61 41.91 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.035 1.302 . . . . 0.0 114.648 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -89.13 97.95 11.49 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 123.266 1.508 . . . . 0.0 112.459 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -72.46 -37.33 68.55 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 110.858 -2.883 . . . . 0.0 116.056 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -95.91 96.4 8.89 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.749 1.262 . . . . 0.0 113.895 -173.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.2 t -129.66 131.96 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.407 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -117.72 154.8 31.07 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -126.96 120.19 28.52 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.31 152.99 39.54 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 113.611 -1.631 . . . . 0.0 109.863 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -78.37 -66.13 0.89 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -129.44 -176.61 3.95 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 117.972 -1.013 . . . . 0.0 112.16 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -45.39 -53.55 7.98 Favored Glycine 0 N--CA 1.482 1.766 0 O-C-N 125.048 1.467 . . . . 0.0 114.112 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -57.32 -57.87 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.348 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -55.52 -34.65 64.84 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.26 -53.56 56.85 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.753 1.221 . . . . 0.0 110.385 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.4 mt -60.27 -41.87 94.2 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.928 0.891 . . . . 0.0 111.313 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -53.35 -52.14 60.18 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.811 0.844 . . . . 0.0 111.233 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -70.36 -41.2 73.43 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 124.212 0.945 . . . . 0.0 113.141 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.9 mt -54.42 -36.42 63.98 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -52.33 -26.46 12.29 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.4 -19.16 64.44 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.44 -170.42 52.17 Favored Glycine 0 N--CA 1.474 1.224 0 C-N-CA 124.427 1.013 . . . . 0.0 111.113 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.75 -29.7 1.52 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 115.504 0.962 . . . . 0.0 115.504 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -67.85 107.99 2.83 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.52 -22.86 52.74 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-N 112.587 -2.097 . . . . 0.0 110.028 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -133.35 141.65 48.02 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -174.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.5 t -127.16 110.68 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 113.765 -1.562 . . . . 0.0 107.343 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.1 tt -110.22 93.3 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 124.094 1.902 . . . . 0.0 106.607 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.1 t -117.27 147.76 42.27 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 111.887 -2.415 . . . . 0.0 115.433 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -79.63 144.29 33.92 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.733 -1.122 . . . . 0.0 112.834 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 20.3 t-105 -61.23 -47.2 87.16 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.077 177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -95.59 103.38 15.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.673 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 54.0 mtm -134.99 134.24 21.58 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-N 113.243 -1.799 . . . . 0.0 110.531 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -60.42 143.62 99.48 Favored 'Trans proline' 0 N--CA 1.482 0.827 0 C-N-CA 123.186 2.59 . . . . 0.0 112.089 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 m120 67.89 -69.81 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.902 1.681 . . . . 0.0 113.763 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.1 ttm -114.86 98.75 7.01 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -61.56 165.87 4.59 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 112.605 -2.088 . . . . 0.0 111.932 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.44 -52.08 29.73 Favored Glycine 0 N--CA 1.476 1.353 0 C-N-CA 124.692 1.139 . . . . 0.0 115.081 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 42.2 tp -58.84 -38.46 78.74 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.225 1.01 . . . . 0.0 113.222 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -72.44 -36.27 68.51 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.57 0.748 . . . . 0.0 111.014 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -59.03 -38.22 78.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.804 0.841 . . . . 0.0 111.016 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.1 mp -50.92 -52.24 44.1 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.76 1.224 . . . . 0.0 109.832 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -56.38 -48.76 76.21 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.042 -1.435 . . . . 0.0 112.505 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.3 p -58.17 -33.42 69.22 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.8 mt -80.8 -57.35 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -49.23 -45.82 45.09 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.344 1.858 . . . . 0.0 114.11 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.74 -25.52 61.23 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -81.34 93.9 6.65 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.187 0.595 . . . . 0.0 109.514 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -25.71 -58.76 0.07 OUTLIER Glycine 0 CA--C 1.542 1.753 0 C-N-CA 127.078 2.275 . . . . 0.0 116.756 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.77 -38.91 83.12 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 91.3 mtp -89.52 -45.38 9.45 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.412 1.485 . . . . 0.0 114.608 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.2 t 8.82 -78.21 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 120.091 3.367 . . . . 0.0 120.091 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.03 29.25 0.13 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 118.655 2.835 . . . . 0.0 118.655 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.4 mt -76.62 133.81 70.12 Favored Pre-proline 0 N--CA 1.479 0.981 0 O-C-N 121.184 -0.947 . . . . 0.0 111.876 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -56.81 114.23 1.83 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.816 2.344 . . . . 0.0 112.806 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 37.0 t -109.94 110.97 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 111.704 -2.498 . . . . 0.0 109.245 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.1 tp -106.56 104.08 13.68 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 112.805 -1.998 . . . . 0.0 109.363 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.5 mmt -78.57 118.13 20.4 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 113.053 -1.885 . . . . 0.0 112.678 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 t -91.18 96.72 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.7 p -94.38 114.97 27.11 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.256 -1.793 . . . . 0.0 112.886 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.05 -22.01 5.37 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -166.74 118.79 0.97 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.61 92.96 4.77 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.578 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -101.68 132.19 47.51 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.395 177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -41.17 -46.78 3.14 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.734 1.213 . . . . 0.0 114.134 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -52.74 -55.32 23.62 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.708 1.603 . . . . 0.0 110.973 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -58.91 -42.91 90.73 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.352 1.461 . . . . 0.0 111.241 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.7 mm -60.39 -49.09 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.52 1.128 . . . . 0.0 111.547 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 37.4 mt -57.73 -50.95 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.81 -45.84 74.43 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.087 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.42 -54.89 41.71 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.693 1.197 . . . . 0.0 112.418 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.38 -41.99 81.27 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.334 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -66.14 -40.04 90.31 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.73 0.55 52.49 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 117.674 2.472 . . . . 0.0 117.674 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.34 21.6 6.85 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 117.702 1.841 . . . . 0.0 117.702 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -82.62 110.32 17.58 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.416 1.108 . . . . 0.0 112.029 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.9 m -59.99 -30.26 69.01 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 113.219 -1.81 . . . . 0.0 113.519 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.25 173.45 46.28 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.198 1.38 . . . . 0.0 110.055 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -148.83 139.08 22.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.052 -0.574 . . . . 0.0 112.527 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.9 p -115.2 117.93 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 124.2 0.937 . . . . 0.0 109.505 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.0 p -71.33 109.45 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 113.076 -1.874 . . . . 0.0 114.261 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -83.13 130.11 58.43 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 111.079 -2.782 . . . . 0.0 107.681 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.6 133.34 26.6 Favored 'Cis proline' 0 CA--C 1.54 0.78 0 O-C-N 123.962 1.506 . . . . 0.0 114.854 0.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -130.58 157.25 43.23 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 112.653 -2.067 . . . . 0.0 109.01 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.2 t -116.61 176.02 5.3 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.063 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.45 -41.78 61.08 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.203 1.001 . . . . 0.0 111.82 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.99 -50.07 73.55 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.568 0.747 . . . . 0.0 112.819 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.32 -45.04 94.81 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.623 1.169 . . . . 0.0 109.982 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 58.1 tp -56.99 -50.54 72.38 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.305 1.042 . . . . 0.0 109.888 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -58.13 -47.65 82.66 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.61 0.764 . . . . 0.0 111.376 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -51.22 -43.36 61.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.484 0.714 . . . . 0.0 112.278 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -72.78 -41.7 64.74 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.187 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.1 mt -56.96 -46.31 82.23 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.398 0.679 . . . . 0.0 111.157 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -52.14 -48.18 65.01 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.089 1.356 . . . . 0.0 111.935 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -52.93 -48.81 67.02 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.129 1.372 . . . . 0.0 111.595 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.1 mt -60.47 -49.43 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.267 1.027 . . . . 0.0 111.68 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 . . . . . 0 N--CA 1.493 1.679 0 C-N-CA 123.686 0.794 . . . . 0.0 112.064 177.991 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.27 50.93 1.82 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.756 1.265 . . . . 0.0 114.042 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.1 tt -109.76 122.96 48.69 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.768 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -81.76 109.28 16.01 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.108 0.956 . . . . 0.0 112.495 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -96.24 139.24 32.67 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 111.802 -2.454 . . . . 0.0 111.783 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -118.19 104.87 11.22 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.437 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.2 t -83.7 111.19 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 112.095 -2.321 . . . . 0.0 108.775 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -114.02 91.13 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.544 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -137.19 115.27 11.59 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.745 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -80.12 77.12 6.85 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.966 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.5 t80 172.25 115.09 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 111.816 -2.447 . . . . 0.0 106.127 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.2 t -42.25 -55.67 3.22 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.228 1.011 . . . . 0.0 113.338 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.69 -47.5 85.38 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.708 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -45.55 92.59 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.165 0.586 . . . . 0.0 111.829 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -59.26 -45.2 91.83 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.759 1.224 . . . . 0.0 110.472 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -43.89 96.01 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.121 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.0 mt -56.17 -57.26 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-O 118.589 -0.719 . . . . 0.0 111.084 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 t -54.1 -44.53 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 123.512 0.507 . . . . 0.0 111.19 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -55.92 -53.45 56.73 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.065 1.346 . . . . 0.0 111.735 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -62.87 -38.8 92.3 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.127 0.971 . . . . 0.0 113.331 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.7 mt -56.92 -48.88 77.22 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.175 0.99 . . . . 0.0 111.114 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.9 mt -60.27 -44.81 94.99 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.783 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -56.44 -45.13 80.95 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.0 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -60.32 -35.99 76.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.479 1.512 . . . . 0.0 113.032 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.0 mt -74.44 -2.03 23.71 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.306 1.443 . . . . 0.0 114.372 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.8 -9.89 60.38 Favored Glycine 0 CA--C 1.542 1.76 0 C-N-CA 124.566 1.079 . . . . 0.0 112.752 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -93.15 76.71 4.63 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 123.126 1.441 . . . . 0.0 110.078 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -66.29 -24.04 66.49 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.593 ' ND2' ' H ' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -78.7 80.83 5.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.653 1.581 . . . . 0.0 112.062 -178.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.5 130.35 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.929 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -120.61 160.91 22.29 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.57 147.87 52.36 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 120.398 3.481 . . . . 0.0 120.398 -176.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.54 163.88 31.64 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 110.94 -2.845 . . . . 0.0 108.307 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -112.04 -35.51 5.64 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -129.07 158.57 38.55 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.875 0.735 . . . . 0.0 111.148 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -39.27 -52.89 2.79 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 125.528 1.767 . . . . 0.0 116.064 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.3 t -59.77 -50.12 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 118.481 -0.771 . . . . 0.0 112.582 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -56.04 -44.05 78.41 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.045 0.926 . . . . 0.0 109.672 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.27 -52.15 65.92 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.398 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.4 mt -51.08 -51.25 55.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.406 1.066 . . . . 0.0 111.022 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -53.29 -54.79 31.28 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.447 1.099 . . . . 0.0 112.475 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -57.6 -48.9 78.12 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 113.808 -1.542 . . . . 0.0 113.043 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 31.2 mt -59.79 -41.74 91.83 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.536 1.134 . . . . 0.0 112.479 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -57.24 -25.43 59.12 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.16 -19.77 63.18 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.41 -166.31 19.68 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.854 1.216 . . . . 0.0 111.434 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.38 -41.43 1.84 Allowed Glycine 0 N--CA 1.483 1.775 0 C-N-CA 124.3 0.952 . . . . 0.0 115.241 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -70.91 136.1 48.36 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.69 16.51 7.87 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 112.656 -2.065 . . . . 0.0 113.397 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -172.41 140.08 1.06 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.367 1.067 . . . . 0.0 111.975 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 t -122.37 114.1 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.045 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.7 mt -108.44 98.96 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.0 t -120.87 137.09 54.75 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -73.18 133.82 44.17 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 112.348 -2.205 . . . . 0.0 110.197 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -59.26 -49.77 76.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.027 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -88.78 99.86 12.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.391 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 8.7 mtm -141.95 121.77 8.17 Favored Pre-proline 0 N--CA 1.478 0.931 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.106 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -62.28 164.42 17.57 Favored 'Trans proline' 0 N--CA 1.479 0.627 0 C-N-CA 123.208 2.605 . . . . 0.0 109.006 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 70.82 -79.68 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.09 0.956 . . . . 0.0 109.633 -176.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.5 ttm -130.36 107.31 9.16 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.854 0.862 . . . . 0.0 108.948 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -62.85 162.08 11.65 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.029 -1.441 . . . . 0.0 112.895 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.21 -53.41 15.41 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 124.975 1.274 . . . . 0.0 114.793 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.67 -44.98 93.38 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.172 0.589 . . . . 0.0 111.887 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.71 -40.81 98.34 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -44.52 88.7 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.722 1.209 . . . . 0.0 110.328 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tp -58.97 -47.09 86.38 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.515 1.126 . . . . 0.0 111.012 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.13 -43.41 91.97 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.536 0.735 . . . . 0.0 112.76 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.268 4.7 p -64.29 -33.93 76.96 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.114 0.966 . . . . 0.0 111.811 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.5 mt -69.32 -56.49 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.0 mmt-85 -53.53 -43.37 68.32 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.476 1.51 . . . . 0.0 113.065 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.77 -30.13 65.22 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -87.84 95.56 10.14 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.136 0.574 . . . . 0.0 112.088 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -13.65 -72.51 0.01 OUTLIER Glycine 0 N--CA 1.489 2.169 0 C-N-CA 127.821 2.629 . . . . 0.0 117.478 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.46 -40.54 68.51 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 50.9 mtm -88.53 -14.16 38.4 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.2 m -48.12 -25.14 1.34 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 117.365 2.358 . . . . 0.0 117.365 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.98 -7.81 50.99 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.2 111.56 9.71 Favored Pre-proline 0 N--CA 1.485 1.283 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -51.96 133.9 47.4 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 123.181 2.587 . . . . 0.0 113.921 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.2 t -120.53 126.82 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 122.812 1.292 . . . . 0.0 113.304 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -113.01 116.89 30.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 111.656 -2.52 . . . . 0.0 107.389 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 28.6 mmt -95.39 109.89 22.0 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 122.734 1.254 . . . . 0.0 113.437 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.31 96.02 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 123.178 1.466 . . . . 0.0 107.428 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -108.17 141.29 40.12 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 112.357 -2.201 . . . . 0.0 114.241 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.3 -29.59 70.88 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.404 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -134.1 129.33 35.81 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.299 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -94.1 55.83 2.13 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 123.997 1.856 . . . . 0.0 108.489 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -98.81 139.91 33.78 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 112.887 -1.961 . . . . 0.0 107.542 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -34.52 -48.47 0.36 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -51.62 -49.83 61.47 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.736 0.647 . . . . 0.0 112.556 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -64.06 -47.81 78.67 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.504 1.122 . . . . 0.0 111.507 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 68.9 mt -57.94 -57.26 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.809 1.244 . . . . 0.0 111.83 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.9 mt -54.56 -52.75 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.878 0.871 . . . . 0.0 110.307 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.21 -52.71 58.01 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.151 0.981 . . . . 0.0 112.194 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.15 -52.58 64.75 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.677 1.191 . . . . 0.0 113.095 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.36 -48.84 80.11 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.64 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -60.07 -36.19 76.8 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.12 -6.58 55.15 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.01 4.14 27.75 Favored Glycine 0 CA--C 1.548 2.148 0 N-CA-C 116.151 1.22 . . . . 0.0 116.151 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.02 119.73 10.67 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.906 1.353 . . . . 0.0 112.099 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.2 m -64.12 -36.32 83.64 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 112.362 -2.199 . . . . 0.0 112.448 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -169.79 178.67 42.61 Favored Glycine 0 CA--C 1.541 1.659 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.749 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -152.96 143.01 22.31 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.4 p -122.39 125.41 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 124.623 1.202 . . . . 0.0 109.972 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.1 p -85.54 122.64 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 113.937 -1.483 . . . . 0.0 111.073 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -83.83 138.12 40.63 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 113.764 -1.562 . . . . 0.0 113.249 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.41 143.01 75.0 Favored 'Cis proline' 0 CA--C 1.546 1.1 0 O-C-N 123.072 1.038 . . . . 0.0 114.787 0.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -134.91 151.12 50.6 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 112.31 -2.223 . . . . 0.0 108.642 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.2 t -107.16 175.61 5.44 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.189 0.931 . . . . 0.0 109.928 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.64 -42.46 56.34 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.936 0.894 . . . . 0.0 111.993 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.3 -44.45 95.0 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.294 1.038 . . . . 0.0 112.886 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.24 -48.66 77.28 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.466 0.707 . . . . 0.0 109.333 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.3 tp -55.94 -46.96 78.35 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.935 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -58.36 -50.9 72.0 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.891 0.876 . . . . 0.0 110.975 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -49.19 -45.25 43.87 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.719 0.808 . . . . 0.0 112.618 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -66.24 -48.09 71.66 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.741 1.216 . . . . 0.0 111.807 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.61 -46.73 83.72 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.064 0.946 . . . . 0.0 111.902 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -48.14 -53.48 16.56 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.478 1.511 . . . . 0.0 112.079 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.1 tttt -51.68 -47.91 63.68 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 113.841 -1.527 . . . . 0.0 112.161 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.3 mm -58.49 -57.47 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.693 1.197 . . . . 0.0 109.644 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 . . . . . 0 N--CA 1.475 0.799 0 C-N-CA 124.597 1.159 . . . . 0.0 113.334 -179.758 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -86.5 66.03 9.31 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 123.42 1.581 . . . . 0.0 110.911 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.2 tt -102.38 135.87 43.23 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.049 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -77.87 110.29 12.63 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -110.07 142.65 41.24 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.824 1.649 . . . . 0.0 112.698 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.89 110.34 17.63 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 122.22 1.01 . . . . 0.0 109.932 173.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.7 t -85.92 107.87 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 113.862 -1.517 . . . . 0.0 107.495 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.74 94.36 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.745 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -135.27 131.92 37.14 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.702 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -60.63 -25.01 65.97 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -101.07 105.34 16.51 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 44.3 p -41.21 -45.61 2.9 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -52.79 61.95 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.404 1.082 . . . . 0.0 112.188 176.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -39.05 87.74 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.561 0.344 . . . . 0.0 110.222 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -55.45 -51.58 66.44 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.495 1.118 . . . . 0.0 110.683 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.629 ' CZ ' HD22 ' A' ' 23' ' ' ASN . 10.3 ttt180 -63.92 -36.53 84.25 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.3 mm -55.73 -47.5 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 122.625 0.37 . . . . 0.0 110.474 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -60.1 -44.44 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 122.849 0.459 . . . . 0.0 110.092 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.492 ' NH1' HH21 ' A' ' 19' ' ' ARG . 0.0 OUTLIER -54.19 -50.03 67.98 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.457 1.103 . . . . 0.0 110.575 176.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.629 HD22 ' CZ ' ' A' ' 19' ' ' ARG . 23.2 m120 -59.69 -44.65 93.57 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.495 0.718 . . . . 0.0 111.814 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.7 mt -56.06 -52.62 63.61 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.293 1.037 . . . . 0.0 111.442 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 73.9 mt -54.91 -45.51 74.74 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.759 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -56.88 -46.39 81.91 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.285 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -59.5 -40.61 87.6 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.879 1.672 . . . . 0.0 111.746 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.4 mp -70.8 -16.14 62.71 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.892 1.677 . . . . 0.0 114.755 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.55 -5.81 33.33 Favored Glycine 0 CA--C 1.543 1.832 0 C-N-CA 125.342 1.448 . . . . 0.0 114.05 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -92.94 67.66 4.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 123.506 1.622 . . . . 0.0 111.022 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -69.48 -14.09 62.69 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 116.974 2.213 . . . . 0.0 116.974 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -92.84 78.2 4.76 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 122.924 1.345 . . . . 0.0 108.987 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 p -126.87 130.87 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 113.757 -1.565 . . . . 0.0 114.189 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -106.64 156.29 18.77 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 113.615 -1.629 . . . . 0.0 107.885 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -123.85 121.92 36.65 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.06 157.47 42.28 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 113.547 -1.661 . . . . 0.0 108.433 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -105.24 -40.63 5.78 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -130.71 162.3 29.75 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.289 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -42.63 -50.58 5.78 Favored Glycine 0 N--CA 1.484 1.855 0 O-C-N 125.531 1.769 . . . . 0.0 115.943 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.4 t -58.69 -53.58 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 119.091 -0.48 . . . . 0.0 111.541 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.51 -37.14 74.96 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.471 0.709 . . . . 0.0 110.995 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.45 -54.08 48.08 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.044 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.46 -38.13 86.1 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 123.862 0.727 . . . . 0.0 112.853 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -57.55 -50.33 73.45 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.126 0.891 . . . . 0.0 111.099 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -67.67 -42.97 81.3 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.828 1.251 . . . . 0.0 112.63 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.87 -45.09 93.58 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.535 1.934 . . . . 0.0 114.563 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -57.8 -14.62 6.23 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.67 -23.64 66.17 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.902 0.881 . . . . 0.0 112.337 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.15 -178.51 43.4 Favored Glycine 0 N--CA 1.48 1.609 0 C-N-CA 125.107 1.337 . . . . 0.0 113.757 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.4 -26.12 3.58 Favored Glycine 0 N--CA 1.482 1.705 0 CA-C-N 113.662 -1.269 . . . . 0.0 116.154 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -64.51 111.03 2.51 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.73 12.57 65.94 Favored Glycine 0 CA--C 1.541 1.665 0 O-C-N 125.103 1.502 . . . . 0.0 112.472 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -168.73 141.06 2.75 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.016 0.926 . . . . 0.0 112.071 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.6 t -129.39 122.58 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.543 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.8 mt -111.68 102.53 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.2 t -122.27 133.84 54.68 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 116.909 2.188 . . . . 0.0 116.909 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -73.82 127.99 34.31 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 111.335 -2.666 . . . . 0.0 110.767 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -56.04 -43.57 77.96 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.778 1.231 . . . . 0.0 110.73 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -91.13 94.49 9.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.202 1.401 . . . . 0.0 109.062 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 15.2 mtm -141.24 121.87 8.72 Favored Pre-proline 0 N--CA 1.476 0.83 0 CA-C-N 114.179 -1.373 . . . . 0.0 113.516 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -55.25 158.74 11.48 Favored 'Trans proline' 0 N--CA 1.479 0.652 0 C-N-CA 123.139 2.56 . . . . 0.0 110.945 175.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.349 21.3 p30 66.84 -72.36 0.09 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.226 2.21 . . . . 0.0 112.024 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 43.4 ttp -128.86 108.18 10.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.508 0.723 . . . . 0.0 109.728 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -62.43 164.6 7.12 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.474 -1.694 . . . . 0.0 113.033 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.78 -54.76 23.7 Favored Glycine 0 N--CA 1.479 1.555 0 C-N-CA 125.132 1.349 . . . . 0.0 114.24 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.3 tp -57.01 -40.95 77.61 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.7 -40.43 84.32 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.553 0.341 . . . . 0.0 111.562 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.01 -41.03 95.75 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.778 1.231 . . . . 0.0 110.784 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tt -51.76 -51.2 58.04 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.286 1.434 . . . . 0.0 108.718 176.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -59.41 -43.19 93.07 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.429 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.7 p -69.25 -0.61 6.37 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.5 mt -109.64 -62.02 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.2 -44.52 61.61 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.16 1.784 . . . . 0.0 113.83 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.83 -3.35 49.1 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -85.69 99.85 11.59 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -10.25 -77.87 0.01 OUTLIER Glycine 0 N--CA 1.488 2.165 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.96 -41.23 99.46 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 76.6 mtp -85.93 -6.71 59.02 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.6 t -34.06 -61.99 0.34 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 118.972 2.953 . . . . 0.0 118.972 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.41 18.05 0.45 Allowed 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 119.248 3.055 . . . . 0.0 119.248 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 69.9 mt -84.9 120.14 73.4 Favored Pre-proline 0 CA--C 1.543 0.708 0 O-C-N 121.215 -0.928 . . . . 0.0 112.689 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.22 132.96 45.97 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.812 3.008 . . . . 0.0 113.901 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.3 t -118.96 115.58 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 112.61 -2.086 . . . . 0.0 112.314 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.5 tp -107.43 105.59 15.58 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 113.858 -1.519 . . . . 0.0 107.635 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.5 mmt -79.35 138.19 37.6 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 113.284 -1.78 . . . . 0.0 111.708 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.7 t -112.43 104.66 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 p -102.47 152.56 20.98 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.439 -1.255 . . . . 0.0 113.587 -175.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.62 -40.12 95.96 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.361 -1.745 . . . . 0.0 111.705 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -159.95 148.36 17.18 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.693 1.597 . . . . 0.0 112.211 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.48 94.68 8.59 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.149 0.906 . . . . 0.0 109.813 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -125.38 130.36 51.76 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.418 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -25.95 -61.11 0.07 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 116.42 2.008 . . . . 0.0 116.42 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -57.19 -46.17 83.08 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -68.62 -37.41 79.72 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 91.5 mt -59.41 -50.02 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.386 1.075 . . . . 0.0 109.051 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.4 mm -55.67 -55.46 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.468 1.107 . . . . 0.0 110.241 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.54 -49.3 62.24 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.237 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.96 -57.28 13.52 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.451 1.1 . . . . 0.0 113.646 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.78 -51.03 71.25 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.244 1.017 . . . . 0.0 111.995 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.19 -30.23 70.92 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.12 -13.19 58.93 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.61 -3.21 12.18 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 116.895 1.518 . . . . 0.0 116.895 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.78 114.09 2.14 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 118.918 1.359 . . . . 0.0 112.878 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.0 m -63.56 -26.79 68.86 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 112.007 -2.36 . . . . 0.0 113.76 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.7 166.25 35.89 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.742 1.163 . . . . 0.0 110.353 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -142.25 137.63 30.83 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 p -121.51 131.95 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.89 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.98 139.63 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.598 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.08 140.42 28.98 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.617 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.62 135.86 20.28 Favored 'Cis proline' 0 C--N 1.352 0.715 0 O-C-N 122.47 0.721 . . . . 0.0 110.983 -2.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -113.43 154.71 26.53 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.293 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.8 t -110.27 178.24 4.45 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.15 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.27 -44.19 61.76 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.664 1.185 . . . . 0.0 111.893 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.24 -51.72 67.78 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.245 1.018 . . . . 0.0 111.888 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.44 -47.21 82.39 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.191 0.996 . . . . 0.0 110.389 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 47.7 tp -56.58 -53.51 56.69 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.11 1.364 . . . . 0.0 109.506 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -53.89 -47.19 71.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.77 1.228 . . . . 0.0 112.354 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.38 -50.25 70.21 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -62.54 -43.15 99.52 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 61.7 mt -52.84 -46.23 67.71 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -55.4 -51.64 66.18 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.584 0.754 . . . . 0.0 112.843 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -56.5 -43.36 79.64 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.35 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 62.2 mt -58.44 -53.56 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.038 0.935 . . . . 0.0 110.58 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 N--CA 1.479 0.992 0 C-N-CA 123.736 0.814 . . . . 0.0 113.144 179.292 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -66.77 9.03 0.2 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.821 2.048 . . . . 0.0 115.574 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.52 97.04 3.61 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -175.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -79.53 111.27 15.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.724 -1.58 . . . . 0.0 111.692 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -92.26 136.58 33.08 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 112.141 -2.3 . . . . 0.0 112.107 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.16 104.04 12.52 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 118.698 -1.201 . . . . 0.0 109.145 173.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.2 t -80.29 97.54 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 112.968 -1.923 . . . . 0.0 105.848 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.0 t -101.04 84.6 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 112.702 -2.044 . . . . 0.0 107.808 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -133.94 121.14 21.25 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.105 -1.861 . . . . 0.0 111.752 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -54.9 -28.23 49.02 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 112.264 -2.244 . . . . 0.0 115.55 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -97.34 119.71 36.37 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.559 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.3 p -50.39 -50.93 50.24 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 125.028 1.455 . . . . 0.0 112.929 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -43.78 98.35 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.188 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 13.2 tpt -62.64 -40.89 98.45 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -56.14 -49.23 74.52 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.695 0.798 . . . . 0.0 111.578 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -60.18 -43.3 95.96 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.523 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.2 mt -56.18 -50.43 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.097 0.559 . . . . 0.0 110.583 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.85 -43.13 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.218 0.607 . . . . 0.0 111.524 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -51.99 -52.0 53.44 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.531 0.732 . . . . 0.0 111.273 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -57.72 -40.84 80.51 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.737 0.815 . . . . 0.0 112.839 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.03 -52.01 67.18 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.445 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.7 mt -58.54 -42.11 87.08 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.083 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -59.1 -47.49 85.06 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.353 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -54.98 -39.44 68.99 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 125.327 1.451 . . . . 0.0 112.293 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.4 mt -73.21 -17.28 61.37 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.21 17.72 19.32 Favored Glycine 0 CA--C 1.543 1.807 0 C-N-CA 124.567 1.08 . . . . 0.0 113.349 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -110.14 89.68 3.09 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 122.943 1.354 . . . . 0.0 112.126 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -68.54 -29.11 67.61 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 112.557 -2.11 . . . . 0.0 115.058 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.24 91.32 7.7 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 123.049 1.405 . . . . 0.0 113.481 -175.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.0 t -133.89 125.89 49.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 112.884 -1.962 . . . . 0.0 110.867 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -110.26 153.59 24.62 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -125.92 124.8 41.62 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.49 153.87 36.06 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.552 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -4.0 19.85 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -165.84 157.4 14.06 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.452 0.701 . . . . 0.0 110.64 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -39.9 -53.78 3.09 Favored Glycine 0 CA--C 1.544 1.856 0 O-C-N 125.04 1.463 . . . . 0.0 115.517 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.01 -52.84 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 122.414 0.286 . . . . 0.0 111.439 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -55.71 -38.76 70.15 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.568 1.147 . . . . 0.0 110.16 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.98 -58.57 7.39 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.233 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.17 -39.51 56.56 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.985 0.803 . . . . 0.0 112.531 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -63.69 -64.2 0.96 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.561 1.144 . . . . 0.0 109.92 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -55.38 -37.65 67.84 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 126.91 2.084 . . . . 0.0 115.319 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.9 tp -54.47 -25.86 27.8 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -90.94 -17.79 25.8 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.95 69.54 7.56 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.73 81.47 1.52 Allowed Glycine 0 CA--C 1.541 1.665 0 N-CA-C 118.496 2.158 . . . . 0.0 118.496 174.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 18.81 76.99 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 C-N-CA 128.012 2.72 . . . . 0.0 119.366 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -83.94 127.69 34.03 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.239 -0.981 . . . . 0.0 110.301 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.78 8.21 50.45 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.201 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -166.64 144.5 5.15 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.85 110.87 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 175.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.8 tt -115.08 98.05 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 t -120.73 142.07 49.86 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 120.485 3.513 . . . . 0.0 120.485 -174.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -72.4 129.2 37.81 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 113.039 -1.892 . . . . 0.0 109.879 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 37.7 t-105 -53.71 -38.73 64.57 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.742 0.817 . . . . 0.0 112.544 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -105.6 108.46 19.99 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.584 0.754 . . . . 0.0 110.139 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 50.7 mtm -139.71 126.39 12.41 Favored Pre-proline 0 N--CA 1.478 0.966 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.78 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.76 118.48 5.41 Favored 'Trans proline' 0 N--CA 1.482 0.829 0 C-N-CA 124.048 3.165 . . . . 0.0 111.837 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 99.17 -76.25 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 129.224 3.01 . . . . 0.0 110.119 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.8 ttm -112.28 93.92 4.68 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.253 0.549 . . . . 0.0 109.744 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -59.74 162.28 5.42 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 112.133 -2.303 . . . . 0.0 112.068 178.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.88 -53.63 25.59 Favored Glycine 0 N--CA 1.477 1.433 0 C-N-CA 124.516 1.055 . . . . 0.0 114.296 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.8 tp -59.64 -37.87 79.85 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -70.69 -40.96 72.6 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.157 0.583 . . . . 0.0 110.369 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.9 tp -56.62 -44.86 81.6 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.111 0.964 . . . . 0.0 110.188 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 tt -48.79 -51.22 30.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.212 1.405 . . . . 0.0 109.363 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.37 -45.86 92.04 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.651 1.18 . . . . 0.0 112.538 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 p -61.9 -15.36 42.26 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.6 mt -96.31 -65.46 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -53.17 -43.35 67.0 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.163 2.185 . . . . 0.0 115.195 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.49 -10.41 49.1 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -89.4 112.32 23.41 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -42.79 -18.64 0.05 OUTLIER Glycine 0 CA--C 1.547 2.092 0 C-N-CA 127.601 2.524 . . . . 0.0 118.978 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.27 -50.77 3.84 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.64 0.776 . . . . 0.0 111.576 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 88.9 mmm -70.08 -25.15 63.39 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 118.718 2.859 . . . . 0.0 118.718 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.6 t -58.64 39.19 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 118.255 2.687 . . . . 0.0 118.255 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -123.55 -37.05 2.69 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.77 2.028 . . . . 0.0 111.073 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.1 mt -66.1 117.6 44.39 Favored Pre-proline 0 N--CA 1.472 0.657 0 C-N-CA 126.158 1.783 . . . . 0.0 115.299 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.35 137.91 63.1 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.631 2.221 . . . . 0.0 111.121 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.94 110.26 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 113.812 -1.54 . . . . 0.0 112.668 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.1 tp -106.7 107.43 18.44 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.142 -1.845 . . . . 0.0 109.46 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.8 mmt -81.71 111.56 18.08 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 113.581 -1.645 . . . . 0.0 113.438 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.0 97.36 7.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 177.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.5 t -107.14 134.57 50.06 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 112.032 -2.349 . . . . 0.0 115.646 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.21 -8.28 56.16 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 113.151 -1.841 . . . . 0.0 112.639 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -144.82 95.92 2.77 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.124 0.964 . . . . 0.0 113.09 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.03 64.17 8.31 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 123.429 1.585 . . . . 0.0 109.766 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -116.21 150.24 37.84 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.963 -1.926 . . . . 0.0 111.123 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -34.48 -51.95 0.48 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 115.329 1.604 . . . . 0.0 115.329 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -52.32 -57.57 9.35 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.494 0.718 . . . . 0.0 112.161 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -61.19 -41.04 96.11 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 85.2 mt -58.09 -51.13 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 124.125 0.891 . . . . 0.0 109.753 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 80.4 mt -54.91 -55.81 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.412 1.085 . . . . 0.0 109.892 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.21 -50.55 64.48 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.146 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.37 -52.42 63.68 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.88 -47.7 84.68 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -63.2 -36.78 84.79 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.52 -21.74 61.87 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.34 20.97 4.95 Favored Glycine 0 N--CA 1.48 1.568 0 N-CA-C 116.445 1.338 . . . . 0.0 116.445 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.77 118.91 12.34 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.456 1.128 . . . . 0.0 112.029 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.8 m -64.05 -28.3 69.7 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 113.52 -1.673 . . . . 0.0 111.992 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.61 172.26 45.23 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 124.149 0.88 . . . . 0.0 110.979 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -148.82 137.4 21.22 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.288 -0.956 . . . . 0.0 111.865 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.43 127.73 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 124.642 1.214 . . . . 0.0 109.438 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.0 p -81.04 139.97 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.782 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -94.6 131.63 30.42 Favored Pre-proline 0 CA--C 1.55 0.976 0 O-C-N 123.883 0.74 . . . . 0.0 111.255 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.3 151.88 69.33 Favored 'Cis proline' 0 N--CA 1.48 0.723 0 O-C-N 123.069 1.036 . . . . 0.0 113.46 -0.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -134.17 152.23 51.73 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 113.316 -1.765 . . . . 0.0 107.724 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.7 p -98.74 172.85 7.2 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.803 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.36 -41.62 72.79 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.822 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.11 -44.35 89.05 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.065 0.946 . . . . 0.0 111.702 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.2 m -61.25 -44.93 96.44 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.319 0.647 . . . . 0.0 110.041 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -60.44 -47.57 85.54 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.59 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -56.61 -43.06 79.81 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.496 1.118 . . . . 0.0 112.283 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -52.55 -45.51 66.41 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.124 0.57 . . . . 0.0 111.758 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -68.14 -42.32 80.3 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.196 0.998 . . . . 0.0 112.176 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 59.2 mt -53.88 -53.45 52.36 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.926 0.89 . . . . 0.0 111.433 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -50.54 -53.7 28.2 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.714 1.606 . . . . 0.0 111.957 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -49.27 -48.48 45.91 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.358 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 26.9 mt -63.01 -50.02 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 125.026 1.33 . . . . 0.0 112.284 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 . . . . . 0 N--CA 1.481 1.089 0 C-N-CA 124.396 1.078 . . . . 0.0 111.875 -179.473 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.7 pttt . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.95 54.41 1.26 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tt -111.41 118.83 36.9 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 113.673 -1.603 . . . . 0.0 112.064 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -75.74 108.83 8.86 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -97.53 140.71 31.56 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.522 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.38 109.6 18.58 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.23 101.37 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 124.972 1.42 . . . . 0.0 107.169 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 t -100.17 85.4 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -123.48 124.6 43.24 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 110.765 -2.925 . . . . 0.0 113.039 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -65.65 -19.22 65.82 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 110.955 -2.839 . . . . 0.0 116.23 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -110.09 127.79 55.07 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.303 0.377 . . . . 0.0 110.436 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.1 p -47.4 -59.31 3.3 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 113.683 -1.598 . . . . 0.0 113.721 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -66.75 -42.3 86.39 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.6 ttt -60.36 -38.32 83.48 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.058 0.39 . . . . 0.0 111.309 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -54.97 -50.91 67.76 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.62 1.168 . . . . 0.0 110.392 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.631 ' NH2' HD22 ' A' ' 23' ' ' ASN . 4.9 mtp-105 -65.03 -39.35 93.23 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.924 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.7 mm -55.95 -51.24 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.1 t -58.78 -45.98 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 123.596 0.56 . . . . 0.0 109.991 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -49.24 -53.92 19.22 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.888 0.875 . . . . 0.0 111.838 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.631 HD22 ' NH2' ' A' ' 19' ' ' ARG . 48.0 m-80 -62.98 -39.01 93.43 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.495 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.8 mt -58.95 -52.41 65.85 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.632 0.773 . . . . 0.0 110.564 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.7 mt -54.98 -47.18 74.93 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.065 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -54.03 -50.15 67.3 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.416 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -58.71 -40.14 82.84 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.601 1.561 . . . . 0.0 112.288 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.7 mt -71.96 -10.35 59.65 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.543 1.137 . . . . 0.0 113.135 177.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.31 -16.39 24.66 Favored Glycine 0 CA--C 1.546 2.002 0 C-N-CA 125.226 1.393 . . . . 0.0 113.677 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -87.69 72.7 9.47 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 123.366 1.555 . . . . 0.0 113.015 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -69.2 -8.42 45.5 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.705 -1.589 . . . . 0.0 113.891 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.402 ' ND2' ' H ' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -94.17 83.9 4.35 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.483 1.513 . . . . 0.0 110.53 -178.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.35 137.8 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.775 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.59 159.15 18.42 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.888 1.275 . . . . 0.0 108.922 176.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -126.5 108.9 11.6 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.47 158.36 20.8 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.967 1.307 . . . . 0.0 110.287 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -101.87 -39.03 7.56 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -138.94 170.44 15.97 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.349 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -47.1 -51.93 13.29 Favored Glycine 0 N--CA 1.474 1.227 0 C-N-CA 124.646 1.117 . . . . 0.0 115.552 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.6 t -57.73 -54.43 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.409 0.683 . . . . 0.0 110.683 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -57.56 -33.61 68.32 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.583 0.753 . . . . 0.0 111.694 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.09 -50.71 67.25 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 117.172 -1.394 . . . . 0.0 110.971 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.8 mt -57.06 -45.99 82.8 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 123.752 0.658 . . . . 0.0 111.131 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -52.62 -54.32 34.73 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.199 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -63.16 -42.45 99.42 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.725 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 26.4 mt -56.7 -35.98 69.13 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.726 1.21 . . . . 0.0 113.139 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.19 -24.36 17.93 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.86 -23.64 67.43 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.251 1.02 . . . . 0.0 113.053 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.74 179.83 50.19 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 124.805 1.193 . . . . 0.0 113.922 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.73 -14.94 8.61 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 116.544 1.377 . . . . 0.0 116.544 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -68.19 121.58 16.5 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.263 1.03 . . . . 0.0 113.64 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -106.23 10.1 43.03 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 112.505 -2.134 . . . . 0.0 111.959 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -168.94 145.43 3.54 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.5 t -128.75 111.15 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 113.389 -1.732 . . . . 0.0 107.663 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.1 tt -107.34 96.64 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.3 t -118.33 134.47 55.01 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -72.08 134.36 45.76 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.883 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -55.63 -48.58 74.7 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.828 0.851 . . . . 0.0 111.498 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -96.52 97.77 9.69 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.224 0.952 . . . . 0.0 111.271 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 29.6 mtm -131.15 138.67 33.43 Favored Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 113.782 -1.553 . . . . 0.0 111.826 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -58.87 143.93 99.06 Favored 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.144 2.562 . . . . 0.0 111.518 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.345 27.9 p30 65.12 -66.64 0.14 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 127.313 2.245 . . . . 0.0 114.295 -177.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.8 ttm -122.36 100.43 6.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.881 0.872 . . . . 0.0 108.691 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.27 167.18 8.71 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 112.413 -2.176 . . . . 0.0 112.875 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.4 -56.18 9.72 Favored Glycine 0 N--CA 1.482 1.717 0 C-N-CA 125.177 1.37 . . . . 0.0 114.123 -178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.7 tp -57.57 -39.89 77.73 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -70.63 -40.45 73.12 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.99 -0.444 . . . . 0.0 110.547 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -57.87 -42.27 84.21 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.071 0.548 . . . . 0.0 110.668 176.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 tt -51.1 -49.93 59.75 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.842 1.657 . . . . 0.0 109.705 176.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -56.89 -47.33 80.77 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.392 1.077 . . . . 0.0 113.66 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.359 13.7 t -70.69 5.58 1.84 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 mt -115.18 -64.68 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 174.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -51.12 -45.59 61.64 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.811 1.644 . . . . 0.0 113.752 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.69 -10.72 42.06 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -83.03 89.94 6.97 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -11.67 -72.06 0.01 OUTLIER Glycine 0 N--CA 1.485 1.929 0 C-N-CA 127.091 2.281 . . . . 0.0 116.641 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.4 -38.64 77.76 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 82.5 mtp -92.51 -14.17 28.79 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.0 t -30.0 -35.92 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 121.681 3.956 . . . . 0.0 121.681 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.71 -8.58 58.15 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 120.849 3.648 . . . . 0.0 120.849 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mp -68.08 119.16 65.29 Favored Pre-proline 0 N--CA 1.477 0.903 0 N-CA-C 118.049 2.611 . . . . 0.0 118.049 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -57.86 142.24 96.25 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.686 2.924 . . . . 0.0 110.949 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.3 t -123.29 121.82 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 113.538 -1.665 . . . . 0.0 113.121 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.3 tp -111.6 102.58 10.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.699 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 31.4 mmt -80.04 105.98 11.72 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 113.416 -1.72 . . . . 0.0 112.845 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.59 98.06 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 113.492 -1.686 . . . . 0.0 107.722 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 t -114.05 121.74 44.77 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.0 -18.8 63.34 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.002 -1.454 . . . . 0.0 112.928 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.78 84.45 1.94 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.218 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.48 100.12 6.74 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.794 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -119.04 137.68 53.37 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 112.951 -1.931 . . . . 0.0 107.876 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -31.14 -57.27 0.24 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -57.51 -47.52 81.74 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.264 30.1 p30 -69.3 -33.99 74.02 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.0 mt -59.72 -49.87 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 124.136 0.974 . . . . 0.0 109.186 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.4 mm -57.83 -50.41 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.228 1.011 . . . . 0.0 110.195 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.32 -50.11 60.03 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.339 1.055 . . . . 0.0 111.272 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.06 -56.4 22.54 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.892 1.277 . . . . 0.0 112.504 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.23 -49.24 74.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.986 0.914 . . . . 0.0 112.623 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -63.43 -37.48 87.45 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.04 -16.99 62.05 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.98 -0.02 10.76 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.07 110.67 3.5 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.404 1.102 . . . . 0.0 111.478 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.9 p -66.85 -18.29 65.31 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 113.681 -1.6 . . . . 0.0 114.644 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.16 168.3 40.02 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.76 1.171 . . . . 0.0 111.866 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -144.73 140.5 28.6 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.423 -0.888 . . . . 0.0 111.793 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.9 p -126.34 134.75 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 124.504 1.127 . . . . 0.0 111.845 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -81.03 128.79 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.983 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -94.03 132.86 28.55 Favored Pre-proline 0 N--CA 1.486 1.333 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.332 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.91 146.88 76.2 Favored 'Cis proline' 0 N--CA 1.478 0.617 0 O-C-N 123.437 1.23 . . . . 0.0 114.497 0.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -126.08 154.07 43.59 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 112.941 -1.936 . . . . 0.0 109.034 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.4 p -99.01 172.07 7.63 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.523 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.97 -39.71 72.2 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.87 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.89 -47.34 69.11 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.637 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.3 m -59.56 -46.91 87.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.584 0.754 . . . . 0.0 109.816 178.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.0 tp -56.76 -54.26 48.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.424 1.49 . . . . 0.0 110.198 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.24 -46.51 76.02 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.857 0.863 . . . . 0.0 112.682 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.28 -44.88 65.24 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.198 0.936 . . . . 0.0 112.134 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -66.54 -49.61 65.9 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.717 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 55.6 mt -55.92 -49.29 73.88 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.15 0.98 . . . . 0.0 111.849 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -55.78 -48.67 74.92 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.369 1.468 . . . . 0.0 112.692 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -54.22 -48.72 70.76 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.632 1.173 . . . . 0.0 110.784 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.21 -47.37 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.262 1.025 . . . . 0.0 110.585 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 179.103 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 65.1 mttm . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.59 60.89 5.82 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 123.209 1.48 . . . . 0.0 108.565 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.5 tt -98.11 123.75 42.31 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.049 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -80.33 105.46 11.61 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.685 1.241 . . . . 0.0 112.657 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -97.47 145.22 26.42 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.005 -1.452 . . . . 0.0 112.615 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.15 107.23 15.64 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 173.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.52 98.85 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.931 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -105.77 89.88 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 113.304 -1.771 . . . . 0.0 109.257 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -134.14 125.68 28.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 112.643 -2.071 . . . . 0.0 111.019 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -55.37 -24.86 31.91 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 110.93 -2.85 . . . . 0.0 116.738 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -106.66 120.69 42.64 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.2 p -42.96 -57.67 2.75 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.937 -1.483 . . . . 0.0 114.305 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.0 p -68.06 -43.37 78.8 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 118.223 -0.894 . . . . 0.0 113.29 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -39.3 90.4 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.249 0.477 . . . . 0.0 110.896 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -56.63 -49.45 74.96 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.386 1.074 . . . . 0.0 109.971 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -42.33 98.23 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.71 177.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.8 mm -56.17 -48.59 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 118.888 -0.577 . . . . 0.0 110.002 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.1 t -59.5 -49.97 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -49.62 -49.08 48.33 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.207 1.403 . . . . 0.0 111.092 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -64.5 -43.32 94.48 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.548 1.139 . . . . 0.0 112.286 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.3 mt -55.72 -50.97 68.92 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.385 1.074 . . . . 0.0 111.31 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 mt -51.01 -48.6 61.38 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.757 1.286 . . . . 0.0 112.187 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -58.96 -44.8 91.56 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.982 -1.463 . . . . 0.0 112.247 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -59.18 -38.47 79.88 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.095 1.358 . . . . 0.0 112.733 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.2 mt -71.14 -18.21 62.52 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.098 1.359 . . . . 0.0 114.239 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.79 9.96 19.81 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 124.476 1.036 . . . . 0.0 113.5 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -96.76 95.39 7.86 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 123.405 1.574 . . . . 0.0 110.199 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -61.95 -34.62 76.46 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 110.501 -3.045 . . . . 0.0 118.746 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -112.3 125.81 54.58 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.4 p -147.96 135.79 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -113.78 161.42 17.56 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.869 175.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -123.38 130.51 52.82 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.12 156.7 46.96 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.377 1.471 . . . . 0.0 109.699 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -113.86 -38.79 4.14 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -123.38 159.79 28.17 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 118.719 -0.658 . . . . 0.0 109.774 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -44.67 -45.68 8.8 Favored Glycine 0 N--CA 1.478 1.445 0 N-CA-C 116.74 1.456 . . . . 0.0 116.74 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.57 -54.77 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 122.559 0.344 . . . . 0.0 110.196 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -57.51 -34.13 68.77 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.446 0.699 . . . . 0.0 110.777 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.94 -55.23 27.76 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.653 1.181 . . . . 0.0 110.32 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.0 mt -56.52 -43.54 79.92 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.66 0.784 . . . . 0.0 110.324 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -53.86 -56.16 20.13 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.318 1.047 . . . . 0.0 110.744 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -59.38 -52.97 63.32 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.213 1.405 . . . . 0.0 111.896 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tp -56.49 -37.21 70.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.933 2.093 . . . . 0.0 114.61 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -54.64 -30.26 54.62 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.472 1.509 . . . . 0.0 113.589 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.77 -22.47 66.99 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.21 -173.13 46.12 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.25 0.928 . . . . 0.0 112.093 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.63 -26.41 3.14 Favored Glycine 0 CA--C 1.543 1.833 0 N-CA-C 114.78 0.672 . . . . 0.0 114.78 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -68.12 108.94 3.31 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.879 0.872 . . . . 0.0 111.799 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.59 3.11 86.41 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.441 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -166.04 143.52 5.45 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.105 0.962 . . . . 0.0 113.441 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.3 t -122.14 113.84 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 113.918 -1.492 . . . . 0.0 107.608 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.8 tt -113.43 97.28 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.7 t -119.53 136.03 54.52 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -175.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -71.98 132.88 44.91 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 112.415 -2.175 . . . . 0.0 110.944 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 26.6 t-105 -56.29 -41.23 75.58 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.41 1.084 . . . . 0.0 111.719 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -99.5 104.44 16.27 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 29.4 mtm -138.83 130.45 15.39 Favored Pre-proline 0 N--CA 1.473 0.689 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.713 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -57.42 149.6 64.76 Favored 'Trans proline' 0 N--CA 1.481 0.766 0 C-N-CA 123.448 2.765 . . . . 0.0 110.944 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 71.19 -61.2 0.49 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 126.119 1.767 . . . . 0.0 112.516 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 55.6 ttm -135.31 108.33 7.64 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.154 1.381 . . . . 0.0 108.101 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -68.88 167.39 15.76 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.457 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.26 -57.01 9.55 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 125.508 1.528 . . . . 0.0 114.527 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.9 tp -57.44 -37.84 73.45 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -71.61 -42.95 67.04 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.668 0.787 . . . . 0.0 111.167 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.07 -41.53 83.59 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.328 1.051 . . . . 0.0 110.246 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 tp -57.23 -46.53 82.88 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.005 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -60.43 -44.0 96.21 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.38 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.26 24.9 p -62.0 -35.44 78.53 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.268 1.027 . . . . 0.0 111.993 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.4 mt -69.33 -56.95 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -53.34 -47.98 68.89 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.718 1.261 . . . . 0.0 113.043 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.14 -33.85 75.26 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.165 0.986 . . . . 0.0 113.097 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -84.68 83.25 8.09 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.794 0.838 . . . . 0.0 108.777 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -4.58 -80.6 0.01 OUTLIER Glycine 0 N--CA 1.484 1.849 0 C-N-CA 127.521 2.486 . . . . 0.0 118.221 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.89 -35.27 57.7 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 94.0 mtp -73.37 -27.11 61.3 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.072 0.949 . . . . 0.0 113.241 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.3 t -53.83 -26.51 24.65 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.43 -14.61 61.74 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.0 mt -86.53 116.19 65.01 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 123.784 0.833 . . . . 0.0 109.876 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.58 143.66 45.03 Favored 'Trans proline' 0 N--CA 1.476 0.488 0 C-N-CA 123.53 2.82 . . . . 0.0 113.71 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 t -121.23 117.86 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.801 -177.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.5 tp -110.64 107.32 16.86 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 113.044 -1.889 . . . . 0.0 109.573 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.4 mmt -82.27 119.23 23.84 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 113.862 -1.517 . . . . 0.0 112.825 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.13 96.29 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 t -105.24 138.52 41.31 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 112.162 -2.29 . . . . 0.0 116.084 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.79 -22.11 66.03 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 113.565 -1.652 . . . . 0.0 113.167 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -142.09 135.4 29.07 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -97.99 60.29 1.46 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 113.344 -1.753 . . . . 0.0 109.492 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -112.28 148.17 34.75 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.652 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -37.17 -45.13 0.61 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 116.32 1.971 . . . . 0.0 116.32 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.12 -60.53 3.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.961 0.904 . . . . 0.0 110.738 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -59.39 -46.75 87.81 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.788 1.235 . . . . 0.0 112.594 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 73.3 mt -57.31 -57.2 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 124.207 0.942 . . . . 0.0 111.598 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.7 mt -60.06 -50.48 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.175 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.96 -49.69 68.17 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.771 0.669 . . . . 0.0 112.228 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.78 -54.94 39.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.348 1.059 . . . . 0.0 111.633 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.42 -48.59 76.65 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.077 0.951 . . . . 0.0 112.408 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -61.18 -31.35 71.1 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.55 1.87 55.37 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.18 -0.28 29.82 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 116.892 1.517 . . . . 0.0 116.892 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.55 109.55 4.91 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.2 1.0 . . . . 0.0 111.856 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.2 p -63.64 -21.48 66.39 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.54 -1.664 . . . . 0.0 114.246 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -170.45 171.07 43.47 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.897 1.237 . . . . 0.0 112.357 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -146.45 127.29 14.42 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.643 -0.778 . . . . 0.0 113.024 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 p -111.2 119.54 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -82.05 125.36 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 113.607 -1.633 . . . . 0.0 112.88 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -87.09 133.95 37.86 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 112.77 -2.014 . . . . 0.0 110.214 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.27 126.71 13.77 Favored 'Cis proline' 0 C--N 1.351 0.663 0 CA-C-O 123.192 1.247 . . . . 0.0 115.223 0.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -115.83 147.81 40.61 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 112.424 -2.171 . . . . 0.0 108.269 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 48.7 p -104.07 171.93 7.08 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.764 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.85 -37.52 66.32 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.99 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.06 -50.33 64.52 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.196 0.998 . . . . 0.0 110.741 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.8 m -58.81 -44.74 90.9 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.701 0.801 . . . . 0.0 110.211 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 36.6 tp -58.18 -55.83 29.95 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.147 1.379 . . . . 0.0 109.844 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -59.3 -41.65 89.52 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.76 0.424 . . . . 0.0 111.72 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -52.52 -46.89 66.88 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.694 0.797 . . . . 0.0 110.868 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -70.4 -42.58 71.5 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.032 178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.1 mt -56.76 -46.65 81.31 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -53.2 -49.54 66.54 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.806 1.242 . . . . 0.0 111.681 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -52.51 -47.86 66.38 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.75 1.62 . . . . 0.0 111.275 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.1 mm -60.32 -48.04 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.207 1.003 . . . . 0.0 110.528 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -179.284 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.3 mttt . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -74.87 5.54 4.96 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.822 1.249 . . . . 0.0 114.342 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.31 126.91 30.24 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.256 1.423 . . . . 0.0 113.032 -177.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.402 ' HZ1' ' CG ' ' A' ' 32' ' ' ASN . 4.5 mptp? -84.25 108.73 17.28 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 112.983 -1.917 . . . . 0.0 112.282 177.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -99.73 127.87 45.85 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.757 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -107.65 95.84 5.97 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.43 104.71 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 111.148 -2.751 . . . . 0.0 108.931 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -104.44 72.56 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 123.553 1.644 . . . . 0.0 107.921 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -129.11 80.23 1.96 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 112.885 -1.961 . . . . 0.0 110.7 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -13.01 -30.61 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 1 N-CA-C 124.421 4.971 . . . . 0.0 124.421 -178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -101.12 124.01 46.17 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.9 m -41.95 -43.54 3.15 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 114.68 -1.145 . . . . 0.0 113.392 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 m -58.21 -55.95 28.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.932 1.293 . . . . 0.0 110.835 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -59.88 -42.61 94.15 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 -55.72 -47.81 76.23 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.766 0.666 . . . . 0.0 111.229 176.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -67.14 -39.92 86.67 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.078 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.2 mm -56.55 -47.76 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 123.307 0.38 . . . . 0.0 110.086 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.7 t -60.59 -42.06 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -53.31 -52.54 58.81 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.582 0.753 . . . . 0.0 110.155 176.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -53.51 -44.46 69.13 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.325 1.05 . . . . 0.0 112.279 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.0 -51.13 69.3 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.963 1.305 . . . . 0.0 112.048 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.0 mt -56.15 -44.31 79.15 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.041 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -57.78 -47.64 81.95 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.927 176.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.19 -39.15 78.18 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.109 1.364 . . . . 0.0 111.733 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.8 mt -73.21 -26.9 61.33 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.86 21.18 7.95 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.567 1.08 . . . . 0.0 114.399 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -92.97 116.44 29.05 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 122.456 1.122 . . . . 0.0 112.645 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.52 -48.27 67.52 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 111.411 -2.631 . . . . 0.0 116.15 -177.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.402 ' CG ' ' HZ1' ' A' ' 7' ' ' LYS . 64.0 m-80 -111.57 122.36 47.62 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 -174.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.31 112.92 8.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 111.154 -2.748 . . . . 0.0 110.781 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -109.44 140.75 42.79 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -123.36 131.64 53.72 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 -174.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.09 157.03 26.56 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 111.493 -2.594 . . . . 0.0 110.271 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -92.23 -55.46 3.42 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -130.34 173.05 11.19 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.703 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -40.57 -54.64 3.35 Favored Glycine 0 CA--C 1.536 1.346 0 O-C-N 124.977 1.423 . . . . 0.0 115.44 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.8 t -57.25 -56.78 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.984 0.914 . . . . 0.0 112.076 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -56.82 -36.72 70.29 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.421 0.688 . . . . 0.0 111.579 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.14 -51.05 65.77 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.126 0.97 . . . . 0.0 111.028 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.2 mt -54.13 -49.27 69.59 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.501 0.72 . . . . 0.0 110.711 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -52.16 -55.45 20.9 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.301 1.041 . . . . 0.0 111.661 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -58.23 -52.78 64.13 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.537 177.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.7 mt -56.34 -39.22 72.48 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.984 1.314 . . . . 0.0 114.092 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -58.79 -23.93 61.06 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.46 -19.25 62.24 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.09 -165.5 29.2 Favored Glycine 0 N--CA 1.481 1.645 0 C-N-CA 124.884 1.23 . . . . 0.0 112.097 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.33 -34.95 1.53 Allowed Glycine 0 CA--C 1.544 1.865 0 N-CA-C 116.0 1.16 . . . . 0.0 116.0 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -66.5 118.38 10.05 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.08 7.36 56.94 Favored Glycine 0 N--CA 1.476 1.316 0 CA-C-N 112.654 -2.067 . . . . 0.0 111.803 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -163.97 138.18 5.69 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.7 t -122.16 110.94 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.5 tt -114.93 97.84 6.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.5 t -118.67 136.01 54.15 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -71.72 132.67 44.86 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 113.2 -1.818 . . . . 0.0 110.745 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 17.6 t-105 -56.39 -46.5 80.09 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.306 177.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -93.29 105.42 17.5 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.883 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 29.5 mtm -140.25 134.39 15.5 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.627 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -58.43 142.25 97.72 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 C-N-CA 123.717 2.945 . . . . 0.0 111.054 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.7 m120 63.75 -67.32 0.1 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.857 1.663 . . . . 0.0 114.304 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.4 ttm -115.73 97.74 6.3 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -60.94 165.74 3.91 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 112.122 -2.308 . . . . 0.0 112.541 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.33 -55.92 11.86 Favored Glycine 0 N--CA 1.484 1.886 0 C-N-CA 124.711 1.148 . . . . 0.0 114.432 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.1 tp -57.26 -43.23 82.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.141 0.576 . . . . 0.0 112.47 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.54 -41.74 92.72 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.875 0.87 . . . . 0.0 111.365 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.53 -46.46 83.81 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.328 1.051 . . . . 0.0 110.225 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.4 tp -55.07 -47.81 74.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.386 1.475 . . . . 0.0 110.737 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -60.0 -47.47 85.71 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.218 0.607 . . . . 0.0 112.125 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.267 16.4 p -57.19 -29.21 63.49 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.019 0.928 . . . . 0.0 112.634 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mt -81.55 -58.01 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.157 0.983 . . . . 0.0 108.891 177.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 81.8 mmt-85 -48.08 -47.78 33.86 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.467 1.907 . . . . 0.0 112.855 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.98 61.66 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -84.33 96.43 9.03 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -17.96 -69.46 0.01 OUTLIER Glycine 0 N--CA 1.488 2.114 0 C-N-CA 126.27 1.891 . . . . 0.0 116.56 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.57 95.33 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 98.7 mtp -75.51 -22.43 57.15 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.1 t -38.03 -36.07 0.19 Allowed 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 117.405 2.372 . . . . 0.0 117.405 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.39 -1.86 51.23 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 117.23 2.308 . . . . 0.0 117.23 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.4 mt -69.42 110.28 6.04 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -54.99 124.33 16.01 Favored 'Trans proline' 0 N--CA 1.483 0.888 0 C-N-CA 123.435 2.757 . . . . 0.0 113.437 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.9 t -112.68 119.27 59.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 114.078 -1.419 . . . . 0.0 114.521 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 66.6 tp -109.09 101.18 10.26 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 111.919 -2.4 . . . . 0.0 107.859 176.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.4 mmt -76.02 104.51 6.59 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.42 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 t -83.94 98.57 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.3 p -90.6 132.13 35.91 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 112.958 -1.928 . . . . 0.0 112.387 -176.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.11 -46.14 89.09 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.959 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -147.11 115.18 6.55 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.97 98.52 5.71 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.657 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -114.64 142.21 46.76 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.114 -1.857 . . . . 0.0 108.69 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER -38.36 -45.17 0.98 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 179.677 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.59 -53.21 59.3 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.631 0.772 . . . . 0.0 112.959 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.01 -37.66 84.57 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.598 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.97 -51.27 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.775 0.83 . . . . 0.0 110.4 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.0 mt -57.84 -51.65 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.38 0.672 . . . . 0.0 109.244 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.02 -44.6 74.74 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.04 0.936 . . . . 0.0 113.369 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.48 -47.77 82.96 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.155 0.982 . . . . 0.0 112.31 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.79 -44.75 96.26 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.886 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -59.06 -31.58 68.99 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.16 -5.8 49.32 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.13 4.4 27.43 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 118.317 2.087 . . . . 0.0 118.317 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.7 121.03 8.84 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.6 m -66.87 -30.67 70.9 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 113.271 -1.786 . . . . 0.0 113.404 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.78 167.42 38.81 Favored Glycine 0 N--CA 1.479 1.556 0 C-N-CA 124.458 1.028 . . . . 0.0 110.819 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -141.92 137.63 31.43 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.31 126.55 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 124.617 1.198 . . . . 0.0 111.66 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.2 p -88.99 135.62 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.706 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.2 pttt -92.75 142.36 25.54 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-O 117.709 -1.138 . . . . 0.0 112.392 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.08 129.81 18.55 Favored 'Cis proline' 0 N--CA 1.481 0.769 0 N-CA-C 116.568 1.718 . . . . 0.0 116.568 0.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -120.38 139.29 53.01 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 112.814 -1.994 . . . . 0.0 107.966 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.5 p -97.82 174.94 6.35 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.876 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.88 -36.39 67.58 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.38 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.02 -47.29 71.89 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.185 0.994 . . . . 0.0 111.44 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 m -59.59 -45.96 90.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.285 0.634 . . . . 0.0 109.623 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 42.4 tp -56.89 -51.64 68.28 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.602 1.161 . . . . 0.0 110.277 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -54.3 -46.85 72.87 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.646 1.178 . . . . 0.0 111.91 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -58.96 -43.76 91.36 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.099 0.874 . . . . 0.0 112.655 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -65.61 -42.26 91.82 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.853 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.2 mt -53.69 -47.69 70.22 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.337 1.023 . . . . 0.0 111.33 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -52.59 -54.98 25.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.592 1.557 . . . . 0.0 111.867 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -52.45 -49.88 63.74 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 113.859 -1.519 . . . . 0.0 112.51 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 58.7 mt -60.14 -45.54 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.852 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.5 m-30 . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 179.035 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.31 62.5 6.04 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 123.127 1.441 . . . . 0.0 111.4 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 tt -106.34 123.64 48.36 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 113.24 -1.8 . . . . 0.0 111.068 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -76.34 103.27 6.27 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.895 1.372 . . . . 0.0 113.976 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -98.47 130.47 45.08 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 112.621 -2.081 . . . . 0.0 112.014 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.64 102.54 11.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 122.748 1.261 . . . . 0.0 108.695 174.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.3 t -88.13 107.16 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.3 t -105.45 101.99 13.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 111.391 -2.641 . . . . 0.0 108.339 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -138.85 133.57 32.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.968 -1.469 . . . . 0.0 112.33 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -63.52 -23.18 67.28 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 113.965 -1.47 . . . . 0.0 112.396 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.49 102.06 11.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.789 177.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.9 p -49.06 -34.09 12.9 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.767 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.65 -41.57 95.22 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.131 1.772 . . . . 0.0 110.726 176.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.3 tpt -66.67 -42.21 86.94 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.3 0.64 . . . . 0.0 110.536 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.492 ' CZ ' ' HE ' ' A' ' 22' ' ' ARG . 1.8 tmm_? -56.51 -42.79 78.97 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 124.285 0.991 . . . . 0.0 109.735 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -56.02 -48.6 75.64 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.147 1.379 . . . . 0.0 110.576 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.3 mm -58.47 -55.85 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.046 0.939 . . . . 0.0 110.382 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.5 t -53.04 -44.79 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.817 0.847 . . . . 0.0 111.566 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HE ' ' CZ ' ' A' ' 18' ' ' ARG . 26.0 ttm180 -52.62 -54.12 37.52 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.054 0.942 . . . . 0.0 111.452 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -60.19 -39.75 87.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.99 0.916 . . . . 0.0 113.299 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.91 -53.13 61.49 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.48 1.112 . . . . 0.0 110.745 177.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.2 mt -57.48 -44.51 84.94 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.835 0.854 . . . . 0.0 112.112 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -53.37 -48.7 68.36 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.486 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -57.45 -38.88 75.15 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.035 1.334 . . . . 0.0 111.985 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.2 mt -74.83 -15.13 60.74 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.37 6.49 29.25 Favored Glycine 0 CA--C 1.545 1.947 0 C-N-CA 125.104 1.335 . . . . 0.0 114.78 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -98.44 91.88 5.4 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 122.758 1.265 . . . . 0.0 112.666 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -79.35 -10.22 59.76 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 119.604 3.187 . . . . 0.0 119.604 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -107.4 99.23 8.77 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 119.404 1.002 . . . . 0.0 112.511 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -130.12 125.04 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.066 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -111.84 163.75 13.84 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.596 0.758 . . . . 0.0 109.851 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -120.67 131.05 54.38 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.03 149.49 47.49 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 112.104 -2.316 . . . . 0.0 108.095 173.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -101.45 -41.65 6.56 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -130.85 159.84 36.19 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.629 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -39.51 -51.71 3.03 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.984 1.754 . . . . 0.0 115.03 177.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.45 -56.19 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 114.852 -0.674 . . . . 0.0 111.23 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.8 -37.58 68.81 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.933 0.893 . . . . 0.0 111.458 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.18 -49.52 77.32 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 117.462 -1.256 . . . . 0.0 111.42 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.7 mt -58.5 -44.77 89.56 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.104 0.562 . . . . 0.0 111.385 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -54.8 -53.02 60.68 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.971 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -59.9 -50.92 71.87 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.681 1.593 . . . . 0.0 111.88 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.4 mt -54.81 -49.28 71.39 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.451 1.9 . . . . 0.0 114.73 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.91 -17.63 10.27 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.64 -19.65 65.81 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.224 0.61 . . . . 0.0 112.499 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.3 -177.88 38.19 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.924 1.249 . . . . 0.0 114.146 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.56 -24.57 2.62 Favored Glycine 0 CA--C 1.541 1.703 0 N-CA-C 116.432 1.333 . . . . 0.0 116.432 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -69.0 113.22 6.19 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.27 5.65 61.07 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 112.725 -2.034 . . . . 0.0 112.01 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -164.24 143.86 7.73 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.88 120.0 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.086 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 71.2 mt -113.07 102.59 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.7 t -119.23 131.78 55.85 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 118.016 2.598 . . . . 0.0 118.016 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -71.98 124.84 25.78 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 112.066 -2.334 . . . . 0.0 109.808 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 18.3 t-105 -55.4 -39.34 70.06 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.232 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -91.41 94.05 9.31 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.797 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 29.6 mtm -139.58 122.52 10.43 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-N 112.83 -1.986 . . . . 0.0 109.589 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -60.82 127.62 23.06 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.893 3.062 . . . . 0.0 113.335 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 m120 81.32 -65.8 0.13 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.02 1.728 . . . . 0.0 113.283 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.2 ttm -115.57 87.72 2.73 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.625 0.726 . . . . 0.0 109.363 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.43 168.87 2.52 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 111.863 -2.426 . . . . 0.0 112.224 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -47.29 -53.43 11.69 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 124.932 1.253 . . . . 0.0 114.223 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.3 tp -57.38 -44.59 84.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.883 0.873 . . . . 0.0 111.997 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -66.23 -40.72 90.48 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.2 tp -61.57 -42.79 99.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.368 0.667 . . . . 0.0 111.27 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.4 tp -53.25 -45.21 68.67 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.831 1.252 . . . . 0.0 110.868 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -64.76 -44.86 88.68 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.488 1.115 . . . . 0.0 111.209 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.2 p -61.0 -25.12 66.66 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.773 1.229 . . . . 0.0 113.219 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.9 mt -84.04 -59.64 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.613 1.165 . . . . 0.0 108.072 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -49.05 -43.39 40.7 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.253 1.821 . . . . 0.0 113.447 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.46 -14.64 52.05 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.83 91.98 7.17 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -7.52 -79.53 0.01 OUTLIER Glycine 0 N--CA 1.488 2.141 0 C-N-CA 126.936 2.208 . . . . 0.0 117.161 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.57 -45.62 88.63 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.8 mtp -80.16 -11.45 59.75 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 117.36 2.355 . . . . 0.0 117.36 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.3 t -30.47 -61.37 0.17 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 118.761 2.874 . . . . 0.0 118.761 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.22 12.82 2.65 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 119.9 3.296 . . . . 0.0 119.9 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.1 mt -76.62 106.37 3.29 Favored Pre-proline 0 N--CA 1.479 0.989 0 O-C-N 121.251 -0.906 . . . . 0.0 112.117 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -40.13 133.86 1.95 Allowed 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 124.567 3.511 . . . . 0.0 117.149 -175.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.4 t -119.28 117.96 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 111.068 -2.787 . . . . 0.0 112.817 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 47.8 tp -108.98 105.64 15.25 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 113.34 -1.754 . . . . 0.0 107.706 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.7 mmt -80.53 114.84 19.7 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 113.597 -1.638 . . . . 0.0 111.686 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.91 110.57 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.6 p -111.53 153.89 25.58 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 117.846 2.536 . . . . 0.0 117.846 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.12 -31.8 73.18 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 112.018 -2.356 . . . . 0.0 113.641 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.03 124.56 3.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.535 1.134 . . . . 0.0 108.518 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.42 90.39 6.71 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 122.529 1.157 . . . . 0.0 110.403 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -121.48 133.28 55.04 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.721 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -25.5 -61.63 0.07 Allowed 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 117.692 2.478 . . . . 0.0 117.692 -177.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -53.58 -46.75 70.42 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -70.27 -34.44 72.79 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.3 mt -60.03 -53.33 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.47 0.708 . . . . 0.0 109.906 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.8 mt -58.56 -46.85 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.707 0.803 . . . . 0.0 109.783 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.08 -47.99 64.9 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.86 0.864 . . . . 0.0 112.294 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.05 -47.38 83.25 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.574 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.79 84.13 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.353 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -60.19 -36.82 78.49 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.035 0.934 . . . . 0.0 112.73 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.71 -5.07 52.17 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.86 -5.23 24.15 Favored Glycine 0 CA--C 1.542 1.761 0 N-CA-C 117.367 1.707 . . . . 0.0 117.367 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.51 115.46 2.53 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.417 1.608 . . . . 0.0 115.314 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.2 p -67.95 -18.65 64.81 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 113.568 -1.651 . . . . 0.0 114.217 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -165.87 162.05 35.56 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.505 1.05 . . . . 0.0 112.304 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -146.14 126.18 13.71 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.665 0.786 . . . . 0.0 111.117 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.27 136.43 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 124.849 1.343 . . . . 0.0 110.864 176.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -93.22 145.37 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.499 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -89.3 128.91 49.55 Favored Pre-proline 0 N--CA 1.476 0.825 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.68 155.66 80.58 Favored 'Cis proline' 0 CA--C 1.54 0.778 0 O-C-N 123.055 1.029 . . . . 0.0 114.371 0.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -146.53 155.72 42.73 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.067 1.747 . . . . 0.0 107.967 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.5 t -117.13 177.18 4.81 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.919 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.48 -41.86 61.22 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.823 0.849 . . . . 0.0 111.563 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.81 -53.02 60.69 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.184 0.994 . . . . 0.0 111.986 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.73 -46.76 84.0 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.757 0.823 . . . . 0.0 110.62 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.65 -52.56 63.41 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.069 1.348 . . . . 0.0 108.551 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -56.11 -46.94 78.93 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.859 1.264 . . . . 0.0 111.981 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.19 -45.86 65.33 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -68.39 -45.17 73.42 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.85 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.3 mt -55.97 -50.84 69.71 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.2 1.0 . . . . 0.0 112.169 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -51.61 -50.17 60.75 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.604 1.561 . . . . 0.0 111.995 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -54.89 -47.7 73.96 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.721 1.208 . . . . 0.0 110.997 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.78 -44.42 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.849 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.322 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.1 mttm . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 121.126 0.488 . . . . 0.0 112.235 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -84.64 60.76 6.3 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 122.388 1.09 . . . . 0.0 109.488 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 tt -108.94 133.04 53.48 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.341 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -79.84 106.75 12.1 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 125.079 1.487 . . . . 0.0 113.588 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -104.09 139.31 39.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 112.672 -2.058 . . . . 0.0 112.704 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.92 107.79 15.45 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.572 174.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.51 99.04 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 112.585 -2.098 . . . . 0.0 107.53 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.75 91.0 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.375 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -136.48 114.11 11.06 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 113.809 -1.541 . . . . 0.0 113.137 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -52.82 -28.1 21.18 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -94.29 113.48 25.39 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.5 p -45.76 -46.69 15.33 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.709 1.204 . . . . 0.0 113.644 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -47.97 83.68 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.78 177.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.1 mmm -61.68 -39.92 93.13 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -55.76 -53.86 51.43 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 124.38 1.05 . . . . 0.0 110.421 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.12 -40.14 92.66 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.852 177.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 74.9 mt -56.03 -56.52 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.958 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -57.76 -45.09 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.041 0.537 . . . . 0.0 111.447 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -51.74 -56.66 12.48 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.151 0.98 . . . . 0.0 111.534 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -59.81 -41.98 92.45 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.576 0.75 . . . . 0.0 112.793 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.8 mt -56.96 -53.64 55.72 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.76 0.824 . . . . 0.0 111.405 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.5 mt -54.4 -47.6 72.55 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.143 0.977 . . . . 0.0 112.029 177.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -57.83 -44.25 86.34 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.871 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -58.71 -38.29 77.97 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.482 1.513 . . . . 0.0 112.174 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.0 mt -75.73 -16.98 60.07 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 124.705 1.253 . . . . 0.0 113.426 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.77 -6.84 20.04 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.738 1.161 . . . . 0.0 114.263 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -90.95 80.82 5.72 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 123.277 1.513 . . . . 0.0 110.46 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -76.62 -17.26 59.28 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -94.47 88.57 5.53 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 122.386 1.088 . . . . 0.0 109.954 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.91 129.04 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 113.991 -1.458 . . . . 0.0 112.213 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -109.93 153.92 23.83 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 175.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -125.62 120.77 31.68 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.35 162.33 19.65 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.37 -1.741 . . . . 0.0 109.848 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.42 -43.27 5.01 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -132.51 170.06 15.68 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.21 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -47.32 -53.15 12.24 Favored Glycine 0 CA--C 1.541 1.707 0 O-C-N 124.675 1.234 . . . . 0.0 114.944 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.8 t -56.3 -54.52 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.542 0.337 . . . . 0.0 111.524 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -56.61 -36.27 69.24 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.559 0.744 . . . . 0.0 111.621 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.32 -49.9 62.29 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.496 1.118 . . . . 0.0 112.507 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.4 mt -53.8 -43.12 69.07 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.339 0.656 . . . . 0.0 111.665 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.14 -59.36 5.42 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 125.059 1.474 . . . . 0.0 110.304 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -57.79 -40.57 80.17 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.1 mt -56.29 -48.55 76.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.535 0.734 . . . . 0.0 112.026 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -71.6 -5.71 35.44 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.9 -7.71 42.58 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.71 147.71 13.59 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 116.813 1.485 . . . . 0.0 116.813 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.96 -12.46 3.01 Favored Glycine 0 CA--C 1.542 1.778 0 N-CA-C 121.934 3.534 . . . . 0.0 121.934 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -66.0 105.2 1.28 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 121.035 2.418 . . . . 0.0 115.79 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.11 20.24 48.31 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 112.44 -2.163 . . . . 0.0 112.372 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -171.05 137.03 1.13 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.861 0.865 . . . . 0.0 112.401 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.59 119.54 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.684 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 87.2 mt -111.69 102.71 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 104.192 -2.521 . . . . 0.0 104.192 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 t -121.29 132.39 54.77 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 -176.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -68.15 131.89 46.22 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 111.815 -2.448 . . . . 0.0 109.536 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 -56.22 -50.99 69.71 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -91.81 89.74 7.19 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 122.527 1.156 . . . . 0.0 113.778 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.2 mtm -124.44 136.01 27.23 Favored Pre-proline 0 N--CA 1.484 1.239 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.373 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -54.16 148.62 39.51 Favored 'Trans proline' 0 N--CA 1.48 0.7 0 C-N-CA 124.172 3.248 . . . . 0.0 110.771 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.313 11.5 p30 60.06 -67.6 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 126.547 1.939 . . . . 0.0 114.534 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 52.0 ttm -122.16 102.09 7.93 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.229 1.012 . . . . 0.0 108.61 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -66.17 167.35 10.27 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 113.01 -1.905 . . . . 0.0 112.428 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.01 -53.44 18.49 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 124.453 1.025 . . . . 0.0 112.875 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.0 tp -57.93 -38.98 76.91 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -72.06 -37.96 69.54 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.768 0.427 . . . . 0.0 111.686 178.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.8 tp -60.56 -42.52 96.76 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.788 0.835 . . . . 0.0 110.345 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.1 tp -55.06 -46.58 75.38 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.726 1.21 . . . . 0.0 109.909 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -60.63 -45.48 93.9 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.915 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.271 38.8 p -60.9 -35.18 75.99 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 124.238 1.015 . . . . 0.0 111.8 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.2 mt -72.53 -56.73 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.647 1.179 . . . . 0.0 108.664 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 76.5 mmt-85 -53.39 -42.65 67.15 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.89 1.676 . . . . 0.0 114.048 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.25 -30.08 69.88 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -88.18 100.01 12.64 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.113 0.565 . . . . 0.0 111.309 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -11.37 -74.18 0.01 OUTLIER Glycine 0 N--CA 1.489 2.175 0 C-N-CA 127.662 2.554 . . . . 0.0 118.266 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.51 84.37 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 96.1 mtp -72.31 -24.06 61.26 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.089 1.356 . . . . 0.0 113.847 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.3 m -51.57 -28.48 14.06 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.321 1.449 . . . . 0.0 114.438 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.85 -11.09 42.99 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.2 mt -77.49 114.72 43.26 Favored Pre-proline 0 N--CA 1.475 0.807 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -49.41 132.7 29.96 Favored 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 124.189 3.259 . . . . 0.0 115.695 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.4 t -120.74 120.53 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 112.739 -2.028 . . . . 0.0 111.955 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 47.8 tp -112.18 107.05 15.81 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 113.313 -1.767 . . . . 0.0 109.323 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 30.9 mmt -81.24 121.97 26.82 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 113.744 -1.571 . . . . 0.0 112.353 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.76 101.52 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.05 145.83 37.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 111.772 -2.467 . . . . 0.0 113.567 -176.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.74 -38.2 72.07 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -156.53 147.28 21.79 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.674 0.789 . . . . 0.0 110.389 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.36 86.78 6.22 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -123.42 134.19 53.98 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 112.667 -2.06 . . . . 0.0 110.351 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -27.19 -60.6 0.09 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.235 1.814 . . . . 0.0 115.481 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -53.58 -52.44 59.77 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -66.69 -38.92 87.75 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.2 mt -59.05 -55.03 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.279 1.032 . . . . 0.0 110.002 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.3 mt -54.84 -54.57 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.301 1.04 . . . . 0.0 109.602 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.18 -49.43 63.87 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.192 0.997 . . . . 0.0 113.308 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.11 -51.02 68.22 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.058 0.943 . . . . 0.0 113.503 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.3 -51.06 71.38 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.047 0.939 . . . . 0.0 112.895 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -64.39 -25.66 68.12 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.44 -5.91 59.04 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.23 2.32 26.39 Favored Glycine 0 CA--C 1.54 1.635 0 N-CA-C 117.408 1.723 . . . . 0.0 117.408 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.92 119.47 8.32 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.4 m -64.93 -30.58 71.59 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.412 -1.722 . . . . 0.0 112.933 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -174.2 170.79 43.95 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.687 1.137 . . . . 0.0 110.587 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -143.21 129.05 19.43 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.462 -0.869 . . . . 0.0 112.458 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.39 124.66 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.743 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.14 123.38 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 112.1 -2.318 . . . . 0.0 111.199 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -90.95 134.79 29.6 Favored Pre-proline 0 N--CA 1.483 1.193 0 CA-C-N 113.65 -1.614 . . . . 0.0 111.284 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -75.45 141.59 71.71 Favored 'Cis proline' 0 CA--C 1.542 0.893 0 O-C-N 123.273 1.144 . . . . 0.0 112.988 0.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -126.69 147.27 49.96 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 113.12 -1.855 . . . . 0.0 109.515 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 52.5 p -97.46 171.03 8.64 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.753 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.22 67.87 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.296 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.99 -49.81 66.51 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.091 0.956 . . . . 0.0 111.533 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.6 m -58.09 -46.12 86.04 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.916 0.886 . . . . 0.0 109.324 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 48.2 tp -58.77 -55.47 34.65 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.438 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . 0.26 1.3 pp20? -59.15 -36.52 75.4 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -55.61 -49.55 72.5 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 123.952 0.783 . . . . 0.0 111.112 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -65.39 -45.41 84.14 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.901 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.0 mt -54.44 -46.91 73.35 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 124.093 0.87 . . . . 0.0 112.222 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -55.0 -52.94 61.58 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.486 1.114 . . . . 0.0 112.308 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -55.36 -42.75 74.31 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.244 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.12 -46.87 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.863 0.865 . . . . 0.0 110.633 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 177.462 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -89.29 60.33 5.24 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 123.426 1.584 . . . . 0.0 110.471 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 tt -106.56 131.03 54.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.004 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -78.32 102.2 7.58 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 113.448 -1.706 . . . . 0.0 111.414 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -102.35 138.6 39.06 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 112.884 -1.962 . . . . 0.0 113.404 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.16 111.41 19.43 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.815 174.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.1 t -87.02 97.11 6.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 123.899 1.809 . . . . 0.0 107.466 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.65 74.0 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 112.72 -2.037 . . . . 0.0 106.808 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -127.25 87.06 2.58 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 112.915 -1.948 . . . . 0.0 113.396 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -11.25 -55.85 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 121.62 3.933 . . . . 0.0 121.62 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -81.72 133.5 35.36 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.75 0.656 . . . . 0.0 109.278 -177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 p -46.33 -50.83 15.82 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.067 0.947 . . . . 0.0 112.908 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -49.73 76.49 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.81 177.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -45.34 85.51 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.959 0.904 . . . . 0.0 111.26 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 -57.66 -52.74 64.2 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.114 0.966 . . . . 0.0 111.496 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.693 ' NH1' HD22 ' A' ' 23' ' ' ASN . 2.1 mmp_? -56.78 -43.49 80.91 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.435 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.5 mm -54.23 -61.44 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.257 0.623 . . . . 0.0 110.939 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.5 t -57.47 -45.16 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.261 0.624 . . . . 0.0 111.63 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -54.44 -53.54 52.75 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.9 0.88 . . . . 0.0 112.13 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.693 HD22 ' NH1' ' A' ' 19' ' ' ARG . 66.2 m-80 -63.55 -37.82 88.77 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.0 mt -56.95 -51.31 69.68 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.877 0.471 . . . . 0.0 111.874 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 49.1 mt -53.36 -47.04 69.75 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.564 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -56.85 -47.5 80.23 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.113 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -59.65 -38.87 82.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.49 1.516 . . . . 0.0 112.64 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.63 -16.14 62.27 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.698 1.599 . . . . 0.0 114.085 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.86 9.7 25.96 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 124.462 1.029 . . . . 0.0 114.759 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -92.11 98.16 11.37 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 123.874 1.797 . . . . 0.0 111.53 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -57.76 -42.62 84.41 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 110.39 -3.096 . . . . 0.0 119.236 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -111.55 106.68 15.61 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 t -133.53 126.63 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -110.85 158.0 19.19 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -130.13 119.52 23.15 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.67 149.38 36.83 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.921 1.288 . . . . 0.0 110.687 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -76.1 -60.83 2.16 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -133.62 -178.22 4.9 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 119.092 -0.48 . . . . 0.0 111.522 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -43.1 -55.7 4.84 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 125.564 1.554 . . . . 0.0 114.652 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.9 t -57.11 -56.69 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 114.335 -0.932 . . . . 0.0 111.947 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -57.26 -38.6 74.12 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.427 0.691 . . . . 0.0 111.631 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.34 -50.25 70.7 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.564 1.146 . . . . 0.0 112.414 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.9 mt -53.85 -40.71 66.71 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.64 0.776 . . . . 0.0 112.862 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -67.55 -55.18 14.48 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 124.325 1.016 . . . . 0.0 110.927 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -57.78 -30.92 66.04 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.4 mt -55.67 -38.21 69.3 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -71.49 -9.25 57.9 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.65 34.84 0.12 Allowed 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 116.258 1.948 . . . . 0.0 116.258 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.1 115.54 2.63 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 117.939 1.936 . . . . 0.0 117.939 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 27.01 47.77 0.05 OUTLIER Glycine 0 CA--C 1.545 1.925 0 N-CA-C 122.249 3.66 . . . . 0.0 122.249 176.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -74.84 87.58 2.26 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 118.547 1.173 . . . . 0.0 113.069 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.6 29.91 5.16 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 113.357 -1.747 . . . . 0.0 111.617 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -175.2 131.86 0.3 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.84 1.305 . . . . 0.0 112.927 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 t -126.99 119.83 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-N 112.436 -2.165 . . . . 0.0 108.88 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.2 mt -110.48 105.89 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.9 t -124.98 132.75 53.22 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 118.128 2.64 . . . . 0.0 118.128 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -73.63 133.08 43.39 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 111.71 -2.495 . . . . 0.0 109.512 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -55.01 -49.28 71.92 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.221 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -90.86 82.09 5.69 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 39.4 mtm -116.77 137.99 24.21 Favored Pre-proline 0 N--CA 1.482 1.15 0 CA-C-N 114.222 -1.354 . . . . 0.0 112.101 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -57.72 139.5 90.47 Favored 'Trans proline' 0 N--CA 1.476 0.478 0 C-N-CA 124.034 3.156 . . . . 0.0 111.903 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 64.42 -73.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.306 1.842 . . . . 0.0 112.487 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.5 ttm -110.2 98.7 7.9 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -64.64 168.08 6.49 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 112.312 -2.222 . . . . 0.0 112.901 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.2 -52.74 21.83 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.028 1.299 . . . . 0.0 114.38 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.01 -40.45 84.97 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -66.83 -43.43 83.74 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.555 0.342 . . . . 0.0 111.515 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -56.13 -47.49 78.06 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.018 0.927 . . . . 0.0 110.993 177.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 tt -49.22 -55.64 11.89 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.982 1.713 . . . . 0.0 109.412 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -61.0 -44.49 97.34 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.909 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.259 29.7 p -59.21 -21.77 60.01 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 124.643 1.177 . . . . 0.0 113.186 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.8 mt -89.99 -58.42 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -47.77 -45.18 28.97 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.953 2.101 . . . . 0.0 114.217 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.73 -11.53 50.86 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -84.01 93.35 8.06 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.199 0.6 . . . . 0.0 110.274 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -12.73 -70.59 0.01 OUTLIER Glycine 0 N--CA 1.495 2.584 0 C-N-CA 126.351 1.929 . . . . 0.0 116.47 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.64 -49.43 75.19 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 90.4 mtp -75.84 -26.68 57.39 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 m -11.0 -61.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 120.585 3.55 . . . . 0.0 120.585 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.56 28.95 0.45 Allowed 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 120.64 3.57 . . . . 0.0 120.64 -174.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.2 mt -89.75 106.79 15.36 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.877 -1.139 . . . . 0.0 110.074 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -47.56 133.06 20.96 Favored 'Trans proline' 0 N--CA 1.48 0.735 0 C-N-CA 123.432 2.755 . . . . 0.0 114.756 -177.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.3 t -118.19 128.31 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 112.891 -1.958 . . . . 0.0 114.202 -176.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.5 tp -116.48 108.71 16.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 113.199 -1.819 . . . . 0.0 109.562 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.0 mmt -83.19 114.55 21.43 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.595 1.188 . . . . 0.0 114.006 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.75 98.6 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.8 t -106.91 144.57 33.36 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 111.861 -2.427 . . . . 0.0 113.993 -175.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.58 -41.2 41.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 113.471 -1.695 . . . . 0.0 115.236 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -161.9 144.19 11.51 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.076 1.35 . . . . 0.0 109.948 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.22 86.87 3.66 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.364 1.078 . . . . 0.0 109.967 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -118.75 122.48 42.54 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.582 -1.644 . . . . 0.0 109.585 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -21.44 -59.34 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 117.414 2.376 . . . . 0.0 117.414 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -46.12 72.61 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -70.97 -38.31 72.78 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.02 -53.77 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.801 1.24 . . . . 0.0 109.012 176.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.0 mt -54.01 -54.95 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.377 1.071 . . . . 0.0 110.24 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.19 -50.5 64.54 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.267 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.24 -55.37 32.78 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.48 -51.51 69.15 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.877 0.871 . . . . 0.0 112.312 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -30.34 71.39 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.02 -13.84 60.22 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 177.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.75 -0.97 11.07 Favored Glycine 0 CA--C 1.545 1.96 0 N-CA-C 116.208 1.243 . . . . 0.0 116.208 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.63 123.99 18.65 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 119.051 1.426 . . . . 0.0 113.744 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.5 m -64.53 -30.51 71.54 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 113.07 -1.877 . . . . 0.0 112.88 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.72 172.84 45.82 Favored Glycine 0 CA--C 1.542 1.727 0 C-N-CA 124.818 1.199 . . . . 0.0 110.697 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -144.14 139.99 29.14 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.1 p -124.41 129.69 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 124.457 1.098 . . . . 0.0 110.459 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.36 127.45 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 113.217 -1.811 . . . . 0.0 111.24 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -92.94 132.39 31.12 Favored Pre-proline 0 N--CA 1.479 1.002 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.055 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -74.25 142.85 76.0 Favored 'Cis proline' 0 CA--C 1.548 1.189 0 O-C-N 123.017 1.009 . . . . 0.0 114.277 0.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -134.1 155.28 50.33 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 112.282 -2.236 . . . . 0.0 107.986 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 44.9 p -106.62 172.42 6.83 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.335 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.93 -38.96 68.33 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 123.612 0.57 . . . . 0.0 111.736 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.32 -46.78 75.7 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.356 1.062 . . . . 0.0 111.37 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.1 m -60.13 -47.02 87.68 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 52.8 tp -57.19 -52.11 66.64 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.525 1.13 . . . . 0.0 109.851 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -54.03 -48.21 70.75 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 124.12 0.888 . . . . 0.0 112.152 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -52.61 -47.42 66.99 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.58 -46.54 82.28 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.329 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 82.5 mt -56.96 -47.91 79.6 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 124.141 0.901 . . . . 0.0 111.212 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -53.74 -53.54 50.78 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.541 1.536 . . . . 0.0 111.669 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -52.11 -46.04 65.14 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.499 1.52 . . . . 0.0 111.566 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 63.7 mt -62.37 -51.78 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.341 1.056 . . . . 0.0 110.447 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 179.475 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . 0.263 63.3 mttp . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 118.089 2.625 . . . . 0.0 118.089 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -90.3 51.34 2.01 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.988 1.375 . . . . 0.0 111.861 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 tt -112.94 130.85 55.97 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.881 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -86.49 111.21 20.35 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.899 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -105.86 145.32 31.38 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.021 1.728 . . . . 0.0 115.287 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -121.5 105.09 10.15 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 112.488 -2.142 . . . . 0.0 110.047 174.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.3 t -82.89 112.52 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 112.87 -1.968 . . . . 0.0 107.763 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.66 96.0 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.697 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -138.44 130.36 28.21 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.166 0.916 . . . . 0.0 112.46 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -72.03 -16.39 62.05 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -101.01 114.68 28.84 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.3 p -40.75 -57.61 1.87 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 125.177 1.548 . . . . 0.0 113.2 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -48.05 80.18 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -60.83 -37.58 82.52 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.9 ttp-105 -59.29 -50.52 73.67 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.437 1.095 . . . . 0.0 110.996 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -60.82 -42.81 98.42 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.655 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 71.7 mt -55.63 -52.66 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.266 1.026 . . . . 0.0 111.113 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.3 t -56.11 -48.29 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 122.501 0.32 . . . . 0.0 110.752 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -55.35 -50.49 69.53 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.649 1.18 . . . . 0.0 110.827 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -59.08 -45.68 90.21 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.99 0.916 . . . . 0.0 112.082 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -54.21 -50.96 65.9 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.334 1.054 . . . . 0.0 111.793 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.3 mt -56.03 -46.56 78.82 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.968 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -55.74 -46.73 77.76 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.567 1.167 . . . . 0.0 111.303 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -59.45 -39.67 84.34 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.381 1.473 . . . . 0.0 112.381 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.1 mt -74.01 -12.66 60.69 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.15 -13.28 33.97 Favored Glycine 0 N--CA 1.479 1.522 0 C-N-CA 124.216 0.912 . . . . 0.0 113.386 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -84.72 62.73 7.56 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 123.42 1.581 . . . . 0.0 111.453 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -68.7 -13.72 62.55 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -86.42 70.83 10.51 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.81 126.35 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -120.42 160.57 22.82 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.044 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -133.69 140.99 47.37 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 119.439 3.125 . . . . 0.0 119.439 -175.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.44 160.75 27.53 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 112.234 -2.257 . . . . 0.0 109.506 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -97.47 -39.43 9.16 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -137.59 170.32 16.27 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.468 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -45.71 -54.08 8.09 Favored Glycine 0 N--CA 1.482 1.736 0 O-C-N 124.651 1.219 . . . . 0.0 115.671 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.1 t -57.7 -54.42 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.665 0.786 . . . . 0.0 111.783 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -55.21 -36.5 66.03 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.935 0.894 . . . . 0.0 112.167 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.69 -50.78 61.77 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.326 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.2 mt -54.17 -46.1 72.25 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 124.541 1.15 . . . . 0.0 110.482 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -57.05 -53.0 63.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.832 0.853 . . . . 0.0 111.506 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -56.94 -45.74 82.58 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.207 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -59.2 -42.68 91.48 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.149 0.98 . . . . 0.0 111.653 176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -60.57 -30.18 69.63 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 125.102 1.361 . . . . 0.0 112.089 177.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.83 -19.5 65.91 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.81 0.844 . . . . 0.0 112.154 175.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.64 175.09 28.33 Favored Glycine 0 N--CA 1.479 1.53 0 N-CA-C 117.508 1.763 . . . . 0.0 117.508 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.62 -33.1 1.63 Allowed Glycine 0 N--CA 1.483 1.781 0 N-CA-C 121.304 3.282 . . . . 0.0 121.304 176.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -65.85 113.37 4.31 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.45 16.87 57.5 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-N 113.761 -1.563 . . . . 0.0 113.124 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -166.23 138.55 3.85 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.229 1.412 . . . . 0.0 110.483 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.5 t -125.31 126.41 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.491 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 91.0 mt -112.13 99.61 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.513 ' HG ' ' CE ' ' A' ' 60' ' ' MET . 41.9 t -109.06 123.68 49.54 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -175.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -73.56 127.25 32.22 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 112.572 -2.104 . . . . 0.0 109.565 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 5.2 t-105 -52.65 -49.14 65.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.032 0.933 . . . . 0.0 111.4 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -88.45 96.77 10.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.971 0.908 . . . . 0.0 110.94 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.513 ' CE ' ' HG ' ' A' ' 56' ' ' SER . 24.4 mtm -138.3 132.3 16.7 Favored Pre-proline 0 N--CA 1.48 1.03 0 CA-C-N 113.742 -1.572 . . . . 0.0 112.589 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -65.87 150.41 85.79 Favored 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 123.933 3.089 . . . . 0.0 111.795 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.3 m120 68.33 -64.01 0.32 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 125.794 1.934 . . . . 0.0 112.694 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.7 ttm -126.44 101.95 6.92 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.277 1.031 . . . . 0.0 108.277 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.36 169.11 6.19 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 113.394 -1.73 . . . . 0.0 111.866 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.0 -52.76 29.65 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.15 0.881 . . . . 0.0 115.156 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 36.3 tp -60.04 -38.6 83.24 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.48 0.712 . . . . 0.0 112.343 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -66.63 -42.75 86.25 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.664 0.386 . . . . 0.0 110.469 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.7 -45.17 92.95 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.987 177.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 tt -50.32 -51.71 43.04 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.75 1.62 . . . . 0.0 109.054 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -59.68 -47.24 86.42 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.984 0.914 . . . . 0.0 113.143 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.268 21.7 p -56.55 -35.38 68.06 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.551 1.14 . . . . 0.0 111.994 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.6 mt -76.29 -54.42 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.152 0.981 . . . . 0.0 109.396 177.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.0 -40.79 64.07 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.678 1.991 . . . . 0.0 113.749 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.42 -31.83 65.83 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -87.23 94.91 9.79 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.825 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -13.68 -71.34 0.01 OUTLIER Glycine 0 N--CA 1.487 2.06 0 C-N-CA 127.345 2.402 . . . . 0.0 118.207 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.98 -41.89 71.77 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.0 mtm -74.61 -30.8 61.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.25 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.7 m -53.77 -29.08 38.54 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.321 1.048 . . . . 0.0 112.585 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.61 -34.63 58.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.305 1.042 . . . . 0.0 113.264 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . 0.273 2.5 pp -84.45 120.55 74.44 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -47.74 146.9 7.64 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 125.123 3.882 . . . . 0.0 120.65 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.8 t -122.02 107.18 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 111.549 -2.568 . . . . 0.0 110.751 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 56.4 tp -101.07 110.97 23.06 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.643 -1.162 . . . . 0.0 107.931 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 90.0 mmm -81.77 133.9 35.39 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.178 -1.374 . . . . 0.0 112.182 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -112.58 109.47 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 177.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.8 p -103.85 134.33 47.33 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.968 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.97 -24.31 52.13 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -165.13 130.51 2.61 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.624 1.97 . . . . 0.0 107.554 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.94 98.23 7.07 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 122.474 1.131 . . . . 0.0 111.106 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -121.87 144.53 48.79 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.746 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -35.1 -50.47 0.51 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.759 1.223 . . . . 0.0 114.121 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -50.79 -58.15 6.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.523 1.129 . . . . 0.0 112.759 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -69.06 -39.91 78.85 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 93.5 mt -57.01 -55.49 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.634 0.774 . . . . 0.0 111.767 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 59.0 mt -59.06 -51.26 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 124.052 0.845 . . . . 0.0 111.143 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.51 -45.1 73.26 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 115.248 -0.887 . . . . 0.0 113.286 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.38 65.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.566 1.146 . . . . 0.0 113.014 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.29 -47.49 83.5 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.723 0.809 . . . . 0.0 111.702 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -58.62 -36.46 74.09 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.6 -13.57 57.82 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.43 3.22 12.92 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.93 125.28 22.4 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.737 1.269 . . . . 0.0 112.807 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.2 m -65.52 -31.97 73.31 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 113.447 -1.706 . . . . 0.0 113.166 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.79 174.99 46.48 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 125.01 1.291 . . . . 0.0 110.333 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -145.81 139.72 26.58 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 p -119.11 130.49 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 125.462 1.726 . . . . 0.0 110.853 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.3 t -75.7 130.53 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.894 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -91.84 123.01 64.43 Favored Pre-proline 0 N--CA 1.479 0.997 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -81.42 156.21 81.98 Favored 'Cis proline' 0 N--CA 1.486 1.069 0 N-CA-C 114.323 0.855 . . . . 0.0 114.323 -0.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -140.67 163.84 31.81 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 112.898 -1.955 . . . . 0.0 109.401 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.3 p -112.53 175.4 5.45 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.271 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.84 81.06 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.156 176.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.21 -48.75 76.99 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.821 0.848 . . . . 0.0 110.97 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.0 m -57.07 -45.94 82.88 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.817 0.847 . . . . 0.0 110.494 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.67 -53.16 61.26 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 124.446 1.091 . . . . 0.0 108.824 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -57.5 -41.86 81.58 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.27 -48.43 65.28 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.845 0.716 . . . . 0.0 111.608 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -63.72 -48.89 75.24 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.965 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.8 mt -49.93 -47.38 52.41 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.822 1.249 . . . . 0.0 113.716 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -63.87 -49.18 73.76 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -53.99 -48.44 70.39 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 124.649 1.218 . . . . 0.0 110.152 176.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 81.1 mt -55.01 -54.72 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.139 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -179.63 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 116.981 2.215 . . . . 0.0 116.981 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.79 39.07 0.78 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.862 -1.517 . . . . 0.0 110.895 177.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.6 tp -95.91 128.05 42.46 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 112.644 -2.071 . . . . 0.0 111.244 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -80.9 106.18 12.7 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 112.874 -1.967 . . . . 0.0 112.107 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -101.73 136.89 40.8 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 113.6 -1.636 . . . . 0.0 113.629 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.5 103.24 10.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.575 -1.648 . . . . 0.0 109.902 172.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.9 t -81.63 91.99 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 112.074 -2.33 . . . . 0.0 107.156 178.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 t -99.53 94.92 3.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 112.753 -2.021 . . . . 0.0 107.983 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -135.47 140.39 44.8 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.258 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -67.08 -27.84 67.69 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 117.017 2.229 . . . . 0.0 117.017 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -107.65 132.15 53.63 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.448 0.299 . . . . 0.0 111.224 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.5 p -51.36 -52.08 48.85 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.754 1.222 . . . . 0.0 113.231 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 m -60.45 -48.82 80.1 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.258 0.974 . . . . 0.0 111.441 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.89 -44.58 94.15 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.224 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -55.39 -58.52 7.39 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.054 1.341 . . . . 0.0 111.039 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -58.9 -36.37 74.58 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.5 mt -58.23 -49.7 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 122.946 0.498 . . . . 0.0 110.09 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.7 t -55.71 -47.35 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 123.525 0.73 . . . . 0.0 110.27 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.689 ' NH2' HD22 ' A' ' 23' ' ' ASN . 7.0 ttp180 -51.51 -51.73 52.7 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.059 1.344 . . . . 0.0 110.843 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.689 HD22 ' NH2' ' A' ' 22' ' ' ARG . 16.1 m120 -62.28 -40.4 96.13 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.206 1.002 . . . . 0.0 112.48 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -58.5 -51.71 68.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.785 0.834 . . . . 0.0 110.69 177.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.1 mt -55.01 -46.27 75.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.125 0.97 . . . . 0.0 112.548 177.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.8 -43.24 90.5 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.661 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -58.78 -39.04 79.89 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.887 1.275 . . . . 0.0 111.995 177.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.0 mt -74.23 -17.49 60.88 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.003 1.321 . . . . 0.0 114.068 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.17 9.71 25.37 Favored Glycine 0 N--CA 1.478 1.477 0 N-CA-C 115.639 1.015 . . . . 0.0 115.639 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -92.6 101.78 14.21 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.753 1.263 . . . . 0.0 112.009 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -64.13 -51.41 64.04 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 118.705 2.854 . . . . 0.0 118.705 -175.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -94.08 101.72 13.76 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.239 1.199 . . . . 0.0 114.239 -174.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.1 t -130.61 118.35 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.002 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -110.79 157.56 19.65 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -127.24 127.93 45.22 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -174.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.03 154.81 32.51 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.501 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -86.93 -48.61 8.0 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -142.74 173.74 11.28 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.245 0.618 . . . . 0.0 109.426 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -43.03 -55.64 4.82 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.071 1.319 . . . . 0.0 116.332 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.87 -54.85 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.366 0.666 . . . . 0.0 111.675 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -56.55 -33.85 66.52 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.665 0.786 . . . . 0.0 111.996 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.86 -48.21 72.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.481 1.112 . . . . 0.0 111.958 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.5 mt -57.62 -40.46 79.2 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.439 0.695 . . . . 0.0 111.464 177.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -59.18 -59.74 4.97 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.402 1.081 . . . . 0.0 109.305 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -58.25 -39.57 79.5 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.3 mt -52.8 -38.47 61.24 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.739 1.216 . . . . 0.0 113.905 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -59.47 -26.17 65.02 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.52 56.89 1.48 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.786 1.234 . . . . 0.0 114.313 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.32 -15.14 7.28 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 117.822 1.889 . . . . 0.0 117.822 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.91 67.24 2.04 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -58.16 129.64 42.93 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.671 1.989 . . . . 0.0 113.114 -177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.64 19.06 16.55 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-N 113.915 -1.493 . . . . 0.0 116.564 -177.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -172.29 128.81 0.57 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 122.551 1.167 . . . . 0.0 112.046 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.3 t -121.8 119.14 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-N 113.521 -1.672 . . . . 0.0 108.182 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.8 mt -108.81 101.77 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.6 t -119.0 125.87 50.39 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 118.185 2.661 . . . . 0.0 118.185 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -67.38 128.21 35.55 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 112.374 -2.194 . . . . 0.0 109.892 178.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -53.92 -50.15 67.04 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.003 0.921 . . . . 0.0 109.934 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -89.19 95.07 10.15 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.548 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 18.4 mtm -134.83 131.66 20.15 Favored Pre-proline 0 N--CA 1.477 0.887 0 CA-C-N 113.08 -1.873 . . . . 0.0 110.882 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -56.65 139.14 87.5 Favored 'Trans proline' 0 N--CA 1.48 0.715 0 C-N-CA 123.945 3.097 . . . . 0.0 111.549 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 m120 64.73 -65.0 0.15 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 126.759 2.024 . . . . 0.0 114.115 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.9 ttm -115.83 92.17 3.82 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -62.16 167.89 3.71 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 111.263 -2.699 . . . . 0.0 112.592 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.28 -55.29 10.73 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 124.298 0.951 . . . . 0.0 113.796 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.3 tp -59.42 -38.14 79.87 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.154 0.981 . . . . 0.0 112.786 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -71.62 -40.05 70.04 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 119.613 -0.232 . . . . 0.0 111.235 177.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.4 tp -60.41 -40.39 90.78 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.679 0.752 . . . . 0.0 110.529 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 tt -51.0 -49.85 59.62 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.089 1.356 . . . . 0.0 108.632 176.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -61.56 -44.96 96.08 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.84 1.256 . . . . 0.0 113.372 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.4 p -61.03 -27.53 68.4 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.625 0.77 . . . . 0.0 111.662 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.0 mt -80.65 -56.9 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.47 1.108 . . . . 0.0 108.78 176.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.0 mmt-85 -51.87 -42.91 63.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.994 1.717 . . . . 0.0 113.346 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.47 -23.69 50.36 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -86.79 95.45 9.84 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.17 0.588 . . . . 0.0 111.807 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -3.5 -83.63 0.0 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 127.106 2.289 . . . . 0.0 118.412 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.94 -39.86 82.89 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 82.3 mtp -71.84 -23.56 61.56 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.573 1.549 . . . . 0.0 113.778 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.6 m -50.8 -26.17 5.36 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.841 1.657 . . . . 0.0 115.147 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.49 -7.43 50.5 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.3 mt -83.42 119.48 73.99 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 123.284 0.633 . . . . 0.0 111.829 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -54.18 138.44 71.69 Favored 'Trans proline' 0 N--CA 1.482 0.812 0 C-N-CA 123.984 3.123 . . . . 0.0 114.892 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 t -120.26 114.47 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-N 112.366 -2.197 . . . . 0.0 111.427 -178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.9 tp -106.64 110.37 22.54 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.969 -1.469 . . . . 0.0 109.36 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.3 mmt -81.11 112.29 18.34 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.911 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.63 102.82 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.4 t -110.18 138.63 46.3 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.13 -1.85 . . . . 0.0 113.78 -176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -48.0 -31.41 5.31 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -161.5 152.73 18.54 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.709 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.24 82.29 3.72 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 123.187 1.47 . . . . 0.0 107.552 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -100.94 121.42 41.71 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 111.343 -2.662 . . . . 0.0 108.362 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -38.48 -53.07 1.58 Allowed 'General case' 0 N--CA 1.483 1.178 0 O-C-N 125.018 1.449 . . . . 0.0 113.892 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -53.17 -53.29 52.74 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.171 0.588 . . . . 0.0 111.188 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -56.79 -49.36 75.57 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.3 1.0 . . . . 0.0 111.833 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.8 mt -55.25 -51.92 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.188 0.995 . . . . 0.0 111.969 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.2 mm -58.98 -54.89 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.606 0.762 . . . . 0.0 110.8 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.63 -47.05 70.65 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.191 0.996 . . . . 0.0 113.234 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.06 -51.72 68.14 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.451 1.1 . . . . 0.0 112.168 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.1 -47.75 84.83 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.284 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -56.3 -40.38 74.23 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.85 1.26 . . . . 0.0 113.489 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.28 -14.41 59.44 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.92 3.11 12.35 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.24 123.02 18.45 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.192 1.496 . . . . 0.0 112.319 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.1 p -69.78 -17.57 63.43 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 113.161 -1.836 . . . . 0.0 114.314 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.54 173.47 43.93 Favored Glycine 0 N--CA 1.481 1.658 0 C-N-CA 124.043 0.83 . . . . 0.0 111.844 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -144.4 136.63 26.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 114.999 -0.601 . . . . 0.0 112.387 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.258 1.0 OUTLIER -118.03 126.9 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 124.413 1.07 . . . . 0.0 110.419 178.363 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.37 114.64 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 112.159 -2.292 . . . . 0.0 111.229 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -90.36 132.28 36.03 Favored Pre-proline 0 N--CA 1.472 0.627 0 CA-C-O 117.725 -1.131 . . . . 0.0 110.611 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.18 132.87 26.91 Favored 'Cis proline' 0 N--CA 1.489 1.228 0 N-CA-C 115.173 1.182 . . . . 0.0 115.173 1.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -124.74 151.62 44.84 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 112.462 -2.154 . . . . 0.0 108.69 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.2 p -102.53 171.63 7.33 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.014 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.71 -39.85 68.6 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.576 0.548 . . . . 0.0 111.396 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.0 -44.41 80.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.427 1.091 . . . . 0.0 111.983 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.4 m -60.15 -49.32 78.09 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 60.3 tp -56.14 -50.45 71.08 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.24 1.416 . . . . 0.0 109.715 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -56.45 -46.86 80.12 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.328 1.051 . . . . 0.0 112.473 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -53.41 -44.08 68.44 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -65.88 -48.43 71.55 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.392 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.7 mt -56.66 -48.94 76.48 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.535 1.134 . . . . 0.0 111.504 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -50.09 -53.24 28.57 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 126.021 1.728 . . . . 0.0 112.056 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -54.15 -45.91 72.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.654 1.182 . . . . 0.0 111.466 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.74 -39.8 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.338 1.055 . . . . 0.0 112.038 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 179.061 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -105.68 45.33 0.98 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.6 tp -83.11 122.78 28.81 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 112.029 -2.351 . . . . 0.0 107.349 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -78.26 115.88 18.3 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.931 -1.486 . . . . 0.0 113.446 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -105.72 138.15 42.4 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.745 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -116.16 99.53 7.3 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.616 1.198 . . . . 0.0 108.822 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.9 t -79.68 104.36 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 111.61 -2.541 . . . . 0.0 108.958 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.89 102.54 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 113.605 -1.634 . . . . 0.0 110.02 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.75 135.05 22.96 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.986 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -66.1 -16.99 64.41 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -106.59 110.36 22.54 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.2 p -46.93 -49.63 20.19 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.691 -1.14 . . . . 0.0 113.273 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -38.93 85.94 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.297 1.039 . . . . 0.0 112.741 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.2 tpt -62.19 -38.98 91.18 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -56.39 -47.89 78.02 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.196 0.522 . . . . 0.0 110.907 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.56 -41.61 73.51 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 114.133 -1.394 . . . . 0.0 112.399 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.5 mt -57.69 -50.99 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.244 0.617 . . . . 0.0 110.23 177.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 t -58.57 -42.47 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.273 0.629 . . . . 0.0 109.97 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 56.0 ttm-85 -53.8 -54.14 42.51 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 123.938 0.774 . . . . 0.0 110.737 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -58.81 -39.78 82.17 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.1 mt -62.59 -53.88 48.05 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.482 0.713 . . . . 0.0 111.492 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.9 mt -54.87 -44.3 73.9 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.988 0.915 . . . . 0.0 111.882 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -56.75 -49.08 76.32 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 113.343 -1.753 . . . . 0.0 110.175 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -56.42 -38.0 70.97 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.05 1.74 . . . . 0.0 112.914 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.4 mt -73.76 -19.17 60.86 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.787 1.235 . . . . 0.0 114.287 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.41 -5.22 23.21 Favored Glycine 0 CA--C 1.551 2.295 0 C-N-CA 124.296 0.951 . . . . 0.0 112.919 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -92.54 86.03 5.49 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 122.557 1.17 . . . . 0.0 109.773 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -85.28 -7.52 58.96 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -98.29 93.37 6.18 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 122.387 1.089 . . . . 0.0 110.343 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.6 t -129.11 136.32 59.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 113.525 -1.67 . . . . 0.0 111.403 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.16 149.85 48.7 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 176.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -127.99 141.27 51.57 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 118.637 2.828 . . . . 0.0 118.637 -176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -131.51 152.44 50.73 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 112.072 -2.331 . . . . 0.0 110.531 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . 0.374 0.0 OUTLIER -100.08 -27.71 13.41 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 -179.057 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.7 p30 -142.7 166.59 24.24 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.476 -0.765 . . . . 0.0 110.831 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -45.08 -49.25 9.7 Favored Glycine 0 N--CA 1.479 1.543 0 C-N-CA 124.6 1.095 . . . . 0.0 115.582 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -58.65 -56.68 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 114.616 -0.792 . . . . 0.0 110.585 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -55.36 -35.38 65.17 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.802 0.841 . . . . 0.0 111.662 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.01 -51.52 57.57 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 117.91 -1.043 . . . . 0.0 111.834 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.6 mt -54.82 -45.77 74.48 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 124.211 0.944 . . . . 0.0 111.068 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -54.96 -54.41 43.17 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 125.166 1.541 . . . . 0.0 111.43 177.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.8 mttt -62.61 -45.14 94.22 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.027 1.331 . . . . 0.0 114.271 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.8 mt -54.09 -28.71 41.02 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -57.88 -25.51 60.87 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.39 -18.89 62.69 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.72 -179.8 50.63 Favored Glycine 0 N--CA 1.48 1.593 0 CA-C-O 122.165 0.869 . . . . 0.0 112.541 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.46 -31.02 3.29 Favored Glycine 0 N--CA 1.485 1.953 0 CA-C-N 113.959 -1.121 . . . . 0.0 114.142 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -60.69 113.29 2.39 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.094 0.558 . . . . 0.0 110.772 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.62 15.3 45.64 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 125.815 1.947 . . . . 0.0 112.222 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -171.3 134.19 0.88 Allowed 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 122.381 1.086 . . . . 0.0 112.348 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.32 121.49 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.538 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 89.8 mt -112.33 98.99 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.5 t -113.46 122.06 46.17 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.02 127.26 32.22 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 111.456 -2.611 . . . . 0.0 110.259 177.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -51.93 -45.04 64.14 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.237 0.961 . . . . 0.0 112.871 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -87.06 103.15 15.11 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.013 0.925 . . . . 0.0 109.438 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.9 mtp -147.23 131.46 8.58 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 123.999 0.92 . . . . 0.0 111.815 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.21 149.42 81.62 Favored 'Trans proline' 0 N--CA 1.48 0.734 0 C-N-CA 123.484 2.789 . . . . 0.0 110.968 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.5 m120 70.94 -71.7 0.13 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.911 1.684 . . . . 0.0 111.05 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.8 ttm -119.84 99.71 6.8 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -61.1 166.59 3.51 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.688 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.91 -56.64 7.45 Favored Glycine 0 N--CA 1.485 1.939 0 O-C-N 124.188 0.93 . . . . 0.0 114.868 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.8 tp -58.59 -37.26 75.43 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -68.31 -39.81 81.89 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.773 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.7 tp -58.99 -42.37 89.87 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.904 0.753 . . . . 0.0 110.372 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.9 tp -54.06 -47.27 71.82 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.059 1.344 . . . . 0.0 111.178 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.36 -47.11 85.62 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.235 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.257 11.4 p -59.15 -32.38 69.83 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.658 1.183 . . . . 0.0 112.943 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.3 mt -74.65 -55.7 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.248 1.019 . . . . 0.0 108.311 176.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.1 mmt-85 -51.03 -48.01 61.57 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.584 1.554 . . . . 0.0 111.769 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.83 -22.32 65.15 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -83.66 110.71 18.5 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.599 0.76 . . . . 0.0 109.411 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -26.28 -69.14 0.05 OUTLIER Glycine 0 CA--C 1.541 1.71 0 C-N-CA 125.981 1.753 . . . . 0.0 115.306 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.02 -35.28 80.68 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 42.7 mtm -85.35 -11.38 54.72 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 64.8 p -42.67 -43.17 3.74 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.456 1.903 . . . . 0.0 116.099 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.64 -3.95 57.01 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.5 mt -73.95 111.07 10.86 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -52.1 131.14 38.0 Favored 'Trans proline' 0 N--CA 1.481 0.749 0 C-N-CA 123.166 2.577 . . . . 0.0 114.249 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 63.3 t -116.86 124.72 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 112.865 -1.97 . . . . 0.0 113.224 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.4 tp -111.97 108.13 17.35 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 112.659 -2.064 . . . . 0.0 108.771 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.0 mmt -81.8 106.13 13.48 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 113.383 -1.735 . . . . 0.0 113.637 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -91.28 98.61 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 123.921 1.819 . . . . 0.0 108.504 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 t -108.9 139.23 44.04 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 111.813 -2.449 . . . . 0.0 112.6 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.19 -41.79 65.63 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 114.213 -1.358 . . . . 0.0 113.495 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -137.32 151.17 48.34 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.472 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.73 78.14 5.51 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.352 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.8 135.99 37.98 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.259 -1.791 . . . . 0.0 108.7 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -41.07 -49.46 3.4 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.077 1.351 . . . . 0.0 113.193 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -58.59 -51.2 70.9 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -56.93 -45.39 82.76 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.343 1.027 . . . . 0.0 111.312 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 78.9 mt -56.87 -55.16 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 124.716 1.206 . . . . 0.0 110.892 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.5 mt -59.32 -50.92 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.021 0.928 . . . . 0.0 110.674 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.58 74.11 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.834 0.854 . . . . 0.0 111.865 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.08 -49.05 79.35 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.507 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.53 88.29 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.305 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -60.12 -38.87 84.31 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.0 -0.66 45.22 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.54 -0.81 29.23 Favored Glycine 0 CA--C 1.545 1.908 0 N-CA-C 117.391 1.716 . . . . 0.0 117.391 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.03 121.65 14.11 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.099 1.449 . . . . 0.0 114.357 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.0 m -65.44 -30.02 70.77 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 111.913 -2.403 . . . . 0.0 113.08 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -173.68 177.23 46.09 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.308 1.432 . . . . 0.0 111.121 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -147.32 131.54 17.42 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.053 -1.073 . . . . 0.0 111.186 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.8 p -120.83 123.85 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 123.988 0.805 . . . . 0.0 110.364 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.8 t -76.41 128.56 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 112.796 -2.002 . . . . 0.0 111.456 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -92.78 138.26 23.67 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.859 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.51 133.75 31.92 Favored 'Cis proline' 0 CA--C 1.54 0.788 0 N-CA-C 115.866 1.449 . . . . 0.0 115.866 0.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -116.95 147.72 42.02 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 112.832 -1.985 . . . . 0.0 108.458 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 59.9 p -105.56 178.48 4.55 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.983 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.11 -42.93 69.99 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.912 0.758 . . . . 0.0 111.97 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.09 72.93 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.738 0.815 . . . . 0.0 111.723 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -60.57 -46.3 90.73 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.475 0.71 . . . . 0.0 110.786 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.3 tp -56.47 -51.2 69.35 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.323 1.049 . . . . 0.0 109.553 177.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -58.67 -47.67 83.71 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.531 0.732 . . . . 0.0 111.752 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -50.42 -45.5 55.82 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 124.195 0.934 . . . . 0.0 110.653 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -68.47 -46.59 69.34 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.159 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.5 mt -55.87 -48.67 75.15 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.503 0.721 . . . . 0.0 111.218 177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -55.15 -52.53 63.0 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.502 1.521 . . . . 0.0 112.004 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -52.85 -46.96 68.05 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.357 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.92 -46.88 93.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.276 1.03 . . . . 0.0 111.528 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 N--CA 1.476 0.858 0 C-N-CA 122.582 0.353 . . . . 0.0 111.722 178.078 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -99.94 46.8 0.95 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.497 1.142 . . . . 0.0 113.802 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.2 tp -79.77 127.68 32.51 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 111.405 -2.634 . . . . 0.0 107.318 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -81.77 110.43 17.08 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.558 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -99.33 141.65 31.84 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.933 -1.94 . . . . 0.0 113.135 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -121.82 98.76 6.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.368 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -80.11 109.68 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 111.955 -2.384 . . . . 0.0 108.419 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 t -108.53 100.64 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.597 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -141.21 133.73 28.44 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.844 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -65.06 -28.37 69.42 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 112.976 -1.92 . . . . 0.0 114.025 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -94.54 102.02 13.94 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.0 p -39.12 -50.09 1.85 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 113.024 -1.898 . . . . 0.0 113.27 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -38.82 92.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.04 1.336 . . . . 0.0 112.61 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 12.4 tpt -63.51 -34.27 77.4 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -56.47 -42.58 78.45 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.507 0.504 . . . . 0.0 111.441 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -60.37 -43.88 96.16 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.114 -1.403 . . . . 0.0 112.533 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.6 mt -59.97 -51.46 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 122.993 0.517 . . . . 0.0 110.231 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.8 t -58.04 -44.41 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 123.806 0.691 . . . . 0.0 109.172 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 37.5 ttm-85 -55.42 -52.49 63.42 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.953 0.901 . . . . 0.0 111.469 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -55.9 -44.87 78.63 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 123.916 0.76 . . . . 0.0 113.04 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.4 mt -59.36 -52.82 64.01 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.506 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.5 mt -54.29 -48.75 70.93 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.541 176.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -52.25 -48.51 65.18 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.64 1.576 . . . . 0.0 111.198 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.33 -39.03 78.36 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.014 1.725 . . . . 0.0 114.017 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.2 mt -73.84 -16.25 61.14 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.962 1.305 . . . . 0.0 114.163 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.62 -8.31 19.8 Favored Glycine 0 N--CA 1.482 1.743 0 C-N-CA 124.696 1.141 . . . . 0.0 112.824 -177.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -90.11 74.07 7.19 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 123.871 1.795 . . . . 0.0 111.675 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -76.18 -14.73 60.15 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 112.256 -2.247 . . . . 0.0 116.167 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -91.79 93.51 8.89 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.465 1.126 . . . . 0.0 110.218 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.8 t -132.63 140.53 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.591 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.93 152.44 47.12 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 175.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -126.67 141.95 51.69 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -131.54 158.15 41.7 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 112.01 -2.359 . . . . 0.0 108.951 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . 0.314 0.0 OUTLIER -105.37 -17.37 14.46 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 -178.05 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -157.17 169.01 25.75 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 122.009 -0.432 . . . . 0.0 109.924 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -44.82 -54.99 6.48 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 124.743 1.164 . . . . 0.0 114.684 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.3 t -56.67 -56.54 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 122.612 0.365 . . . . 0.0 111.096 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -52.29 -35.91 51.63 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.113 0.965 . . . . 0.0 112.748 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.9 -52.92 24.35 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.551 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.3 mt -52.89 -42.5 65.36 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.801 0.688 . . . . 0.0 111.412 178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -55.71 -57.29 12.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.601 1.56 . . . . 0.0 110.592 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -58.65 -42.2 87.81 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.536 1.535 . . . . 0.0 113.252 177.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.3 mt -59.98 -32.33 70.75 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -55.27 -26.66 41.44 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.83 -15.0 61.25 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.82 -177.43 47.57 Favored Glycine 0 CA--C 1.542 1.73 0 C-N-CA 124.033 0.825 . . . . 0.0 112.566 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.93 -33.2 4.06 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 114.753 -0.723 . . . . 0.0 113.495 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -69.16 122.56 19.04 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.944 0.897 . . . . 0.0 111.827 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.46 23.97 8.27 Favored Glycine 0 N--CA 1.478 1.49 0 O-C-N 126.17 2.169 . . . . 0.0 112.322 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -173.94 133.32 0.44 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.779 1.232 . . . . 0.0 111.398 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.6 t -122.77 122.95 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.823 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.5 mt -110.93 100.04 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 105.861 -1.904 . . . . 0.0 105.861 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.466 ' HG ' ' CE ' ' A' ' 60' ' ' MET . 29.8 t -118.0 130.02 55.93 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -68.5 127.65 33.76 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 111.624 -2.535 . . . . 0.0 110.828 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 32.1 t-105 -48.11 -54.62 12.61 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.515 1.126 . . . . 0.0 112.54 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -104.43 114.35 28.53 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 122.323 1.058 . . . . 0.0 111.167 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.466 ' CE ' ' HG ' ' A' ' 56' ' ' SER . 32.8 mtm -139.73 137.28 18.33 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 111.916 -2.402 . . . . 0.0 109.383 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -57.04 145.54 85.27 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.645 2.897 . . . . 0.0 112.23 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.7 m120 69.41 -59.22 0.49 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.49 1.916 . . . . 0.0 115.009 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 59.3 ttm -133.02 101.4 5.21 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -68.81 164.24 22.37 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 113.634 -1.621 . . . . 0.0 112.323 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -43.91 -50.36 7.41 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 124.857 1.217 . . . . 0.0 114.453 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.9 tp -61.19 -42.6 98.87 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.743 -0.729 . . . . 0.0 112.84 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -65.63 -38.86 90.6 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.631 0.373 . . . . 0.0 111.198 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.14 -43.94 95.34 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.046 0.841 . . . . 0.0 110.345 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.4 tp -55.15 -46.28 75.69 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.697 1.199 . . . . 0.0 110.685 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.63 -46.4 89.1 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.254 0.622 . . . . 0.0 112.366 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.25 12.8 p -62.55 -16.61 56.98 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.954 1.302 . . . . 0.0 114.069 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.9 mt -92.68 -59.76 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.111 1.364 . . . . 0.0 108.08 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.2 mmt-85 -53.32 -46.48 69.46 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 126.386 1.874 . . . . 0.0 113.873 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.74 -29.92 65.04 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -86.37 103.27 14.78 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -23.0 -71.19 0.01 OUTLIER Glycine 0 N--CA 1.483 1.818 0 C-N-CA 126.188 1.852 . . . . 0.0 115.692 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.01 -43.46 77.73 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 75.5 mmm -68.11 -27.02 66.11 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 96.1 p -47.36 -27.87 1.81 Allowed 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.73 -12.23 44.81 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 mt -95.86 115.2 65.37 Favored Pre-proline 0 N--CA 1.485 1.312 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -59.42 142.98 99.81 Favored 'Trans proline' 0 N--CA 1.483 0.903 0 C-N-CA 123.439 2.759 . . . . 0.0 111.329 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.0 t -121.3 126.97 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-O 122.681 1.229 . . . . 0.0 113.234 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.4 tp -112.96 112.11 23.34 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 112.336 -2.211 . . . . 0.0 109.932 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 31.5 mmt -85.85 108.36 18.1 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.955 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.1 t -86.85 98.69 7.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-O 123.234 1.492 . . . . 0.0 107.692 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.8 t -113.26 140.57 47.87 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 112.03 -2.35 . . . . 0.0 109.947 -177.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.12 -50.57 58.57 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.542 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -138.92 153.6 48.27 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.974 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.14 83.74 7.74 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 122.83 1.3 . . . . 0.0 109.209 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -108.89 141.41 41.0 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 112.592 -2.095 . . . . 0.0 111.6 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -40.96 -52.77 3.07 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.621 1.568 . . . . 0.0 113.443 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -55.73 -50.19 71.05 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -62.98 -47.14 84.45 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.184 0.994 . . . . 0.0 111.323 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.8 mt -55.97 -54.57 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.783 1.233 . . . . 0.0 112.585 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.3 mt -55.83 -53.88 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.184 0.594 . . . . 0.0 109.9 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.71 -45.57 74.05 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.481 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.77 -48.7 79.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.23 1.012 . . . . 0.0 113.041 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.59 -43.17 97.74 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.983 0.913 . . . . 0.0 111.633 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -57.86 -33.73 68.99 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.314 1.046 . . . . 0.0 113.541 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.9 -1.62 57.82 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 100.33 13.32 36.21 Favored Glycine 0 CA--C 1.547 2.088 0 N-CA-C 117.676 1.83 . . . . 0.0 117.676 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.04 129.9 43.75 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 118.921 1.36 . . . . 0.0 114.57 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 28.3 m -73.82 -29.29 62.06 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 113.085 -1.87 . . . . 0.0 112.439 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.12 174.99 47.22 Favored Glycine 0 N--CA 1.481 1.672 0 C-N-CA 124.898 1.237 . . . . 0.0 110.466 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -144.88 130.51 18.96 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 113.924 -1.138 . . . . 0.0 111.304 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.292 1.4 p -114.68 121.19 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.205 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.0 t -74.69 115.41 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 111.479 -2.6 . . . . 0.0 111.316 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -91.65 135.57 27.58 Favored Pre-proline 0 C--O 1.24 0.567 0 O-C-N 124.421 1.075 . . . . 0.0 112.298 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -72.75 130.66 20.32 Favored 'Cis proline' 0 N--CA 1.475 0.423 0 N-CA-C 116.725 1.779 . . . . 0.0 116.725 0.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -120.63 137.83 54.23 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 112.073 -2.331 . . . . 0.0 108.213 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 54.3 p -96.48 179.52 4.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 123.85 0.719 . . . . 0.0 110.079 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.26 -36.53 68.67 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 119.504 -0.284 . . . . 0.0 111.324 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.45 -49.54 66.34 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.82 0.848 . . . . 0.0 110.839 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.99 -43.14 99.47 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.146 0.579 . . . . 0.0 110.123 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 40.2 tp -60.66 -53.72 54.03 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.695 0.798 . . . . 0.0 110.492 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -55.16 -45.87 75.71 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.459 0.704 . . . . 0.0 111.083 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -54.79 -47.36 74.08 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.337 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -66.8 -41.92 86.77 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 55.9 mt -57.76 -47.73 81.66 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.722 0.809 . . . . 0.0 109.621 177.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -54.64 -54.02 47.11 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.761 1.624 . . . . 0.0 112.074 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -52.74 -43.65 65.88 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.955 0.902 . . . . 0.0 112.331 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 68.8 mt -60.65 -49.82 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.509 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 N--CA 1.482 1.125 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.218 179.802 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -109.71 61.26 0.6 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 123.347 1.546 . . . . 0.0 109.541 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.1 tp -86.71 136.19 33.11 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 110.846 -2.888 . . . . 0.0 110.212 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -86.96 118.57 26.43 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 125.674 1.859 . . . . 0.0 111.89 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -108.2 148.93 29.24 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 112.826 -1.988 . . . . 0.0 112.868 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.23 104.01 7.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.639 175.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.4 t -84.1 105.3 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 112.526 -2.125 . . . . 0.0 109.197 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 t -104.08 92.45 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.817 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -135.62 127.54 29.49 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.36 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -60.36 -21.41 62.08 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -101.89 131.22 48.38 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.429 0.633 . . . . 0.0 110.995 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.5 p -50.44 -58.55 5.46 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.006 -1.907 . . . . 0.0 112.568 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -45.24 93.77 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.471 1.108 . . . . 0.0 112.614 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 11.9 tpt -59.87 -37.29 78.89 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.4 mtm-85 -58.21 -47.35 83.75 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 176.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -59.61 -43.44 93.77 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.396 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 83.2 mt -56.35 -48.26 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.537 178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 t -63.07 -41.56 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 CA-C-O 118.943 -0.551 . . . . 0.0 109.982 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 57.7 ttm-85 -54.67 -52.47 62.25 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.378 0.671 . . . . 0.0 110.047 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -59.57 -38.43 81.13 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.415 1.086 . . . . 0.0 113.624 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.36 -54.39 37.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.753 0.821 . . . . 0.0 110.91 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.8 mt -55.66 -43.29 76.15 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.139 0.976 . . . . 0.0 111.743 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -56.68 -47.59 79.52 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.103 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -59.95 -37.43 79.55 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.038 1.735 . . . . 0.0 112.684 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.9 mt -72.66 -20.33 61.27 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.639 1.176 . . . . 0.0 113.21 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.81 -15.31 11.31 Favored Glycine 0 CA--C 1.546 2.028 0 C-N-CA 124.591 1.091 . . . . 0.0 114.336 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -89.71 82.23 6.32 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 123.408 1.575 . . . . 0.0 110.578 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -76.65 -7.97 56.33 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -96.98 97.95 9.68 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.071 0.939 . . . . 0.0 110.067 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 83.1 t -134.16 141.45 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.904 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.49 153.2 43.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 174.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -126.07 142.54 51.48 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 116.143 1.905 . . . . 0.0 116.143 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.62 157.25 46.22 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 112.53 -2.123 . . . . 0.0 108.097 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.6 -33.15 9.1 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -138.91 173.09 11.93 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.98 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.67 -56.85 7.08 Favored Glycine 0 N--CA 1.474 1.23 0 CA-C-N 114.254 -1.339 . . . . 0.0 115.551 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.9 t -58.07 -53.84 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 122.922 0.489 . . . . 0.0 111.496 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -51.83 -40.62 60.81 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.939 0.895 . . . . 0.0 111.969 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.8 -51.27 65.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.414 1.086 . . . . 0.0 112.728 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.6 mt -54.47 -47.32 73.09 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.776 0.831 . . . . 0.0 112.104 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -56.77 -55.35 35.38 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.777 1.298 . . . . 0.0 110.256 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -58.19 -39.34 78.71 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.008 -1.451 . . . . 0.0 114.597 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 34.0 mt -58.43 -31.0 67.33 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.962 1.468 . . . . 0.0 114.962 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -58.41 -22.37 53.85 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.534 1.134 . . . . 0.0 114.018 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.86 -26.36 67.32 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.55 175.97 48.48 Favored Glycine 0 N--CA 1.479 1.533 0 C-N-CA 124.211 0.91 . . . . 0.0 113.445 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.19 -27.79 3.49 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 113.539 -1.33 . . . . 0.0 114.933 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -61.44 108.64 0.98 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.959 0.904 . . . . 0.0 112.499 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.42 15.92 59.55 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-N 113.634 -1.621 . . . . 0.0 111.837 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -173.61 141.21 0.84 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.257 1.023 . . . . 0.0 113.757 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.6 t -123.18 111.82 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 113.318 -1.765 . . . . 0.0 108.267 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 76.5 mt -100.9 101.8 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.5 t -119.44 128.21 53.81 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -74.14 132.34 42.15 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.052 -1.886 . . . . 0.0 110.426 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -54.01 -44.02 70.57 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.388 1.055 . . . . 0.0 113.098 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -93.7 99.52 11.92 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.673 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.7 mtm -139.88 137.3 18.17 Favored Pre-proline 0 N--CA 1.478 0.967 0 CA-C-N 114.511 -1.222 . . . . 0.0 112.127 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.1 145.13 93.67 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.789 2.993 . . . . 0.0 113.177 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 65.05 -69.09 0.1 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.316 1.847 . . . . 0.0 112.415 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.6 ttm -116.81 100.27 7.67 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -65.32 173.35 2.61 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 113.476 -1.693 . . . . 0.0 113.24 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -52.23 -54.97 24.04 Favored Glycine 0 N--CA 1.478 1.474 0 C-N-CA 124.703 1.144 . . . . 0.0 115.051 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.8 tp -59.4 -39.85 84.75 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.599 0.76 . . . . 0.0 111.925 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -66.87 -39.8 87.64 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.354 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.24 -45.34 93.59 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.878 0.871 . . . . 0.0 110.089 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.7 tp -52.32 -45.62 65.69 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.517 1.127 . . . . 0.0 111.77 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -60.31 -47.69 84.93 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.998 0.919 . . . . 0.0 113.082 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.32 -38.24 86.17 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.247 1.019 . . . . 0.0 111.335 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.8 mt -67.91 -54.67 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 123.893 0.877 . . . . 0.0 109.467 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 62.1 mmt-85 -54.1 -41.11 67.9 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 125.61 1.564 . . . . 0.0 111.918 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.44 -30.73 68.72 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.963 1.305 . . . . 0.0 113.982 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -83.84 93.98 8.11 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.553 0.741 . . . . 0.0 110.36 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -8.86 -80.15 0.01 OUTLIER Glycine 0 N--CA 1.482 1.729 0 C-N-CA 126.85 2.167 . . . . 0.0 117.254 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.18 -42.81 86.88 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -63.61 -25.28 68.16 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.5 p -53.64 -25.78 19.3 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.22 -22.51 61.25 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.413 1.485 . . . . 0.0 114.439 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . 0.355 1.5 pp -94.02 111.62 53.87 Favored Pre-proline 0 N--CA 1.479 0.997 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -47.46 143.97 10.82 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 125.086 3.857 . . . . 0.0 117.453 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 87.7 t -117.44 121.29 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 112.248 -2.251 . . . . 0.0 111.575 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.8 tp -112.55 115.5 28.73 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.343 -1.753 . . . . 0.0 108.992 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.9 mmt -88.21 112.25 22.55 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.533 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -92.23 96.84 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 123.377 1.56 . . . . 0.0 108.155 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 t -109.22 128.6 55.18 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 111.457 -2.611 . . . . 0.0 111.494 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.12 -38.7 25.77 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -143.37 138.6 29.53 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.24 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.23 84.89 5.13 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.265 -1.334 . . . . 0.0 107.912 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -100.38 133.69 44.43 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 112.055 -2.338 . . . . 0.0 107.253 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -39.12 -49.46 1.8 Allowed 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.941 1.401 . . . . 0.0 113.593 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -58.5 -52.76 64.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.159 0.984 . . . . 0.0 112.079 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -56.33 -44.69 80.24 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.906 0.882 . . . . 0.0 110.928 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 83.4 mt -58.7 -56.15 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.856 0.863 . . . . 0.0 111.195 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.4 mt -57.41 -50.82 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.231 0.612 . . . . 0.0 110.511 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.72 -48.32 72.67 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.891 0.876 . . . . 0.0 113.248 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.21 -48.88 79.98 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.687 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.0 -48.25 82.27 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.27 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -55.6 -42.8 75.36 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.391 1.076 . . . . 0.0 113.897 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.05 -1.37 43.82 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.41 11.47 25.3 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 117.823 1.889 . . . . 0.0 117.823 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.41 125.65 24.89 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.198 1.499 . . . . 0.0 114.86 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.0 m -70.47 -23.15 62.64 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 112.445 -2.161 . . . . 0.0 112.684 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.01 -179.68 45.21 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.541 1.544 . . . . 0.0 110.348 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -147.27 130.45 16.47 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.216 -0.992 . . . . 0.0 111.715 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.7 p -115.36 123.54 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.852 0.834 . . . . 0.0 110.393 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.9 t -77.8 125.44 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 113.231 -1.804 . . . . 0.0 110.679 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -92.66 139.19 23.52 Favored Pre-proline 0 N--CA 1.478 0.934 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.914 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.64 125.36 11.68 Favored 'Cis proline' 0 CA--C 1.54 0.812 0 CA-C-O 122.734 1.056 . . . . 0.0 114.629 0.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -110.01 145.16 37.48 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.039 -1.891 . . . . 0.0 109.015 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 49.9 p -97.89 171.14 8.48 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.35 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.24 -39.07 63.52 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.934 176.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.43 -46.18 84.28 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.88 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.8 m -64.2 -45.98 85.92 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.084 0.954 . . . . 0.0 109.489 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 30.4 tp -56.59 -51.32 69.08 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.099 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -58.22 -47.77 82.47 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.51 0.724 . . . . 0.0 112.372 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -46.08 -47.41 17.2 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.106 0.879 . . . . 0.0 112.291 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -71.54 -47.57 54.32 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.472 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.5 mt -55.86 -45.24 78.54 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.858 0.863 . . . . 0.0 112.27 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -53.66 -55.86 22.33 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.786 1.234 . . . . 0.0 113.295 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -53.17 -47.47 68.8 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.783 -1.553 . . . . 0.0 112.088 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.5 mt -57.1 -44.41 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 114.2 -1.364 . . . . 0.0 113.238 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.835 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.549 0.941 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -84.57 27.46 0.72 Allowed 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.508 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 tt -82.9 130.53 35.15 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.409 1.084 . . . . 0.0 109.898 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.45 102.01 14.14 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.764 176.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -92.85 133.68 35.83 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.183 -1.826 . . . . 0.0 111.638 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.46 104.23 13.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.754 174.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.8 t -80.73 98.27 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.519 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.7 78.61 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 112.69 -2.05 . . . . 0.0 108.42 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -128.47 100.12 5.66 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 113.044 -1.889 . . . . 0.0 112.313 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -27.69 -41.44 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -92.34 124.76 36.64 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.8 p -47.86 -50.5 26.2 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.143 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.91 -46.24 85.26 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.264 0.626 . . . . 0.0 111.456 177.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.06 -45.8 91.95 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.393 0.677 . . . . 0.0 111.373 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -53.67 -46.78 70.73 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.727 0.811 . . . . 0.0 111.133 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -61.92 -43.02 99.71 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 112.993 -1.912 . . . . 0.0 113.735 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.1 mm -57.83 -54.74 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.376 0.671 . . . . 0.0 110.311 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.7 t -55.05 -44.49 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.67 0.788 . . . . 0.0 110.855 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -53.67 -54.83 32.23 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.475 1.11 . . . . 0.0 110.936 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -55.74 -39.71 71.51 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.311 1.044 . . . . 0.0 112.743 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.02 -53.55 53.91 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.559 1.144 . . . . 0.0 111.393 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.1 mt -53.98 -41.86 68.34 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.329 1.052 . . . . 0.0 111.832 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -56.94 -51.43 69.18 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.128 -1.397 . . . . 0.0 109.982 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -56.82 -37.68 71.54 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.654 1.581 . . . . 0.0 112.55 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.2 mt -74.03 -18.08 60.89 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.91 15.5 19.99 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.868 1.223 . . . . 0.0 114.356 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -96.27 101.0 12.58 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 123.347 1.546 . . . . 0.0 112.152 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -60.44 -45.33 94.04 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 111.494 -2.594 . . . . 0.0 117.689 -178.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -100.16 108.55 20.7 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -173.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.1 t -133.24 120.17 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 112.291 -2.231 . . . . 0.0 109.433 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -111.47 154.89 24.05 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -122.46 125.32 45.57 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.5 148.25 44.09 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.073 -1.876 . . . . 0.0 109.844 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.58 -61.08 1.98 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -129.67 179.41 5.84 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.799 -176.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -45.45 -52.79 8.59 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-N 114.594 -1.184 . . . . 0.0 115.182 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.7 t -57.79 -57.86 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.027 0.931 . . . . 0.0 111.471 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -55.68 -36.98 67.71 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.07 0.948 . . . . 0.0 111.335 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.78 -51.36 65.2 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.868 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.8 mt -55.05 -45.95 75.31 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.321 0.648 . . . . 0.0 110.936 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -56.46 -58.01 9.86 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.188 0.995 . . . . 0.0 110.933 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -58.18 -40.92 82.73 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.643 1.577 . . . . 0.0 114.569 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.4 mt -53.57 -41.01 66.08 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -65.04 -15.83 62.77 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.75 14.32 0.21 Allowed 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.28 160.09 6.91 Favored Glycine 0 N--CA 1.483 1.784 0 C-N-CA 126.024 1.773 . . . . 0.0 116.788 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.92 -13.48 3.2 Favored Glycine 0 CA--C 1.546 1.987 0 N-CA-C 120.461 2.944 . . . . 0.0 120.461 176.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -65.76 99.97 0.5 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.923 1.861 . . . . 0.0 115.52 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.4 15.77 62.59 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-N 112.55 -2.114 . . . . 0.0 111.797 177.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -168.31 136.48 2.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 122.577 1.179 . . . . 0.0 113.756 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.4 t -124.23 112.86 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.106 177.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.0 tt -115.96 97.89 6.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 113.714 -1.585 . . . . 0.0 107.055 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.3 t -118.37 139.67 51.01 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 119.523 3.157 . . . . 0.0 119.523 -174.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -73.45 129.64 38.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.324 -2.217 . . . . 0.0 110.662 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 25.0 t-105 -56.15 -39.69 72.67 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.648 0.779 . . . . 0.0 112.401 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -99.35 93.55 5.98 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.497 1.519 . . . . 0.0 110.334 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.0 mtm -132.95 134.88 25.01 Favored Pre-proline 0 N--CA 1.479 1.023 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.79 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -57.11 144.58 89.74 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.729 2.953 . . . . 0.0 111.162 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.7 m120 65.69 -73.62 0.06 Allowed 'General case' 0 N--CA 1.483 1.205 0 O-C-N 125.182 1.551 . . . . 0.0 112.659 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 55.0 ttm -115.12 98.4 6.76 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.84 168.56 3.02 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 112.34 -2.209 . . . . 0.0 112.691 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.46 -52.91 26.76 Favored Glycine 0 N--CA 1.481 1.653 0 C-N-CA 124.632 1.11 . . . . 0.0 114.247 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.5 tp -59.81 -40.99 90.25 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.645 0.778 . . . . 0.0 112.247 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -66.03 -43.64 87.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.703 0.801 . . . . 0.0 111.159 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -58.42 -45.66 88.03 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.499 1.12 . . . . 0.0 110.821 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -52.32 -50.07 62.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.205 1.402 . . . . 0.0 109.818 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -59.28 -47.01 86.99 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.678 1.191 . . . . 0.0 112.836 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.263 27.6 p -61.24 -23.7 65.83 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.585 1.154 . . . . 0.0 112.291 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.3 mt -84.32 -58.88 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.959 0.904 . . . . 0.0 108.65 174.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.5 mmt-85 -48.67 -51.34 28.94 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.909 2.083 . . . . 0.0 113.968 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.1 -21.4 59.91 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.06 97.64 8.87 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -22.25 -61.45 0.03 OUTLIER Glycine 0 N--CA 1.486 2.033 0 C-N-CA 125.976 1.751 . . . . 0.0 116.37 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.11 91.55 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 97.7 mtp -78.44 -24.27 46.18 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.899 1.815 . . . . 0.0 115.899 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 t -27.94 -33.15 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 118.609 2.818 . . . . 0.0 118.609 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.69 -1.52 58.12 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.6 mt -75.23 113.25 23.58 Favored Pre-proline 0 N--CA 1.489 1.491 0 CA-C-N 119.248 0.931 . . . . 0.0 113.119 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -56.62 134.46 64.56 Favored 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.436 2.757 . . . . 0.0 113.245 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.3 t -118.9 120.09 62.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 113.971 -1.468 . . . . 0.0 113.413 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.4 tp -112.22 105.4 13.72 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.815 -1.993 . . . . 0.0 109.361 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.2 mmt -78.25 107.53 10.91 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.815 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -87.18 96.22 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 t -100.15 136.78 39.53 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 111.422 -2.627 . . . . 0.0 114.898 -176.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.88 -24.41 66.86 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 112.691 -2.049 . . . . 0.0 113.487 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -155.91 126.23 6.68 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.173 1.389 . . . . 0.0 111.911 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.0 81.07 7.56 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 122.096 0.951 . . . . 0.0 108.897 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -110.32 136.38 49.59 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.775 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.29 0.0 OUTLIER -33.4 -52.26 0.37 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 117.049 2.241 . . . . 0.0 117.049 -178.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . 0.334 0.8 OUTLIER -63.91 -42.41 97.41 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -179.458 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.301 32.1 p-10 -73.94 -30.68 62.68 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.868 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.3 mt -61.05 -50.85 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.3 mt -53.42 -54.22 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.349 1.46 . . . . 0.0 110.132 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.72 -48.84 72.0 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.484 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.9 -55.54 33.58 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.831 1.252 . . . . 0.0 112.976 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.83 85.28 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.593 0.757 . . . . 0.0 112.283 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -64.36 -34.12 77.42 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.041 1.496 . . . . 0.0 115.041 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.56 -13.18 59.95 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.12 1.01 8.08 Favored Glycine 0 CA--C 1.547 2.058 0 N-CA-C 117.391 1.716 . . . . 0.0 117.391 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.5 120.43 7.17 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 119.707 1.753 . . . . 0.0 115.116 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.7 m -64.31 -32.95 74.75 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.355 -1.748 . . . . 0.0 112.327 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.72 172.85 45.56 Favored Glycine 0 N--CA 1.477 1.378 0 C-N-CA 125.162 1.363 . . . . 0.0 110.061 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -144.01 140.32 29.51 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.4 p -122.63 127.1 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 124.942 1.401 . . . . 0.0 109.959 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.7 p -86.62 132.76 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.829 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.32 137.61 24.64 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.549 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -77.29 139.35 58.13 Favored 'Cis proline' 0 N--CA 1.482 0.799 0 N-CA-C 115.112 1.158 . . . . 0.0 115.112 -0.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -126.92 147.73 50.07 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 112.424 -2.171 . . . . 0.0 107.953 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.4 p -100.3 174.35 6.17 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.298 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.38 -37.93 62.9 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.178 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.26 -47.71 66.99 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.287 1.035 . . . . 0.0 111.89 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 m -58.25 -47.88 82.17 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.3 tp -56.27 -52.12 65.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.757 1.223 . . . . 0.0 111.412 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.81 -44.15 77.57 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.991 0.917 . . . . 0.0 112.449 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -57.72 -43.91 85.6 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -64.55 -45.19 88.14 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.273 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.3 mt -54.08 -49.39 69.19 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.188 0.995 . . . . 0.0 111.468 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -53.94 -55.05 30.56 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.488 1.115 . . . . 0.0 111.945 178.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -51.78 -46.95 64.37 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.147 1.379 . . . . 0.0 111.607 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.4 mt -60.91 -52.15 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.485 1.114 . . . . 0.0 110.646 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 . . . . . 0 N--CA 1.48 1.051 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.383 179.365 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 16.7 ptt-85 . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 p -70.92 79.75 0.64 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 113.166 -1.834 . . . . 0.0 114.831 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -68.75 -26.43 65.23 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 113.659 -1.61 . . . . 0.0 114.325 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 70.55 -32.73 0.25 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 129.323 3.049 . . . . 0.0 117.367 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.92 89.86 3.21 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.548 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 tt -144.26 128.57 17.83 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 112.28 -2.236 . . . . 0.0 107.687 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -82.06 112.86 19.5 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -104.32 132.97 50.0 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.47 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -111.95 99.76 8.35 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.103 0.954 . . . . 0.0 110.06 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.9 t -78.94 103.61 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 112.03 -2.35 . . . . 0.0 108.467 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 t -100.85 90.05 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 113.555 -1.657 . . . . 0.0 107.785 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -132.34 121.59 23.75 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.818 1.294 . . . . 0.0 112.275 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.84 -29.9 70.48 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 111.979 -2.373 . . . . 0.0 115.345 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -98.4 121.31 40.18 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.7 0.625 . . . . 0.0 109.452 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.1 p -50.04 -50.67 46.91 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 m -59.45 -50.12 75.16 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.046 0.538 . . . . 0.0 111.137 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -40.35 94.58 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.135 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.526 HH21 ' NH1' ' A' ' 19' ' ' ARG . 37.1 ttp180 -58.88 -48.33 81.78 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.315 1.046 . . . . 0.0 111.147 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.526 ' NH1' HH21 ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.74 -46.47 89.04 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.387 1.054 . . . . 0.0 111.994 177.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.2 mt -53.97 -50.92 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.828 0.851 . . . . 0.0 110.932 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.8 t -57.23 -48.45 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 122.506 0.323 . . . . 0.0 110.732 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -56.39 -50.77 70.63 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.86 0.725 . . . . 0.0 110.946 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -55.83 -43.33 76.89 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.268 1.027 . . . . 0.0 110.769 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.9 mt -59.97 -51.82 68.03 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.718 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.7 mt -57.11 -43.19 82.06 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.718 0.807 . . . . 0.0 112.81 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -58.2 -48.9 78.88 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.383 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -60.69 -33.99 73.68 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.748 1.619 . . . . 0.0 113.008 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.5 mt -76.2 -13.7 60.17 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.06 -14.44 26.17 Favored Glycine 0 N--CA 1.482 1.755 0 C-N-CA 124.359 0.98 . . . . 0.0 113.741 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -81.23 85.41 6.38 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 122.384 1.088 . . . . 0.0 111.999 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -81.37 13.55 2.91 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -121.83 85.9 2.49 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 123.461 1.601 . . . . 0.0 110.756 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p -136.78 127.63 41.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 113.562 -1.653 . . . . 0.0 111.374 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -119.43 155.29 32.29 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -127.8 139.7 52.49 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.79 167.15 17.72 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 111.175 -2.738 . . . . 0.0 109.748 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -104.35 -53.78 2.65 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -125.0 171.33 10.32 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.199 0.599 . . . . 0.0 110.989 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -45.58 -53.77 8.12 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.992 1.282 . . . . 0.0 115.662 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.5 t -58.25 -55.06 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.671 0.788 . . . . 0.0 111.27 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -54.49 -41.51 69.67 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.672 1.189 . . . . 0.0 111.318 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.1 -49.45 74.41 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.501 1.121 . . . . 0.0 112.146 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.0 mt -52.25 -53.91 37.83 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 124.332 1.02 . . . . 0.0 110.706 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -52.11 -52.2 52.99 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.39 1.056 . . . . 0.0 112.426 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -57.93 -52.8 63.99 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.634 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.1 mt -59.56 -33.09 70.98 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -62.29 -26.27 68.32 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.87 -25.84 68.07 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.79 -168.37 15.96 Favored Glycine 0 N--CA 1.478 1.449 0 O-C-N 124.585 1.178 . . . . 0.0 110.588 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.61 -41.73 2.15 Favored Glycine 0 CA--C 1.541 1.71 0 N-CA-C 116.17 1.228 . . . . 0.0 116.17 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -66.77 135.42 53.95 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.83 19.87 7.34 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 113.801 -1.545 . . . . 0.0 113.62 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -174.29 144.06 0.91 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.762 1.225 . . . . 0.0 111.776 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 t -125.64 124.66 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.886 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.0 mt -115.92 99.99 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.8 t -116.93 137.5 52.17 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 -176.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -77.37 129.49 35.87 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 113.456 -1.702 . . . . 0.0 110.236 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -56.58 -50.4 72.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.101 0.96 . . . . 0.0 112.534 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -87.92 77.28 8.52 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.146 1.379 . . . . 0.0 113.338 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.4 mtm -117.66 133.23 23.32 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-N 113.576 -1.647 . . . . 0.0 113.706 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -61.68 147.02 96.28 Favored 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 123.982 3.122 . . . . 0.0 112.505 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 68.9 -64.08 0.34 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.565 1.946 . . . . 0.0 112.208 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 60.4 ttm -126.69 104.31 8.02 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 124.779 1.231 . . . . 0.0 107.887 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -69.71 168.61 14.57 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 113.614 -1.63 . . . . 0.0 113.178 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.3 -54.57 12.37 Favored Glycine 0 N--CA 1.476 1.314 0 C-N-CA 125.046 1.308 . . . . 0.0 114.393 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.8 tp -59.99 -41.5 92.21 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.66 0.784 . . . . 0.0 112.846 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.5 -43.91 88.65 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.627 0.371 . . . . 0.0 111.228 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.1 tp -58.73 -40.82 84.87 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.091 0.956 . . . . 0.0 110.736 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.0 tp -56.0 -45.64 78.99 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.178 0.991 . . . . 0.0 110.675 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.75 -45.42 89.94 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.018 0.927 . . . . 0.0 112.083 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.251 67.8 p -59.84 -38.31 81.71 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.109 0.964 . . . . 0.0 110.54 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.8 mt -68.98 -54.28 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.637 0.775 . . . . 0.0 109.473 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -52.92 -28.59 24.07 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 126.925 2.09 . . . . 0.0 114.231 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.5 -12.75 15.86 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -80.37 60.39 3.78 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.992 0.917 . . . . 0.0 113.437 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 32.98 -89.5 0.01 OUTLIER Glycine 0 N--CA 1.485 1.964 0 C-N-CA 127.856 2.646 . . . . 0.0 115.036 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.36 -38.58 80.78 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.072 0.949 . . . . 0.0 113.137 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 87.0 mtp -78.17 -11.17 59.9 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.6 m -57.68 -17.6 15.91 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.64 8.31 41.77 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.1 mt -85.11 112.42 43.3 Favored Pre-proline 0 N--CA 1.484 1.247 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.86 139.52 49.95 Favored 'Trans proline' 0 N--CA 1.477 0.547 0 C-N-CA 123.872 3.048 . . . . 0.0 113.365 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.0 t -122.53 127.42 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.457 -1.247 . . . . 0.0 113.684 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.2 tp -114.66 102.2 9.81 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.534 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.4 mmt -78.96 108.31 12.35 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.361 -1.745 . . . . 0.0 113.162 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -85.93 104.89 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.5 p -94.64 139.74 30.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.703 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.93 -45.39 74.47 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.13 -1.396 . . . . 0.0 110.72 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -136.45 128.39 29.39 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.649 -1.614 . . . . 0.0 107.226 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.16 113.46 26.75 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.715 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.4 153.01 51.22 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 113.171 -1.832 . . . . 0.0 108.277 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -41.25 -43.54 2.42 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -53.37 -61.14 2.49 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.463 1.105 . . . . 0.0 112.933 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -69.94 -28.94 65.98 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 88.1 mt -61.55 -52.7 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.739 0.816 . . . . 0.0 110.102 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.6 mt -62.56 -44.33 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.98 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.54 -47.54 69.89 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.187 0.995 . . . . 0.0 112.104 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.71 -53.4 58.65 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.782 1.233 . . . . 0.0 111.75 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.67 90.72 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.204 1.002 . . . . 0.0 112.279 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -57.61 -38.37 74.81 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.64 1.176 . . . . 0.0 113.325 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.96 5.57 32.59 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.06 -5.56 30.5 Favored Glycine 0 CA--C 1.541 1.718 0 N-CA-C 116.825 1.49 . . . . 0.0 116.825 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.55 117.13 5.81 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 119.454 1.627 . . . . 0.0 113.906 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.3 m -62.59 -28.58 69.98 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 112.109 -2.314 . . . . 0.0 113.142 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.1 170.8 43.14 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.982 1.277 . . . . 0.0 110.706 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -143.81 142.16 30.73 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.18 -1.01 . . . . 0.0 111.738 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.0 p -128.92 126.97 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.198 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.4 p -84.47 142.56 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.755 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -90.4 137.85 27.3 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.692 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -86.87 135.63 17.02 Favored 'Cis proline' 0 CA--C 1.539 0.729 0 CA-C-O 122.722 1.051 . . . . 0.0 113.624 -0.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -116.09 151.29 35.88 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 113.467 -1.697 . . . . 0.0 109.558 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.5 p -105.7 177.9 4.72 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.35 0.595 . . . . 0.0 111.384 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.6 -45.1 69.93 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.027 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.33 -48.72 76.85 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.624 0.77 . . . . 0.0 111.221 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.65 -47.97 78.6 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.43 0.692 . . . . 0.0 110.291 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -51.44 70.02 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.445 1.098 . . . . 0.0 109.095 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -55.7 -46.28 77.7 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.644 1.178 . . . . 0.0 112.685 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.03 -48.09 70.88 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.249 0.62 . . . . 0.0 111.352 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -61.94 -47.28 85.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.817 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.5 mt -55.3 -51.1 67.78 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.037 0.835 . . . . 0.0 112.534 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -53.34 -50.51 64.86 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.558 1.143 . . . . 0.0 111.882 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -56.07 -49.01 74.99 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.817 1.647 . . . . 0.0 112.035 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.4 mt -59.47 -48.64 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.278 1.031 . . . . 0.0 110.53 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -58.51 -41.15 84.76 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.03 0.831 . . . . 0.0 112.83 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -62.11 -49.6 75.24 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 124.725 1.266 . . . . 0.0 111.68 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -58.46 -45.88 87.72 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 124.095 0.872 . . . . 0.0 112.462 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.32 -32.14 72.9 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.21 31.99 72.2 Favored Glycine 0 N--CA 1.488 2.128 0 O-C-N 124.406 1.066 . . . . 0.0 111.479 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 4.4 ppp? . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -178.727 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 p -78.54 75.11 5.07 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 112.412 -2.176 . . . . 0.0 111.195 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -129.29 130.38 46.09 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.004 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.4 tptt -54.51 -30.2 52.82 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -118.8 73.29 0.92 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.899 0.857 . . . . 0.0 108.884 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.3 tp -102.27 128.6 48.74 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 112.534 -2.121 . . . . 0.0 109.572 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -74.48 113.42 11.71 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.53 -1.214 . . . . 0.0 114.017 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -107.84 142.53 37.75 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.106 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -123.23 103.76 8.73 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.221 175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 77.1 t -81.28 101.15 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 111.889 -2.414 . . . . 0.0 109.333 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.7 t -100.39 94.65 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 113.685 -1.598 . . . . 0.0 107.149 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -139.23 124.75 19.33 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.779 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.6 p-10 -61.92 -30.7 71.07 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.16 121.56 38.06 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.092 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.3 p -47.0 -50.6 18.88 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 113.2 -1.818 . . . . 0.0 113.025 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 m -60.56 -55.27 35.43 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.1 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -62.69 -35.8 80.85 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -58.55 -47.59 83.69 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.3 1.04 . . . . 0.0 110.395 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.747 ' CZ ' HD22 ' A' ' 23' ' ' ASN . 28.4 tpt180 -60.71 -45.53 93.89 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.286 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 45.5 mm -52.98 -54.73 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.274 1.03 . . . . 0.0 110.41 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.94 -49.05 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 123.562 0.539 . . . . 0.0 111.345 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.601 HH11 HH12 ' A' ' 19' ' ' ARG . 3.3 tmt_? -54.69 -46.3 74.09 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 124.088 0.867 . . . . 0.0 110.592 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.747 HD22 ' CZ ' ' A' ' 19' ' ' ARG . 12.0 m120 -63.81 -47.49 80.62 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.56 1.144 . . . . 0.0 112.158 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.0 mt -52.97 -53.77 45.02 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.284 1.034 . . . . 0.0 112.313 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.7 mt -55.61 -48.0 75.6 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.192 0.997 . . . . 0.0 113.372 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -55.89 -46.56 78.29 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 113.215 -1.811 . . . . 0.0 110.476 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -62.4 -31.1 71.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.073 1.749 . . . . 0.0 113.706 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 73.4 mt -77.15 -10.06 59.15 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.835 1.254 . . . . 0.0 113.904 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.76 -12.83 20.43 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 125.302 1.43 . . . . 0.0 114.53 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -85.57 81.29 8.73 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 122.48 1.133 . . . . 0.0 113.629 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -85.42 29.24 0.69 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 113.168 -1.833 . . . . 0.0 114.431 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -127.62 53.38 1.76 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 123.789 1.757 . . . . 0.0 109.788 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.95 126.19 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.602 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -117.49 165.03 14.01 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.33 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -127.41 141.4 51.69 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 119.508 3.151 . . . . 0.0 119.508 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -132.46 148.96 52.41 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 111.301 -2.681 . . . . 0.0 109.098 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -85.81 -53.77 4.92 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.526 -1.215 . . . . 0.0 112.777 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -130.72 171.06 13.52 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.899 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -45.14 -44.11 9.45 Favored Glycine 0 N--CA 1.477 1.426 0 O-C-N 125.11 1.506 . . . . 0.0 116.524 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.3 t -61.76 -55.76 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 118.18 -0.914 . . . . 0.0 109.908 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -54.54 -40.01 68.25 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 123.596 0.56 . . . . 0.0 110.726 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.41 -54.46 45.37 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.453 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.3 mt -54.65 -51.26 66.01 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.31 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -46.08 -48.65 17.0 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.961 0.904 . . . . 0.0 112.733 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -69.0 -49.83 54.25 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.917 2.087 . . . . 0.0 113.591 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.4 mt -59.44 -36.66 76.34 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -55.43 -25.66 37.44 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.26 -28.1 68.45 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.95 -170.42 23.82 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.538 1.065 . . . . 0.0 111.405 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.05 -46.06 3.1 Favored Glycine 0 N--CA 1.483 1.817 0 CA-C-N 113.814 -1.193 . . . . 0.0 113.748 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -62.21 109.57 1.36 Allowed 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.134 0.969 . . . . 0.0 111.961 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.3 29.56 11.36 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-N 113.2 -1.818 . . . . 0.0 113.363 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -178.72 129.49 0.12 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.053 1.341 . . . . 0.0 112.404 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 t -116.35 116.4 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 113.536 -1.665 . . . . 0.0 107.384 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 77.4 mt -107.2 98.77 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.5 t -118.28 127.11 53.4 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 117.895 2.554 . . . . 0.0 117.895 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.88 128.55 35.83 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.228 -2.26 . . . . 0.0 111.0 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -49.33 -47.32 47.31 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -92.8 106.76 18.68 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.972 0.891 . . . . 0.0 109.125 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.9 mtp -145.98 133.53 10.33 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.687 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.08 146.8 78.08 Favored 'Trans proline' 0 N--CA 1.48 0.691 0 C-N-CA 123.299 2.666 . . . . 0.0 111.969 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 m120 70.31 -72.92 0.1 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.106 1.762 . . . . 0.0 111.069 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.1 ttm -116.88 97.74 6.12 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -64.48 168.75 5.47 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 113.006 -1.906 . . . . 0.0 113.64 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.22 -56.6 10.25 Favored Glycine 0 N--CA 1.479 1.563 0 C-N-CA 124.664 1.126 . . . . 0.0 114.242 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.7 tp -61.03 -37.85 84.05 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.099 0.959 . . . . 0.0 112.96 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -68.53 -38.85 81.2 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.368 0.667 . . . . 0.0 111.151 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 65.4 tp -64.9 -38.93 92.62 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.861 0.864 . . . . 0.0 110.648 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.8 tt -50.63 -49.44 56.79 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.027 0.931 . . . . 0.0 109.254 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -60.43 -42.86 96.93 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.936 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 47.8 p -69.22 -14.92 63.24 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.4 1.08 . . . . 0.0 113.014 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.5 mt -92.51 -54.34 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.156 1.382 . . . . 0.0 107.679 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -50.8 -52.81 37.51 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.688 1.995 . . . . 0.0 112.761 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.0 -14.7 59.42 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -86.85 75.75 9.55 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.664 0.745 . . . . 0.0 111.847 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 30.99 -100.0 0.01 OUTLIER Glycine 0 N--CA 1.483 1.818 0 C-N-CA 126.828 2.156 . . . . 0.0 115.151 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.84 -31.19 72.15 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 95.5 mtp -62.98 -18.0 62.75 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.7 p -53.17 -26.85 18.62 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.82 -16.43 36.21 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.6 mt -76.56 111.41 15.63 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 123.153 0.581 . . . . 0.0 111.51 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -52.49 130.57 36.94 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.389 2.726 . . . . 0.0 115.367 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.61 117.78 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 112.462 -2.154 . . . . 0.0 110.754 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.0 tp -110.37 114.77 28.48 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 113.207 -1.815 . . . . 0.0 108.863 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 28.4 mmt -87.92 104.42 16.59 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 122.91 1.338 . . . . 0.0 114.441 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.02 99.38 7.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 122.91 1.338 . . . . 0.0 107.82 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.2 t -123.1 129.1 51.02 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 113.256 -1.793 . . . . 0.0 112.546 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.75 -32.02 73.33 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.109 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -107.47 106.5 16.93 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.128 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.05 66.15 4.91 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 123.767 1.746 . . . . 0.0 107.098 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -115.99 150.88 36.49 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 111.868 -2.424 . . . . 0.0 111.056 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -33.61 -57.91 0.43 Allowed 'General case' 0 N--CA 1.476 0.826 0 O-C-N 125.488 1.743 . . . . 0.0 114.725 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -51.69 -52.34 48.95 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -61.72 -49.05 77.99 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.317 0.647 . . . . 0.0 111.53 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.0 mt -56.47 -54.89 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.539 1.136 . . . . 0.0 111.629 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.0 mm -57.86 -54.77 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.548 1.139 . . . . 0.0 111.056 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.83 -45.22 67.21 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.05 0.94 . . . . 0.0 112.47 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.17 -53.14 49.35 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.973 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.97 -46.16 85.6 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -57.72 -39.68 77.84 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.371 1.068 . . . . 0.0 113.579 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.51 -26.93 46.02 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 129.22 13.78 2.32 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 116.651 1.42 . . . . 0.0 116.651 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.43 121.37 13.64 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 118.79 1.295 . . . . 0.0 112.295 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.9 m -67.29 -25.78 66.22 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 112.988 -1.914 . . . . 0.0 112.482 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.0 173.11 40.52 Favored Glycine 0 N--CA 1.482 1.705 0 C-N-CA 125.686 1.613 . . . . 0.0 109.66 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -143.35 130.97 21.24 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.25 1.8 p -113.09 123.57 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 122.195 0.998 . . . . 0.0 111.97 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.2 t -72.41 128.36 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 111.609 -2.541 . . . . 0.0 108.963 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -99.93 134.89 20.63 Favored Pre-proline 0 N--CA 1.472 0.638 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.431 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.68 144.28 79.64 Favored 'Cis proline' 0 N--CA 1.482 0.815 0 N-CA-C 115.123 1.163 . . . . 0.0 115.123 0.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -129.77 150.88 50.88 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 112.384 -2.189 . . . . 0.0 107.517 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.3 t -102.34 172.05 7.11 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.773 0.671 . . . . 0.0 110.29 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.34 -43.9 61.89 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.93 0.892 . . . . 0.0 111.698 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.32 -46.64 87.84 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.134 0.974 . . . . 0.0 112.412 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.79 -48.31 81.7 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.456 1.103 . . . . 0.0 109.181 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 48.8 tp -57.67 -51.32 70.01 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.201 1.4 . . . . 0.0 110.329 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -55.53 -47.36 76.42 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.685 0.794 . . . . 0.0 111.54 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.79 -46.43 74.46 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.429 0.692 . . . . 0.0 112.025 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.9 mmmt -63.95 -48.4 76.66 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 124.2 0.937 . . . . 0.0 112.328 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 48.5 mt -53.18 -48.41 68.04 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.498 1.119 . . . . 0.0 110.961 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -55.95 -58.46 7.79 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.534 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -51.32 -44.06 61.86 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.894 1.278 . . . . 0.0 112.37 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 79.3 mt -57.2 -52.06 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.164 1.386 . . . . 0.0 112.307 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -56.64 -42.24 78.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 123.885 0.74 . . . . 0.0 112.19 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -57.13 -52.12 66.57 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 125.237 1.586 . . . . 0.0 111.378 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -65.15 -43.07 93.03 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.15 4.53 17.08 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 58.48 41.5 95.4 Favored Glycine 0 CA--C 1.546 2.007 0 C-N-CA 124.549 1.071 . . . . 0.0 113.05 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 73.2 mtp . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 117.31 -1.328 . . . . 0.0 112.755 -178.669 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.419 ' CG ' ' H ' ' A' ' 2' ' ' SER . 13.9 ptt-85 . . . . . 0 CA--C 1.555 1.154 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.419 ' H ' ' CG ' ' A' ' 1' ' ' ARG . 15.2 m -81.27 65.43 6.4 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.056 1.342 . . . . 0.0 110.068 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -86.13 121.76 29.18 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 113.737 -1.574 . . . . 0.0 111.452 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -51.46 -39.14 56.85 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.282 1.433 . . . . 0.0 113.513 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.83 71.15 10.69 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.591 0.71 . . . . 0.0 109.172 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 tt -121.28 132.77 55.0 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.154 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -77.06 105.51 8.18 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.162 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -109.43 144.9 37.02 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.139 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.71 110.91 16.52 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.64 -1.163 . . . . 0.0 112.012 174.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.5 t -89.84 106.03 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.22 90.06 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 112.864 -1.971 . . . . 0.0 108.888 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -137.88 124.17 20.55 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.184 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -59.88 -25.85 65.41 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -97.88 119.45 36.51 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.248 0.546 . . . . 0.0 110.347 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.9 p -46.05 -48.39 16.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 113.926 -1.488 . . . . 0.0 113.517 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -60.85 -55.06 37.52 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.682 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.2 mmm -59.95 -38.95 83.95 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.492 ' NH1' HH22 ' A' ' 19' ' ' ARG . 15.5 ttm180 -57.1 -53.08 62.16 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.813 0.845 . . . . 0.0 110.153 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.492 HH22 ' NH1' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -58.64 -41.72 86.68 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.142 1.377 . . . . 0.0 113.477 177.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.9 mm -57.1 -58.63 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.261 1.024 . . . . 0.0 110.724 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 t -55.99 -44.56 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.231 0.613 . . . . 0.0 111.537 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 28.6 mtp-105 -54.25 -55.45 28.04 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.96 0.904 . . . . 0.0 112.376 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -59.92 -39.83 86.79 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.9 mt -55.38 -52.38 63.74 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.553 0.692 . . . . 0.0 111.358 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.0 mt -54.66 -48.97 71.71 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.47 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -56.45 -44.89 80.94 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.287 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -58.06 -40.48 81.12 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.434 1.894 . . . . 0.0 112.308 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.2 mt -73.47 -13.95 61.15 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.069 1.347 . . . . 0.0 113.605 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.34 -11.4 24.04 Favored Glycine 0 CA--C 1.544 1.901 0 C-N-CA 124.816 1.198 . . . . 0.0 113.757 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -85.7 76.5 9.95 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 123.23 1.49 . . . . 0.0 111.537 -177.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -72.32 -24.72 61.35 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 118.04 2.607 . . . . 0.0 118.04 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.22 71.68 10.02 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.505 1.145 . . . . 0.0 112.178 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.2 p -120.04 128.6 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -110.79 167.18 10.43 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.573 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -126.75 126.15 42.96 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 -176.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.29 150.97 41.61 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.093 -1.867 . . . . 0.0 108.893 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -92.05 -43.67 9.27 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -141.49 173.34 11.59 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.241 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -43.15 -56.6 4.54 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.065 1.317 . . . . 0.0 115.852 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.1 t -56.16 -54.61 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 123.429 0.691 . . . . 0.0 110.997 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -56.94 -34.27 67.85 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.941 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.41 -48.89 71.24 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.347 1.059 . . . . 0.0 110.971 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.5 mt -57.46 -45.47 84.71 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -55.42 -54.79 39.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.541 1.136 . . . . 0.0 110.927 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -59.66 -45.03 93.27 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 114.399 -1.273 . . . . 0.0 113.641 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.2 mt -55.42 -42.83 74.66 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.327 1.051 . . . . 0.0 112.433 177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -52.92 -35.57 58.47 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.758 1.223 . . . . 0.0 111.493 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.73 59.17 3.55 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.07 -19.63 4.61 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 118.466 2.147 . . . . 0.0 118.466 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.86 56.37 21.39 Favored Glycine 0 CA--C 1.548 2.138 0 CA-C-N 118.23 1.015 . . . . 0.0 112.296 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -50.71 135.63 23.14 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.063 2.145 . . . . 0.0 113.427 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.47 22.18 9.29 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -178.13 129.26 0.13 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.698 1.237 . . . . 0.0 112.237 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.4 t -117.82 113.58 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 112.907 -1.951 . . . . 0.0 107.537 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt -107.94 97.52 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 t -119.04 136.62 54.04 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -71.13 130.18 40.83 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 112.258 -2.246 . . . . 0.0 109.195 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.7 t-105 -58.29 -44.7 88.62 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.706 0.802 . . . . 0.0 111.428 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -94.53 96.17 9.29 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.747 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.6 mtm -134.71 132.76 20.78 Favored Pre-proline 0 N--CA 1.486 1.33 0 CA-C-N 113.651 -1.613 . . . . 0.0 110.362 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -59.34 144.06 99.52 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.763 2.975 . . . . 0.0 112.517 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.8 m120 69.69 -65.02 0.32 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.543 1.937 . . . . 0.0 113.062 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.0 ttm -123.3 96.77 5.12 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -68.34 167.12 15.18 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.034 -1.894 . . . . 0.0 112.548 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -47.0 -55.04 8.8 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.645 1.593 . . . . 0.0 116.152 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.9 tp -56.71 -48.88 76.71 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . 0.268 7.1 pm0 -67.98 -33.76 75.25 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 177.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.11 -43.96 95.22 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.855 0.722 . . . . 0.0 110.079 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.2 tp -54.09 -44.41 71.17 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.416 1.086 . . . . 0.0 110.865 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -64.15 -43.68 94.48 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.55 0.74 . . . . 0.0 111.785 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.263 33.0 p -58.6 -29.86 66.78 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 123.682 0.793 . . . . 0.0 111.99 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.6 mt -80.02 -56.61 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.855 1.262 . . . . 0.0 109.217 177.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -53.94 -47.48 71.23 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.539 1.536 . . . . 0.0 114.076 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.31 -26.32 67.72 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.284 1.033 . . . . 0.0 113.557 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -85.11 108.17 17.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.294 1.038 . . . . 0.0 108.827 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -29.14 -61.78 0.15 Allowed Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.046 1.784 . . . . 0.0 114.95 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.38 -47.9 80.12 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.4 mtm -68.31 -22.19 64.73 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.8 p -46.45 -35.73 5.9 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.31 -13.11 59.45 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 77.4 mt -79.31 111.87 23.96 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 122.857 0.463 . . . . 0.0 111.388 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -51.31 136.42 46.99 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.685 2.923 . . . . 0.0 115.919 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.2 t -120.08 123.34 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 112.843 -1.98 . . . . 0.0 112.686 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.45 110.15 20.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 112.887 -1.96 . . . . 0.0 107.864 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 30.1 mmt -85.22 105.3 15.81 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 113.628 -1.624 . . . . 0.0 111.991 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.52 103.51 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.34 138.38 42.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 112.068 -2.333 . . . . 0.0 115.851 -174.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.17 -27.92 69.4 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.045 -1.889 . . . . 0.0 113.157 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -151.97 110.99 3.86 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 124.171 0.92 . . . . 0.0 110.21 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.43 86.42 4.48 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.494 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -118.85 147.22 44.19 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.956 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -33.53 -55.66 0.44 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -53.24 -49.5 66.7 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.613 0.765 . . . . 0.0 112.33 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.68 -49.07 79.0 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.006 1.323 . . . . 0.0 110.811 177.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 79.4 mt -58.73 -53.21 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 124.508 1.13 . . . . 0.0 111.411 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.0 mt -55.39 -54.49 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.642 1.177 . . . . 0.0 110.537 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.58 -47.2 73.6 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.812 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.52 -58.0 10.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.3 1.04 . . . . 0.0 112.84 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.16 -49.01 78.49 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.518 0.727 . . . . 0.0 112.619 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -65.91 -25.37 67.12 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.4 1.45 54.67 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.75 -4.84 24.38 Favored Glycine 0 CA--C 1.545 1.95 0 N-CA-C 116.829 1.492 . . . . 0.0 116.829 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.63 119.81 9.96 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.098 1.449 . . . . 0.0 114.686 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.5 m -63.48 -30.45 71.57 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 110.823 -2.899 . . . . 0.0 113.691 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -174.58 167.07 39.21 Favored Glycine 0 N--CA 1.476 1.32 0 C-N-CA 124.501 1.048 . . . . 0.0 110.761 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -142.5 138.42 30.93 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.625 -0.788 . . . . 0.0 112.065 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.98 131.17 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 124.243 0.964 . . . . 0.0 112.277 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.5 p -79.26 134.79 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 113.417 -1.72 . . . . 0.0 110.803 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.13 136.73 37.84 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.022 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -87.22 153.34 42.85 Favored 'Cis proline' 0 CA--C 1.541 0.873 0 CA-C-O 122.451 0.938 . . . . 0.0 112.771 -1.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -131.42 150.61 52.08 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 113.468 -1.696 . . . . 0.0 108.949 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.7 t -101.92 169.71 8.6 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 123.776 0.673 . . . . 0.0 111.829 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.33 37.38 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.427 1.091 . . . . 0.0 112.187 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.22 -52.02 66.54 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.877 0.871 . . . . 0.0 112.31 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -57.09 -48.96 77.32 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.249 1.02 . . . . 0.0 110.081 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.1 tp -56.49 -52.82 63.3 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.919 1.387 . . . . 0.0 110.349 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -55.24 -48.97 73.17 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.497 1.119 . . . . 0.0 112.573 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -50.91 -46.68 60.8 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.978 0.911 . . . . 0.0 112.107 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -67.78 -52.38 37.85 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.233 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.2 mt -48.04 -51.36 24.53 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.68 0.792 . . . . 0.0 112.238 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -52.25 -55.92 18.1 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.846 1.258 . . . . 0.0 112.32 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -61.57 -39.71 92.13 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.193 1.397 . . . . 0.0 113.096 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 31.6 mm -57.56 -49.18 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.962 0.905 . . . . 0.0 111.045 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -52.12 -45.42 64.91 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.357 0.663 . . . . 0.0 112.364 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -59.38 -53.55 56.94 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.092 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -59.28 -42.91 92.35 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.51 6.14 7.64 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.54 -7.68 46.36 Favored Glycine 0 CA--C 1.545 1.946 0 C-N-CA 124.59 1.09 . . . . 0.0 114.922 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 89.7 mtp . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.023 -1.465 . . . . 0.0 113.122 -178.827 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 . . . . . 0 CA--C 1.559 1.291 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.1 p -74.14 20.01 0.11 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.205 1.402 . . . . 0.0 114.378 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -117.25 77.65 1.15 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 123.105 1.431 . . . . 0.0 111.684 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -55.43 -31.88 62.26 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 112.341 -2.209 . . . . 0.0 116.409 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.13 27.82 0.65 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 tt -77.91 132.59 37.99 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.618 0.767 . . . . 0.0 109.932 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -84.04 104.51 14.17 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 125.032 1.458 . . . . 0.0 112.762 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -104.28 142.29 34.81 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 113.081 -1.872 . . . . 0.0 114.165 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.71 112.14 18.91 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.447 173.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 83.1 t -84.26 94.0 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 t -98.21 85.8 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 123.832 1.777 . . . . 0.0 106.284 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -126.97 121.08 30.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 111.908 -2.405 . . . . 0.0 113.488 -175.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -60.04 -28.15 67.52 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 112.233 -2.258 . . . . 0.0 115.702 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -99.03 103.88 15.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.211 -1.404 . . . . 0.0 107.211 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -41.79 -42.82 2.76 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.975 1.31 . . . . 0.0 113.735 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -51.75 62.98 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.801 1.24 . . . . 0.0 111.41 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 13.4 ttt -64.27 -36.19 83.28 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.87 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -52.71 -50.27 63.7 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.633 1.173 . . . . 0.0 110.533 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -58.6 -51.08 71.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.771 1.228 . . . . 0.0 110.211 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.0 mt -55.11 -51.8 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.047 0.939 . . . . 0.0 112.162 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 t -57.09 -44.48 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 118.461 0.573 . . . . 0.0 110.992 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -50.26 71.73 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.205 1.402 . . . . 0.0 109.615 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -60.3 -41.59 93.73 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.6 1.16 . . . . 0.0 112.302 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.2 mt -56.87 -51.13 70.28 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.252 1.021 . . . . 0.0 110.685 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.8 mt -55.88 -45.71 78.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.018 0.927 . . . . 0.0 111.857 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -56.36 -46.73 79.89 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.678 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -59.83 -38.7 82.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.358 1.463 . . . . 0.0 112.602 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.8 mt -71.2 -13.17 61.83 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.507 1.123 . . . . 0.0 113.836 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.3 -1.17 32.95 Favored Glycine 0 CA--C 1.541 1.676 0 C-N-CA 124.808 1.194 . . . . 0.0 114.806 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -79.2 108.93 13.06 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 123.322 1.534 . . . . 0.0 114.385 -177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -67.87 -51.34 49.32 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 110.726 -2.943 . . . . 0.0 117.42 -176.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -97.45 97.24 8.93 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -174.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -133.21 118.39 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.971 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -106.28 161.49 14.5 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.31 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.89 119.37 21.07 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.61 165.45 16.44 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 113.299 -1.773 . . . . 0.0 109.597 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -109.69 -38.71 5.33 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 118.017 2.599 . . . . 0.0 118.017 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -128.67 167.62 16.94 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.867 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -44.24 -57.71 4.81 Favored Glycine 0 N--CA 1.478 1.477 0 C-N-CA 125.831 1.681 . . . . 0.0 114.529 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.7 t -55.3 -58.45 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.549 0.739 . . . . 0.0 111.702 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.38 -32.83 57.93 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.74 -50.57 64.31 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.51 1.124 . . . . 0.0 111.249 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.4 mt -58.55 -43.38 89.27 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.873 0.733 . . . . 0.0 110.679 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -54.3 -58.49 7.21 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.492 0.717 . . . . 0.0 110.641 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -61.69 -39.66 92.22 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 tp -54.66 -37.26 65.51 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.914 1.286 . . . . 0.0 113.669 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -68.63 -10.17 54.39 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.81 15.85 0.34 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.82 94.3 1.98 Allowed Glycine 0 N--CA 1.481 1.661 0 N-CA-C 115.443 0.937 . . . . 0.0 115.443 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 17.84 88.46 0.01 OUTLIER Glycine 0 CA--C 1.546 2.021 0 C-N-CA 128.683 3.039 . . . . 0.0 120.248 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -88.63 104.32 16.75 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.894 -1.153 . . . . 0.0 109.89 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.64 27.22 1.9 Allowed Glycine 0 N--CA 1.478 1.458 0 CA-C-N 114.039 -1.437 . . . . 0.0 114.919 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -178.71 131.52 0.12 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.49 1.516 . . . . 0.0 113.062 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.1 t -126.55 115.0 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 113.188 -1.823 . . . . 0.0 107.744 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 94.9 mt -106.2 101.17 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.6 t -120.0 133.42 55.55 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 117.623 2.453 . . . . 0.0 117.623 -175.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -73.67 136.39 43.8 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.185 -1.371 . . . . 0.0 111.059 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -56.73 -49.31 75.59 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.016 0.822 . . . . 0.0 111.324 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -92.29 101.38 13.86 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.11 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 30.0 mtm -133.85 125.28 18.19 Favored Pre-proline 0 N--CA 1.482 1.131 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.363 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -55.52 150.55 42.37 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 124.009 3.139 . . . . 0.0 111.635 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 70.47 -69.51 0.17 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.461 1.904 . . . . 0.0 111.5 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 18.6 ttp -127.04 109.21 11.65 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -64.94 167.29 7.93 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.327 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.56 -48.82 63.54 Favored Glycine 0 N--CA 1.48 1.619 0 C-N-CA 124.273 0.939 . . . . 0.0 114.602 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.45 -40.07 93.13 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.826 0.45 . . . . 0.0 112.183 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -63.37 -41.82 98.84 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.83 -49.83 75.89 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.949 0.9 . . . . 0.0 110.964 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 tt -46.75 -50.79 17.56 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.28 1.432 . . . . 0.0 109.274 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.69 -46.57 84.92 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.266 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 47.2 p -59.24 -25.31 63.92 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.094 0.958 . . . . 0.0 112.982 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.4 mt -84.02 -58.04 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -49.74 -46.77 50.74 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.875 1.67 . . . . 0.0 113.122 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.37 -18.79 57.05 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -82.57 94.82 7.58 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.736 -0.602 . . . . 0.0 110.178 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -21.18 -62.48 0.02 OUTLIER Glycine 0 CA--C 1.547 2.062 0 C-N-CA 126.88 2.181 . . . . 0.0 116.232 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.16 89.07 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.1 mtm -87.26 -34.67 18.85 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.4 t 2.57 -61.03 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 121.385 3.846 . . . . 0.0 121.385 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.24 25.03 0.62 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 118.855 2.909 . . . . 0.0 118.855 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.2 mt -83.05 118.94 73.25 Favored Pre-proline 0 N--CA 1.483 1.19 0 O-C-N 121.306 -0.872 . . . . 0.0 112.794 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.36 128.34 28.85 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 123.53 2.82 . . . . 0.0 113.675 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 t -116.57 119.89 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 113.13 -1.85 . . . . 0.0 112.645 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.2 tp -108.55 109.45 20.69 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.384 -1.734 . . . . 0.0 108.766 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 82.9 mmm -87.32 112.44 22.08 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 113.89 -1.505 . . . . 0.0 114.597 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.56 102.62 13.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 123.901 1.81 . . . . 0.0 108.319 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.9 t -115.71 130.26 56.79 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 111.593 -2.549 . . . . 0.0 109.426 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -46.42 -40.99 13.07 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -141.78 148.55 39.1 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.41 83.3 3.85 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 122.97 1.366 . . . . 0.0 107.718 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -92.68 112.36 24.29 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 111.011 -2.813 . . . . 0.0 109.139 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -34.57 -56.03 0.54 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 117.431 2.382 . . . . 0.0 117.431 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . 0.258 0.0 OUTLIER -55.58 -42.86 75.35 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 177.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -62.63 -47.59 83.07 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.672 1.189 . . . . 0.0 110.335 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.1 mm -58.08 -49.71 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.1 1.36 . . . . 0.0 112.537 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.7 mt -60.1 -50.66 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.284 0.634 . . . . 0.0 110.271 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.89 -46.43 81.92 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.777 0.831 . . . . 0.0 111.908 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.71 -56.24 19.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.427 1.491 . . . . 0.0 112.241 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.38 -48.35 82.13 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.071 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -56.53 -37.72 70.88 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.84 -16.45 55.41 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.65 12.65 7.15 Favored Glycine 0 CA--C 1.545 1.916 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.34 106.1 3.25 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.981 1.372 . . . . 0.0 111.36 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.9 m -56.89 -27.22 60.33 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 112.234 -2.257 . . . . 0.0 113.25 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -173.6 169.08 42.14 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.209 0.909 . . . . 0.0 111.406 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -142.62 142.27 32.08 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.643 -0.778 . . . . 0.0 110.948 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.61 131.47 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 124.742 1.276 . . . . 0.0 111.491 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -79.79 126.0 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 112.34 -2.209 . . . . 0.0 110.301 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -91.52 130.6 38.76 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 112.843 -1.98 . . . . 0.0 110.511 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.41 148.39 77.07 Favored 'Cis proline' 0 N--CA 1.484 0.937 0 O-C-N 123.233 1.123 . . . . 0.0 114.953 0.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -130.31 156.53 44.51 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.002 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 69.9 p -108.96 174.83 5.69 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.693 0.797 . . . . 0.0 111.013 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.99 -39.0 68.56 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.142 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.71 -47.39 72.5 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.039 0.936 . . . . 0.0 111.263 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.0 m -61.32 -46.0 92.12 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 50.6 tp -56.24 -50.67 70.65 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.925 1.29 . . . . 0.0 109.529 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -55.42 -48.77 73.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.293 1.037 . . . . 0.0 111.488 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -55.93 -46.89 78.37 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.361 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.3 mptp? -63.92 -42.18 97.45 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.114 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.8 mt -53.87 -51.02 64.97 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.219 0.608 . . . . 0.0 111.101 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -50.05 -52.29 35.59 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.333 1.053 . . . . 0.0 113.137 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -53.59 -47.05 70.52 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.478 1.511 . . . . 0.0 112.386 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 57.8 mt -57.46 -51.52 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.872 1.269 . . . . 0.0 111.925 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -56.51 -38.83 72.33 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -61.86 -48.06 82.22 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.817 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -58.25 -41.12 83.53 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.364 1.066 . . . . 0.0 112.175 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -73.4 13.29 0.47 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.66 23.41 73.87 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 125.374 1.464 . . . . 0.0 114.508 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 76.2 mtp . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 116.704 -1.617 . . . . 0.0 112.219 -179.061 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.081 0 N-CA-C 116.048 1.869 . . . . 0.0 116.048 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.6 t -52.26 112.27 0.77 Allowed 'General case' 0 C--O 1.241 0.628 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -76.06 85.74 2.95 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -54.71 -28.79 50.46 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -100.07 41.1 1.18 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 123.206 1.479 . . . . 0.0 113.791 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 tt -86.25 124.72 32.94 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.277 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -75.96 107.92 8.5 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 125.095 1.497 . . . . 0.0 113.393 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -102.88 132.83 48.82 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 112.402 -2.181 . . . . 0.0 111.8 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.46 102.7 11.77 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.069 -1.053 . . . . 0.0 109.288 173.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.14 98.72 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 113.481 -1.69 . . . . 0.0 106.777 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.3 t -108.24 60.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 112.241 -2.254 . . . . 0.0 107.138 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -109.56 90.38 3.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 113.359 -1.746 . . . . 0.0 108.638 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -13.58 -42.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 121.58 3.919 . . . . 0.0 121.58 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.532 ' C ' ' H ' ' A' ' 16' ' ' THR . 2.6 t80 -87.57 109.6 19.76 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.487 ' HG ' ' CZ ' ' A' ' 18' ' ' ARG . 3.3 t -65.98 27.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 124.167 1.937 . . . . 0.0 115.697 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -123.72 -58.52 1.58 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.062 2.545 . . . . 0.0 105.448 177.031 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -35.82 75.96 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.696 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.487 ' CZ ' ' HG ' ' A' ' 15' ' ' SER . 8.8 ttp180 -53.76 -50.93 64.94 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.521 1.529 . . . . 0.0 112.139 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.617 ' CZ ' HD22 ' A' ' 23' ' ' ASN . 3.0 tmt_? -65.24 -38.37 90.15 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.809 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 71.6 mt -57.73 -46.3 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.7 t -58.26 -42.52 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.462 0.705 . . . . 0.0 110.049 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.437 ' NH2' ' HE ' ' A' ' 19' ' ' ARG . 46.9 ttp180 -53.01 -52.57 57.97 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.187 0.995 . . . . 0.0 110.575 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.617 HD22 ' CZ ' ' A' ' 19' ' ' ARG . 80.9 m-20 -57.71 -41.02 80.88 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.355 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -59.62 -51.44 69.79 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.135 0.974 . . . . 0.0 110.774 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.9 mt -56.56 -44.51 81.01 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.015 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -58.59 -42.26 87.69 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.981 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -59.78 -38.55 82.16 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.627 1.171 . . . . 0.0 110.48 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 mp -74.94 -11.9 60.22 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.29 2.236 . . . . 0.0 115.17 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.82 -0.61 41.91 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.035 1.302 . . . . 0.0 114.648 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -89.13 97.95 11.49 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 123.266 1.508 . . . . 0.0 112.459 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -72.46 -37.33 68.55 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 110.858 -2.883 . . . . 0.0 116.056 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -95.91 96.4 8.89 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.749 1.262 . . . . 0.0 113.895 -173.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.2 t -129.66 131.96 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.407 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -117.72 154.8 31.07 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -126.96 120.19 28.52 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.31 152.99 39.54 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 113.611 -1.631 . . . . 0.0 109.863 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -78.37 -66.13 0.89 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -129.44 -176.61 3.95 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 117.972 -1.013 . . . . 0.0 112.16 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -45.39 -53.55 7.98 Favored Glycine 0 N--CA 1.482 1.766 0 O-C-N 125.048 1.467 . . . . 0.0 114.112 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -57.32 -57.87 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.348 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -55.52 -34.65 64.84 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.26 -53.56 56.85 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.753 1.221 . . . . 0.0 110.385 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.4 mt -60.27 -41.87 94.2 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.928 0.891 . . . . 0.0 111.313 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -53.35 -52.14 60.18 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.811 0.844 . . . . 0.0 111.233 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -70.36 -41.2 73.43 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 124.212 0.945 . . . . 0.0 113.141 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.9 mt -54.42 -36.42 63.98 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -52.33 -26.46 12.29 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.4 -19.16 64.44 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.44 -170.42 52.17 Favored Glycine 0 N--CA 1.474 1.224 0 C-N-CA 124.427 1.013 . . . . 0.0 111.113 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.75 -29.7 1.52 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 115.504 0.962 . . . . 0.0 115.504 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -67.85 107.99 2.83 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.52 -22.86 52.74 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-N 112.587 -2.097 . . . . 0.0 110.028 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -133.35 141.65 48.02 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -174.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.5 t -127.16 110.68 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 113.765 -1.562 . . . . 0.0 107.343 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.1 tt -110.22 93.3 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 124.094 1.902 . . . . 0.0 106.607 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.1 t -117.27 147.76 42.27 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 111.887 -2.415 . . . . 0.0 115.433 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -79.63 144.29 33.92 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.733 -1.122 . . . . 0.0 112.834 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 20.3 t-105 -61.23 -47.2 87.16 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.077 177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -95.59 103.38 15.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.673 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 54.0 mtm -134.99 134.24 21.58 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-N 113.243 -1.799 . . . . 0.0 110.531 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -60.42 143.62 99.48 Favored 'Trans proline' 0 N--CA 1.482 0.827 0 C-N-CA 123.186 2.59 . . . . 0.0 112.089 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 m120 67.89 -69.81 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.902 1.681 . . . . 0.0 113.763 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.1 ttm -114.86 98.75 7.01 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -61.56 165.87 4.59 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 112.605 -2.088 . . . . 0.0 111.932 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.44 -52.08 29.73 Favored Glycine 0 N--CA 1.476 1.353 0 C-N-CA 124.692 1.139 . . . . 0.0 115.081 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 42.2 tp -58.84 -38.46 78.74 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.225 1.01 . . . . 0.0 113.222 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -72.44 -36.27 68.51 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.57 0.748 . . . . 0.0 111.014 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -59.03 -38.22 78.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.804 0.841 . . . . 0.0 111.016 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.1 mp -50.92 -52.24 44.1 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.76 1.224 . . . . 0.0 109.832 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -56.38 -48.76 76.21 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.042 -1.435 . . . . 0.0 112.505 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.3 p -58.17 -33.42 69.22 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.8 mt -80.8 -57.35 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -49.23 -45.82 45.09 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.344 1.858 . . . . 0.0 114.11 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.74 -25.52 61.23 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -81.34 93.9 6.65 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.187 0.595 . . . . 0.0 109.514 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -25.71 -58.76 0.07 OUTLIER Glycine 0 CA--C 1.542 1.753 0 C-N-CA 127.078 2.275 . . . . 0.0 116.756 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.77 -38.91 83.12 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 91.3 mtp -89.52 -45.38 9.45 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.412 1.485 . . . . 0.0 114.608 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.2 t 8.82 -78.21 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 120.091 3.367 . . . . 0.0 120.091 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.03 29.25 0.13 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 118.655 2.835 . . . . 0.0 118.655 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.4 mt -76.62 133.81 70.12 Favored Pre-proline 0 N--CA 1.479 0.981 0 O-C-N 121.184 -0.947 . . . . 0.0 111.876 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -56.81 114.23 1.83 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.816 2.344 . . . . 0.0 112.806 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 37.0 t -109.94 110.97 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 111.704 -2.498 . . . . 0.0 109.245 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.1 tp -106.56 104.08 13.68 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 112.805 -1.998 . . . . 0.0 109.363 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.5 mmt -78.57 118.13 20.4 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 113.053 -1.885 . . . . 0.0 112.678 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 t -91.18 96.72 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.7 p -94.38 114.97 27.11 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.256 -1.793 . . . . 0.0 112.886 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.05 -22.01 5.37 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -166.74 118.79 0.97 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.61 92.96 4.77 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.578 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -101.68 132.19 47.51 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.395 177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -41.17 -46.78 3.14 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.734 1.213 . . . . 0.0 114.134 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -52.74 -55.32 23.62 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.708 1.603 . . . . 0.0 110.973 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -58.91 -42.91 90.73 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.352 1.461 . . . . 0.0 111.241 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.7 mm -60.39 -49.09 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.52 1.128 . . . . 0.0 111.547 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 37.4 mt -57.73 -50.95 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.81 -45.84 74.43 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.087 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.42 -54.89 41.71 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.693 1.197 . . . . 0.0 112.418 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.38 -41.99 81.27 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.334 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -66.14 -40.04 90.31 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.73 0.55 52.49 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 117.674 2.472 . . . . 0.0 117.674 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.34 21.6 6.85 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 117.702 1.841 . . . . 0.0 117.702 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -82.62 110.32 17.58 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.416 1.108 . . . . 0.0 112.029 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.9 m -59.99 -30.26 69.01 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 113.219 -1.81 . . . . 0.0 113.519 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.25 173.45 46.28 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.198 1.38 . . . . 0.0 110.055 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -148.83 139.08 22.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.052 -0.574 . . . . 0.0 112.527 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.9 p -115.2 117.93 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 124.2 0.937 . . . . 0.0 109.505 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.0 p -71.33 109.45 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 113.076 -1.874 . . . . 0.0 114.261 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -83.13 130.11 58.43 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 111.079 -2.782 . . . . 0.0 107.681 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.6 133.34 26.6 Favored 'Cis proline' 0 CA--C 1.54 0.78 0 O-C-N 123.962 1.506 . . . . 0.0 114.854 0.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -130.58 157.25 43.23 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 112.653 -2.067 . . . . 0.0 109.01 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.2 t -116.61 176.02 5.3 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.063 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.45 -41.78 61.08 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.203 1.001 . . . . 0.0 111.82 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.99 -50.07 73.55 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.568 0.747 . . . . 0.0 112.819 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.32 -45.04 94.81 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.623 1.169 . . . . 0.0 109.982 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 58.1 tp -56.99 -50.54 72.38 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.305 1.042 . . . . 0.0 109.888 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -58.13 -47.65 82.66 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.61 0.764 . . . . 0.0 111.376 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -51.22 -43.36 61.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.484 0.714 . . . . 0.0 112.278 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -72.78 -41.7 64.74 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.187 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.1 mt -56.96 -46.31 82.23 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.398 0.679 . . . . 0.0 111.157 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -52.14 -48.18 65.01 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.089 1.356 . . . . 0.0 111.935 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -52.93 -48.81 67.02 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.129 1.372 . . . . 0.0 111.595 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.1 mt -60.47 -49.43 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.267 1.027 . . . . 0.0 111.68 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -57.01 -38.96 73.83 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.686 0.794 . . . . 0.0 112.064 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -63.21 -43.04 99.25 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 123.773 0.671 . . . . 0.0 112.153 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -73.14 -54.18 9.14 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.275 1.03 . . . . 0.0 113.32 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.3 mt -90.65 36.43 0.9 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 32.28 51.64 0.4 Allowed Glycine 0 N--CA 1.489 2.204 0 C-N-CA 126.202 1.858 . . . . 0.0 116.519 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 7.2 mmt . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 115.041 -2.409 . . . . 0.0 116.221 -178.947 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -73.67 79.81 1.52 Allowed 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 122.598 1.19 . . . . 0.0 113.41 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -79.12 80.17 5.48 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.045 0.926 . . . . 0.0 112.178 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -50.63 -49.49 56.73 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.27 50.93 1.82 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.756 1.265 . . . . 0.0 114.042 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.1 tt -109.76 122.96 48.69 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.768 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -81.76 109.28 16.01 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.108 0.956 . . . . 0.0 112.495 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -96.24 139.24 32.67 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 111.802 -2.454 . . . . 0.0 111.783 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -118.19 104.87 11.22 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.437 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.2 t -83.7 111.19 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 112.095 -2.321 . . . . 0.0 108.775 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -114.02 91.13 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.544 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -137.19 115.27 11.59 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.745 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -80.12 77.12 6.85 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.966 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.5 t80 172.25 115.09 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 111.816 -2.447 . . . . 0.0 106.127 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.2 t -42.25 -55.67 3.22 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.228 1.011 . . . . 0.0 113.338 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.69 -47.5 85.38 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.708 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -45.55 92.59 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.165 0.586 . . . . 0.0 111.829 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -59.26 -45.2 91.83 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.759 1.224 . . . . 0.0 110.472 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -43.89 96.01 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.121 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.0 mt -56.17 -57.26 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-O 118.589 -0.719 . . . . 0.0 111.084 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 t -54.1 -44.53 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 123.512 0.507 . . . . 0.0 111.19 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -55.92 -53.45 56.73 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.065 1.346 . . . . 0.0 111.735 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -62.87 -38.8 92.3 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.127 0.971 . . . . 0.0 113.331 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.7 mt -56.92 -48.88 77.22 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.175 0.99 . . . . 0.0 111.114 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.9 mt -60.27 -44.81 94.99 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.783 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -56.44 -45.13 80.95 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.0 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -60.32 -35.99 76.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.479 1.512 . . . . 0.0 113.032 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.0 mt -74.44 -2.03 23.71 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.306 1.443 . . . . 0.0 114.372 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.8 -9.89 60.38 Favored Glycine 0 CA--C 1.542 1.76 0 C-N-CA 124.566 1.079 . . . . 0.0 112.752 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -93.15 76.71 4.63 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 123.126 1.441 . . . . 0.0 110.078 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -66.29 -24.04 66.49 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.593 ' ND2' ' H ' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -78.7 80.83 5.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.653 1.581 . . . . 0.0 112.062 -178.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.5 130.35 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.929 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -120.61 160.91 22.29 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.57 147.87 52.36 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 120.398 3.481 . . . . 0.0 120.398 -176.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.54 163.88 31.64 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 110.94 -2.845 . . . . 0.0 108.307 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -112.04 -35.51 5.64 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -129.07 158.57 38.55 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.875 0.735 . . . . 0.0 111.148 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -39.27 -52.89 2.79 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 125.528 1.767 . . . . 0.0 116.064 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.3 t -59.77 -50.12 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 118.481 -0.771 . . . . 0.0 112.582 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -56.04 -44.05 78.41 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.045 0.926 . . . . 0.0 109.672 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.27 -52.15 65.92 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.398 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.4 mt -51.08 -51.25 55.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.406 1.066 . . . . 0.0 111.022 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -53.29 -54.79 31.28 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.447 1.099 . . . . 0.0 112.475 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -57.6 -48.9 78.12 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 113.808 -1.542 . . . . 0.0 113.043 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 31.2 mt -59.79 -41.74 91.83 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.536 1.134 . . . . 0.0 112.479 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -57.24 -25.43 59.12 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.16 -19.77 63.18 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.41 -166.31 19.68 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.854 1.216 . . . . 0.0 111.434 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.38 -41.43 1.84 Allowed Glycine 0 N--CA 1.483 1.775 0 C-N-CA 124.3 0.952 . . . . 0.0 115.241 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -70.91 136.1 48.36 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.69 16.51 7.87 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 112.656 -2.065 . . . . 0.0 113.397 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -172.41 140.08 1.06 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.367 1.067 . . . . 0.0 111.975 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 t -122.37 114.1 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.045 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.7 mt -108.44 98.96 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.0 t -120.87 137.09 54.75 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -73.18 133.82 44.17 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 112.348 -2.205 . . . . 0.0 110.197 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -59.26 -49.77 76.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.027 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -88.78 99.86 12.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.391 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 8.7 mtm -141.95 121.77 8.17 Favored Pre-proline 0 N--CA 1.478 0.931 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.106 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -62.28 164.42 17.57 Favored 'Trans proline' 0 N--CA 1.479 0.627 0 C-N-CA 123.208 2.605 . . . . 0.0 109.006 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 70.82 -79.68 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.09 0.956 . . . . 0.0 109.633 -176.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.5 ttm -130.36 107.31 9.16 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.854 0.862 . . . . 0.0 108.948 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -62.85 162.08 11.65 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.029 -1.441 . . . . 0.0 112.895 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.21 -53.41 15.41 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 124.975 1.274 . . . . 0.0 114.793 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.67 -44.98 93.38 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.172 0.589 . . . . 0.0 111.887 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.71 -40.81 98.34 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -44.52 88.7 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.722 1.209 . . . . 0.0 110.328 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tp -58.97 -47.09 86.38 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.515 1.126 . . . . 0.0 111.012 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.13 -43.41 91.97 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.536 0.735 . . . . 0.0 112.76 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.268 4.7 p -64.29 -33.93 76.96 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.114 0.966 . . . . 0.0 111.811 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.5 mt -69.32 -56.49 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.0 mmt-85 -53.53 -43.37 68.32 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.476 1.51 . . . . 0.0 113.065 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.77 -30.13 65.22 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -87.84 95.56 10.14 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.136 0.574 . . . . 0.0 112.088 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -13.65 -72.51 0.01 OUTLIER Glycine 0 N--CA 1.489 2.169 0 C-N-CA 127.821 2.629 . . . . 0.0 117.478 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.46 -40.54 68.51 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 50.9 mtm -88.53 -14.16 38.4 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.2 m -48.12 -25.14 1.34 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 117.365 2.358 . . . . 0.0 117.365 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.98 -7.81 50.99 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.2 111.56 9.71 Favored Pre-proline 0 N--CA 1.485 1.283 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -51.96 133.9 47.4 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 123.181 2.587 . . . . 0.0 113.921 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.2 t -120.53 126.82 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 122.812 1.292 . . . . 0.0 113.304 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -113.01 116.89 30.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 111.656 -2.52 . . . . 0.0 107.389 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 28.6 mmt -95.39 109.89 22.0 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 122.734 1.254 . . . . 0.0 113.437 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.31 96.02 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 123.178 1.466 . . . . 0.0 107.428 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -108.17 141.29 40.12 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 112.357 -2.201 . . . . 0.0 114.241 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.3 -29.59 70.88 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.404 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -134.1 129.33 35.81 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.299 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -94.1 55.83 2.13 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 123.997 1.856 . . . . 0.0 108.489 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -98.81 139.91 33.78 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 112.887 -1.961 . . . . 0.0 107.542 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -34.52 -48.47 0.36 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -51.62 -49.83 61.47 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.736 0.647 . . . . 0.0 112.556 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -64.06 -47.81 78.67 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.504 1.122 . . . . 0.0 111.507 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 68.9 mt -57.94 -57.26 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.809 1.244 . . . . 0.0 111.83 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.9 mt -54.56 -52.75 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.878 0.871 . . . . 0.0 110.307 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.21 -52.71 58.01 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.151 0.981 . . . . 0.0 112.194 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.15 -52.58 64.75 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.677 1.191 . . . . 0.0 113.095 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.36 -48.84 80.11 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.64 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -60.07 -36.19 76.8 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.12 -6.58 55.15 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.01 4.14 27.75 Favored Glycine 0 CA--C 1.548 2.148 0 N-CA-C 116.151 1.22 . . . . 0.0 116.151 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.02 119.73 10.67 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.906 1.353 . . . . 0.0 112.099 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.2 m -64.12 -36.32 83.64 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 112.362 -2.199 . . . . 0.0 112.448 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -169.79 178.67 42.61 Favored Glycine 0 CA--C 1.541 1.659 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.749 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -152.96 143.01 22.31 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.4 p -122.39 125.41 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 124.623 1.202 . . . . 0.0 109.972 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.1 p -85.54 122.64 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 113.937 -1.483 . . . . 0.0 111.073 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -83.83 138.12 40.63 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 113.764 -1.562 . . . . 0.0 113.249 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.41 143.01 75.0 Favored 'Cis proline' 0 CA--C 1.546 1.1 0 O-C-N 123.072 1.038 . . . . 0.0 114.787 0.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -134.91 151.12 50.6 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 112.31 -2.223 . . . . 0.0 108.642 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.2 t -107.16 175.61 5.44 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.189 0.931 . . . . 0.0 109.928 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.64 -42.46 56.34 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.936 0.894 . . . . 0.0 111.993 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.3 -44.45 95.0 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.294 1.038 . . . . 0.0 112.886 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.24 -48.66 77.28 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.466 0.707 . . . . 0.0 109.333 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.3 tp -55.94 -46.96 78.35 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.935 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -58.36 -50.9 72.0 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.891 0.876 . . . . 0.0 110.975 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -49.19 -45.25 43.87 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.719 0.808 . . . . 0.0 112.618 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -66.24 -48.09 71.66 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.741 1.216 . . . . 0.0 111.807 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.61 -46.73 83.72 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.064 0.946 . . . . 0.0 111.902 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -48.14 -53.48 16.56 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.478 1.511 . . . . 0.0 112.079 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.1 tttt -51.68 -47.91 63.68 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 113.841 -1.527 . . . . 0.0 112.161 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.3 mm -58.49 -57.47 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.693 1.197 . . . . 0.0 109.644 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -52.47 -49.31 64.92 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.597 1.159 . . . . 0.0 113.334 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.52 -46.73 89.08 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.71 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.96 -41.52 96.52 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.926 1.291 . . . . 0.0 111.792 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.6 mp -93.6 15.45 16.13 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.74 -46.79 2.07 Favored Glycine 0 N--CA 1.48 1.599 0 C-N-CA 125.053 1.311 . . . . 0.0 114.397 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 21.0 ptt? . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -179.445 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t -124.14 145.21 49.44 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.36 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -81.74 92.93 6.71 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.197 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -56.39 -24.15 42.74 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -86.5 66.03 9.31 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 123.42 1.581 . . . . 0.0 110.911 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.2 tt -102.38 135.87 43.23 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.049 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -77.87 110.29 12.63 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -110.07 142.65 41.24 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.824 1.649 . . . . 0.0 112.698 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.89 110.34 17.63 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 122.22 1.01 . . . . 0.0 109.932 173.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.7 t -85.92 107.87 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 113.862 -1.517 . . . . 0.0 107.495 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.74 94.36 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.745 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -135.27 131.92 37.14 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.702 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -60.63 -25.01 65.97 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -101.07 105.34 16.51 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 44.3 p -41.21 -45.61 2.9 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -52.79 61.95 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.404 1.082 . . . . 0.0 112.188 176.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -39.05 87.74 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.561 0.344 . . . . 0.0 110.222 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -55.45 -51.58 66.44 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.495 1.118 . . . . 0.0 110.683 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.629 ' CZ ' HD22 ' A' ' 23' ' ' ASN . 10.3 ttt180 -63.92 -36.53 84.25 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.3 mm -55.73 -47.5 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 122.625 0.37 . . . . 0.0 110.474 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -60.1 -44.44 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 122.849 0.459 . . . . 0.0 110.092 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.492 ' NH1' HH21 ' A' ' 19' ' ' ARG . 0.0 OUTLIER -54.19 -50.03 67.98 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.457 1.103 . . . . 0.0 110.575 176.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.629 HD22 ' CZ ' ' A' ' 19' ' ' ARG . 23.2 m120 -59.69 -44.65 93.57 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.495 0.718 . . . . 0.0 111.814 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.7 mt -56.06 -52.62 63.61 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.293 1.037 . . . . 0.0 111.442 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 73.9 mt -54.91 -45.51 74.74 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.759 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -56.88 -46.39 81.91 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.285 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -59.5 -40.61 87.6 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.879 1.672 . . . . 0.0 111.746 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.4 mp -70.8 -16.14 62.71 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.892 1.677 . . . . 0.0 114.755 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.55 -5.81 33.33 Favored Glycine 0 CA--C 1.543 1.832 0 C-N-CA 125.342 1.448 . . . . 0.0 114.05 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -92.94 67.66 4.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 123.506 1.622 . . . . 0.0 111.022 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -69.48 -14.09 62.69 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 116.974 2.213 . . . . 0.0 116.974 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -92.84 78.2 4.76 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 122.924 1.345 . . . . 0.0 108.987 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 p -126.87 130.87 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 113.757 -1.565 . . . . 0.0 114.189 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -106.64 156.29 18.77 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 113.615 -1.629 . . . . 0.0 107.885 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -123.85 121.92 36.65 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.06 157.47 42.28 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 113.547 -1.661 . . . . 0.0 108.433 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -105.24 -40.63 5.78 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -130.71 162.3 29.75 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.289 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -42.63 -50.58 5.78 Favored Glycine 0 N--CA 1.484 1.855 0 O-C-N 125.531 1.769 . . . . 0.0 115.943 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.4 t -58.69 -53.58 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 119.091 -0.48 . . . . 0.0 111.541 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.51 -37.14 74.96 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.471 0.709 . . . . 0.0 110.995 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.45 -54.08 48.08 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.044 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.46 -38.13 86.1 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 123.862 0.727 . . . . 0.0 112.853 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -57.55 -50.33 73.45 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.126 0.891 . . . . 0.0 111.099 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -67.67 -42.97 81.3 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.828 1.251 . . . . 0.0 112.63 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.87 -45.09 93.58 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.535 1.934 . . . . 0.0 114.563 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -57.8 -14.62 6.23 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.67 -23.64 66.17 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.902 0.881 . . . . 0.0 112.337 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.15 -178.51 43.4 Favored Glycine 0 N--CA 1.48 1.609 0 C-N-CA 125.107 1.337 . . . . 0.0 113.757 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.4 -26.12 3.58 Favored Glycine 0 N--CA 1.482 1.705 0 CA-C-N 113.662 -1.269 . . . . 0.0 116.154 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -64.51 111.03 2.51 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.73 12.57 65.94 Favored Glycine 0 CA--C 1.541 1.665 0 O-C-N 125.103 1.502 . . . . 0.0 112.472 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -168.73 141.06 2.75 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.016 0.926 . . . . 0.0 112.071 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.6 t -129.39 122.58 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.543 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.8 mt -111.68 102.53 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.2 t -122.27 133.84 54.68 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 116.909 2.188 . . . . 0.0 116.909 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -73.82 127.99 34.31 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 111.335 -2.666 . . . . 0.0 110.767 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -56.04 -43.57 77.96 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.778 1.231 . . . . 0.0 110.73 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -91.13 94.49 9.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.202 1.401 . . . . 0.0 109.062 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 15.2 mtm -141.24 121.87 8.72 Favored Pre-proline 0 N--CA 1.476 0.83 0 CA-C-N 114.179 -1.373 . . . . 0.0 113.516 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -55.25 158.74 11.48 Favored 'Trans proline' 0 N--CA 1.479 0.652 0 C-N-CA 123.139 2.56 . . . . 0.0 110.945 175.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.349 21.3 p30 66.84 -72.36 0.09 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.226 2.21 . . . . 0.0 112.024 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 43.4 ttp -128.86 108.18 10.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.508 0.723 . . . . 0.0 109.728 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -62.43 164.6 7.12 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.474 -1.694 . . . . 0.0 113.033 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.78 -54.76 23.7 Favored Glycine 0 N--CA 1.479 1.555 0 C-N-CA 125.132 1.349 . . . . 0.0 114.24 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.3 tp -57.01 -40.95 77.61 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.7 -40.43 84.32 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.553 0.341 . . . . 0.0 111.562 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.01 -41.03 95.75 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.778 1.231 . . . . 0.0 110.784 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tt -51.76 -51.2 58.04 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.286 1.434 . . . . 0.0 108.718 176.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -59.41 -43.19 93.07 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.429 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.7 p -69.25 -0.61 6.37 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.5 mt -109.64 -62.02 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.2 -44.52 61.61 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.16 1.784 . . . . 0.0 113.83 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.83 -3.35 49.1 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -85.69 99.85 11.59 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -10.25 -77.87 0.01 OUTLIER Glycine 0 N--CA 1.488 2.165 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.96 -41.23 99.46 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 76.6 mtp -85.93 -6.71 59.02 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.6 t -34.06 -61.99 0.34 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 118.972 2.953 . . . . 0.0 118.972 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.41 18.05 0.45 Allowed 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 119.248 3.055 . . . . 0.0 119.248 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 69.9 mt -84.9 120.14 73.4 Favored Pre-proline 0 CA--C 1.543 0.708 0 O-C-N 121.215 -0.928 . . . . 0.0 112.689 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.22 132.96 45.97 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.812 3.008 . . . . 0.0 113.901 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.3 t -118.96 115.58 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 112.61 -2.086 . . . . 0.0 112.314 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.5 tp -107.43 105.59 15.58 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 113.858 -1.519 . . . . 0.0 107.635 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.5 mmt -79.35 138.19 37.6 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 113.284 -1.78 . . . . 0.0 111.708 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.7 t -112.43 104.66 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 p -102.47 152.56 20.98 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.439 -1.255 . . . . 0.0 113.587 -175.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.62 -40.12 95.96 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.361 -1.745 . . . . 0.0 111.705 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -159.95 148.36 17.18 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.693 1.597 . . . . 0.0 112.211 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.48 94.68 8.59 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.149 0.906 . . . . 0.0 109.813 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -125.38 130.36 51.76 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.418 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -25.95 -61.11 0.07 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 116.42 2.008 . . . . 0.0 116.42 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -57.19 -46.17 83.08 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -68.62 -37.41 79.72 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 91.5 mt -59.41 -50.02 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.386 1.075 . . . . 0.0 109.051 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.4 mm -55.67 -55.46 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.468 1.107 . . . . 0.0 110.241 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.54 -49.3 62.24 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.237 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.96 -57.28 13.52 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.451 1.1 . . . . 0.0 113.646 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.78 -51.03 71.25 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.244 1.017 . . . . 0.0 111.995 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.19 -30.23 70.92 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.12 -13.19 58.93 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.61 -3.21 12.18 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 116.895 1.518 . . . . 0.0 116.895 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.78 114.09 2.14 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 118.918 1.359 . . . . 0.0 112.878 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.0 m -63.56 -26.79 68.86 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 112.007 -2.36 . . . . 0.0 113.76 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.7 166.25 35.89 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.742 1.163 . . . . 0.0 110.353 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -142.25 137.63 30.83 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 p -121.51 131.95 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.89 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.98 139.63 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.598 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.08 140.42 28.98 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.617 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.62 135.86 20.28 Favored 'Cis proline' 0 C--N 1.352 0.715 0 O-C-N 122.47 0.721 . . . . 0.0 110.983 -2.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -113.43 154.71 26.53 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.293 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.8 t -110.27 178.24 4.45 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.15 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.27 -44.19 61.76 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.664 1.185 . . . . 0.0 111.893 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.24 -51.72 67.78 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.245 1.018 . . . . 0.0 111.888 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.44 -47.21 82.39 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.191 0.996 . . . . 0.0 110.389 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 47.7 tp -56.58 -53.51 56.69 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.11 1.364 . . . . 0.0 109.506 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -53.89 -47.19 71.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.77 1.228 . . . . 0.0 112.354 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.38 -50.25 70.21 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -62.54 -43.15 99.52 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 61.7 mt -52.84 -46.23 67.71 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -55.4 -51.64 66.18 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.584 0.754 . . . . 0.0 112.843 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -56.5 -43.36 79.64 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.35 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 62.2 mt -58.44 -53.56 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.038 0.935 . . . . 0.0 110.58 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -56.45 -39.87 73.87 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.736 0.814 . . . . 0.0 113.144 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.43 -52.83 62.95 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.098 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -57.6 -41.23 80.78 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.777 0.831 . . . . 0.0 112.006 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.8 mp -60.79 -22.8 64.49 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.041 1.336 . . . . 0.0 114.428 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 61.9 39.37 97.43 Favored Glycine 0 CA--C 1.542 1.75 0 C-N-CA 124.04 0.829 . . . . 0.0 111.963 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 26.1 ptm . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -178.588 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.1 t -84.05 76.66 10.04 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -38.26 -31.22 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -176.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -26.14 24.68 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 177.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -66.77 9.03 0.2 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.821 2.048 . . . . 0.0 115.574 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.52 97.04 3.61 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -175.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -79.53 111.27 15.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.724 -1.58 . . . . 0.0 111.692 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -92.26 136.58 33.08 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 112.141 -2.3 . . . . 0.0 112.107 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.16 104.04 12.52 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 118.698 -1.201 . . . . 0.0 109.145 173.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.2 t -80.29 97.54 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 112.968 -1.923 . . . . 0.0 105.848 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.0 t -101.04 84.6 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 112.702 -2.044 . . . . 0.0 107.808 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -133.94 121.14 21.25 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.105 -1.861 . . . . 0.0 111.752 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -54.9 -28.23 49.02 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 112.264 -2.244 . . . . 0.0 115.55 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -97.34 119.71 36.37 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.559 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.3 p -50.39 -50.93 50.24 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 125.028 1.455 . . . . 0.0 112.929 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -43.78 98.35 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.188 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 13.2 tpt -62.64 -40.89 98.45 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -56.14 -49.23 74.52 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.695 0.798 . . . . 0.0 111.578 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -60.18 -43.3 95.96 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.523 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.2 mt -56.18 -50.43 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.097 0.559 . . . . 0.0 110.583 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.85 -43.13 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.218 0.607 . . . . 0.0 111.524 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -51.99 -52.0 53.44 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.531 0.732 . . . . 0.0 111.273 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -57.72 -40.84 80.51 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.737 0.815 . . . . 0.0 112.839 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.03 -52.01 67.18 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.445 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.7 mt -58.54 -42.11 87.08 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.083 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -59.1 -47.49 85.06 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.353 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -54.98 -39.44 68.99 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 125.327 1.451 . . . . 0.0 112.293 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.4 mt -73.21 -17.28 61.37 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.21 17.72 19.32 Favored Glycine 0 CA--C 1.543 1.807 0 C-N-CA 124.567 1.08 . . . . 0.0 113.349 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -110.14 89.68 3.09 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 122.943 1.354 . . . . 0.0 112.126 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -68.54 -29.11 67.61 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 112.557 -2.11 . . . . 0.0 115.058 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.24 91.32 7.7 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 123.049 1.405 . . . . 0.0 113.481 -175.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.0 t -133.89 125.89 49.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 112.884 -1.962 . . . . 0.0 110.867 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -110.26 153.59 24.62 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -125.92 124.8 41.62 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.49 153.87 36.06 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.552 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -4.0 19.85 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -165.84 157.4 14.06 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.452 0.701 . . . . 0.0 110.64 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -39.9 -53.78 3.09 Favored Glycine 0 CA--C 1.544 1.856 0 O-C-N 125.04 1.463 . . . . 0.0 115.517 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.01 -52.84 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 122.414 0.286 . . . . 0.0 111.439 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -55.71 -38.76 70.15 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.568 1.147 . . . . 0.0 110.16 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.98 -58.57 7.39 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.233 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.17 -39.51 56.56 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.985 0.803 . . . . 0.0 112.531 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -63.69 -64.2 0.96 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.561 1.144 . . . . 0.0 109.92 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -55.38 -37.65 67.84 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 126.91 2.084 . . . . 0.0 115.319 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.9 tp -54.47 -25.86 27.8 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -90.94 -17.79 25.8 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.95 69.54 7.56 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.73 81.47 1.52 Allowed Glycine 0 CA--C 1.541 1.665 0 N-CA-C 118.496 2.158 . . . . 0.0 118.496 174.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 18.81 76.99 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 C-N-CA 128.012 2.72 . . . . 0.0 119.366 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -83.94 127.69 34.03 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.239 -0.981 . . . . 0.0 110.301 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.78 8.21 50.45 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.201 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -166.64 144.5 5.15 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.85 110.87 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 175.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.8 tt -115.08 98.05 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 t -120.73 142.07 49.86 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 120.485 3.513 . . . . 0.0 120.485 -174.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -72.4 129.2 37.81 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 113.039 -1.892 . . . . 0.0 109.879 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 37.7 t-105 -53.71 -38.73 64.57 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.742 0.817 . . . . 0.0 112.544 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -105.6 108.46 19.99 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.584 0.754 . . . . 0.0 110.139 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 50.7 mtm -139.71 126.39 12.41 Favored Pre-proline 0 N--CA 1.478 0.966 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.78 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.76 118.48 5.41 Favored 'Trans proline' 0 N--CA 1.482 0.829 0 C-N-CA 124.048 3.165 . . . . 0.0 111.837 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 99.17 -76.25 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 129.224 3.01 . . . . 0.0 110.119 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.8 ttm -112.28 93.92 4.68 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.253 0.549 . . . . 0.0 109.744 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -59.74 162.28 5.42 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 112.133 -2.303 . . . . 0.0 112.068 178.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.88 -53.63 25.59 Favored Glycine 0 N--CA 1.477 1.433 0 C-N-CA 124.516 1.055 . . . . 0.0 114.296 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.8 tp -59.64 -37.87 79.85 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -70.69 -40.96 72.6 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.157 0.583 . . . . 0.0 110.369 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.9 tp -56.62 -44.86 81.6 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.111 0.964 . . . . 0.0 110.188 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 tt -48.79 -51.22 30.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.212 1.405 . . . . 0.0 109.363 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.37 -45.86 92.04 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.651 1.18 . . . . 0.0 112.538 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 p -61.9 -15.36 42.26 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.6 mt -96.31 -65.46 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -53.17 -43.35 67.0 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.163 2.185 . . . . 0.0 115.195 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.49 -10.41 49.1 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -89.4 112.32 23.41 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -42.79 -18.64 0.05 OUTLIER Glycine 0 CA--C 1.547 2.092 0 C-N-CA 127.601 2.524 . . . . 0.0 118.978 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.27 -50.77 3.84 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.64 0.776 . . . . 0.0 111.576 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 88.9 mmm -70.08 -25.15 63.39 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 118.718 2.859 . . . . 0.0 118.718 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.6 t -58.64 39.19 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 118.255 2.687 . . . . 0.0 118.255 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -123.55 -37.05 2.69 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.77 2.028 . . . . 0.0 111.073 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.1 mt -66.1 117.6 44.39 Favored Pre-proline 0 N--CA 1.472 0.657 0 C-N-CA 126.158 1.783 . . . . 0.0 115.299 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.35 137.91 63.1 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.631 2.221 . . . . 0.0 111.121 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.94 110.26 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 113.812 -1.54 . . . . 0.0 112.668 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.1 tp -106.7 107.43 18.44 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.142 -1.845 . . . . 0.0 109.46 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.8 mmt -81.71 111.56 18.08 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 113.581 -1.645 . . . . 0.0 113.438 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.0 97.36 7.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 177.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.5 t -107.14 134.57 50.06 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 112.032 -2.349 . . . . 0.0 115.646 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.21 -8.28 56.16 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 113.151 -1.841 . . . . 0.0 112.639 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -144.82 95.92 2.77 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.124 0.964 . . . . 0.0 113.09 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.03 64.17 8.31 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 123.429 1.585 . . . . 0.0 109.766 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -116.21 150.24 37.84 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.963 -1.926 . . . . 0.0 111.123 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -34.48 -51.95 0.48 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 115.329 1.604 . . . . 0.0 115.329 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -52.32 -57.57 9.35 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.494 0.718 . . . . 0.0 112.161 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -61.19 -41.04 96.11 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 85.2 mt -58.09 -51.13 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 124.125 0.891 . . . . 0.0 109.753 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 80.4 mt -54.91 -55.81 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.412 1.085 . . . . 0.0 109.892 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.21 -50.55 64.48 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.146 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.37 -52.42 63.68 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.88 -47.7 84.68 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -63.2 -36.78 84.79 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.52 -21.74 61.87 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.34 20.97 4.95 Favored Glycine 0 N--CA 1.48 1.568 0 N-CA-C 116.445 1.338 . . . . 0.0 116.445 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.77 118.91 12.34 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.456 1.128 . . . . 0.0 112.029 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.8 m -64.05 -28.3 69.7 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 113.52 -1.673 . . . . 0.0 111.992 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.61 172.26 45.23 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 124.149 0.88 . . . . 0.0 110.979 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -148.82 137.4 21.22 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.288 -0.956 . . . . 0.0 111.865 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.43 127.73 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 124.642 1.214 . . . . 0.0 109.438 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.0 p -81.04 139.97 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.782 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -94.6 131.63 30.42 Favored Pre-proline 0 CA--C 1.55 0.976 0 O-C-N 123.883 0.74 . . . . 0.0 111.255 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.3 151.88 69.33 Favored 'Cis proline' 0 N--CA 1.48 0.723 0 O-C-N 123.069 1.036 . . . . 0.0 113.46 -0.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -134.17 152.23 51.73 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 113.316 -1.765 . . . . 0.0 107.724 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.7 p -98.74 172.85 7.2 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.803 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.36 -41.62 72.79 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.822 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.11 -44.35 89.05 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.065 0.946 . . . . 0.0 111.702 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.2 m -61.25 -44.93 96.44 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.319 0.647 . . . . 0.0 110.041 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -60.44 -47.57 85.54 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.59 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -56.61 -43.06 79.81 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.496 1.118 . . . . 0.0 112.283 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -52.55 -45.51 66.41 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.124 0.57 . . . . 0.0 111.758 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -68.14 -42.32 80.3 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.196 0.998 . . . . 0.0 112.176 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 59.2 mt -53.88 -53.45 52.36 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.926 0.89 . . . . 0.0 111.433 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -50.54 -53.7 28.2 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.714 1.606 . . . . 0.0 111.957 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -49.27 -48.48 45.91 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.358 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 26.9 mt -63.01 -50.02 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 125.026 1.33 . . . . 0.0 112.284 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -58.72 -43.02 90.04 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.396 1.078 . . . . 0.0 111.875 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.69 -27.99 68.08 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -102.1 -53.45 2.92 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 117.755 2.502 . . . . 0.0 117.755 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 pp -111.61 -3.72 14.99 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.07 -160.39 18.62 Favored Glycine 0 N--CA 1.475 1.287 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . 0.307 14.3 ptp . . . . . 0 C--O 1.256 1.416 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.764 ' CZ ' HD21 ' A' ' 121' ' ' ASN . 18.7 ptt180 . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.5 p -73.68 87.58 1.69 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.728 1.252 . . . . 0.0 113.698 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -73.33 98.52 2.71 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.277 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -49.6 -38.85 33.35 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.95 54.41 1.26 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tt -111.41 118.83 36.9 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 113.673 -1.603 . . . . 0.0 112.064 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -75.74 108.83 8.86 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -97.53 140.71 31.56 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.522 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.38 109.6 18.58 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.23 101.37 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 124.972 1.42 . . . . 0.0 107.169 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 t -100.17 85.4 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -123.48 124.6 43.24 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 110.765 -2.925 . . . . 0.0 113.039 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -65.65 -19.22 65.82 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 110.955 -2.839 . . . . 0.0 116.23 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -110.09 127.79 55.07 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.303 0.377 . . . . 0.0 110.436 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.1 p -47.4 -59.31 3.3 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 113.683 -1.598 . . . . 0.0 113.721 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -66.75 -42.3 86.39 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.6 ttt -60.36 -38.32 83.48 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.058 0.39 . . . . 0.0 111.309 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -54.97 -50.91 67.76 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.62 1.168 . . . . 0.0 110.392 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.631 ' NH2' HD22 ' A' ' 23' ' ' ASN . 4.9 mtp-105 -65.03 -39.35 93.23 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.924 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.7 mm -55.95 -51.24 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.1 t -58.78 -45.98 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 123.596 0.56 . . . . 0.0 109.991 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -49.24 -53.92 19.22 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.888 0.875 . . . . 0.0 111.838 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.631 HD22 ' NH2' ' A' ' 19' ' ' ARG . 48.0 m-80 -62.98 -39.01 93.43 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.495 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.8 mt -58.95 -52.41 65.85 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.632 0.773 . . . . 0.0 110.564 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.7 mt -54.98 -47.18 74.93 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.065 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -54.03 -50.15 67.3 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.416 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -58.71 -40.14 82.84 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.601 1.561 . . . . 0.0 112.288 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.7 mt -71.96 -10.35 59.65 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.543 1.137 . . . . 0.0 113.135 177.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.31 -16.39 24.66 Favored Glycine 0 CA--C 1.546 2.002 0 C-N-CA 125.226 1.393 . . . . 0.0 113.677 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -87.69 72.7 9.47 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 123.366 1.555 . . . . 0.0 113.015 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -69.2 -8.42 45.5 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.705 -1.589 . . . . 0.0 113.891 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.402 ' ND2' ' H ' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -94.17 83.9 4.35 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.483 1.513 . . . . 0.0 110.53 -178.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.35 137.8 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.775 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.59 159.15 18.42 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.888 1.275 . . . . 0.0 108.922 176.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -126.5 108.9 11.6 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.47 158.36 20.8 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.967 1.307 . . . . 0.0 110.287 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -101.87 -39.03 7.56 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -138.94 170.44 15.97 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.349 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -47.1 -51.93 13.29 Favored Glycine 0 N--CA 1.474 1.227 0 C-N-CA 124.646 1.117 . . . . 0.0 115.552 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.6 t -57.73 -54.43 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.409 0.683 . . . . 0.0 110.683 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -57.56 -33.61 68.32 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.583 0.753 . . . . 0.0 111.694 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.09 -50.71 67.25 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 117.172 -1.394 . . . . 0.0 110.971 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.8 mt -57.06 -45.99 82.8 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 123.752 0.658 . . . . 0.0 111.131 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -52.62 -54.32 34.73 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.199 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -63.16 -42.45 99.42 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.725 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 26.4 mt -56.7 -35.98 69.13 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.726 1.21 . . . . 0.0 113.139 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.19 -24.36 17.93 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.86 -23.64 67.43 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.251 1.02 . . . . 0.0 113.053 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.74 179.83 50.19 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 124.805 1.193 . . . . 0.0 113.922 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.73 -14.94 8.61 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 116.544 1.377 . . . . 0.0 116.544 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -68.19 121.58 16.5 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.263 1.03 . . . . 0.0 113.64 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -106.23 10.1 43.03 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 112.505 -2.134 . . . . 0.0 111.959 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -168.94 145.43 3.54 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.5 t -128.75 111.15 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 113.389 -1.732 . . . . 0.0 107.663 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.1 tt -107.34 96.64 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.3 t -118.33 134.47 55.01 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -72.08 134.36 45.76 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.883 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -55.63 -48.58 74.7 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.828 0.851 . . . . 0.0 111.498 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -96.52 97.77 9.69 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.224 0.952 . . . . 0.0 111.271 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 29.6 mtm -131.15 138.67 33.43 Favored Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 113.782 -1.553 . . . . 0.0 111.826 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -58.87 143.93 99.06 Favored 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.144 2.562 . . . . 0.0 111.518 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.345 27.9 p30 65.12 -66.64 0.14 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 127.313 2.245 . . . . 0.0 114.295 -177.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.8 ttm -122.36 100.43 6.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.881 0.872 . . . . 0.0 108.691 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.27 167.18 8.71 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 112.413 -2.176 . . . . 0.0 112.875 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.4 -56.18 9.72 Favored Glycine 0 N--CA 1.482 1.717 0 C-N-CA 125.177 1.37 . . . . 0.0 114.123 -178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.7 tp -57.57 -39.89 77.73 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -70.63 -40.45 73.12 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.99 -0.444 . . . . 0.0 110.547 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -57.87 -42.27 84.21 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.071 0.548 . . . . 0.0 110.668 176.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 tt -51.1 -49.93 59.75 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.842 1.657 . . . . 0.0 109.705 176.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -56.89 -47.33 80.77 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.392 1.077 . . . . 0.0 113.66 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.359 13.7 t -70.69 5.58 1.84 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 mt -115.18 -64.68 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 174.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -51.12 -45.59 61.64 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.811 1.644 . . . . 0.0 113.752 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.69 -10.72 42.06 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -83.03 89.94 6.97 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -11.67 -72.06 0.01 OUTLIER Glycine 0 N--CA 1.485 1.929 0 C-N-CA 127.091 2.281 . . . . 0.0 116.641 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.4 -38.64 77.76 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 82.5 mtp -92.51 -14.17 28.79 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.0 t -30.0 -35.92 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 121.681 3.956 . . . . 0.0 121.681 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.71 -8.58 58.15 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 120.849 3.648 . . . . 0.0 120.849 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mp -68.08 119.16 65.29 Favored Pre-proline 0 N--CA 1.477 0.903 0 N-CA-C 118.049 2.611 . . . . 0.0 118.049 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -57.86 142.24 96.25 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.686 2.924 . . . . 0.0 110.949 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.3 t -123.29 121.82 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 113.538 -1.665 . . . . 0.0 113.121 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.3 tp -111.6 102.58 10.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.699 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 31.4 mmt -80.04 105.98 11.72 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 113.416 -1.72 . . . . 0.0 112.845 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.59 98.06 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 113.492 -1.686 . . . . 0.0 107.722 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 t -114.05 121.74 44.77 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.0 -18.8 63.34 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.002 -1.454 . . . . 0.0 112.928 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.78 84.45 1.94 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.218 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.48 100.12 6.74 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.794 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -119.04 137.68 53.37 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 112.951 -1.931 . . . . 0.0 107.876 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -31.14 -57.27 0.24 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -57.51 -47.52 81.74 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.264 30.1 p30 -69.3 -33.99 74.02 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.0 mt -59.72 -49.87 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 124.136 0.974 . . . . 0.0 109.186 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.4 mm -57.83 -50.41 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.228 1.011 . . . . 0.0 110.195 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.32 -50.11 60.03 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.339 1.055 . . . . 0.0 111.272 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.06 -56.4 22.54 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.892 1.277 . . . . 0.0 112.504 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.23 -49.24 74.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.986 0.914 . . . . 0.0 112.623 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -63.43 -37.48 87.45 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.04 -16.99 62.05 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.98 -0.02 10.76 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.07 110.67 3.5 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.404 1.102 . . . . 0.0 111.478 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.9 p -66.85 -18.29 65.31 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 113.681 -1.6 . . . . 0.0 114.644 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.16 168.3 40.02 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.76 1.171 . . . . 0.0 111.866 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -144.73 140.5 28.6 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.423 -0.888 . . . . 0.0 111.793 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.9 p -126.34 134.75 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 124.504 1.127 . . . . 0.0 111.845 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -81.03 128.79 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.983 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -94.03 132.86 28.55 Favored Pre-proline 0 N--CA 1.486 1.333 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.332 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.91 146.88 76.2 Favored 'Cis proline' 0 N--CA 1.478 0.617 0 O-C-N 123.437 1.23 . . . . 0.0 114.497 0.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -126.08 154.07 43.59 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 112.941 -1.936 . . . . 0.0 109.034 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.4 p -99.01 172.07 7.63 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.523 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.97 -39.71 72.2 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.87 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.89 -47.34 69.11 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.637 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.3 m -59.56 -46.91 87.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.584 0.754 . . . . 0.0 109.816 178.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.0 tp -56.76 -54.26 48.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.424 1.49 . . . . 0.0 110.198 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.24 -46.51 76.02 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.857 0.863 . . . . 0.0 112.682 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.28 -44.88 65.24 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.198 0.936 . . . . 0.0 112.134 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -66.54 -49.61 65.9 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.717 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 55.6 mt -55.92 -49.29 73.88 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.15 0.98 . . . . 0.0 111.849 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.764 HD21 ' CZ ' ' A' ' 1' ' ' ARG . 3.7 m-20 -55.78 -48.67 74.92 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.369 1.468 . . . . 0.0 112.692 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -54.22 -48.72 70.76 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.632 1.173 . . . . 0.0 110.784 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.21 -47.37 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.262 1.025 . . . . 0.0 110.585 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -57.79 -36.6 72.4 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -61.79 -44.65 96.44 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.636 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -62.15 -43.14 99.49 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.687 1.195 . . . . 0.0 110.777 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -74.92 4.63 6.21 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.08 30.97 74.22 Favored Glycine 0 N--CA 1.484 1.838 0 C-N-CA 125.351 1.453 . . . . 0.0 116.266 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 20.8 mmt . . . . . 0 C--O 1.255 1.345 0 CA-C-O 116.753 -1.594 . . . . 0.0 114.092 179.63 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.9 p -81.56 74.59 8.54 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 123.647 1.689 . . . . 0.0 110.151 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -71.48 81.84 0.8 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -88.96 -37.47 15.2 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.22 -1.355 . . . . 0.0 113.352 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.59 60.89 5.82 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 123.209 1.48 . . . . 0.0 108.565 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.5 tt -98.11 123.75 42.31 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.049 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -80.33 105.46 11.61 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.685 1.241 . . . . 0.0 112.657 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -97.47 145.22 26.42 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.005 -1.452 . . . . 0.0 112.615 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.15 107.23 15.64 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 173.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.52 98.85 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.931 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -105.77 89.88 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 113.304 -1.771 . . . . 0.0 109.257 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -134.14 125.68 28.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 112.643 -2.071 . . . . 0.0 111.019 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -55.37 -24.86 31.91 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 110.93 -2.85 . . . . 0.0 116.738 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -106.66 120.69 42.64 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.2 p -42.96 -57.67 2.75 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.937 -1.483 . . . . 0.0 114.305 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.0 p -68.06 -43.37 78.8 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 118.223 -0.894 . . . . 0.0 113.29 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -39.3 90.4 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.249 0.477 . . . . 0.0 110.896 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -56.63 -49.45 74.96 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.386 1.074 . . . . 0.0 109.971 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -42.33 98.23 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.71 177.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.8 mm -56.17 -48.59 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 118.888 -0.577 . . . . 0.0 110.002 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.1 t -59.5 -49.97 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -49.62 -49.08 48.33 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.207 1.403 . . . . 0.0 111.092 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -64.5 -43.32 94.48 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.548 1.139 . . . . 0.0 112.286 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.3 mt -55.72 -50.97 68.92 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.385 1.074 . . . . 0.0 111.31 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 mt -51.01 -48.6 61.38 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.757 1.286 . . . . 0.0 112.187 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -58.96 -44.8 91.56 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.982 -1.463 . . . . 0.0 112.247 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -59.18 -38.47 79.88 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.095 1.358 . . . . 0.0 112.733 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.2 mt -71.14 -18.21 62.52 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.098 1.359 . . . . 0.0 114.239 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.79 9.96 19.81 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 124.476 1.036 . . . . 0.0 113.5 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -96.76 95.39 7.86 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 123.405 1.574 . . . . 0.0 110.199 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -61.95 -34.62 76.46 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 110.501 -3.045 . . . . 0.0 118.746 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -112.3 125.81 54.58 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.4 p -147.96 135.79 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -113.78 161.42 17.56 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.869 175.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -123.38 130.51 52.82 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.12 156.7 46.96 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.377 1.471 . . . . 0.0 109.699 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -113.86 -38.79 4.14 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -123.38 159.79 28.17 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 118.719 -0.658 . . . . 0.0 109.774 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -44.67 -45.68 8.8 Favored Glycine 0 N--CA 1.478 1.445 0 N-CA-C 116.74 1.456 . . . . 0.0 116.74 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.57 -54.77 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 122.559 0.344 . . . . 0.0 110.196 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -57.51 -34.13 68.77 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.446 0.699 . . . . 0.0 110.777 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.94 -55.23 27.76 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.653 1.181 . . . . 0.0 110.32 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.0 mt -56.52 -43.54 79.92 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.66 0.784 . . . . 0.0 110.324 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -53.86 -56.16 20.13 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.318 1.047 . . . . 0.0 110.744 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -59.38 -52.97 63.32 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.213 1.405 . . . . 0.0 111.896 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tp -56.49 -37.21 70.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.933 2.093 . . . . 0.0 114.61 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -54.64 -30.26 54.62 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.472 1.509 . . . . 0.0 113.589 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.77 -22.47 66.99 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.21 -173.13 46.12 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.25 0.928 . . . . 0.0 112.093 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.63 -26.41 3.14 Favored Glycine 0 CA--C 1.543 1.833 0 N-CA-C 114.78 0.672 . . . . 0.0 114.78 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -68.12 108.94 3.31 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.879 0.872 . . . . 0.0 111.799 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.59 3.11 86.41 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.441 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -166.04 143.52 5.45 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.105 0.962 . . . . 0.0 113.441 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.3 t -122.14 113.84 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 113.918 -1.492 . . . . 0.0 107.608 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.8 tt -113.43 97.28 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.7 t -119.53 136.03 54.52 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -175.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -71.98 132.88 44.91 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 112.415 -2.175 . . . . 0.0 110.944 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 26.6 t-105 -56.29 -41.23 75.58 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.41 1.084 . . . . 0.0 111.719 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -99.5 104.44 16.27 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 29.4 mtm -138.83 130.45 15.39 Favored Pre-proline 0 N--CA 1.473 0.689 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.713 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -57.42 149.6 64.76 Favored 'Trans proline' 0 N--CA 1.481 0.766 0 C-N-CA 123.448 2.765 . . . . 0.0 110.944 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 71.19 -61.2 0.49 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 126.119 1.767 . . . . 0.0 112.516 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 55.6 ttm -135.31 108.33 7.64 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.154 1.381 . . . . 0.0 108.101 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -68.88 167.39 15.76 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.457 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.26 -57.01 9.55 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 125.508 1.528 . . . . 0.0 114.527 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.9 tp -57.44 -37.84 73.45 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -71.61 -42.95 67.04 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.668 0.787 . . . . 0.0 111.167 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.07 -41.53 83.59 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.328 1.051 . . . . 0.0 110.246 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 tp -57.23 -46.53 82.88 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.005 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -60.43 -44.0 96.21 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.38 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.26 24.9 p -62.0 -35.44 78.53 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.268 1.027 . . . . 0.0 111.993 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.4 mt -69.33 -56.95 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -53.34 -47.98 68.89 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.718 1.261 . . . . 0.0 113.043 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.14 -33.85 75.26 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.165 0.986 . . . . 0.0 113.097 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -84.68 83.25 8.09 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.794 0.838 . . . . 0.0 108.777 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -4.58 -80.6 0.01 OUTLIER Glycine 0 N--CA 1.484 1.849 0 C-N-CA 127.521 2.486 . . . . 0.0 118.221 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.89 -35.27 57.7 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 94.0 mtp -73.37 -27.11 61.3 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.072 0.949 . . . . 0.0 113.241 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.3 t -53.83 -26.51 24.65 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.43 -14.61 61.74 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.0 mt -86.53 116.19 65.01 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 123.784 0.833 . . . . 0.0 109.876 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.58 143.66 45.03 Favored 'Trans proline' 0 N--CA 1.476 0.488 0 C-N-CA 123.53 2.82 . . . . 0.0 113.71 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 t -121.23 117.86 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.801 -177.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.5 tp -110.64 107.32 16.86 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 113.044 -1.889 . . . . 0.0 109.573 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.4 mmt -82.27 119.23 23.84 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 113.862 -1.517 . . . . 0.0 112.825 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.13 96.29 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 t -105.24 138.52 41.31 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 112.162 -2.29 . . . . 0.0 116.084 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.79 -22.11 66.03 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 113.565 -1.652 . . . . 0.0 113.167 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -142.09 135.4 29.07 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -97.99 60.29 1.46 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 113.344 -1.753 . . . . 0.0 109.492 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -112.28 148.17 34.75 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.652 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -37.17 -45.13 0.61 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 116.32 1.971 . . . . 0.0 116.32 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.12 -60.53 3.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.961 0.904 . . . . 0.0 110.738 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -59.39 -46.75 87.81 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.788 1.235 . . . . 0.0 112.594 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 73.3 mt -57.31 -57.2 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 124.207 0.942 . . . . 0.0 111.598 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.7 mt -60.06 -50.48 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.175 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.96 -49.69 68.17 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.771 0.669 . . . . 0.0 112.228 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.78 -54.94 39.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.348 1.059 . . . . 0.0 111.633 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.42 -48.59 76.65 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.077 0.951 . . . . 0.0 112.408 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -61.18 -31.35 71.1 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.55 1.87 55.37 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.18 -0.28 29.82 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 116.892 1.517 . . . . 0.0 116.892 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.55 109.55 4.91 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.2 1.0 . . . . 0.0 111.856 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.2 p -63.64 -21.48 66.39 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.54 -1.664 . . . . 0.0 114.246 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -170.45 171.07 43.47 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.897 1.237 . . . . 0.0 112.357 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -146.45 127.29 14.42 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.643 -0.778 . . . . 0.0 113.024 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 p -111.2 119.54 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -82.05 125.36 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 113.607 -1.633 . . . . 0.0 112.88 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -87.09 133.95 37.86 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 112.77 -2.014 . . . . 0.0 110.214 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.27 126.71 13.77 Favored 'Cis proline' 0 C--N 1.351 0.663 0 CA-C-O 123.192 1.247 . . . . 0.0 115.223 0.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -115.83 147.81 40.61 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 112.424 -2.171 . . . . 0.0 108.269 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 48.7 p -104.07 171.93 7.08 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.764 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.85 -37.52 66.32 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.99 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.06 -50.33 64.52 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.196 0.998 . . . . 0.0 110.741 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.8 m -58.81 -44.74 90.9 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.701 0.801 . . . . 0.0 110.211 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 36.6 tp -58.18 -55.83 29.95 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.147 1.379 . . . . 0.0 109.844 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -59.3 -41.65 89.52 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.76 0.424 . . . . 0.0 111.72 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -52.52 -46.89 66.88 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.694 0.797 . . . . 0.0 110.868 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -70.4 -42.58 71.5 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.032 178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.1 mt -56.76 -46.65 81.31 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -53.2 -49.54 66.54 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.806 1.242 . . . . 0.0 111.681 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -52.51 -47.86 66.38 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.75 1.62 . . . . 0.0 111.275 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.1 mm -60.32 -48.04 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.207 1.003 . . . . 0.0 110.528 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -57.66 -38.32 74.87 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -61.66 -44.09 97.61 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 124.435 1.085 . . . . 0.0 110.879 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -61.83 -33.47 74.2 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.29 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 mt -88.68 4.92 45.52 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.291 1.436 . . . . 0.0 114.67 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.85 19.76 77.11 Favored Glycine 0 CA--C 1.543 1.842 0 C-N-CA 124.193 0.902 . . . . 0.0 114.116 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 68.0 mtt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 116.873 -1.537 . . . . 0.0 112.064 179.348 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.6 p -71.35 81.64 0.76 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.212 1.005 . . . . 0.0 112.678 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -73.23 86.88 1.44 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.258 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -53.41 -33.14 52.72 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -74.87 5.54 4.96 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.822 1.249 . . . . 0.0 114.342 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.31 126.91 30.24 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.256 1.423 . . . . 0.0 113.032 -177.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.402 ' HZ1' ' CG ' ' A' ' 32' ' ' ASN . 4.5 mptp? -84.25 108.73 17.28 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 112.983 -1.917 . . . . 0.0 112.282 177.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -99.73 127.87 45.85 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.757 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -107.65 95.84 5.97 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.43 104.71 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 111.148 -2.751 . . . . 0.0 108.931 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -104.44 72.56 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 123.553 1.644 . . . . 0.0 107.921 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -129.11 80.23 1.96 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 112.885 -1.961 . . . . 0.0 110.7 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -13.01 -30.61 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 1 N-CA-C 124.421 4.971 . . . . 0.0 124.421 -178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -101.12 124.01 46.17 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.9 m -41.95 -43.54 3.15 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 114.68 -1.145 . . . . 0.0 113.392 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 m -58.21 -55.95 28.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.932 1.293 . . . . 0.0 110.835 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -59.88 -42.61 94.15 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 -55.72 -47.81 76.23 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.766 0.666 . . . . 0.0 111.229 176.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -67.14 -39.92 86.67 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.078 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.2 mm -56.55 -47.76 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 123.307 0.38 . . . . 0.0 110.086 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.7 t -60.59 -42.06 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -53.31 -52.54 58.81 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.582 0.753 . . . . 0.0 110.155 176.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -53.51 -44.46 69.13 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.325 1.05 . . . . 0.0 112.279 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.0 -51.13 69.3 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.963 1.305 . . . . 0.0 112.048 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.0 mt -56.15 -44.31 79.15 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.041 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -57.78 -47.64 81.95 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.927 176.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.19 -39.15 78.18 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.109 1.364 . . . . 0.0 111.733 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.8 mt -73.21 -26.9 61.33 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.86 21.18 7.95 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.567 1.08 . . . . 0.0 114.399 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -92.97 116.44 29.05 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 122.456 1.122 . . . . 0.0 112.645 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.52 -48.27 67.52 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 111.411 -2.631 . . . . 0.0 116.15 -177.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.402 ' CG ' ' HZ1' ' A' ' 7' ' ' LYS . 64.0 m-80 -111.57 122.36 47.62 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 -174.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.31 112.92 8.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 111.154 -2.748 . . . . 0.0 110.781 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -109.44 140.75 42.79 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -123.36 131.64 53.72 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 -174.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.09 157.03 26.56 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 111.493 -2.594 . . . . 0.0 110.271 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -92.23 -55.46 3.42 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -130.34 173.05 11.19 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.703 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -40.57 -54.64 3.35 Favored Glycine 0 CA--C 1.536 1.346 0 O-C-N 124.977 1.423 . . . . 0.0 115.44 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.8 t -57.25 -56.78 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.984 0.914 . . . . 0.0 112.076 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -56.82 -36.72 70.29 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.421 0.688 . . . . 0.0 111.579 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.14 -51.05 65.77 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.126 0.97 . . . . 0.0 111.028 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.2 mt -54.13 -49.27 69.59 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.501 0.72 . . . . 0.0 110.711 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -52.16 -55.45 20.9 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.301 1.041 . . . . 0.0 111.661 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -58.23 -52.78 64.13 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.537 177.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.7 mt -56.34 -39.22 72.48 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.984 1.314 . . . . 0.0 114.092 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -58.79 -23.93 61.06 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.46 -19.25 62.24 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.09 -165.5 29.2 Favored Glycine 0 N--CA 1.481 1.645 0 C-N-CA 124.884 1.23 . . . . 0.0 112.097 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.33 -34.95 1.53 Allowed Glycine 0 CA--C 1.544 1.865 0 N-CA-C 116.0 1.16 . . . . 0.0 116.0 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -66.5 118.38 10.05 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.08 7.36 56.94 Favored Glycine 0 N--CA 1.476 1.316 0 CA-C-N 112.654 -2.067 . . . . 0.0 111.803 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -163.97 138.18 5.69 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.7 t -122.16 110.94 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.5 tt -114.93 97.84 6.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.5 t -118.67 136.01 54.15 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -71.72 132.67 44.86 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 113.2 -1.818 . . . . 0.0 110.745 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 17.6 t-105 -56.39 -46.5 80.09 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.306 177.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -93.29 105.42 17.5 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.883 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 29.5 mtm -140.25 134.39 15.5 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.627 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -58.43 142.25 97.72 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 C-N-CA 123.717 2.945 . . . . 0.0 111.054 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.7 m120 63.75 -67.32 0.1 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.857 1.663 . . . . 0.0 114.304 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.4 ttm -115.73 97.74 6.3 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -60.94 165.74 3.91 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 112.122 -2.308 . . . . 0.0 112.541 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.33 -55.92 11.86 Favored Glycine 0 N--CA 1.484 1.886 0 C-N-CA 124.711 1.148 . . . . 0.0 114.432 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.1 tp -57.26 -43.23 82.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.141 0.576 . . . . 0.0 112.47 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.54 -41.74 92.72 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.875 0.87 . . . . 0.0 111.365 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.53 -46.46 83.81 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.328 1.051 . . . . 0.0 110.225 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.4 tp -55.07 -47.81 74.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.386 1.475 . . . . 0.0 110.737 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -60.0 -47.47 85.71 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.218 0.607 . . . . 0.0 112.125 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.267 16.4 p -57.19 -29.21 63.49 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.019 0.928 . . . . 0.0 112.634 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mt -81.55 -58.01 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.157 0.983 . . . . 0.0 108.891 177.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 81.8 mmt-85 -48.08 -47.78 33.86 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.467 1.907 . . . . 0.0 112.855 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.98 61.66 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -84.33 96.43 9.03 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -17.96 -69.46 0.01 OUTLIER Glycine 0 N--CA 1.488 2.114 0 C-N-CA 126.27 1.891 . . . . 0.0 116.56 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.57 95.33 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 98.7 mtp -75.51 -22.43 57.15 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.1 t -38.03 -36.07 0.19 Allowed 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 117.405 2.372 . . . . 0.0 117.405 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.39 -1.86 51.23 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 117.23 2.308 . . . . 0.0 117.23 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.4 mt -69.42 110.28 6.04 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -54.99 124.33 16.01 Favored 'Trans proline' 0 N--CA 1.483 0.888 0 C-N-CA 123.435 2.757 . . . . 0.0 113.437 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.9 t -112.68 119.27 59.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 114.078 -1.419 . . . . 0.0 114.521 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 66.6 tp -109.09 101.18 10.26 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 111.919 -2.4 . . . . 0.0 107.859 176.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.4 mmt -76.02 104.51 6.59 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.42 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 t -83.94 98.57 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.3 p -90.6 132.13 35.91 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 112.958 -1.928 . . . . 0.0 112.387 -176.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.11 -46.14 89.09 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.959 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -147.11 115.18 6.55 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.97 98.52 5.71 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.657 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -114.64 142.21 46.76 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.114 -1.857 . . . . 0.0 108.69 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER -38.36 -45.17 0.98 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 179.677 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.59 -53.21 59.3 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.631 0.772 . . . . 0.0 112.959 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.01 -37.66 84.57 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.598 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.97 -51.27 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.775 0.83 . . . . 0.0 110.4 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.0 mt -57.84 -51.65 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.38 0.672 . . . . 0.0 109.244 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.02 -44.6 74.74 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.04 0.936 . . . . 0.0 113.369 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.48 -47.77 82.96 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.155 0.982 . . . . 0.0 112.31 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.79 -44.75 96.26 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.886 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -59.06 -31.58 68.99 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.16 -5.8 49.32 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.13 4.4 27.43 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 118.317 2.087 . . . . 0.0 118.317 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.7 121.03 8.84 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.6 m -66.87 -30.67 70.9 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 113.271 -1.786 . . . . 0.0 113.404 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.78 167.42 38.81 Favored Glycine 0 N--CA 1.479 1.556 0 C-N-CA 124.458 1.028 . . . . 0.0 110.819 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -141.92 137.63 31.43 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.31 126.55 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 124.617 1.198 . . . . 0.0 111.66 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.2 p -88.99 135.62 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.706 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.2 pttt -92.75 142.36 25.54 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-O 117.709 -1.138 . . . . 0.0 112.392 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.08 129.81 18.55 Favored 'Cis proline' 0 N--CA 1.481 0.769 0 N-CA-C 116.568 1.718 . . . . 0.0 116.568 0.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -120.38 139.29 53.01 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 112.814 -1.994 . . . . 0.0 107.966 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.5 p -97.82 174.94 6.35 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.876 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.88 -36.39 67.58 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.38 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.02 -47.29 71.89 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.185 0.994 . . . . 0.0 111.44 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 m -59.59 -45.96 90.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.285 0.634 . . . . 0.0 109.623 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 42.4 tp -56.89 -51.64 68.28 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.602 1.161 . . . . 0.0 110.277 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -54.3 -46.85 72.87 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.646 1.178 . . . . 0.0 111.91 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -58.96 -43.76 91.36 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.099 0.874 . . . . 0.0 112.655 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -65.61 -42.26 91.82 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.853 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.2 mt -53.69 -47.69 70.22 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.337 1.023 . . . . 0.0 111.33 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -52.59 -54.98 25.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.592 1.557 . . . . 0.0 111.867 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -52.45 -49.88 63.74 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 113.859 -1.519 . . . . 0.0 112.51 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 58.7 mt -60.14 -45.54 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.852 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.5 m-30 -61.78 -33.8 74.74 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -61.26 -45.23 95.36 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.41 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -61.39 -34.08 74.74 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.121 0.968 . . . . 0.0 112.166 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.9 mt -77.79 5.66 9.06 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.88 11.37 65.51 Favored Glycine 0 CA--C 1.542 1.721 0 C-N-CA 124.641 1.115 . . . . 0.0 115.684 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 76.0 mtm . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 179.657 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.1 m -85.04 71.37 10.94 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 -176.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -92.77 66.27 4.33 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.427 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -151.88 -69.34 0.17 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 113.502 -1.681 . . . . 0.0 113.058 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.31 62.5 6.04 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 123.127 1.441 . . . . 0.0 111.4 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 tt -106.34 123.64 48.36 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 113.24 -1.8 . . . . 0.0 111.068 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -76.34 103.27 6.27 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.895 1.372 . . . . 0.0 113.976 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -98.47 130.47 45.08 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 112.621 -2.081 . . . . 0.0 112.014 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.64 102.54 11.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 122.748 1.261 . . . . 0.0 108.695 174.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.3 t -88.13 107.16 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.3 t -105.45 101.99 13.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 111.391 -2.641 . . . . 0.0 108.339 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -138.85 133.57 32.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.968 -1.469 . . . . 0.0 112.33 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -63.52 -23.18 67.28 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 113.965 -1.47 . . . . 0.0 112.396 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.49 102.06 11.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.789 177.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.9 p -49.06 -34.09 12.9 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.767 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.65 -41.57 95.22 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.131 1.772 . . . . 0.0 110.726 176.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.3 tpt -66.67 -42.21 86.94 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.3 0.64 . . . . 0.0 110.536 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.492 ' CZ ' ' HE ' ' A' ' 22' ' ' ARG . 1.8 tmm_? -56.51 -42.79 78.97 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 124.285 0.991 . . . . 0.0 109.735 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -56.02 -48.6 75.64 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.147 1.379 . . . . 0.0 110.576 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.3 mm -58.47 -55.85 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.046 0.939 . . . . 0.0 110.382 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.5 t -53.04 -44.79 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.817 0.847 . . . . 0.0 111.566 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HE ' ' CZ ' ' A' ' 18' ' ' ARG . 26.0 ttm180 -52.62 -54.12 37.52 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.054 0.942 . . . . 0.0 111.452 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -60.19 -39.75 87.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.99 0.916 . . . . 0.0 113.299 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.91 -53.13 61.49 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.48 1.112 . . . . 0.0 110.745 177.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.2 mt -57.48 -44.51 84.94 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.835 0.854 . . . . 0.0 112.112 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -53.37 -48.7 68.36 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.486 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -57.45 -38.88 75.15 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.035 1.334 . . . . 0.0 111.985 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.2 mt -74.83 -15.13 60.74 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.37 6.49 29.25 Favored Glycine 0 CA--C 1.545 1.947 0 C-N-CA 125.104 1.335 . . . . 0.0 114.78 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -98.44 91.88 5.4 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 122.758 1.265 . . . . 0.0 112.666 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -79.35 -10.22 59.76 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 119.604 3.187 . . . . 0.0 119.604 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -107.4 99.23 8.77 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 119.404 1.002 . . . . 0.0 112.511 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -130.12 125.04 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.066 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -111.84 163.75 13.84 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.596 0.758 . . . . 0.0 109.851 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -120.67 131.05 54.38 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.03 149.49 47.49 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 112.104 -2.316 . . . . 0.0 108.095 173.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -101.45 -41.65 6.56 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -130.85 159.84 36.19 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.629 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -39.51 -51.71 3.03 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.984 1.754 . . . . 0.0 115.03 177.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.45 -56.19 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 114.852 -0.674 . . . . 0.0 111.23 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.8 -37.58 68.81 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.933 0.893 . . . . 0.0 111.458 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.18 -49.52 77.32 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 117.462 -1.256 . . . . 0.0 111.42 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.7 mt -58.5 -44.77 89.56 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.104 0.562 . . . . 0.0 111.385 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -54.8 -53.02 60.68 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.971 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -59.9 -50.92 71.87 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.681 1.593 . . . . 0.0 111.88 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.4 mt -54.81 -49.28 71.39 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.451 1.9 . . . . 0.0 114.73 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.91 -17.63 10.27 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.64 -19.65 65.81 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.224 0.61 . . . . 0.0 112.499 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.3 -177.88 38.19 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.924 1.249 . . . . 0.0 114.146 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.56 -24.57 2.62 Favored Glycine 0 CA--C 1.541 1.703 0 N-CA-C 116.432 1.333 . . . . 0.0 116.432 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -69.0 113.22 6.19 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.27 5.65 61.07 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 112.725 -2.034 . . . . 0.0 112.01 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -164.24 143.86 7.73 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.88 120.0 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.086 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 71.2 mt -113.07 102.59 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.7 t -119.23 131.78 55.85 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 118.016 2.598 . . . . 0.0 118.016 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -71.98 124.84 25.78 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 112.066 -2.334 . . . . 0.0 109.808 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 18.3 t-105 -55.4 -39.34 70.06 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.232 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -91.41 94.05 9.31 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.797 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 29.6 mtm -139.58 122.52 10.43 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-N 112.83 -1.986 . . . . 0.0 109.589 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -60.82 127.62 23.06 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.893 3.062 . . . . 0.0 113.335 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 m120 81.32 -65.8 0.13 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.02 1.728 . . . . 0.0 113.283 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.2 ttm -115.57 87.72 2.73 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.625 0.726 . . . . 0.0 109.363 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.43 168.87 2.52 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 111.863 -2.426 . . . . 0.0 112.224 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -47.29 -53.43 11.69 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 124.932 1.253 . . . . 0.0 114.223 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.3 tp -57.38 -44.59 84.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.883 0.873 . . . . 0.0 111.997 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -66.23 -40.72 90.48 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.2 tp -61.57 -42.79 99.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.368 0.667 . . . . 0.0 111.27 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.4 tp -53.25 -45.21 68.67 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.831 1.252 . . . . 0.0 110.868 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -64.76 -44.86 88.68 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.488 1.115 . . . . 0.0 111.209 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.2 p -61.0 -25.12 66.66 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.773 1.229 . . . . 0.0 113.219 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.9 mt -84.04 -59.64 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.613 1.165 . . . . 0.0 108.072 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -49.05 -43.39 40.7 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.253 1.821 . . . . 0.0 113.447 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.46 -14.64 52.05 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.83 91.98 7.17 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -7.52 -79.53 0.01 OUTLIER Glycine 0 N--CA 1.488 2.141 0 C-N-CA 126.936 2.208 . . . . 0.0 117.161 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.57 -45.62 88.63 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.8 mtp -80.16 -11.45 59.75 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 117.36 2.355 . . . . 0.0 117.36 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.3 t -30.47 -61.37 0.17 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 118.761 2.874 . . . . 0.0 118.761 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.22 12.82 2.65 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 119.9 3.296 . . . . 0.0 119.9 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.1 mt -76.62 106.37 3.29 Favored Pre-proline 0 N--CA 1.479 0.989 0 O-C-N 121.251 -0.906 . . . . 0.0 112.117 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -40.13 133.86 1.95 Allowed 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 124.567 3.511 . . . . 0.0 117.149 -175.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.4 t -119.28 117.96 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 111.068 -2.787 . . . . 0.0 112.817 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 47.8 tp -108.98 105.64 15.25 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 113.34 -1.754 . . . . 0.0 107.706 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.7 mmt -80.53 114.84 19.7 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 113.597 -1.638 . . . . 0.0 111.686 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.91 110.57 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.6 p -111.53 153.89 25.58 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 117.846 2.536 . . . . 0.0 117.846 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.12 -31.8 73.18 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 112.018 -2.356 . . . . 0.0 113.641 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.03 124.56 3.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.535 1.134 . . . . 0.0 108.518 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.42 90.39 6.71 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 122.529 1.157 . . . . 0.0 110.403 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -121.48 133.28 55.04 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.721 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -25.5 -61.63 0.07 Allowed 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 117.692 2.478 . . . . 0.0 117.692 -177.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -53.58 -46.75 70.42 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -70.27 -34.44 72.79 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.3 mt -60.03 -53.33 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.47 0.708 . . . . 0.0 109.906 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.8 mt -58.56 -46.85 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.707 0.803 . . . . 0.0 109.783 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.08 -47.99 64.9 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.86 0.864 . . . . 0.0 112.294 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.05 -47.38 83.25 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.574 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.79 84.13 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.353 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -60.19 -36.82 78.49 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.035 0.934 . . . . 0.0 112.73 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.71 -5.07 52.17 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.86 -5.23 24.15 Favored Glycine 0 CA--C 1.542 1.761 0 N-CA-C 117.367 1.707 . . . . 0.0 117.367 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.51 115.46 2.53 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.417 1.608 . . . . 0.0 115.314 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.2 p -67.95 -18.65 64.81 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 113.568 -1.651 . . . . 0.0 114.217 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -165.87 162.05 35.56 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.505 1.05 . . . . 0.0 112.304 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -146.14 126.18 13.71 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.665 0.786 . . . . 0.0 111.117 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.27 136.43 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 124.849 1.343 . . . . 0.0 110.864 176.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -93.22 145.37 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.499 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -89.3 128.91 49.55 Favored Pre-proline 0 N--CA 1.476 0.825 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.68 155.66 80.58 Favored 'Cis proline' 0 CA--C 1.54 0.778 0 O-C-N 123.055 1.029 . . . . 0.0 114.371 0.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -146.53 155.72 42.73 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.067 1.747 . . . . 0.0 107.967 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.5 t -117.13 177.18 4.81 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.919 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.48 -41.86 61.22 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.823 0.849 . . . . 0.0 111.563 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.81 -53.02 60.69 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.184 0.994 . . . . 0.0 111.986 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.73 -46.76 84.0 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.757 0.823 . . . . 0.0 110.62 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.65 -52.56 63.41 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.069 1.348 . . . . 0.0 108.551 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -56.11 -46.94 78.93 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.859 1.264 . . . . 0.0 111.981 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.19 -45.86 65.33 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -68.39 -45.17 73.42 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.85 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.3 mt -55.97 -50.84 69.71 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.2 1.0 . . . . 0.0 112.169 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -51.61 -50.17 60.75 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.604 1.561 . . . . 0.0 111.995 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -54.89 -47.7 73.96 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.721 1.208 . . . . 0.0 110.997 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.78 -44.42 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.849 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -61.01 -33.36 73.15 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -62.87 -44.65 95.54 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.033 176.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -62.82 -39.66 95.0 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.08 1.352 . . . . 0.0 110.741 177.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.7 mt -77.48 0.04 24.26 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.24 28.31 72.84 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 123.687 0.661 . . . . 0.0 114.563 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 117.556 -1.211 . . . . 0.0 112.75 179.731 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.3 m 61.66 -30.78 0.07 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 118.805 2.891 . . . . 0.0 118.805 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -113.34 139.36 48.92 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 126.343 1.857 . . . . 0.0 111.984 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -133.18 -51.97 0.89 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 113.53 -1.668 . . . . 0.0 112.235 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -84.64 60.76 6.3 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 122.388 1.09 . . . . 0.0 109.488 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 tt -108.94 133.04 53.48 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.341 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -79.84 106.75 12.1 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 125.079 1.487 . . . . 0.0 113.588 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -104.09 139.31 39.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 112.672 -2.058 . . . . 0.0 112.704 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.92 107.79 15.45 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.572 174.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.51 99.04 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 112.585 -2.098 . . . . 0.0 107.53 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.75 91.0 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.375 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -136.48 114.11 11.06 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 113.809 -1.541 . . . . 0.0 113.137 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -52.82 -28.1 21.18 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -94.29 113.48 25.39 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.5 p -45.76 -46.69 15.33 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.709 1.204 . . . . 0.0 113.644 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -47.97 83.68 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.78 177.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.1 mmm -61.68 -39.92 93.13 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -55.76 -53.86 51.43 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 124.38 1.05 . . . . 0.0 110.421 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.12 -40.14 92.66 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.852 177.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 74.9 mt -56.03 -56.52 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.958 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -57.76 -45.09 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.041 0.537 . . . . 0.0 111.447 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -51.74 -56.66 12.48 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.151 0.98 . . . . 0.0 111.534 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -59.81 -41.98 92.45 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.576 0.75 . . . . 0.0 112.793 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.8 mt -56.96 -53.64 55.72 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.76 0.824 . . . . 0.0 111.405 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.5 mt -54.4 -47.6 72.55 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.143 0.977 . . . . 0.0 112.029 177.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -57.83 -44.25 86.34 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.871 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -58.71 -38.29 77.97 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.482 1.513 . . . . 0.0 112.174 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.0 mt -75.73 -16.98 60.07 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 124.705 1.253 . . . . 0.0 113.426 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.77 -6.84 20.04 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.738 1.161 . . . . 0.0 114.263 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -90.95 80.82 5.72 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 123.277 1.513 . . . . 0.0 110.46 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -76.62 -17.26 59.28 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -94.47 88.57 5.53 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 122.386 1.088 . . . . 0.0 109.954 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.91 129.04 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 113.991 -1.458 . . . . 0.0 112.213 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -109.93 153.92 23.83 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 175.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -125.62 120.77 31.68 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.35 162.33 19.65 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.37 -1.741 . . . . 0.0 109.848 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.42 -43.27 5.01 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -132.51 170.06 15.68 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.21 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -47.32 -53.15 12.24 Favored Glycine 0 CA--C 1.541 1.707 0 O-C-N 124.675 1.234 . . . . 0.0 114.944 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.8 t -56.3 -54.52 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.542 0.337 . . . . 0.0 111.524 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -56.61 -36.27 69.24 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.559 0.744 . . . . 0.0 111.621 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.32 -49.9 62.29 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.496 1.118 . . . . 0.0 112.507 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.4 mt -53.8 -43.12 69.07 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.339 0.656 . . . . 0.0 111.665 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.14 -59.36 5.42 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 125.059 1.474 . . . . 0.0 110.304 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -57.79 -40.57 80.17 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.1 mt -56.29 -48.55 76.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.535 0.734 . . . . 0.0 112.026 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -71.6 -5.71 35.44 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.9 -7.71 42.58 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.71 147.71 13.59 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 116.813 1.485 . . . . 0.0 116.813 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.96 -12.46 3.01 Favored Glycine 0 CA--C 1.542 1.778 0 N-CA-C 121.934 3.534 . . . . 0.0 121.934 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -66.0 105.2 1.28 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 121.035 2.418 . . . . 0.0 115.79 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.11 20.24 48.31 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 112.44 -2.163 . . . . 0.0 112.372 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -171.05 137.03 1.13 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.861 0.865 . . . . 0.0 112.401 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.59 119.54 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.684 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 87.2 mt -111.69 102.71 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 104.192 -2.521 . . . . 0.0 104.192 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 t -121.29 132.39 54.77 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 -176.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -68.15 131.89 46.22 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 111.815 -2.448 . . . . 0.0 109.536 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 -56.22 -50.99 69.71 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -91.81 89.74 7.19 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 122.527 1.156 . . . . 0.0 113.778 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.2 mtm -124.44 136.01 27.23 Favored Pre-proline 0 N--CA 1.484 1.239 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.373 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -54.16 148.62 39.51 Favored 'Trans proline' 0 N--CA 1.48 0.7 0 C-N-CA 124.172 3.248 . . . . 0.0 110.771 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.313 11.5 p30 60.06 -67.6 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 126.547 1.939 . . . . 0.0 114.534 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 52.0 ttm -122.16 102.09 7.93 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.229 1.012 . . . . 0.0 108.61 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -66.17 167.35 10.27 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 113.01 -1.905 . . . . 0.0 112.428 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.01 -53.44 18.49 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 124.453 1.025 . . . . 0.0 112.875 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.0 tp -57.93 -38.98 76.91 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -72.06 -37.96 69.54 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.768 0.427 . . . . 0.0 111.686 178.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.8 tp -60.56 -42.52 96.76 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.788 0.835 . . . . 0.0 110.345 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.1 tp -55.06 -46.58 75.38 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.726 1.21 . . . . 0.0 109.909 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -60.63 -45.48 93.9 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.915 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.271 38.8 p -60.9 -35.18 75.99 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 124.238 1.015 . . . . 0.0 111.8 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.2 mt -72.53 -56.73 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.647 1.179 . . . . 0.0 108.664 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 76.5 mmt-85 -53.39 -42.65 67.15 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.89 1.676 . . . . 0.0 114.048 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.25 -30.08 69.88 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -88.18 100.01 12.64 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.113 0.565 . . . . 0.0 111.309 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -11.37 -74.18 0.01 OUTLIER Glycine 0 N--CA 1.489 2.175 0 C-N-CA 127.662 2.554 . . . . 0.0 118.266 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.51 84.37 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 96.1 mtp -72.31 -24.06 61.26 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.089 1.356 . . . . 0.0 113.847 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.3 m -51.57 -28.48 14.06 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.321 1.449 . . . . 0.0 114.438 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.85 -11.09 42.99 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.2 mt -77.49 114.72 43.26 Favored Pre-proline 0 N--CA 1.475 0.807 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -49.41 132.7 29.96 Favored 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 124.189 3.259 . . . . 0.0 115.695 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.4 t -120.74 120.53 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 112.739 -2.028 . . . . 0.0 111.955 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 47.8 tp -112.18 107.05 15.81 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 113.313 -1.767 . . . . 0.0 109.323 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 30.9 mmt -81.24 121.97 26.82 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 113.744 -1.571 . . . . 0.0 112.353 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.76 101.52 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.05 145.83 37.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 111.772 -2.467 . . . . 0.0 113.567 -176.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.74 -38.2 72.07 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -156.53 147.28 21.79 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.674 0.789 . . . . 0.0 110.389 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.36 86.78 6.22 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -123.42 134.19 53.98 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 112.667 -2.06 . . . . 0.0 110.351 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -27.19 -60.6 0.09 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.235 1.814 . . . . 0.0 115.481 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -53.58 -52.44 59.77 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -66.69 -38.92 87.75 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.2 mt -59.05 -55.03 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.279 1.032 . . . . 0.0 110.002 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.3 mt -54.84 -54.57 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.301 1.04 . . . . 0.0 109.602 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.18 -49.43 63.87 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.192 0.997 . . . . 0.0 113.308 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.11 -51.02 68.22 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.058 0.943 . . . . 0.0 113.503 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.3 -51.06 71.38 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.047 0.939 . . . . 0.0 112.895 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -64.39 -25.66 68.12 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.44 -5.91 59.04 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.23 2.32 26.39 Favored Glycine 0 CA--C 1.54 1.635 0 N-CA-C 117.408 1.723 . . . . 0.0 117.408 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.92 119.47 8.32 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.4 m -64.93 -30.58 71.59 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.412 -1.722 . . . . 0.0 112.933 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -174.2 170.79 43.95 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.687 1.137 . . . . 0.0 110.587 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -143.21 129.05 19.43 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.462 -0.869 . . . . 0.0 112.458 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.39 124.66 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.743 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.14 123.38 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 112.1 -2.318 . . . . 0.0 111.199 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -90.95 134.79 29.6 Favored Pre-proline 0 N--CA 1.483 1.193 0 CA-C-N 113.65 -1.614 . . . . 0.0 111.284 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -75.45 141.59 71.71 Favored 'Cis proline' 0 CA--C 1.542 0.893 0 O-C-N 123.273 1.144 . . . . 0.0 112.988 0.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -126.69 147.27 49.96 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 113.12 -1.855 . . . . 0.0 109.515 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 52.5 p -97.46 171.03 8.64 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.753 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.22 67.87 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.296 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.99 -49.81 66.51 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.091 0.956 . . . . 0.0 111.533 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.6 m -58.09 -46.12 86.04 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.916 0.886 . . . . 0.0 109.324 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 48.2 tp -58.77 -55.47 34.65 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.438 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . 0.26 1.3 pp20? -59.15 -36.52 75.4 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -55.61 -49.55 72.5 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 123.952 0.783 . . . . 0.0 111.112 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -65.39 -45.41 84.14 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.901 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.0 mt -54.44 -46.91 73.35 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 124.093 0.87 . . . . 0.0 112.222 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -55.0 -52.94 61.58 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.486 1.114 . . . . 0.0 112.308 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -55.36 -42.75 74.31 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.244 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.12 -46.87 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.863 0.865 . . . . 0.0 110.633 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -59.5 -35.12 73.52 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -62.97 -48.82 77.22 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.267 1.027 . . . . 0.0 110.18 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -60.44 -40.1 89.88 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.83 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.9 16.88 6.26 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.065 1.346 . . . . 0.0 113.7 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.72 -68.98 2.14 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 124.644 1.116 . . . . 0.0 111.667 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 C--O 1.254 1.342 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 -179.923 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 t -79.14 93.14 5.14 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 113.275 -1.784 . . . . 0.0 111.038 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.2 p30 -81.56 52.09 1.81 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -65.41 -45.24 84.71 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 115.058 -0.973 . . . . 0.0 112.885 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -89.29 60.33 5.24 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 123.426 1.584 . . . . 0.0 110.471 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 tt -106.56 131.03 54.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.004 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -78.32 102.2 7.58 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 113.448 -1.706 . . . . 0.0 111.414 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -102.35 138.6 39.06 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 112.884 -1.962 . . . . 0.0 113.404 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.16 111.41 19.43 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.815 174.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.1 t -87.02 97.11 6.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 123.899 1.809 . . . . 0.0 107.466 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.65 74.0 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 112.72 -2.037 . . . . 0.0 106.808 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -127.25 87.06 2.58 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 112.915 -1.948 . . . . 0.0 113.396 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -11.25 -55.85 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 121.62 3.933 . . . . 0.0 121.62 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -81.72 133.5 35.36 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.75 0.656 . . . . 0.0 109.278 -177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 p -46.33 -50.83 15.82 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.067 0.947 . . . . 0.0 112.908 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -49.73 76.49 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.81 177.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -45.34 85.51 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.959 0.904 . . . . 0.0 111.26 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 -57.66 -52.74 64.2 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.114 0.966 . . . . 0.0 111.496 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.693 ' NH1' HD22 ' A' ' 23' ' ' ASN . 2.1 mmp_? -56.78 -43.49 80.91 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.435 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.5 mm -54.23 -61.44 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.257 0.623 . . . . 0.0 110.939 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.5 t -57.47 -45.16 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.261 0.624 . . . . 0.0 111.63 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -54.44 -53.54 52.75 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.9 0.88 . . . . 0.0 112.13 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.693 HD22 ' NH1' ' A' ' 19' ' ' ARG . 66.2 m-80 -63.55 -37.82 88.77 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.0 mt -56.95 -51.31 69.68 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.877 0.471 . . . . 0.0 111.874 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 49.1 mt -53.36 -47.04 69.75 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.564 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -56.85 -47.5 80.23 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.113 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -59.65 -38.87 82.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.49 1.516 . . . . 0.0 112.64 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.63 -16.14 62.27 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.698 1.599 . . . . 0.0 114.085 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.86 9.7 25.96 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 124.462 1.029 . . . . 0.0 114.759 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -92.11 98.16 11.37 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 123.874 1.797 . . . . 0.0 111.53 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -57.76 -42.62 84.41 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 110.39 -3.096 . . . . 0.0 119.236 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -111.55 106.68 15.61 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 t -133.53 126.63 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -110.85 158.0 19.19 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -130.13 119.52 23.15 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.67 149.38 36.83 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.921 1.288 . . . . 0.0 110.687 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -76.1 -60.83 2.16 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -133.62 -178.22 4.9 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 119.092 -0.48 . . . . 0.0 111.522 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -43.1 -55.7 4.84 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 125.564 1.554 . . . . 0.0 114.652 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.9 t -57.11 -56.69 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 114.335 -0.932 . . . . 0.0 111.947 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -57.26 -38.6 74.12 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.427 0.691 . . . . 0.0 111.631 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.34 -50.25 70.7 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.564 1.146 . . . . 0.0 112.414 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.9 mt -53.85 -40.71 66.71 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.64 0.776 . . . . 0.0 112.862 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -67.55 -55.18 14.48 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 124.325 1.016 . . . . 0.0 110.927 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -57.78 -30.92 66.04 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.4 mt -55.67 -38.21 69.3 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -71.49 -9.25 57.9 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.65 34.84 0.12 Allowed 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 116.258 1.948 . . . . 0.0 116.258 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.1 115.54 2.63 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 117.939 1.936 . . . . 0.0 117.939 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 27.01 47.77 0.05 OUTLIER Glycine 0 CA--C 1.545 1.925 0 N-CA-C 122.249 3.66 . . . . 0.0 122.249 176.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -74.84 87.58 2.26 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 118.547 1.173 . . . . 0.0 113.069 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.6 29.91 5.16 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 113.357 -1.747 . . . . 0.0 111.617 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -175.2 131.86 0.3 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.84 1.305 . . . . 0.0 112.927 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 t -126.99 119.83 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-N 112.436 -2.165 . . . . 0.0 108.88 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.2 mt -110.48 105.89 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.9 t -124.98 132.75 53.22 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 118.128 2.64 . . . . 0.0 118.128 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -73.63 133.08 43.39 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 111.71 -2.495 . . . . 0.0 109.512 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -55.01 -49.28 71.92 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.221 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -90.86 82.09 5.69 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 39.4 mtm -116.77 137.99 24.21 Favored Pre-proline 0 N--CA 1.482 1.15 0 CA-C-N 114.222 -1.354 . . . . 0.0 112.101 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -57.72 139.5 90.47 Favored 'Trans proline' 0 N--CA 1.476 0.478 0 C-N-CA 124.034 3.156 . . . . 0.0 111.903 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 64.42 -73.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.306 1.842 . . . . 0.0 112.487 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.5 ttm -110.2 98.7 7.9 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -64.64 168.08 6.49 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 112.312 -2.222 . . . . 0.0 112.901 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.2 -52.74 21.83 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.028 1.299 . . . . 0.0 114.38 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.01 -40.45 84.97 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -66.83 -43.43 83.74 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.555 0.342 . . . . 0.0 111.515 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -56.13 -47.49 78.06 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.018 0.927 . . . . 0.0 110.993 177.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 tt -49.22 -55.64 11.89 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.982 1.713 . . . . 0.0 109.412 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -61.0 -44.49 97.34 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.909 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.259 29.7 p -59.21 -21.77 60.01 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 124.643 1.177 . . . . 0.0 113.186 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.8 mt -89.99 -58.42 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -47.77 -45.18 28.97 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.953 2.101 . . . . 0.0 114.217 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.73 -11.53 50.86 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -84.01 93.35 8.06 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.199 0.6 . . . . 0.0 110.274 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -12.73 -70.59 0.01 OUTLIER Glycine 0 N--CA 1.495 2.584 0 C-N-CA 126.351 1.929 . . . . 0.0 116.47 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.64 -49.43 75.19 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 90.4 mtp -75.84 -26.68 57.39 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 m -11.0 -61.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 120.585 3.55 . . . . 0.0 120.585 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.56 28.95 0.45 Allowed 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 120.64 3.57 . . . . 0.0 120.64 -174.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.2 mt -89.75 106.79 15.36 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.877 -1.139 . . . . 0.0 110.074 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -47.56 133.06 20.96 Favored 'Trans proline' 0 N--CA 1.48 0.735 0 C-N-CA 123.432 2.755 . . . . 0.0 114.756 -177.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.3 t -118.19 128.31 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 112.891 -1.958 . . . . 0.0 114.202 -176.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.5 tp -116.48 108.71 16.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 113.199 -1.819 . . . . 0.0 109.562 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.0 mmt -83.19 114.55 21.43 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.595 1.188 . . . . 0.0 114.006 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.75 98.6 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.8 t -106.91 144.57 33.36 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 111.861 -2.427 . . . . 0.0 113.993 -175.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.58 -41.2 41.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 113.471 -1.695 . . . . 0.0 115.236 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -161.9 144.19 11.51 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.076 1.35 . . . . 0.0 109.948 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.22 86.87 3.66 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.364 1.078 . . . . 0.0 109.967 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -118.75 122.48 42.54 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.582 -1.644 . . . . 0.0 109.585 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -21.44 -59.34 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 117.414 2.376 . . . . 0.0 117.414 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -46.12 72.61 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -70.97 -38.31 72.78 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.02 -53.77 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.801 1.24 . . . . 0.0 109.012 176.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.0 mt -54.01 -54.95 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.377 1.071 . . . . 0.0 110.24 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.19 -50.5 64.54 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.267 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.24 -55.37 32.78 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.48 -51.51 69.15 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.877 0.871 . . . . 0.0 112.312 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -30.34 71.39 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.02 -13.84 60.22 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 177.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.75 -0.97 11.07 Favored Glycine 0 CA--C 1.545 1.96 0 N-CA-C 116.208 1.243 . . . . 0.0 116.208 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.63 123.99 18.65 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 119.051 1.426 . . . . 0.0 113.744 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.5 m -64.53 -30.51 71.54 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 113.07 -1.877 . . . . 0.0 112.88 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.72 172.84 45.82 Favored Glycine 0 CA--C 1.542 1.727 0 C-N-CA 124.818 1.199 . . . . 0.0 110.697 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -144.14 139.99 29.14 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.1 p -124.41 129.69 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 124.457 1.098 . . . . 0.0 110.459 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.36 127.45 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 113.217 -1.811 . . . . 0.0 111.24 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -92.94 132.39 31.12 Favored Pre-proline 0 N--CA 1.479 1.002 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.055 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -74.25 142.85 76.0 Favored 'Cis proline' 0 CA--C 1.548 1.189 0 O-C-N 123.017 1.009 . . . . 0.0 114.277 0.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -134.1 155.28 50.33 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 112.282 -2.236 . . . . 0.0 107.986 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 44.9 p -106.62 172.42 6.83 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.335 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.93 -38.96 68.33 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 123.612 0.57 . . . . 0.0 111.736 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.32 -46.78 75.7 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.356 1.062 . . . . 0.0 111.37 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.1 m -60.13 -47.02 87.68 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 52.8 tp -57.19 -52.11 66.64 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.525 1.13 . . . . 0.0 109.851 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -54.03 -48.21 70.75 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 124.12 0.888 . . . . 0.0 112.152 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -52.61 -47.42 66.99 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.58 -46.54 82.28 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.329 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 82.5 mt -56.96 -47.91 79.6 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 124.141 0.901 . . . . 0.0 111.212 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -53.74 -53.54 50.78 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.541 1.536 . . . . 0.0 111.669 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -52.11 -46.04 65.14 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.499 1.52 . . . . 0.0 111.566 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 63.7 mt -62.37 -51.78 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.341 1.056 . . . . 0.0 110.447 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -57.84 -39.25 77.26 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -58.58 -42.63 88.49 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.735 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -60.98 -39.04 88.09 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.966 0.907 . . . . 0.0 111.264 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.2 mt -83.96 8.87 13.79 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.051 1.341 . . . . 0.0 114.001 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.58 13.98 77.73 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 115.744 1.057 . . . . 0.0 115.744 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.5 mtm . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 117.091 -1.433 . . . . 0.0 113.043 179.544 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.427 ' NE ' ' H1 ' ' A' ' 1' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 m -55.84 82.05 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 116.828 2.159 . . . . 0.0 116.828 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -62.11 -30.66 71.17 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . 0.263 63.3 mttp 75.02 -37.18 0.34 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 128.655 2.782 . . . . 0.0 118.089 178.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -90.3 51.34 2.01 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.988 1.375 . . . . 0.0 111.861 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 tt -112.94 130.85 55.97 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.881 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -86.49 111.21 20.35 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.899 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -105.86 145.32 31.38 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.021 1.728 . . . . 0.0 115.287 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -121.5 105.09 10.15 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 112.488 -2.142 . . . . 0.0 110.047 174.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.3 t -82.89 112.52 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 112.87 -1.968 . . . . 0.0 107.763 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.66 96.0 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.697 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -138.44 130.36 28.21 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.166 0.916 . . . . 0.0 112.46 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -72.03 -16.39 62.05 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -101.01 114.68 28.84 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.3 p -40.75 -57.61 1.87 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 125.177 1.548 . . . . 0.0 113.2 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -48.05 80.18 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -60.83 -37.58 82.52 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.9 ttp-105 -59.29 -50.52 73.67 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.437 1.095 . . . . 0.0 110.996 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -60.82 -42.81 98.42 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.655 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 71.7 mt -55.63 -52.66 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.266 1.026 . . . . 0.0 111.113 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.3 t -56.11 -48.29 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 122.501 0.32 . . . . 0.0 110.752 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -55.35 -50.49 69.53 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.649 1.18 . . . . 0.0 110.827 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -59.08 -45.68 90.21 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.99 0.916 . . . . 0.0 112.082 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -54.21 -50.96 65.9 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.334 1.054 . . . . 0.0 111.793 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.3 mt -56.03 -46.56 78.82 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.968 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -55.74 -46.73 77.76 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.567 1.167 . . . . 0.0 111.303 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -59.45 -39.67 84.34 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.381 1.473 . . . . 0.0 112.381 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.1 mt -74.01 -12.66 60.69 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.15 -13.28 33.97 Favored Glycine 0 N--CA 1.479 1.522 0 C-N-CA 124.216 0.912 . . . . 0.0 113.386 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -84.72 62.73 7.56 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 123.42 1.581 . . . . 0.0 111.453 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -68.7 -13.72 62.55 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -86.42 70.83 10.51 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.81 126.35 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -120.42 160.57 22.82 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.044 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -133.69 140.99 47.37 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 119.439 3.125 . . . . 0.0 119.439 -175.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.44 160.75 27.53 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 112.234 -2.257 . . . . 0.0 109.506 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -97.47 -39.43 9.16 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -137.59 170.32 16.27 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.468 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -45.71 -54.08 8.09 Favored Glycine 0 N--CA 1.482 1.736 0 O-C-N 124.651 1.219 . . . . 0.0 115.671 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.1 t -57.7 -54.42 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.665 0.786 . . . . 0.0 111.783 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -55.21 -36.5 66.03 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.935 0.894 . . . . 0.0 112.167 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.69 -50.78 61.77 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.326 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.2 mt -54.17 -46.1 72.25 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 124.541 1.15 . . . . 0.0 110.482 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -57.05 -53.0 63.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.832 0.853 . . . . 0.0 111.506 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -56.94 -45.74 82.58 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.207 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -59.2 -42.68 91.48 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.149 0.98 . . . . 0.0 111.653 176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -60.57 -30.18 69.63 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 125.102 1.361 . . . . 0.0 112.089 177.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.83 -19.5 65.91 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.81 0.844 . . . . 0.0 112.154 175.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.64 175.09 28.33 Favored Glycine 0 N--CA 1.479 1.53 0 N-CA-C 117.508 1.763 . . . . 0.0 117.508 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.62 -33.1 1.63 Allowed Glycine 0 N--CA 1.483 1.781 0 N-CA-C 121.304 3.282 . . . . 0.0 121.304 176.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -65.85 113.37 4.31 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.45 16.87 57.5 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-N 113.761 -1.563 . . . . 0.0 113.124 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -166.23 138.55 3.85 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.229 1.412 . . . . 0.0 110.483 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.5 t -125.31 126.41 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.491 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 91.0 mt -112.13 99.61 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.513 ' HG ' ' CE ' ' A' ' 60' ' ' MET . 41.9 t -109.06 123.68 49.54 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -175.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -73.56 127.25 32.22 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 112.572 -2.104 . . . . 0.0 109.565 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 5.2 t-105 -52.65 -49.14 65.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.032 0.933 . . . . 0.0 111.4 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -88.45 96.77 10.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.971 0.908 . . . . 0.0 110.94 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.513 ' CE ' ' HG ' ' A' ' 56' ' ' SER . 24.4 mtm -138.3 132.3 16.7 Favored Pre-proline 0 N--CA 1.48 1.03 0 CA-C-N 113.742 -1.572 . . . . 0.0 112.589 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -65.87 150.41 85.79 Favored 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 123.933 3.089 . . . . 0.0 111.795 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.3 m120 68.33 -64.01 0.32 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 125.794 1.934 . . . . 0.0 112.694 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.7 ttm -126.44 101.95 6.92 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.277 1.031 . . . . 0.0 108.277 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.36 169.11 6.19 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 113.394 -1.73 . . . . 0.0 111.866 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.0 -52.76 29.65 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.15 0.881 . . . . 0.0 115.156 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 36.3 tp -60.04 -38.6 83.24 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.48 0.712 . . . . 0.0 112.343 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -66.63 -42.75 86.25 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.664 0.386 . . . . 0.0 110.469 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.7 -45.17 92.95 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.987 177.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 tt -50.32 -51.71 43.04 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.75 1.62 . . . . 0.0 109.054 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -59.68 -47.24 86.42 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.984 0.914 . . . . 0.0 113.143 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.268 21.7 p -56.55 -35.38 68.06 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.551 1.14 . . . . 0.0 111.994 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.6 mt -76.29 -54.42 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.152 0.981 . . . . 0.0 109.396 177.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.0 -40.79 64.07 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.678 1.991 . . . . 0.0 113.749 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.42 -31.83 65.83 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -87.23 94.91 9.79 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.825 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -13.68 -71.34 0.01 OUTLIER Glycine 0 N--CA 1.487 2.06 0 C-N-CA 127.345 2.402 . . . . 0.0 118.207 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.98 -41.89 71.77 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.0 mtm -74.61 -30.8 61.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.25 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.7 m -53.77 -29.08 38.54 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.321 1.048 . . . . 0.0 112.585 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.61 -34.63 58.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.305 1.042 . . . . 0.0 113.264 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . 0.273 2.5 pp -84.45 120.55 74.44 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -47.74 146.9 7.64 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 125.123 3.882 . . . . 0.0 120.65 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.8 t -122.02 107.18 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 111.549 -2.568 . . . . 0.0 110.751 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 56.4 tp -101.07 110.97 23.06 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.643 -1.162 . . . . 0.0 107.931 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 90.0 mmm -81.77 133.9 35.39 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.178 -1.374 . . . . 0.0 112.182 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -112.58 109.47 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 177.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.8 p -103.85 134.33 47.33 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.968 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.97 -24.31 52.13 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -165.13 130.51 2.61 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.624 1.97 . . . . 0.0 107.554 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.94 98.23 7.07 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 122.474 1.131 . . . . 0.0 111.106 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -121.87 144.53 48.79 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.746 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -35.1 -50.47 0.51 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.759 1.223 . . . . 0.0 114.121 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -50.79 -58.15 6.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.523 1.129 . . . . 0.0 112.759 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -69.06 -39.91 78.85 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 93.5 mt -57.01 -55.49 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.634 0.774 . . . . 0.0 111.767 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 59.0 mt -59.06 -51.26 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 124.052 0.845 . . . . 0.0 111.143 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.51 -45.1 73.26 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 115.248 -0.887 . . . . 0.0 113.286 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.38 65.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.566 1.146 . . . . 0.0 113.014 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.29 -47.49 83.5 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.723 0.809 . . . . 0.0 111.702 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -58.62 -36.46 74.09 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.6 -13.57 57.82 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.43 3.22 12.92 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.93 125.28 22.4 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.737 1.269 . . . . 0.0 112.807 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.2 m -65.52 -31.97 73.31 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 113.447 -1.706 . . . . 0.0 113.166 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.79 174.99 46.48 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 125.01 1.291 . . . . 0.0 110.333 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -145.81 139.72 26.58 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 p -119.11 130.49 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 125.462 1.726 . . . . 0.0 110.853 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.3 t -75.7 130.53 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.894 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -91.84 123.01 64.43 Favored Pre-proline 0 N--CA 1.479 0.997 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -81.42 156.21 81.98 Favored 'Cis proline' 0 N--CA 1.486 1.069 0 N-CA-C 114.323 0.855 . . . . 0.0 114.323 -0.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -140.67 163.84 31.81 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 112.898 -1.955 . . . . 0.0 109.401 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.3 p -112.53 175.4 5.45 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.271 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.84 81.06 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.156 176.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.21 -48.75 76.99 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.821 0.848 . . . . 0.0 110.97 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.0 m -57.07 -45.94 82.88 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.817 0.847 . . . . 0.0 110.494 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.67 -53.16 61.26 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 124.446 1.091 . . . . 0.0 108.824 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -57.5 -41.86 81.58 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.27 -48.43 65.28 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.845 0.716 . . . . 0.0 111.608 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -63.72 -48.89 75.24 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.965 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.8 mt -49.93 -47.38 52.41 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.822 1.249 . . . . 0.0 113.716 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -63.87 -49.18 73.76 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -53.99 -48.44 70.39 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 124.649 1.218 . . . . 0.0 110.152 176.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 81.1 mt -55.01 -54.72 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.139 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -53.6 -39.34 64.81 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.46 -29.75 69.29 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.67 -45.15 7.15 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.689 1.196 . . . . 0.0 113.508 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 46.5 tp -132.73 88.46 2.52 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.868 1.667 . . . . 0.0 108.932 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.23 89.81 0.01 OUTLIER Glycine 0 CA--C 1.546 1.971 0 CA-C-N 110.579 -3.009 . . . . 0.0 112.746 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.17 0 N-CA-C 119.117 3.006 . . . . 0.0 119.117 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 . . . . . 0 CA--C 1.551 0.992 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 p -72.15 14.25 0.24 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 116.609 2.077 . . . . 0.0 116.609 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -120.41 72.36 0.95 Allowed 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -176.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 69.58 -37.64 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 127.312 2.245 . . . . 0.0 116.981 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.79 39.07 0.78 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.862 -1.517 . . . . 0.0 110.895 177.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.6 tp -95.91 128.05 42.46 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 112.644 -2.071 . . . . 0.0 111.244 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -80.9 106.18 12.7 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 112.874 -1.967 . . . . 0.0 112.107 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -101.73 136.89 40.8 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 113.6 -1.636 . . . . 0.0 113.629 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.5 103.24 10.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.575 -1.648 . . . . 0.0 109.902 172.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.9 t -81.63 91.99 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 112.074 -2.33 . . . . 0.0 107.156 178.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 t -99.53 94.92 3.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 112.753 -2.021 . . . . 0.0 107.983 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -135.47 140.39 44.8 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.258 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -67.08 -27.84 67.69 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 117.017 2.229 . . . . 0.0 117.017 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -107.65 132.15 53.63 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.448 0.299 . . . . 0.0 111.224 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.5 p -51.36 -52.08 48.85 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.754 1.222 . . . . 0.0 113.231 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 m -60.45 -48.82 80.1 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.258 0.974 . . . . 0.0 111.441 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.89 -44.58 94.15 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.224 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -55.39 -58.52 7.39 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.054 1.341 . . . . 0.0 111.039 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -58.9 -36.37 74.58 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.5 mt -58.23 -49.7 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 122.946 0.498 . . . . 0.0 110.09 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.7 t -55.71 -47.35 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 123.525 0.73 . . . . 0.0 110.27 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.689 ' NH2' HD22 ' A' ' 23' ' ' ASN . 7.0 ttp180 -51.51 -51.73 52.7 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.059 1.344 . . . . 0.0 110.843 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.689 HD22 ' NH2' ' A' ' 22' ' ' ARG . 16.1 m120 -62.28 -40.4 96.13 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.206 1.002 . . . . 0.0 112.48 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -58.5 -51.71 68.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.785 0.834 . . . . 0.0 110.69 177.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.1 mt -55.01 -46.27 75.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.125 0.97 . . . . 0.0 112.548 177.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.8 -43.24 90.5 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.661 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -58.78 -39.04 79.89 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.887 1.275 . . . . 0.0 111.995 177.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.0 mt -74.23 -17.49 60.88 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.003 1.321 . . . . 0.0 114.068 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.17 9.71 25.37 Favored Glycine 0 N--CA 1.478 1.477 0 N-CA-C 115.639 1.015 . . . . 0.0 115.639 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -92.6 101.78 14.21 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.753 1.263 . . . . 0.0 112.009 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -64.13 -51.41 64.04 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 118.705 2.854 . . . . 0.0 118.705 -175.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -94.08 101.72 13.76 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.239 1.199 . . . . 0.0 114.239 -174.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.1 t -130.61 118.35 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.002 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -110.79 157.56 19.65 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -127.24 127.93 45.22 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -174.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.03 154.81 32.51 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.501 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -86.93 -48.61 8.0 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -142.74 173.74 11.28 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.245 0.618 . . . . 0.0 109.426 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -43.03 -55.64 4.82 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.071 1.319 . . . . 0.0 116.332 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.87 -54.85 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.366 0.666 . . . . 0.0 111.675 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -56.55 -33.85 66.52 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.665 0.786 . . . . 0.0 111.996 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.86 -48.21 72.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.481 1.112 . . . . 0.0 111.958 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.5 mt -57.62 -40.46 79.2 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.439 0.695 . . . . 0.0 111.464 177.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -59.18 -59.74 4.97 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.402 1.081 . . . . 0.0 109.305 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -58.25 -39.57 79.5 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.3 mt -52.8 -38.47 61.24 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.739 1.216 . . . . 0.0 113.905 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -59.47 -26.17 65.02 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.52 56.89 1.48 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.786 1.234 . . . . 0.0 114.313 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.32 -15.14 7.28 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 117.822 1.889 . . . . 0.0 117.822 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.91 67.24 2.04 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -58.16 129.64 42.93 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.671 1.989 . . . . 0.0 113.114 -177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.64 19.06 16.55 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-N 113.915 -1.493 . . . . 0.0 116.564 -177.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -172.29 128.81 0.57 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 122.551 1.167 . . . . 0.0 112.046 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.3 t -121.8 119.14 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-N 113.521 -1.672 . . . . 0.0 108.182 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.8 mt -108.81 101.77 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.6 t -119.0 125.87 50.39 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 118.185 2.661 . . . . 0.0 118.185 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -67.38 128.21 35.55 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 112.374 -2.194 . . . . 0.0 109.892 178.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -53.92 -50.15 67.04 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.003 0.921 . . . . 0.0 109.934 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -89.19 95.07 10.15 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.548 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 18.4 mtm -134.83 131.66 20.15 Favored Pre-proline 0 N--CA 1.477 0.887 0 CA-C-N 113.08 -1.873 . . . . 0.0 110.882 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -56.65 139.14 87.5 Favored 'Trans proline' 0 N--CA 1.48 0.715 0 C-N-CA 123.945 3.097 . . . . 0.0 111.549 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 m120 64.73 -65.0 0.15 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 126.759 2.024 . . . . 0.0 114.115 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.9 ttm -115.83 92.17 3.82 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -62.16 167.89 3.71 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 111.263 -2.699 . . . . 0.0 112.592 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.28 -55.29 10.73 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 124.298 0.951 . . . . 0.0 113.796 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.3 tp -59.42 -38.14 79.87 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.154 0.981 . . . . 0.0 112.786 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -71.62 -40.05 70.04 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 119.613 -0.232 . . . . 0.0 111.235 177.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.4 tp -60.41 -40.39 90.78 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.679 0.752 . . . . 0.0 110.529 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 tt -51.0 -49.85 59.62 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.089 1.356 . . . . 0.0 108.632 176.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -61.56 -44.96 96.08 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.84 1.256 . . . . 0.0 113.372 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.4 p -61.03 -27.53 68.4 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.625 0.77 . . . . 0.0 111.662 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.0 mt -80.65 -56.9 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.47 1.108 . . . . 0.0 108.78 176.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.0 mmt-85 -51.87 -42.91 63.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.994 1.717 . . . . 0.0 113.346 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.47 -23.69 50.36 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -86.79 95.45 9.84 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.17 0.588 . . . . 0.0 111.807 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -3.5 -83.63 0.0 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 127.106 2.289 . . . . 0.0 118.412 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.94 -39.86 82.89 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 82.3 mtp -71.84 -23.56 61.56 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.573 1.549 . . . . 0.0 113.778 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.6 m -50.8 -26.17 5.36 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.841 1.657 . . . . 0.0 115.147 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.49 -7.43 50.5 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.3 mt -83.42 119.48 73.99 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 123.284 0.633 . . . . 0.0 111.829 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -54.18 138.44 71.69 Favored 'Trans proline' 0 N--CA 1.482 0.812 0 C-N-CA 123.984 3.123 . . . . 0.0 114.892 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 t -120.26 114.47 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-N 112.366 -2.197 . . . . 0.0 111.427 -178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.9 tp -106.64 110.37 22.54 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.969 -1.469 . . . . 0.0 109.36 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.3 mmt -81.11 112.29 18.34 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.911 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.63 102.82 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.4 t -110.18 138.63 46.3 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.13 -1.85 . . . . 0.0 113.78 -176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -48.0 -31.41 5.31 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -161.5 152.73 18.54 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.709 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.24 82.29 3.72 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 123.187 1.47 . . . . 0.0 107.552 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -100.94 121.42 41.71 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 111.343 -2.662 . . . . 0.0 108.362 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -38.48 -53.07 1.58 Allowed 'General case' 0 N--CA 1.483 1.178 0 O-C-N 125.018 1.449 . . . . 0.0 113.892 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -53.17 -53.29 52.74 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.171 0.588 . . . . 0.0 111.188 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -56.79 -49.36 75.57 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.3 1.0 . . . . 0.0 111.833 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.8 mt -55.25 -51.92 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.188 0.995 . . . . 0.0 111.969 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.2 mm -58.98 -54.89 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.606 0.762 . . . . 0.0 110.8 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.63 -47.05 70.65 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.191 0.996 . . . . 0.0 113.234 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.06 -51.72 68.14 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.451 1.1 . . . . 0.0 112.168 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.1 -47.75 84.83 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.284 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -56.3 -40.38 74.23 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.85 1.26 . . . . 0.0 113.489 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.28 -14.41 59.44 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.92 3.11 12.35 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.24 123.02 18.45 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.192 1.496 . . . . 0.0 112.319 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.1 p -69.78 -17.57 63.43 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 113.161 -1.836 . . . . 0.0 114.314 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.54 173.47 43.93 Favored Glycine 0 N--CA 1.481 1.658 0 C-N-CA 124.043 0.83 . . . . 0.0 111.844 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -144.4 136.63 26.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 114.999 -0.601 . . . . 0.0 112.387 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.258 1.0 OUTLIER -118.03 126.9 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 124.413 1.07 . . . . 0.0 110.419 178.363 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.37 114.64 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 112.159 -2.292 . . . . 0.0 111.229 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -90.36 132.28 36.03 Favored Pre-proline 0 N--CA 1.472 0.627 0 CA-C-O 117.725 -1.131 . . . . 0.0 110.611 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.18 132.87 26.91 Favored 'Cis proline' 0 N--CA 1.489 1.228 0 N-CA-C 115.173 1.182 . . . . 0.0 115.173 1.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -124.74 151.62 44.84 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 112.462 -2.154 . . . . 0.0 108.69 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.2 p -102.53 171.63 7.33 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.014 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.71 -39.85 68.6 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.576 0.548 . . . . 0.0 111.396 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.0 -44.41 80.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.427 1.091 . . . . 0.0 111.983 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.4 m -60.15 -49.32 78.09 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 60.3 tp -56.14 -50.45 71.08 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.24 1.416 . . . . 0.0 109.715 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -56.45 -46.86 80.12 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.328 1.051 . . . . 0.0 112.473 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -53.41 -44.08 68.44 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -65.88 -48.43 71.55 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.392 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.7 mt -56.66 -48.94 76.48 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.535 1.134 . . . . 0.0 111.504 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -50.09 -53.24 28.57 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 126.021 1.728 . . . . 0.0 112.056 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -54.15 -45.91 72.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.654 1.182 . . . . 0.0 111.466 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.74 -39.8 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.338 1.055 . . . . 0.0 112.038 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -61.3 -25.46 67.13 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -57.91 -44.62 86.95 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 124.004 0.815 . . . . 0.0 109.542 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -68.18 -35.83 78.64 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.28 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.7 mt -86.85 44.23 1.15 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.672 1.589 . . . . 0.0 112.468 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 61.04 15.26 42.59 Favored Glycine 0 CA--C 1.55 2.276 0 C-N-CA 127.081 2.277 . . . . 0.0 118.35 177.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 116.984 -1.484 . . . . 0.0 113.083 179.176 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 . . . . . 0 CA--C 1.554 1.132 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.4 p -82.91 81.22 8.71 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 122.969 1.366 . . . . 0.0 112.011 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -65.34 105.23 1.09 Allowed 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.761 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -51.19 -39.9 57.49 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -105.68 45.33 0.98 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.6 tp -83.11 122.78 28.81 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 112.029 -2.351 . . . . 0.0 107.349 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -78.26 115.88 18.3 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.931 -1.486 . . . . 0.0 113.446 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -105.72 138.15 42.4 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.745 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -116.16 99.53 7.3 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.616 1.198 . . . . 0.0 108.822 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.9 t -79.68 104.36 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 111.61 -2.541 . . . . 0.0 108.958 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.89 102.54 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 113.605 -1.634 . . . . 0.0 110.02 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.75 135.05 22.96 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.986 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -66.1 -16.99 64.41 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -106.59 110.36 22.54 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.2 p -46.93 -49.63 20.19 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.691 -1.14 . . . . 0.0 113.273 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -38.93 85.94 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.297 1.039 . . . . 0.0 112.741 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.2 tpt -62.19 -38.98 91.18 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -56.39 -47.89 78.02 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.196 0.522 . . . . 0.0 110.907 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.56 -41.61 73.51 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 114.133 -1.394 . . . . 0.0 112.399 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.5 mt -57.69 -50.99 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.244 0.617 . . . . 0.0 110.23 177.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 t -58.57 -42.47 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.273 0.629 . . . . 0.0 109.97 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 56.0 ttm-85 -53.8 -54.14 42.51 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 123.938 0.774 . . . . 0.0 110.737 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -58.81 -39.78 82.17 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.1 mt -62.59 -53.88 48.05 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.482 0.713 . . . . 0.0 111.492 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.9 mt -54.87 -44.3 73.9 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.988 0.915 . . . . 0.0 111.882 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -56.75 -49.08 76.32 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 113.343 -1.753 . . . . 0.0 110.175 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -56.42 -38.0 70.97 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.05 1.74 . . . . 0.0 112.914 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.4 mt -73.76 -19.17 60.86 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.787 1.235 . . . . 0.0 114.287 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.41 -5.22 23.21 Favored Glycine 0 CA--C 1.551 2.295 0 C-N-CA 124.296 0.951 . . . . 0.0 112.919 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -92.54 86.03 5.49 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 122.557 1.17 . . . . 0.0 109.773 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -85.28 -7.52 58.96 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -98.29 93.37 6.18 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 122.387 1.089 . . . . 0.0 110.343 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.6 t -129.11 136.32 59.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 113.525 -1.67 . . . . 0.0 111.403 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.16 149.85 48.7 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 176.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -127.99 141.27 51.57 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 118.637 2.828 . . . . 0.0 118.637 -176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -131.51 152.44 50.73 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 112.072 -2.331 . . . . 0.0 110.531 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . 0.374 0.0 OUTLIER -100.08 -27.71 13.41 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 -179.057 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.7 p30 -142.7 166.59 24.24 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.476 -0.765 . . . . 0.0 110.831 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -45.08 -49.25 9.7 Favored Glycine 0 N--CA 1.479 1.543 0 C-N-CA 124.6 1.095 . . . . 0.0 115.582 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -58.65 -56.68 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 114.616 -0.792 . . . . 0.0 110.585 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -55.36 -35.38 65.17 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.802 0.841 . . . . 0.0 111.662 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.01 -51.52 57.57 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 117.91 -1.043 . . . . 0.0 111.834 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.6 mt -54.82 -45.77 74.48 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 124.211 0.944 . . . . 0.0 111.068 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -54.96 -54.41 43.17 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 125.166 1.541 . . . . 0.0 111.43 177.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.8 mttt -62.61 -45.14 94.22 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.027 1.331 . . . . 0.0 114.271 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.8 mt -54.09 -28.71 41.02 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -57.88 -25.51 60.87 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.39 -18.89 62.69 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.72 -179.8 50.63 Favored Glycine 0 N--CA 1.48 1.593 0 CA-C-O 122.165 0.869 . . . . 0.0 112.541 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.46 -31.02 3.29 Favored Glycine 0 N--CA 1.485 1.953 0 CA-C-N 113.959 -1.121 . . . . 0.0 114.142 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -60.69 113.29 2.39 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.094 0.558 . . . . 0.0 110.772 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.62 15.3 45.64 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 125.815 1.947 . . . . 0.0 112.222 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -171.3 134.19 0.88 Allowed 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 122.381 1.086 . . . . 0.0 112.348 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.32 121.49 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.538 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 89.8 mt -112.33 98.99 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.5 t -113.46 122.06 46.17 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.02 127.26 32.22 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 111.456 -2.611 . . . . 0.0 110.259 177.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -51.93 -45.04 64.14 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.237 0.961 . . . . 0.0 112.871 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -87.06 103.15 15.11 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.013 0.925 . . . . 0.0 109.438 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.9 mtp -147.23 131.46 8.58 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 123.999 0.92 . . . . 0.0 111.815 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.21 149.42 81.62 Favored 'Trans proline' 0 N--CA 1.48 0.734 0 C-N-CA 123.484 2.789 . . . . 0.0 110.968 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.5 m120 70.94 -71.7 0.13 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.911 1.684 . . . . 0.0 111.05 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.8 ttm -119.84 99.71 6.8 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -61.1 166.59 3.51 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.688 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.91 -56.64 7.45 Favored Glycine 0 N--CA 1.485 1.939 0 O-C-N 124.188 0.93 . . . . 0.0 114.868 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.8 tp -58.59 -37.26 75.43 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -68.31 -39.81 81.89 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.773 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.7 tp -58.99 -42.37 89.87 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.904 0.753 . . . . 0.0 110.372 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.9 tp -54.06 -47.27 71.82 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.059 1.344 . . . . 0.0 111.178 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.36 -47.11 85.62 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.235 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.257 11.4 p -59.15 -32.38 69.83 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.658 1.183 . . . . 0.0 112.943 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.3 mt -74.65 -55.7 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.248 1.019 . . . . 0.0 108.311 176.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.1 mmt-85 -51.03 -48.01 61.57 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.584 1.554 . . . . 0.0 111.769 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.83 -22.32 65.15 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -83.66 110.71 18.5 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.599 0.76 . . . . 0.0 109.411 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -26.28 -69.14 0.05 OUTLIER Glycine 0 CA--C 1.541 1.71 0 C-N-CA 125.981 1.753 . . . . 0.0 115.306 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.02 -35.28 80.68 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 42.7 mtm -85.35 -11.38 54.72 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 64.8 p -42.67 -43.17 3.74 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.456 1.903 . . . . 0.0 116.099 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.64 -3.95 57.01 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.5 mt -73.95 111.07 10.86 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -52.1 131.14 38.0 Favored 'Trans proline' 0 N--CA 1.481 0.749 0 C-N-CA 123.166 2.577 . . . . 0.0 114.249 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 63.3 t -116.86 124.72 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 112.865 -1.97 . . . . 0.0 113.224 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.4 tp -111.97 108.13 17.35 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 112.659 -2.064 . . . . 0.0 108.771 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.0 mmt -81.8 106.13 13.48 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 113.383 -1.735 . . . . 0.0 113.637 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -91.28 98.61 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 123.921 1.819 . . . . 0.0 108.504 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 t -108.9 139.23 44.04 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 111.813 -2.449 . . . . 0.0 112.6 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.19 -41.79 65.63 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 114.213 -1.358 . . . . 0.0 113.495 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -137.32 151.17 48.34 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.472 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.73 78.14 5.51 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.352 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.8 135.99 37.98 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.259 -1.791 . . . . 0.0 108.7 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -41.07 -49.46 3.4 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.077 1.351 . . . . 0.0 113.193 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -58.59 -51.2 70.9 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -56.93 -45.39 82.76 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.343 1.027 . . . . 0.0 111.312 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 78.9 mt -56.87 -55.16 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 124.716 1.206 . . . . 0.0 110.892 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.5 mt -59.32 -50.92 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.021 0.928 . . . . 0.0 110.674 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.58 74.11 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.834 0.854 . . . . 0.0 111.865 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.08 -49.05 79.35 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.507 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.53 88.29 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.305 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -60.12 -38.87 84.31 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.0 -0.66 45.22 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.54 -0.81 29.23 Favored Glycine 0 CA--C 1.545 1.908 0 N-CA-C 117.391 1.716 . . . . 0.0 117.391 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.03 121.65 14.11 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.099 1.449 . . . . 0.0 114.357 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.0 m -65.44 -30.02 70.77 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 111.913 -2.403 . . . . 0.0 113.08 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -173.68 177.23 46.09 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.308 1.432 . . . . 0.0 111.121 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -147.32 131.54 17.42 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.053 -1.073 . . . . 0.0 111.186 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.8 p -120.83 123.85 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 123.988 0.805 . . . . 0.0 110.364 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.8 t -76.41 128.56 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 112.796 -2.002 . . . . 0.0 111.456 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -92.78 138.26 23.67 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.859 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.51 133.75 31.92 Favored 'Cis proline' 0 CA--C 1.54 0.788 0 N-CA-C 115.866 1.449 . . . . 0.0 115.866 0.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -116.95 147.72 42.02 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 112.832 -1.985 . . . . 0.0 108.458 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 59.9 p -105.56 178.48 4.55 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.983 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.11 -42.93 69.99 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.912 0.758 . . . . 0.0 111.97 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.09 72.93 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.738 0.815 . . . . 0.0 111.723 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -60.57 -46.3 90.73 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.475 0.71 . . . . 0.0 110.786 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.3 tp -56.47 -51.2 69.35 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.323 1.049 . . . . 0.0 109.553 177.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -58.67 -47.67 83.71 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.531 0.732 . . . . 0.0 111.752 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -50.42 -45.5 55.82 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 124.195 0.934 . . . . 0.0 110.653 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -68.47 -46.59 69.34 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.159 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.5 mt -55.87 -48.67 75.15 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.503 0.721 . . . . 0.0 111.218 177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -55.15 -52.53 63.0 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.502 1.521 . . . . 0.0 112.004 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -52.85 -46.96 68.05 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.357 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.92 -46.88 93.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.276 1.03 . . . . 0.0 111.528 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -61.33 -40.89 95.88 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.582 0.353 . . . . 0.0 111.722 178.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.58 -48.9 77.41 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.581 1.152 . . . . 0.0 110.346 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -54.9 -39.83 69.17 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.033 1.333 . . . . 0.0 111.563 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.9 33.4 0.59 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.308 1.443 . . . . 0.0 113.919 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.38 -5.41 2.2 Favored Glycine 0 CA--C 1.546 1.995 0 N-CA-C 117.122 1.609 . . . . 0.0 117.122 178.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 71.1 mtm . . . . . 0 C--O 1.255 1.374 0 CA-C-O 118.606 -0.712 . . . . 0.0 112.815 179.977 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.6 p -66.73 90.36 0.17 Allowed 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.43 124.6 22.69 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 111.983 -2.371 . . . . 0.0 112.111 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -59.83 -31.51 69.81 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -99.94 46.8 0.95 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.497 1.142 . . . . 0.0 113.802 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.2 tp -79.77 127.68 32.51 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 111.405 -2.634 . . . . 0.0 107.318 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -81.77 110.43 17.08 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.558 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -99.33 141.65 31.84 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.933 -1.94 . . . . 0.0 113.135 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -121.82 98.76 6.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.368 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -80.11 109.68 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 111.955 -2.384 . . . . 0.0 108.419 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 t -108.53 100.64 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.597 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -141.21 133.73 28.44 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.844 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -65.06 -28.37 69.42 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 112.976 -1.92 . . . . 0.0 114.025 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -94.54 102.02 13.94 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.0 p -39.12 -50.09 1.85 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 113.024 -1.898 . . . . 0.0 113.27 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -38.82 92.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.04 1.336 . . . . 0.0 112.61 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 12.4 tpt -63.51 -34.27 77.4 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -56.47 -42.58 78.45 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.507 0.504 . . . . 0.0 111.441 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -60.37 -43.88 96.16 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.114 -1.403 . . . . 0.0 112.533 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.6 mt -59.97 -51.46 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 122.993 0.517 . . . . 0.0 110.231 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.8 t -58.04 -44.41 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 123.806 0.691 . . . . 0.0 109.172 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 37.5 ttm-85 -55.42 -52.49 63.42 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.953 0.901 . . . . 0.0 111.469 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -55.9 -44.87 78.63 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 123.916 0.76 . . . . 0.0 113.04 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.4 mt -59.36 -52.82 64.01 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.506 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.5 mt -54.29 -48.75 70.93 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.541 176.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -52.25 -48.51 65.18 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.64 1.576 . . . . 0.0 111.198 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.33 -39.03 78.36 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.014 1.725 . . . . 0.0 114.017 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.2 mt -73.84 -16.25 61.14 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.962 1.305 . . . . 0.0 114.163 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.62 -8.31 19.8 Favored Glycine 0 N--CA 1.482 1.743 0 C-N-CA 124.696 1.141 . . . . 0.0 112.824 -177.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -90.11 74.07 7.19 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 123.871 1.795 . . . . 0.0 111.675 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -76.18 -14.73 60.15 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 112.256 -2.247 . . . . 0.0 116.167 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -91.79 93.51 8.89 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.465 1.126 . . . . 0.0 110.218 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.8 t -132.63 140.53 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.591 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.93 152.44 47.12 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 175.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -126.67 141.95 51.69 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -131.54 158.15 41.7 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 112.01 -2.359 . . . . 0.0 108.951 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . 0.314 0.0 OUTLIER -105.37 -17.37 14.46 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 -178.05 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -157.17 169.01 25.75 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 122.009 -0.432 . . . . 0.0 109.924 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -44.82 -54.99 6.48 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 124.743 1.164 . . . . 0.0 114.684 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.3 t -56.67 -56.54 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 122.612 0.365 . . . . 0.0 111.096 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -52.29 -35.91 51.63 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.113 0.965 . . . . 0.0 112.748 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.9 -52.92 24.35 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.551 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.3 mt -52.89 -42.5 65.36 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.801 0.688 . . . . 0.0 111.412 178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -55.71 -57.29 12.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.601 1.56 . . . . 0.0 110.592 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -58.65 -42.2 87.81 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.536 1.535 . . . . 0.0 113.252 177.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.3 mt -59.98 -32.33 70.75 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -55.27 -26.66 41.44 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.83 -15.0 61.25 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.82 -177.43 47.57 Favored Glycine 0 CA--C 1.542 1.73 0 C-N-CA 124.033 0.825 . . . . 0.0 112.566 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.93 -33.2 4.06 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 114.753 -0.723 . . . . 0.0 113.495 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -69.16 122.56 19.04 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.944 0.897 . . . . 0.0 111.827 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.46 23.97 8.27 Favored Glycine 0 N--CA 1.478 1.49 0 O-C-N 126.17 2.169 . . . . 0.0 112.322 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -173.94 133.32 0.44 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.779 1.232 . . . . 0.0 111.398 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.6 t -122.77 122.95 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.823 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.5 mt -110.93 100.04 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 105.861 -1.904 . . . . 0.0 105.861 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.466 ' HG ' ' CE ' ' A' ' 60' ' ' MET . 29.8 t -118.0 130.02 55.93 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -68.5 127.65 33.76 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 111.624 -2.535 . . . . 0.0 110.828 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 32.1 t-105 -48.11 -54.62 12.61 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.515 1.126 . . . . 0.0 112.54 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -104.43 114.35 28.53 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 122.323 1.058 . . . . 0.0 111.167 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.466 ' CE ' ' HG ' ' A' ' 56' ' ' SER . 32.8 mtm -139.73 137.28 18.33 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 111.916 -2.402 . . . . 0.0 109.383 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -57.04 145.54 85.27 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.645 2.897 . . . . 0.0 112.23 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.7 m120 69.41 -59.22 0.49 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.49 1.916 . . . . 0.0 115.009 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 59.3 ttm -133.02 101.4 5.21 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -68.81 164.24 22.37 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 113.634 -1.621 . . . . 0.0 112.323 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -43.91 -50.36 7.41 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 124.857 1.217 . . . . 0.0 114.453 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.9 tp -61.19 -42.6 98.87 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.743 -0.729 . . . . 0.0 112.84 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -65.63 -38.86 90.6 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.631 0.373 . . . . 0.0 111.198 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.14 -43.94 95.34 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.046 0.841 . . . . 0.0 110.345 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.4 tp -55.15 -46.28 75.69 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.697 1.199 . . . . 0.0 110.685 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.63 -46.4 89.1 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.254 0.622 . . . . 0.0 112.366 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.25 12.8 p -62.55 -16.61 56.98 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.954 1.302 . . . . 0.0 114.069 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.9 mt -92.68 -59.76 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.111 1.364 . . . . 0.0 108.08 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.2 mmt-85 -53.32 -46.48 69.46 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 126.386 1.874 . . . . 0.0 113.873 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.74 -29.92 65.04 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -86.37 103.27 14.78 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -23.0 -71.19 0.01 OUTLIER Glycine 0 N--CA 1.483 1.818 0 C-N-CA 126.188 1.852 . . . . 0.0 115.692 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.01 -43.46 77.73 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 75.5 mmm -68.11 -27.02 66.11 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 96.1 p -47.36 -27.87 1.81 Allowed 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.73 -12.23 44.81 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 mt -95.86 115.2 65.37 Favored Pre-proline 0 N--CA 1.485 1.312 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -59.42 142.98 99.81 Favored 'Trans proline' 0 N--CA 1.483 0.903 0 C-N-CA 123.439 2.759 . . . . 0.0 111.329 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.0 t -121.3 126.97 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-O 122.681 1.229 . . . . 0.0 113.234 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.4 tp -112.96 112.11 23.34 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 112.336 -2.211 . . . . 0.0 109.932 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 31.5 mmt -85.85 108.36 18.1 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.955 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.1 t -86.85 98.69 7.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-O 123.234 1.492 . . . . 0.0 107.692 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.8 t -113.26 140.57 47.87 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 112.03 -2.35 . . . . 0.0 109.947 -177.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.12 -50.57 58.57 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.542 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -138.92 153.6 48.27 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.974 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.14 83.74 7.74 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 122.83 1.3 . . . . 0.0 109.209 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -108.89 141.41 41.0 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 112.592 -2.095 . . . . 0.0 111.6 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -40.96 -52.77 3.07 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.621 1.568 . . . . 0.0 113.443 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -55.73 -50.19 71.05 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -62.98 -47.14 84.45 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.184 0.994 . . . . 0.0 111.323 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.8 mt -55.97 -54.57 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.783 1.233 . . . . 0.0 112.585 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.3 mt -55.83 -53.88 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.184 0.594 . . . . 0.0 109.9 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.71 -45.57 74.05 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.481 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.77 -48.7 79.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.23 1.012 . . . . 0.0 113.041 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.59 -43.17 97.74 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.983 0.913 . . . . 0.0 111.633 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -57.86 -33.73 68.99 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.314 1.046 . . . . 0.0 113.541 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.9 -1.62 57.82 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 100.33 13.32 36.21 Favored Glycine 0 CA--C 1.547 2.088 0 N-CA-C 117.676 1.83 . . . . 0.0 117.676 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.04 129.9 43.75 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 118.921 1.36 . . . . 0.0 114.57 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 28.3 m -73.82 -29.29 62.06 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 113.085 -1.87 . . . . 0.0 112.439 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.12 174.99 47.22 Favored Glycine 0 N--CA 1.481 1.672 0 C-N-CA 124.898 1.237 . . . . 0.0 110.466 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -144.88 130.51 18.96 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 113.924 -1.138 . . . . 0.0 111.304 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.292 1.4 p -114.68 121.19 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.205 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.0 t -74.69 115.41 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 111.479 -2.6 . . . . 0.0 111.316 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -91.65 135.57 27.58 Favored Pre-proline 0 C--O 1.24 0.567 0 O-C-N 124.421 1.075 . . . . 0.0 112.298 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -72.75 130.66 20.32 Favored 'Cis proline' 0 N--CA 1.475 0.423 0 N-CA-C 116.725 1.779 . . . . 0.0 116.725 0.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -120.63 137.83 54.23 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 112.073 -2.331 . . . . 0.0 108.213 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 54.3 p -96.48 179.52 4.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 123.85 0.719 . . . . 0.0 110.079 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.26 -36.53 68.67 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 119.504 -0.284 . . . . 0.0 111.324 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.45 -49.54 66.34 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.82 0.848 . . . . 0.0 110.839 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.99 -43.14 99.47 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.146 0.579 . . . . 0.0 110.123 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 40.2 tp -60.66 -53.72 54.03 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.695 0.798 . . . . 0.0 110.492 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -55.16 -45.87 75.71 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.459 0.704 . . . . 0.0 111.083 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -54.79 -47.36 74.08 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.337 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -66.8 -41.92 86.77 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 55.9 mt -57.76 -47.73 81.66 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.722 0.809 . . . . 0.0 109.621 177.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -54.64 -54.02 47.11 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.761 1.624 . . . . 0.0 112.074 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -52.74 -43.65 65.88 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.955 0.902 . . . . 0.0 112.331 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 68.8 mt -60.65 -49.82 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.509 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -59.44 -40.97 88.5 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.218 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -56.75 -50.65 71.62 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 125.083 1.489 . . . . 0.0 110.691 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -60.94 -40.75 94.48 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.278 1.031 . . . . 0.0 111.385 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.7 1.44 26.47 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.14 -35.81 4.35 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 116.24 1.256 . . . . 0.0 116.24 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 75.4 mtm . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 -178.747 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 119.826 3.269 . . . . 0.0 119.826 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.9 p -87.12 119.29 27.2 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.8 1.286 . . . . 0.0 110.788 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -98.44 109.39 22.16 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.097 -1.865 . . . . 0.0 111.188 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -61.43 -17.83 56.07 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -109.71 61.26 0.6 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 123.347 1.546 . . . . 0.0 109.541 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.1 tp -86.71 136.19 33.11 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 110.846 -2.888 . . . . 0.0 110.212 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -86.96 118.57 26.43 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 125.674 1.859 . . . . 0.0 111.89 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -108.2 148.93 29.24 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 112.826 -1.988 . . . . 0.0 112.868 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.23 104.01 7.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.639 175.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.4 t -84.1 105.3 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 112.526 -2.125 . . . . 0.0 109.197 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 t -104.08 92.45 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.817 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -135.62 127.54 29.49 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.36 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -60.36 -21.41 62.08 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -101.89 131.22 48.38 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.429 0.633 . . . . 0.0 110.995 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.5 p -50.44 -58.55 5.46 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.006 -1.907 . . . . 0.0 112.568 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -45.24 93.77 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.471 1.108 . . . . 0.0 112.614 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 11.9 tpt -59.87 -37.29 78.89 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.4 mtm-85 -58.21 -47.35 83.75 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 176.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -59.61 -43.44 93.77 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.396 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 83.2 mt -56.35 -48.26 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.537 178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 t -63.07 -41.56 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 CA-C-O 118.943 -0.551 . . . . 0.0 109.982 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 57.7 ttm-85 -54.67 -52.47 62.25 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.378 0.671 . . . . 0.0 110.047 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -59.57 -38.43 81.13 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.415 1.086 . . . . 0.0 113.624 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.36 -54.39 37.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.753 0.821 . . . . 0.0 110.91 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.8 mt -55.66 -43.29 76.15 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.139 0.976 . . . . 0.0 111.743 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -56.68 -47.59 79.52 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.103 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -59.95 -37.43 79.55 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.038 1.735 . . . . 0.0 112.684 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.9 mt -72.66 -20.33 61.27 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.639 1.176 . . . . 0.0 113.21 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.81 -15.31 11.31 Favored Glycine 0 CA--C 1.546 2.028 0 C-N-CA 124.591 1.091 . . . . 0.0 114.336 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -89.71 82.23 6.32 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 123.408 1.575 . . . . 0.0 110.578 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -76.65 -7.97 56.33 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -96.98 97.95 9.68 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.071 0.939 . . . . 0.0 110.067 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 83.1 t -134.16 141.45 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.904 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.49 153.2 43.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 174.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -126.07 142.54 51.48 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 116.143 1.905 . . . . 0.0 116.143 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.62 157.25 46.22 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 112.53 -2.123 . . . . 0.0 108.097 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.6 -33.15 9.1 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -138.91 173.09 11.93 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.98 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.67 -56.85 7.08 Favored Glycine 0 N--CA 1.474 1.23 0 CA-C-N 114.254 -1.339 . . . . 0.0 115.551 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.9 t -58.07 -53.84 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 122.922 0.489 . . . . 0.0 111.496 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -51.83 -40.62 60.81 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.939 0.895 . . . . 0.0 111.969 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.8 -51.27 65.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.414 1.086 . . . . 0.0 112.728 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.6 mt -54.47 -47.32 73.09 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.776 0.831 . . . . 0.0 112.104 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -56.77 -55.35 35.38 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.777 1.298 . . . . 0.0 110.256 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -58.19 -39.34 78.71 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.008 -1.451 . . . . 0.0 114.597 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 34.0 mt -58.43 -31.0 67.33 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.962 1.468 . . . . 0.0 114.962 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -58.41 -22.37 53.85 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.534 1.134 . . . . 0.0 114.018 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.86 -26.36 67.32 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.55 175.97 48.48 Favored Glycine 0 N--CA 1.479 1.533 0 C-N-CA 124.211 0.91 . . . . 0.0 113.445 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.19 -27.79 3.49 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 113.539 -1.33 . . . . 0.0 114.933 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -61.44 108.64 0.98 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.959 0.904 . . . . 0.0 112.499 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.42 15.92 59.55 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-N 113.634 -1.621 . . . . 0.0 111.837 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -173.61 141.21 0.84 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.257 1.023 . . . . 0.0 113.757 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.6 t -123.18 111.82 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 113.318 -1.765 . . . . 0.0 108.267 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 76.5 mt -100.9 101.8 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.5 t -119.44 128.21 53.81 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -74.14 132.34 42.15 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.052 -1.886 . . . . 0.0 110.426 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -54.01 -44.02 70.57 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.388 1.055 . . . . 0.0 113.098 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -93.7 99.52 11.92 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.673 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.7 mtm -139.88 137.3 18.17 Favored Pre-proline 0 N--CA 1.478 0.967 0 CA-C-N 114.511 -1.222 . . . . 0.0 112.127 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.1 145.13 93.67 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.789 2.993 . . . . 0.0 113.177 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 65.05 -69.09 0.1 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.316 1.847 . . . . 0.0 112.415 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.6 ttm -116.81 100.27 7.67 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -65.32 173.35 2.61 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 113.476 -1.693 . . . . 0.0 113.24 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -52.23 -54.97 24.04 Favored Glycine 0 N--CA 1.478 1.474 0 C-N-CA 124.703 1.144 . . . . 0.0 115.051 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.8 tp -59.4 -39.85 84.75 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.599 0.76 . . . . 0.0 111.925 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -66.87 -39.8 87.64 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.354 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.24 -45.34 93.59 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.878 0.871 . . . . 0.0 110.089 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.7 tp -52.32 -45.62 65.69 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.517 1.127 . . . . 0.0 111.77 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -60.31 -47.69 84.93 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.998 0.919 . . . . 0.0 113.082 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.32 -38.24 86.17 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.247 1.019 . . . . 0.0 111.335 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.8 mt -67.91 -54.67 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 123.893 0.877 . . . . 0.0 109.467 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 62.1 mmt-85 -54.1 -41.11 67.9 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 125.61 1.564 . . . . 0.0 111.918 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.44 -30.73 68.72 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.963 1.305 . . . . 0.0 113.982 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -83.84 93.98 8.11 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.553 0.741 . . . . 0.0 110.36 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -8.86 -80.15 0.01 OUTLIER Glycine 0 N--CA 1.482 1.729 0 C-N-CA 126.85 2.167 . . . . 0.0 117.254 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.18 -42.81 86.88 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -63.61 -25.28 68.16 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.5 p -53.64 -25.78 19.3 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.22 -22.51 61.25 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.413 1.485 . . . . 0.0 114.439 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . 0.355 1.5 pp -94.02 111.62 53.87 Favored Pre-proline 0 N--CA 1.479 0.997 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -47.46 143.97 10.82 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 125.086 3.857 . . . . 0.0 117.453 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 87.7 t -117.44 121.29 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 112.248 -2.251 . . . . 0.0 111.575 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.8 tp -112.55 115.5 28.73 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.343 -1.753 . . . . 0.0 108.992 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.9 mmt -88.21 112.25 22.55 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.533 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -92.23 96.84 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 123.377 1.56 . . . . 0.0 108.155 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 t -109.22 128.6 55.18 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 111.457 -2.611 . . . . 0.0 111.494 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.12 -38.7 25.77 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -143.37 138.6 29.53 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.24 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.23 84.89 5.13 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.265 -1.334 . . . . 0.0 107.912 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -100.38 133.69 44.43 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 112.055 -2.338 . . . . 0.0 107.253 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -39.12 -49.46 1.8 Allowed 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.941 1.401 . . . . 0.0 113.593 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -58.5 -52.76 64.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.159 0.984 . . . . 0.0 112.079 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -56.33 -44.69 80.24 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.906 0.882 . . . . 0.0 110.928 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 83.4 mt -58.7 -56.15 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.856 0.863 . . . . 0.0 111.195 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.4 mt -57.41 -50.82 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.231 0.612 . . . . 0.0 110.511 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.72 -48.32 72.67 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.891 0.876 . . . . 0.0 113.248 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.21 -48.88 79.98 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.687 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.0 -48.25 82.27 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.27 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -55.6 -42.8 75.36 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.391 1.076 . . . . 0.0 113.897 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.05 -1.37 43.82 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.41 11.47 25.3 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 117.823 1.889 . . . . 0.0 117.823 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.41 125.65 24.89 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.198 1.499 . . . . 0.0 114.86 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.0 m -70.47 -23.15 62.64 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 112.445 -2.161 . . . . 0.0 112.684 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.01 -179.68 45.21 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.541 1.544 . . . . 0.0 110.348 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -147.27 130.45 16.47 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.216 -0.992 . . . . 0.0 111.715 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.7 p -115.36 123.54 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.852 0.834 . . . . 0.0 110.393 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.9 t -77.8 125.44 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 113.231 -1.804 . . . . 0.0 110.679 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -92.66 139.19 23.52 Favored Pre-proline 0 N--CA 1.478 0.934 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.914 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.64 125.36 11.68 Favored 'Cis proline' 0 CA--C 1.54 0.812 0 CA-C-O 122.734 1.056 . . . . 0.0 114.629 0.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -110.01 145.16 37.48 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.039 -1.891 . . . . 0.0 109.015 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 49.9 p -97.89 171.14 8.48 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.35 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.24 -39.07 63.52 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.934 176.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.43 -46.18 84.28 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.88 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.8 m -64.2 -45.98 85.92 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.084 0.954 . . . . 0.0 109.489 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 30.4 tp -56.59 -51.32 69.08 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.099 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -58.22 -47.77 82.47 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.51 0.724 . . . . 0.0 112.372 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -46.08 -47.41 17.2 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.106 0.879 . . . . 0.0 112.291 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -71.54 -47.57 54.32 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.472 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.5 mt -55.86 -45.24 78.54 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.858 0.863 . . . . 0.0 112.27 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -53.66 -55.86 22.33 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.786 1.234 . . . . 0.0 113.295 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -53.17 -47.47 68.8 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.783 -1.553 . . . . 0.0 112.088 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.5 mt -57.1 -44.41 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 114.2 -1.364 . . . . 0.0 113.238 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -59.55 -36.71 76.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -76.03 -46.18 30.67 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 113.732 -1.576 . . . . 0.0 110.279 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -61.37 -29.05 69.67 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.898 1.279 . . . . 0.0 112.527 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 mp -91.73 1.85 56.88 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 64.94 23.57 69.49 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 115.957 1.143 . . . . 0.0 115.957 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 27.0 mtt . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 116.329 -1.796 . . . . 0.0 114.417 179.596 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 t -85.52 72.71 10.59 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 112.79 -2.005 . . . . 0.0 105.616 177.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.269 0.0 OUTLIER -71.25 45.24 0.1 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 111.072 -2.786 . . . . 0.0 115.282 -177.647 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -27.1 68.87 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 113.682 -1.599 . . . . 0.0 114.638 178.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -84.57 27.46 0.72 Allowed 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.508 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 tt -82.9 130.53 35.15 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.409 1.084 . . . . 0.0 109.898 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.45 102.01 14.14 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.764 176.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -92.85 133.68 35.83 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.183 -1.826 . . . . 0.0 111.638 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.46 104.23 13.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.754 174.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.8 t -80.73 98.27 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.519 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.7 78.61 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 112.69 -2.05 . . . . 0.0 108.42 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -128.47 100.12 5.66 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 113.044 -1.889 . . . . 0.0 112.313 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -27.69 -41.44 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -92.34 124.76 36.64 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.8 p -47.86 -50.5 26.2 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.143 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.91 -46.24 85.26 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.264 0.626 . . . . 0.0 111.456 177.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.06 -45.8 91.95 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.393 0.677 . . . . 0.0 111.373 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -53.67 -46.78 70.73 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.727 0.811 . . . . 0.0 111.133 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -61.92 -43.02 99.71 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 112.993 -1.912 . . . . 0.0 113.735 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.1 mm -57.83 -54.74 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.376 0.671 . . . . 0.0 110.311 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.7 t -55.05 -44.49 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.67 0.788 . . . . 0.0 110.855 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -53.67 -54.83 32.23 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.475 1.11 . . . . 0.0 110.936 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -55.74 -39.71 71.51 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.311 1.044 . . . . 0.0 112.743 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.02 -53.55 53.91 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.559 1.144 . . . . 0.0 111.393 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.1 mt -53.98 -41.86 68.34 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.329 1.052 . . . . 0.0 111.832 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -56.94 -51.43 69.18 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.128 -1.397 . . . . 0.0 109.982 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -56.82 -37.68 71.54 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.654 1.581 . . . . 0.0 112.55 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.2 mt -74.03 -18.08 60.89 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.91 15.5 19.99 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.868 1.223 . . . . 0.0 114.356 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -96.27 101.0 12.58 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 123.347 1.546 . . . . 0.0 112.152 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -60.44 -45.33 94.04 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 111.494 -2.594 . . . . 0.0 117.689 -178.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -100.16 108.55 20.7 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -173.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.1 t -133.24 120.17 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 112.291 -2.231 . . . . 0.0 109.433 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -111.47 154.89 24.05 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -122.46 125.32 45.57 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.5 148.25 44.09 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.073 -1.876 . . . . 0.0 109.844 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.58 -61.08 1.98 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -129.67 179.41 5.84 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.799 -176.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -45.45 -52.79 8.59 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-N 114.594 -1.184 . . . . 0.0 115.182 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.7 t -57.79 -57.86 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.027 0.931 . . . . 0.0 111.471 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -55.68 -36.98 67.71 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.07 0.948 . . . . 0.0 111.335 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.78 -51.36 65.2 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.868 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.8 mt -55.05 -45.95 75.31 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.321 0.648 . . . . 0.0 110.936 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -56.46 -58.01 9.86 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.188 0.995 . . . . 0.0 110.933 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -58.18 -40.92 82.73 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.643 1.577 . . . . 0.0 114.569 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.4 mt -53.57 -41.01 66.08 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -65.04 -15.83 62.77 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.75 14.32 0.21 Allowed 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.28 160.09 6.91 Favored Glycine 0 N--CA 1.483 1.784 0 C-N-CA 126.024 1.773 . . . . 0.0 116.788 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.92 -13.48 3.2 Favored Glycine 0 CA--C 1.546 1.987 0 N-CA-C 120.461 2.944 . . . . 0.0 120.461 176.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -65.76 99.97 0.5 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.923 1.861 . . . . 0.0 115.52 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.4 15.77 62.59 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-N 112.55 -2.114 . . . . 0.0 111.797 177.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -168.31 136.48 2.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 122.577 1.179 . . . . 0.0 113.756 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.4 t -124.23 112.86 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.106 177.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.0 tt -115.96 97.89 6.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 113.714 -1.585 . . . . 0.0 107.055 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.3 t -118.37 139.67 51.01 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 119.523 3.157 . . . . 0.0 119.523 -174.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -73.45 129.64 38.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.324 -2.217 . . . . 0.0 110.662 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 25.0 t-105 -56.15 -39.69 72.67 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.648 0.779 . . . . 0.0 112.401 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -99.35 93.55 5.98 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.497 1.519 . . . . 0.0 110.334 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.0 mtm -132.95 134.88 25.01 Favored Pre-proline 0 N--CA 1.479 1.023 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.79 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -57.11 144.58 89.74 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.729 2.953 . . . . 0.0 111.162 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.7 m120 65.69 -73.62 0.06 Allowed 'General case' 0 N--CA 1.483 1.205 0 O-C-N 125.182 1.551 . . . . 0.0 112.659 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 55.0 ttm -115.12 98.4 6.76 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.84 168.56 3.02 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 112.34 -2.209 . . . . 0.0 112.691 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.46 -52.91 26.76 Favored Glycine 0 N--CA 1.481 1.653 0 C-N-CA 124.632 1.11 . . . . 0.0 114.247 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.5 tp -59.81 -40.99 90.25 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.645 0.778 . . . . 0.0 112.247 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -66.03 -43.64 87.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.703 0.801 . . . . 0.0 111.159 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -58.42 -45.66 88.03 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.499 1.12 . . . . 0.0 110.821 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -52.32 -50.07 62.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.205 1.402 . . . . 0.0 109.818 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -59.28 -47.01 86.99 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.678 1.191 . . . . 0.0 112.836 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.263 27.6 p -61.24 -23.7 65.83 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.585 1.154 . . . . 0.0 112.291 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.3 mt -84.32 -58.88 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.959 0.904 . . . . 0.0 108.65 174.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.5 mmt-85 -48.67 -51.34 28.94 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.909 2.083 . . . . 0.0 113.968 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.1 -21.4 59.91 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.06 97.64 8.87 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -22.25 -61.45 0.03 OUTLIER Glycine 0 N--CA 1.486 2.033 0 C-N-CA 125.976 1.751 . . . . 0.0 116.37 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.11 91.55 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 97.7 mtp -78.44 -24.27 46.18 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.899 1.815 . . . . 0.0 115.899 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 t -27.94 -33.15 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 118.609 2.818 . . . . 0.0 118.609 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.69 -1.52 58.12 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.6 mt -75.23 113.25 23.58 Favored Pre-proline 0 N--CA 1.489 1.491 0 CA-C-N 119.248 0.931 . . . . 0.0 113.119 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -56.62 134.46 64.56 Favored 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.436 2.757 . . . . 0.0 113.245 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.3 t -118.9 120.09 62.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 113.971 -1.468 . . . . 0.0 113.413 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.4 tp -112.22 105.4 13.72 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.815 -1.993 . . . . 0.0 109.361 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.2 mmt -78.25 107.53 10.91 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.815 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -87.18 96.22 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 t -100.15 136.78 39.53 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 111.422 -2.627 . . . . 0.0 114.898 -176.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.88 -24.41 66.86 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 112.691 -2.049 . . . . 0.0 113.487 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -155.91 126.23 6.68 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.173 1.389 . . . . 0.0 111.911 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.0 81.07 7.56 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 122.096 0.951 . . . . 0.0 108.897 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -110.32 136.38 49.59 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.775 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.29 0.0 OUTLIER -33.4 -52.26 0.37 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 117.049 2.241 . . . . 0.0 117.049 -178.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . 0.334 0.8 OUTLIER -63.91 -42.41 97.41 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -179.458 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.301 32.1 p-10 -73.94 -30.68 62.68 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.868 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.3 mt -61.05 -50.85 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.3 mt -53.42 -54.22 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.349 1.46 . . . . 0.0 110.132 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.72 -48.84 72.0 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.484 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.9 -55.54 33.58 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.831 1.252 . . . . 0.0 112.976 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.83 85.28 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.593 0.757 . . . . 0.0 112.283 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -64.36 -34.12 77.42 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.041 1.496 . . . . 0.0 115.041 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.56 -13.18 59.95 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.12 1.01 8.08 Favored Glycine 0 CA--C 1.547 2.058 0 N-CA-C 117.391 1.716 . . . . 0.0 117.391 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.5 120.43 7.17 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 119.707 1.753 . . . . 0.0 115.116 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.7 m -64.31 -32.95 74.75 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.355 -1.748 . . . . 0.0 112.327 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.72 172.85 45.56 Favored Glycine 0 N--CA 1.477 1.378 0 C-N-CA 125.162 1.363 . . . . 0.0 110.061 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -144.01 140.32 29.51 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.4 p -122.63 127.1 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 124.942 1.401 . . . . 0.0 109.959 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.7 p -86.62 132.76 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.829 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.32 137.61 24.64 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.549 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -77.29 139.35 58.13 Favored 'Cis proline' 0 N--CA 1.482 0.799 0 N-CA-C 115.112 1.158 . . . . 0.0 115.112 -0.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -126.92 147.73 50.07 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 112.424 -2.171 . . . . 0.0 107.953 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.4 p -100.3 174.35 6.17 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.298 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.38 -37.93 62.9 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.178 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.26 -47.71 66.99 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.287 1.035 . . . . 0.0 111.89 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 m -58.25 -47.88 82.17 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.3 tp -56.27 -52.12 65.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.757 1.223 . . . . 0.0 111.412 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.81 -44.15 77.57 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.991 0.917 . . . . 0.0 112.449 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -57.72 -43.91 85.6 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -64.55 -45.19 88.14 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.273 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.3 mt -54.08 -49.39 69.19 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.188 0.995 . . . . 0.0 111.468 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -53.94 -55.05 30.56 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.488 1.115 . . . . 0.0 111.945 178.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -51.78 -46.95 64.37 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.147 1.379 . . . . 0.0 111.607 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.4 mt -60.91 -52.15 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.485 1.114 . . . . 0.0 110.646 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -55.78 -44.29 77.59 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.383 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -56.93 -41.46 78.24 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 124.319 1.012 . . . . 0.0 111.952 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -64.44 -50.2 68.49 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.742 0.817 . . . . 0.0 111.242 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.7 mt -69.2 -7.71 39.02 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.112 1.765 . . . . 0.0 115.404 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 102.88 -28.33 16.32 Favored Glycine 0 N--CA 1.478 1.457 0 C-N-CA 123.753 0.692 . . . . 0.0 112.766 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 59.9 mtm . . . . . 0 C--O 1.257 1.458 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 179.598 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 91.4 mttt . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 117.367 2.358 . . . . 0.0 117.367 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.414 ' HG3' ' OD1' ' A' ' 32' ' ' ASN . 0.5 OUTLIER -120.92 89.86 3.21 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.548 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 tt -144.26 128.57 17.83 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 112.28 -2.236 . . . . 0.0 107.687 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.485 ' HG2' ' HB3' ' A' ' 32' ' ' ASN . 65.1 mttm -82.06 112.86 19.5 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -104.32 132.97 50.0 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.47 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.476 ' CD1' HG22 ' A' ' 11' ' ' VAL . 2.0 tm? -111.95 99.76 8.35 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.103 0.954 . . . . 0.0 110.06 176.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.469 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 53.9 t -78.94 103.61 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 112.03 -2.35 . . . . 0.0 108.467 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.495 ' CG1' ' HB2' ' A' ' 42' ' ' ALA . 1.3 t -100.85 90.05 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 113.555 -1.657 . . . . 0.0 107.785 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -132.34 121.59 23.75 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.818 1.294 . . . . 0.0 112.275 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.84 -29.9 70.48 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 111.979 -2.373 . . . . 0.0 115.345 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -98.4 121.31 40.18 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.7 0.625 . . . . 0.0 109.452 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.1 p -50.04 -50.67 46.91 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 m -59.45 -50.12 75.16 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.046 0.538 . . . . 0.0 111.137 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -40.35 94.58 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.135 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.528 HH21 ' NH1' ' A' ' 19' ' ' ARG . 37.1 ttp180 -58.88 -48.33 81.78 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.315 1.046 . . . . 0.0 111.147 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.528 ' NH1' HH21 ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.74 -46.47 89.04 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.387 1.054 . . . . 0.0 111.994 177.714 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.424 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 61.2 mt -53.97 -50.92 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.828 0.851 . . . . 0.0 110.932 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.428 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 5.8 t -57.23 -48.45 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 122.506 0.323 . . . . 0.0 110.732 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -56.39 -50.77 70.63 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.86 0.725 . . . . 0.0 110.946 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -55.83 -43.33 76.89 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.268 1.027 . . . . 0.0 110.769 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 20' ' ' ILE . 67.9 mt -59.97 -51.82 68.03 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.718 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.7 mt -57.11 -43.19 82.06 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.718 0.807 . . . . 0.0 112.81 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -58.2 -48.9 78.88 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.383 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -60.69 -33.99 73.68 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.748 1.619 . . . . 0.0 113.008 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.5 mt -76.2 -13.7 60.17 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.06 -14.44 26.17 Favored Glycine 0 N--CA 1.482 1.755 0 C-N-CA 124.359 0.98 . . . . 0.0 113.741 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -81.23 85.41 6.38 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 122.384 1.088 . . . . 0.0 111.999 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -81.37 13.55 2.91 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.485 ' HB3' ' HG2' ' A' ' 7' ' ' LYS . 20.8 m120 -121.83 85.9 2.49 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 123.461 1.601 . . . . 0.0 110.756 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p -136.78 127.63 41.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 113.562 -1.653 . . . . 0.0 111.374 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.594 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 23.3 mp0 -119.43 155.29 32.29 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.469 ' HG2' ' HB ' ' A' ' 10' ' ' VAL . 29.9 mt-10 -127.8 139.7 52.49 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -177.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.79 167.15 17.72 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 111.175 -2.738 . . . . 0.0 109.748 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -104.35 -53.78 2.65 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -125.0 171.33 10.32 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.199 0.599 . . . . 0.0 110.989 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.475 ' HA2' HD22 ' A' ' 68' ' ' LEU . . . -45.58 -53.77 8.12 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.992 1.282 . . . . 0.0 115.662 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.5 t -58.25 -55.06 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.671 0.788 . . . . 0.0 111.27 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -54.49 -41.51 69.67 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.672 1.189 . . . . 0.0 111.318 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.495 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . . . -63.1 -49.45 74.41 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.501 1.121 . . . . 0.0 112.146 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.518 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 18.0 mt -52.25 -53.91 37.83 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 124.332 1.02 . . . . 0.0 110.706 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -52.11 -52.2 52.99 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.39 1.056 . . . . 0.0 112.426 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -57.93 -52.8 63.99 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.634 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.1 mt -59.56 -33.09 70.98 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 83.3 mt-30 -62.29 -26.27 68.32 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.87 -25.84 68.07 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.79 -168.37 15.96 Favored Glycine 0 N--CA 1.478 1.449 0 O-C-N 124.585 1.178 . . . . 0.0 110.588 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.61 -41.73 2.15 Favored Glycine 0 CA--C 1.541 1.71 0 N-CA-C 116.17 1.228 . . . . 0.0 116.17 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.594 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 76.8 m-85 -66.77 135.42 53.95 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.83 19.87 7.34 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 113.801 -1.545 . . . . 0.0 113.62 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -174.29 144.06 0.91 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.762 1.225 . . . . 0.0 111.776 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 t -125.64 124.66 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.886 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.0 mt -115.92 99.99 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.8 t -116.93 137.5 52.17 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 -176.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -77.37 129.49 35.87 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 113.456 -1.702 . . . . 0.0 110.236 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -56.58 -50.4 72.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.101 0.96 . . . . 0.0 112.534 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.437 ' OD1' ' HB2' ' A' ' 88' ' ' ALA . 4.4 p-10 -87.92 77.28 8.52 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.146 1.379 . . . . 0.0 113.338 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.436 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 3.4 mtm -117.66 133.23 23.32 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-N 113.576 -1.647 . . . . 0.0 113.706 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 60' ' ' MET . 71.5 Cg_exo -61.68 147.02 96.28 Favored 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 123.982 3.122 . . . . 0.0 112.505 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 68.9 -64.08 0.34 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.565 1.946 . . . . 0.0 112.208 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 60.4 ttm -126.69 104.31 8.02 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 124.779 1.231 . . . . 0.0 107.887 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -69.71 168.61 14.57 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 113.614 -1.63 . . . . 0.0 113.178 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.3 -54.57 12.37 Favored Glycine 0 N--CA 1.476 1.314 0 C-N-CA 125.046 1.308 . . . . 0.0 114.393 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.645 HD12 HD23 ' A' ' 69' ' ' LEU . 41.8 tp -59.99 -41.5 92.21 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.66 0.784 . . . . 0.0 112.846 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.5 -43.91 88.65 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.627 0.371 . . . . 0.0 111.228 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.475 HD22 ' HA2' ' A' ' 39' ' ' GLY . 61.1 tp -58.73 -40.82 84.87 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.091 0.956 . . . . 0.0 110.736 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.645 HD23 HD12 ' A' ' 66' ' ' LEU . 13.0 tp -56.0 -45.64 78.99 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.178 0.991 . . . . 0.0 110.675 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.75 -45.42 89.94 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.018 0.927 . . . . 0.0 112.083 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 75' ' ' ASP 0.251 67.8 p -59.84 -38.31 81.71 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.109 0.964 . . . . 0.0 110.54 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.8 mt -68.98 -54.28 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.637 0.775 . . . . 0.0 109.473 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.543 ' HD3' HD12 ' A' ' 69' ' ' LEU . 2.2 mpt_? -52.92 -28.59 24.07 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 126.925 2.09 . . . . 0.0 114.231 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.5 -12.75 15.86 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 78' ' ' MET . 30.8 t0 -80.37 60.39 3.78 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.992 0.917 . . . . 0.0 113.437 -177.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 32.98 -89.5 0.01 OUTLIER Glycine 0 N--CA 1.485 1.964 0 C-N-CA 127.856 2.646 . . . . 0.0 115.036 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.36 -38.58 80.78 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.072 0.949 . . . . 0.0 113.137 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.505 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 87.0 mtp -78.17 -11.17 59.9 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.6 m -57.68 -17.6 15.91 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.64 8.31 41.77 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 86.1 mt -85.11 112.42 43.3 Favored Pre-proline 0 N--CA 1.484 1.247 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 10.9 Cg_endo -51.86 139.52 49.95 Favored 'Trans proline' 0 N--CA 1.477 0.547 0 C-N-CA 123.872 3.048 . . . . 0.0 113.365 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.0 t -122.53 127.42 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.457 -1.247 . . . . 0.0 113.684 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.2 tp -114.66 102.2 9.81 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.534 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.4 mmt -78.96 108.31 12.35 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.361 -1.745 . . . . 0.0 113.162 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 3.9 t -85.93 104.89 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.5 p -94.64 139.74 30.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.703 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.437 ' HB2' ' OD1' ' A' ' 59' ' ' ASN . . . -67.93 -45.39 74.47 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.13 -1.396 . . . . 0.0 110.72 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -136.45 128.39 29.39 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.649 -1.614 . . . . 0.0 107.226 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.16 113.46 26.75 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.715 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.4 153.01 51.22 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 113.171 -1.832 . . . . 0.0 108.277 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -41.25 -43.54 2.42 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -53.37 -61.14 2.49 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.463 1.105 . . . . 0.0 112.933 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -69.94 -28.94 65.98 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 88.1 mt -61.55 -52.7 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.739 0.816 . . . . 0.0 110.102 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.6 mt -62.56 -44.33 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.98 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.54 -47.54 69.89 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.187 0.995 . . . . 0.0 112.104 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.71 -53.4 58.65 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.782 1.233 . . . . 0.0 111.75 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.67 90.72 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.204 1.002 . . . . 0.0 112.279 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -57.61 -38.37 74.81 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.64 1.176 . . . . 0.0 113.325 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.96 5.57 32.59 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.446 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 110.06 -5.56 30.5 Favored Glycine 0 CA--C 1.541 1.718 0 N-CA-C 116.825 1.49 . . . . 0.0 116.825 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.55 117.13 5.81 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 119.454 1.627 . . . . 0.0 113.906 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.3 m -62.59 -28.58 69.98 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 112.109 -2.314 . . . . 0.0 113.142 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.1 170.8 43.14 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.982 1.277 . . . . 0.0 110.706 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -143.81 142.16 30.73 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.18 -1.01 . . . . 0.0 111.738 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 2.0 p -128.92 126.97 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.198 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.4 p -84.47 142.56 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.755 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -90.4 137.85 27.3 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.692 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -86.87 135.63 17.02 Favored 'Cis proline' 0 CA--C 1.539 0.729 0 CA-C-O 122.722 1.051 . . . . 0.0 113.624 -0.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.428 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 28.0 p90 -116.09 151.29 35.88 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 113.467 -1.697 . . . . 0.0 109.558 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.5 p -105.7 177.9 4.72 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.35 0.595 . . . . 0.0 111.384 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.6 -45.1 69.93 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.027 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.33 -48.72 76.85 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.624 0.77 . . . . 0.0 111.221 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.65 -47.97 78.6 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.43 0.692 . . . . 0.0 110.291 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -51.44 70.02 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.445 1.098 . . . . 0.0 109.095 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -55.7 -46.28 77.7 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.644 1.178 . . . . 0.0 112.685 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.03 -48.09 70.88 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.249 0.62 . . . . 0.0 111.352 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -61.94 -47.28 85.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.817 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.5 mt -55.3 -51.1 67.78 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.037 0.835 . . . . 0.0 112.534 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -53.34 -50.51 64.86 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.558 1.143 . . . . 0.0 111.882 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -56.07 -49.01 74.99 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.817 1.647 . . . . 0.0 112.035 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.4 mt -59.47 -48.64 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.278 1.031 . . . . 0.0 110.53 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 . . . . . 0 N--CA 1.479 0.987 0 O-C-N 124.03 0.831 . . . . 0.0 112.83 179.653 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.4 tptt . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -118.8 73.29 0.92 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.899 0.857 . . . . 0.0 108.884 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.3 tp -102.27 128.6 48.74 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 112.534 -2.121 . . . . 0.0 109.572 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HG2' ' HB3' ' A' ' 32' ' ' ASN . 43.2 mtpt -74.48 113.42 11.71 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.53 -1.214 . . . . 0.0 114.017 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -107.84 142.53 37.75 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.106 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.415 ' CD1' HG22 ' A' ' 11' ' ' VAL . 1.5 tm? -123.23 103.76 8.73 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.221 175.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 77.1 t -81.28 101.15 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 111.889 -2.414 . . . . 0.0 109.333 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.415 HG22 ' CD1' ' A' ' 9' ' ' LEU . 1.7 t -100.39 94.65 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 113.685 -1.598 . . . . 0.0 107.149 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -139.23 124.75 19.33 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.779 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.6 p-10 -61.92 -30.7 71.07 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.16 121.56 38.06 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.092 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.3 p -47.0 -50.6 18.88 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 113.2 -1.818 . . . . 0.0 113.025 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.407 ' O ' HG12 ' A' ' 20' ' ' ILE . 2.8 m -60.56 -55.27 35.43 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.1 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.441 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -62.69 -35.8 80.85 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -58.55 -47.59 83.69 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.3 1.04 . . . . 0.0 110.395 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.675 HH12 HH11 ' A' ' 22' ' ' ARG . 28.4 tpt180 -60.71 -45.53 93.89 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.286 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.462 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 45.5 mm -52.98 -54.73 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.274 1.03 . . . . 0.0 110.41 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.473 HG11 HG21 ' A' ' 55' ' ' ILE . 2.9 t -59.94 -49.05 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 123.562 0.539 . . . . 0.0 111.345 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.675 HH11 HH12 ' A' ' 19' ' ' ARG . 3.3 tmt_? -54.69 -46.3 74.09 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 124.088 0.867 . . . . 0.0 110.592 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -63.81 -47.49 80.62 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.56 1.144 . . . . 0.0 112.158 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 20' ' ' ILE . 72.0 mt -52.97 -53.77 45.02 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.284 1.034 . . . . 0.0 112.313 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.7 mt -55.61 -48.0 75.6 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.192 0.997 . . . . 0.0 113.372 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -55.89 -46.56 78.29 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 113.215 -1.811 . . . . 0.0 110.476 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -62.4 -31.1 71.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.073 1.749 . . . . 0.0 113.706 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 73.4 mt -77.15 -10.06 59.15 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.835 1.254 . . . . 0.0 113.904 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.76 -12.83 20.43 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 125.302 1.43 . . . . 0.0 114.53 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -85.57 81.29 8.73 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 122.48 1.133 . . . . 0.0 113.629 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -85.42 29.24 0.69 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 113.168 -1.833 . . . . 0.0 114.431 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.575 ' HB3' ' HG2' ' A' ' 7' ' ' LYS . 4.4 m120 -127.62 53.38 1.76 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 123.789 1.757 . . . . 0.0 109.788 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.95 126.19 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.602 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.58 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 72.5 mm-40 -117.49 165.03 14.01 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.33 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -127.41 141.4 51.69 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 119.508 3.151 . . . . 0.0 119.508 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -132.46 148.96 52.41 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 111.301 -2.681 . . . . 0.0 109.098 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -85.81 -53.77 4.92 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.526 -1.215 . . . . 0.0 112.777 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -130.72 171.06 13.52 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.899 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.427 ' HA2' HD22 ' A' ' 68' ' ' LEU . . . -45.14 -44.11 9.45 Favored Glycine 0 N--CA 1.477 1.426 0 O-C-N 125.11 1.506 . . . . 0.0 116.524 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.3 t -61.76 -55.76 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 118.18 -0.914 . . . . 0.0 109.908 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -54.54 -40.01 68.25 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 123.596 0.56 . . . . 0.0 110.726 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.41 -54.46 45.37 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.453 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.529 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 32.3 mt -54.65 -51.26 66.01 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.31 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -46.08 -48.65 17.0 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.961 0.904 . . . . 0.0 112.733 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -69.0 -49.83 54.25 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.917 2.087 . . . . 0.0 113.591 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.4 mt -59.44 -36.66 76.34 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 10.2 mm100 -55.43 -25.66 37.44 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.26 -28.1 68.45 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.95 -170.42 23.82 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.538 1.065 . . . . 0.0 111.405 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.05 -46.06 3.1 Favored Glycine 0 N--CA 1.483 1.817 0 CA-C-N 113.814 -1.193 . . . . 0.0 113.748 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.58 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 74.3 m-85 -62.21 109.57 1.36 Allowed 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.134 0.969 . . . . 0.0 111.961 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.534 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -105.3 29.56 11.36 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-N 113.2 -1.818 . . . . 0.0 113.363 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.569 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -178.72 129.49 0.12 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.053 1.341 . . . . 0.0 112.404 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 t -116.35 116.4 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 113.536 -1.665 . . . . 0.0 107.384 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.473 HG21 HG11 ' A' ' 21' ' ' VAL . 77.4 mt -107.2 98.77 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.5 t -118.28 127.11 53.4 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 117.895 2.554 . . . . 0.0 117.895 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.88 128.55 35.83 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.228 -2.26 . . . . 0.0 111.0 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -49.33 -47.32 47.31 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -92.8 106.76 18.68 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.972 0.891 . . . . 0.0 109.125 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.459 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 2.9 mtp -145.98 133.53 10.33 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.687 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.08 146.8 78.08 Favored 'Trans proline' 0 N--CA 1.48 0.691 0 C-N-CA 123.299 2.666 . . . . 0.0 111.969 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 m120 70.31 -72.92 0.1 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.106 1.762 . . . . 0.0 111.069 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.418 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 56.1 ttm -116.88 97.74 6.12 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.1 p30 -64.48 168.75 5.47 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 113.006 -1.906 . . . . 0.0 113.64 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.22 -56.6 10.25 Favored Glycine 0 N--CA 1.479 1.563 0 C-N-CA 124.664 1.126 . . . . 0.0 114.242 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.473 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 60.7 tp -61.03 -37.85 84.05 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.099 0.959 . . . . 0.0 112.96 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -68.53 -38.85 81.2 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.368 0.667 . . . . 0.0 111.151 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.427 HD22 ' HA2' ' A' ' 39' ' ' GLY . 65.4 tp -64.9 -38.93 92.62 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.861 0.864 . . . . 0.0 110.648 177.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.664 HD23 ' HD3' ' A' ' 73' ' ' ARG . 5.8 tt -50.63 -49.44 56.79 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.027 0.931 . . . . 0.0 109.254 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -60.43 -42.86 96.93 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.936 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.514 ' HB ' HD11 ' A' ' 43' ' ' LEU . 47.8 p -69.22 -14.92 63.24 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.4 1.08 . . . . 0.0 113.014 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.5 mt -92.51 -54.34 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.156 1.382 . . . . 0.0 107.679 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.664 ' HD3' HD23 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -50.8 -52.81 37.51 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.688 1.995 . . . . 0.0 112.761 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.0 -14.7 59.42 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 71' ' ' THR . 7.9 t70 -86.85 75.75 9.55 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.664 0.745 . . . . 0.0 111.847 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 30.99 -100.0 0.01 OUTLIER Glycine 0 N--CA 1.483 1.818 0 C-N-CA 126.828 2.156 . . . . 0.0 115.151 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.84 -31.19 72.15 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 95.5 mtp -62.98 -18.0 62.75 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.7 p -53.17 -26.85 18.62 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.82 -16.43 36.21 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.534 HD22 ' HA2' ' A' ' 52' ' ' GLY . 94.6 mt -76.56 111.41 15.63 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 123.153 0.581 . . . . 0.0 111.51 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -52.49 130.57 36.94 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.389 2.726 . . . . 0.0 115.367 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.418 HG11 ' HG ' ' A' ' 69' ' ' LEU . 47.0 t -113.61 117.78 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 112.462 -2.154 . . . . 0.0 110.754 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.569 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 48.0 tp -110.37 114.77 28.48 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 113.207 -1.815 . . . . 0.0 108.863 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 28.4 mmt -87.92 104.42 16.59 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 122.91 1.338 . . . . 0.0 114.441 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.02 99.38 7.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 122.91 1.338 . . . . 0.0 107.82 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 4.2 t -123.1 129.1 51.02 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 113.256 -1.793 . . . . 0.0 112.546 -177.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.75 -32.02 73.33 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.109 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -107.47 106.5 16.93 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.128 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.434 ' HB2' HG22 ' A' ' 108' ' ' VAL . . . -92.05 66.15 4.91 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 123.767 1.746 . . . . 0.0 107.098 177.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -115.99 150.88 36.49 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 111.868 -2.424 . . . . 0.0 111.056 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -33.61 -57.91 0.43 Allowed 'General case' 0 N--CA 1.476 0.826 0 O-C-N 125.488 1.743 . . . . 0.0 114.725 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -51.69 -52.34 48.95 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -61.72 -49.05 77.99 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.317 0.647 . . . . 0.0 111.53 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.0 mt -56.47 -54.89 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.539 1.136 . . . . 0.0 111.629 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.0 mm -57.86 -54.77 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.548 1.139 . . . . 0.0 111.056 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.83 -45.22 67.21 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.05 0.94 . . . . 0.0 112.47 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.17 -53.14 49.35 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.973 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.97 -46.16 85.6 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -57.72 -39.68 77.84 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.371 1.068 . . . . 0.0 113.579 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.51 -26.93 46.02 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 129.22 13.78 2.32 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 116.651 1.42 . . . . 0.0 116.651 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.629 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -63.43 121.37 13.64 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 118.79 1.295 . . . . 0.0 112.295 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.502 ' HB3' HG23 ' A' ' 123' ' ' ILE . 7.9 m -67.29 -25.78 66.22 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 112.988 -1.914 . . . . 0.0 112.482 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.0 173.11 40.52 Favored Glycine 0 N--CA 1.482 1.705 0 C-N-CA 125.686 1.613 . . . . 0.0 109.66 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -143.35 130.97 21.24 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.25 1.8 p -113.09 123.57 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 122.195 0.998 . . . . 0.0 111.97 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 87' ' ' THR . 8.2 t -72.41 128.36 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 111.609 -2.541 . . . . 0.0 108.963 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -99.93 134.89 20.63 Favored Pre-proline 0 N--CA 1.472 0.638 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.431 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.68 144.28 79.64 Favored 'Cis proline' 0 N--CA 1.482 0.815 0 N-CA-C 115.123 1.163 . . . . 0.0 115.123 0.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -129.77 150.88 50.88 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 112.384 -2.189 . . . . 0.0 107.517 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.414 HG22 ' OG1' ' A' ' 115' ' ' THR . 14.3 t -102.34 172.05 7.11 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.773 0.671 . . . . 0.0 110.29 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.34 -43.9 61.89 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.93 0.892 . . . . 0.0 111.698 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.32 -46.64 87.84 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.134 0.974 . . . . 0.0 112.412 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.414 ' OG1' HG22 ' A' ' 112' ' ' THR . 1.0 OUTLIER -58.79 -48.31 81.7 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.456 1.103 . . . . 0.0 109.181 178.715 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.416 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 48.8 tp -57.67 -51.32 70.01 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.201 1.4 . . . . 0.0 110.329 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.451 ' HA ' HD12 ' A' ' 120' ' ' LEU . 17.6 tp10 -55.53 -47.36 76.42 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.685 0.794 . . . . 0.0 111.54 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.79 -46.43 74.46 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.429 0.692 . . . . 0.0 112.025 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.9 mmmt -63.95 -48.4 76.66 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 124.2 0.937 . . . . 0.0 112.328 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 117' ' ' GLU . 48.5 mt -53.18 -48.41 68.04 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.498 1.119 . . . . 0.0 110.961 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -55.95 -58.46 7.79 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.534 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -51.32 -44.06 61.86 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.894 1.278 . . . . 0.0 112.37 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.502 HG23 ' HB3' ' A' ' 104' ' ' SER . 79.3 mt -57.2 -52.06 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.164 1.386 . . . . 0.0 112.307 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 . . . . . 0 N--CA 1.49 1.562 0 O-C-N 123.885 0.74 . . . . 0.0 112.19 -179.667 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 85.2 mttt . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.83 71.15 10.69 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.591 0.71 . . . . 0.0 109.172 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 tt -121.28 132.77 55.0 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.154 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -77.06 105.51 8.18 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.162 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -109.43 144.9 37.02 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.139 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.71 110.91 16.52 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.64 -1.163 . . . . 0.0 112.012 174.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.5 t -89.84 106.03 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.501 HG11 ' HB2' ' A' ' 42' ' ' ALA . 4.4 t -106.22 90.06 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 112.864 -1.971 . . . . 0.0 108.888 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -137.88 124.17 20.55 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.184 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -59.88 -25.85 65.41 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -97.88 119.45 36.51 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.248 0.546 . . . . 0.0 110.347 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.9 p -46.05 -48.39 16.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 113.926 -1.488 . . . . 0.0 113.517 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.532 ' O ' HG12 ' A' ' 20' ' ' ILE . 2.9 m -60.85 -55.06 37.52 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.682 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.481 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.2 mmm -59.95 -38.95 83.95 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.507 ' NH1' HH22 ' A' ' 19' ' ' ARG . 15.5 ttm180 -57.1 -53.08 62.16 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.813 0.845 . . . . 0.0 110.153 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.507 HH22 ' NH1' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -58.64 -41.72 86.68 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.142 1.377 . . . . 0.0 113.477 177.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 16' ' ' THR . 39.9 mm -57.1 -58.63 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.261 1.024 . . . . 0.0 110.724 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.58 HG11 HG21 ' A' ' 55' ' ' ILE . 3.4 t -55.99 -44.56 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.231 0.613 . . . . 0.0 111.537 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.592 ' HD2' ' HB3' ' A' ' 35' ' ' GLU . 28.6 mtp-105 -54.25 -55.45 28.04 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.96 0.904 . . . . 0.0 112.376 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -59.92 -39.83 86.79 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 75.9 mt -55.38 -52.38 63.74 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.553 0.692 . . . . 0.0 111.358 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.0 mt -54.66 -48.97 71.71 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.47 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -56.45 -44.89 80.94 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.287 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 29.6 mt-10 -58.06 -40.48 81.12 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.434 1.894 . . . . 0.0 112.308 177.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.2 mt -73.47 -13.95 61.15 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.069 1.347 . . . . 0.0 113.605 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.34 -11.4 24.04 Favored Glycine 0 CA--C 1.544 1.901 0 C-N-CA 124.816 1.198 . . . . 0.0 113.757 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 57.1 m-85 -85.7 76.5 9.95 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 123.23 1.49 . . . . 0.0 111.537 -177.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -72.32 -24.72 61.35 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 118.04 2.607 . . . . 0.0 118.04 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.22 71.68 10.02 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.505 1.145 . . . . 0.0 112.178 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.2 p -120.04 128.6 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HB2' ' HE2' ' A' ' 51' ' ' TYR . 80.7 mm-40 -110.79 167.18 10.43 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.573 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.592 ' HB3' ' HD2' ' A' ' 22' ' ' ARG . 1.2 pp20? -126.75 126.15 42.96 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 -176.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.403 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -122.29 150.97 41.61 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.093 -1.867 . . . . 0.0 108.893 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -92.05 -43.67 9.27 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -141.49 173.34 11.59 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.241 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -43.15 -56.6 4.54 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.065 1.317 . . . . 0.0 115.852 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.1 t -56.16 -54.61 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 123.429 0.691 . . . . 0.0 110.997 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -56.94 -34.27 67.85 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.941 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.501 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -65.41 -48.89 71.24 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.347 1.059 . . . . 0.0 110.971 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.441 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 99.5 mt -57.46 -45.47 84.71 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -55.42 -54.79 39.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.541 1.136 . . . . 0.0 110.927 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -59.66 -45.03 93.27 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 114.399 -1.273 . . . . 0.0 113.641 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.497 HD21 HG22 ' A' ' 54' ' ' VAL . 25.2 mt -55.42 -42.83 74.66 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.327 1.051 . . . . 0.0 112.433 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 53.0 mt-30 -52.92 -35.57 58.47 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.758 1.223 . . . . 0.0 111.493 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.73 59.17 3.55 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.07 -19.63 4.61 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 118.466 2.147 . . . . 0.0 118.466 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.86 56.37 21.39 Favored Glycine 0 CA--C 1.548 2.138 0 CA-C-N 118.23 1.015 . . . . 0.0 112.296 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.579 ' H ' ' HD1' ' A' ' 51' ' ' TYR . 1.4 m-85 -50.71 135.63 23.14 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.063 2.145 . . . . 0.0 113.427 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.486 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -84.47 22.18 9.29 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 -177.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.669 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -178.13 129.26 0.13 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.698 1.237 . . . . 0.0 112.237 177.375 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.497 HG22 HD21 ' A' ' 46' ' ' LEU . 38.4 t -117.82 113.58 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 112.907 -1.951 . . . . 0.0 107.537 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.58 HG21 HG11 ' A' ' 21' ' ' VAL . 96.5 mt -107.94 97.52 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 t -119.04 136.62 54.04 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -71.13 130.18 40.83 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 112.258 -2.246 . . . . 0.0 109.195 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.447 ' O ' ' HB3' ' A' ' 64' ' ' ASP . 38.7 t-105 -58.29 -44.7 88.62 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.706 0.802 . . . . 0.0 111.428 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -94.53 96.17 9.29 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.747 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.493 ' SD ' HG12 ' A' ' 11' ' ' VAL . 33.6 mtm -134.71 132.76 20.78 Favored Pre-proline 0 N--CA 1.486 1.33 0 CA-C-N 113.651 -1.613 . . . . 0.0 110.362 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -59.34 144.06 99.52 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.763 2.975 . . . . 0.0 112.517 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.8 m120 69.69 -65.02 0.32 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.543 1.937 . . . . 0.0 113.062 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.0 ttm -123.3 96.77 5.12 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.489 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 6.0 m-20 -68.34 167.12 15.18 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.034 -1.894 . . . . 0.0 112.548 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -47.0 -55.04 8.8 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.645 1.593 . . . . 0.0 116.152 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.48 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 48.9 tp -56.71 -48.88 76.71 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . 0.268 7.1 pm0 -67.98 -33.76 75.25 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 177.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.11 -43.96 95.22 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.855 0.722 . . . . 0.0 110.079 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.48 ' HB3' ' O ' ' A' ' 66' ' ' LEU . 12.2 tp -54.09 -44.41 71.17 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.416 1.086 . . . . 0.0 110.865 175.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -64.15 -43.68 94.48 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.55 0.74 . . . . 0.0 111.785 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.263 33.0 p -58.6 -29.86 66.78 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 123.682 0.793 . . . . 0.0 111.99 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.552 HG23 ' HB3' ' A' ' 78' ' ' MET . 45.6 mt -80.02 -56.61 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.855 1.262 . . . . 0.0 109.217 177.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.47 ' HG3' ' HA3' ' A' ' 102' ' ' GLY . 77.4 mmt-85 -53.94 -47.48 71.23 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.539 1.536 . . . . 0.0 114.076 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.31 -26.32 67.72 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.284 1.033 . . . . 0.0 113.557 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -85.11 108.17 17.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.294 1.038 . . . . 0.0 108.827 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -29.14 -61.78 0.15 Allowed Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.046 1.784 . . . . 0.0 114.95 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.38 -47.9 80.12 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.552 ' HB3' HG23 ' A' ' 72' ' ' ILE . 55.4 mtm -68.31 -22.19 64.73 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.8 p -46.45 -35.73 5.9 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.31 -13.11 59.45 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.486 HD22 ' HA2' ' A' ' 52' ' ' GLY . 77.4 mt -79.31 111.87 23.96 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 122.857 0.463 . . . . 0.0 111.388 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 11.6 Cg_endo -51.31 136.42 46.99 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.685 2.923 . . . . 0.0 115.919 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.474 HG11 HD13 ' A' ' 69' ' ' LEU . 67.2 t -120.08 123.34 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 112.843 -1.98 . . . . 0.0 112.686 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.669 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -112.45 110.15 20.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 112.887 -1.96 . . . . 0.0 107.864 177.383 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 30.1 mmt -85.22 105.3 15.81 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 113.628 -1.624 . . . . 0.0 111.991 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.52 103.51 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.34 138.38 42.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 112.068 -2.333 . . . . 0.0 115.851 -174.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.17 -27.92 69.4 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.045 -1.889 . . . . 0.0 113.157 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -151.97 110.99 3.86 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 124.171 0.92 . . . . 0.0 110.21 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.43 86.42 4.48 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.494 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -118.85 147.22 44.19 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.956 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -33.53 -55.66 0.44 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -53.24 -49.5 66.7 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.613 0.765 . . . . 0.0 112.33 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.68 -49.07 79.0 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.006 1.323 . . . . 0.0 110.811 177.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 79.4 mt -58.73 -53.21 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 124.508 1.13 . . . . 0.0 111.411 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.528 HG23 ' OE1' ' A' ' 100' ' ' GLN . 57.0 mt -55.39 -54.49 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.642 1.177 . . . . 0.0 110.537 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.58 -47.2 73.6 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.812 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.404 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -59.52 -58.0 10.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.3 1.04 . . . . 0.0 112.84 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.16 -49.01 78.49 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.518 0.727 . . . . 0.0 112.619 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.528 ' OE1' HG23 ' A' ' 96' ' ' ILE . 29.2 mt-30 -65.91 -25.37 67.12 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.4 1.45 54.67 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.47 ' HA3' ' HG3' ' A' ' 73' ' ' ARG . . . 113.75 -4.84 24.38 Favored Glycine 0 CA--C 1.545 1.95 0 N-CA-C 116.829 1.492 . . . . 0.0 116.829 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.63 119.81 9.96 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.098 1.449 . . . . 0.0 114.686 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.479 ' HB3' HG23 ' A' ' 123' ' ' ILE . 14.5 m -63.48 -30.45 71.57 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 110.823 -2.899 . . . . 0.0 113.691 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -174.58 167.07 39.21 Favored Glycine 0 N--CA 1.476 1.32 0 C-N-CA 124.501 1.048 . . . . 0.0 110.761 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -142.5 138.42 30.93 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.625 -0.788 . . . . 0.0 112.065 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.98 131.17 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 124.243 0.964 . . . . 0.0 112.277 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.5 p -79.26 134.79 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 113.417 -1.72 . . . . 0.0 110.803 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.435 ' HB3' ' HZ3' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -85.13 136.73 37.84 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.022 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -87.22 153.34 42.85 Favored 'Cis proline' 0 CA--C 1.541 0.873 0 CA-C-O 122.451 0.938 . . . . 0.0 112.771 -1.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -131.42 150.61 52.08 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 113.468 -1.696 . . . . 0.0 108.949 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.7 t -101.92 169.71 8.6 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 123.776 0.673 . . . . 0.0 111.829 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.33 37.38 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.427 1.091 . . . . 0.0 112.187 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.22 -52.02 66.54 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.877 0.871 . . . . 0.0 112.31 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -57.09 -48.96 77.32 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.249 1.02 . . . . 0.0 110.081 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.1 tp -56.49 -52.82 63.3 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.919 1.387 . . . . 0.0 110.349 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -55.24 -48.97 73.17 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.497 1.119 . . . . 0.0 112.573 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -50.91 -46.68 60.8 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.978 0.911 . . . . 0.0 112.107 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.634 ' O ' HG12 ' A' ' 123' ' ' ILE . 35.6 mttp -67.78 -52.38 37.85 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.233 177.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.2 mt -48.04 -51.36 24.53 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.68 0.792 . . . . 0.0 112.238 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -52.25 -55.92 18.1 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.846 1.258 . . . . 0.0 112.32 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -61.57 -39.71 92.13 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.193 1.397 . . . . 0.0 113.096 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.634 HG12 ' O ' ' A' ' 119' ' ' LYS . 31.6 mm -57.56 -49.18 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.962 0.905 . . . . 0.0 111.045 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 . . . . . 0 N--CA 1.478 0.942 0 C-N-CA 123.357 0.663 . . . . 0.0 112.364 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.13 27.82 0.65 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 tt -77.91 132.59 37.99 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.618 0.767 . . . . 0.0 109.932 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 51' ' ' TYR . 4.8 ttmm -84.04 104.51 14.17 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 125.032 1.458 . . . . 0.0 112.762 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -104.28 142.29 34.81 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 113.081 -1.872 . . . . 0.0 114.165 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 45' ' ' LYS . 0.3 OUTLIER -119.71 112.14 18.91 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.447 173.819 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 83.1 t -84.26 94.0 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.495 HG12 ' SD ' ' A' ' 60' ' ' MET . 4.2 t -98.21 85.8 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 123.832 1.777 . . . . 0.0 106.284 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -126.97 121.08 30.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 111.908 -2.405 . . . . 0.0 113.488 -175.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.442 ' HB3' ' HG2' ' A' ' 60' ' ' MET . 11.8 p-10 -60.04 -28.15 67.52 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 112.233 -2.258 . . . . 0.0 115.702 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -99.03 103.88 15.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.211 -1.404 . . . . 0.0 107.211 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -41.79 -42.82 2.76 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.975 1.31 . . . . 0.0 113.735 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -51.75 62.98 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.801 1.24 . . . . 0.0 111.41 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.443 ' O ' HG23 ' A' ' 21' ' ' VAL . 13.4 ttt -64.27 -36.19 83.28 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.87 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -52.71 -50.27 63.7 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.633 1.173 . . . . 0.0 110.533 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -58.6 -51.08 71.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.771 1.228 . . . . 0.0 110.211 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.43 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 51.0 mt -55.11 -51.8 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.047 0.939 . . . . 0.0 112.162 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 17' ' ' MET . 16.4 t -57.09 -44.48 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 118.461 0.573 . . . . 0.0 110.992 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -50.26 71.73 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.205 1.402 . . . . 0.0 109.615 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -60.3 -41.59 93.73 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.6 1.16 . . . . 0.0 112.302 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.45 HD22 ' HB2' ' A' ' 113' ' ' ALA . 78.2 mt -56.87 -51.13 70.28 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.252 1.021 . . . . 0.0 110.685 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.8 mt -55.88 -45.71 78.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.018 0.927 . . . . 0.0 111.857 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -56.36 -46.73 79.89 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.678 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -59.83 -38.7 82.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.358 1.463 . . . . 0.0 112.602 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.8 mt -71.2 -13.17 61.83 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.507 1.123 . . . . 0.0 113.836 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.3 -1.17 32.95 Favored Glycine 0 CA--C 1.541 1.676 0 C-N-CA 124.808 1.194 . . . . 0.0 114.806 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -79.2 108.93 13.06 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 123.322 1.534 . . . . 0.0 114.385 -177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -67.87 -51.34 49.32 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 110.726 -2.943 . . . . 0.0 117.42 -176.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.424 ' HB3' ' HG3' ' A' ' 7' ' ' LYS . 78.0 m-20 -97.45 97.24 8.93 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -174.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -133.21 118.39 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.971 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.692 ' HB2' ' HE2' ' A' ' 51' ' ' TYR . 4.1 mp0 -106.28 161.49 14.5 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.31 178.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.89 119.37 21.07 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.61 165.45 16.44 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 113.299 -1.773 . . . . 0.0 109.597 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -109.69 -38.71 5.33 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 118.017 2.599 . . . . 0.0 118.017 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -128.67 167.62 16.94 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.867 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.506 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -44.24 -57.71 4.81 Favored Glycine 0 N--CA 1.478 1.477 0 C-N-CA 125.831 1.681 . . . . 0.0 114.529 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.7 t -55.3 -58.45 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.549 0.739 . . . . 0.0 111.702 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.38 -32.83 57.93 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.462 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . . . -65.74 -50.57 64.31 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.51 1.124 . . . . 0.0 111.249 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.4 mt -58.55 -43.38 89.27 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.873 0.733 . . . . 0.0 110.679 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -54.3 -58.49 7.21 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.492 0.717 . . . . 0.0 110.641 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.598 ' HB3' HD11 ' A' ' 9' ' ' LEU . 16.0 tttt -61.69 -39.66 92.22 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.427 HD11 HG22 ' A' ' 54' ' ' VAL . 3.4 tp -54.66 -37.26 65.51 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.914 1.286 . . . . 0.0 113.669 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -68.63 -10.17 54.39 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.81 15.85 0.34 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.82 94.3 1.98 Allowed Glycine 0 N--CA 1.481 1.661 0 N-CA-C 115.443 0.937 . . . . 0.0 115.443 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 17.84 88.46 0.01 OUTLIER Glycine 0 CA--C 1.546 2.021 0 C-N-CA 128.683 3.039 . . . . 0.0 120.248 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.692 ' HE2' ' HB2' ' A' ' 34' ' ' GLU . 37.6 m-85 -88.63 104.32 16.75 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.894 -1.153 . . . . 0.0 109.89 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.64 27.22 1.9 Allowed Glycine 0 N--CA 1.478 1.458 0 CA-C-N 114.039 -1.437 . . . . 0.0 114.919 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.583 ' HZ ' HD13 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -178.71 131.52 0.12 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.49 1.516 . . . . 0.0 113.062 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.427 HG22 HD11 ' A' ' 46' ' ' LEU . 59.1 t -126.55 115.0 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 113.188 -1.823 . . . . 0.0 107.744 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 94.9 mt -106.2 101.17 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.6 t -120.0 133.42 55.55 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 117.623 2.453 . . . . 0.0 117.623 -175.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 60' ' ' MET . 6.3 m-20 -73.67 136.39 43.8 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.185 -1.371 . . . . 0.0 111.059 176.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -56.73 -49.31 75.59 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.016 0.822 . . . . 0.0 111.324 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -92.29 101.38 13.86 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.11 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.495 ' SD ' HG12 ' A' ' 11' ' ' VAL . 30.0 mtm -133.85 125.28 18.19 Favored Pre-proline 0 N--CA 1.482 1.131 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.363 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -55.52 150.55 42.37 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 124.009 3.139 . . . . 0.0 111.635 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 70.47 -69.51 0.17 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.461 1.904 . . . . 0.0 111.5 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.506 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 18.6 ttp -127.04 109.21 11.65 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -64.94 167.29 7.93 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.327 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.56 -48.82 63.54 Favored Glycine 0 N--CA 1.48 1.619 0 C-N-CA 124.273 0.939 . . . . 0.0 114.602 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.45 -40.07 93.13 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.826 0.45 . . . . 0.0 112.183 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -63.37 -41.82 98.84 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.83 -49.83 75.89 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.949 0.9 . . . . 0.0 110.964 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.715 HD11 ' HB2' ' A' ' 103' ' ' ALA . 4.0 tt -46.75 -50.79 17.56 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.28 1.432 . . . . 0.0 109.274 176.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.69 -46.57 84.92 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.266 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 47.2 p -59.24 -25.31 63.92 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.094 0.958 . . . . 0.0 112.982 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.4 mt -84.02 -58.04 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 73' ' ' ARG . 25.8 mmt180 -49.74 -46.77 50.74 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.875 1.67 . . . . 0.0 113.122 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.37 -18.79 57.05 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -82.57 94.82 7.58 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.736 -0.602 . . . . 0.0 110.178 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -21.18 -62.48 0.02 OUTLIER Glycine 0 CA--C 1.547 2.062 0 C-N-CA 126.88 2.181 . . . . 0.0 116.232 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.16 89.07 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.523 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 49.1 mtm -87.26 -34.67 18.85 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.4 t 2.57 -61.03 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 121.385 3.846 . . . . 0.0 121.385 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.24 25.03 0.62 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 118.855 2.909 . . . . 0.0 118.855 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 78' ' ' MET . 86.2 mt -83.05 118.94 73.25 Favored Pre-proline 0 N--CA 1.483 1.19 0 O-C-N 121.306 -0.872 . . . . 0.0 112.794 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.36 128.34 28.85 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 123.53 2.82 . . . . 0.0 113.675 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.468 HG11 ' HG ' ' A' ' 69' ' ' LEU . 3.4 t -116.57 119.89 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 113.13 -1.85 . . . . 0.0 112.645 -177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.53 HD13 HD11 ' A' ' 123' ' ' ILE . 45.2 tp -108.55 109.45 20.69 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.384 -1.734 . . . . 0.0 108.766 176.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 82.9 mmm -87.32 112.44 22.08 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 113.89 -1.505 . . . . 0.0 114.597 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.56 102.62 13.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 123.901 1.81 . . . . 0.0 108.319 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.9 t -115.71 130.26 56.79 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 111.593 -2.549 . . . . 0.0 109.426 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -46.42 -40.99 13.07 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -141.78 148.55 39.1 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.41 83.3 3.85 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 122.97 1.366 . . . . 0.0 107.718 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.48 ' O ' HG12 ' A' ' 95' ' ' ILE . 87.8 mttt -92.68 112.36 24.29 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 111.011 -2.813 . . . . 0.0 109.139 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 92' ' ' LYS . 71.6 mmtt -34.57 -56.03 0.54 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 117.431 2.382 . . . . 0.0 117.431 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . 0.258 0.0 OUTLIER -55.58 -42.86 75.35 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 177.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -62.63 -47.59 83.07 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.672 1.189 . . . . 0.0 110.335 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 91' ' ' LYS . 18.1 mm -58.08 -49.71 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.1 1.36 . . . . 0.0 112.537 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.439 HG22 ' OE1' ' A' ' 100' ' ' GLN . 31.7 mt -60.1 -50.66 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.284 0.634 . . . . 0.0 110.271 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.89 -46.43 81.92 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.777 0.831 . . . . 0.0 111.908 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.71 -56.24 19.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.427 1.491 . . . . 0.0 112.241 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.38 -48.35 82.13 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.071 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.439 ' OE1' HG22 ' A' ' 96' ' ' ILE . 72.8 mt-30 -56.53 -37.72 70.88 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.84 -16.45 55.41 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.65 12.65 7.15 Favored Glycine 0 CA--C 1.545 1.916 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.715 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -70.34 106.1 3.25 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.981 1.372 . . . . 0.0 111.36 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.473 ' HB3' HG23 ' A' ' 123' ' ' ILE . 6.9 m -56.89 -27.22 60.33 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 112.234 -2.257 . . . . 0.0 113.25 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -173.6 169.08 42.14 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.209 0.909 . . . . 0.0 111.406 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -142.62 142.27 32.08 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.643 -0.778 . . . . 0.0 110.948 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.61 131.47 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 124.742 1.276 . . . . 0.0 111.491 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -79.79 126.0 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 112.34 -2.209 . . . . 0.0 110.301 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 110' ' ' PRO . 34.5 ttpt -91.52 130.6 38.76 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 112.843 -1.98 . . . . 0.0 110.511 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 92.8 Cg_endo -80.41 148.39 77.07 Favored 'Cis proline' 0 N--CA 1.484 0.937 0 O-C-N 123.233 1.123 . . . . 0.0 114.953 0.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -130.31 156.53 44.51 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.002 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 69.9 p -108.96 174.83 5.69 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.693 0.797 . . . . 0.0 111.013 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.45 ' HB2' HD22 ' A' ' 24' ' ' LEU . . . -54.99 -39.0 68.56 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.142 175.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.71 -47.39 72.5 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.039 0.936 . . . . 0.0 111.263 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.0 m -61.32 -46.0 92.12 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 50.6 tp -56.24 -50.67 70.65 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.925 1.29 . . . . 0.0 109.529 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.483 ' HA ' HD12 ' A' ' 120' ' ' LEU . 40.5 tt0 -55.42 -48.77 73.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.293 1.037 . . . . 0.0 111.488 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -55.93 -46.89 78.37 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.361 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.3 mptp? -63.92 -42.18 97.45 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.114 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 117' ' ' GLU . 86.8 mt -53.87 -51.02 64.97 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.219 0.608 . . . . 0.0 111.101 177.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -50.05 -52.29 35.59 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.333 1.053 . . . . 0.0 113.137 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -53.59 -47.05 70.52 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.478 1.511 . . . . 0.0 112.386 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.583 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 57.8 mt -57.46 -51.52 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.872 1.269 . . . . 0.0 111.925 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 179.244 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.9 mttt . . . . . 0 CA--C 1.544 0.745 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -100.07 41.1 1.18 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 123.206 1.479 . . . . 0.0 113.791 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 tt -86.25 124.72 32.94 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.277 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.61 ' HE3' HD22 ' A' ' 32' ' ' ASN . 12.9 mptt -75.96 107.92 8.5 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 125.095 1.497 . . . . 0.0 113.393 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -102.88 132.83 48.82 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 112.402 -2.181 . . . . 0.0 111.8 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.529 HD21 ' HD3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -108.46 102.7 11.77 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.069 -1.053 . . . . 0.0 109.288 173.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.526 ' HA ' HG23 ' A' ' 55' ' ' ILE . 46.6 t -79.14 98.72 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 113.481 -1.69 . . . . 0.0 106.777 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.754 HG11 ' HB2' ' A' ' 42' ' ' ALA . 3.3 t -108.24 60.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 112.241 -2.254 . . . . 0.0 107.138 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.612 ' HA ' ' HB2' ' A' ' 57' ' ' ASP . 11.6 t70 -109.56 90.38 3.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 113.359 -1.746 . . . . 0.0 108.638 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -13.58 -42.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 121.58 3.919 . . . . 0.0 121.58 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.523 ' C ' ' H ' ' A' ' 16' ' ' THR . 2.6 t80 -87.57 109.6 19.76 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 t -65.98 27.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 124.167 1.937 . . . . 0.0 115.697 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.523 ' H ' ' C ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -123.72 -58.52 1.58 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.062 2.545 . . . . 0.0 105.448 177.031 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.528 ' HA ' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -60.05 -35.82 75.96 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.696 177.747 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 36' ' ' ALA . 8.8 ttp180 -53.76 -50.93 64.94 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.521 1.529 . . . . 0.0 112.139 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.632 ' CZ ' HD21 ' A' ' 23' ' ' ASN . 3.0 tmt_? -65.24 -38.37 90.15 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.809 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 17' ' ' MET . 71.6 mt -57.73 -46.3 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 17' ' ' MET . 12.7 t -58.26 -42.52 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.462 0.705 . . . . 0.0 110.049 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.459 ' NH2' ' HE ' ' A' ' 19' ' ' ARG . 46.9 ttp180 -53.01 -52.57 57.97 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.187 0.995 . . . . 0.0 110.575 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.632 HD21 ' CZ ' ' A' ' 19' ' ' ARG . 80.9 m-20 -57.71 -41.02 80.88 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.355 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -59.62 -51.44 69.79 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.135 0.974 . . . . 0.0 110.774 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.9 mt -56.56 -44.51 81.01 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.015 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -58.59 -42.26 87.69 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.981 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -59.78 -38.55 82.16 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.627 1.171 . . . . 0.0 110.48 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 mp -74.94 -11.9 60.22 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.29 2.236 . . . . 0.0 115.17 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.82 -0.61 41.91 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.035 1.302 . . . . 0.0 114.648 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -89.13 97.95 11.49 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 123.266 1.508 . . . . 0.0 112.459 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -72.46 -37.33 68.55 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 110.858 -2.883 . . . . 0.0 116.056 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.61 HD22 ' HE3' ' A' ' 7' ' ' LYS . 3.6 m120 -95.91 96.4 8.89 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.749 1.262 . . . . 0.0 113.895 -173.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.2 t -129.66 131.96 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.407 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -117.72 154.8 31.07 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -126.96 120.19 28.52 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -122.31 152.99 39.54 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 113.611 -1.631 . . . . 0.0 109.863 177.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -78.37 -66.13 0.89 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -129.44 -176.61 3.95 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 117.972 -1.013 . . . . 0.0 112.16 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 42' ' ' ALA . . . -45.39 -53.55 7.98 Favored Glycine 0 N--CA 1.482 1.766 0 O-C-N 125.048 1.467 . . . . 0.0 114.112 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -57.32 -57.87 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.348 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -55.52 -34.65 64.84 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.754 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -58.26 -53.56 56.85 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.753 1.221 . . . . 0.0 110.385 177.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.4 mt -60.27 -41.87 94.2 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.928 0.891 . . . . 0.0 111.313 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.418 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 24.8 m120 -53.35 -52.14 60.18 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.811 0.844 . . . . 0.0 111.233 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HD3' HD21 ' A' ' 9' ' ' LEU . 12.7 tttp -70.36 -41.2 73.43 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 124.212 0.945 . . . . 0.0 113.141 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.9 mt -54.42 -36.42 63.98 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 10.6 pt20 -52.33 -26.46 12.29 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.4 -19.16 64.44 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.44 -170.42 52.17 Favored Glycine 0 N--CA 1.474 1.224 0 C-N-CA 124.427 1.013 . . . . 0.0 111.113 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.75 -29.7 1.52 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 115.504 0.962 . . . . 0.0 115.504 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -67.85 107.99 2.83 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.52 -22.86 52.74 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-N 112.587 -2.097 . . . . 0.0 110.028 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.514 ' HZ ' HD13 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -133.35 141.65 48.02 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -174.212 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.5 t -127.16 110.68 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 113.765 -1.562 . . . . 0.0 107.343 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.526 HG23 ' HA ' ' A' ' 10' ' ' VAL . 13.1 tt -110.22 93.3 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 124.094 1.902 . . . . 0.0 106.607 177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.1 t -117.27 147.76 42.27 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 111.887 -2.415 . . . . 0.0 115.433 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.612 ' HB2' ' HA ' ' A' ' 12' ' ' ASP . 4.8 t70 -79.63 144.29 33.92 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.733 -1.122 . . . . 0.0 112.834 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.482 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 20.3 t-105 -61.23 -47.2 87.16 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.077 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -95.59 103.38 15.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.673 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 54.0 mtm -134.99 134.24 21.58 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-N 113.243 -1.799 . . . . 0.0 110.531 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -60.42 143.62 99.48 Favored 'Trans proline' 0 N--CA 1.482 0.827 0 C-N-CA 123.186 2.59 . . . . 0.0 112.089 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 m120 67.89 -69.81 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.902 1.681 . . . . 0.0 113.763 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.1 ttm -114.86 98.75 7.01 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -61.56 165.87 4.59 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 112.605 -2.088 . . . . 0.0 111.932 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.44 -52.08 29.73 Favored Glycine 0 N--CA 1.476 1.353 0 C-N-CA 124.692 1.139 . . . . 0.0 115.081 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 42.2 tp -58.84 -38.46 78.74 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.225 1.01 . . . . 0.0 113.222 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -72.44 -36.27 68.51 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.57 0.748 . . . . 0.0 111.014 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -59.03 -38.22 78.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.804 0.841 . . . . 0.0 111.016 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' A' ' 103' ' ' ALA . 9.1 mp -50.92 -52.24 44.1 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.76 1.224 . . . . 0.0 109.832 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -56.38 -48.76 76.21 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.042 -1.435 . . . . 0.0 112.505 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.3 p -58.17 -33.42 69.22 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.8 mt -80.8 -57.35 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.5 ' HG3' ' HA3' ' A' ' 102' ' ' GLY . 24.9 mmt180 -49.23 -45.82 45.09 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.344 1.858 . . . . 0.0 114.11 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.74 -25.52 61.23 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -81.34 93.9 6.65 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.187 0.595 . . . . 0.0 109.514 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -25.71 -58.76 0.07 OUTLIER Glycine 0 CA--C 1.542 1.753 0 C-N-CA 127.078 2.275 . . . . 0.0 116.756 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.77 -38.91 83.12 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.47 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 91.3 mtp -89.52 -45.38 9.45 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.412 1.485 . . . . 0.0 114.608 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.2 t 8.82 -78.21 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 120.091 3.367 . . . . 0.0 120.091 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.03 29.25 0.13 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 118.655 2.835 . . . . 0.0 118.655 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 78' ' ' MET . 82.4 mt -76.62 133.81 70.12 Favored Pre-proline 0 N--CA 1.479 0.981 0 O-C-N 121.184 -0.947 . . . . 0.0 111.876 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -56.81 114.23 1.83 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.816 2.344 . . . . 0.0 112.806 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 81' ' ' LEU . 37.0 t -109.94 110.97 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 111.704 -2.498 . . . . 0.0 109.245 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.51 HD23 HD12 ' A' ' 55' ' ' ILE . 41.1 tp -106.56 104.08 13.68 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 112.805 -1.998 . . . . 0.0 109.363 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.5 mmt -78.57 118.13 20.4 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 113.053 -1.885 . . . . 0.0 112.678 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.674 HG12 ' HB2' ' A' ' 109' ' ' LYS . 1.5 t -91.18 96.72 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.7 p -94.38 114.97 27.11 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.256 -1.793 . . . . 0.0 112.886 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.05 -22.01 5.37 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -166.74 118.79 0.97 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.61 92.96 4.77 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.578 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 95' ' ' ILE . 78.0 mttt -101.68 132.19 47.51 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.395 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -41.17 -46.78 3.14 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.734 1.213 . . . . 0.0 114.134 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -52.74 -55.32 23.62 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.708 1.603 . . . . 0.0 110.973 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -58.91 -42.91 90.73 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.352 1.461 . . . . 0.0 111.241 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 91' ' ' LYS . 14.7 mm -60.39 -49.09 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.52 1.128 . . . . 0.0 111.547 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 37.4 mt -57.73 -50.95 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.81 -45.84 74.43 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.087 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.482 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -57.42 -54.89 41.71 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.693 1.197 . . . . 0.0 112.418 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.38 -41.99 81.27 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.334 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -66.14 -40.04 90.31 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.73 0.55 52.49 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 117.674 2.472 . . . . 0.0 117.674 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.5 ' HA3' ' HG3' ' A' ' 73' ' ' ARG . . . 110.34 21.6 6.85 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 117.702 1.841 . . . . 0.0 117.702 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.599 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -82.62 110.32 17.58 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.416 1.108 . . . . 0.0 112.029 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.9 m -59.99 -30.26 69.01 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 113.219 -1.81 . . . . 0.0 113.519 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.25 173.45 46.28 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.198 1.38 . . . . 0.0 110.055 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -148.83 139.08 22.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.052 -0.574 . . . . 0.0 112.527 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.9 p -115.2 117.93 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 124.2 0.937 . . . . 0.0 109.505 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.0 p -71.33 109.45 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 113.076 -1.874 . . . . 0.0 114.261 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.674 ' HB2' HG12 ' A' ' 86' ' ' VAL . 68.1 tttt -83.13 130.11 58.43 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 111.079 -2.782 . . . . 0.0 107.681 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.6 133.34 26.6 Favored 'Cis proline' 0 CA--C 1.54 0.78 0 O-C-N 123.962 1.506 . . . . 0.0 114.854 0.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.441 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 17.9 p90 -130.58 157.25 43.23 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 112.653 -2.067 . . . . 0.0 109.01 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.2 t -116.61 176.02 5.3 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.063 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.45 -41.78 61.08 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.203 1.001 . . . . 0.0 111.82 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.99 -50.07 73.55 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.568 0.747 . . . . 0.0 112.819 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.32 -45.04 94.81 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.623 1.169 . . . . 0.0 109.982 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 58.1 tp -56.99 -50.54 72.38 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.305 1.042 . . . . 0.0 109.888 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -58.13 -47.65 82.66 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.61 0.764 . . . . 0.0 111.376 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -51.22 -43.36 61.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.484 0.714 . . . . 0.0 112.278 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -72.78 -41.7 64.74 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.187 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.1 mt -56.96 -46.31 82.23 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.398 0.679 . . . . 0.0 111.157 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -52.14 -48.18 65.01 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.089 1.356 . . . . 0.0 111.935 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -52.93 -48.81 67.02 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.129 1.372 . . . . 0.0 111.595 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.514 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 9.1 mt -60.47 -49.43 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.267 1.027 . . . . 0.0 111.68 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 . . . . . 0 N--CA 1.493 1.679 0 C-N-CA 123.686 0.794 . . . . 0.0 112.064 177.991 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HA ' ' HD1' ' A' ' 30' ' ' PHE . 42.8 mmtm . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.27 50.93 1.82 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.756 1.265 . . . . 0.0 114.042 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 53' ' ' PHE . 5.1 tt -109.76 122.96 48.69 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.768 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -81.76 109.28 16.01 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.108 0.956 . . . . 0.0 112.495 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -96.24 139.24 32.67 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 111.802 -2.454 . . . . 0.0 111.783 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.462 ' CD1' HG22 ' A' ' 11' ' ' VAL . 2.1 tm? -118.19 104.87 11.22 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.437 176.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.2 t -83.7 111.19 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 112.095 -2.321 . . . . 0.0 108.775 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -114.02 91.13 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.544 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 57' ' ' ASP . 8.5 m-20 -137.19 115.27 11.59 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.745 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.418 ' OD1' ' HB3' ' A' ' 37' ' ' GLU . 3.5 t70 -80.12 77.12 6.85 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.966 -178.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.435 ' HD2' ' HB2' ' A' ' 17' ' ' MET . 11.5 t80 172.25 115.09 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 111.816 -2.447 . . . . 0.0 106.127 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.2 t -42.25 -55.67 3.22 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.228 1.011 . . . . 0.0 113.338 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.69 -47.5 85.38 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.708 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.435 ' HB2' ' HD2' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -62.43 -45.55 92.59 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.165 0.586 . . . . 0.0 111.829 -179.599 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.417 ' HD2' ' HB2' ' A' ' 35' ' ' GLU . 38.1 ttp180 -59.26 -45.2 91.83 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.759 1.224 . . . . 0.0 110.472 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -43.89 96.01 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.121 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.0 mt -56.17 -57.26 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-O 118.589 -0.719 . . . . 0.0 111.084 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.519 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 13.6 t -54.1 -44.53 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 123.512 0.507 . . . . 0.0 111.19 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.59 ' HG2' ' NZ ' ' A' ' 26' ' ' LYS . 34.9 ttt180 -55.92 -53.45 56.73 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.065 1.346 . . . . 0.0 111.735 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -62.87 -38.8 92.3 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.127 0.971 . . . . 0.0 113.331 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 75.7 mt -56.92 -48.88 77.22 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.175 0.99 . . . . 0.0 111.114 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.9 mt -60.27 -44.81 94.99 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.783 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.59 ' NZ ' ' HG2' ' A' ' 22' ' ' ARG . 63.5 mttp -56.44 -45.13 80.95 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.0 176.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 36.3 mt-10 -60.32 -35.99 76.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.479 1.512 . . . . 0.0 113.032 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.0 mt -74.44 -2.03 23.71 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.306 1.443 . . . . 0.0 114.372 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.8 -9.89 60.38 Favored Glycine 0 CA--C 1.542 1.76 0 C-N-CA 124.566 1.079 . . . . 0.0 112.752 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.432 ' HD1' ' HA ' ' A' ' 4' ' ' LYS . 6.5 m-85 -93.15 76.71 4.63 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 123.126 1.441 . . . . 0.0 110.078 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -66.29 -24.04 66.49 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.594 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -78.7 80.83 5.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.653 1.581 . . . . 0.0 112.062 -178.632 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.5 130.35 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.929 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.609 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 6.8 mp0 -120.61 160.91 22.29 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.417 ' HB2' ' HD2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -132.57 147.87 52.36 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 120.398 3.481 . . . . 0.0 120.398 -176.081 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.469 ' HB2' ' HD2' ' A' ' 45' ' ' LYS . . . -140.54 163.88 31.64 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 110.94 -2.845 . . . . 0.0 108.307 177.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . 22.5 mt-10 -112.04 -35.51 5.64 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -129.07 158.57 38.55 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.875 0.735 . . . . 0.0 111.148 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -39.27 -52.89 2.79 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 125.528 1.767 . . . . 0.0 116.064 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.476 HG21 HD21 ' A' ' 62' ' ' ASN . 74.3 t -59.77 -50.12 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 118.481 -0.771 . . . . 0.0 112.582 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -56.04 -44.05 78.41 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.045 0.926 . . . . 0.0 109.672 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.27 -52.15 65.92 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.398 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.4 mt -51.08 -51.25 55.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.406 1.066 . . . . 0.0 111.022 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -53.29 -54.79 31.28 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.447 1.099 . . . . 0.0 112.475 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HD2' ' HB2' ' A' ' 36' ' ' ALA . 29.4 mttp -57.6 -48.9 78.12 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 113.808 -1.542 . . . . 0.0 113.043 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 31.2 mt -59.79 -41.74 91.83 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.536 1.134 . . . . 0.0 112.479 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -57.24 -25.43 59.12 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.16 -19.77 63.18 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.41 -166.31 19.68 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.854 1.216 . . . . 0.0 111.434 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.38 -41.43 1.84 Allowed Glycine 0 N--CA 1.483 1.775 0 C-N-CA 124.3 0.952 . . . . 0.0 115.241 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.609 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 78.9 m-85 -70.91 136.1 48.36 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.69 16.51 7.87 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 112.656 -2.065 . . . . 0.0 113.397 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.653 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -172.41 140.08 1.06 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.367 1.067 . . . . 0.0 111.975 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 t -122.37 114.1 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.045 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.7 mt -108.44 98.96 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.0 t -120.87 137.09 54.75 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.445 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 31.0 t0 -73.18 133.82 44.17 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 112.348 -2.205 . . . . 0.0 110.197 177.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.447 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 30.9 t-105 -59.26 -49.77 76.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.027 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -88.78 99.86 12.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.391 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.524 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 8.7 mtm -141.95 121.77 8.17 Favored Pre-proline 0 N--CA 1.478 0.931 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.106 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -62.28 164.42 17.57 Favored 'Trans proline' 0 N--CA 1.479 0.627 0 C-N-CA 123.208 2.605 . . . . 0.0 109.006 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.476 HD21 HG21 ' A' ' 40' ' ' VAL . 0.6 OUTLIER 70.82 -79.68 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.09 0.956 . . . . 0.0 109.633 -176.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.5 ttm -130.36 107.31 9.16 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.854 0.862 . . . . 0.0 108.948 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.524 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.7 p30 -62.85 162.08 11.65 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.029 -1.441 . . . . 0.0 112.895 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.21 -53.41 15.41 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 124.975 1.274 . . . . 0.0 114.793 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.67 -44.98 93.38 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.172 0.589 . . . . 0.0 111.887 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.71 -40.81 98.34 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -44.52 88.7 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.722 1.209 . . . . 0.0 110.328 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tp -58.97 -47.09 86.38 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.515 1.126 . . . . 0.0 111.012 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.13 -43.41 91.97 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.536 0.735 . . . . 0.0 112.76 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.268 4.7 p -64.29 -33.93 76.96 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.114 0.966 . . . . 0.0 111.811 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.5 mt -69.32 -56.49 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 73' ' ' ARG . 71.0 mmt-85 -53.53 -43.37 68.32 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.476 1.51 . . . . 0.0 113.065 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.77 -30.13 65.22 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -87.84 95.56 10.14 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.136 0.574 . . . . 0.0 112.088 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -13.65 -72.51 0.01 OUTLIER Glycine 0 N--CA 1.489 2.169 0 C-N-CA 127.821 2.629 . . . . 0.0 117.478 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.46 -40.54 68.51 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 50.9 mtm -88.53 -14.16 38.4 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.2 m -48.12 -25.14 1.34 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 117.365 2.358 . . . . 0.0 117.365 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.98 -7.81 50.99 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.426 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 96.4 mt -70.2 111.56 9.71 Favored Pre-proline 0 N--CA 1.485 1.283 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 11.5 Cg_endo -51.96 133.9 47.4 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 123.181 2.587 . . . . 0.0 113.921 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.2 t -120.53 126.82 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 122.812 1.292 . . . . 0.0 113.304 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.653 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 1.7 tm? -113.01 116.89 30.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 111.656 -2.52 . . . . 0.0 107.389 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 28.6 mmt -95.39 109.89 22.0 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 122.734 1.254 . . . . 0.0 113.437 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.31 96.02 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 123.178 1.466 . . . . 0.0 107.428 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -108.17 141.29 40.12 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 112.357 -2.201 . . . . 0.0 114.241 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.3 -29.59 70.88 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.404 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -134.1 129.33 35.81 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.299 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -94.1 55.83 2.13 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 123.997 1.856 . . . . 0.0 108.489 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -98.81 139.91 33.78 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 112.887 -1.961 . . . . 0.0 107.542 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 25.3 mmtp -34.52 -48.47 0.36 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -51.62 -49.83 61.47 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.736 0.647 . . . . 0.0 112.556 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -64.06 -47.81 78.67 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.504 1.122 . . . . 0.0 111.507 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 68.9 mt -57.94 -57.26 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.809 1.244 . . . . 0.0 111.83 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.9 mt -54.56 -52.75 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.878 0.871 . . . . 0.0 110.307 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.21 -52.71 58.01 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.151 0.981 . . . . 0.0 112.194 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.447 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -57.15 -52.58 64.75 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.677 1.191 . . . . 0.0 113.095 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.36 -48.84 80.11 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.64 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -60.07 -36.19 76.8 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 73' ' ' ARG . . . -78.12 -6.58 55.15 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.01 4.14 27.75 Favored Glycine 0 CA--C 1.548 2.148 0 N-CA-C 116.151 1.22 . . . . 0.0 116.151 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.02 119.73 10.67 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.906 1.353 . . . . 0.0 112.099 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.2 m -64.12 -36.32 83.64 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 112.362 -2.199 . . . . 0.0 112.448 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -169.79 178.67 42.61 Favored Glycine 0 CA--C 1.541 1.659 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.749 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -152.96 143.01 22.31 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.4 p -122.39 125.41 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 124.623 1.202 . . . . 0.0 109.972 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.1 p -85.54 122.64 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 113.937 -1.483 . . . . 0.0 111.073 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -83.83 138.12 40.63 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 113.764 -1.562 . . . . 0.0 113.249 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.41 143.01 75.0 Favored 'Cis proline' 0 CA--C 1.546 1.1 0 O-C-N 123.072 1.038 . . . . 0.0 114.787 0.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.519 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 33.8 p90 -134.91 151.12 50.6 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 112.31 -2.223 . . . . 0.0 108.642 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.2 t -107.16 175.61 5.44 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.189 0.931 . . . . 0.0 109.928 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.64 -42.46 56.34 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.936 0.894 . . . . 0.0 111.993 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.3 -44.45 95.0 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.294 1.038 . . . . 0.0 112.886 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.24 -48.66 77.28 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.466 0.707 . . . . 0.0 109.333 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.3 tp -55.94 -46.96 78.35 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.935 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.485 ' HG2' ' OD1' ' A' ' 121' ' ' ASN . 7.0 tt0 -58.36 -50.9 72.0 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.891 0.876 . . . . 0.0 110.975 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -49.19 -45.25 43.87 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.719 0.808 . . . . 0.0 112.618 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -66.24 -48.09 71.66 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.741 1.216 . . . . 0.0 111.807 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.401 ' HB3' ' CE2' ' A' ' 124' ' ' PHE . 96.3 mt -57.61 -46.73 83.72 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.064 0.946 . . . . 0.0 111.902 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.485 ' OD1' ' HG2' ' A' ' 117' ' ' GLU . 31.5 m-20 -48.14 -53.48 16.56 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.478 1.511 . . . . 0.0 112.079 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.1 tttt -51.68 -47.91 63.68 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 113.841 -1.527 . . . . 0.0 112.161 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.606 HG13 ' HZ ' ' A' ' 53' ' ' PHE . 8.3 mm -58.49 -57.47 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.693 1.197 . . . . 0.0 109.644 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' A' ' 120' ' ' LEU . 22.3 m-85 . . . . . 0 N--CA 1.475 0.799 0 C-N-CA 124.597 1.159 . . . . 0.0 113.334 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 54.0 mtmt . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -86.5 66.03 9.31 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 123.42 1.581 . . . . 0.0 110.911 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.2 tt -102.38 135.87 43.23 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.049 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -77.87 110.29 12.63 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -110.07 142.65 41.24 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.824 1.649 . . . . 0.0 112.698 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.589 HD12 ' HG ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -117.89 110.34 17.63 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 122.22 1.01 . . . . 0.0 109.932 173.402 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.7 t -85.92 107.87 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 113.862 -1.517 . . . . 0.0 107.495 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' A' ' 42' ' ' ALA . 2.8 t -112.74 94.36 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.745 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -135.27 131.92 37.14 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.702 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -60.63 -25.01 65.97 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -101.07 105.34 16.51 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 44.3 p -41.21 -45.61 2.9 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.417 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -62.64 -52.79 61.95 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.404 1.082 . . . . 0.0 112.188 176.689 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -39.05 87.74 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.561 0.344 . . . . 0.0 110.222 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -55.45 -51.58 66.44 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.495 1.118 . . . . 0.0 110.683 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.466 HH21 ' NH1' ' A' ' 22' ' ' ARG . 10.3 ttt180 -63.92 -36.53 84.25 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.47 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 42.3 mm -55.73 -47.5 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 122.625 0.37 . . . . 0.0 110.474 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -60.1 -44.44 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 122.849 0.459 . . . . 0.0 110.092 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.466 ' NH1' HH21 ' A' ' 19' ' ' ARG . 0.0 OUTLIER -54.19 -50.03 67.98 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.457 1.103 . . . . 0.0 110.575 176.885 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -59.69 -44.65 93.57 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.495 0.718 . . . . 0.0 111.814 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.536 HD22 ' HB2' ' A' ' 113' ' ' ALA . 77.7 mt -56.06 -52.62 63.61 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.293 1.037 . . . . 0.0 111.442 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 73.9 mt -54.91 -45.51 74.74 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.759 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 27.3 mtpp -56.88 -46.39 81.91 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.285 177.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 28.5 mt-10 -59.5 -40.61 87.6 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.879 1.672 . . . . 0.0 111.746 177.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.4 mp -70.8 -16.14 62.71 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.892 1.677 . . . . 0.0 114.755 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.55 -5.81 33.33 Favored Glycine 0 CA--C 1.543 1.832 0 C-N-CA 125.342 1.448 . . . . 0.0 114.05 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 65.1 m-85 -92.94 67.66 4.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 123.506 1.622 . . . . 0.0 111.022 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -69.48 -14.09 62.69 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 116.974 2.213 . . . . 0.0 116.974 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -92.84 78.2 4.76 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 122.924 1.345 . . . . 0.0 108.987 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 p -126.87 130.87 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 113.757 -1.565 . . . . 0.0 114.189 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.435 ' O ' HD23 ' A' ' 9' ' ' LEU . 4.5 tm-20 -106.64 156.29 18.77 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 113.615 -1.629 . . . . 0.0 107.885 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -123.85 121.92 36.65 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -130.06 157.47 42.28 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 113.547 -1.661 . . . . 0.0 108.433 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -105.24 -40.63 5.78 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -130.71 162.3 29.75 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.289 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -42.63 -50.58 5.78 Favored Glycine 0 N--CA 1.484 1.855 0 O-C-N 125.531 1.769 . . . . 0.0 115.943 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.4 t -58.69 -53.58 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 119.091 -0.48 . . . . 0.0 111.541 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.51 -37.14 74.96 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.471 0.709 . . . . 0.0 110.995 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.555 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -61.45 -54.08 48.08 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.044 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.46 -38.13 86.1 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 123.862 0.727 . . . . 0.0 112.853 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 20.7 m120 -57.55 -50.33 73.45 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.126 0.891 . . . . 0.0 111.099 175.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -67.67 -42.97 81.3 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.828 1.251 . . . . 0.0 112.63 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.589 ' HG ' HD12 ' A' ' 9' ' ' LEU . 16.5 mt -59.87 -45.09 93.58 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.535 1.934 . . . . 0.0 114.563 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 19.0 pt20 -57.8 -14.62 6.23 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.67 -23.64 66.17 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.902 0.881 . . . . 0.0 112.337 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.15 -178.51 43.4 Favored Glycine 0 N--CA 1.48 1.609 0 C-N-CA 125.107 1.337 . . . . 0.0 113.757 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.4 -26.12 3.58 Favored Glycine 0 N--CA 1.482 1.705 0 CA-C-N 113.662 -1.269 . . . . 0.0 116.154 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -64.51 111.03 2.51 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.73 12.57 65.94 Favored Glycine 0 CA--C 1.541 1.665 0 O-C-N 125.103 1.502 . . . . 0.0 112.472 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.529 ' HZ ' HD13 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -168.73 141.06 2.75 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.016 0.926 . . . . 0.0 112.071 179.118 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.6 t -129.39 122.58 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.543 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.8 mt -111.68 102.53 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.2 t -122.27 133.84 54.68 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 116.909 2.188 . . . . 0.0 116.909 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -73.82 127.99 34.31 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 111.335 -2.666 . . . . 0.0 110.767 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.46 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 13.6 t-105 -56.04 -43.57 77.96 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.778 1.231 . . . . 0.0 110.73 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -91.13 94.49 9.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.202 1.401 . . . . 0.0 109.062 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.503 ' SD ' HG12 ' A' ' 11' ' ' VAL . 15.2 mtm -141.24 121.87 8.72 Favored Pre-proline 0 N--CA 1.476 0.83 0 CA-C-N 114.179 -1.373 . . . . 0.0 113.516 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -55.25 158.74 11.48 Favored 'Trans proline' 0 N--CA 1.479 0.652 0 C-N-CA 123.139 2.56 . . . . 0.0 110.945 175.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.349 21.3 p30 66.84 -72.36 0.09 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.226 2.21 . . . . 0.0 112.024 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.496 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 43.4 ttp -128.86 108.18 10.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.508 0.723 . . . . 0.0 109.728 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -62.43 164.6 7.12 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.474 -1.694 . . . . 0.0 113.033 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.78 -54.76 23.7 Favored Glycine 0 N--CA 1.479 1.555 0 C-N-CA 125.132 1.349 . . . . 0.0 114.24 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.3 tp -57.01 -40.95 77.61 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.7 -40.43 84.32 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.553 0.341 . . . . 0.0 111.562 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.01 -41.03 95.75 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.778 1.231 . . . . 0.0 110.784 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 103' ' ' ALA . 2.9 tt -51.76 -51.2 58.04 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.286 1.434 . . . . 0.0 108.718 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -59.41 -43.19 93.07 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.429 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.7 p -69.25 -0.61 6.37 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.5 mt -109.64 -62.02 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.647 ' HG2' ' HA3' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -51.2 -44.52 61.61 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.16 1.784 . . . . 0.0 113.83 -179.372 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.83 -3.35 49.1 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -85.69 99.85 11.59 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -10.25 -77.87 0.01 OUTLIER Glycine 0 N--CA 1.488 2.165 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.96 -41.23 99.46 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 76.6 mtp -85.93 -6.71 59.02 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.6 t -34.06 -61.99 0.34 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 118.972 2.953 . . . . 0.0 118.972 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.41 18.05 0.45 Allowed 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 119.248 3.055 . . . . 0.0 119.248 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 69.9 mt -84.9 120.14 73.4 Favored Pre-proline 0 CA--C 1.543 0.708 0 O-C-N 121.215 -0.928 . . . . 0.0 112.689 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 9.5 Cg_endo -52.22 132.96 45.97 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.812 3.008 . . . . 0.0 113.901 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.506 HG11 ' HG ' ' A' ' 69' ' ' LEU . 11.3 t -118.96 115.58 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 112.61 -2.086 . . . . 0.0 112.314 -176.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.556 HD13 HD11 ' A' ' 123' ' ' ILE . 62.5 tp -107.43 105.59 15.58 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 113.858 -1.519 . . . . 0.0 107.635 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.5 mmt -79.35 138.19 37.6 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 113.284 -1.78 . . . . 0.0 111.708 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.7 t -112.43 104.66 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 p -102.47 152.56 20.98 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.439 -1.255 . . . . 0.0 113.587 -175.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.62 -40.12 95.96 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.361 -1.745 . . . . 0.0 111.705 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -159.95 148.36 17.18 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.693 1.597 . . . . 0.0 112.211 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.48 94.68 8.59 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.149 0.906 . . . . 0.0 109.813 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -125.38 130.36 51.76 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.418 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -25.95 -61.11 0.07 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 116.42 2.008 . . . . 0.0 116.42 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -57.19 -46.17 83.08 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -68.62 -37.41 79.72 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 91.5 mt -59.41 -50.02 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.386 1.075 . . . . 0.0 109.051 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.4 mm -55.67 -55.46 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.468 1.107 . . . . 0.0 110.241 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.54 -49.3 62.24 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.237 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.46 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -59.96 -57.28 13.52 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.451 1.1 . . . . 0.0 113.646 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.78 -51.03 71.25 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.244 1.017 . . . . 0.0 111.995 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.19 -30.23 70.92 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.12 -13.19 58.93 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.647 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 120.61 -3.21 12.18 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 116.895 1.518 . . . . 0.0 116.895 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.566 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -57.78 114.09 2.14 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 118.918 1.359 . . . . 0.0 112.878 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.481 ' HB3' HG23 ' A' ' 123' ' ' ILE . 5.0 m -63.56 -26.79 68.86 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 112.007 -2.36 . . . . 0.0 113.76 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.7 166.25 35.89 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.742 1.163 . . . . 0.0 110.353 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -142.25 137.63 30.83 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 p -121.51 131.95 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.89 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.98 139.63 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.598 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.08 140.42 28.98 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.617 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.62 135.86 20.28 Favored 'Cis proline' 0 C--N 1.352 0.715 0 O-C-N 122.47 0.721 . . . . 0.0 110.983 -2.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -113.43 154.71 26.53 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.293 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.8 t -110.27 178.24 4.45 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.15 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.536 ' HB2' HD22 ' A' ' 24' ' ' LEU . . . -51.27 -44.19 61.76 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.664 1.185 . . . . 0.0 111.893 178.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.24 -51.72 67.78 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.245 1.018 . . . . 0.0 111.888 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.44 -47.21 82.39 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.191 0.996 . . . . 0.0 110.389 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 47.7 tp -56.58 -53.51 56.69 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.11 1.364 . . . . 0.0 109.506 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -53.89 -47.19 71.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.77 1.228 . . . . 0.0 112.354 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.38 -50.25 70.21 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -62.54 -43.15 99.52 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 61.7 mt -52.84 -46.23 67.71 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -55.4 -51.64 66.18 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.584 0.754 . . . . 0.0 112.843 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -56.5 -43.36 79.64 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.35 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.556 HD11 HD13 ' A' ' 84' ' ' LEU . 62.2 mt -58.44 -53.56 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.038 0.935 . . . . 0.0 110.58 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 N--CA 1.479 0.992 0 C-N-CA 123.736 0.814 . . . . 0.0 113.144 179.292 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -66.77 9.03 0.2 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.821 2.048 . . . . 0.0 115.574 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.52 97.04 3.61 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -175.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.4 ' HG3' ' HB2' ' A' ' 32' ' ' ASN . 34.0 tttt -79.53 111.27 15.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.724 -1.58 . . . . 0.0 111.692 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -92.26 136.58 33.08 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 112.141 -2.3 . . . . 0.0 112.107 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.561 HD12 HD13 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -111.16 104.04 12.52 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 118.698 -1.201 . . . . 0.0 109.145 173.193 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.552 ' HA ' HG23 ' A' ' 55' ' ' ILE . 48.2 t -80.29 97.54 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 112.968 -1.923 . . . . 0.0 105.848 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.506 HG11 ' HB2' ' A' ' 42' ' ' ALA . 5.0 t -101.04 84.6 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 112.702 -2.044 . . . . 0.0 107.808 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.611 ' HB3' ' HG3' ' A' ' 18' ' ' ARG . 7.0 t70 -133.94 121.14 21.25 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.105 -1.861 . . . . 0.0 111.752 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -54.9 -28.23 49.02 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 112.264 -2.244 . . . . 0.0 115.55 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -97.34 119.71 36.37 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.559 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.3 p -50.39 -50.93 50.24 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 125.028 1.455 . . . . 0.0 112.929 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -43.78 98.35 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.188 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 13.2 tpt -62.64 -40.89 98.45 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.611 ' HG3' ' HB3' ' A' ' 12' ' ' ASP . 10.1 mtm180 -56.14 -49.23 74.52 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.695 0.798 . . . . 0.0 111.578 175.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -60.18 -43.3 95.96 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.523 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.2 mt -56.18 -50.43 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.097 0.559 . . . . 0.0 110.583 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.85 -43.13 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.218 0.607 . . . . 0.0 111.524 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -51.99 -52.0 53.44 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.531 0.732 . . . . 0.0 111.273 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -57.72 -40.84 80.51 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.737 0.815 . . . . 0.0 112.839 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.03 -52.01 67.18 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.445 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.7 mt -58.54 -42.11 87.08 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.083 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -59.1 -47.49 85.06 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.353 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -54.98 -39.44 68.99 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 125.327 1.451 . . . . 0.0 112.293 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.4 mt -73.21 -17.28 61.37 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.21 17.72 19.32 Favored Glycine 0 CA--C 1.543 1.807 0 C-N-CA 124.567 1.08 . . . . 0.0 113.349 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -110.14 89.68 3.09 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 122.943 1.354 . . . . 0.0 112.126 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -68.54 -29.11 67.61 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 112.557 -2.11 . . . . 0.0 115.058 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.4 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -84.24 91.32 7.7 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 123.049 1.405 . . . . 0.0 113.481 -175.948 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.0 t -133.89 125.89 49.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 112.884 -1.962 . . . . 0.0 110.867 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.45 ' OE1' ' HB3' ' A' ' 45' ' ' LYS . 5.5 tt0 -110.26 153.59 24.62 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 175.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 36.9 mt-10 -125.92 124.8 41.62 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.49 153.87 36.06 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.552 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -4.0 19.85 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -165.84 157.4 14.06 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.452 0.701 . . . . 0.0 110.64 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 42' ' ' ALA . . . -39.9 -53.78 3.09 Favored Glycine 0 CA--C 1.544 1.856 0 O-C-N 125.04 1.463 . . . . 0.0 115.517 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.01 -52.84 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 122.414 0.286 . . . . 0.0 111.439 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -55.71 -38.76 70.15 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.568 1.147 . . . . 0.0 110.16 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.506 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -61.98 -58.57 7.39 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.233 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.17 -39.51 56.56 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.985 0.803 . . . . 0.0 112.531 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -63.69 -64.2 0.96 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.561 1.144 . . . . 0.0 109.92 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.45 ' HB3' ' OE1' ' A' ' 34' ' ' GLU . 46.1 mttm -55.38 -37.65 67.84 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 126.91 2.084 . . . . 0.0 115.319 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.581 HD11 HG22 ' A' ' 54' ' ' VAL . 5.9 tp -54.47 -25.86 27.8 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -90.94 -17.79 25.8 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.95 69.54 7.56 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.73 81.47 1.52 Allowed Glycine 0 CA--C 1.541 1.665 0 N-CA-C 118.496 2.158 . . . . 0.0 118.496 174.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 18.81 76.99 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 C-N-CA 128.012 2.72 . . . . 0.0 119.366 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -83.94 127.69 34.03 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.239 -0.981 . . . . 0.0 110.301 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.78 8.21 50.45 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.201 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.518 ' HA ' ' HG2' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -166.64 144.5 5.15 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 -179.201 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.581 HG22 HD11 ' A' ' 46' ' ' LEU . 21.4 t -123.85 110.87 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 175.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.552 HG23 ' HA ' ' A' ' 10' ' ' VAL . 14.8 tt -115.08 98.05 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 t -120.73 142.07 49.86 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 120.485 3.513 . . . . 0.0 120.485 -174.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -72.4 129.2 37.81 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 113.039 -1.892 . . . . 0.0 109.879 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.411 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 37.7 t-105 -53.71 -38.73 64.57 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.742 0.817 . . . . 0.0 112.544 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -105.6 108.46 19.99 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.584 0.754 . . . . 0.0 110.139 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.489 ' SD ' HG12 ' A' ' 11' ' ' VAL . 50.7 mtm -139.71 126.39 12.41 Favored Pre-proline 0 N--CA 1.478 0.966 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.78 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.76 118.48 5.41 Favored 'Trans proline' 0 N--CA 1.482 0.829 0 C-N-CA 124.048 3.165 . . . . 0.0 111.837 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 99.17 -76.25 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 129.224 3.01 . . . . 0.0 110.119 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.8 ttm -112.28 93.92 4.68 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.253 0.549 . . . . 0.0 109.744 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.6 p30 -59.74 162.28 5.42 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 112.133 -2.303 . . . . 0.0 112.068 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.88 -53.63 25.59 Favored Glycine 0 N--CA 1.477 1.433 0 C-N-CA 124.516 1.055 . . . . 0.0 114.296 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.488 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 60.8 tp -59.64 -37.87 79.85 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -70.69 -40.96 72.6 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.157 0.583 . . . . 0.0 110.369 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.9 tp -56.62 -44.86 81.6 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.111 0.964 . . . . 0.0 110.188 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' A' ' 103' ' ' ALA . 4.8 tt -48.79 -51.22 30.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.212 1.405 . . . . 0.0 109.363 175.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.37 -45.86 92.04 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.651 1.18 . . . . 0.0 112.538 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 p -61.9 -15.36 42.26 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.6 mt -96.31 -65.46 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.762 ' HG2' ' HA3' ' A' ' 102' ' ' GLY . 6.5 tpp180 -53.17 -43.35 67.0 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.163 2.185 . . . . 0.0 115.195 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.49 -10.41 49.1 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 78' ' ' MET . 12.6 t70 -89.4 112.32 23.41 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -42.79 -18.64 0.05 OUTLIER Glycine 0 CA--C 1.547 2.092 0 C-N-CA 127.601 2.524 . . . . 0.0 118.978 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.27 -50.77 3.84 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.64 0.776 . . . . 0.0 111.576 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.406 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 88.9 mmm -70.08 -25.15 63.39 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 118.718 2.859 . . . . 0.0 118.718 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.6 t -58.64 39.19 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 118.255 2.687 . . . . 0.0 118.255 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -123.55 -37.05 2.69 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.77 2.028 . . . . 0.0 111.073 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.447 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 6.1 mt -66.1 117.6 44.39 Favored Pre-proline 0 N--CA 1.472 0.657 0 C-N-CA 126.158 1.783 . . . . 0.0 115.299 -178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.518 ' HG2' ' HA ' ' A' ' 53' ' ' PHE . 35.4 Cg_endo -63.35 137.91 63.1 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.631 2.221 . . . . 0.0 111.121 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.94 110.26 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 113.812 -1.54 . . . . 0.0 112.668 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.421 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 33.1 tp -106.7 107.43 18.44 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.142 -1.845 . . . . 0.0 109.46 178.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.8 mmt -81.71 111.56 18.08 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 113.581 -1.645 . . . . 0.0 113.438 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.0 97.36 7.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 177.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 2.5 t -107.14 134.57 50.06 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 112.032 -2.349 . . . . 0.0 115.646 -174.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.21 -8.28 56.16 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 113.151 -1.841 . . . . 0.0 112.639 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -144.82 95.92 2.77 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.124 0.964 . . . . 0.0 113.09 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.03 64.17 8.31 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 123.429 1.585 . . . . 0.0 109.766 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -116.21 150.24 37.84 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.963 -1.926 . . . . 0.0 111.123 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -34.48 -51.95 0.48 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 115.329 1.604 . . . . 0.0 115.329 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -52.32 -57.57 9.35 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.494 0.718 . . . . 0.0 112.161 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -61.19 -41.04 96.11 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 85.2 mt -58.09 -51.13 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 124.125 0.891 . . . . 0.0 109.753 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 80.4 mt -54.91 -55.81 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.412 1.085 . . . . 0.0 109.892 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.21 -50.55 64.48 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.146 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -62.37 -52.42 63.68 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.88 -47.7 84.68 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -63.2 -36.78 84.79 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.52 -21.74 61.87 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.762 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 116.34 20.97 4.95 Favored Glycine 0 N--CA 1.48 1.568 0 N-CA-C 116.445 1.338 . . . . 0.0 116.445 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.61 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -68.77 118.91 12.34 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.456 1.128 . . . . 0.0 112.029 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.8 m -64.05 -28.3 69.7 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 113.52 -1.673 . . . . 0.0 111.992 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.61 172.26 45.23 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 124.149 0.88 . . . . 0.0 110.979 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -148.82 137.4 21.22 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.288 -0.956 . . . . 0.0 111.865 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.43 127.73 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 124.642 1.214 . . . . 0.0 109.438 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 87' ' ' THR . 11.0 p -81.04 139.97 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.782 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -94.6 131.63 30.42 Favored Pre-proline 0 CA--C 1.55 0.976 0 O-C-N 123.883 0.74 . . . . 0.0 111.255 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.3 151.88 69.33 Favored 'Cis proline' 0 N--CA 1.48 0.723 0 O-C-N 123.069 1.036 . . . . 0.0 113.46 -0.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -134.17 152.23 51.73 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 113.316 -1.765 . . . . 0.0 107.724 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.7 p -98.74 172.85 7.2 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.803 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.36 -41.62 72.79 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.822 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.11 -44.35 89.05 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.065 0.946 . . . . 0.0 111.702 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.2 m -61.25 -44.93 96.44 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.319 0.647 . . . . 0.0 110.041 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.449 HD21 HD12 ' A' ' 55' ' ' ILE . 2.0 tm? -60.44 -47.57 85.54 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.59 177.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -56.61 -43.06 79.81 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.496 1.118 . . . . 0.0 112.283 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -52.55 -45.51 66.41 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.124 0.57 . . . . 0.0 111.758 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -68.14 -42.32 80.3 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.196 0.998 . . . . 0.0 112.176 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 59.2 mt -53.88 -53.45 52.36 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.926 0.89 . . . . 0.0 111.433 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -50.54 -53.7 28.2 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.714 1.606 . . . . 0.0 111.957 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -49.27 -48.48 45.91 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.358 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 26.9 mt -63.01 -50.02 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 125.026 1.33 . . . . 0.0 112.284 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 . . . . . 0 N--CA 1.481 1.089 0 C-N-CA 124.396 1.078 . . . . 0.0 111.875 -179.473 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.7 pttt . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.95 54.41 1.26 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 1.2 tt -111.41 118.83 36.9 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 113.673 -1.603 . . . . 0.0 112.064 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -75.74 108.83 8.86 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.513 ' HE2' HD22 ' A' ' 120' ' ' LEU . 74.4 m-85 -97.53 140.71 31.56 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.522 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.44 HD12 ' HG ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -114.38 109.6 18.58 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.604 ' HA ' HG23 ' A' ' 55' ' ' ILE . 9.9 p -81.23 101.37 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 124.972 1.42 . . . . 0.0 107.169 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.524 HG12 ' SD ' ' A' ' 60' ' ' MET . 4.0 t -100.17 85.4 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -123.48 124.6 43.24 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 110.765 -2.925 . . . . 0.0 113.039 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -65.65 -19.22 65.82 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 110.955 -2.839 . . . . 0.0 116.23 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -110.09 127.79 55.07 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.303 0.377 . . . . 0.0 110.436 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.1 p -47.4 -59.31 3.3 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 113.683 -1.598 . . . . 0.0 113.721 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.454 ' O ' HG12 ' A' ' 20' ' ' ILE . 1.8 p -66.75 -42.3 86.39 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.439 ' O ' HG23 ' A' ' 21' ' ' VAL . 9.6 ttt -60.36 -38.32 83.48 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.058 0.39 . . . . 0.0 111.309 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -54.97 -50.91 67.76 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.62 1.168 . . . . 0.0 110.392 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.635 ' NH2' HD21 ' A' ' 23' ' ' ASN . 4.9 mtp-105 -65.03 -39.35 93.23 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.924 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 16' ' ' THR . 43.7 mm -55.95 -51.24 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 17' ' ' MET . 6.1 t -58.78 -45.98 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 123.596 0.56 . . . . 0.0 109.991 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -49.24 -53.92 19.22 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.888 0.875 . . . . 0.0 111.838 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.635 HD21 ' NH2' ' A' ' 19' ' ' ARG . 48.0 m-80 -62.98 -39.01 93.43 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.495 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.8 mt -58.95 -52.41 65.85 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.632 0.773 . . . . 0.0 110.564 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.7 mt -54.98 -47.18 74.93 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.065 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.425 ' HG3' ' OD1' ' A' ' 31' ' ' ASN . 36.4 ttpt -54.03 -50.15 67.3 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.416 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -58.71 -40.14 82.84 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.601 1.561 . . . . 0.0 112.288 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.7 mt -71.96 -10.35 59.65 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.543 1.137 . . . . 0.0 113.135 177.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.31 -16.39 24.66 Favored Glycine 0 CA--C 1.546 2.002 0 C-N-CA 125.226 1.393 . . . . 0.0 113.677 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -87.69 72.7 9.47 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 123.366 1.555 . . . . 0.0 113.015 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.425 ' OD1' ' HG3' ' A' ' 26' ' ' LYS . 4.8 m-80 -69.2 -8.42 45.5 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.705 -1.589 . . . . 0.0 113.891 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.447 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -94.17 83.9 4.35 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.483 1.513 . . . . 0.0 110.53 -178.478 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.35 137.8 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.775 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.582 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -111.59 159.15 18.42 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.888 1.275 . . . . 0.0 108.922 176.352 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -126.5 108.9 11.6 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.47 158.36 20.8 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.967 1.307 . . . . 0.0 110.287 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -101.87 -39.03 7.56 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -138.94 170.44 15.97 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.349 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -47.1 -51.93 13.29 Favored Glycine 0 N--CA 1.474 1.227 0 C-N-CA 124.646 1.117 . . . . 0.0 115.552 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.6 t -57.73 -54.43 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.409 0.683 . . . . 0.0 110.683 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -57.56 -33.61 68.32 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.583 0.753 . . . . 0.0 111.694 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . . . -64.09 -50.71 67.25 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 117.172 -1.394 . . . . 0.0 110.971 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.462 HD11 ' OG1' ' A' ' 71' ' ' THR . 61.8 mt -57.06 -45.99 82.8 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 123.752 0.658 . . . . 0.0 111.131 178.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -52.62 -54.32 34.73 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.199 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -63.16 -42.45 99.42 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.725 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.44 ' HG ' HD12 ' A' ' 9' ' ' LEU . 26.4 mt -56.7 -35.98 69.13 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.726 1.21 . . . . 0.0 113.139 177.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.19 -24.36 17.93 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.86 -23.64 67.43 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.251 1.02 . . . . 0.0 113.053 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.74 179.83 50.19 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 124.805 1.193 . . . . 0.0 113.922 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.73 -14.94 8.61 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 116.544 1.377 . . . . 0.0 116.544 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.582 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 84.1 m-85 -68.19 121.58 16.5 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.263 1.03 . . . . 0.0 113.64 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -106.23 10.1 43.03 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 112.505 -2.134 . . . . 0.0 111.959 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.732 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.6 OUTLIER -168.94 145.43 3.54 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.5 t -128.75 111.15 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 113.389 -1.732 . . . . 0.0 107.663 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.604 HG23 ' HA ' ' A' ' 10' ' ' VAL . 12.1 tt -107.34 96.64 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.3 t -118.33 134.47 55.01 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 60' ' ' MET . 12.3 m-20 -72.08 134.36 45.76 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.883 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.459 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 14.7 t-105 -55.63 -48.58 74.7 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.828 0.851 . . . . 0.0 111.498 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -96.52 97.77 9.69 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.224 0.952 . . . . 0.0 111.271 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.524 ' SD ' HG12 ' A' ' 11' ' ' VAL . 29.6 mtm -131.15 138.67 33.43 Favored Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 113.782 -1.553 . . . . 0.0 111.826 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -58.87 143.93 99.06 Favored 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.144 2.562 . . . . 0.0 111.518 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.345 27.9 p30 65.12 -66.64 0.14 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 127.313 2.245 . . . . 0.0 114.295 -177.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.8 ttm -122.36 100.43 6.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.881 0.872 . . . . 0.0 108.691 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 7.3 m-20 -65.27 167.18 8.71 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 112.413 -2.176 . . . . 0.0 112.875 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.4 -56.18 9.72 Favored Glycine 0 N--CA 1.482 1.717 0 C-N-CA 125.177 1.37 . . . . 0.0 114.123 -178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.463 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 43.7 tp -57.57 -39.89 77.73 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -70.63 -40.45 73.12 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.99 -0.444 . . . . 0.0 110.547 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.428 ' HA ' HG22 ' A' ' 71' ' ' THR . 1.4 tm? -57.87 -42.27 84.21 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.071 0.548 . . . . 0.0 110.668 176.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 103' ' ' ALA . 4.8 tt -51.1 -49.93 59.75 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.842 1.657 . . . . 0.0 109.705 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -56.89 -47.33 80.77 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.392 1.077 . . . . 0.0 113.66 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.462 ' OG1' HD11 ' A' ' 43' ' ' LEU 0.359 13.7 t -70.69 5.58 1.84 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 mt -115.18 -64.68 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 174.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.405 ' HG3' ' HA3' ' A' ' 102' ' ' GLY . 24.9 mmt180 -51.12 -45.59 61.64 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.811 1.644 . . . . 0.0 113.752 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.69 -10.72 42.06 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -83.03 89.94 6.97 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -11.67 -72.06 0.01 OUTLIER Glycine 0 N--CA 1.485 1.929 0 C-N-CA 127.091 2.281 . . . . 0.0 116.641 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.4 -38.64 77.76 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 82.5 mtp -92.51 -14.17 28.79 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.0 t -30.0 -35.92 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 121.681 3.956 . . . . 0.0 121.681 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.71 -8.58 58.15 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 120.849 3.648 . . . . 0.0 120.849 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 2.3 mp -68.08 119.16 65.29 Favored Pre-proline 0 N--CA 1.477 0.903 0 N-CA-C 118.049 2.611 . . . . 0.0 118.049 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 7.5 Cg_endo -57.86 142.24 96.25 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.686 2.924 . . . . 0.0 110.949 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 103' ' ' ALA . 1.3 t -123.29 121.82 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 113.538 -1.665 . . . . 0.0 113.121 -175.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.732 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 28.3 tp -111.6 102.58 10.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.699 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 31.4 mmt -80.04 105.98 11.72 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 113.416 -1.72 . . . . 0.0 112.845 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.59 98.06 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 113.492 -1.686 . . . . 0.0 107.722 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 1.7 t -114.05 121.74 44.77 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 -176.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.757 ' HB2' ' HE3' ' A' ' 109' ' ' LYS . . . -70.0 -18.8 63.34 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.002 -1.454 . . . . 0.0 112.928 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.78 84.45 1.94 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.218 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.48 100.12 6.74 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.794 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -119.04 137.68 53.37 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 112.951 -1.931 . . . . 0.0 107.876 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.479 ' O ' HG12 ' A' ' 96' ' ' ILE . 64.4 tttp -31.14 -57.27 0.24 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -57.51 -47.52 81.74 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.264 30.1 p30 -69.3 -33.99 74.02 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.0 mt -59.72 -49.87 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 124.136 0.974 . . . . 0.0 109.186 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 92' ' ' LYS . 42.4 mm -57.83 -50.41 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.228 1.011 . . . . 0.0 110.195 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.32 -50.11 60.03 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.339 1.055 . . . . 0.0 111.272 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.459 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -58.06 -56.4 22.54 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.892 1.277 . . . . 0.0 112.504 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.23 -49.24 74.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.986 0.914 . . . . 0.0 112.623 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -63.43 -37.48 87.45 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.04 -16.99 62.05 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.405 ' HA3' ' HG3' ' A' ' 73' ' ' ARG . . . 121.98 -0.02 10.76 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.618 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -67.07 110.67 3.5 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.404 1.102 . . . . 0.0 111.478 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.9 p -66.85 -18.29 65.31 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 113.681 -1.6 . . . . 0.0 114.644 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.16 168.3 40.02 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.76 1.171 . . . . 0.0 111.866 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -144.73 140.5 28.6 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.423 -0.888 . . . . 0.0 111.793 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.9 p -126.34 134.75 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 124.504 1.127 . . . . 0.0 111.845 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 87' ' ' THR . 47.8 t -81.03 128.79 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.983 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.757 ' HE3' ' HB2' ' A' ' 88' ' ' ALA . 42.1 pttt -94.03 132.86 28.55 Favored Pre-proline 0 N--CA 1.486 1.333 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.332 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.91 146.88 76.2 Favored 'Cis proline' 0 N--CA 1.478 0.617 0 O-C-N 123.437 1.23 . . . . 0.0 114.497 0.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -126.08 154.07 43.59 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 112.941 -1.936 . . . . 0.0 109.034 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.4 p -99.01 172.07 7.63 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.523 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.97 -39.71 72.2 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.87 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.89 -47.34 69.11 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.637 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.3 m -59.56 -46.91 87.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.584 0.754 . . . . 0.0 109.816 178.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.0 tp -56.76 -54.26 48.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.424 1.49 . . . . 0.0 110.198 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.24 -46.51 76.02 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.857 0.863 . . . . 0.0 112.682 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.28 -44.88 65.24 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.198 0.936 . . . . 0.0 112.134 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -66.54 -49.61 65.9 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.717 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.513 HD22 ' HE2' ' A' ' 8' ' ' PHE . 55.6 mt -55.92 -49.29 73.88 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.15 0.98 . . . . 0.0 111.849 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -55.78 -48.67 74.92 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.369 1.468 . . . . 0.0 112.692 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -54.22 -48.72 70.76 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.632 1.173 . . . . 0.0 110.784 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.21 -47.37 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.262 1.025 . . . . 0.0 110.585 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 179.103 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 65.1 mttm . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.59 60.89 5.82 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 123.209 1.48 . . . . 0.0 108.565 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.435 HD21 ' HB2' ' A' ' 53' ' ' PHE . 5.5 tt -98.11 123.75 42.31 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.049 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 46.4 tttp -80.33 105.46 11.61 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.685 1.241 . . . . 0.0 112.657 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -97.47 145.22 26.42 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.005 -1.452 . . . . 0.0 112.615 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.838 HD12 HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -113.15 107.23 15.64 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 173.592 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.52 98.85 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.931 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.674 HG11 ' HB2' ' A' ' 42' ' ' ALA . 2.2 t -105.77 89.88 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 113.304 -1.771 . . . . 0.0 109.257 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -134.14 125.68 28.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 112.643 -2.071 . . . . 0.0 111.019 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -55.37 -24.86 31.91 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 110.93 -2.85 . . . . 0.0 116.738 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -106.66 120.69 42.64 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.2 p -42.96 -57.67 2.75 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.937 -1.483 . . . . 0.0 114.305 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.44 ' O ' HG12 ' A' ' 20' ' ' ILE . 11.0 p -68.06 -43.37 78.8 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 118.223 -0.894 . . . . 0.0 113.29 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -39.3 90.4 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.249 0.477 . . . . 0.0 110.896 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -56.63 -49.45 74.96 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.386 1.074 . . . . 0.0 109.971 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -61.0 -42.33 98.23 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.71 177.611 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 16' ' ' THR . 42.8 mm -56.17 -48.59 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 118.888 -0.577 . . . . 0.0 110.002 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.464 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 4.1 t -59.5 -49.97 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 19' ' ' ARG . 42.5 ttt180 -49.62 -49.08 48.33 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.207 1.403 . . . . 0.0 111.092 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -64.5 -43.32 94.48 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.548 1.139 . . . . 0.0 112.286 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.496 HD22 ' HB2' ' A' ' 113' ' ' ALA . 57.3 mt -55.72 -50.97 68.92 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.385 1.074 . . . . 0.0 111.31 177.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 mt -51.01 -48.6 61.38 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.757 1.286 . . . . 0.0 112.187 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.406 ' NZ ' ' HG2' ' A' ' 22' ' ' ARG . 32.0 mtmm -58.96 -44.8 91.56 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.982 -1.463 . . . . 0.0 112.247 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 32.5 mt-10 -59.18 -38.47 79.88 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.095 1.358 . . . . 0.0 112.733 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.543 HD22 ' HB2' ' A' ' 117' ' ' GLU . 60.2 mt -71.14 -18.21 62.52 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.098 1.359 . . . . 0.0 114.239 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.79 9.96 19.81 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 124.476 1.036 . . . . 0.0 113.5 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -96.76 95.39 7.86 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 123.405 1.574 . . . . 0.0 110.199 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -61.95 -34.62 76.46 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 110.501 -3.045 . . . . 0.0 118.746 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 7' ' ' LYS . 9.1 t-20 -112.3 125.81 54.58 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 -174.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.4 p -147.96 135.79 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.77 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 12.9 mm-40 -113.78 161.42 17.56 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.869 175.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -123.38 130.51 52.82 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -139.12 156.7 46.96 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.377 1.471 . . . . 0.0 109.699 175.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -113.86 -38.79 4.14 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 61' ' ' PRO . 6.6 p-10 -123.38 159.79 28.17 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 118.719 -0.658 . . . . 0.0 109.774 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.575 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -44.67 -45.68 8.8 Favored Glycine 0 N--CA 1.478 1.445 0 N-CA-C 116.74 1.456 . . . . 0.0 116.74 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.57 -54.77 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 122.559 0.344 . . . . 0.0 110.196 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -57.51 -34.13 68.77 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.446 0.699 . . . . 0.0 110.777 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.674 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -62.94 -55.23 27.76 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.653 1.181 . . . . 0.0 110.32 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.0 mt -56.52 -43.54 79.92 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.66 0.784 . . . . 0.0 110.324 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -53.86 -56.16 20.13 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.318 1.047 . . . . 0.0 110.744 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -59.38 -52.97 63.32 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.213 1.405 . . . . 0.0 111.896 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.838 HD13 HD12 ' A' ' 9' ' ' LEU . 4.0 tp -56.49 -37.21 70.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.933 2.093 . . . . 0.0 114.61 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -54.64 -30.26 54.62 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.472 1.509 . . . . 0.0 113.589 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.77 -22.47 66.99 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.21 -173.13 46.12 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.25 0.928 . . . . 0.0 112.093 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.63 -26.41 3.14 Favored Glycine 0 CA--C 1.543 1.833 0 N-CA-C 114.78 0.672 . . . . 0.0 114.78 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.77 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 91.3 m-85 -68.12 108.94 3.31 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.879 0.872 . . . . 0.0 111.799 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.59 3.11 86.41 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.441 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.646 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -166.04 143.52 5.45 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.105 0.962 . . . . 0.0 113.441 179.609 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.543 HG22 HD11 ' A' ' 46' ' ' LEU . 31.3 t -122.14 113.84 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 113.918 -1.492 . . . . 0.0 107.608 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.549 HD12 HD23 ' A' ' 84' ' ' LEU . 18.8 tt -113.43 97.28 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 178.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.7 t -119.53 136.03 54.52 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -175.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.408 ' O ' ' HG3' ' A' ' 60' ' ' MET . 8.0 t0 -71.98 132.88 44.91 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 112.415 -2.175 . . . . 0.0 110.944 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.479 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 26.6 t-105 -56.29 -41.23 75.58 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.41 1.084 . . . . 0.0 111.719 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -99.5 104.44 16.27 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.481 ' SD ' HG12 ' A' ' 11' ' ' VAL . 29.4 mtm -138.83 130.45 15.39 Favored Pre-proline 0 N--CA 1.473 0.689 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.713 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.508 ' O ' ' HB2' ' A' ' 38' ' ' ASP . 99.0 Cg_exo -57.42 149.6 64.76 Favored 'Trans proline' 0 N--CA 1.481 0.766 0 C-N-CA 123.448 2.765 . . . . 0.0 110.944 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 71.19 -61.2 0.49 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 126.119 1.767 . . . . 0.0 112.516 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.575 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 55.6 ttm -135.31 108.33 7.64 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.154 1.381 . . . . 0.0 108.101 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 10.7 m-20 -68.88 167.39 15.76 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.457 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.26 -57.01 9.55 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 125.508 1.528 . . . . 0.0 114.527 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.455 HD12 HD23 ' A' ' 69' ' ' LEU . 56.9 tp -57.44 -37.84 73.45 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -71.61 -42.95 67.04 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.668 0.787 . . . . 0.0 111.167 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.07 -41.53 83.59 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.328 1.051 . . . . 0.0 110.246 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.577 HD13 HG11 ' A' ' 83' ' ' VAL . 8.4 tp -57.23 -46.53 82.88 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.005 176.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -60.43 -44.0 96.21 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.38 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.26 24.9 p -62.0 -35.44 78.53 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.268 1.027 . . . . 0.0 111.993 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.4 mt -69.33 -56.95 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.499 ' HG3' ' HA3' ' A' ' 102' ' ' GLY . 30.1 mmt180 -53.34 -47.98 68.89 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.718 1.261 . . . . 0.0 113.043 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.14 -33.85 75.26 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.165 0.986 . . . . 0.0 113.097 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -84.68 83.25 8.09 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.794 0.838 . . . . 0.0 108.777 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -4.58 -80.6 0.01 OUTLIER Glycine 0 N--CA 1.484 1.849 0 C-N-CA 127.521 2.486 . . . . 0.0 118.221 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.89 -35.27 57.7 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 94.0 mtp -73.37 -27.11 61.3 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.072 0.949 . . . . 0.0 113.241 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.3 t -53.83 -26.51 24.65 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.43 -14.61 61.74 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.516 HD22 ' O ' ' A' ' 51' ' ' TYR . 16.0 mt -86.53 116.19 65.01 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 123.784 0.833 . . . . 0.0 109.876 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 9.4 Cg_endo -52.58 143.66 45.03 Favored 'Trans proline' 0 N--CA 1.476 0.488 0 C-N-CA 123.53 2.82 . . . . 0.0 113.71 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.577 HG11 HD13 ' A' ' 69' ' ' LEU . 13.5 t -121.23 117.86 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.801 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.646 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 29.5 tp -110.64 107.32 16.86 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 113.044 -1.889 . . . . 0.0 109.573 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.4 mmt -82.27 119.23 23.84 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 113.862 -1.517 . . . . 0.0 112.825 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 2.2 t -94.13 96.29 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 t -105.24 138.52 41.31 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 112.162 -2.29 . . . . 0.0 116.084 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.79 -22.11 66.03 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 113.565 -1.652 . . . . 0.0 113.167 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -142.09 135.4 29.07 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 1.006 ' HB2' HG21 ' A' ' 108' ' ' VAL . . . -97.99 60.29 1.46 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 113.344 -1.753 . . . . 0.0 109.492 176.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -112.28 148.17 34.75 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.652 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -37.17 -45.13 0.61 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 116.32 1.971 . . . . 0.0 116.32 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.12 -60.53 3.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.961 0.904 . . . . 0.0 110.738 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -59.39 -46.75 87.81 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.788 1.235 . . . . 0.0 112.594 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 73.3 mt -57.31 -57.2 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 124.207 0.942 . . . . 0.0 111.598 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.7 mt -60.06 -50.48 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.175 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.96 -49.69 68.17 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.771 0.669 . . . . 0.0 112.228 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.479 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -60.78 -54.94 39.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.348 1.059 . . . . 0.0 111.633 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.42 -48.59 76.65 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.077 0.951 . . . . 0.0 112.408 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -61.18 -31.35 71.1 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.55 1.87 55.37 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.499 ' HA3' ' HG3' ' A' ' 73' ' ' ARG . . . 110.18 -0.28 29.82 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 116.892 1.517 . . . . 0.0 116.892 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.452 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -70.55 109.55 4.91 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.2 1.0 . . . . 0.0 111.856 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.2 p -63.64 -21.48 66.39 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.54 -1.664 . . . . 0.0 114.246 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -170.45 171.07 43.47 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.897 1.237 . . . . 0.0 112.357 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.494 ' O ' ' HE2' ' A' ' 119' ' ' LYS . 31.2 p90 -146.45 127.29 14.42 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.643 -0.778 . . . . 0.0 113.024 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 1.5 p -111.2 119.54 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.006 HG21 ' HB2' ' A' ' 90' ' ' ALA . 63.2 t -82.05 125.36 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 113.607 -1.633 . . . . 0.0 112.88 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -87.09 133.95 37.86 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 112.77 -2.014 . . . . 0.0 110.214 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.27 126.71 13.77 Favored 'Cis proline' 0 C--N 1.351 0.663 0 CA-C-O 123.192 1.247 . . . . 0.0 115.223 0.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.464 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 21.6 p90 -115.83 147.81 40.61 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 112.424 -2.171 . . . . 0.0 108.269 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 48.7 p -104.07 171.93 7.08 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.764 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.496 ' HB2' HD22 ' A' ' 24' ' ' LEU . . . -54.85 -37.52 66.32 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.99 176.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.06 -50.33 64.52 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.196 0.998 . . . . 0.0 110.741 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.8 m -58.81 -44.74 90.9 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.701 0.801 . . . . 0.0 110.211 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 36.6 tp -58.18 -55.83 29.95 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.147 1.379 . . . . 0.0 109.844 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.543 ' HB2' HD22 ' A' ' 28' ' ' LEU . 23.5 tt0 -59.3 -41.65 89.52 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.76 0.424 . . . . 0.0 111.72 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -52.52 -46.89 66.88 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.694 0.797 . . . . 0.0 110.868 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 106' ' ' TYR . 31.3 mmmt -70.4 -42.58 71.5 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.032 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.1 mt -56.76 -46.65 81.31 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -53.2 -49.54 66.54 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.806 1.242 . . . . 0.0 111.681 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 119' ' ' LYS . 59.0 tttm -52.51 -47.86 66.38 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.75 1.62 . . . . 0.0 111.275 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.585 HG13 ' HZ ' ' A' ' 53' ' ' PHE . 14.1 mm -60.32 -48.04 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.207 1.003 . . . . 0.0 110.528 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -179.284 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.3 mttt . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -74.87 5.54 4.96 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.822 1.249 . . . . 0.0 114.342 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.31 126.91 30.24 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.256 1.423 . . . . 0.0 113.032 -177.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -84.25 108.73 17.28 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 112.983 -1.917 . . . . 0.0 112.282 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -99.73 127.87 45.85 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.757 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.544 HD13 HG22 ' A' ' 11' ' ' VAL . 1.4 tm? -107.65 95.84 5.97 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.71 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 45.6 t -79.43 104.71 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 111.148 -2.751 . . . . 0.0 108.931 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.544 HG22 HD13 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -104.44 72.56 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 123.553 1.644 . . . . 0.0 107.921 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -129.11 80.23 1.96 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 112.885 -1.961 . . . . 0.0 110.7 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -13.01 -30.61 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 1 N-CA-C 124.421 4.971 . . . . 0.0 124.421 -178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -101.12 124.01 46.17 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.418 ' HA ' HH11 ' A' ' 18' ' ' ARG . 11.9 m -41.95 -43.54 3.15 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 114.68 -1.145 . . . . 0.0 113.392 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.525 ' O ' HG12 ' A' ' 20' ' ' ILE . 2.1 m -58.21 -55.95 28.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.932 1.293 . . . . 0.0 110.835 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.449 ' O ' HG23 ' A' ' 21' ' ' VAL . 1.1 tmm? -59.88 -42.61 94.15 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.487 ' HB3' ' OE1' ' A' ' 35' ' ' GLU . 12.9 mtp180 -55.72 -47.81 76.23 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.766 0.666 . . . . 0.0 111.229 176.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 15.0 ttp180 -67.14 -39.92 86.67 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.078 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 16' ' ' THR . 37.2 mm -56.55 -47.76 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 123.307 0.38 . . . . 0.0 110.086 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 17' ' ' MET . 18.7 t -60.59 -42.06 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.617 ' HG3' HG11 ' A' ' 33' ' ' VAL . 24.5 ttt85 -53.31 -52.54 58.81 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.582 0.753 . . . . 0.0 110.155 176.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -53.51 -44.46 69.13 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.325 1.05 . . . . 0.0 112.279 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.0 -51.13 69.3 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.963 1.305 . . . . 0.0 112.048 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.0 mt -56.15 -44.31 79.15 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.041 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -57.78 -47.64 81.95 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.927 176.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.19 -39.15 78.18 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.109 1.364 . . . . 0.0 111.733 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.8 mt -73.21 -26.9 61.33 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.86 21.18 7.95 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.567 1.08 . . . . 0.0 114.399 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -92.97 116.44 29.05 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 122.456 1.122 . . . . 0.0 112.645 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -67.52 -48.27 67.52 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 111.411 -2.631 . . . . 0.0 116.15 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -111.57 122.36 47.62 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 -174.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG11 ' HG3' ' A' ' 22' ' ' ARG . 7.9 p -138.31 112.92 8.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 111.154 -2.748 . . . . 0.0 110.781 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.632 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 31.9 mt-10 -109.44 140.75 42.79 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.71 ' HG2' ' HB ' ' A' ' 10' ' ' VAL . 45.0 mt-10 -123.36 131.64 53.72 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 -174.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.407 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -117.09 157.03 26.56 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 111.493 -2.594 . . . . 0.0 110.271 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -92.23 -55.46 3.42 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -130.34 173.05 11.19 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.703 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -40.57 -54.64 3.35 Favored Glycine 0 CA--C 1.536 1.346 0 O-C-N 124.977 1.423 . . . . 0.0 115.44 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.8 t -57.25 -56.78 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.984 0.914 . . . . 0.0 112.076 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -56.82 -36.72 70.29 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.421 0.688 . . . . 0.0 111.579 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.536 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -64.14 -51.05 65.77 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.126 0.97 . . . . 0.0 111.028 177.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.2 mt -54.13 -49.27 69.59 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.501 0.72 . . . . 0.0 110.711 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -52.16 -55.45 20.9 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.301 1.041 . . . . 0.0 111.661 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.489 ' HD3' HD21 ' A' ' 9' ' ' LEU . 41.3 mttm -58.23 -52.78 64.13 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.537 177.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.7 mt -56.34 -39.22 72.48 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.984 1.314 . . . . 0.0 114.092 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -58.79 -23.93 61.06 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.46 -19.25 62.24 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.09 -165.5 29.2 Favored Glycine 0 N--CA 1.481 1.645 0 C-N-CA 124.884 1.23 . . . . 0.0 112.097 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.33 -34.95 1.53 Allowed Glycine 0 CA--C 1.544 1.865 0 N-CA-C 116.0 1.16 . . . . 0.0 116.0 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.632 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 80.9 m-85 -66.5 118.38 10.05 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.08 7.36 56.94 Favored Glycine 0 N--CA 1.476 1.316 0 CA-C-N 112.654 -2.067 . . . . 0.0 111.803 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.511 ' HA ' ' HG2' ' A' ' 82' ' ' PRO . 2.4 t80 -163.97 138.18 5.69 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.7 t -122.16 110.94 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.581 HG23 ' HA ' ' A' ' 10' ' ' VAL . 12.5 tt -114.93 97.84 6.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.5 t -118.67 136.01 54.15 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 60' ' ' MET . 53.6 t0 -71.72 132.67 44.86 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 113.2 -1.818 . . . . 0.0 110.745 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.441 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 17.6 t-105 -56.39 -46.5 80.09 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.306 177.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -93.29 105.42 17.5 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.883 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.41 ' HE2' ' HA2' ' A' ' 65' ' ' GLY . 29.5 mtm -140.25 134.39 15.5 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.627 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -58.43 142.25 97.72 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 C-N-CA 123.717 2.945 . . . . 0.0 111.054 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.7 m120 63.75 -67.32 0.1 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.857 1.663 . . . . 0.0 114.304 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.401 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 57.4 ttm -115.73 97.74 6.3 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 4.0 p30 -60.94 165.74 3.91 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 112.122 -2.308 . . . . 0.0 112.541 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.41 ' HA2' ' HE2' ' A' ' 60' ' ' MET . . . -49.33 -55.92 11.86 Favored Glycine 0 N--CA 1.484 1.886 0 C-N-CA 124.711 1.148 . . . . 0.0 114.432 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.455 HD12 HD23 ' A' ' 69' ' ' LEU . 41.1 tp -57.26 -43.23 82.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.141 0.576 . . . . 0.0 112.47 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.54 -41.74 92.72 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.875 0.87 . . . . 0.0 111.365 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.53 -46.46 83.81 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.328 1.051 . . . . 0.0 110.225 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.455 HD23 HD12 ' A' ' 66' ' ' LEU . 18.4 tp -55.07 -47.81 74.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.386 1.475 . . . . 0.0 110.737 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -60.0 -47.47 85.71 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.218 0.607 . . . . 0.0 112.125 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.267 16.4 p -57.19 -29.21 63.49 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.019 0.928 . . . . 0.0 112.634 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mt -81.55 -58.01 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.157 0.983 . . . . 0.0 108.891 177.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 81.8 mmt-85 -48.08 -47.78 33.86 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.467 1.907 . . . . 0.0 112.855 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.98 61.66 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -84.33 96.43 9.03 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -17.96 -69.46 0.01 OUTLIER Glycine 0 N--CA 1.488 2.114 0 C-N-CA 126.27 1.891 . . . . 0.0 116.56 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.57 95.33 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 98.7 mtp -75.51 -22.43 57.15 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.1 t -38.03 -36.07 0.19 Allowed 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 117.405 2.372 . . . . 0.0 117.405 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.39 -1.86 51.23 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 117.23 2.308 . . . . 0.0 117.23 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.4 mt -69.42 110.28 6.04 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.511 ' HG2' ' HA ' ' A' ' 53' ' ' PHE . 39.5 Cg_endo -54.99 124.33 16.01 Favored 'Trans proline' 0 N--CA 1.483 0.888 0 C-N-CA 123.435 2.757 . . . . 0.0 113.437 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.9 t -112.68 119.27 59.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 114.078 -1.419 . . . . 0.0 114.521 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 66.6 tp -109.09 101.18 10.26 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 111.919 -2.4 . . . . 0.0 107.859 176.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.4 mmt -76.02 104.51 6.59 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.42 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 t -83.94 98.57 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.3 p -90.6 132.13 35.91 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 112.958 -1.928 . . . . 0.0 112.387 -176.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.11 -46.14 89.09 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.959 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -147.11 115.18 6.55 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.97 98.52 5.71 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.657 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -114.64 142.21 46.76 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.114 -1.857 . . . . 0.0 108.69 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' A' ' 93' ' ' GLU 0.264 0.0 OUTLIER -38.36 -45.17 0.98 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 179.677 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.403 ' H ' ' HD2' ' A' ' 92' ' ' LYS . 0.8 OUTLIER -55.59 -53.21 59.3 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.631 0.772 . . . . 0.0 112.959 178.584 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.01 -37.66 84.57 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.598 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.97 -51.27 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.775 0.83 . . . . 0.0 110.4 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.0 mt -57.84 -51.65 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.38 0.672 . . . . 0.0 109.244 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.02 -44.6 74.74 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.04 0.936 . . . . 0.0 113.369 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.441 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -58.48 -47.77 82.96 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.155 0.982 . . . . 0.0 112.31 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.79 -44.75 96.26 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.886 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -59.06 -31.58 68.99 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.16 -5.8 49.32 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.13 4.4 27.43 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 118.317 2.087 . . . . 0.0 118.317 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.7 121.03 8.84 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.402 ' HB3' HG23 ' A' ' 123' ' ' ILE . 13.6 m -66.87 -30.67 70.9 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 113.271 -1.786 . . . . 0.0 113.404 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.78 167.42 38.81 Favored Glycine 0 N--CA 1.479 1.556 0 C-N-CA 124.458 1.028 . . . . 0.0 110.819 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -141.92 137.63 31.43 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.31 126.55 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 124.617 1.198 . . . . 0.0 111.66 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.2 p -88.99 135.62 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.706 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.2 pttt -92.75 142.36 25.54 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-O 117.709 -1.138 . . . . 0.0 112.392 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.08 129.81 18.55 Favored 'Cis proline' 0 N--CA 1.481 0.769 0 N-CA-C 116.568 1.718 . . . . 0.0 116.568 0.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -120.38 139.29 53.01 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 112.814 -1.994 . . . . 0.0 107.966 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.5 p -97.82 174.94 6.35 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.876 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.88 -36.39 67.58 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.38 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.02 -47.29 71.89 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.185 0.994 . . . . 0.0 111.44 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 m -59.59 -45.96 90.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.285 0.634 . . . . 0.0 109.623 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 42.4 tp -56.89 -51.64 68.28 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.602 1.161 . . . . 0.0 110.277 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.55 ' HA ' HD12 ' A' ' 120' ' ' LEU . 15.2 tm-20 -54.3 -46.85 72.87 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.646 1.178 . . . . 0.0 111.91 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -58.96 -43.76 91.36 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.099 0.874 . . . . 0.0 112.655 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -65.61 -42.26 91.82 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.853 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 117' ' ' GLU . 89.2 mt -53.69 -47.69 70.22 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.337 1.023 . . . . 0.0 111.33 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -52.59 -54.98 25.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.592 1.557 . . . . 0.0 111.867 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -52.45 -49.88 63.74 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 113.859 -1.519 . . . . 0.0 112.51 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.463 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 58.7 mt -60.14 -45.54 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.852 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.5 m-30 . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 179.035 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.31 62.5 6.04 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 123.127 1.441 . . . . 0.0 111.4 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 tt -106.34 123.64 48.36 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 113.24 -1.8 . . . . 0.0 111.068 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -76.34 103.27 6.27 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.895 1.372 . . . . 0.0 113.976 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -98.47 130.47 45.08 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 112.621 -2.081 . . . . 0.0 112.014 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.535 HD12 ' HG ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -108.64 102.54 11.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 122.748 1.261 . . . . 0.0 108.695 174.42 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.3 t -88.13 107.16 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.501 HG12 ' SD ' ' A' ' 60' ' ' MET . 4.3 t -105.45 101.99 13.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 111.391 -2.641 . . . . 0.0 108.339 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -138.85 133.57 32.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.968 -1.469 . . . . 0.0 112.33 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -63.52 -23.18 67.28 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 113.965 -1.47 . . . . 0.0 112.396 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.49 102.06 11.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.789 177.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.9 p -49.06 -34.09 12.9 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.767 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.65 -41.57 95.22 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.131 1.772 . . . . 0.0 110.726 176.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.422 ' O ' HG23 ' A' ' 21' ' ' VAL . 10.3 tpt -66.67 -42.21 86.94 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.3 0.64 . . . . 0.0 110.536 177.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.667 ' HG3' ' HG3' ' A' ' 35' ' ' GLU . 1.8 tmm_? -56.51 -42.79 78.97 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 124.285 0.991 . . . . 0.0 109.735 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.714 ' HD3' HH22 ' A' ' 22' ' ' ARG . 1.8 tpp180 -56.02 -48.6 75.64 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.147 1.379 . . . . 0.0 110.576 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.3 mm -58.47 -55.85 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.046 0.939 . . . . 0.0 110.382 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 17' ' ' MET . 4.5 t -53.04 -44.79 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.817 0.847 . . . . 0.0 111.566 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.714 HH22 ' HD3' ' A' ' 19' ' ' ARG . 26.0 ttm180 -52.62 -54.12 37.52 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.054 0.942 . . . . 0.0 111.452 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -60.19 -39.75 87.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.99 0.916 . . . . 0.0 113.299 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.91 -53.13 61.49 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.48 1.112 . . . . 0.0 110.745 177.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.2 mt -57.48 -44.51 84.94 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.835 0.854 . . . . 0.0 112.112 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -53.37 -48.7 68.36 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.486 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -57.45 -38.88 75.15 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.035 1.334 . . . . 0.0 111.985 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.2 mt -74.83 -15.13 60.74 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.37 6.49 29.25 Favored Glycine 0 CA--C 1.545 1.947 0 C-N-CA 125.104 1.335 . . . . 0.0 114.78 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -98.44 91.88 5.4 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 122.758 1.265 . . . . 0.0 112.666 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -79.35 -10.22 59.76 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 119.604 3.187 . . . . 0.0 119.604 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -107.4 99.23 8.77 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 119.404 1.002 . . . . 0.0 112.511 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -130.12 125.04 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.066 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -111.84 163.75 13.84 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.596 0.758 . . . . 0.0 109.851 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.667 ' HG3' ' HG3' ' A' ' 18' ' ' ARG . 44.1 tt0 -120.67 131.05 54.38 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 -176.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.452 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -137.03 149.49 47.49 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 112.104 -2.316 . . . . 0.0 108.095 173.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -101.45 -41.65 6.56 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -130.85 159.84 36.19 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.629 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -39.51 -51.71 3.03 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.984 1.754 . . . . 0.0 115.03 177.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.45 -56.19 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 114.852 -0.674 . . . . 0.0 111.23 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.8 -37.58 68.81 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.933 0.893 . . . . 0.0 111.458 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.436 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -60.18 -49.52 77.32 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 117.462 -1.256 . . . . 0.0 111.42 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.7 mt -58.5 -44.77 89.56 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.104 0.562 . . . . 0.0 111.385 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -54.8 -53.02 60.68 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.971 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -59.9 -50.92 71.87 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.681 1.593 . . . . 0.0 111.88 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.535 ' HG ' HD12 ' A' ' 9' ' ' LEU . 16.4 mt -54.81 -49.28 71.39 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.451 1.9 . . . . 0.0 114.73 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.91 -17.63 10.27 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.64 -19.65 65.81 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.224 0.61 . . . . 0.0 112.499 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.3 -177.88 38.19 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.924 1.249 . . . . 0.0 114.146 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.56 -24.57 2.62 Favored Glycine 0 CA--C 1.541 1.703 0 N-CA-C 116.432 1.333 . . . . 0.0 116.432 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -69.0 113.22 6.19 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.27 5.65 61.07 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 112.725 -2.034 . . . . 0.0 112.01 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -164.24 143.86 7.73 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.469 HG22 HD21 ' A' ' 46' ' ' LEU . 21.3 t -127.88 120.0 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.086 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 84' ' ' LEU . 71.2 mt -113.07 102.59 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.7 t -119.23 131.78 55.85 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 118.016 2.598 . . . . 0.0 118.016 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -71.98 124.84 25.78 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 112.066 -2.334 . . . . 0.0 109.808 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.498 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 18.3 t-105 -55.4 -39.34 70.06 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.232 178.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -91.41 94.05 9.31 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.797 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.501 ' SD ' HG12 ' A' ' 11' ' ' VAL . 29.6 mtm -139.58 122.52 10.43 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-N 112.83 -1.986 . . . . 0.0 109.589 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -60.82 127.62 23.06 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.893 3.062 . . . . 0.0 113.335 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 m120 81.32 -65.8 0.13 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.02 1.728 . . . . 0.0 113.283 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.2 ttm -115.57 87.72 2.73 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.625 0.726 . . . . 0.0 109.363 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.5 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.1 p30 -61.43 168.87 2.52 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 111.863 -2.426 . . . . 0.0 112.224 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 58' ' ' TRP . . . -47.29 -53.43 11.69 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 124.932 1.253 . . . . 0.0 114.223 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.42 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 62.3 tp -57.38 -44.59 84.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.883 0.873 . . . . 0.0 111.997 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.522 ' HA ' ' HD3' ' A' ' 70' ' ' LYS . 32.5 mm-40 -66.23 -40.72 90.48 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.2 tp -61.57 -42.79 99.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.368 0.667 . . . . 0.0 111.27 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.605 HD12 ' HD3' ' A' ' 73' ' ' ARG . 5.4 tp -53.25 -45.21 68.67 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.831 1.252 . . . . 0.0 110.868 177.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.522 ' HD3' ' HA ' ' A' ' 67' ' ' GLU . 13.8 mtpp -64.76 -44.86 88.68 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.488 1.115 . . . . 0.0 111.209 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.2 p -61.0 -25.12 66.66 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.773 1.229 . . . . 0.0 113.219 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.9 mt -84.04 -59.64 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.613 1.165 . . . . 0.0 108.072 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.605 ' HD3' HD12 ' A' ' 69' ' ' LEU . 2.9 mpt_? -49.05 -43.39 40.7 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.253 1.821 . . . . 0.0 113.447 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.46 -14.64 52.05 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.83 91.98 7.17 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -7.52 -79.53 0.01 OUTLIER Glycine 0 N--CA 1.488 2.141 0 C-N-CA 126.936 2.208 . . . . 0.0 117.161 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.57 -45.62 88.63 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.8 mtp -80.16 -11.45 59.75 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 117.36 2.355 . . . . 0.0 117.36 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.3 t -30.47 -61.37 0.17 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 118.761 2.874 . . . . 0.0 118.761 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.22 12.82 2.65 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 119.9 3.296 . . . . 0.0 119.9 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.1 mt -76.62 106.37 3.29 Favored Pre-proline 0 N--CA 1.479 0.989 0 O-C-N 121.251 -0.906 . . . . 0.0 112.117 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -40.13 133.86 1.95 Allowed 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 124.567 3.511 . . . . 0.0 117.149 -175.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.4 t -119.28 117.96 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 111.068 -2.787 . . . . 0.0 112.817 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.402 ' HB3' HG12 ' A' ' 55' ' ' ILE . 47.8 tp -108.98 105.64 15.25 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 113.34 -1.754 . . . . 0.0 107.706 177.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.7 mmt -80.53 114.84 19.7 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 113.597 -1.638 . . . . 0.0 111.686 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.54 HG12 ' HG3' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -98.91 110.57 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 179.497 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.6 p -111.53 153.89 25.58 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 117.846 2.536 . . . . 0.0 117.846 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.12 -31.8 73.18 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 112.018 -2.356 . . . . 0.0 113.641 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.03 124.56 3.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.535 1.134 . . . . 0.0 108.518 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.42 90.39 6.71 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 122.529 1.157 . . . . 0.0 110.403 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -121.48 133.28 55.04 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.721 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -25.5 -61.63 0.07 Allowed 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 117.692 2.478 . . . . 0.0 117.692 -177.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -53.58 -46.75 70.42 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -70.27 -34.44 72.79 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.3 mt -60.03 -53.33 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.47 0.708 . . . . 0.0 109.906 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.434 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 33.8 mt -58.56 -46.85 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.707 0.803 . . . . 0.0 109.783 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.08 -47.99 64.9 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.86 0.864 . . . . 0.0 112.294 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.498 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -63.05 -47.38 83.25 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.574 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.79 84.13 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.353 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 96' ' ' ILE . 24.6 mm100 -60.19 -36.82 78.49 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.035 0.934 . . . . 0.0 112.73 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.71 -5.07 52.17 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.561 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 113.86 -5.23 24.15 Favored Glycine 0 CA--C 1.542 1.761 0 N-CA-C 117.367 1.707 . . . . 0.0 117.367 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.51 115.46 2.53 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.417 1.608 . . . . 0.0 115.314 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.2 p -67.95 -18.65 64.81 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 113.568 -1.651 . . . . 0.0 114.217 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.416 ' HA3' HD11 ' A' ' 123' ' ' ILE . . . -165.87 162.05 35.56 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.505 1.05 . . . . 0.0 112.304 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -146.14 126.18 13.71 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.665 0.786 . . . . 0.0 111.117 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 1.4 p -131.27 136.43 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 124.849 1.343 . . . . 0.0 110.864 176.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -93.22 145.37 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.499 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.54 ' HG3' HG12 ' A' ' 86' ' ' VAL . 10.1 mtmp? -89.3 128.91 49.55 Favored Pre-proline 0 N--CA 1.476 0.825 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.68 155.66 80.58 Favored 'Cis proline' 0 CA--C 1.54 0.778 0 O-C-N 123.055 1.029 . . . . 0.0 114.371 0.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -146.53 155.72 42.73 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.067 1.747 . . . . 0.0 107.967 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.5 t -117.13 177.18 4.81 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.919 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.48 -41.86 61.22 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.823 0.849 . . . . 0.0 111.563 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.81 -53.02 60.69 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.184 0.994 . . . . 0.0 111.986 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.73 -46.76 84.0 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.757 0.823 . . . . 0.0 110.62 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.65 -52.56 63.41 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.069 1.348 . . . . 0.0 108.551 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -56.11 -46.94 78.93 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.859 1.264 . . . . 0.0 111.981 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.19 -45.86 65.33 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -68.39 -45.17 73.42 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.85 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.3 mt -55.97 -50.84 69.71 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.2 1.0 . . . . 0.0 112.169 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -51.61 -50.17 60.75 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.604 1.561 . . . . 0.0 111.995 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -54.89 -47.7 73.96 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.721 1.208 . . . . 0.0 110.997 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.416 HD11 ' HA3' ' A' ' 105' ' ' GLY . 96.4 mt -62.78 -44.42 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.849 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.322 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 62.1 mttm . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 121.126 0.488 . . . . 0.0 112.235 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -84.64 60.76 6.3 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 122.388 1.09 . . . . 0.0 109.488 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 tt -108.94 133.04 53.48 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.341 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -79.84 106.75 12.1 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 125.079 1.487 . . . . 0.0 113.588 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -104.09 139.31 39.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 112.672 -2.058 . . . . 0.0 112.704 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -115.92 107.79 15.45 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.572 174.055 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.51 99.04 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 112.585 -2.098 . . . . 0.0 107.53 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.432 HG12 ' SD ' ' A' ' 60' ' ' MET . 3.5 t -101.75 91.0 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.375 -178.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.44 ' OD1' ' HB2' ' A' ' 57' ' ' ASP . 12.0 m-20 -136.48 114.11 11.06 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 113.809 -1.541 . . . . 0.0 113.137 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -52.82 -28.1 21.18 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.628 ' HB3' ' HB2' ' A' ' 17' ' ' MET . 5.4 t80 -94.29 113.48 25.39 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.5 p -45.76 -46.69 15.33 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.709 1.204 . . . . 0.0 113.644 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -47.97 83.68 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.78 177.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.628 ' HB2' ' HB3' ' A' ' 14' ' ' PHE . 2.1 mmm -61.68 -39.92 93.13 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -55.76 -53.86 51.43 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 124.38 1.05 . . . . 0.0 110.421 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.12 -40.14 92.66 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.852 177.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 74.9 mt -56.03 -56.52 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.958 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.487 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 3.3 t -57.76 -45.09 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.041 0.537 . . . . 0.0 111.447 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -51.74 -56.66 12.48 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.151 0.98 . . . . 0.0 111.534 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -59.81 -41.98 92.45 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.576 0.75 . . . . 0.0 112.793 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 71.8 mt -56.96 -53.64 55.72 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.76 0.824 . . . . 0.0 111.405 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.5 mt -54.4 -47.6 72.55 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.143 0.977 . . . . 0.0 112.029 177.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 31' ' ' ASN . 97.7 mttt -57.83 -44.25 86.34 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.871 177.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 28.4 mt-10 -58.71 -38.29 77.97 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.482 1.513 . . . . 0.0 112.174 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.0 mt -75.73 -16.98 60.07 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 124.705 1.253 . . . . 0.0 113.426 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.77 -6.84 20.04 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.738 1.161 . . . . 0.0 114.263 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 68.0 m-85 -90.95 80.82 5.72 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 123.277 1.513 . . . . 0.0 110.46 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.47 ' HA ' ' HG2' ' A' ' 26' ' ' LYS . 9.2 p30 -76.62 -17.26 59.28 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 -177.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -94.47 88.57 5.53 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 122.386 1.088 . . . . 0.0 109.954 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.91 129.04 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 113.991 -1.458 . . . . 0.0 112.213 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.485 ' OE1' ' HB3' ' A' ' 45' ' ' LYS . 29.7 tt0 -109.93 153.92 23.83 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 175.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -125.62 120.77 31.68 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.35 162.33 19.65 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.37 -1.741 . . . . 0.0 109.848 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.42 -43.27 5.01 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -132.51 170.06 15.68 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.21 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.485 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -47.32 -53.15 12.24 Favored Glycine 0 CA--C 1.541 1.707 0 O-C-N 124.675 1.234 . . . . 0.0 114.944 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.8 t -56.3 -54.52 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.542 0.337 . . . . 0.0 111.524 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -56.61 -36.27 69.24 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.559 0.744 . . . . 0.0 111.621 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.32 -49.9 62.29 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.496 1.118 . . . . 0.0 112.507 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.4 mt -53.8 -43.12 69.07 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.339 0.656 . . . . 0.0 111.665 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.14 -59.36 5.42 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 125.059 1.474 . . . . 0.0 110.304 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.485 ' HB3' ' OE1' ' A' ' 34' ' ' GLU . 62.1 mttm -57.79 -40.57 80.17 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.624 HD21 HG22 ' A' ' 54' ' ' VAL . 19.1 mt -56.29 -48.55 76.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.535 0.734 . . . . 0.0 112.026 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -71.6 -5.71 35.44 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.9 -7.71 42.58 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.71 147.71 13.59 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 116.813 1.485 . . . . 0.0 116.813 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.96 -12.46 3.01 Favored Glycine 0 CA--C 1.542 1.778 0 N-CA-C 121.934 3.534 . . . . 0.0 121.934 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -66.0 105.2 1.28 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 121.035 2.418 . . . . 0.0 115.79 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.685 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -101.11 20.24 48.31 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 112.44 -2.163 . . . . 0.0 112.372 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.409 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -171.05 137.03 1.13 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.861 0.865 . . . . 0.0 112.401 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.624 HG22 HD21 ' A' ' 46' ' ' LEU . 22.0 t -124.59 119.54 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.684 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.424 HG21 HG11 ' A' ' 21' ' ' VAL . 87.2 mt -111.69 102.71 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 104.192 -2.521 . . . . 0.0 104.192 176.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 t -121.29 132.39 54.77 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 -176.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.44 ' HB2' ' OD1' ' A' ' 12' ' ' ASP . 13.6 t0 -68.15 131.89 46.22 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 111.815 -2.448 . . . . 0.0 109.536 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 -56.22 -50.99 69.71 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -91.81 89.74 7.19 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 122.527 1.156 . . . . 0.0 113.778 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.539 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 25.2 mtm -124.44 136.01 27.23 Favored Pre-proline 0 N--CA 1.484 1.239 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.373 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -54.16 148.62 39.51 Favored 'Trans proline' 0 N--CA 1.48 0.7 0 C-N-CA 124.172 3.248 . . . . 0.0 110.771 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.313 11.5 p30 60.06 -67.6 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 126.547 1.939 . . . . 0.0 114.534 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.485 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 52.0 ttm -122.16 102.09 7.93 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.229 1.012 . . . . 0.0 108.61 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 8.7 m-20 -66.17 167.35 10.27 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 113.01 -1.905 . . . . 0.0 112.428 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.01 -53.44 18.49 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 124.453 1.025 . . . . 0.0 112.875 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.429 HD12 HD23 ' A' ' 69' ' ' LEU . 60.0 tp -57.93 -38.98 76.91 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.4 ' OE1' ' HB2' ' A' ' 64' ' ' ASP . 12.1 mp0 -72.06 -37.96 69.54 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.768 0.427 . . . . 0.0 111.686 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.8 tp -60.56 -42.52 96.76 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.788 0.835 . . . . 0.0 110.345 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.429 HD23 HD12 ' A' ' 66' ' ' LEU . 10.1 tp -55.06 -46.58 75.38 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.726 1.21 . . . . 0.0 109.909 176.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -60.63 -45.48 93.9 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.915 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.271 38.8 p -60.9 -35.18 75.99 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 124.238 1.015 . . . . 0.0 111.8 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.479 HG23 ' HB3' ' A' ' 78' ' ' MET . 41.2 mt -72.53 -56.73 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.647 1.179 . . . . 0.0 108.664 177.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 73' ' ' ARG . 76.5 mmt-85 -53.39 -42.65 67.15 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.89 1.676 . . . . 0.0 114.048 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.25 -30.08 69.88 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -88.18 100.01 12.64 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.113 0.565 . . . . 0.0 111.309 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -11.37 -74.18 0.01 OUTLIER Glycine 0 N--CA 1.489 2.175 0 C-N-CA 127.662 2.554 . . . . 0.0 118.266 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.51 84.37 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.479 ' HB3' HG23 ' A' ' 72' ' ' ILE . 96.1 mtp -72.31 -24.06 61.26 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.089 1.356 . . . . 0.0 113.847 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.3 m -51.57 -28.48 14.06 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.321 1.449 . . . . 0.0 114.438 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.85 -11.09 42.99 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.685 HD22 ' HA2' ' A' ' 52' ' ' GLY . 83.2 mt -77.49 114.72 43.26 Favored Pre-proline 0 N--CA 1.475 0.807 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 11.3 Cg_endo -49.41 132.7 29.96 Favored 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 124.189 3.259 . . . . 0.0 115.695 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.4 t -120.74 120.53 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 112.739 -2.028 . . . . 0.0 111.955 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.409 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 47.8 tp -112.18 107.05 15.81 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 113.313 -1.767 . . . . 0.0 109.323 178.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 30.9 mmt -81.24 121.97 26.82 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 113.744 -1.571 . . . . 0.0 112.353 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.76 101.52 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.05 145.83 37.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 111.772 -2.467 . . . . 0.0 113.567 -176.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.74 -38.2 72.07 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -156.53 147.28 21.79 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.674 0.789 . . . . 0.0 110.389 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.36 86.78 6.22 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -123.42 134.19 53.98 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 112.667 -2.06 . . . . 0.0 110.351 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -27.19 -60.6 0.09 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.235 1.814 . . . . 0.0 115.481 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -53.58 -52.44 59.77 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -66.69 -38.92 87.75 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.2 mt -59.05 -55.03 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.279 1.032 . . . . 0.0 110.002 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.3 mt -54.84 -54.57 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.301 1.04 . . . . 0.0 109.602 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.18 -49.43 63.87 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.192 0.997 . . . . 0.0 113.308 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.11 -51.02 68.22 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.058 0.943 . . . . 0.0 113.503 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.3 -51.06 71.38 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.047 0.939 . . . . 0.0 112.895 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -64.39 -25.66 68.12 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.44 -5.91 59.04 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.23 2.32 26.39 Favored Glycine 0 CA--C 1.54 1.635 0 N-CA-C 117.408 1.723 . . . . 0.0 117.408 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.92 119.47 8.32 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.4 m -64.93 -30.58 71.59 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.412 -1.722 . . . . 0.0 112.933 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -174.2 170.79 43.95 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.687 1.137 . . . . 0.0 110.587 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.49 ' O ' ' HE2' ' A' ' 119' ' ' LYS . 50.5 p90 -143.21 129.05 19.43 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.462 -0.869 . . . . 0.0 112.458 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.39 124.66 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.743 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.14 123.38 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 112.1 -2.318 . . . . 0.0 111.199 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -90.95 134.79 29.6 Favored Pre-proline 0 N--CA 1.483 1.193 0 CA-C-N 113.65 -1.614 . . . . 0.0 111.284 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -75.45 141.59 71.71 Favored 'Cis proline' 0 CA--C 1.542 0.893 0 O-C-N 123.273 1.144 . . . . 0.0 112.988 0.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.487 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 37.9 p90 -126.69 147.27 49.96 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 113.12 -1.855 . . . . 0.0 109.515 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 52.5 p -97.46 171.03 8.64 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.753 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.22 67.87 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.296 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.99 -49.81 66.51 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.091 0.956 . . . . 0.0 111.533 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.6 m -58.09 -46.12 86.04 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.916 0.886 . . . . 0.0 109.324 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 48.2 tp -58.77 -55.47 34.65 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.438 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . 0.26 1.3 pp20? -59.15 -36.52 75.4 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -55.61 -49.55 72.5 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 123.952 0.783 . . . . 0.0 111.112 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.49 ' HE2' ' O ' ' A' ' 106' ' ' TYR . 32.8 mmmt -65.39 -45.41 84.14 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.901 178.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.0 mt -54.44 -46.91 73.35 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 124.093 0.87 . . . . 0.0 112.222 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -55.0 -52.94 61.58 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.486 1.114 . . . . 0.0 112.308 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -55.36 -42.75 74.31 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.244 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.12 -46.87 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.863 0.865 . . . . 0.0 110.633 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 177.462 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -89.29 60.33 5.24 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 123.426 1.584 . . . . 0.0 110.471 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.408 HD23 ' N ' ' A' ' 7' ' ' LYS . 3.9 tt -106.56 131.03 54.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.004 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.408 ' N ' HD23 ' A' ' 6' ' ' LEU . 14.8 mmtp -78.32 102.2 7.58 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 113.448 -1.706 . . . . 0.0 111.414 177.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -102.35 138.6 39.06 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 112.884 -1.962 . . . . 0.0 113.404 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.16 111.41 19.43 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.815 174.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.1 t -87.02 97.11 6.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 123.899 1.809 . . . . 0.0 107.466 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.552 HG12 ' SD ' ' A' ' 60' ' ' MET . 5.2 t -101.65 74.0 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 112.72 -2.037 . . . . 0.0 106.808 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 8.3 m-20 -127.25 87.06 2.58 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 112.915 -1.948 . . . . 0.0 113.396 -176.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -11.25 -55.85 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 121.62 3.933 . . . . 0.0 121.62 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.545 ' HB3' ' HB2' ' A' ' 17' ' ' MET . 6.2 t80 -81.72 133.5 35.36 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.75 0.656 . . . . 0.0 109.278 -177.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 p -46.33 -50.83 15.82 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.067 0.947 . . . . 0.0 112.908 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.562 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -60.13 -49.73 76.49 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.81 177.488 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.545 ' HB2' ' HB3' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -57.62 -45.34 85.51 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.959 0.904 . . . . 0.0 111.26 -179.717 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 12' ' ' ASP . 9.0 mtm180 -57.66 -52.74 64.2 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.114 0.966 . . . . 0.0 111.496 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.757 HH21 ' HD3' ' A' ' 22' ' ' ARG . 2.1 mmp_? -56.78 -43.49 80.91 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.435 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.562 HG12 ' O ' ' A' ' 16' ' ' THR . 34.5 mm -54.23 -61.44 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.257 0.623 . . . . 0.0 110.939 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.637 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 3.5 t -57.47 -45.16 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.261 0.624 . . . . 0.0 111.63 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.757 ' HD3' HH21 ' A' ' 19' ' ' ARG . 58.7 ttt180 -54.44 -53.54 52.75 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.9 0.88 . . . . 0.0 112.13 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.493 ' HA ' ' HD2' ' A' ' 26' ' ' LYS . 22.4 m120 -63.55 -37.82 88.77 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.499 HD22 ' HB2' ' A' ' 113' ' ' ALA . 57.0 mt -56.95 -51.31 69.68 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.877 0.471 . . . . 0.0 111.874 176.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.416 HD11 HD12 ' A' ' 55' ' ' ILE . 49.1 mt -53.36 -47.04 69.75 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.564 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.493 ' HD2' ' HA ' ' A' ' 23' ' ' ASN . 87.8 mttt -56.85 -47.5 80.23 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.113 177.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 35.2 mt-10 -59.65 -38.87 82.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.49 1.516 . . . . 0.0 112.64 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.63 -16.14 62.27 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.698 1.599 . . . . 0.0 114.085 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.86 9.7 25.96 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 124.462 1.029 . . . . 0.0 114.759 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -92.11 98.16 11.37 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 123.874 1.797 . . . . 0.0 111.53 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -57.76 -42.62 84.41 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 110.39 -3.096 . . . . 0.0 119.236 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -111.55 106.68 15.61 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 t -133.53 126.63 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -110.85 158.0 19.19 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.433 ' OE1' ' HB3' ' A' ' 18' ' ' ARG . 14.9 pt-20 -130.13 119.52 23.15 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -114.67 149.38 36.83 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.921 1.288 . . . . 0.0 110.687 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -76.1 -60.83 2.16 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -133.62 -178.22 4.9 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 119.092 -0.48 . . . . 0.0 111.522 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -43.1 -55.7 4.84 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 125.564 1.554 . . . . 0.0 114.652 177.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.9 t -57.11 -56.69 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 114.335 -0.932 . . . . 0.0 111.947 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -57.26 -38.6 74.12 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.427 0.691 . . . . 0.0 111.631 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.34 -50.25 70.7 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.564 1.146 . . . . 0.0 112.414 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' A' ' 46' ' ' LEU . 78.9 mt -53.85 -40.71 66.71 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.64 0.776 . . . . 0.0 112.862 179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -67.55 -55.18 14.48 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 124.325 1.016 . . . . 0.0 110.927 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -57.78 -30.92 66.04 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.496 HD21 HG22 ' A' ' 54' ' ' VAL . 22.4 mt -55.67 -38.21 69.3 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -71.49 -9.25 57.9 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.65 34.84 0.12 Allowed 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 116.258 1.948 . . . . 0.0 116.258 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.1 115.54 2.63 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 117.939 1.936 . . . . 0.0 117.939 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 27.01 47.77 0.05 OUTLIER Glycine 0 CA--C 1.545 1.925 0 N-CA-C 122.249 3.66 . . . . 0.0 122.249 176.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.477 ' O ' HD22 ' A' ' 81' ' ' LEU . 97.7 m-85 -74.84 87.58 2.26 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 118.547 1.173 . . . . 0.0 113.069 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.6 29.91 5.16 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 113.357 -1.747 . . . . 0.0 111.617 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.408 ' HZ ' HD13 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -175.2 131.86 0.3 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.84 1.305 . . . . 0.0 112.927 178.136 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.496 HG22 HD21 ' A' ' 46' ' ' LEU . 10.7 t -126.99 119.83 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-N 112.436 -2.165 . . . . 0.0 108.88 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.613 HG21 HG11 ' A' ' 21' ' ' VAL . 96.2 mt -110.48 105.89 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.9 t -124.98 132.75 53.22 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 118.128 2.64 . . . . 0.0 118.128 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.555 ' O ' ' HG3' ' A' ' 60' ' ' MET . 20.3 t0 -73.63 133.08 43.39 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 111.71 -2.495 . . . . 0.0 109.512 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.495 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 15.5 t-105 -55.01 -49.28 71.92 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.221 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -90.86 82.09 5.69 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.555 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 39.4 mtm -116.77 137.99 24.21 Favored Pre-proline 0 N--CA 1.482 1.15 0 CA-C-N 114.222 -1.354 . . . . 0.0 112.101 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -57.72 139.5 90.47 Favored 'Trans proline' 0 N--CA 1.476 0.478 0 C-N-CA 124.034 3.156 . . . . 0.0 111.903 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 64.42 -73.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.306 1.842 . . . . 0.0 112.487 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.453 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 51.5 ttm -110.2 98.7 7.9 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 2.6 p30 -64.64 168.08 6.49 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 112.312 -2.222 . . . . 0.0 112.901 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.2 -52.74 21.83 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.028 1.299 . . . . 0.0 114.38 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.459 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 59.8 tp -59.01 -40.45 84.97 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -66.83 -43.43 83.74 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.555 0.342 . . . . 0.0 111.515 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.447 HD11 HG11 ' A' ' 54' ' ' VAL . 1.5 tm? -56.13 -47.49 78.06 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.018 0.927 . . . . 0.0 110.993 177.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 103' ' ' ALA . 4.5 tt -49.22 -55.64 11.89 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.982 1.713 . . . . 0.0 109.412 175.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -61.0 -44.49 97.34 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.909 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.259 29.7 p -59.21 -21.77 60.01 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 124.643 1.177 . . . . 0.0 113.186 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.8 mt -89.99 -58.42 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.573 ' HG2' ' HA3' ' A' ' 102' ' ' GLY . 2.7 mpt_? -47.77 -45.18 28.97 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.953 2.101 . . . . 0.0 114.217 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.73 -11.53 50.86 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -84.01 93.35 8.06 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.199 0.6 . . . . 0.0 110.274 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -12.73 -70.59 0.01 OUTLIER Glycine 0 N--CA 1.495 2.584 0 C-N-CA 126.351 1.929 . . . . 0.0 116.47 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.64 -49.43 75.19 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.43 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 90.4 mtp -75.84 -26.68 57.39 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 m -11.0 -61.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 120.585 3.55 . . . . 0.0 120.585 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.56 28.95 0.45 Allowed 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 120.64 3.57 . . . . 0.0 120.64 -174.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.477 HD22 ' O ' ' A' ' 51' ' ' TYR . 61.2 mt -89.75 106.79 15.36 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.877 -1.139 . . . . 0.0 110.074 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -47.56 133.06 20.96 Favored 'Trans proline' 0 N--CA 1.48 0.735 0 C-N-CA 123.432 2.755 . . . . 0.0 114.756 -177.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.468 HG11 ' HG ' ' A' ' 69' ' ' LEU . 39.3 t -118.19 128.31 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 112.891 -1.958 . . . . 0.0 114.202 -176.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.5 tp -116.48 108.71 16.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 113.199 -1.819 . . . . 0.0 109.562 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.0 mmt -83.19 114.55 21.43 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.595 1.188 . . . . 0.0 114.006 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.75 98.6 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.8 t -106.91 144.57 33.36 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 111.861 -2.427 . . . . 0.0 113.993 -175.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.58 -41.2 41.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 113.471 -1.695 . . . . 0.0 115.236 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -161.9 144.19 11.51 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.076 1.35 . . . . 0.0 109.948 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.22 86.87 3.66 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.364 1.078 . . . . 0.0 109.967 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -118.75 122.48 42.54 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.582 -1.644 . . . . 0.0 109.585 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -21.44 -59.34 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 117.414 2.376 . . . . 0.0 117.414 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -46.12 72.61 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -70.97 -38.31 72.78 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.02 -53.77 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.801 1.24 . . . . 0.0 109.012 176.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.0 mt -54.01 -54.95 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.377 1.071 . . . . 0.0 110.24 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.19 -50.5 64.54 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.267 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.495 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -61.24 -55.37 32.78 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.48 -51.51 69.15 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.877 0.871 . . . . 0.0 112.312 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -30.34 71.39 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.02 -13.84 60.22 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 177.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.573 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 121.75 -0.97 11.07 Favored Glycine 0 CA--C 1.545 1.96 0 N-CA-C 116.208 1.243 . . . . 0.0 116.208 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.666 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -59.63 123.99 18.65 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 119.051 1.426 . . . . 0.0 113.744 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.5 m -64.53 -30.51 71.54 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 113.07 -1.877 . . . . 0.0 112.88 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.72 172.84 45.82 Favored Glycine 0 CA--C 1.542 1.727 0 C-N-CA 124.818 1.199 . . . . 0.0 110.697 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -144.14 139.99 29.14 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.1 p -124.41 129.69 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 124.457 1.098 . . . . 0.0 110.459 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.36 127.45 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 113.217 -1.811 . . . . 0.0 111.24 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -92.94 132.39 31.12 Favored Pre-proline 0 N--CA 1.479 1.002 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.055 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -74.25 142.85 76.0 Favored 'Cis proline' 0 CA--C 1.548 1.189 0 O-C-N 123.017 1.009 . . . . 0.0 114.277 0.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.637 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 33.0 p90 -134.1 155.28 50.33 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 112.282 -2.236 . . . . 0.0 107.986 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 44.9 p -106.62 172.42 6.83 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.335 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.499 ' HB2' HD22 ' A' ' 24' ' ' LEU . . . -54.93 -38.96 68.33 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 123.612 0.57 . . . . 0.0 111.736 176.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.32 -46.78 75.7 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.356 1.062 . . . . 0.0 111.37 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.1 m -60.13 -47.02 87.68 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 52.8 tp -57.19 -52.11 66.64 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.525 1.13 . . . . 0.0 109.851 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -54.03 -48.21 70.75 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 124.12 0.888 . . . . 0.0 112.152 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -52.61 -47.42 66.99 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.58 -46.54 82.28 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.329 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 82.5 mt -56.96 -47.91 79.6 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 124.141 0.901 . . . . 0.0 111.212 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -53.74 -53.54 50.78 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.541 1.536 . . . . 0.0 111.669 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -52.11 -46.04 65.14 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.499 1.52 . . . . 0.0 111.566 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.408 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 63.7 mt -62.37 -51.78 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.341 1.056 . . . . 0.0 110.447 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 179.475 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . 0.263 63.3 mttp . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 118.089 2.625 . . . . 0.0 118.089 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -90.3 51.34 2.01 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.988 1.375 . . . . 0.0 111.861 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 1.9 tt -112.94 130.85 55.97 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.881 -177.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -86.49 111.21 20.35 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.899 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -105.86 145.32 31.38 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.021 1.728 . . . . 0.0 115.287 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.447 ' CD1' HG22 ' A' ' 11' ' ' VAL . 1.9 tm? -121.5 105.09 10.15 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 112.488 -2.142 . . . . 0.0 110.047 174.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.3 t -82.89 112.52 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 112.87 -1.968 . . . . 0.0 107.763 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.496 ' CG1' ' HB2' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -111.66 96.0 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.697 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -138.44 130.36 28.21 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.166 0.916 . . . . 0.0 112.46 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -72.03 -16.39 62.05 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.529 ' HB3' ' HB2' ' A' ' 17' ' ' MET . 5.5 t80 -101.01 114.68 28.84 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.509 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 35.3 p -40.75 -57.61 1.87 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 125.177 1.548 . . . . 0.0 113.2 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -48.05 80.18 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.529 ' HB2' ' HB3' ' A' ' 14' ' ' PHE . 1.2 tmm? -60.83 -37.58 82.52 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.443 ' NH1' ' HG2' ' A' ' 37' ' ' GLU . 36.9 ttp-105 -59.29 -50.52 73.67 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.437 1.095 . . . . 0.0 110.996 177.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 15' ' ' SER . 9.0 mmt180 -60.82 -42.81 98.42 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.655 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.407 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 71.7 mt -55.63 -52.66 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.266 1.026 . . . . 0.0 111.113 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 17' ' ' MET . 6.3 t -56.11 -48.29 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 122.501 0.32 . . . . 0.0 110.752 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.443 ' HD2' ' OE1' ' A' ' 35' ' ' GLU . 56.4 ttt180 -55.35 -50.49 69.53 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.649 1.18 . . . . 0.0 110.827 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -59.08 -45.68 90.21 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.99 0.916 . . . . 0.0 112.082 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 78.1 mt -54.21 -50.96 65.9 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.334 1.054 . . . . 0.0 111.793 177.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.3 mt -56.03 -46.56 78.82 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.968 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -55.74 -46.73 77.76 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.567 1.167 . . . . 0.0 111.303 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 44.5 mt-10 -59.45 -39.67 84.34 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.381 1.473 . . . . 0.0 112.381 177.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.1 mt -74.01 -12.66 60.69 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.15 -13.28 33.97 Favored Glycine 0 N--CA 1.479 1.522 0 C-N-CA 124.216 0.912 . . . . 0.0 113.386 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -84.72 62.73 7.56 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 123.42 1.581 . . . . 0.0 111.453 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -68.7 -13.72 62.55 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 6.6 m120 -86.42 70.83 10.51 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.81 126.35 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.623 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 16.4 mt-10 -120.42 160.57 22.82 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.044 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.443 ' OE1' ' HD2' ' A' ' 22' ' ' ARG . 7.9 pt-20 -133.69 140.99 47.37 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 119.439 3.125 . . . . 0.0 119.439 -175.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.524 ' HB2' ' HD2' ' A' ' 45' ' ' LYS . . . -124.44 160.75 27.53 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 112.234 -2.257 . . . . 0.0 109.506 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.443 ' HG2' ' NH1' ' A' ' 18' ' ' ARG . 38.1 mt-10 -97.47 -39.43 9.16 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 -177.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -137.59 170.32 16.27 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.468 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.434 ' HA2' HD22 ' A' ' 68' ' ' LEU . . . -45.71 -54.08 8.09 Favored Glycine 0 N--CA 1.482 1.736 0 O-C-N 124.651 1.219 . . . . 0.0 115.671 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.1 t -57.7 -54.42 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.665 0.786 . . . . 0.0 111.783 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -55.21 -36.5 66.03 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.935 0.894 . . . . 0.0 112.167 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.496 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . . . -66.69 -50.78 61.77 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.326 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.2 mt -54.17 -46.1 72.25 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 124.541 1.15 . . . . 0.0 110.482 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -57.05 -53.0 63.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.832 0.853 . . . . 0.0 111.506 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.524 ' HD2' ' HB2' ' A' ' 36' ' ' ALA . 51.2 mttm -56.94 -45.74 82.58 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.207 175.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.552 HD23 ' HB2' ' A' ' 51' ' ' TYR . 19.4 mt -59.2 -42.68 91.48 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.149 0.98 . . . . 0.0 111.653 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -60.57 -30.18 69.63 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 125.102 1.361 . . . . 0.0 112.089 177.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.83 -19.5 65.91 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.81 0.844 . . . . 0.0 112.154 175.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.64 175.09 28.33 Favored Glycine 0 N--CA 1.479 1.53 0 N-CA-C 117.508 1.763 . . . . 0.0 117.508 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.62 -33.1 1.63 Allowed Glycine 0 N--CA 1.483 1.781 0 N-CA-C 121.304 3.282 . . . . 0.0 121.304 176.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.623 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 37.4 m-85 -65.85 113.37 4.31 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -176.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.45 16.87 57.5 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-N 113.761 -1.563 . . . . 0.0 113.124 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -166.23 138.55 3.85 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.229 1.412 . . . . 0.0 110.483 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.449 HG22 HD21 ' A' ' 46' ' ' LEU . 26.5 t -125.31 126.41 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.491 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 91.0 mt -112.13 99.61 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.9 t -109.06 123.68 49.54 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -73.56 127.25 32.22 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 112.572 -2.104 . . . . 0.0 109.565 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.52 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 5.2 t-105 -52.65 -49.14 65.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.032 0.933 . . . . 0.0 111.4 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -88.45 96.77 10.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.971 0.908 . . . . 0.0 110.94 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.4 mtm -138.3 132.3 16.7 Favored Pre-proline 0 N--CA 1.48 1.03 0 CA-C-N 113.742 -1.572 . . . . 0.0 112.589 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -65.87 150.41 85.79 Favored 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 123.933 3.089 . . . . 0.0 111.795 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.3 m120 68.33 -64.01 0.32 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 125.794 1.934 . . . . 0.0 112.694 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.405 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 57.7 ttm -126.44 101.95 6.92 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.277 1.031 . . . . 0.0 108.277 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.36 169.11 6.19 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 113.394 -1.73 . . . . 0.0 111.866 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.0 -52.76 29.65 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.15 0.881 . . . . 0.0 115.156 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.446 HD12 HD13 ' A' ' 69' ' ' LEU . 36.3 tp -60.04 -38.6 83.24 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.48 0.712 . . . . 0.0 112.343 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -66.63 -42.75 86.25 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.664 0.386 . . . . 0.0 110.469 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.434 HD22 ' HA2' ' A' ' 39' ' ' GLY . 58.9 tp -59.7 -45.17 92.95 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.987 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 103' ' ' ALA . 5.6 tt -50.32 -51.71 43.04 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.75 1.62 . . . . 0.0 109.054 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -59.68 -47.24 86.42 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.984 0.914 . . . . 0.0 113.143 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.268 21.7 p -56.55 -35.38 68.06 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.551 1.14 . . . . 0.0 111.994 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.671 HG23 ' HB3' ' A' ' 78' ' ' MET . 42.6 mt -76.29 -54.42 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.152 0.981 . . . . 0.0 109.396 177.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HD3' HD23 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -53.0 -40.79 64.07 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.678 1.991 . . . . 0.0 113.749 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.42 -31.83 65.83 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -87.23 94.91 9.79 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.825 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -13.68 -71.34 0.01 OUTLIER Glycine 0 N--CA 1.487 2.06 0 C-N-CA 127.345 2.402 . . . . 0.0 118.207 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.98 -41.89 71.77 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.671 ' HB3' HG23 ' A' ' 72' ' ' ILE . 35.0 mtm -74.61 -30.8 61.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.25 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.7 m -53.77 -29.08 38.54 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.321 1.048 . . . . 0.0 112.585 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.61 -34.63 58.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.305 1.042 . . . . 0.0 113.264 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.505 ' HA ' ' HD2' ' A' ' 82' ' ' PRO 0.273 2.5 pp -84.45 120.55 74.44 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.505 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 18.8 Cg_endo -47.74 146.9 7.64 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 125.123 3.882 . . . . 0.0 120.65 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.8 t -122.02 107.18 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 111.549 -2.568 . . . . 0.0 110.751 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 56.4 tp -101.07 110.97 23.06 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.643 -1.162 . . . . 0.0 107.931 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 90.0 mmm -81.77 133.9 35.39 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.178 -1.374 . . . . 0.0 112.182 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.427 HG12 ' HB2' ' A' ' 109' ' ' LYS . 3.5 t -112.58 109.47 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 177.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.8 p -103.85 134.33 47.33 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.968 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.97 -24.31 52.13 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -165.13 130.51 2.61 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.624 1.97 . . . . 0.0 107.554 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.621 ' HB2' HG22 ' A' ' 108' ' ' VAL . . . -79.94 98.23 7.07 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 122.474 1.131 . . . . 0.0 111.106 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -121.87 144.53 48.79 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.746 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -35.1 -50.47 0.51 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.759 1.223 . . . . 0.0 114.121 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -50.79 -58.15 6.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.523 1.129 . . . . 0.0 112.759 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -69.06 -39.91 78.85 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 93.5 mt -57.01 -55.49 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.634 0.774 . . . . 0.0 111.767 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.441 HG22 ' OE1' ' A' ' 100' ' ' GLN . 59.0 mt -59.06 -51.26 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 124.052 0.845 . . . . 0.0 111.143 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.51 -45.1 73.26 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 115.248 -0.887 . . . . 0.0 113.286 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.52 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -60.92 -52.38 65.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.566 1.146 . . . . 0.0 113.014 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.29 -47.49 83.5 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.723 0.809 . . . . 0.0 111.702 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.441 ' OE1' HG22 ' A' ' 96' ' ' ILE . 61.1 mt-30 -58.62 -36.46 74.09 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.6 -13.57 57.82 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.446 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 119.43 3.22 12.92 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.679 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -57.93 125.28 22.4 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.737 1.269 . . . . 0.0 112.807 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.2 m -65.52 -31.97 73.31 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 113.447 -1.706 . . . . 0.0 113.166 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.79 174.99 46.48 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 125.01 1.291 . . . . 0.0 110.333 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -145.81 139.72 26.58 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 p -119.11 130.49 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 125.462 1.726 . . . . 0.0 110.853 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.621 HG22 ' HB2' ' A' ' 90' ' ' ALA . 3.3 t -75.7 130.53 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.894 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.427 ' HB2' HG12 ' A' ' 86' ' ' VAL . 1.8 ttmp? -91.84 123.01 64.43 Favored Pre-proline 0 N--CA 1.479 0.997 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -81.42 156.21 81.98 Favored 'Cis proline' 0 N--CA 1.486 1.069 0 N-CA-C 114.323 0.855 . . . . 0.0 114.323 -0.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -140.67 163.84 31.81 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 112.898 -1.955 . . . . 0.0 109.401 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.3 p -112.53 175.4 5.45 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.271 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.84 81.06 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.156 176.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.21 -48.75 76.99 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.821 0.848 . . . . 0.0 110.97 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.0 m -57.07 -45.94 82.88 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.817 0.847 . . . . 0.0 110.494 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.434 HD22 HD11 ' A' ' 120' ' ' LEU . 1.1 tt -59.67 -53.16 61.26 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 124.446 1.091 . . . . 0.0 108.824 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.611 ' HA ' HD12 ' A' ' 120' ' ' LEU . 51.5 tt0 -57.5 -41.86 81.58 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.27 -48.43 65.28 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.845 0.716 . . . . 0.0 111.608 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -63.72 -48.89 75.24 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.965 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 117' ' ' GLU . 96.8 mt -49.93 -47.38 52.41 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.822 1.249 . . . . 0.0 113.716 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -63.87 -49.18 73.76 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -53.99 -48.44 70.39 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 124.649 1.218 . . . . 0.0 110.152 176.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 81.1 mt -55.01 -54.72 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.139 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -179.63 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 116.981 2.215 . . . . 0.0 116.981 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.79 39.07 0.78 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.862 -1.517 . . . . 0.0 110.895 177.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.455 HD21 ' HD2' ' A' ' 53' ' ' PHE . 28.6 tp -95.91 128.05 42.46 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 112.644 -2.071 . . . . 0.0 111.244 -177.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.433 ' NZ ' ' HA3' ' A' ' 49' ' ' GLY . 49.2 mtpt -80.9 106.18 12.7 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 112.874 -1.967 . . . . 0.0 112.107 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -101.73 136.89 40.8 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 113.6 -1.636 . . . . 0.0 113.629 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -115.5 103.24 10.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.575 -1.648 . . . . 0.0 109.902 172.767 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.9 t -81.63 91.99 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 112.074 -2.33 . . . . 0.0 107.156 178.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.511 HG12 ' SD ' ' A' ' 60' ' ' MET . 3.2 t -99.53 94.92 3.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 112.753 -2.021 . . . . 0.0 107.983 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.424 ' OD1' ' HB2' ' A' ' 57' ' ' ASP . 18.2 m-20 -135.47 140.39 44.8 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.258 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -67.08 -27.84 67.69 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 117.017 2.229 . . . . 0.0 117.017 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -107.65 132.15 53.63 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.448 0.299 . . . . 0.0 111.224 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.5 p -51.36 -52.08 48.85 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.754 1.222 . . . . 0.0 113.231 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 m -60.45 -48.82 80.1 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.258 0.974 . . . . 0.0 111.441 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.4 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -59.89 -44.58 94.15 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.224 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -55.39 -58.52 7.39 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.054 1.341 . . . . 0.0 111.039 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 30.4 ptt180 -58.9 -36.37 74.58 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.5 mt -58.23 -49.7 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 122.946 0.498 . . . . 0.0 110.09 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 17' ' ' MET . 9.7 t -55.71 -47.35 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 123.525 0.73 . . . . 0.0 110.27 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.526 ' HA ' HG11 ' A' ' 33' ' ' VAL . 7.0 ttp180 -51.51 -51.73 52.7 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.059 1.344 . . . . 0.0 110.843 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.488 HD22 HH21 ' A' ' 22' ' ' ARG . 66.4 m-20 -62.28 -40.4 96.13 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.206 1.002 . . . . 0.0 112.48 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 84.8 mt -58.5 -51.71 68.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.785 0.834 . . . . 0.0 110.69 177.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.1 mt -55.01 -46.27 75.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.125 0.97 . . . . 0.0 112.548 177.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.8 -43.24 90.5 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.661 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 25.0 mt-10 -58.78 -39.04 79.89 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.887 1.275 . . . . 0.0 111.995 177.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.0 mt -74.23 -17.49 60.88 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.003 1.321 . . . . 0.0 114.068 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.17 9.71 25.37 Favored Glycine 0 N--CA 1.478 1.477 0 N-CA-C 115.639 1.015 . . . . 0.0 115.639 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -92.6 101.78 14.21 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.753 1.263 . . . . 0.0 112.009 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -64.13 -51.41 64.04 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 118.705 2.854 . . . . 0.0 118.705 -175.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -94.08 101.72 13.76 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.239 1.199 . . . . 0.0 114.239 -174.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.526 HG11 ' HA ' ' A' ' 22' ' ' ARG . 32.1 t -130.61 118.35 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.002 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.697 ' HB2' ' HE2' ' A' ' 51' ' ' TYR . 12.5 mp0 -110.79 157.56 19.65 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -127.24 127.93 45.22 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -174.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.03 154.81 32.51 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.501 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -86.93 -48.61 8.0 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -142.74 173.74 11.28 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.245 0.618 . . . . 0.0 109.426 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -43.03 -55.64 4.82 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.071 1.319 . . . . 0.0 116.332 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.87 -54.85 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.366 0.666 . . . . 0.0 111.675 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -56.55 -33.85 66.52 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.665 0.786 . . . . 0.0 111.996 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.86 -48.21 72.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.481 1.112 . . . . 0.0 111.958 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.5 mt -57.62 -40.46 79.2 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.439 0.695 . . . . 0.0 111.464 177.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -59.18 -59.74 4.97 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.402 1.081 . . . . 0.0 109.305 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -58.25 -39.57 79.5 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.414 ' HG ' HD12 ' A' ' 9' ' ' LEU . 16.3 mt -52.8 -38.47 61.24 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.739 1.216 . . . . 0.0 113.905 177.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -59.47 -26.17 65.02 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.52 56.89 1.48 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.786 1.234 . . . . 0.0 114.313 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.433 ' HA3' ' NZ ' ' A' ' 7' ' ' LYS . . . 125.32 -15.14 7.28 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 117.822 1.889 . . . . 0.0 117.822 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.91 67.24 2.04 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.697 ' HE2' ' HB2' ' A' ' 34' ' ' GLU . 1.7 m-85 -58.16 129.64 42.93 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.671 1.989 . . . . 0.0 113.114 -177.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.685 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -83.64 19.06 16.55 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-N 113.915 -1.493 . . . . 0.0 116.564 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.49 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -172.29 128.81 0.57 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 122.551 1.167 . . . . 0.0 112.046 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.3 t -121.8 119.14 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-N 113.521 -1.672 . . . . 0.0 108.182 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.8 mt -108.81 101.77 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 177.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.6 t -119.0 125.87 50.39 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 118.185 2.661 . . . . 0.0 118.185 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.424 ' HB2' ' OD1' ' A' ' 12' ' ' ASP . 54.7 t0 -67.38 128.21 35.55 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 112.374 -2.194 . . . . 0.0 109.892 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.411 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 17.1 t-105 -53.92 -50.15 67.04 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.003 0.921 . . . . 0.0 109.934 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -89.19 95.07 10.15 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.548 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.511 ' SD ' HG12 ' A' ' 11' ' ' VAL . 18.4 mtm -134.83 131.66 20.15 Favored Pre-proline 0 N--CA 1.477 0.887 0 CA-C-N 113.08 -1.873 . . . . 0.0 110.882 177.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -56.65 139.14 87.5 Favored 'Trans proline' 0 N--CA 1.48 0.715 0 C-N-CA 123.945 3.097 . . . . 0.0 111.549 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 m120 64.73 -65.0 0.15 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 126.759 2.024 . . . . 0.0 114.115 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.434 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 57.9 ttm -115.83 92.17 3.82 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.7 p30 -62.16 167.89 3.71 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 111.263 -2.699 . . . . 0.0 112.592 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.28 -55.29 10.73 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 124.298 0.951 . . . . 0.0 113.796 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.425 HD12 HD13 ' A' ' 69' ' ' LEU . 53.3 tp -59.42 -38.14 79.87 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.154 0.981 . . . . 0.0 112.786 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -71.62 -40.05 70.04 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 119.613 -0.232 . . . . 0.0 111.235 177.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.4 tp -60.41 -40.39 90.78 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.679 0.752 . . . . 0.0 110.529 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 103' ' ' ALA . 4.2 tt -51.0 -49.85 59.62 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.089 1.356 . . . . 0.0 108.632 176.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -61.56 -44.96 96.08 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.84 1.256 . . . . 0.0 113.372 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.4 p -61.03 -27.53 68.4 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.625 0.77 . . . . 0.0 111.662 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.0 mt -80.65 -56.9 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.47 1.108 . . . . 0.0 108.78 176.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.416 ' HD3' ' HA ' ' A' ' 73' ' ' ARG . 58.0 mmt-85 -51.87 -42.91 63.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.994 1.717 . . . . 0.0 113.346 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.47 -23.69 50.36 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -86.79 95.45 9.84 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.17 0.588 . . . . 0.0 111.807 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -3.5 -83.63 0.0 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 127.106 2.289 . . . . 0.0 118.412 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.94 -39.86 82.89 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 82.3 mtp -71.84 -23.56 61.56 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.573 1.549 . . . . 0.0 113.778 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.6 m -50.8 -26.17 5.36 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.841 1.657 . . . . 0.0 115.147 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.49 -7.43 50.5 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.685 HD22 ' HA2' ' A' ' 52' ' ' GLY . 54.3 mt -83.42 119.48 73.99 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 123.284 0.633 . . . . 0.0 111.829 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 14.6 Cg_endo -54.18 138.44 71.69 Favored 'Trans proline' 0 N--CA 1.482 0.812 0 C-N-CA 123.984 3.123 . . . . 0.0 114.892 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.46 HG11 ' HG ' ' A' ' 69' ' ' LEU . 13.0 t -120.26 114.47 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-N 112.366 -2.197 . . . . 0.0 111.427 -178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.49 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 30.9 tp -106.64 110.37 22.54 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.969 -1.469 . . . . 0.0 109.36 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.3 mmt -81.11 112.29 18.34 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.911 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.63 102.82 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.4 t -110.18 138.63 46.3 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.13 -1.85 . . . . 0.0 113.78 -176.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -48.0 -31.41 5.31 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -161.5 152.73 18.54 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.709 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.438 ' HB2' HG21 ' A' ' 108' ' ' VAL . . . -77.24 82.29 3.72 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 123.187 1.47 . . . . 0.0 107.552 176.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -100.94 121.42 41.71 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 111.343 -2.662 . . . . 0.0 108.362 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.531 ' O ' HG12 ' A' ' 96' ' ' ILE . 33.0 ttmt -38.48 -53.07 1.58 Allowed 'General case' 0 N--CA 1.483 1.178 0 O-C-N 125.018 1.449 . . . . 0.0 113.892 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -53.17 -53.29 52.74 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.171 0.588 . . . . 0.0 111.188 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -56.79 -49.36 75.57 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.3 1.0 . . . . 0.0 111.833 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.8 mt -55.25 -51.92 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.188 0.995 . . . . 0.0 111.969 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 92' ' ' LYS . 32.2 mm -58.98 -54.89 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.606 0.762 . . . . 0.0 110.8 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.63 -47.05 70.65 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.191 0.996 . . . . 0.0 113.234 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -57.06 -51.72 68.14 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.451 1.1 . . . . 0.0 112.168 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.1 -47.75 84.83 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.284 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.455 ' OE1' HG22 ' A' ' 96' ' ' ILE . 65.9 mt-30 -56.3 -40.38 74.23 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.85 1.26 . . . . 0.0 113.489 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.28 -14.41 59.44 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.92 3.11 12.35 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.631 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -65.24 123.02 18.45 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.192 1.496 . . . . 0.0 112.319 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.1 p -69.78 -17.57 63.43 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 113.161 -1.836 . . . . 0.0 114.314 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.54 173.47 43.93 Favored Glycine 0 N--CA 1.481 1.658 0 C-N-CA 124.043 0.83 . . . . 0.0 111.844 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -144.4 136.63 26.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 114.999 -0.601 . . . . 0.0 112.387 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.258 1.0 OUTLIER -118.03 126.9 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 124.413 1.07 . . . . 0.0 110.419 178.363 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 25.4 t -80.37 114.64 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 112.159 -2.292 . . . . 0.0 111.229 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -90.36 132.28 36.03 Favored Pre-proline 0 N--CA 1.472 0.627 0 CA-C-O 117.725 -1.131 . . . . 0.0 110.611 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.18 132.87 26.91 Favored 'Cis proline' 0 N--CA 1.489 1.228 0 N-CA-C 115.173 1.182 . . . . 0.0 115.173 1.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.442 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 35.0 p90 -124.74 151.62 44.84 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 112.462 -2.154 . . . . 0.0 108.69 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.2 p -102.53 171.63 7.33 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.014 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.71 -39.85 68.6 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.576 0.548 . . . . 0.0 111.396 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.0 -44.41 80.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.427 1.091 . . . . 0.0 111.983 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.4 m -60.15 -49.32 78.09 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 60.3 tp -56.14 -50.45 71.08 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.24 1.416 . . . . 0.0 109.715 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -56.45 -46.86 80.12 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.328 1.051 . . . . 0.0 112.473 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -53.41 -44.08 68.44 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -65.88 -48.43 71.55 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.392 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.7 mt -56.66 -48.94 76.48 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.535 1.134 . . . . 0.0 111.504 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -50.09 -53.24 28.57 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 126.021 1.728 . . . . 0.0 112.056 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -54.15 -45.91 72.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.654 1.182 . . . . 0.0 111.466 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.74 -39.8 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.338 1.055 . . . . 0.0 112.038 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 179.061 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 57.6 mmtt . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -105.68 45.33 0.98 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.6 tp -83.11 122.78 28.81 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 112.029 -2.351 . . . . 0.0 107.349 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 51' ' ' TYR . 69.1 tttt -78.26 115.88 18.3 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.931 -1.486 . . . . 0.0 113.446 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.509 ' HB2' HG22 ' A' ' 33' ' ' VAL . 65.1 m-85 -105.72 138.15 42.4 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.745 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.661 HD23 ' HB3' ' A' ' 34' ' ' GLU . 1.6 tm? -116.16 99.53 7.3 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.616 1.198 . . . . 0.0 108.822 175.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.71 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 94.9 t -79.68 104.36 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 111.61 -2.541 . . . . 0.0 108.958 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.56 HG22 HD13 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -104.89 102.54 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 113.605 -1.634 . . . . 0.0 110.02 -178.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.75 135.05 22.96 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.986 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -66.1 -16.99 64.41 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -106.59 110.36 22.54 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.2 p -46.93 -49.63 20.19 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.691 -1.14 . . . . 0.0 113.273 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -38.93 85.94 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.297 1.039 . . . . 0.0 112.741 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.2 tpt -62.19 -38.98 91.18 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.515 ' HD2' ' HB3' ' A' ' 35' ' ' GLU . 77.4 mtm180 -56.39 -47.89 78.02 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.196 0.522 . . . . 0.0 110.907 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.56 -41.61 73.51 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 114.133 -1.394 . . . . 0.0 112.399 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.5 mt -57.69 -50.99 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.244 0.617 . . . . 0.0 110.23 177.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 t -58.57 -42.47 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.273 0.629 . . . . 0.0 109.97 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 56.0 ttm-85 -53.8 -54.14 42.51 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 123.938 0.774 . . . . 0.0 110.737 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -58.81 -39.78 82.17 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 81.1 mt -62.59 -53.88 48.05 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.482 0.713 . . . . 0.0 111.492 177.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.9 mt -54.87 -44.3 73.9 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.988 0.915 . . . . 0.0 111.882 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -56.75 -49.08 76.32 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 113.343 -1.753 . . . . 0.0 110.175 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 28.5 mt-10 -56.42 -38.0 70.97 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.05 1.74 . . . . 0.0 112.914 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.4 mt -73.76 -19.17 60.86 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.787 1.235 . . . . 0.0 114.287 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.41 -5.22 23.21 Favored Glycine 0 CA--C 1.551 2.295 0 C-N-CA 124.296 0.951 . . . . 0.0 112.919 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 22.3 m-85 -92.54 86.03 5.49 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 122.557 1.17 . . . . 0.0 109.773 -178.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -85.28 -7.52 58.96 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -98.29 93.37 6.18 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 122.387 1.089 . . . . 0.0 110.343 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.509 HG22 ' HB2' ' A' ' 8' ' ' PHE . 54.6 t -129.11 136.32 59.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 113.525 -1.67 . . . . 0.0 111.403 -178.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.661 ' HB3' HD23 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -126.16 149.85 48.7 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 176.387 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.71 ' HG2' ' HB ' ' A' ' 10' ' ' VAL . 87.8 mt-10 -127.99 141.27 51.57 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 118.637 2.828 . . . . 0.0 118.637 -176.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -131.51 152.44 50.73 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 112.072 -2.331 . . . . 0.0 110.531 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . 0.374 0.0 OUTLIER -100.08 -27.71 13.41 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 -179.057 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.7 p30 -142.7 166.59 24.24 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.476 -0.765 . . . . 0.0 110.831 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -45.08 -49.25 9.7 Favored Glycine 0 N--CA 1.479 1.543 0 C-N-CA 124.6 1.095 . . . . 0.0 115.582 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -58.65 -56.68 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 114.616 -0.792 . . . . 0.0 110.585 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -55.36 -35.38 65.17 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.802 0.841 . . . . 0.0 111.662 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.01 -51.52 57.57 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 117.91 -1.043 . . . . 0.0 111.834 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 50.6 mt -54.82 -45.77 74.48 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 124.211 0.944 . . . . 0.0 111.068 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -54.96 -54.41 43.17 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 125.166 1.541 . . . . 0.0 111.43 177.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.8 mttt -62.61 -45.14 94.22 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.027 1.331 . . . . 0.0 114.271 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.8 mt -54.09 -28.71 41.02 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 98.3 mm-40 -57.88 -25.51 60.87 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.39 -18.89 62.69 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.72 -179.8 50.63 Favored Glycine 0 N--CA 1.48 1.593 0 CA-C-O 122.165 0.869 . . . . 0.0 112.541 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.46 -31.02 3.29 Favored Glycine 0 N--CA 1.485 1.953 0 CA-C-N 113.959 -1.121 . . . . 0.0 114.142 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.546 ' HA ' ' HB3' ' A' ' 7' ' ' LYS . 65.3 m-85 -60.69 113.29 2.39 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.094 0.558 . . . . 0.0 110.772 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.62 15.3 45.64 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 125.815 1.947 . . . . 0.0 112.222 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.529 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.6 OUTLIER -171.3 134.19 0.88 Allowed 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 122.381 1.086 . . . . 0.0 112.348 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.32 121.49 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.538 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 89.8 mt -112.33 98.99 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.5 t -113.46 122.06 46.17 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.02 127.26 32.22 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 111.456 -2.611 . . . . 0.0 110.259 177.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -51.93 -45.04 64.14 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.237 0.961 . . . . 0.0 112.871 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -87.06 103.15 15.11 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.013 0.925 . . . . 0.0 109.438 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.9 mtp -147.23 131.46 8.58 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 123.999 0.92 . . . . 0.0 111.815 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.21 149.42 81.62 Favored 'Trans proline' 0 N--CA 1.48 0.734 0 C-N-CA 123.484 2.789 . . . . 0.0 110.968 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.5 m120 70.94 -71.7 0.13 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.911 1.684 . . . . 0.0 111.05 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.4 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 58.8 ttm -119.84 99.71 6.8 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -61.1 166.59 3.51 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.688 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.91 -56.64 7.45 Favored Glycine 0 N--CA 1.485 1.939 0 O-C-N 124.188 0.93 . . . . 0.0 114.868 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.627 HD12 HD23 ' A' ' 69' ' ' LEU . 50.8 tp -58.59 -37.26 75.43 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -68.31 -39.81 81.89 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.773 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.7 tp -58.99 -42.37 89.87 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.904 0.753 . . . . 0.0 110.372 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.627 HD23 HD12 ' A' ' 66' ' ' LEU . 12.9 tp -54.06 -47.27 71.82 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.059 1.344 . . . . 0.0 111.178 176.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.36 -47.11 85.62 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.235 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.257 11.4 p -59.15 -32.38 69.83 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.658 1.183 . . . . 0.0 112.943 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.452 HG23 ' HB3' ' A' ' 78' ' ' MET . 53.3 mt -74.65 -55.7 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.248 1.019 . . . . 0.0 108.311 176.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.439 ' HD3' ' HA ' ' A' ' 73' ' ' ARG . 71.1 mmt-85 -51.03 -48.01 61.57 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.584 1.554 . . . . 0.0 111.769 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.83 -22.32 65.15 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -83.66 110.71 18.5 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.599 0.76 . . . . 0.0 109.411 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -26.28 -69.14 0.05 OUTLIER Glycine 0 CA--C 1.541 1.71 0 C-N-CA 125.981 1.753 . . . . 0.0 115.306 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.02 -35.28 80.68 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.452 ' HB3' HG23 ' A' ' 72' ' ' ILE . 42.7 mtm -85.35 -11.38 54.72 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 64.8 p -42.67 -43.17 3.74 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.456 1.903 . . . . 0.0 116.099 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.64 -3.95 57.01 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 90.5 mt -73.95 111.07 10.86 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 11.8 Cg_endo -52.1 131.14 38.0 Favored 'Trans proline' 0 N--CA 1.481 0.749 0 C-N-CA 123.166 2.577 . . . . 0.0 114.249 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 63.3 t -116.86 124.72 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 112.865 -1.97 . . . . 0.0 113.224 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.529 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 50.4 tp -111.97 108.13 17.35 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 112.659 -2.064 . . . . 0.0 108.771 178.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.0 mmt -81.8 106.13 13.48 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 113.383 -1.735 . . . . 0.0 113.637 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -91.28 98.61 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 123.921 1.819 . . . . 0.0 108.504 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 t -108.9 139.23 44.04 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 111.813 -2.449 . . . . 0.0 112.6 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.19 -41.79 65.63 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 114.213 -1.358 . . . . 0.0 113.495 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -137.32 151.17 48.34 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.472 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.565 ' HB2' HG21 ' A' ' 108' ' ' VAL . . . -91.73 78.14 5.51 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.352 177.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.8 135.99 37.98 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.259 -1.791 . . . . 0.0 108.7 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -41.07 -49.46 3.4 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.077 1.351 . . . . 0.0 113.193 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -58.59 -51.2 70.9 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -56.93 -45.39 82.76 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.343 1.027 . . . . 0.0 111.312 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 78.9 mt -56.87 -55.16 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 124.716 1.206 . . . . 0.0 110.892 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.448 HG22 ' OE1' ' A' ' 100' ' ' GLN . 44.5 mt -59.32 -50.92 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.021 0.928 . . . . 0.0 110.674 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.58 74.11 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.834 0.854 . . . . 0.0 111.865 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.08 -49.05 79.35 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.507 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.53 88.29 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.305 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.448 ' OE1' HG22 ' A' ' 96' ' ' ILE . 78.5 mt-30 -60.12 -38.87 84.31 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.0 -0.66 45.22 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.54 -0.81 29.23 Favored Glycine 0 CA--C 1.545 1.908 0 N-CA-C 117.391 1.716 . . . . 0.0 117.391 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.03 121.65 14.11 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.099 1.449 . . . . 0.0 114.357 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.0 m -65.44 -30.02 70.77 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 111.913 -2.403 . . . . 0.0 113.08 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -173.68 177.23 46.09 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.308 1.432 . . . . 0.0 111.121 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -147.32 131.54 17.42 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.053 -1.073 . . . . 0.0 111.186 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.8 p -120.83 123.85 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 123.988 0.805 . . . . 0.0 110.364 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.565 HG21 ' HB2' ' A' ' 90' ' ' ALA . 93.8 t -76.41 128.56 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 112.796 -2.002 . . . . 0.0 111.456 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -92.78 138.26 23.67 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.859 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.51 133.75 31.92 Favored 'Cis proline' 0 CA--C 1.54 0.788 0 N-CA-C 115.866 1.449 . . . . 0.0 115.866 0.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -116.95 147.72 42.02 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 112.832 -1.985 . . . . 0.0 108.458 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 59.9 p -105.56 178.48 4.55 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.983 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.11 -42.93 69.99 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.912 0.758 . . . . 0.0 111.97 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.09 72.93 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.738 0.815 . . . . 0.0 111.723 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -60.57 -46.3 90.73 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.475 0.71 . . . . 0.0 110.786 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.3 tp -56.47 -51.2 69.35 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.323 1.049 . . . . 0.0 109.553 177.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.436 ' HA ' HD12 ' A' ' 120' ' ' LEU . 8.3 tt0 -58.67 -47.67 83.71 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.531 0.732 . . . . 0.0 111.752 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -50.42 -45.5 55.82 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 124.195 0.934 . . . . 0.0 110.653 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -68.47 -46.59 69.34 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.159 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 117' ' ' GLU . 46.5 mt -55.87 -48.67 75.15 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.503 0.721 . . . . 0.0 111.218 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -55.15 -52.53 63.0 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.502 1.521 . . . . 0.0 112.004 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -52.85 -46.96 68.05 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.357 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.92 -46.88 93.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.276 1.03 . . . . 0.0 111.528 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 N--CA 1.476 0.858 0 C-N-CA 122.582 0.353 . . . . 0.0 111.722 178.078 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 33.5 mmtp . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -99.94 46.8 0.95 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.497 1.142 . . . . 0.0 113.802 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.424 HD23 ' CZ ' ' A' ' 8' ' ' PHE . 38.2 tp -79.77 127.68 32.51 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 111.405 -2.634 . . . . 0.0 107.318 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 51' ' ' TYR . 76.8 tttt -81.77 110.43 17.08 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.558 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 30' ' ' PHE . 89.4 m-85 -99.33 141.65 31.84 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.933 -1.94 . . . . 0.0 113.135 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.745 HD23 ' HB3' ' A' ' 34' ' ' GLU . 1.3 tm? -121.82 98.76 6.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.368 174.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -80.11 109.68 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 111.955 -2.384 . . . . 0.0 108.419 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.6 HG22 HD13 ' A' ' 9' ' ' LEU . 1.4 t -108.53 100.64 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.597 -179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -141.21 133.73 28.44 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.844 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -65.06 -28.37 69.42 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 112.976 -1.92 . . . . 0.0 114.025 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -94.54 102.02 13.94 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.0 p -39.12 -50.09 1.85 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 113.024 -1.898 . . . . 0.0 113.27 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -38.82 92.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.04 1.336 . . . . 0.0 112.61 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 12.4 tpt -63.51 -34.27 77.4 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.473 ' HD2' ' HB3' ' A' ' 35' ' ' GLU . 72.0 mtm180 -56.47 -42.58 78.45 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.507 0.504 . . . . 0.0 111.441 178.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -60.37 -43.88 96.16 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.114 -1.403 . . . . 0.0 112.533 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.6 mt -59.97 -51.46 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 122.993 0.517 . . . . 0.0 110.231 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.8 t -58.04 -44.41 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 123.806 0.691 . . . . 0.0 109.172 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 37.5 ttm-85 -55.42 -52.49 63.42 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.953 0.901 . . . . 0.0 111.469 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -55.9 -44.87 78.63 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 123.916 0.76 . . . . 0.0 113.04 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 68.4 mt -59.36 -52.82 64.01 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.506 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.5 mt -54.29 -48.75 70.93 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.541 176.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -52.25 -48.51 65.18 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.64 1.576 . . . . 0.0 111.198 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 35.3 mt-10 -58.33 -39.03 78.36 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.014 1.725 . . . . 0.0 114.017 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.2 mt -73.84 -16.25 61.14 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.962 1.305 . . . . 0.0 114.163 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.62 -8.31 19.8 Favored Glycine 0 N--CA 1.482 1.743 0 C-N-CA 124.696 1.141 . . . . 0.0 112.824 -177.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 51.9 m-85 -90.11 74.07 7.19 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 123.871 1.795 . . . . 0.0 111.675 -178.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -76.18 -14.73 60.15 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 112.256 -2.247 . . . . 0.0 116.167 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -91.79 93.51 8.89 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.465 1.126 . . . . 0.0 110.218 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.8 t -132.63 140.53 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.591 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.745 ' HB3' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -126.93 152.44 47.12 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 175.388 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 36.8 mt-10 -126.67 141.95 51.69 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -178.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.458 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -131.54 158.15 41.7 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 112.01 -2.359 . . . . 0.0 108.951 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . 0.314 0.0 OUTLIER -105.37 -17.37 14.46 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 -178.05 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -157.17 169.01 25.75 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 122.009 -0.432 . . . . 0.0 109.924 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -44.82 -54.99 6.48 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 124.743 1.164 . . . . 0.0 114.684 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.3 t -56.67 -56.54 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 122.612 0.365 . . . . 0.0 111.096 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -52.29 -35.91 51.63 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.113 0.965 . . . . 0.0 112.748 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . . . -68.9 -52.92 24.35 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.551 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.3 mt -52.89 -42.5 65.36 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.801 0.688 . . . . 0.0 111.412 178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -55.71 -57.29 12.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.601 1.56 . . . . 0.0 110.592 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -58.65 -42.2 87.81 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.536 1.535 . . . . 0.0 113.252 177.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.3 mt -59.98 -32.33 70.75 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -55.27 -26.66 41.44 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.83 -15.0 61.25 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.82 -177.43 47.57 Favored Glycine 0 CA--C 1.542 1.73 0 C-N-CA 124.033 0.825 . . . . 0.0 112.566 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.93 -33.2 4.06 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 114.753 -0.723 . . . . 0.0 113.495 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.547 ' O ' HD22 ' A' ' 81' ' ' LEU . 50.9 m-85 -69.16 122.56 19.04 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.944 0.897 . . . . 0.0 111.827 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.46 23.97 8.27 Favored Glycine 0 N--CA 1.478 1.49 0 O-C-N 126.17 2.169 . . . . 0.0 112.322 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.504 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -173.94 133.32 0.44 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.779 1.232 . . . . 0.0 111.398 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.6 t -122.77 122.95 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.823 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.5 mt -110.93 100.04 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 105.861 -1.904 . . . . 0.0 105.861 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.401 ' OG ' ' HA2' ' A' ' 65' ' ' GLY . 29.8 t -118.0 130.02 55.93 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -68.5 127.65 33.76 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 111.624 -2.535 . . . . 0.0 110.828 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.495 ' O ' ' HB2' ' A' ' 64' ' ' ASP . 32.1 t-105 -48.11 -54.62 12.61 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.515 1.126 . . . . 0.0 112.54 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -104.43 114.35 28.53 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 122.323 1.058 . . . . 0.0 111.167 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.455 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 32.8 mtm -139.73 137.28 18.33 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 111.916 -2.402 . . . . 0.0 109.383 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -57.04 145.54 85.27 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.645 2.897 . . . . 0.0 112.23 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.7 m120 69.41 -59.22 0.49 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.49 1.916 . . . . 0.0 115.009 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 59.3 ttm -133.02 101.4 5.21 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 58' ' ' TRP . 3.0 p30 -68.81 164.24 22.37 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 113.634 -1.621 . . . . 0.0 112.323 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.401 ' HA2' ' OG ' ' A' ' 56' ' ' SER . . . -43.91 -50.36 7.41 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 124.857 1.217 . . . . 0.0 114.453 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 61.9 tp -61.19 -42.6 98.87 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.743 -0.729 . . . . 0.0 112.84 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -65.63 -38.86 90.6 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.631 0.373 . . . . 0.0 111.198 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.14 -43.94 95.34 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.046 0.841 . . . . 0.0 110.345 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 66' ' ' LEU . 19.4 tp -55.15 -46.28 75.69 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.697 1.199 . . . . 0.0 110.685 176.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.63 -46.4 89.1 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.254 0.622 . . . . 0.0 112.366 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.25 12.8 p -62.55 -16.61 56.98 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.954 1.302 . . . . 0.0 114.069 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.9 mt -92.68 -59.76 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.111 1.364 . . . . 0.0 108.08 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 101' ' ' ALA . 77.2 mmt-85 -53.32 -46.48 69.46 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 126.386 1.874 . . . . 0.0 113.873 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.74 -29.92 65.04 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' A' ' 78' ' ' MET . 37.1 t0 -86.37 103.27 14.78 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -23.0 -71.19 0.01 OUTLIER Glycine 0 N--CA 1.483 1.818 0 C-N-CA 126.188 1.852 . . . . 0.0 115.692 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.01 -43.46 77.73 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.421 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 75.5 mmm -68.11 -27.02 66.11 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 -179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 96.1 p -47.36 -27.87 1.81 Allowed 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.73 -12.23 44.81 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 51' ' ' TYR . 2.6 mt -95.86 115.2 65.37 Favored Pre-proline 0 N--CA 1.485 1.312 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -59.42 142.98 99.81 Favored 'Trans proline' 0 N--CA 1.483 0.903 0 C-N-CA 123.439 2.759 . . . . 0.0 111.329 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.0 t -121.3 126.97 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-O 122.681 1.229 . . . . 0.0 113.234 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.504 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 54.4 tp -112.96 112.11 23.34 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 112.336 -2.211 . . . . 0.0 109.932 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 31.5 mmt -85.85 108.36 18.1 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.955 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.1 t -86.85 98.69 7.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-O 123.234 1.492 . . . . 0.0 107.692 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 1.8 t -113.26 140.57 47.87 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 112.03 -2.35 . . . . 0.0 109.947 -177.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.12 -50.57 58.57 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.542 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.405 ' HA ' HG13 ' A' ' 108' ' ' VAL . 39.1 mt-10 -138.92 153.6 48.27 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.974 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.14 83.74 7.74 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 122.83 1.3 . . . . 0.0 109.209 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -108.89 141.41 41.0 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 112.592 -2.095 . . . . 0.0 111.6 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -40.96 -52.77 3.07 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.621 1.568 . . . . 0.0 113.443 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -55.73 -50.19 71.05 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -62.98 -47.14 84.45 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.184 0.994 . . . . 0.0 111.323 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.8 mt -55.97 -54.57 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.783 1.233 . . . . 0.0 112.585 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.542 HG22 ' OE1' ' A' ' 100' ' ' GLN . 24.3 mt -55.83 -53.88 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.184 0.594 . . . . 0.0 109.9 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.71 -45.57 74.05 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.481 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.77 -48.7 79.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.23 1.012 . . . . 0.0 113.041 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.59 -43.17 97.74 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.983 0.913 . . . . 0.0 111.633 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.542 ' OE1' HG22 ' A' ' 96' ' ' ILE . 54.0 mt-30 -57.86 -33.73 68.99 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.314 1.046 . . . . 0.0 113.541 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.52 ' O ' ' HG3' ' A' ' 73' ' ' ARG . . . -90.9 -1.62 57.82 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 100.33 13.32 36.21 Favored Glycine 0 CA--C 1.547 2.088 0 N-CA-C 117.676 1.83 . . . . 0.0 117.676 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.04 129.9 43.75 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 118.921 1.36 . . . . 0.0 114.57 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.443 ' HB3' HG23 ' A' ' 123' ' ' ILE . 28.3 m -73.82 -29.29 62.06 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 113.085 -1.87 . . . . 0.0 112.439 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.12 174.99 47.22 Favored Glycine 0 N--CA 1.481 1.672 0 C-N-CA 124.898 1.237 . . . . 0.0 110.466 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.548 ' O ' ' HE2' ' A' ' 119' ' ' LYS . 37.0 p90 -144.88 130.51 18.96 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 113.924 -1.138 . . . . 0.0 111.304 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.292 1.4 p -114.68 121.19 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.205 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.405 HG13 ' HA ' ' A' ' 89' ' ' GLU . 94.0 t -74.69 115.41 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 111.479 -2.6 . . . . 0.0 111.316 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -91.65 135.57 27.58 Favored Pre-proline 0 C--O 1.24 0.567 0 O-C-N 124.421 1.075 . . . . 0.0 112.298 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -72.75 130.66 20.32 Favored 'Cis proline' 0 N--CA 1.475 0.423 0 N-CA-C 116.725 1.779 . . . . 0.0 116.725 0.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -120.63 137.83 54.23 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 112.073 -2.331 . . . . 0.0 108.213 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 54.3 p -96.48 179.52 4.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 123.85 0.719 . . . . 0.0 110.079 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.26 -36.53 68.67 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 119.504 -0.284 . . . . 0.0 111.324 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.45 -49.54 66.34 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.82 0.848 . . . . 0.0 110.839 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.99 -43.14 99.47 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.146 0.579 . . . . 0.0 110.123 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 40.2 tp -60.66 -53.72 54.03 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.695 0.798 . . . . 0.0 110.492 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -55.16 -45.87 75.71 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.459 0.704 . . . . 0.0 111.083 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -54.79 -47.36 74.08 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.337 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.548 ' HE2' ' O ' ' A' ' 106' ' ' TYR . 31.9 mmmt -66.8 -41.92 86.77 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 55.9 mt -57.76 -47.73 81.66 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.722 0.809 . . . . 0.0 109.621 177.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -54.64 -54.02 47.11 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.761 1.624 . . . . 0.0 112.074 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -52.74 -43.65 65.88 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.955 0.902 . . . . 0.0 112.331 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.443 HG23 ' HB3' ' A' ' 104' ' ' SER . 68.8 mt -60.65 -49.82 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.509 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 N--CA 1.482 1.125 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.218 179.802 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 4' ' ' LYS . 55.3 mmtt . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -109.71 61.26 0.6 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 123.347 1.546 . . . . 0.0 109.541 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.401 HD11 ' HA3' ' A' ' 52' ' ' GLY . 59.1 tp -86.71 136.19 33.11 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 110.846 -2.888 . . . . 0.0 110.212 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -86.96 118.57 26.43 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 125.674 1.859 . . . . 0.0 111.89 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.565 ' HB2' HG22 ' A' ' 33' ' ' VAL . 61.1 m-85 -108.2 148.93 29.24 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 112.826 -1.988 . . . . 0.0 112.868 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.649 HD23 ' HB3' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -127.23 104.01 7.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.639 175.484 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.451 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 95.4 t -84.1 105.3 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 112.526 -2.125 . . . . 0.0 109.197 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.534 HG22 HD13 ' A' ' 9' ' ' LEU . 1.4 t -104.08 92.45 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.817 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -135.62 127.54 29.49 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.36 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -60.36 -21.41 62.08 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -101.89 131.22 48.38 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.429 0.633 . . . . 0.0 110.995 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.5 p -50.44 -58.55 5.46 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.006 -1.907 . . . . 0.0 112.568 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -45.24 93.77 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.471 1.108 . . . . 0.0 112.614 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 11.9 tpt -59.87 -37.29 78.89 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.523 ' HD2' ' HB3' ' A' ' 35' ' ' GLU . 64.4 mtm-85 -58.21 -47.35 83.75 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -59.61 -43.44 93.77 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.396 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.403 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 83.2 mt -56.35 -48.26 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.537 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.423 HG11 HG21 ' A' ' 55' ' ' ILE . 4.6 t -63.07 -41.56 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 CA-C-O 118.943 -0.551 . . . . 0.0 109.982 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 57.7 ttm-85 -54.67 -52.47 62.25 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.378 0.671 . . . . 0.0 110.047 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -59.57 -38.43 81.13 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.415 1.086 . . . . 0.0 113.624 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 20' ' ' ILE . 83.1 mt -63.36 -54.39 37.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.753 0.821 . . . . 0.0 110.91 177.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.8 mt -55.66 -43.29 76.15 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.139 0.976 . . . . 0.0 111.743 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -56.68 -47.59 79.52 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.103 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -59.95 -37.43 79.55 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.038 1.735 . . . . 0.0 112.684 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.9 mt -72.66 -20.33 61.27 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.639 1.176 . . . . 0.0 113.21 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.81 -15.31 11.31 Favored Glycine 0 CA--C 1.546 2.028 0 C-N-CA 124.591 1.091 . . . . 0.0 114.336 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -89.71 82.23 6.32 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 123.408 1.575 . . . . 0.0 110.578 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -76.65 -7.97 56.33 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -96.98 97.95 9.68 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.071 0.939 . . . . 0.0 110.067 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.565 HG22 ' HB2' ' A' ' 8' ' ' PHE . 83.1 t -134.16 141.45 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.904 -178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.649 ' HB3' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -125.49 153.2 43.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 174.759 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.523 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 89.3 mt-10 -126.07 142.54 51.48 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 116.143 1.905 . . . . 0.0 116.143 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.62 157.25 46.22 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 112.53 -2.123 . . . . 0.0 108.097 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.6 -33.15 9.1 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -138.91 173.09 11.93 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.98 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.67 -56.85 7.08 Favored Glycine 0 N--CA 1.474 1.23 0 CA-C-N 114.254 -1.339 . . . . 0.0 115.551 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.9 t -58.07 -53.84 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 122.922 0.489 . . . . 0.0 111.496 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -51.83 -40.62 60.81 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.939 0.895 . . . . 0.0 111.969 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.8 -51.27 65.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.414 1.086 . . . . 0.0 112.728 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.6 mt -54.47 -47.32 73.09 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.776 0.831 . . . . 0.0 112.104 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -56.77 -55.35 35.38 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.777 1.298 . . . . 0.0 110.256 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -58.19 -39.34 78.71 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.008 -1.451 . . . . 0.0 114.597 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 34.0 mt -58.43 -31.0 67.33 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.962 1.468 . . . . 0.0 114.962 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -58.41 -22.37 53.85 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.534 1.134 . . . . 0.0 114.018 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.86 -26.36 67.32 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.55 175.97 48.48 Favored Glycine 0 N--CA 1.479 1.533 0 C-N-CA 124.211 0.91 . . . . 0.0 113.445 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.19 -27.79 3.49 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 113.539 -1.33 . . . . 0.0 114.933 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -61.44 108.64 0.98 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.959 0.904 . . . . 0.0 112.499 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.401 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -99.42 15.92 59.55 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-N 113.634 -1.621 . . . . 0.0 111.837 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.728 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -173.61 141.21 0.84 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.257 1.023 . . . . 0.0 113.757 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.6 t -123.18 111.82 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 113.318 -1.765 . . . . 0.0 108.267 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.423 HG21 HG11 ' A' ' 21' ' ' VAL . 76.5 mt -100.9 101.8 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.5 t -119.44 128.21 53.81 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -74.14 132.34 42.15 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.052 -1.886 . . . . 0.0 110.426 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -54.01 -44.02 70.57 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.388 1.055 . . . . 0.0 113.098 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -93.7 99.52 11.92 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.673 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.468 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 9.7 mtm -139.88 137.3 18.17 Favored Pre-proline 0 N--CA 1.478 0.967 0 CA-C-N 114.511 -1.222 . . . . 0.0 112.127 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.1 145.13 93.67 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.789 2.993 . . . . 0.0 113.177 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 65.05 -69.09 0.1 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.316 1.847 . . . . 0.0 112.415 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.6 ttm -116.81 100.27 7.67 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.468 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 2.3 p30 -65.32 173.35 2.61 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 113.476 -1.693 . . . . 0.0 113.24 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -52.23 -54.97 24.04 Favored Glycine 0 N--CA 1.478 1.474 0 C-N-CA 124.703 1.144 . . . . 0.0 115.051 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 57.8 tp -59.4 -39.85 84.75 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.599 0.76 . . . . 0.0 111.925 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -66.87 -39.8 87.64 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.354 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.24 -45.34 93.59 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.878 0.871 . . . . 0.0 110.089 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.514 HD13 HG11 ' A' ' 83' ' ' VAL . 9.7 tp -52.32 -45.62 65.69 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.517 1.127 . . . . 0.0 111.77 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -60.31 -47.69 84.93 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.998 0.919 . . . . 0.0 113.082 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.32 -38.24 86.17 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.247 1.019 . . . . 0.0 111.335 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' A' ' 78' ' ' MET . 47.8 mt -67.91 -54.67 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 123.893 0.877 . . . . 0.0 109.467 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.451 ' HD3' ' HA ' ' A' ' 73' ' ' ARG . 62.1 mmt-85 -54.1 -41.11 67.9 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 125.61 1.564 . . . . 0.0 111.918 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.44 -30.73 68.72 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.963 1.305 . . . . 0.0 113.982 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.535 ' OD2' ' HG3' ' A' ' 78' ' ' MET . 27.0 t70 -83.84 93.98 8.11 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.553 0.741 . . . . 0.0 110.36 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -8.86 -80.15 0.01 OUTLIER Glycine 0 N--CA 1.482 1.729 0 C-N-CA 126.85 2.167 . . . . 0.0 117.254 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.18 -42.81 86.88 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.535 ' HG3' ' OD2' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -63.61 -25.28 68.16 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -179.179 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.5 p -53.64 -25.78 19.3 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.22 -22.51 61.25 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.413 1.485 . . . . 0.0 114.439 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.472 ' HA ' ' HD2' ' A' ' 82' ' ' PRO 0.355 1.5 pp -94.02 111.62 53.87 Favored Pre-proline 0 N--CA 1.479 0.997 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 179.463 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 11.4 Cg_endo -47.46 143.97 10.82 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 125.086 3.857 . . . . 0.0 117.453 -177.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.514 HG11 HD13 ' A' ' 69' ' ' LEU . 87.7 t -117.44 121.29 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 112.248 -2.251 . . . . 0.0 111.575 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.728 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 46.8 tp -112.55 115.5 28.73 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.343 -1.753 . . . . 0.0 108.992 178.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.9 mmt -88.21 112.25 22.55 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.533 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -92.23 96.84 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 123.377 1.56 . . . . 0.0 108.155 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 1.3 t -109.22 128.6 55.18 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 111.457 -2.611 . . . . 0.0 111.494 -178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.12 -38.7 25.77 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -143.37 138.6 29.53 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.24 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.23 84.89 5.13 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.265 -1.334 . . . . 0.0 107.912 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -100.38 133.69 44.43 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 112.055 -2.338 . . . . 0.0 107.253 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -39.12 -49.46 1.8 Allowed 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.941 1.401 . . . . 0.0 113.593 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -58.5 -52.76 64.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.159 0.984 . . . . 0.0 112.079 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -56.33 -44.69 80.24 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.906 0.882 . . . . 0.0 110.928 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 83.4 mt -58.7 -56.15 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.856 0.863 . . . . 0.0 111.195 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.422 HG22 ' OE1' ' A' ' 100' ' ' GLN . 52.4 mt -57.41 -50.82 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.231 0.612 . . . . 0.0 110.511 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.72 -48.32 72.67 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.891 0.876 . . . . 0.0 113.248 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.21 -48.88 79.98 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.687 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.0 -48.25 82.27 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.27 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.422 ' OE1' HG22 ' A' ' 96' ' ' ILE . 62.6 mt-30 -55.6 -42.8 75.36 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.391 1.076 . . . . 0.0 113.897 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.05 -1.37 43.82 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.417 ' C ' HD11 ' A' ' 69' ' ' LEU . . . 107.41 11.47 25.3 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 117.823 1.889 . . . . 0.0 117.823 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.41 125.65 24.89 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.198 1.499 . . . . 0.0 114.86 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.0 m -70.47 -23.15 62.64 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 112.445 -2.161 . . . . 0.0 112.684 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.01 -179.68 45.21 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.541 1.544 . . . . 0.0 110.348 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -147.27 130.45 16.47 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.216 -0.992 . . . . 0.0 111.715 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.7 p -115.36 123.54 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.852 0.834 . . . . 0.0 110.393 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 87' ' ' THR . 67.9 t -77.8 125.44 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 113.231 -1.804 . . . . 0.0 110.679 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -92.66 139.19 23.52 Favored Pre-proline 0 N--CA 1.478 0.934 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.914 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.64 125.36 11.68 Favored 'Cis proline' 0 CA--C 1.54 0.812 0 CA-C-O 122.734 1.056 . . . . 0.0 114.629 0.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.421 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 15.6 p90 -110.01 145.16 37.48 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.039 -1.891 . . . . 0.0 109.015 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 49.9 p -97.89 171.14 8.48 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.35 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.24 -39.07 63.52 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.934 176.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.43 -46.18 84.28 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.88 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.8 m -64.2 -45.98 85.92 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.084 0.954 . . . . 0.0 109.489 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 30.4 tp -56.59 -51.32 69.08 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.099 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -58.22 -47.77 82.47 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.51 0.724 . . . . 0.0 112.372 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -46.08 -47.41 17.2 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.106 0.879 . . . . 0.0 112.291 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -71.54 -47.57 54.32 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.472 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 116' ' ' LEU . 37.5 mt -55.86 -45.24 78.54 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.858 0.863 . . . . 0.0 112.27 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -53.66 -55.86 22.33 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.786 1.234 . . . . 0.0 113.295 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -53.17 -47.47 68.8 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.783 -1.553 . . . . 0.0 112.088 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.407 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 65.5 mt -57.1 -44.41 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 114.2 -1.364 . . . . 0.0 113.238 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.835 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.549 0.941 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -84.57 27.46 0.72 Allowed 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.508 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 7' ' ' LYS . 3.9 tt -82.9 130.53 35.15 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.409 1.084 . . . . 0.0 109.898 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.728 ' HG3' ' HB3' ' A' ' 32' ' ' ASN . 0.4 OUTLIER -87.45 102.01 14.14 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.764 176.687 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -92.85 133.68 35.83 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.183 -1.826 . . . . 0.0 111.638 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.455 HD12 ' HG ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -109.46 104.23 13.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.754 174.845 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.514 ' HA ' HG23 ' A' ' 55' ' ' ILE . 54.8 t -80.73 98.27 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.519 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.526 HG12 ' SD ' ' A' ' 60' ' ' MET . 2.7 t -101.7 78.61 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 112.69 -2.05 . . . . 0.0 108.42 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 3.7 m-20 -128.47 100.12 5.66 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 113.044 -1.889 . . . . 0.0 112.313 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -27.69 -41.44 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -92.34 124.76 36.64 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.8 p -47.86 -50.5 26.2 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.143 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.523 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -57.91 -46.24 85.26 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.264 0.626 . . . . 0.0 111.456 177.929 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.06 -45.8 91.95 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.393 0.677 . . . . 0.0 111.373 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.74 ' HD2' ' HB3' ' A' ' 35' ' ' GLU . 6.6 mtm180 -53.67 -46.78 70.73 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.727 0.811 . . . . 0.0 111.133 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 10.5 mtp180 -61.92 -43.02 99.71 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 112.993 -1.912 . . . . 0.0 113.735 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 16' ' ' THR . 40.1 mm -57.83 -54.74 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.376 0.671 . . . . 0.0 110.311 178.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.535 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 20.7 t -55.05 -44.49 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.67 0.788 . . . . 0.0 110.855 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.415 ' HB3' ' O ' ' A' ' 19' ' ' ARG . 52.4 ttt180 -53.67 -54.83 32.23 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.475 1.11 . . . . 0.0 110.936 177.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -55.74 -39.71 71.51 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.311 1.044 . . . . 0.0 112.743 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.02 -53.55 53.91 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.559 1.144 . . . . 0.0 111.393 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.1 mt -53.98 -41.86 68.34 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.329 1.052 . . . . 0.0 111.832 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -56.94 -51.43 69.18 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.128 -1.397 . . . . 0.0 109.982 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -56.82 -37.68 71.54 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.654 1.581 . . . . 0.0 112.55 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.2 mt -74.03 -18.08 60.89 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.91 15.5 19.99 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.868 1.223 . . . . 0.0 114.356 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -96.27 101.0 12.58 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 123.347 1.546 . . . . 0.0 112.152 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -60.44 -45.33 94.04 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 111.494 -2.594 . . . . 0.0 117.689 -178.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.728 ' HB3' ' HG3' ' A' ' 7' ' ' LYS . 69.8 m-80 -100.16 108.55 20.7 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -173.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.1 t -133.24 120.17 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 112.291 -2.231 . . . . 0.0 109.433 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.436 ' O ' HD23 ' A' ' 9' ' ' LEU . 7.7 tt0 -111.47 154.89 24.05 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 175.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.74 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 33.0 mt-10 -122.46 125.32 45.57 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -120.5 148.25 44.09 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.073 -1.876 . . . . 0.0 109.844 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.58 -61.08 1.98 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -129.67 179.41 5.84 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.799 -176.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -45.45 -52.79 8.59 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-N 114.594 -1.184 . . . . 0.0 115.182 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.7 t -57.79 -57.86 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.027 0.931 . . . . 0.0 111.471 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -55.68 -36.98 67.71 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.07 0.948 . . . . 0.0 111.335 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.441 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -63.78 -51.36 65.2 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.868 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.8 mt -55.05 -45.95 75.31 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.321 0.648 . . . . 0.0 110.936 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -56.46 -58.01 9.86 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.188 0.995 . . . . 0.0 110.933 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -58.18 -40.92 82.73 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.643 1.577 . . . . 0.0 114.569 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 54' ' ' VAL . 25.4 mt -53.57 -41.01 66.08 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -65.04 -15.83 62.77 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.75 14.32 0.21 Allowed 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.28 160.09 6.91 Favored Glycine 0 N--CA 1.483 1.784 0 C-N-CA 126.024 1.773 . . . . 0.0 116.788 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.92 -13.48 3.2 Favored Glycine 0 CA--C 1.546 1.987 0 N-CA-C 120.461 2.944 . . . . 0.0 120.461 176.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.562 ' O ' HD22 ' A' ' 81' ' ' LEU . 76.0 m-85 -65.76 99.97 0.5 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.923 1.861 . . . . 0.0 115.52 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.4 15.77 62.59 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-N 112.55 -2.114 . . . . 0.0 111.797 177.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.468 ' HB2' HD21 ' A' ' 6' ' ' LEU . 0.6 OUTLIER -168.31 136.48 2.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 122.577 1.179 . . . . 0.0 113.756 178.634 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.505 HG22 HD21 ' A' ' 46' ' ' LEU . 13.4 t -124.23 112.86 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.106 177.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.514 HG23 ' HA ' ' A' ' 10' ' ' VAL . 18.0 tt -115.96 97.89 6.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 113.714 -1.585 . . . . 0.0 107.055 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.3 t -118.37 139.67 51.01 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 119.523 3.157 . . . . 0.0 119.523 -174.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 60' ' ' MET . 15.1 t0 -73.45 129.64 38.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.324 -2.217 . . . . 0.0 110.662 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.493 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 25.0 t-105 -56.15 -39.69 72.67 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.648 0.779 . . . . 0.0 112.401 178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -99.35 93.55 5.98 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.497 1.519 . . . . 0.0 110.334 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.526 ' SD ' HG12 ' A' ' 11' ' ' VAL . 20.0 mtm -132.95 134.88 25.01 Favored Pre-proline 0 N--CA 1.479 1.023 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.79 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -57.11 144.58 89.74 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.729 2.953 . . . . 0.0 111.162 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.7 m120 65.69 -73.62 0.06 Allowed 'General case' 0 N--CA 1.483 1.205 0 O-C-N 125.182 1.551 . . . . 0.0 112.659 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.468 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 55.0 ttm -115.12 98.4 6.76 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.1 p30 -61.84 168.56 3.02 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 112.34 -2.209 . . . . 0.0 112.691 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.46 -52.91 26.76 Favored Glycine 0 N--CA 1.481 1.653 0 C-N-CA 124.632 1.11 . . . . 0.0 114.247 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 60.5 tp -59.81 -40.99 90.25 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.645 0.778 . . . . 0.0 112.247 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -66.03 -43.64 87.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.703 0.801 . . . . 0.0 111.159 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -58.42 -45.66 88.03 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.499 1.12 . . . . 0.0 110.821 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 103' ' ' ALA . 7.4 tt -52.32 -50.07 62.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.205 1.402 . . . . 0.0 109.818 176.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -59.28 -47.01 86.99 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.678 1.191 . . . . 0.0 112.836 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.263 27.6 p -61.24 -23.7 65.83 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.585 1.154 . . . . 0.0 112.291 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.3 mt -84.32 -58.88 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.959 0.904 . . . . 0.0 108.65 174.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.5 mmt-85 -48.67 -51.34 28.94 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.909 2.083 . . . . 0.0 113.968 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.1 -21.4 59.91 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.06 97.64 8.87 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -22.25 -61.45 0.03 OUTLIER Glycine 0 N--CA 1.486 2.033 0 C-N-CA 125.976 1.751 . . . . 0.0 116.37 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.11 91.55 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 97.7 mtp -78.44 -24.27 46.18 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.899 1.815 . . . . 0.0 115.899 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 t -27.94 -33.15 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 118.609 2.818 . . . . 0.0 118.609 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.69 -1.52 58.12 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.562 HD22 ' O ' ' A' ' 51' ' ' TYR . 59.6 mt -75.23 113.25 23.58 Favored Pre-proline 0 N--CA 1.489 1.491 0 CA-C-N 119.248 0.931 . . . . 0.0 113.119 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -56.62 134.46 64.56 Favored 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.436 2.757 . . . . 0.0 113.245 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.3 t -118.9 120.09 62.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 113.971 -1.468 . . . . 0.0 113.413 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.509 HD23 HD12 ' A' ' 55' ' ' ILE . 59.4 tp -112.22 105.4 13.72 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.815 -1.993 . . . . 0.0 109.361 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.2 mmt -78.25 107.53 10.91 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.815 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -87.18 96.22 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 t -100.15 136.78 39.53 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 111.422 -2.627 . . . . 0.0 114.898 -176.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.88 -24.41 66.86 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 112.691 -2.049 . . . . 0.0 113.487 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.503 ' HB3' ' HG3' ' A' ' 91' ' ' LYS . 12.6 mt-10 -155.91 126.23 6.68 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.173 1.389 . . . . 0.0 111.911 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.0 81.07 7.56 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 122.096 0.951 . . . . 0.0 108.897 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.503 ' HG3' ' HB3' ' A' ' 89' ' ' GLU . 43.3 mtmt -110.32 136.38 49.59 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.775 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' A' ' 93' ' ' GLU 0.29 0.0 OUTLIER -33.4 -52.26 0.37 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 117.049 2.241 . . . . 0.0 117.049 -178.993 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.485 ' N ' ' HD2' ' A' ' 92' ' ' LYS 0.334 0.8 OUTLIER -63.91 -42.41 97.41 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -179.458 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.301 32.1 p-10 -73.94 -30.68 62.68 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.868 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.3 mt -61.05 -50.85 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.3 mt -53.42 -54.22 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.349 1.46 . . . . 0.0 110.132 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.72 -48.84 72.0 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.484 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.493 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -57.9 -55.54 33.58 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.831 1.252 . . . . 0.0 112.976 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.83 85.28 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.593 0.757 . . . . 0.0 112.283 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -64.36 -34.12 77.42 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.041 1.496 . . . . 0.0 115.041 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.56 -13.18 59.95 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.12 1.01 8.08 Favored Glycine 0 CA--C 1.547 2.058 0 N-CA-C 117.391 1.716 . . . . 0.0 117.391 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.674 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -55.5 120.43 7.17 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 119.707 1.753 . . . . 0.0 115.116 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.7 m -64.31 -32.95 74.75 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.355 -1.748 . . . . 0.0 112.327 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.72 172.85 45.56 Favored Glycine 0 N--CA 1.477 1.378 0 C-N-CA 125.162 1.363 . . . . 0.0 110.061 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -144.01 140.32 29.51 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.4 p -122.63 127.1 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 124.942 1.401 . . . . 0.0 109.959 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.7 p -86.62 132.76 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.829 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.32 137.61 24.64 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.549 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -77.29 139.35 58.13 Favored 'Cis proline' 0 N--CA 1.482 0.799 0 N-CA-C 115.112 1.158 . . . . 0.0 115.112 -0.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.535 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 25.8 p90 -126.92 147.73 50.07 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 112.424 -2.171 . . . . 0.0 107.953 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.4 p -100.3 174.35 6.17 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.298 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.38 -37.93 62.9 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.178 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.26 -47.71 66.99 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.287 1.035 . . . . 0.0 111.89 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 m -58.25 -47.88 82.17 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.3 tp -56.27 -52.12 65.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.757 1.223 . . . . 0.0 111.412 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.486 ' HA ' HD12 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -55.81 -44.15 77.57 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.991 0.917 . . . . 0.0 112.449 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -57.72 -43.91 85.6 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -64.55 -45.19 88.14 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.273 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 117' ' ' GLU . 94.3 mt -54.08 -49.39 69.19 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.188 0.995 . . . . 0.0 111.468 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -53.94 -55.05 30.56 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.488 1.115 . . . . 0.0 111.945 178.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -51.78 -46.95 64.37 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.147 1.379 . . . . 0.0 111.607 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.4 mt -60.91 -52.15 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.485 1.114 . . . . 0.0 110.646 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 . . . . . 0 N--CA 1.48 1.051 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.383 179.365 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 16.7 ptt-85 . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 p -70.92 79.75 0.64 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 113.166 -1.834 . . . . 0.0 114.831 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.489 ' OD1' ' HB2' ' A' ' 6' ' ' LEU . 2.2 p30 -68.75 -26.43 65.23 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 113.659 -1.61 . . . . 0.0 114.325 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 70.55 -32.73 0.25 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 129.323 3.049 . . . . 0.0 117.367 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.414 ' HG3' ' OD1' ' A' ' 32' ' ' ASN . 0.5 OUTLIER -120.92 89.86 3.21 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.548 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.489 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 5.2 tt -144.26 128.57 17.83 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 112.28 -2.236 . . . . 0.0 107.687 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.485 ' HG2' ' HB3' ' A' ' 32' ' ' ASN . 65.1 mttm -82.06 112.86 19.5 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -104.32 132.97 50.0 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.47 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.476 ' CD1' HG22 ' A' ' 11' ' ' VAL . 2.0 tm? -111.95 99.76 8.35 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.103 0.954 . . . . 0.0 110.06 176.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.469 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 53.9 t -78.94 103.61 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 112.03 -2.35 . . . . 0.0 108.467 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.495 ' CG1' ' HB2' ' A' ' 42' ' ' ALA . 1.3 t -100.85 90.05 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 113.555 -1.657 . . . . 0.0 107.785 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -132.34 121.59 23.75 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.818 1.294 . . . . 0.0 112.275 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.84 -29.9 70.48 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 111.979 -2.373 . . . . 0.0 115.345 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -98.4 121.31 40.18 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.7 0.625 . . . . 0.0 109.452 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.1 p -50.04 -50.67 46.91 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 m -59.45 -50.12 75.16 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.046 0.538 . . . . 0.0 111.137 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -40.35 94.58 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.135 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.528 HH21 ' NH1' ' A' ' 19' ' ' ARG . 37.1 ttp180 -58.88 -48.33 81.78 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.315 1.046 . . . . 0.0 111.147 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.528 ' NH1' HH21 ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.74 -46.47 89.04 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.387 1.054 . . . . 0.0 111.994 177.714 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.424 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 61.2 mt -53.97 -50.92 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.828 0.851 . . . . 0.0 110.932 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.428 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 5.8 t -57.23 -48.45 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 122.506 0.323 . . . . 0.0 110.732 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -56.39 -50.77 70.63 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.86 0.725 . . . . 0.0 110.946 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -55.83 -43.33 76.89 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.268 1.027 . . . . 0.0 110.769 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 20' ' ' ILE . 67.9 mt -59.97 -51.82 68.03 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.718 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.7 mt -57.11 -43.19 82.06 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.718 0.807 . . . . 0.0 112.81 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -58.2 -48.9 78.88 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.383 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -60.69 -33.99 73.68 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.748 1.619 . . . . 0.0 113.008 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.5 mt -76.2 -13.7 60.17 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.06 -14.44 26.17 Favored Glycine 0 N--CA 1.482 1.755 0 C-N-CA 124.359 0.98 . . . . 0.0 113.741 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -81.23 85.41 6.38 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 122.384 1.088 . . . . 0.0 111.999 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -81.37 13.55 2.91 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.485 ' HB3' ' HG2' ' A' ' 7' ' ' LYS . 20.8 m120 -121.83 85.9 2.49 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 123.461 1.601 . . . . 0.0 110.756 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p -136.78 127.63 41.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 113.562 -1.653 . . . . 0.0 111.374 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.594 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 23.3 mp0 -119.43 155.29 32.29 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.469 ' HG2' ' HB ' ' A' ' 10' ' ' VAL . 29.9 mt-10 -127.8 139.7 52.49 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -177.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.79 167.15 17.72 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 111.175 -2.738 . . . . 0.0 109.748 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -104.35 -53.78 2.65 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -125.0 171.33 10.32 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.199 0.599 . . . . 0.0 110.989 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.475 ' HA2' HD22 ' A' ' 68' ' ' LEU . . . -45.58 -53.77 8.12 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.992 1.282 . . . . 0.0 115.662 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.5 t -58.25 -55.06 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.671 0.788 . . . . 0.0 111.27 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -54.49 -41.51 69.67 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.672 1.189 . . . . 0.0 111.318 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.495 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . . . -63.1 -49.45 74.41 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.501 1.121 . . . . 0.0 112.146 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.518 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 18.0 mt -52.25 -53.91 37.83 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 124.332 1.02 . . . . 0.0 110.706 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -52.11 -52.2 52.99 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.39 1.056 . . . . 0.0 112.426 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -57.93 -52.8 63.99 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.634 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.1 mt -59.56 -33.09 70.98 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 83.3 mt-30 -62.29 -26.27 68.32 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.87 -25.84 68.07 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.79 -168.37 15.96 Favored Glycine 0 N--CA 1.478 1.449 0 O-C-N 124.585 1.178 . . . . 0.0 110.588 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.61 -41.73 2.15 Favored Glycine 0 CA--C 1.541 1.71 0 N-CA-C 116.17 1.228 . . . . 0.0 116.17 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.594 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 76.8 m-85 -66.77 135.42 53.95 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.83 19.87 7.34 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 113.801 -1.545 . . . . 0.0 113.62 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -174.29 144.06 0.91 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.762 1.225 . . . . 0.0 111.776 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 t -125.64 124.66 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.886 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.0 mt -115.92 99.99 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.8 t -116.93 137.5 52.17 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 -176.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -77.37 129.49 35.87 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 113.456 -1.702 . . . . 0.0 110.236 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -56.58 -50.4 72.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.101 0.96 . . . . 0.0 112.534 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.437 ' OD1' ' HB2' ' A' ' 88' ' ' ALA . 4.4 p-10 -87.92 77.28 8.52 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.146 1.379 . . . . 0.0 113.338 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.436 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 3.4 mtm -117.66 133.23 23.32 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-N 113.576 -1.647 . . . . 0.0 113.706 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 60' ' ' MET . 71.5 Cg_exo -61.68 147.02 96.28 Favored 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 123.982 3.122 . . . . 0.0 112.505 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 68.9 -64.08 0.34 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.565 1.946 . . . . 0.0 112.208 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 60.4 ttm -126.69 104.31 8.02 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 124.779 1.231 . . . . 0.0 107.887 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -69.71 168.61 14.57 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 113.614 -1.63 . . . . 0.0 113.178 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.3 -54.57 12.37 Favored Glycine 0 N--CA 1.476 1.314 0 C-N-CA 125.046 1.308 . . . . 0.0 114.393 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.645 HD12 HD23 ' A' ' 69' ' ' LEU . 41.8 tp -59.99 -41.5 92.21 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.66 0.784 . . . . 0.0 112.846 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.5 -43.91 88.65 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.627 0.371 . . . . 0.0 111.228 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.475 HD22 ' HA2' ' A' ' 39' ' ' GLY . 61.1 tp -58.73 -40.82 84.87 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.091 0.956 . . . . 0.0 110.736 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.645 HD23 HD12 ' A' ' 66' ' ' LEU . 13.0 tp -56.0 -45.64 78.99 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.178 0.991 . . . . 0.0 110.675 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.75 -45.42 89.94 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.018 0.927 . . . . 0.0 112.083 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 75' ' ' ASP 0.251 67.8 p -59.84 -38.31 81.71 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.109 0.964 . . . . 0.0 110.54 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.8 mt -68.98 -54.28 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.637 0.775 . . . . 0.0 109.473 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.543 ' HD3' HD12 ' A' ' 69' ' ' LEU . 2.2 mpt_? -52.92 -28.59 24.07 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 126.925 2.09 . . . . 0.0 114.231 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.5 -12.75 15.86 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 78' ' ' MET . 30.8 t0 -80.37 60.39 3.78 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.992 0.917 . . . . 0.0 113.437 -177.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 32.98 -89.5 0.01 OUTLIER Glycine 0 N--CA 1.485 1.964 0 C-N-CA 127.856 2.646 . . . . 0.0 115.036 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.36 -38.58 80.78 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.072 0.949 . . . . 0.0 113.137 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.505 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 87.0 mtp -78.17 -11.17 59.9 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.6 m -57.68 -17.6 15.91 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.64 8.31 41.77 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 86.1 mt -85.11 112.42 43.3 Favored Pre-proline 0 N--CA 1.484 1.247 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 10.9 Cg_endo -51.86 139.52 49.95 Favored 'Trans proline' 0 N--CA 1.477 0.547 0 C-N-CA 123.872 3.048 . . . . 0.0 113.365 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.0 t -122.53 127.42 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.457 -1.247 . . . . 0.0 113.684 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.2 tp -114.66 102.2 9.81 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.534 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.4 mmt -78.96 108.31 12.35 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.361 -1.745 . . . . 0.0 113.162 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 3.9 t -85.93 104.89 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.5 p -94.64 139.74 30.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.703 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.437 ' HB2' ' OD1' ' A' ' 59' ' ' ASN . . . -67.93 -45.39 74.47 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.13 -1.396 . . . . 0.0 110.72 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -136.45 128.39 29.39 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.649 -1.614 . . . . 0.0 107.226 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.16 113.46 26.75 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.715 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.4 153.01 51.22 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 113.171 -1.832 . . . . 0.0 108.277 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -41.25 -43.54 2.42 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -53.37 -61.14 2.49 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.463 1.105 . . . . 0.0 112.933 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -69.94 -28.94 65.98 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 88.1 mt -61.55 -52.7 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.739 0.816 . . . . 0.0 110.102 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.6 mt -62.56 -44.33 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.98 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.54 -47.54 69.89 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.187 0.995 . . . . 0.0 112.104 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.71 -53.4 58.65 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.782 1.233 . . . . 0.0 111.75 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.67 90.72 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.204 1.002 . . . . 0.0 112.279 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -57.61 -38.37 74.81 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.64 1.176 . . . . 0.0 113.325 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.96 5.57 32.59 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.446 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 110.06 -5.56 30.5 Favored Glycine 0 CA--C 1.541 1.718 0 N-CA-C 116.825 1.49 . . . . 0.0 116.825 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.55 117.13 5.81 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 119.454 1.627 . . . . 0.0 113.906 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.3 m -62.59 -28.58 69.98 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 112.109 -2.314 . . . . 0.0 113.142 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.1 170.8 43.14 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.982 1.277 . . . . 0.0 110.706 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -143.81 142.16 30.73 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.18 -1.01 . . . . 0.0 111.738 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 2.0 p -128.92 126.97 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.198 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.4 p -84.47 142.56 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.755 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -90.4 137.85 27.3 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.692 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -86.87 135.63 17.02 Favored 'Cis proline' 0 CA--C 1.539 0.729 0 CA-C-O 122.722 1.051 . . . . 0.0 113.624 -0.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.428 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 28.0 p90 -116.09 151.29 35.88 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 113.467 -1.697 . . . . 0.0 109.558 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.5 p -105.7 177.9 4.72 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.35 0.595 . . . . 0.0 111.384 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.6 -45.1 69.93 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.027 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.33 -48.72 76.85 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.624 0.77 . . . . 0.0 111.221 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.65 -47.97 78.6 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.43 0.692 . . . . 0.0 110.291 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -51.44 70.02 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.445 1.098 . . . . 0.0 109.095 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -55.7 -46.28 77.7 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.644 1.178 . . . . 0.0 112.685 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.03 -48.09 70.88 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.249 0.62 . . . . 0.0 111.352 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -61.94 -47.28 85.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.817 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.5 mt -55.3 -51.1 67.78 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.037 0.835 . . . . 0.0 112.534 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -53.34 -50.51 64.86 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.558 1.143 . . . . 0.0 111.882 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -56.07 -49.01 74.99 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.817 1.647 . . . . 0.0 112.035 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.4 mt -59.47 -48.64 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.278 1.031 . . . . 0.0 110.53 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -58.51 -41.15 84.76 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.03 0.831 . . . . 0.0 112.83 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -62.11 -49.6 75.24 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 124.725 1.266 . . . . 0.0 111.68 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -58.46 -45.88 87.72 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 124.095 0.872 . . . . 0.0 112.462 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.32 -32.14 72.9 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.21 31.99 72.2 Favored Glycine 0 N--CA 1.488 2.128 0 O-C-N 124.406 1.066 . . . . 0.0 111.479 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 4.4 ppp? . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -178.727 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.44 ' O ' HD22 ' A' ' 6' ' ' LEU . 16.5 ptp180 . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 p -78.54 75.11 5.07 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 112.412 -2.176 . . . . 0.0 111.195 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -129.29 130.38 46.09 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.004 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.4 tptt -54.51 -30.2 52.82 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -118.8 73.29 0.92 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.899 0.857 . . . . 0.0 108.884 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.44 HD22 ' O ' ' A' ' 1' ' ' ARG . 50.3 tp -102.27 128.6 48.74 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 112.534 -2.121 . . . . 0.0 109.572 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HG2' ' HB3' ' A' ' 32' ' ' ASN . 43.2 mtpt -74.48 113.42 11.71 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.53 -1.214 . . . . 0.0 114.017 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -107.84 142.53 37.75 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.106 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.415 ' CD1' HG22 ' A' ' 11' ' ' VAL . 1.5 tm? -123.23 103.76 8.73 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.221 175.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 77.1 t -81.28 101.15 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 111.889 -2.414 . . . . 0.0 109.333 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.415 HG22 ' CD1' ' A' ' 9' ' ' LEU . 1.7 t -100.39 94.65 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 113.685 -1.598 . . . . 0.0 107.149 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -139.23 124.75 19.33 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.779 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.6 p-10 -61.92 -30.7 71.07 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.16 121.56 38.06 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.092 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.3 p -47.0 -50.6 18.88 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 113.2 -1.818 . . . . 0.0 113.025 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.407 ' O ' HG12 ' A' ' 20' ' ' ILE . 2.8 m -60.56 -55.27 35.43 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.1 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.441 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -62.69 -35.8 80.85 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -58.55 -47.59 83.69 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.3 1.04 . . . . 0.0 110.395 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.675 HH12 HH11 ' A' ' 22' ' ' ARG . 28.4 tpt180 -60.71 -45.53 93.89 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.286 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.462 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 45.5 mm -52.98 -54.73 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.274 1.03 . . . . 0.0 110.41 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.473 HG11 HG21 ' A' ' 55' ' ' ILE . 2.9 t -59.94 -49.05 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 123.562 0.539 . . . . 0.0 111.345 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.675 HH11 HH12 ' A' ' 19' ' ' ARG . 3.3 tmt_? -54.69 -46.3 74.09 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 124.088 0.867 . . . . 0.0 110.592 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -63.81 -47.49 80.62 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.56 1.144 . . . . 0.0 112.158 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 20' ' ' ILE . 72.0 mt -52.97 -53.77 45.02 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.284 1.034 . . . . 0.0 112.313 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.7 mt -55.61 -48.0 75.6 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.192 0.997 . . . . 0.0 113.372 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -55.89 -46.56 78.29 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 113.215 -1.811 . . . . 0.0 110.476 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -62.4 -31.1 71.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.073 1.749 . . . . 0.0 113.706 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 73.4 mt -77.15 -10.06 59.15 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.835 1.254 . . . . 0.0 113.904 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.76 -12.83 20.43 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 125.302 1.43 . . . . 0.0 114.53 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -85.57 81.29 8.73 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 122.48 1.133 . . . . 0.0 113.629 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -85.42 29.24 0.69 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 113.168 -1.833 . . . . 0.0 114.431 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.575 ' HB3' ' HG2' ' A' ' 7' ' ' LYS . 4.4 m120 -127.62 53.38 1.76 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 123.789 1.757 . . . . 0.0 109.788 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.95 126.19 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.602 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.58 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 72.5 mm-40 -117.49 165.03 14.01 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.33 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -127.41 141.4 51.69 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 119.508 3.151 . . . . 0.0 119.508 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -132.46 148.96 52.41 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 111.301 -2.681 . . . . 0.0 109.098 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -85.81 -53.77 4.92 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.526 -1.215 . . . . 0.0 112.777 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -130.72 171.06 13.52 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.899 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.427 ' HA2' HD22 ' A' ' 68' ' ' LEU . . . -45.14 -44.11 9.45 Favored Glycine 0 N--CA 1.477 1.426 0 O-C-N 125.11 1.506 . . . . 0.0 116.524 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.3 t -61.76 -55.76 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 118.18 -0.914 . . . . 0.0 109.908 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -54.54 -40.01 68.25 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 123.596 0.56 . . . . 0.0 110.726 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.41 -54.46 45.37 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.453 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.529 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 32.3 mt -54.65 -51.26 66.01 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.31 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -46.08 -48.65 17.0 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.961 0.904 . . . . 0.0 112.733 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -69.0 -49.83 54.25 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.917 2.087 . . . . 0.0 113.591 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.4 mt -59.44 -36.66 76.34 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 10.2 mm100 -55.43 -25.66 37.44 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.26 -28.1 68.45 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.95 -170.42 23.82 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.538 1.065 . . . . 0.0 111.405 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.05 -46.06 3.1 Favored Glycine 0 N--CA 1.483 1.817 0 CA-C-N 113.814 -1.193 . . . . 0.0 113.748 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.58 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 74.3 m-85 -62.21 109.57 1.36 Allowed 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.134 0.969 . . . . 0.0 111.961 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.534 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -105.3 29.56 11.36 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-N 113.2 -1.818 . . . . 0.0 113.363 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.569 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -178.72 129.49 0.12 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.053 1.341 . . . . 0.0 112.404 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 t -116.35 116.4 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 113.536 -1.665 . . . . 0.0 107.384 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.473 HG21 HG11 ' A' ' 21' ' ' VAL . 77.4 mt -107.2 98.77 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.5 t -118.28 127.11 53.4 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 117.895 2.554 . . . . 0.0 117.895 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.88 128.55 35.83 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.228 -2.26 . . . . 0.0 111.0 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -49.33 -47.32 47.31 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -92.8 106.76 18.68 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.972 0.891 . . . . 0.0 109.125 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.459 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 2.9 mtp -145.98 133.53 10.33 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.687 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.08 146.8 78.08 Favored 'Trans proline' 0 N--CA 1.48 0.691 0 C-N-CA 123.299 2.666 . . . . 0.0 111.969 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 m120 70.31 -72.92 0.1 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.106 1.762 . . . . 0.0 111.069 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.418 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 56.1 ttm -116.88 97.74 6.12 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.1 p30 -64.48 168.75 5.47 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 113.006 -1.906 . . . . 0.0 113.64 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.22 -56.6 10.25 Favored Glycine 0 N--CA 1.479 1.563 0 C-N-CA 124.664 1.126 . . . . 0.0 114.242 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.473 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 60.7 tp -61.03 -37.85 84.05 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.099 0.959 . . . . 0.0 112.96 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -68.53 -38.85 81.2 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.368 0.667 . . . . 0.0 111.151 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.427 HD22 ' HA2' ' A' ' 39' ' ' GLY . 65.4 tp -64.9 -38.93 92.62 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.861 0.864 . . . . 0.0 110.648 177.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.664 HD23 ' HD3' ' A' ' 73' ' ' ARG . 5.8 tt -50.63 -49.44 56.79 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.027 0.931 . . . . 0.0 109.254 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -60.43 -42.86 96.93 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.936 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.514 ' HB ' HD11 ' A' ' 43' ' ' LEU . 47.8 p -69.22 -14.92 63.24 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.4 1.08 . . . . 0.0 113.014 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.5 mt -92.51 -54.34 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.156 1.382 . . . . 0.0 107.679 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.664 ' HD3' HD23 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -50.8 -52.81 37.51 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.688 1.995 . . . . 0.0 112.761 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.0 -14.7 59.42 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 71' ' ' THR . 7.9 t70 -86.85 75.75 9.55 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.664 0.745 . . . . 0.0 111.847 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 30.99 -100.0 0.01 OUTLIER Glycine 0 N--CA 1.483 1.818 0 C-N-CA 126.828 2.156 . . . . 0.0 115.151 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.84 -31.19 72.15 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 95.5 mtp -62.98 -18.0 62.75 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.7 p -53.17 -26.85 18.62 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.82 -16.43 36.21 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.534 HD22 ' HA2' ' A' ' 52' ' ' GLY . 94.6 mt -76.56 111.41 15.63 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 123.153 0.581 . . . . 0.0 111.51 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -52.49 130.57 36.94 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.389 2.726 . . . . 0.0 115.367 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.418 HG11 ' HG ' ' A' ' 69' ' ' LEU . 47.0 t -113.61 117.78 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 112.462 -2.154 . . . . 0.0 110.754 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.569 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 48.0 tp -110.37 114.77 28.48 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 113.207 -1.815 . . . . 0.0 108.863 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 28.4 mmt -87.92 104.42 16.59 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 122.91 1.338 . . . . 0.0 114.441 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.02 99.38 7.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 122.91 1.338 . . . . 0.0 107.82 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 4.2 t -123.1 129.1 51.02 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 113.256 -1.793 . . . . 0.0 112.546 -177.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.75 -32.02 73.33 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.109 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -107.47 106.5 16.93 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.128 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.434 ' HB2' HG22 ' A' ' 108' ' ' VAL . . . -92.05 66.15 4.91 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 123.767 1.746 . . . . 0.0 107.098 177.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -115.99 150.88 36.49 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 111.868 -2.424 . . . . 0.0 111.056 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -33.61 -57.91 0.43 Allowed 'General case' 0 N--CA 1.476 0.826 0 O-C-N 125.488 1.743 . . . . 0.0 114.725 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -51.69 -52.34 48.95 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -61.72 -49.05 77.99 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.317 0.647 . . . . 0.0 111.53 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.0 mt -56.47 -54.89 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.539 1.136 . . . . 0.0 111.629 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.0 mm -57.86 -54.77 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.548 1.139 . . . . 0.0 111.056 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.83 -45.22 67.21 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.05 0.94 . . . . 0.0 112.47 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.17 -53.14 49.35 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.973 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.97 -46.16 85.6 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -57.72 -39.68 77.84 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.371 1.068 . . . . 0.0 113.579 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.51 -26.93 46.02 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 129.22 13.78 2.32 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 116.651 1.42 . . . . 0.0 116.651 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.629 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -63.43 121.37 13.64 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 118.79 1.295 . . . . 0.0 112.295 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.502 ' HB3' HG23 ' A' ' 123' ' ' ILE . 7.9 m -67.29 -25.78 66.22 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 112.988 -1.914 . . . . 0.0 112.482 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.0 173.11 40.52 Favored Glycine 0 N--CA 1.482 1.705 0 C-N-CA 125.686 1.613 . . . . 0.0 109.66 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -143.35 130.97 21.24 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.25 1.8 p -113.09 123.57 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 122.195 0.998 . . . . 0.0 111.97 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 87' ' ' THR . 8.2 t -72.41 128.36 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 111.609 -2.541 . . . . 0.0 108.963 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -99.93 134.89 20.63 Favored Pre-proline 0 N--CA 1.472 0.638 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.431 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.68 144.28 79.64 Favored 'Cis proline' 0 N--CA 1.482 0.815 0 N-CA-C 115.123 1.163 . . . . 0.0 115.123 0.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -129.77 150.88 50.88 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 112.384 -2.189 . . . . 0.0 107.517 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.414 HG22 ' OG1' ' A' ' 115' ' ' THR . 14.3 t -102.34 172.05 7.11 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.773 0.671 . . . . 0.0 110.29 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.34 -43.9 61.89 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.93 0.892 . . . . 0.0 111.698 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.32 -46.64 87.84 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.134 0.974 . . . . 0.0 112.412 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.414 ' OG1' HG22 ' A' ' 112' ' ' THR . 1.0 OUTLIER -58.79 -48.31 81.7 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.456 1.103 . . . . 0.0 109.181 178.715 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.416 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 48.8 tp -57.67 -51.32 70.01 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.201 1.4 . . . . 0.0 110.329 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.451 ' HA ' HD12 ' A' ' 120' ' ' LEU . 17.6 tp10 -55.53 -47.36 76.42 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.685 0.794 . . . . 0.0 111.54 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.79 -46.43 74.46 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.429 0.692 . . . . 0.0 112.025 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.9 mmmt -63.95 -48.4 76.66 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 124.2 0.937 . . . . 0.0 112.328 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 117' ' ' GLU . 48.5 mt -53.18 -48.41 68.04 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.498 1.119 . . . . 0.0 110.961 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -55.95 -58.46 7.79 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.534 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -51.32 -44.06 61.86 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.894 1.278 . . . . 0.0 112.37 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.502 HG23 ' HB3' ' A' ' 104' ' ' SER . 79.3 mt -57.2 -52.06 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.164 1.386 . . . . 0.0 112.307 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -56.64 -42.24 78.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 123.885 0.74 . . . . 0.0 112.19 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -57.13 -52.12 66.57 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 125.237 1.586 . . . . 0.0 111.378 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -65.15 -43.07 93.03 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.15 4.53 17.08 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 58.48 41.5 95.4 Favored Glycine 0 CA--C 1.546 2.007 0 C-N-CA 124.549 1.071 . . . . 0.0 113.05 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 73.2 mtp . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 117.31 -1.328 . . . . 0.0 112.755 -178.669 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.724 ' HG3' ' H ' ' A' ' 2' ' ' SER . 13.9 ptt-85 . . . . . 0 CA--C 1.555 1.154 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.724 ' H ' ' HG3' ' A' ' 1' ' ' ARG . 15.2 m -81.27 65.43 6.4 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.056 1.342 . . . . 0.0 110.068 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 54.2 t0 -86.13 121.76 29.18 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 113.737 -1.574 . . . . 0.0 111.452 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 85.2 mttt -51.46 -39.14 56.85 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.282 1.433 . . . . 0.0 113.513 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.83 71.15 10.69 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.591 0.71 . . . . 0.0 109.172 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 4.3 tt -121.28 132.77 55.0 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.154 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -77.06 105.51 8.18 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.162 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -109.43 144.9 37.02 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.139 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.71 110.91 16.52 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.64 -1.163 . . . . 0.0 112.012 174.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.5 t -89.84 106.03 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.501 HG11 ' HB2' ' A' ' 42' ' ' ALA . 4.4 t -106.22 90.06 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 112.864 -1.971 . . . . 0.0 108.888 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -137.88 124.17 20.55 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.184 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -59.88 -25.85 65.41 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -97.88 119.45 36.51 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.248 0.546 . . . . 0.0 110.347 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.9 p -46.05 -48.39 16.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 113.926 -1.488 . . . . 0.0 113.517 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.532 ' O ' HG12 ' A' ' 20' ' ' ILE . 2.9 m -60.85 -55.06 37.52 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.682 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.481 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.2 mmm -59.95 -38.95 83.95 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.507 ' NH1' HH22 ' A' ' 19' ' ' ARG . 15.5 ttm180 -57.1 -53.08 62.16 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.813 0.845 . . . . 0.0 110.153 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.507 HH22 ' NH1' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -58.64 -41.72 86.68 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.142 1.377 . . . . 0.0 113.477 177.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 16' ' ' THR . 39.9 mm -57.1 -58.63 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.261 1.024 . . . . 0.0 110.724 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.58 HG11 HG21 ' A' ' 55' ' ' ILE . 3.4 t -55.99 -44.56 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.231 0.613 . . . . 0.0 111.537 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.592 ' HD2' ' HB3' ' A' ' 35' ' ' GLU . 28.6 mtp-105 -54.25 -55.45 28.04 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.96 0.904 . . . . 0.0 112.376 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -59.92 -39.83 86.79 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 75.9 mt -55.38 -52.38 63.74 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.553 0.692 . . . . 0.0 111.358 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.0 mt -54.66 -48.97 71.71 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.47 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -56.45 -44.89 80.94 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.287 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 29.6 mt-10 -58.06 -40.48 81.12 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.434 1.894 . . . . 0.0 112.308 177.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.2 mt -73.47 -13.95 61.15 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.069 1.347 . . . . 0.0 113.605 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.34 -11.4 24.04 Favored Glycine 0 CA--C 1.544 1.901 0 C-N-CA 124.816 1.198 . . . . 0.0 113.757 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 57.1 m-85 -85.7 76.5 9.95 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 123.23 1.49 . . . . 0.0 111.537 -177.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -72.32 -24.72 61.35 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 118.04 2.607 . . . . 0.0 118.04 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.22 71.68 10.02 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.505 1.145 . . . . 0.0 112.178 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.2 p -120.04 128.6 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HB2' ' HE2' ' A' ' 51' ' ' TYR . 80.7 mm-40 -110.79 167.18 10.43 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.573 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.592 ' HB3' ' HD2' ' A' ' 22' ' ' ARG . 1.2 pp20? -126.75 126.15 42.96 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 -176.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.403 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -122.29 150.97 41.61 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.093 -1.867 . . . . 0.0 108.893 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -92.05 -43.67 9.27 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -141.49 173.34 11.59 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.241 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -43.15 -56.6 4.54 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.065 1.317 . . . . 0.0 115.852 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.1 t -56.16 -54.61 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 123.429 0.691 . . . . 0.0 110.997 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -56.94 -34.27 67.85 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.941 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.501 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -65.41 -48.89 71.24 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.347 1.059 . . . . 0.0 110.971 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.441 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 99.5 mt -57.46 -45.47 84.71 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -55.42 -54.79 39.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.541 1.136 . . . . 0.0 110.927 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -59.66 -45.03 93.27 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 114.399 -1.273 . . . . 0.0 113.641 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.497 HD21 HG22 ' A' ' 54' ' ' VAL . 25.2 mt -55.42 -42.83 74.66 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.327 1.051 . . . . 0.0 112.433 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 53.0 mt-30 -52.92 -35.57 58.47 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.758 1.223 . . . . 0.0 111.493 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.73 59.17 3.55 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.07 -19.63 4.61 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 118.466 2.147 . . . . 0.0 118.466 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.86 56.37 21.39 Favored Glycine 0 CA--C 1.548 2.138 0 CA-C-N 118.23 1.015 . . . . 0.0 112.296 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.579 ' H ' ' HD1' ' A' ' 51' ' ' TYR . 1.4 m-85 -50.71 135.63 23.14 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.063 2.145 . . . . 0.0 113.427 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.486 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -84.47 22.18 9.29 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 -177.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.669 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -178.13 129.26 0.13 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.698 1.237 . . . . 0.0 112.237 177.375 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.497 HG22 HD21 ' A' ' 46' ' ' LEU . 38.4 t -117.82 113.58 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 112.907 -1.951 . . . . 0.0 107.537 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.58 HG21 HG11 ' A' ' 21' ' ' VAL . 96.5 mt -107.94 97.52 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 t -119.04 136.62 54.04 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -71.13 130.18 40.83 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 112.258 -2.246 . . . . 0.0 109.195 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.447 ' O ' ' HB3' ' A' ' 64' ' ' ASP . 38.7 t-105 -58.29 -44.7 88.62 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.706 0.802 . . . . 0.0 111.428 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -94.53 96.17 9.29 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.747 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.493 ' SD ' HG12 ' A' ' 11' ' ' VAL . 33.6 mtm -134.71 132.76 20.78 Favored Pre-proline 0 N--CA 1.486 1.33 0 CA-C-N 113.651 -1.613 . . . . 0.0 110.362 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -59.34 144.06 99.52 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.763 2.975 . . . . 0.0 112.517 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.8 m120 69.69 -65.02 0.32 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.543 1.937 . . . . 0.0 113.062 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.0 ttm -123.3 96.77 5.12 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.489 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 6.0 m-20 -68.34 167.12 15.18 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.034 -1.894 . . . . 0.0 112.548 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -47.0 -55.04 8.8 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.645 1.593 . . . . 0.0 116.152 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.48 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 48.9 tp -56.71 -48.88 76.71 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . 0.268 7.1 pm0 -67.98 -33.76 75.25 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 177.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.11 -43.96 95.22 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.855 0.722 . . . . 0.0 110.079 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.48 ' HB3' ' O ' ' A' ' 66' ' ' LEU . 12.2 tp -54.09 -44.41 71.17 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.416 1.086 . . . . 0.0 110.865 175.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -64.15 -43.68 94.48 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.55 0.74 . . . . 0.0 111.785 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.263 33.0 p -58.6 -29.86 66.78 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 123.682 0.793 . . . . 0.0 111.99 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.552 HG23 ' HB3' ' A' ' 78' ' ' MET . 45.6 mt -80.02 -56.61 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.855 1.262 . . . . 0.0 109.217 177.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.47 ' HG3' ' HA3' ' A' ' 102' ' ' GLY . 77.4 mmt-85 -53.94 -47.48 71.23 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.539 1.536 . . . . 0.0 114.076 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.31 -26.32 67.72 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.284 1.033 . . . . 0.0 113.557 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -85.11 108.17 17.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.294 1.038 . . . . 0.0 108.827 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -29.14 -61.78 0.15 Allowed Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.046 1.784 . . . . 0.0 114.95 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.38 -47.9 80.12 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.552 ' HB3' HG23 ' A' ' 72' ' ' ILE . 55.4 mtm -68.31 -22.19 64.73 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.8 p -46.45 -35.73 5.9 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.31 -13.11 59.45 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.486 HD22 ' HA2' ' A' ' 52' ' ' GLY . 77.4 mt -79.31 111.87 23.96 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 122.857 0.463 . . . . 0.0 111.388 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 11.6 Cg_endo -51.31 136.42 46.99 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.685 2.923 . . . . 0.0 115.919 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.474 HG11 HD13 ' A' ' 69' ' ' LEU . 67.2 t -120.08 123.34 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 112.843 -1.98 . . . . 0.0 112.686 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.669 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -112.45 110.15 20.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 112.887 -1.96 . . . . 0.0 107.864 177.383 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 30.1 mmt -85.22 105.3 15.81 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 113.628 -1.624 . . . . 0.0 111.991 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.52 103.51 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.34 138.38 42.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 112.068 -2.333 . . . . 0.0 115.851 -174.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.17 -27.92 69.4 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.045 -1.889 . . . . 0.0 113.157 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -151.97 110.99 3.86 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 124.171 0.92 . . . . 0.0 110.21 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.43 86.42 4.48 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.494 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -118.85 147.22 44.19 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.956 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -33.53 -55.66 0.44 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -53.24 -49.5 66.7 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.613 0.765 . . . . 0.0 112.33 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.68 -49.07 79.0 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.006 1.323 . . . . 0.0 110.811 177.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 79.4 mt -58.73 -53.21 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 124.508 1.13 . . . . 0.0 111.411 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.528 HG23 ' OE1' ' A' ' 100' ' ' GLN . 57.0 mt -55.39 -54.49 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.642 1.177 . . . . 0.0 110.537 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.58 -47.2 73.6 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.812 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.404 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -59.52 -58.0 10.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.3 1.04 . . . . 0.0 112.84 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.16 -49.01 78.49 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.518 0.727 . . . . 0.0 112.619 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.528 ' OE1' HG23 ' A' ' 96' ' ' ILE . 29.2 mt-30 -65.91 -25.37 67.12 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.4 1.45 54.67 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.47 ' HA3' ' HG3' ' A' ' 73' ' ' ARG . . . 113.75 -4.84 24.38 Favored Glycine 0 CA--C 1.545 1.95 0 N-CA-C 116.829 1.492 . . . . 0.0 116.829 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.63 119.81 9.96 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.098 1.449 . . . . 0.0 114.686 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.479 ' HB3' HG23 ' A' ' 123' ' ' ILE . 14.5 m -63.48 -30.45 71.57 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 110.823 -2.899 . . . . 0.0 113.691 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -174.58 167.07 39.21 Favored Glycine 0 N--CA 1.476 1.32 0 C-N-CA 124.501 1.048 . . . . 0.0 110.761 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -142.5 138.42 30.93 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.625 -0.788 . . . . 0.0 112.065 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.98 131.17 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 124.243 0.964 . . . . 0.0 112.277 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.5 p -79.26 134.79 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 113.417 -1.72 . . . . 0.0 110.803 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.435 ' HB3' ' HZ3' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -85.13 136.73 37.84 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.022 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -87.22 153.34 42.85 Favored 'Cis proline' 0 CA--C 1.541 0.873 0 CA-C-O 122.451 0.938 . . . . 0.0 112.771 -1.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -131.42 150.61 52.08 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 113.468 -1.696 . . . . 0.0 108.949 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.7 t -101.92 169.71 8.6 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 123.776 0.673 . . . . 0.0 111.829 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.33 37.38 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.427 1.091 . . . . 0.0 112.187 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.22 -52.02 66.54 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.877 0.871 . . . . 0.0 112.31 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -57.09 -48.96 77.32 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.249 1.02 . . . . 0.0 110.081 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.1 tp -56.49 -52.82 63.3 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.919 1.387 . . . . 0.0 110.349 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -55.24 -48.97 73.17 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.497 1.119 . . . . 0.0 112.573 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -50.91 -46.68 60.8 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.978 0.911 . . . . 0.0 112.107 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.634 ' O ' HG12 ' A' ' 123' ' ' ILE . 35.6 mttp -67.78 -52.38 37.85 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.233 177.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.2 mt -48.04 -51.36 24.53 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.68 0.792 . . . . 0.0 112.238 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -52.25 -55.92 18.1 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.846 1.258 . . . . 0.0 112.32 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -61.57 -39.71 92.13 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.193 1.397 . . . . 0.0 113.096 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.634 HG12 ' O ' ' A' ' 119' ' ' LYS . 31.6 mm -57.56 -49.18 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.962 0.905 . . . . 0.0 111.045 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -52.12 -45.42 64.91 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.357 0.663 . . . . 0.0 112.364 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -59.38 -53.55 56.94 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.092 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -59.28 -42.91 92.35 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.51 6.14 7.64 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.54 -7.68 46.36 Favored Glycine 0 CA--C 1.545 1.946 0 C-N-CA 124.59 1.09 . . . . 0.0 114.922 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 89.7 mtp . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.023 -1.465 . . . . 0.0 113.122 -178.827 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 . . . . . 0 CA--C 1.559 1.291 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.1 p -74.14 20.01 0.11 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.205 1.402 . . . . 0.0 114.378 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -117.25 77.65 1.15 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 123.105 1.431 . . . . 0.0 111.684 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -55.43 -31.88 62.26 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 112.341 -2.209 . . . . 0.0 116.409 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.13 27.82 0.65 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 tt -77.91 132.59 37.99 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.618 0.767 . . . . 0.0 109.932 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 51' ' ' TYR . 4.8 ttmm -84.04 104.51 14.17 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 125.032 1.458 . . . . 0.0 112.762 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -104.28 142.29 34.81 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 113.081 -1.872 . . . . 0.0 114.165 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 45' ' ' LYS . 0.3 OUTLIER -119.71 112.14 18.91 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.447 173.819 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 83.1 t -84.26 94.0 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.495 HG12 ' SD ' ' A' ' 60' ' ' MET . 4.2 t -98.21 85.8 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 123.832 1.777 . . . . 0.0 106.284 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -126.97 121.08 30.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 111.908 -2.405 . . . . 0.0 113.488 -175.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.442 ' HB3' ' HG2' ' A' ' 60' ' ' MET . 11.8 p-10 -60.04 -28.15 67.52 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 112.233 -2.258 . . . . 0.0 115.702 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -99.03 103.88 15.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.211 -1.404 . . . . 0.0 107.211 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -41.79 -42.82 2.76 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.975 1.31 . . . . 0.0 113.735 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -51.75 62.98 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.801 1.24 . . . . 0.0 111.41 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.443 ' O ' HG23 ' A' ' 21' ' ' VAL . 13.4 ttt -64.27 -36.19 83.28 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.87 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -52.71 -50.27 63.7 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.633 1.173 . . . . 0.0 110.533 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -58.6 -51.08 71.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.771 1.228 . . . . 0.0 110.211 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.43 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 51.0 mt -55.11 -51.8 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.047 0.939 . . . . 0.0 112.162 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 17' ' ' MET . 16.4 t -57.09 -44.48 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 118.461 0.573 . . . . 0.0 110.992 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -50.26 71.73 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.205 1.402 . . . . 0.0 109.615 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -60.3 -41.59 93.73 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.6 1.16 . . . . 0.0 112.302 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.45 HD22 ' HB2' ' A' ' 113' ' ' ALA . 78.2 mt -56.87 -51.13 70.28 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.252 1.021 . . . . 0.0 110.685 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.8 mt -55.88 -45.71 78.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.018 0.927 . . . . 0.0 111.857 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -56.36 -46.73 79.89 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.678 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -59.83 -38.7 82.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.358 1.463 . . . . 0.0 112.602 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.8 mt -71.2 -13.17 61.83 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.507 1.123 . . . . 0.0 113.836 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.3 -1.17 32.95 Favored Glycine 0 CA--C 1.541 1.676 0 C-N-CA 124.808 1.194 . . . . 0.0 114.806 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -79.2 108.93 13.06 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 123.322 1.534 . . . . 0.0 114.385 -177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -67.87 -51.34 49.32 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 110.726 -2.943 . . . . 0.0 117.42 -176.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.424 ' HB3' ' HG3' ' A' ' 7' ' ' LYS . 78.0 m-20 -97.45 97.24 8.93 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -174.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -133.21 118.39 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.971 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.692 ' HB2' ' HE2' ' A' ' 51' ' ' TYR . 4.1 mp0 -106.28 161.49 14.5 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.31 178.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.89 119.37 21.07 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.61 165.45 16.44 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 113.299 -1.773 . . . . 0.0 109.597 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -109.69 -38.71 5.33 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 118.017 2.599 . . . . 0.0 118.017 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -128.67 167.62 16.94 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.867 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.506 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -44.24 -57.71 4.81 Favored Glycine 0 N--CA 1.478 1.477 0 C-N-CA 125.831 1.681 . . . . 0.0 114.529 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.7 t -55.3 -58.45 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.549 0.739 . . . . 0.0 111.702 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.38 -32.83 57.93 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.462 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . . . -65.74 -50.57 64.31 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.51 1.124 . . . . 0.0 111.249 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.4 mt -58.55 -43.38 89.27 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.873 0.733 . . . . 0.0 110.679 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -54.3 -58.49 7.21 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.492 0.717 . . . . 0.0 110.641 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.598 ' HB3' HD11 ' A' ' 9' ' ' LEU . 16.0 tttt -61.69 -39.66 92.22 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.427 HD11 HG22 ' A' ' 54' ' ' VAL . 3.4 tp -54.66 -37.26 65.51 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.914 1.286 . . . . 0.0 113.669 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -68.63 -10.17 54.39 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.81 15.85 0.34 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.82 94.3 1.98 Allowed Glycine 0 N--CA 1.481 1.661 0 N-CA-C 115.443 0.937 . . . . 0.0 115.443 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 17.84 88.46 0.01 OUTLIER Glycine 0 CA--C 1.546 2.021 0 C-N-CA 128.683 3.039 . . . . 0.0 120.248 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.692 ' HE2' ' HB2' ' A' ' 34' ' ' GLU . 37.6 m-85 -88.63 104.32 16.75 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.894 -1.153 . . . . 0.0 109.89 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.64 27.22 1.9 Allowed Glycine 0 N--CA 1.478 1.458 0 CA-C-N 114.039 -1.437 . . . . 0.0 114.919 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.583 ' HZ ' HD13 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -178.71 131.52 0.12 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.49 1.516 . . . . 0.0 113.062 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.427 HG22 HD11 ' A' ' 46' ' ' LEU . 59.1 t -126.55 115.0 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 113.188 -1.823 . . . . 0.0 107.744 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 94.9 mt -106.2 101.17 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.6 t -120.0 133.42 55.55 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 117.623 2.453 . . . . 0.0 117.623 -175.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 60' ' ' MET . 6.3 m-20 -73.67 136.39 43.8 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.185 -1.371 . . . . 0.0 111.059 176.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -56.73 -49.31 75.59 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.016 0.822 . . . . 0.0 111.324 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -92.29 101.38 13.86 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.11 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.495 ' SD ' HG12 ' A' ' 11' ' ' VAL . 30.0 mtm -133.85 125.28 18.19 Favored Pre-proline 0 N--CA 1.482 1.131 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.363 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -55.52 150.55 42.37 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 124.009 3.139 . . . . 0.0 111.635 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 70.47 -69.51 0.17 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.461 1.904 . . . . 0.0 111.5 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.506 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 18.6 ttp -127.04 109.21 11.65 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -64.94 167.29 7.93 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.327 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.56 -48.82 63.54 Favored Glycine 0 N--CA 1.48 1.619 0 C-N-CA 124.273 0.939 . . . . 0.0 114.602 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.45 -40.07 93.13 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.826 0.45 . . . . 0.0 112.183 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -63.37 -41.82 98.84 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.83 -49.83 75.89 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.949 0.9 . . . . 0.0 110.964 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.715 HD11 ' HB2' ' A' ' 103' ' ' ALA . 4.0 tt -46.75 -50.79 17.56 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.28 1.432 . . . . 0.0 109.274 176.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.69 -46.57 84.92 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.266 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 47.2 p -59.24 -25.31 63.92 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.094 0.958 . . . . 0.0 112.982 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.4 mt -84.02 -58.04 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 73' ' ' ARG . 25.8 mmt180 -49.74 -46.77 50.74 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.875 1.67 . . . . 0.0 113.122 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.37 -18.79 57.05 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -82.57 94.82 7.58 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.736 -0.602 . . . . 0.0 110.178 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -21.18 -62.48 0.02 OUTLIER Glycine 0 CA--C 1.547 2.062 0 C-N-CA 126.88 2.181 . . . . 0.0 116.232 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.16 89.07 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.523 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 49.1 mtm -87.26 -34.67 18.85 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.4 t 2.57 -61.03 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 121.385 3.846 . . . . 0.0 121.385 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.24 25.03 0.62 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 118.855 2.909 . . . . 0.0 118.855 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 78' ' ' MET . 86.2 mt -83.05 118.94 73.25 Favored Pre-proline 0 N--CA 1.483 1.19 0 O-C-N 121.306 -0.872 . . . . 0.0 112.794 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.36 128.34 28.85 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 123.53 2.82 . . . . 0.0 113.675 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.468 HG11 ' HG ' ' A' ' 69' ' ' LEU . 3.4 t -116.57 119.89 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 113.13 -1.85 . . . . 0.0 112.645 -177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.53 HD13 HD11 ' A' ' 123' ' ' ILE . 45.2 tp -108.55 109.45 20.69 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.384 -1.734 . . . . 0.0 108.766 176.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 82.9 mmm -87.32 112.44 22.08 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 113.89 -1.505 . . . . 0.0 114.597 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.56 102.62 13.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 123.901 1.81 . . . . 0.0 108.319 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.9 t -115.71 130.26 56.79 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 111.593 -2.549 . . . . 0.0 109.426 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -46.42 -40.99 13.07 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -141.78 148.55 39.1 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.41 83.3 3.85 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 122.97 1.366 . . . . 0.0 107.718 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.48 ' O ' HG12 ' A' ' 95' ' ' ILE . 87.8 mttt -92.68 112.36 24.29 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 111.011 -2.813 . . . . 0.0 109.139 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 92' ' ' LYS . 71.6 mmtt -34.57 -56.03 0.54 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 117.431 2.382 . . . . 0.0 117.431 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . 0.258 0.0 OUTLIER -55.58 -42.86 75.35 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 177.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -62.63 -47.59 83.07 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.672 1.189 . . . . 0.0 110.335 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 91' ' ' LYS . 18.1 mm -58.08 -49.71 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.1 1.36 . . . . 0.0 112.537 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.439 HG22 ' OE1' ' A' ' 100' ' ' GLN . 31.7 mt -60.1 -50.66 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.284 0.634 . . . . 0.0 110.271 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.89 -46.43 81.92 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.777 0.831 . . . . 0.0 111.908 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.71 -56.24 19.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.427 1.491 . . . . 0.0 112.241 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.38 -48.35 82.13 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.071 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.439 ' OE1' HG22 ' A' ' 96' ' ' ILE . 72.8 mt-30 -56.53 -37.72 70.88 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.84 -16.45 55.41 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.65 12.65 7.15 Favored Glycine 0 CA--C 1.545 1.916 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.715 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -70.34 106.1 3.25 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.981 1.372 . . . . 0.0 111.36 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.473 ' HB3' HG23 ' A' ' 123' ' ' ILE . 6.9 m -56.89 -27.22 60.33 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 112.234 -2.257 . . . . 0.0 113.25 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -173.6 169.08 42.14 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.209 0.909 . . . . 0.0 111.406 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -142.62 142.27 32.08 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.643 -0.778 . . . . 0.0 110.948 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.61 131.47 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 124.742 1.276 . . . . 0.0 111.491 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -79.79 126.0 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 112.34 -2.209 . . . . 0.0 110.301 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 110' ' ' PRO . 34.5 ttpt -91.52 130.6 38.76 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 112.843 -1.98 . . . . 0.0 110.511 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 92.8 Cg_endo -80.41 148.39 77.07 Favored 'Cis proline' 0 N--CA 1.484 0.937 0 O-C-N 123.233 1.123 . . . . 0.0 114.953 0.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -130.31 156.53 44.51 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.002 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 69.9 p -108.96 174.83 5.69 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.693 0.797 . . . . 0.0 111.013 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.45 ' HB2' HD22 ' A' ' 24' ' ' LEU . . . -54.99 -39.0 68.56 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.142 175.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.71 -47.39 72.5 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.039 0.936 . . . . 0.0 111.263 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.0 m -61.32 -46.0 92.12 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 50.6 tp -56.24 -50.67 70.65 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.925 1.29 . . . . 0.0 109.529 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.483 ' HA ' HD12 ' A' ' 120' ' ' LEU . 40.5 tt0 -55.42 -48.77 73.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.293 1.037 . . . . 0.0 111.488 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -55.93 -46.89 78.37 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.361 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.3 mptp? -63.92 -42.18 97.45 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.114 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 117' ' ' GLU . 86.8 mt -53.87 -51.02 64.97 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.219 0.608 . . . . 0.0 111.101 177.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -50.05 -52.29 35.59 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.333 1.053 . . . . 0.0 113.137 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -53.59 -47.05 70.52 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.478 1.511 . . . . 0.0 112.386 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.583 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 57.8 mt -57.46 -51.52 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.872 1.269 . . . . 0.0 111.925 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -56.51 -38.83 72.33 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -61.86 -48.06 82.22 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.817 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -58.25 -41.12 83.53 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.364 1.066 . . . . 0.0 112.175 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -73.4 13.29 0.47 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.66 23.41 73.87 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 125.374 1.464 . . . . 0.0 114.508 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 76.2 mtp . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 116.704 -1.617 . . . . 0.0 112.219 -179.061 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.081 0 N-CA-C 116.048 1.869 . . . . 0.0 116.048 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.6 t -52.26 112.27 0.77 Allowed 'General case' 0 C--O 1.241 0.628 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 43.9 t0 -76.06 85.74 2.95 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -54.71 -28.79 50.46 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -100.07 41.1 1.18 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 123.206 1.479 . . . . 0.0 113.791 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 4.6 tt -86.25 124.72 32.94 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.277 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.61 ' HE3' HD22 ' A' ' 32' ' ' ASN . 12.9 mptt -75.96 107.92 8.5 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 125.095 1.497 . . . . 0.0 113.393 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -102.88 132.83 48.82 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 112.402 -2.181 . . . . 0.0 111.8 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.529 HD21 ' HD3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -108.46 102.7 11.77 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.069 -1.053 . . . . 0.0 109.288 173.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.526 ' HA ' HG23 ' A' ' 55' ' ' ILE . 46.6 t -79.14 98.72 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 113.481 -1.69 . . . . 0.0 106.777 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.754 HG11 ' HB2' ' A' ' 42' ' ' ALA . 3.3 t -108.24 60.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 112.241 -2.254 . . . . 0.0 107.138 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.612 ' HA ' ' HB2' ' A' ' 57' ' ' ASP . 11.6 t70 -109.56 90.38 3.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 113.359 -1.746 . . . . 0.0 108.638 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -13.58 -42.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 121.58 3.919 . . . . 0.0 121.58 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.523 ' C ' ' H ' ' A' ' 16' ' ' THR . 2.6 t80 -87.57 109.6 19.76 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 t -65.98 27.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 124.167 1.937 . . . . 0.0 115.697 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.523 ' H ' ' C ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -123.72 -58.52 1.58 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.062 2.545 . . . . 0.0 105.448 177.031 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.528 ' HA ' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -60.05 -35.82 75.96 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.696 177.747 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 36' ' ' ALA . 8.8 ttp180 -53.76 -50.93 64.94 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.521 1.529 . . . . 0.0 112.139 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.632 ' CZ ' HD21 ' A' ' 23' ' ' ASN . 3.0 tmt_? -65.24 -38.37 90.15 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.809 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 17' ' ' MET . 71.6 mt -57.73 -46.3 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 17' ' ' MET . 12.7 t -58.26 -42.52 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.462 0.705 . . . . 0.0 110.049 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.459 ' NH2' ' HE ' ' A' ' 19' ' ' ARG . 46.9 ttp180 -53.01 -52.57 57.97 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.187 0.995 . . . . 0.0 110.575 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.632 HD21 ' CZ ' ' A' ' 19' ' ' ARG . 80.9 m-20 -57.71 -41.02 80.88 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.355 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -59.62 -51.44 69.79 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.135 0.974 . . . . 0.0 110.774 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.9 mt -56.56 -44.51 81.01 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.015 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -58.59 -42.26 87.69 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.981 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -59.78 -38.55 82.16 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.627 1.171 . . . . 0.0 110.48 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 mp -74.94 -11.9 60.22 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.29 2.236 . . . . 0.0 115.17 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.82 -0.61 41.91 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.035 1.302 . . . . 0.0 114.648 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -89.13 97.95 11.49 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 123.266 1.508 . . . . 0.0 112.459 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -72.46 -37.33 68.55 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 110.858 -2.883 . . . . 0.0 116.056 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.61 HD22 ' HE3' ' A' ' 7' ' ' LYS . 3.6 m120 -95.91 96.4 8.89 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.749 1.262 . . . . 0.0 113.895 -173.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.2 t -129.66 131.96 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.407 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -117.72 154.8 31.07 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -126.96 120.19 28.52 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -122.31 152.99 39.54 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 113.611 -1.631 . . . . 0.0 109.863 177.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -78.37 -66.13 0.89 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -129.44 -176.61 3.95 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 117.972 -1.013 . . . . 0.0 112.16 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 42' ' ' ALA . . . -45.39 -53.55 7.98 Favored Glycine 0 N--CA 1.482 1.766 0 O-C-N 125.048 1.467 . . . . 0.0 114.112 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -57.32 -57.87 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.348 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -55.52 -34.65 64.84 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.754 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -58.26 -53.56 56.85 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.753 1.221 . . . . 0.0 110.385 177.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.4 mt -60.27 -41.87 94.2 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.928 0.891 . . . . 0.0 111.313 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.418 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 24.8 m120 -53.35 -52.14 60.18 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.811 0.844 . . . . 0.0 111.233 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HD3' HD21 ' A' ' 9' ' ' LEU . 12.7 tttp -70.36 -41.2 73.43 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 124.212 0.945 . . . . 0.0 113.141 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.9 mt -54.42 -36.42 63.98 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 10.6 pt20 -52.33 -26.46 12.29 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.4 -19.16 64.44 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.44 -170.42 52.17 Favored Glycine 0 N--CA 1.474 1.224 0 C-N-CA 124.427 1.013 . . . . 0.0 111.113 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.75 -29.7 1.52 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 115.504 0.962 . . . . 0.0 115.504 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -67.85 107.99 2.83 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.52 -22.86 52.74 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-N 112.587 -2.097 . . . . 0.0 110.028 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.514 ' HZ ' HD13 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -133.35 141.65 48.02 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -174.212 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.5 t -127.16 110.68 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 113.765 -1.562 . . . . 0.0 107.343 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.526 HG23 ' HA ' ' A' ' 10' ' ' VAL . 13.1 tt -110.22 93.3 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 124.094 1.902 . . . . 0.0 106.607 177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.1 t -117.27 147.76 42.27 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 111.887 -2.415 . . . . 0.0 115.433 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.612 ' HB2' ' HA ' ' A' ' 12' ' ' ASP . 4.8 t70 -79.63 144.29 33.92 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.733 -1.122 . . . . 0.0 112.834 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.482 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 20.3 t-105 -61.23 -47.2 87.16 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.077 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -95.59 103.38 15.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.673 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 54.0 mtm -134.99 134.24 21.58 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-N 113.243 -1.799 . . . . 0.0 110.531 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -60.42 143.62 99.48 Favored 'Trans proline' 0 N--CA 1.482 0.827 0 C-N-CA 123.186 2.59 . . . . 0.0 112.089 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 m120 67.89 -69.81 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.902 1.681 . . . . 0.0 113.763 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.1 ttm -114.86 98.75 7.01 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -61.56 165.87 4.59 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 112.605 -2.088 . . . . 0.0 111.932 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.44 -52.08 29.73 Favored Glycine 0 N--CA 1.476 1.353 0 C-N-CA 124.692 1.139 . . . . 0.0 115.081 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 42.2 tp -58.84 -38.46 78.74 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.225 1.01 . . . . 0.0 113.222 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -72.44 -36.27 68.51 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.57 0.748 . . . . 0.0 111.014 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -59.03 -38.22 78.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.804 0.841 . . . . 0.0 111.016 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' A' ' 103' ' ' ALA . 9.1 mp -50.92 -52.24 44.1 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.76 1.224 . . . . 0.0 109.832 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -56.38 -48.76 76.21 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.042 -1.435 . . . . 0.0 112.505 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.3 p -58.17 -33.42 69.22 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.8 mt -80.8 -57.35 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.5 ' HG3' ' HA3' ' A' ' 102' ' ' GLY . 24.9 mmt180 -49.23 -45.82 45.09 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.344 1.858 . . . . 0.0 114.11 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.74 -25.52 61.23 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -81.34 93.9 6.65 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.187 0.595 . . . . 0.0 109.514 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -25.71 -58.76 0.07 OUTLIER Glycine 0 CA--C 1.542 1.753 0 C-N-CA 127.078 2.275 . . . . 0.0 116.756 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.77 -38.91 83.12 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.47 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 91.3 mtp -89.52 -45.38 9.45 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.412 1.485 . . . . 0.0 114.608 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.2 t 8.82 -78.21 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 120.091 3.367 . . . . 0.0 120.091 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.03 29.25 0.13 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 118.655 2.835 . . . . 0.0 118.655 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 78' ' ' MET . 82.4 mt -76.62 133.81 70.12 Favored Pre-proline 0 N--CA 1.479 0.981 0 O-C-N 121.184 -0.947 . . . . 0.0 111.876 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -56.81 114.23 1.83 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.816 2.344 . . . . 0.0 112.806 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 81' ' ' LEU . 37.0 t -109.94 110.97 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 111.704 -2.498 . . . . 0.0 109.245 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.51 HD23 HD12 ' A' ' 55' ' ' ILE . 41.1 tp -106.56 104.08 13.68 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 112.805 -1.998 . . . . 0.0 109.363 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.5 mmt -78.57 118.13 20.4 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 113.053 -1.885 . . . . 0.0 112.678 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.674 HG12 ' HB2' ' A' ' 109' ' ' LYS . 1.5 t -91.18 96.72 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.7 p -94.38 114.97 27.11 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.256 -1.793 . . . . 0.0 112.886 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.05 -22.01 5.37 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -166.74 118.79 0.97 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.61 92.96 4.77 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.578 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 95' ' ' ILE . 78.0 mttt -101.68 132.19 47.51 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.395 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -41.17 -46.78 3.14 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.734 1.213 . . . . 0.0 114.134 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -52.74 -55.32 23.62 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.708 1.603 . . . . 0.0 110.973 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -58.91 -42.91 90.73 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.352 1.461 . . . . 0.0 111.241 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 91' ' ' LYS . 14.7 mm -60.39 -49.09 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.52 1.128 . . . . 0.0 111.547 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 37.4 mt -57.73 -50.95 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.81 -45.84 74.43 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.087 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.482 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -57.42 -54.89 41.71 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.693 1.197 . . . . 0.0 112.418 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.38 -41.99 81.27 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.334 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -66.14 -40.04 90.31 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.73 0.55 52.49 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 117.674 2.472 . . . . 0.0 117.674 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.5 ' HA3' ' HG3' ' A' ' 73' ' ' ARG . . . 110.34 21.6 6.85 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 117.702 1.841 . . . . 0.0 117.702 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.599 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -82.62 110.32 17.58 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.416 1.108 . . . . 0.0 112.029 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.9 m -59.99 -30.26 69.01 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 113.219 -1.81 . . . . 0.0 113.519 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.25 173.45 46.28 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.198 1.38 . . . . 0.0 110.055 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -148.83 139.08 22.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.052 -0.574 . . . . 0.0 112.527 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.9 p -115.2 117.93 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 124.2 0.937 . . . . 0.0 109.505 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.0 p -71.33 109.45 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 113.076 -1.874 . . . . 0.0 114.261 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.674 ' HB2' HG12 ' A' ' 86' ' ' VAL . 68.1 tttt -83.13 130.11 58.43 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 111.079 -2.782 . . . . 0.0 107.681 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.6 133.34 26.6 Favored 'Cis proline' 0 CA--C 1.54 0.78 0 O-C-N 123.962 1.506 . . . . 0.0 114.854 0.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.441 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 17.9 p90 -130.58 157.25 43.23 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 112.653 -2.067 . . . . 0.0 109.01 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.2 t -116.61 176.02 5.3 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.063 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.45 -41.78 61.08 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.203 1.001 . . . . 0.0 111.82 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.99 -50.07 73.55 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.568 0.747 . . . . 0.0 112.819 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.32 -45.04 94.81 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.623 1.169 . . . . 0.0 109.982 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 58.1 tp -56.99 -50.54 72.38 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.305 1.042 . . . . 0.0 109.888 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -58.13 -47.65 82.66 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.61 0.764 . . . . 0.0 111.376 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -51.22 -43.36 61.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.484 0.714 . . . . 0.0 112.278 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -72.78 -41.7 64.74 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.187 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.1 mt -56.96 -46.31 82.23 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.398 0.679 . . . . 0.0 111.157 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -52.14 -48.18 65.01 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.089 1.356 . . . . 0.0 111.935 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -52.93 -48.81 67.02 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.129 1.372 . . . . 0.0 111.595 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.514 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 9.1 mt -60.47 -49.43 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.267 1.027 . . . . 0.0 111.68 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -57.01 -38.96 73.83 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.686 0.794 . . . . 0.0 112.064 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -63.21 -43.04 99.25 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 123.773 0.671 . . . . 0.0 112.153 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -73.14 -54.18 9.14 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.275 1.03 . . . . 0.0 113.32 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.3 mt -90.65 36.43 0.9 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 32.28 51.64 0.4 Allowed Glycine 0 N--CA 1.489 2.204 0 C-N-CA 126.202 1.858 . . . . 0.0 116.519 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 7.2 mmt . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 115.041 -2.409 . . . . 0.0 116.221 -178.947 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -73.67 79.81 1.52 Allowed 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 122.598 1.19 . . . . 0.0 113.41 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -79.12 80.17 5.48 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.045 0.926 . . . . 0.0 112.178 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HA ' ' HD1' ' A' ' 30' ' ' PHE . 42.8 mmtm -50.63 -49.49 56.73 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.27 50.93 1.82 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.756 1.265 . . . . 0.0 114.042 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 53' ' ' PHE . 5.1 tt -109.76 122.96 48.69 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.768 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -81.76 109.28 16.01 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.108 0.956 . . . . 0.0 112.495 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -96.24 139.24 32.67 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 111.802 -2.454 . . . . 0.0 111.783 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.462 ' CD1' HG22 ' A' ' 11' ' ' VAL . 2.1 tm? -118.19 104.87 11.22 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.437 176.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.2 t -83.7 111.19 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 112.095 -2.321 . . . . 0.0 108.775 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -114.02 91.13 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.544 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 57' ' ' ASP . 8.5 m-20 -137.19 115.27 11.59 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.745 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.418 ' OD1' ' HB3' ' A' ' 37' ' ' GLU . 3.5 t70 -80.12 77.12 6.85 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.966 -178.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.435 ' HD2' ' HB2' ' A' ' 17' ' ' MET . 11.5 t80 172.25 115.09 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 111.816 -2.447 . . . . 0.0 106.127 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.2 t -42.25 -55.67 3.22 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.228 1.011 . . . . 0.0 113.338 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.69 -47.5 85.38 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.708 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.435 ' HB2' ' HD2' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -62.43 -45.55 92.59 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.165 0.586 . . . . 0.0 111.829 -179.599 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.417 ' HD2' ' HB2' ' A' ' 35' ' ' GLU . 38.1 ttp180 -59.26 -45.2 91.83 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.759 1.224 . . . . 0.0 110.472 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -43.89 96.01 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.121 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.0 mt -56.17 -57.26 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-O 118.589 -0.719 . . . . 0.0 111.084 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.519 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 13.6 t -54.1 -44.53 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 123.512 0.507 . . . . 0.0 111.19 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.59 ' HG2' ' NZ ' ' A' ' 26' ' ' LYS . 34.9 ttt180 -55.92 -53.45 56.73 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.065 1.346 . . . . 0.0 111.735 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -62.87 -38.8 92.3 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.127 0.971 . . . . 0.0 113.331 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 75.7 mt -56.92 -48.88 77.22 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.175 0.99 . . . . 0.0 111.114 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.9 mt -60.27 -44.81 94.99 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.783 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.59 ' NZ ' ' HG2' ' A' ' 22' ' ' ARG . 63.5 mttp -56.44 -45.13 80.95 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.0 176.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 36.3 mt-10 -60.32 -35.99 76.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.479 1.512 . . . . 0.0 113.032 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.0 mt -74.44 -2.03 23.71 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.306 1.443 . . . . 0.0 114.372 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.8 -9.89 60.38 Favored Glycine 0 CA--C 1.542 1.76 0 C-N-CA 124.566 1.079 . . . . 0.0 112.752 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.432 ' HD1' ' HA ' ' A' ' 4' ' ' LYS . 6.5 m-85 -93.15 76.71 4.63 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 123.126 1.441 . . . . 0.0 110.078 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -66.29 -24.04 66.49 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.594 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -78.7 80.83 5.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.653 1.581 . . . . 0.0 112.062 -178.632 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.5 130.35 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.929 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.609 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 6.8 mp0 -120.61 160.91 22.29 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.417 ' HB2' ' HD2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -132.57 147.87 52.36 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 120.398 3.481 . . . . 0.0 120.398 -176.081 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.469 ' HB2' ' HD2' ' A' ' 45' ' ' LYS . . . -140.54 163.88 31.64 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 110.94 -2.845 . . . . 0.0 108.307 177.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . 22.5 mt-10 -112.04 -35.51 5.64 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -129.07 158.57 38.55 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.875 0.735 . . . . 0.0 111.148 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -39.27 -52.89 2.79 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 125.528 1.767 . . . . 0.0 116.064 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.476 HG21 HD21 ' A' ' 62' ' ' ASN . 74.3 t -59.77 -50.12 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 118.481 -0.771 . . . . 0.0 112.582 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -56.04 -44.05 78.41 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.045 0.926 . . . . 0.0 109.672 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.27 -52.15 65.92 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.398 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.4 mt -51.08 -51.25 55.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.406 1.066 . . . . 0.0 111.022 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -53.29 -54.79 31.28 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.447 1.099 . . . . 0.0 112.475 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HD2' ' HB2' ' A' ' 36' ' ' ALA . 29.4 mttp -57.6 -48.9 78.12 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 113.808 -1.542 . . . . 0.0 113.043 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 31.2 mt -59.79 -41.74 91.83 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.536 1.134 . . . . 0.0 112.479 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -57.24 -25.43 59.12 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.16 -19.77 63.18 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.41 -166.31 19.68 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.854 1.216 . . . . 0.0 111.434 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.38 -41.43 1.84 Allowed Glycine 0 N--CA 1.483 1.775 0 C-N-CA 124.3 0.952 . . . . 0.0 115.241 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.609 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 78.9 m-85 -70.91 136.1 48.36 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.69 16.51 7.87 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 112.656 -2.065 . . . . 0.0 113.397 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.653 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -172.41 140.08 1.06 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.367 1.067 . . . . 0.0 111.975 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 t -122.37 114.1 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.045 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.7 mt -108.44 98.96 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.0 t -120.87 137.09 54.75 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.445 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 31.0 t0 -73.18 133.82 44.17 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 112.348 -2.205 . . . . 0.0 110.197 177.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.447 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 30.9 t-105 -59.26 -49.77 76.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.027 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -88.78 99.86 12.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.391 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.524 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 8.7 mtm -141.95 121.77 8.17 Favored Pre-proline 0 N--CA 1.478 0.931 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.106 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -62.28 164.42 17.57 Favored 'Trans proline' 0 N--CA 1.479 0.627 0 C-N-CA 123.208 2.605 . . . . 0.0 109.006 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.476 HD21 HG21 ' A' ' 40' ' ' VAL . 0.6 OUTLIER 70.82 -79.68 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.09 0.956 . . . . 0.0 109.633 -176.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.5 ttm -130.36 107.31 9.16 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.854 0.862 . . . . 0.0 108.948 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.524 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.7 p30 -62.85 162.08 11.65 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.029 -1.441 . . . . 0.0 112.895 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.21 -53.41 15.41 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 124.975 1.274 . . . . 0.0 114.793 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.67 -44.98 93.38 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.172 0.589 . . . . 0.0 111.887 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.71 -40.81 98.34 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -44.52 88.7 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.722 1.209 . . . . 0.0 110.328 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tp -58.97 -47.09 86.38 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.515 1.126 . . . . 0.0 111.012 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.13 -43.41 91.97 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.536 0.735 . . . . 0.0 112.76 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.268 4.7 p -64.29 -33.93 76.96 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.114 0.966 . . . . 0.0 111.811 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.5 mt -69.32 -56.49 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 73' ' ' ARG . 71.0 mmt-85 -53.53 -43.37 68.32 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.476 1.51 . . . . 0.0 113.065 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.77 -30.13 65.22 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -87.84 95.56 10.14 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.136 0.574 . . . . 0.0 112.088 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -13.65 -72.51 0.01 OUTLIER Glycine 0 N--CA 1.489 2.169 0 C-N-CA 127.821 2.629 . . . . 0.0 117.478 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.46 -40.54 68.51 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 50.9 mtm -88.53 -14.16 38.4 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.2 m -48.12 -25.14 1.34 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 117.365 2.358 . . . . 0.0 117.365 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.98 -7.81 50.99 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.426 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 96.4 mt -70.2 111.56 9.71 Favored Pre-proline 0 N--CA 1.485 1.283 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 11.5 Cg_endo -51.96 133.9 47.4 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 123.181 2.587 . . . . 0.0 113.921 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.2 t -120.53 126.82 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 122.812 1.292 . . . . 0.0 113.304 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.653 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 1.7 tm? -113.01 116.89 30.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 111.656 -2.52 . . . . 0.0 107.389 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 28.6 mmt -95.39 109.89 22.0 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 122.734 1.254 . . . . 0.0 113.437 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.31 96.02 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 123.178 1.466 . . . . 0.0 107.428 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -108.17 141.29 40.12 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 112.357 -2.201 . . . . 0.0 114.241 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.3 -29.59 70.88 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.404 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -134.1 129.33 35.81 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.299 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -94.1 55.83 2.13 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 123.997 1.856 . . . . 0.0 108.489 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -98.81 139.91 33.78 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 112.887 -1.961 . . . . 0.0 107.542 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 25.3 mmtp -34.52 -48.47 0.36 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -51.62 -49.83 61.47 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.736 0.647 . . . . 0.0 112.556 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -64.06 -47.81 78.67 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.504 1.122 . . . . 0.0 111.507 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 68.9 mt -57.94 -57.26 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.809 1.244 . . . . 0.0 111.83 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.9 mt -54.56 -52.75 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.878 0.871 . . . . 0.0 110.307 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.21 -52.71 58.01 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.151 0.981 . . . . 0.0 112.194 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.447 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -57.15 -52.58 64.75 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.677 1.191 . . . . 0.0 113.095 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.36 -48.84 80.11 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.64 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -60.07 -36.19 76.8 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 73' ' ' ARG . . . -78.12 -6.58 55.15 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.01 4.14 27.75 Favored Glycine 0 CA--C 1.548 2.148 0 N-CA-C 116.151 1.22 . . . . 0.0 116.151 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.02 119.73 10.67 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.906 1.353 . . . . 0.0 112.099 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.2 m -64.12 -36.32 83.64 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 112.362 -2.199 . . . . 0.0 112.448 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -169.79 178.67 42.61 Favored Glycine 0 CA--C 1.541 1.659 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.749 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -152.96 143.01 22.31 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.4 p -122.39 125.41 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 124.623 1.202 . . . . 0.0 109.972 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.1 p -85.54 122.64 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 113.937 -1.483 . . . . 0.0 111.073 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -83.83 138.12 40.63 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 113.764 -1.562 . . . . 0.0 113.249 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.41 143.01 75.0 Favored 'Cis proline' 0 CA--C 1.546 1.1 0 O-C-N 123.072 1.038 . . . . 0.0 114.787 0.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.519 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 33.8 p90 -134.91 151.12 50.6 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 112.31 -2.223 . . . . 0.0 108.642 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.2 t -107.16 175.61 5.44 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.189 0.931 . . . . 0.0 109.928 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.64 -42.46 56.34 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.936 0.894 . . . . 0.0 111.993 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.3 -44.45 95.0 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.294 1.038 . . . . 0.0 112.886 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.24 -48.66 77.28 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.466 0.707 . . . . 0.0 109.333 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.3 tp -55.94 -46.96 78.35 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.935 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.485 ' HG2' ' OD1' ' A' ' 121' ' ' ASN . 7.0 tt0 -58.36 -50.9 72.0 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.891 0.876 . . . . 0.0 110.975 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -49.19 -45.25 43.87 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.719 0.808 . . . . 0.0 112.618 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -66.24 -48.09 71.66 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.741 1.216 . . . . 0.0 111.807 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.401 ' HB3' ' CE2' ' A' ' 124' ' ' PHE . 96.3 mt -57.61 -46.73 83.72 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.064 0.946 . . . . 0.0 111.902 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.485 ' OD1' ' HG2' ' A' ' 117' ' ' GLU . 31.5 m-20 -48.14 -53.48 16.56 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.478 1.511 . . . . 0.0 112.079 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.1 tttt -51.68 -47.91 63.68 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 113.841 -1.527 . . . . 0.0 112.161 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.606 HG13 ' HZ ' ' A' ' 53' ' ' PHE . 8.3 mm -58.49 -57.47 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.693 1.197 . . . . 0.0 109.644 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' A' ' 120' ' ' LEU . 22.3 m-85 -52.47 -49.31 64.92 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.597 1.159 . . . . 0.0 113.334 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.52 -46.73 89.08 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.71 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.96 -41.52 96.52 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.926 1.291 . . . . 0.0 111.792 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.6 mp -93.6 15.45 16.13 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.74 -46.79 2.07 Favored Glycine 0 N--CA 1.48 1.599 0 C-N-CA 125.053 1.311 . . . . 0.0 114.397 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 21.0 ptt? . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -179.445 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t -124.14 145.21 49.44 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.36 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -81.74 92.93 6.71 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.197 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 54.0 mtmt -56.39 -24.15 42.74 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -86.5 66.03 9.31 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 123.42 1.581 . . . . 0.0 110.911 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.2 tt -102.38 135.87 43.23 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.049 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -77.87 110.29 12.63 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -110.07 142.65 41.24 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.824 1.649 . . . . 0.0 112.698 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.589 HD12 ' HG ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -117.89 110.34 17.63 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 122.22 1.01 . . . . 0.0 109.932 173.402 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.7 t -85.92 107.87 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 113.862 -1.517 . . . . 0.0 107.495 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' A' ' 42' ' ' ALA . 2.8 t -112.74 94.36 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.745 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -135.27 131.92 37.14 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.702 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -60.63 -25.01 65.97 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -101.07 105.34 16.51 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 44.3 p -41.21 -45.61 2.9 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.417 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -62.64 -52.79 61.95 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.404 1.082 . . . . 0.0 112.188 176.689 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -39.05 87.74 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.561 0.344 . . . . 0.0 110.222 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -55.45 -51.58 66.44 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.495 1.118 . . . . 0.0 110.683 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.466 HH21 ' NH1' ' A' ' 22' ' ' ARG . 10.3 ttt180 -63.92 -36.53 84.25 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.47 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 42.3 mm -55.73 -47.5 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 122.625 0.37 . . . . 0.0 110.474 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -60.1 -44.44 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 122.849 0.459 . . . . 0.0 110.092 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.466 ' NH1' HH21 ' A' ' 19' ' ' ARG . 0.0 OUTLIER -54.19 -50.03 67.98 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.457 1.103 . . . . 0.0 110.575 176.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -59.69 -44.65 93.57 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.495 0.718 . . . . 0.0 111.814 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.536 HD22 ' HB2' ' A' ' 113' ' ' ALA . 77.7 mt -56.06 -52.62 63.61 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.293 1.037 . . . . 0.0 111.442 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 73.9 mt -54.91 -45.51 74.74 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.759 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 27.3 mtpp -56.88 -46.39 81.91 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.285 177.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 28.5 mt-10 -59.5 -40.61 87.6 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.879 1.672 . . . . 0.0 111.746 177.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.4 mp -70.8 -16.14 62.71 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.892 1.677 . . . . 0.0 114.755 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.55 -5.81 33.33 Favored Glycine 0 CA--C 1.543 1.832 0 C-N-CA 125.342 1.448 . . . . 0.0 114.05 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 65.1 m-85 -92.94 67.66 4.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 123.506 1.622 . . . . 0.0 111.022 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -69.48 -14.09 62.69 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 116.974 2.213 . . . . 0.0 116.974 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -92.84 78.2 4.76 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 122.924 1.345 . . . . 0.0 108.987 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 p -126.87 130.87 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 113.757 -1.565 . . . . 0.0 114.189 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' O ' HD23 ' A' ' 9' ' ' LEU . 4.5 tm-20 -106.64 156.29 18.77 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 113.615 -1.629 . . . . 0.0 107.885 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -123.85 121.92 36.65 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -130.06 157.47 42.28 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 113.547 -1.661 . . . . 0.0 108.433 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -105.24 -40.63 5.78 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -130.71 162.3 29.75 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.289 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -42.63 -50.58 5.78 Favored Glycine 0 N--CA 1.484 1.855 0 O-C-N 125.531 1.769 . . . . 0.0 115.943 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.4 t -58.69 -53.58 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 119.091 -0.48 . . . . 0.0 111.541 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.51 -37.14 74.96 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.471 0.709 . . . . 0.0 110.995 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.555 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -61.45 -54.08 48.08 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.044 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.46 -38.13 86.1 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 123.862 0.727 . . . . 0.0 112.853 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 20.7 m120 -57.55 -50.33 73.45 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.126 0.891 . . . . 0.0 111.099 175.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -67.67 -42.97 81.3 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.828 1.251 . . . . 0.0 112.63 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.589 ' HG ' HD12 ' A' ' 9' ' ' LEU . 16.5 mt -59.87 -45.09 93.58 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.535 1.934 . . . . 0.0 114.563 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 19.0 pt20 -57.8 -14.62 6.23 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.67 -23.64 66.17 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.902 0.881 . . . . 0.0 112.337 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.15 -178.51 43.4 Favored Glycine 0 N--CA 1.48 1.609 0 C-N-CA 125.107 1.337 . . . . 0.0 113.757 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.4 -26.12 3.58 Favored Glycine 0 N--CA 1.482 1.705 0 CA-C-N 113.662 -1.269 . . . . 0.0 116.154 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -64.51 111.03 2.51 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.73 12.57 65.94 Favored Glycine 0 CA--C 1.541 1.665 0 O-C-N 125.103 1.502 . . . . 0.0 112.472 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.529 ' HZ ' HD13 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -168.73 141.06 2.75 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.016 0.926 . . . . 0.0 112.071 179.118 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.6 t -129.39 122.58 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.543 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.8 mt -111.68 102.53 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.2 t -122.27 133.84 54.68 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 116.909 2.188 . . . . 0.0 116.909 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -73.82 127.99 34.31 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 111.335 -2.666 . . . . 0.0 110.767 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.46 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 13.6 t-105 -56.04 -43.57 77.96 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.778 1.231 . . . . 0.0 110.73 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -91.13 94.49 9.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.202 1.401 . . . . 0.0 109.062 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.503 ' SD ' HG12 ' A' ' 11' ' ' VAL . 15.2 mtm -141.24 121.87 8.72 Favored Pre-proline 0 N--CA 1.476 0.83 0 CA-C-N 114.179 -1.373 . . . . 0.0 113.516 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -55.25 158.74 11.48 Favored 'Trans proline' 0 N--CA 1.479 0.652 0 C-N-CA 123.139 2.56 . . . . 0.0 110.945 175.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.349 21.3 p30 66.84 -72.36 0.09 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.226 2.21 . . . . 0.0 112.024 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.496 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 43.4 ttp -128.86 108.18 10.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.508 0.723 . . . . 0.0 109.728 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -62.43 164.6 7.12 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.474 -1.694 . . . . 0.0 113.033 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.78 -54.76 23.7 Favored Glycine 0 N--CA 1.479 1.555 0 C-N-CA 125.132 1.349 . . . . 0.0 114.24 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.3 tp -57.01 -40.95 77.61 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.7 -40.43 84.32 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.553 0.341 . . . . 0.0 111.562 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.01 -41.03 95.75 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.778 1.231 . . . . 0.0 110.784 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 103' ' ' ALA . 2.9 tt -51.76 -51.2 58.04 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.286 1.434 . . . . 0.0 108.718 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -59.41 -43.19 93.07 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.429 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.7 p -69.25 -0.61 6.37 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.5 mt -109.64 -62.02 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.647 ' HG2' ' HA3' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -51.2 -44.52 61.61 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.16 1.784 . . . . 0.0 113.83 -179.372 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.83 -3.35 49.1 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -85.69 99.85 11.59 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -10.25 -77.87 0.01 OUTLIER Glycine 0 N--CA 1.488 2.165 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.96 -41.23 99.46 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 76.6 mtp -85.93 -6.71 59.02 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.6 t -34.06 -61.99 0.34 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 118.972 2.953 . . . . 0.0 118.972 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.41 18.05 0.45 Allowed 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 119.248 3.055 . . . . 0.0 119.248 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 69.9 mt -84.9 120.14 73.4 Favored Pre-proline 0 CA--C 1.543 0.708 0 O-C-N 121.215 -0.928 . . . . 0.0 112.689 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 9.5 Cg_endo -52.22 132.96 45.97 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.812 3.008 . . . . 0.0 113.901 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.506 HG11 ' HG ' ' A' ' 69' ' ' LEU . 11.3 t -118.96 115.58 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 112.61 -2.086 . . . . 0.0 112.314 -176.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.556 HD13 HD11 ' A' ' 123' ' ' ILE . 62.5 tp -107.43 105.59 15.58 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 113.858 -1.519 . . . . 0.0 107.635 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.5 mmt -79.35 138.19 37.6 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 113.284 -1.78 . . . . 0.0 111.708 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.7 t -112.43 104.66 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 p -102.47 152.56 20.98 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.439 -1.255 . . . . 0.0 113.587 -175.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.62 -40.12 95.96 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.361 -1.745 . . . . 0.0 111.705 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -159.95 148.36 17.18 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.693 1.597 . . . . 0.0 112.211 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.48 94.68 8.59 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.149 0.906 . . . . 0.0 109.813 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -125.38 130.36 51.76 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.418 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -25.95 -61.11 0.07 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 116.42 2.008 . . . . 0.0 116.42 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -57.19 -46.17 83.08 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -68.62 -37.41 79.72 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 91.5 mt -59.41 -50.02 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.386 1.075 . . . . 0.0 109.051 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.4 mm -55.67 -55.46 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.468 1.107 . . . . 0.0 110.241 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.54 -49.3 62.24 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.237 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.46 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -59.96 -57.28 13.52 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.451 1.1 . . . . 0.0 113.646 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.78 -51.03 71.25 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.244 1.017 . . . . 0.0 111.995 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.19 -30.23 70.92 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.12 -13.19 58.93 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.647 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 120.61 -3.21 12.18 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 116.895 1.518 . . . . 0.0 116.895 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.566 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -57.78 114.09 2.14 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 118.918 1.359 . . . . 0.0 112.878 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.481 ' HB3' HG23 ' A' ' 123' ' ' ILE . 5.0 m -63.56 -26.79 68.86 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 112.007 -2.36 . . . . 0.0 113.76 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.7 166.25 35.89 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.742 1.163 . . . . 0.0 110.353 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -142.25 137.63 30.83 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 p -121.51 131.95 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.89 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.98 139.63 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.598 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.08 140.42 28.98 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.617 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.62 135.86 20.28 Favored 'Cis proline' 0 C--N 1.352 0.715 0 O-C-N 122.47 0.721 . . . . 0.0 110.983 -2.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -113.43 154.71 26.53 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.293 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.8 t -110.27 178.24 4.45 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.15 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.536 ' HB2' HD22 ' A' ' 24' ' ' LEU . . . -51.27 -44.19 61.76 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.664 1.185 . . . . 0.0 111.893 178.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.24 -51.72 67.78 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.245 1.018 . . . . 0.0 111.888 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.44 -47.21 82.39 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.191 0.996 . . . . 0.0 110.389 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 47.7 tp -56.58 -53.51 56.69 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.11 1.364 . . . . 0.0 109.506 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -53.89 -47.19 71.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.77 1.228 . . . . 0.0 112.354 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.38 -50.25 70.21 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -62.54 -43.15 99.52 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 61.7 mt -52.84 -46.23 67.71 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -55.4 -51.64 66.18 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.584 0.754 . . . . 0.0 112.843 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -56.5 -43.36 79.64 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.35 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.556 HD11 HD13 ' A' ' 84' ' ' LEU . 62.2 mt -58.44 -53.56 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.038 0.935 . . . . 0.0 110.58 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.454 ' HB3' ' SD ' ' A' ' 129' ' ' MET . 21.5 m-85 -56.45 -39.87 73.87 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.736 0.814 . . . . 0.0 113.144 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.43 -52.83 62.95 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.098 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -57.6 -41.23 80.78 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.777 0.831 . . . . 0.0 112.006 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.8 mp -60.79 -22.8 64.49 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.041 1.336 . . . . 0.0 114.428 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 61.9 39.37 97.43 Favored Glycine 0 CA--C 1.542 1.75 0 C-N-CA 124.04 0.829 . . . . 0.0 111.963 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.454 ' SD ' ' HB3' ' A' ' 124' ' ' PHE . 26.1 ptm . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.1 t -84.05 76.66 10.04 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -38.26 -31.22 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -176.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -26.14 24.68 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 177.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -66.77 9.03 0.2 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.821 2.048 . . . . 0.0 115.574 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.52 97.04 3.61 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -175.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.4 ' HG3' ' HB2' ' A' ' 32' ' ' ASN . 34.0 tttt -79.53 111.27 15.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.724 -1.58 . . . . 0.0 111.692 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -92.26 136.58 33.08 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 112.141 -2.3 . . . . 0.0 112.107 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.561 HD12 HD13 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -111.16 104.04 12.52 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 118.698 -1.201 . . . . 0.0 109.145 173.193 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.552 ' HA ' HG23 ' A' ' 55' ' ' ILE . 48.2 t -80.29 97.54 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 112.968 -1.923 . . . . 0.0 105.848 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.506 HG11 ' HB2' ' A' ' 42' ' ' ALA . 5.0 t -101.04 84.6 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 112.702 -2.044 . . . . 0.0 107.808 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.611 ' HB3' ' HG3' ' A' ' 18' ' ' ARG . 7.0 t70 -133.94 121.14 21.25 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.105 -1.861 . . . . 0.0 111.752 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -54.9 -28.23 49.02 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 112.264 -2.244 . . . . 0.0 115.55 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -97.34 119.71 36.37 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.559 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.3 p -50.39 -50.93 50.24 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 125.028 1.455 . . . . 0.0 112.929 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -43.78 98.35 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.188 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 13.2 tpt -62.64 -40.89 98.45 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.611 ' HG3' ' HB3' ' A' ' 12' ' ' ASP . 10.1 mtm180 -56.14 -49.23 74.52 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.695 0.798 . . . . 0.0 111.578 175.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -60.18 -43.3 95.96 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.523 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.2 mt -56.18 -50.43 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.097 0.559 . . . . 0.0 110.583 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.85 -43.13 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.218 0.607 . . . . 0.0 111.524 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -51.99 -52.0 53.44 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.531 0.732 . . . . 0.0 111.273 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -57.72 -40.84 80.51 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.737 0.815 . . . . 0.0 112.839 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.03 -52.01 67.18 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.445 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.7 mt -58.54 -42.11 87.08 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.083 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -59.1 -47.49 85.06 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.353 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -54.98 -39.44 68.99 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 125.327 1.451 . . . . 0.0 112.293 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.4 mt -73.21 -17.28 61.37 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.21 17.72 19.32 Favored Glycine 0 CA--C 1.543 1.807 0 C-N-CA 124.567 1.08 . . . . 0.0 113.349 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -110.14 89.68 3.09 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 122.943 1.354 . . . . 0.0 112.126 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -68.54 -29.11 67.61 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 112.557 -2.11 . . . . 0.0 115.058 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.4 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -84.24 91.32 7.7 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 123.049 1.405 . . . . 0.0 113.481 -175.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.0 t -133.89 125.89 49.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 112.884 -1.962 . . . . 0.0 110.867 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.45 ' OE1' ' HB3' ' A' ' 45' ' ' LYS . 5.5 tt0 -110.26 153.59 24.62 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 175.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 36.9 mt-10 -125.92 124.8 41.62 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.49 153.87 36.06 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.552 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -4.0 19.85 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -165.84 157.4 14.06 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.452 0.701 . . . . 0.0 110.64 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 42' ' ' ALA . . . -39.9 -53.78 3.09 Favored Glycine 0 CA--C 1.544 1.856 0 O-C-N 125.04 1.463 . . . . 0.0 115.517 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.01 -52.84 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 122.414 0.286 . . . . 0.0 111.439 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -55.71 -38.76 70.15 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.568 1.147 . . . . 0.0 110.16 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.506 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -61.98 -58.57 7.39 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.233 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.17 -39.51 56.56 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.985 0.803 . . . . 0.0 112.531 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -63.69 -64.2 0.96 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.561 1.144 . . . . 0.0 109.92 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.45 ' HB3' ' OE1' ' A' ' 34' ' ' GLU . 46.1 mttm -55.38 -37.65 67.84 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 126.91 2.084 . . . . 0.0 115.319 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.581 HD11 HG22 ' A' ' 54' ' ' VAL . 5.9 tp -54.47 -25.86 27.8 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -90.94 -17.79 25.8 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.95 69.54 7.56 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.73 81.47 1.52 Allowed Glycine 0 CA--C 1.541 1.665 0 N-CA-C 118.496 2.158 . . . . 0.0 118.496 174.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 18.81 76.99 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 C-N-CA 128.012 2.72 . . . . 0.0 119.366 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -83.94 127.69 34.03 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.239 -0.981 . . . . 0.0 110.301 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.78 8.21 50.45 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.201 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.518 ' HA ' ' HG2' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -166.64 144.5 5.15 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 -179.201 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.581 HG22 HD11 ' A' ' 46' ' ' LEU . 21.4 t -123.85 110.87 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 175.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.552 HG23 ' HA ' ' A' ' 10' ' ' VAL . 14.8 tt -115.08 98.05 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 t -120.73 142.07 49.86 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 120.485 3.513 . . . . 0.0 120.485 -174.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -72.4 129.2 37.81 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 113.039 -1.892 . . . . 0.0 109.879 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.411 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 37.7 t-105 -53.71 -38.73 64.57 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.742 0.817 . . . . 0.0 112.544 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -105.6 108.46 19.99 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.584 0.754 . . . . 0.0 110.139 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.489 ' SD ' HG12 ' A' ' 11' ' ' VAL . 50.7 mtm -139.71 126.39 12.41 Favored Pre-proline 0 N--CA 1.478 0.966 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.78 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.76 118.48 5.41 Favored 'Trans proline' 0 N--CA 1.482 0.829 0 C-N-CA 124.048 3.165 . . . . 0.0 111.837 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 99.17 -76.25 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 129.224 3.01 . . . . 0.0 110.119 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.8 ttm -112.28 93.92 4.68 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.253 0.549 . . . . 0.0 109.744 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.6 p30 -59.74 162.28 5.42 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 112.133 -2.303 . . . . 0.0 112.068 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.88 -53.63 25.59 Favored Glycine 0 N--CA 1.477 1.433 0 C-N-CA 124.516 1.055 . . . . 0.0 114.296 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.488 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 60.8 tp -59.64 -37.87 79.85 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -70.69 -40.96 72.6 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.157 0.583 . . . . 0.0 110.369 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.9 tp -56.62 -44.86 81.6 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.111 0.964 . . . . 0.0 110.188 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' A' ' 103' ' ' ALA . 4.8 tt -48.79 -51.22 30.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.212 1.405 . . . . 0.0 109.363 175.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.37 -45.86 92.04 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.651 1.18 . . . . 0.0 112.538 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 p -61.9 -15.36 42.26 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.6 mt -96.31 -65.46 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.762 ' HG2' ' HA3' ' A' ' 102' ' ' GLY . 6.5 tpp180 -53.17 -43.35 67.0 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.163 2.185 . . . . 0.0 115.195 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.49 -10.41 49.1 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 78' ' ' MET . 12.6 t70 -89.4 112.32 23.41 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -42.79 -18.64 0.05 OUTLIER Glycine 0 CA--C 1.547 2.092 0 C-N-CA 127.601 2.524 . . . . 0.0 118.978 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.27 -50.77 3.84 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.64 0.776 . . . . 0.0 111.576 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.406 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 88.9 mmm -70.08 -25.15 63.39 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 118.718 2.859 . . . . 0.0 118.718 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.6 t -58.64 39.19 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 118.255 2.687 . . . . 0.0 118.255 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -123.55 -37.05 2.69 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.77 2.028 . . . . 0.0 111.073 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.447 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 6.1 mt -66.1 117.6 44.39 Favored Pre-proline 0 N--CA 1.472 0.657 0 C-N-CA 126.158 1.783 . . . . 0.0 115.299 -178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.518 ' HG2' ' HA ' ' A' ' 53' ' ' PHE . 35.4 Cg_endo -63.35 137.91 63.1 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.631 2.221 . . . . 0.0 111.121 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.94 110.26 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 113.812 -1.54 . . . . 0.0 112.668 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.421 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 33.1 tp -106.7 107.43 18.44 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.142 -1.845 . . . . 0.0 109.46 178.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.8 mmt -81.71 111.56 18.08 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 113.581 -1.645 . . . . 0.0 113.438 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.0 97.36 7.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 177.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 2.5 t -107.14 134.57 50.06 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 112.032 -2.349 . . . . 0.0 115.646 -174.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.21 -8.28 56.16 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 113.151 -1.841 . . . . 0.0 112.639 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -144.82 95.92 2.77 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.124 0.964 . . . . 0.0 113.09 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.03 64.17 8.31 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 123.429 1.585 . . . . 0.0 109.766 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -116.21 150.24 37.84 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.963 -1.926 . . . . 0.0 111.123 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -34.48 -51.95 0.48 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 115.329 1.604 . . . . 0.0 115.329 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -52.32 -57.57 9.35 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.494 0.718 . . . . 0.0 112.161 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -61.19 -41.04 96.11 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 85.2 mt -58.09 -51.13 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 124.125 0.891 . . . . 0.0 109.753 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 80.4 mt -54.91 -55.81 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.412 1.085 . . . . 0.0 109.892 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.21 -50.55 64.48 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.146 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -62.37 -52.42 63.68 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.88 -47.7 84.68 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -63.2 -36.78 84.79 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.52 -21.74 61.87 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.762 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 116.34 20.97 4.95 Favored Glycine 0 N--CA 1.48 1.568 0 N-CA-C 116.445 1.338 . . . . 0.0 116.445 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.61 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -68.77 118.91 12.34 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.456 1.128 . . . . 0.0 112.029 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.8 m -64.05 -28.3 69.7 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 113.52 -1.673 . . . . 0.0 111.992 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.61 172.26 45.23 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 124.149 0.88 . . . . 0.0 110.979 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -148.82 137.4 21.22 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.288 -0.956 . . . . 0.0 111.865 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.43 127.73 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 124.642 1.214 . . . . 0.0 109.438 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 87' ' ' THR . 11.0 p -81.04 139.97 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.782 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -94.6 131.63 30.42 Favored Pre-proline 0 CA--C 1.55 0.976 0 O-C-N 123.883 0.74 . . . . 0.0 111.255 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.3 151.88 69.33 Favored 'Cis proline' 0 N--CA 1.48 0.723 0 O-C-N 123.069 1.036 . . . . 0.0 113.46 -0.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -134.17 152.23 51.73 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 113.316 -1.765 . . . . 0.0 107.724 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.7 p -98.74 172.85 7.2 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.803 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.36 -41.62 72.79 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.822 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.11 -44.35 89.05 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.065 0.946 . . . . 0.0 111.702 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.2 m -61.25 -44.93 96.44 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.319 0.647 . . . . 0.0 110.041 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.449 HD21 HD12 ' A' ' 55' ' ' ILE . 2.0 tm? -60.44 -47.57 85.54 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.59 177.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -56.61 -43.06 79.81 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.496 1.118 . . . . 0.0 112.283 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -52.55 -45.51 66.41 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.124 0.57 . . . . 0.0 111.758 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -68.14 -42.32 80.3 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.196 0.998 . . . . 0.0 112.176 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 59.2 mt -53.88 -53.45 52.36 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.926 0.89 . . . . 0.0 111.433 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -50.54 -53.7 28.2 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.714 1.606 . . . . 0.0 111.957 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -49.27 -48.48 45.91 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.358 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 26.9 mt -63.01 -50.02 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 125.026 1.33 . . . . 0.0 112.284 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -58.72 -43.02 90.04 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.396 1.078 . . . . 0.0 111.875 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.69 -27.99 68.08 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -102.1 -53.45 2.92 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 117.755 2.502 . . . . 0.0 117.755 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 pp -111.61 -3.72 14.99 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.07 -160.39 18.62 Favored Glycine 0 N--CA 1.475 1.287 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.464 ' OXT' ' HG3' ' A' ' 82' ' ' PRO 0.307 14.3 ptp . . . . . 0 C--O 1.256 1.416 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.5 p -73.68 87.58 1.69 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.728 1.252 . . . . 0.0 113.698 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -73.33 98.52 2.71 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.277 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -49.6 -38.85 33.35 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.95 54.41 1.26 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 1.2 tt -111.41 118.83 36.9 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 113.673 -1.603 . . . . 0.0 112.064 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -75.74 108.83 8.86 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.513 ' HE2' HD22 ' A' ' 120' ' ' LEU . 74.4 m-85 -97.53 140.71 31.56 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.522 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.44 HD12 ' HG ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -114.38 109.6 18.58 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.604 ' HA ' HG23 ' A' ' 55' ' ' ILE . 9.9 p -81.23 101.37 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 124.972 1.42 . . . . 0.0 107.169 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.524 HG12 ' SD ' ' A' ' 60' ' ' MET . 4.0 t -100.17 85.4 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -123.48 124.6 43.24 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 110.765 -2.925 . . . . 0.0 113.039 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -65.65 -19.22 65.82 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 110.955 -2.839 . . . . 0.0 116.23 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -110.09 127.79 55.07 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.303 0.377 . . . . 0.0 110.436 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.1 p -47.4 -59.31 3.3 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 113.683 -1.598 . . . . 0.0 113.721 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.454 ' O ' HG12 ' A' ' 20' ' ' ILE . 1.8 p -66.75 -42.3 86.39 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.439 ' O ' HG23 ' A' ' 21' ' ' VAL . 9.6 ttt -60.36 -38.32 83.48 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.058 0.39 . . . . 0.0 111.309 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -54.97 -50.91 67.76 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.62 1.168 . . . . 0.0 110.392 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.635 ' NH2' HD21 ' A' ' 23' ' ' ASN . 4.9 mtp-105 -65.03 -39.35 93.23 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.924 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 16' ' ' THR . 43.7 mm -55.95 -51.24 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 17' ' ' MET . 6.1 t -58.78 -45.98 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 123.596 0.56 . . . . 0.0 109.991 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -49.24 -53.92 19.22 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.888 0.875 . . . . 0.0 111.838 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.635 HD21 ' NH2' ' A' ' 19' ' ' ARG . 48.0 m-80 -62.98 -39.01 93.43 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.495 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.8 mt -58.95 -52.41 65.85 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.632 0.773 . . . . 0.0 110.564 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.7 mt -54.98 -47.18 74.93 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.065 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.425 ' HG3' ' OD1' ' A' ' 31' ' ' ASN . 36.4 ttpt -54.03 -50.15 67.3 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.416 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -58.71 -40.14 82.84 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.601 1.561 . . . . 0.0 112.288 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.7 mt -71.96 -10.35 59.65 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.543 1.137 . . . . 0.0 113.135 177.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.31 -16.39 24.66 Favored Glycine 0 CA--C 1.546 2.002 0 C-N-CA 125.226 1.393 . . . . 0.0 113.677 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -87.69 72.7 9.47 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 123.366 1.555 . . . . 0.0 113.015 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.425 ' OD1' ' HG3' ' A' ' 26' ' ' LYS . 4.8 m-80 -69.2 -8.42 45.5 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.705 -1.589 . . . . 0.0 113.891 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.447 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -94.17 83.9 4.35 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.483 1.513 . . . . 0.0 110.53 -178.478 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.35 137.8 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.775 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.582 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -111.59 159.15 18.42 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.888 1.275 . . . . 0.0 108.922 176.352 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -126.5 108.9 11.6 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.47 158.36 20.8 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.967 1.307 . . . . 0.0 110.287 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -101.87 -39.03 7.56 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -138.94 170.44 15.97 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.349 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -47.1 -51.93 13.29 Favored Glycine 0 N--CA 1.474 1.227 0 C-N-CA 124.646 1.117 . . . . 0.0 115.552 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.6 t -57.73 -54.43 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.409 0.683 . . . . 0.0 110.683 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -57.56 -33.61 68.32 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.583 0.753 . . . . 0.0 111.694 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . . . -64.09 -50.71 67.25 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 117.172 -1.394 . . . . 0.0 110.971 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.462 HD11 ' OG1' ' A' ' 71' ' ' THR . 61.8 mt -57.06 -45.99 82.8 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 123.752 0.658 . . . . 0.0 111.131 178.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -52.62 -54.32 34.73 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.199 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -63.16 -42.45 99.42 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.725 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.44 ' HG ' HD12 ' A' ' 9' ' ' LEU . 26.4 mt -56.7 -35.98 69.13 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.726 1.21 . . . . 0.0 113.139 177.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.19 -24.36 17.93 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.86 -23.64 67.43 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.251 1.02 . . . . 0.0 113.053 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.74 179.83 50.19 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 124.805 1.193 . . . . 0.0 113.922 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.73 -14.94 8.61 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 116.544 1.377 . . . . 0.0 116.544 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.582 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 84.1 m-85 -68.19 121.58 16.5 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.263 1.03 . . . . 0.0 113.64 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -106.23 10.1 43.03 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 112.505 -2.134 . . . . 0.0 111.959 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.732 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.6 OUTLIER -168.94 145.43 3.54 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.5 t -128.75 111.15 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 113.389 -1.732 . . . . 0.0 107.663 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.604 HG23 ' HA ' ' A' ' 10' ' ' VAL . 12.1 tt -107.34 96.64 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.3 t -118.33 134.47 55.01 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 60' ' ' MET . 12.3 m-20 -72.08 134.36 45.76 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.883 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.459 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 14.7 t-105 -55.63 -48.58 74.7 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.828 0.851 . . . . 0.0 111.498 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -96.52 97.77 9.69 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.224 0.952 . . . . 0.0 111.271 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.524 ' SD ' HG12 ' A' ' 11' ' ' VAL . 29.6 mtm -131.15 138.67 33.43 Favored Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 113.782 -1.553 . . . . 0.0 111.826 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -58.87 143.93 99.06 Favored 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.144 2.562 . . . . 0.0 111.518 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.345 27.9 p30 65.12 -66.64 0.14 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 127.313 2.245 . . . . 0.0 114.295 -177.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.8 ttm -122.36 100.43 6.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.881 0.872 . . . . 0.0 108.691 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 7.3 m-20 -65.27 167.18 8.71 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 112.413 -2.176 . . . . 0.0 112.875 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.4 -56.18 9.72 Favored Glycine 0 N--CA 1.482 1.717 0 C-N-CA 125.177 1.37 . . . . 0.0 114.123 -178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.463 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 43.7 tp -57.57 -39.89 77.73 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -70.63 -40.45 73.12 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.99 -0.444 . . . . 0.0 110.547 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.428 ' HA ' HG22 ' A' ' 71' ' ' THR . 1.4 tm? -57.87 -42.27 84.21 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.071 0.548 . . . . 0.0 110.668 176.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 103' ' ' ALA . 4.8 tt -51.1 -49.93 59.75 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.842 1.657 . . . . 0.0 109.705 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -56.89 -47.33 80.77 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.392 1.077 . . . . 0.0 113.66 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.462 ' OG1' HD11 ' A' ' 43' ' ' LEU 0.359 13.7 t -70.69 5.58 1.84 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 mt -115.18 -64.68 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 174.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.405 ' HG3' ' HA3' ' A' ' 102' ' ' GLY . 24.9 mmt180 -51.12 -45.59 61.64 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.811 1.644 . . . . 0.0 113.752 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.69 -10.72 42.06 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -83.03 89.94 6.97 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -11.67 -72.06 0.01 OUTLIER Glycine 0 N--CA 1.485 1.929 0 C-N-CA 127.091 2.281 . . . . 0.0 116.641 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.4 -38.64 77.76 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 82.5 mtp -92.51 -14.17 28.79 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.0 t -30.0 -35.92 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 121.681 3.956 . . . . 0.0 121.681 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.71 -8.58 58.15 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 120.849 3.648 . . . . 0.0 120.849 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 2.3 mp -68.08 119.16 65.29 Favored Pre-proline 0 N--CA 1.477 0.903 0 N-CA-C 118.049 2.611 . . . . 0.0 118.049 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 7.5 Cg_endo -57.86 142.24 96.25 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.686 2.924 . . . . 0.0 110.949 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 103' ' ' ALA . 1.3 t -123.29 121.82 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 113.538 -1.665 . . . . 0.0 113.121 -175.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.732 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 28.3 tp -111.6 102.58 10.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.699 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 31.4 mmt -80.04 105.98 11.72 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 113.416 -1.72 . . . . 0.0 112.845 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.59 98.06 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 113.492 -1.686 . . . . 0.0 107.722 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 1.7 t -114.05 121.74 44.77 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 -176.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.757 ' HB2' ' HE3' ' A' ' 109' ' ' LYS . . . -70.0 -18.8 63.34 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.002 -1.454 . . . . 0.0 112.928 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.78 84.45 1.94 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.218 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.48 100.12 6.74 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.794 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -119.04 137.68 53.37 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 112.951 -1.931 . . . . 0.0 107.876 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.479 ' O ' HG12 ' A' ' 96' ' ' ILE . 64.4 tttp -31.14 -57.27 0.24 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -57.51 -47.52 81.74 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.264 30.1 p30 -69.3 -33.99 74.02 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.0 mt -59.72 -49.87 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 124.136 0.974 . . . . 0.0 109.186 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 92' ' ' LYS . 42.4 mm -57.83 -50.41 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.228 1.011 . . . . 0.0 110.195 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.32 -50.11 60.03 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.339 1.055 . . . . 0.0 111.272 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.459 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -58.06 -56.4 22.54 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.892 1.277 . . . . 0.0 112.504 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.23 -49.24 74.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.986 0.914 . . . . 0.0 112.623 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -63.43 -37.48 87.45 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.04 -16.99 62.05 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.405 ' HA3' ' HG3' ' A' ' 73' ' ' ARG . . . 121.98 -0.02 10.76 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.618 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -67.07 110.67 3.5 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.404 1.102 . . . . 0.0 111.478 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.9 p -66.85 -18.29 65.31 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 113.681 -1.6 . . . . 0.0 114.644 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.16 168.3 40.02 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.76 1.171 . . . . 0.0 111.866 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -144.73 140.5 28.6 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.423 -0.888 . . . . 0.0 111.793 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.9 p -126.34 134.75 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 124.504 1.127 . . . . 0.0 111.845 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 87' ' ' THR . 47.8 t -81.03 128.79 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.983 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.757 ' HE3' ' HB2' ' A' ' 88' ' ' ALA . 42.1 pttt -94.03 132.86 28.55 Favored Pre-proline 0 N--CA 1.486 1.333 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.332 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.91 146.88 76.2 Favored 'Cis proline' 0 N--CA 1.478 0.617 0 O-C-N 123.437 1.23 . . . . 0.0 114.497 0.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -126.08 154.07 43.59 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 112.941 -1.936 . . . . 0.0 109.034 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.4 p -99.01 172.07 7.63 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.523 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.97 -39.71 72.2 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.87 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.89 -47.34 69.11 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.637 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.3 m -59.56 -46.91 87.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.584 0.754 . . . . 0.0 109.816 178.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.0 tp -56.76 -54.26 48.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.424 1.49 . . . . 0.0 110.198 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.401 ' HG2' ' ND2' ' A' ' 121' ' ' ASN . 0.9 OUTLIER -55.24 -46.51 76.02 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.857 0.863 . . . . 0.0 112.682 -179.566 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.28 -44.88 65.24 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.198 0.936 . . . . 0.0 112.134 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -66.54 -49.61 65.9 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.717 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.513 HD22 ' HE2' ' A' ' 8' ' ' PHE . 55.6 mt -55.92 -49.29 73.88 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.15 0.98 . . . . 0.0 111.849 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.401 ' ND2' ' HG2' ' A' ' 117' ' ' GLU . 1.0 OUTLIER -55.78 -48.67 74.92 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.369 1.468 . . . . 0.0 112.692 178.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -54.22 -48.72 70.76 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.632 1.173 . . . . 0.0 110.784 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.21 -47.37 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.262 1.025 . . . . 0.0 110.585 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' A' ' 129' ' ' MET . 22.2 m-30 -57.79 -36.6 72.4 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -61.79 -44.65 96.44 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.636 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -62.15 -43.14 99.49 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.687 1.195 . . . . 0.0 110.777 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -74.92 4.63 6.21 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.08 30.97 74.22 Favored Glycine 0 N--CA 1.484 1.838 0 C-N-CA 125.351 1.453 . . . . 0.0 116.266 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.458 ' HB2' ' HB3' ' A' ' 124' ' ' PHE . 20.8 mmt . . . . . 0 C--O 1.255 1.345 0 CA-C-O 116.753 -1.594 . . . . 0.0 114.092 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.9 p -81.56 74.59 8.54 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 123.647 1.689 . . . . 0.0 110.151 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -71.48 81.84 0.8 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -88.96 -37.47 15.2 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.22 -1.355 . . . . 0.0 113.352 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.59 60.89 5.82 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 123.209 1.48 . . . . 0.0 108.565 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.435 HD21 ' HB2' ' A' ' 53' ' ' PHE . 5.5 tt -98.11 123.75 42.31 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.049 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 46.4 tttp -80.33 105.46 11.61 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.685 1.241 . . . . 0.0 112.657 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -97.47 145.22 26.42 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.005 -1.452 . . . . 0.0 112.615 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.838 HD12 HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -113.15 107.23 15.64 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 173.592 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.52 98.85 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.931 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.674 HG11 ' HB2' ' A' ' 42' ' ' ALA . 2.2 t -105.77 89.88 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 113.304 -1.771 . . . . 0.0 109.257 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -134.14 125.68 28.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 112.643 -2.071 . . . . 0.0 111.019 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -55.37 -24.86 31.91 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 110.93 -2.85 . . . . 0.0 116.738 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -106.66 120.69 42.64 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.2 p -42.96 -57.67 2.75 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.937 -1.483 . . . . 0.0 114.305 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.44 ' O ' HG12 ' A' ' 20' ' ' ILE . 11.0 p -68.06 -43.37 78.8 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 118.223 -0.894 . . . . 0.0 113.29 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -39.3 90.4 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.249 0.477 . . . . 0.0 110.896 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -56.63 -49.45 74.96 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.386 1.074 . . . . 0.0 109.971 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -61.0 -42.33 98.23 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.71 177.611 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 16' ' ' THR . 42.8 mm -56.17 -48.59 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 118.888 -0.577 . . . . 0.0 110.002 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.464 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 4.1 t -59.5 -49.97 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 19' ' ' ARG . 42.5 ttt180 -49.62 -49.08 48.33 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.207 1.403 . . . . 0.0 111.092 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -64.5 -43.32 94.48 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.548 1.139 . . . . 0.0 112.286 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.496 HD22 ' HB2' ' A' ' 113' ' ' ALA . 57.3 mt -55.72 -50.97 68.92 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.385 1.074 . . . . 0.0 111.31 177.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 mt -51.01 -48.6 61.38 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.757 1.286 . . . . 0.0 112.187 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.406 ' NZ ' ' HG2' ' A' ' 22' ' ' ARG . 32.0 mtmm -58.96 -44.8 91.56 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.982 -1.463 . . . . 0.0 112.247 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 32.5 mt-10 -59.18 -38.47 79.88 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.095 1.358 . . . . 0.0 112.733 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.543 HD22 ' HB2' ' A' ' 117' ' ' GLU . 60.2 mt -71.14 -18.21 62.52 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.098 1.359 . . . . 0.0 114.239 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.79 9.96 19.81 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 124.476 1.036 . . . . 0.0 113.5 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -96.76 95.39 7.86 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 123.405 1.574 . . . . 0.0 110.199 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -61.95 -34.62 76.46 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 110.501 -3.045 . . . . 0.0 118.746 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 7' ' ' LYS . 9.1 t-20 -112.3 125.81 54.58 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 -174.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.4 p -147.96 135.79 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.77 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 12.9 mm-40 -113.78 161.42 17.56 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.869 175.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -123.38 130.51 52.82 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -139.12 156.7 46.96 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.377 1.471 . . . . 0.0 109.699 175.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -113.86 -38.79 4.14 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 61' ' ' PRO . 6.6 p-10 -123.38 159.79 28.17 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 118.719 -0.658 . . . . 0.0 109.774 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.575 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -44.67 -45.68 8.8 Favored Glycine 0 N--CA 1.478 1.445 0 N-CA-C 116.74 1.456 . . . . 0.0 116.74 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.57 -54.77 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 122.559 0.344 . . . . 0.0 110.196 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -57.51 -34.13 68.77 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.446 0.699 . . . . 0.0 110.777 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.674 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -62.94 -55.23 27.76 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.653 1.181 . . . . 0.0 110.32 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.0 mt -56.52 -43.54 79.92 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.66 0.784 . . . . 0.0 110.324 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -53.86 -56.16 20.13 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.318 1.047 . . . . 0.0 110.744 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -59.38 -52.97 63.32 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.213 1.405 . . . . 0.0 111.896 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.838 HD13 HD12 ' A' ' 9' ' ' LEU . 4.0 tp -56.49 -37.21 70.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.933 2.093 . . . . 0.0 114.61 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -54.64 -30.26 54.62 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.472 1.509 . . . . 0.0 113.589 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.77 -22.47 66.99 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.21 -173.13 46.12 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.25 0.928 . . . . 0.0 112.093 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.63 -26.41 3.14 Favored Glycine 0 CA--C 1.543 1.833 0 N-CA-C 114.78 0.672 . . . . 0.0 114.78 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.77 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 91.3 m-85 -68.12 108.94 3.31 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.879 0.872 . . . . 0.0 111.799 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.59 3.11 86.41 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.441 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.646 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -166.04 143.52 5.45 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.105 0.962 . . . . 0.0 113.441 179.609 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.543 HG22 HD11 ' A' ' 46' ' ' LEU . 31.3 t -122.14 113.84 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 113.918 -1.492 . . . . 0.0 107.608 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.549 HD12 HD23 ' A' ' 84' ' ' LEU . 18.8 tt -113.43 97.28 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 178.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.7 t -119.53 136.03 54.52 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -175.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.408 ' O ' ' HG3' ' A' ' 60' ' ' MET . 8.0 t0 -71.98 132.88 44.91 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 112.415 -2.175 . . . . 0.0 110.944 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.479 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 26.6 t-105 -56.29 -41.23 75.58 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.41 1.084 . . . . 0.0 111.719 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -99.5 104.44 16.27 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.481 ' SD ' HG12 ' A' ' 11' ' ' VAL . 29.4 mtm -138.83 130.45 15.39 Favored Pre-proline 0 N--CA 1.473 0.689 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.713 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.508 ' O ' ' HB2' ' A' ' 38' ' ' ASP . 99.0 Cg_exo -57.42 149.6 64.76 Favored 'Trans proline' 0 N--CA 1.481 0.766 0 C-N-CA 123.448 2.765 . . . . 0.0 110.944 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 71.19 -61.2 0.49 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 126.119 1.767 . . . . 0.0 112.516 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.575 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 55.6 ttm -135.31 108.33 7.64 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.154 1.381 . . . . 0.0 108.101 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 10.7 m-20 -68.88 167.39 15.76 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.457 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.26 -57.01 9.55 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 125.508 1.528 . . . . 0.0 114.527 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.455 HD12 HD23 ' A' ' 69' ' ' LEU . 56.9 tp -57.44 -37.84 73.45 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -71.61 -42.95 67.04 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.668 0.787 . . . . 0.0 111.167 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.07 -41.53 83.59 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.328 1.051 . . . . 0.0 110.246 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.577 HD13 HG11 ' A' ' 83' ' ' VAL . 8.4 tp -57.23 -46.53 82.88 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.005 176.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -60.43 -44.0 96.21 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.38 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.26 24.9 p -62.0 -35.44 78.53 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.268 1.027 . . . . 0.0 111.993 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.4 mt -69.33 -56.95 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.499 ' HG3' ' HA3' ' A' ' 102' ' ' GLY . 30.1 mmt180 -53.34 -47.98 68.89 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.718 1.261 . . . . 0.0 113.043 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.14 -33.85 75.26 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.165 0.986 . . . . 0.0 113.097 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -84.68 83.25 8.09 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.794 0.838 . . . . 0.0 108.777 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -4.58 -80.6 0.01 OUTLIER Glycine 0 N--CA 1.484 1.849 0 C-N-CA 127.521 2.486 . . . . 0.0 118.221 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.89 -35.27 57.7 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 94.0 mtp -73.37 -27.11 61.3 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.072 0.949 . . . . 0.0 113.241 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.3 t -53.83 -26.51 24.65 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.43 -14.61 61.74 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.516 HD22 ' O ' ' A' ' 51' ' ' TYR . 16.0 mt -86.53 116.19 65.01 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 123.784 0.833 . . . . 0.0 109.876 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 9.4 Cg_endo -52.58 143.66 45.03 Favored 'Trans proline' 0 N--CA 1.476 0.488 0 C-N-CA 123.53 2.82 . . . . 0.0 113.71 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.577 HG11 HD13 ' A' ' 69' ' ' LEU . 13.5 t -121.23 117.86 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.801 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.646 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 29.5 tp -110.64 107.32 16.86 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 113.044 -1.889 . . . . 0.0 109.573 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.4 mmt -82.27 119.23 23.84 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 113.862 -1.517 . . . . 0.0 112.825 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 2.2 t -94.13 96.29 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 t -105.24 138.52 41.31 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 112.162 -2.29 . . . . 0.0 116.084 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.79 -22.11 66.03 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 113.565 -1.652 . . . . 0.0 113.167 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -142.09 135.4 29.07 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 1.006 ' HB2' HG21 ' A' ' 108' ' ' VAL . . . -97.99 60.29 1.46 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 113.344 -1.753 . . . . 0.0 109.492 176.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -112.28 148.17 34.75 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.652 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -37.17 -45.13 0.61 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 116.32 1.971 . . . . 0.0 116.32 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.12 -60.53 3.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.961 0.904 . . . . 0.0 110.738 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -59.39 -46.75 87.81 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.788 1.235 . . . . 0.0 112.594 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 73.3 mt -57.31 -57.2 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 124.207 0.942 . . . . 0.0 111.598 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.7 mt -60.06 -50.48 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.175 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.96 -49.69 68.17 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.771 0.669 . . . . 0.0 112.228 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.479 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -60.78 -54.94 39.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.348 1.059 . . . . 0.0 111.633 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.42 -48.59 76.65 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.077 0.951 . . . . 0.0 112.408 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -61.18 -31.35 71.1 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.55 1.87 55.37 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.499 ' HA3' ' HG3' ' A' ' 73' ' ' ARG . . . 110.18 -0.28 29.82 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 116.892 1.517 . . . . 0.0 116.892 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.452 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -70.55 109.55 4.91 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.2 1.0 . . . . 0.0 111.856 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.2 p -63.64 -21.48 66.39 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.54 -1.664 . . . . 0.0 114.246 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -170.45 171.07 43.47 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.897 1.237 . . . . 0.0 112.357 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.494 ' O ' ' HE2' ' A' ' 119' ' ' LYS . 31.2 p90 -146.45 127.29 14.42 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.643 -0.778 . . . . 0.0 113.024 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 1.5 p -111.2 119.54 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.006 HG21 ' HB2' ' A' ' 90' ' ' ALA . 63.2 t -82.05 125.36 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 113.607 -1.633 . . . . 0.0 112.88 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -87.09 133.95 37.86 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 112.77 -2.014 . . . . 0.0 110.214 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.27 126.71 13.77 Favored 'Cis proline' 0 C--N 1.351 0.663 0 CA-C-O 123.192 1.247 . . . . 0.0 115.223 0.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.464 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 21.6 p90 -115.83 147.81 40.61 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 112.424 -2.171 . . . . 0.0 108.269 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 48.7 p -104.07 171.93 7.08 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.764 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.496 ' HB2' HD22 ' A' ' 24' ' ' LEU . . . -54.85 -37.52 66.32 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.99 176.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.06 -50.33 64.52 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.196 0.998 . . . . 0.0 110.741 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.8 m -58.81 -44.74 90.9 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.701 0.801 . . . . 0.0 110.211 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 36.6 tp -58.18 -55.83 29.95 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.147 1.379 . . . . 0.0 109.844 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.543 ' HB2' HD22 ' A' ' 28' ' ' LEU . 23.5 tt0 -59.3 -41.65 89.52 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.76 0.424 . . . . 0.0 111.72 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -52.52 -46.89 66.88 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.694 0.797 . . . . 0.0 110.868 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 106' ' ' TYR . 31.3 mmmt -70.4 -42.58 71.5 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.032 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.1 mt -56.76 -46.65 81.31 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -53.2 -49.54 66.54 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.806 1.242 . . . . 0.0 111.681 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 119' ' ' LYS . 59.0 tttm -52.51 -47.86 66.38 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.75 1.62 . . . . 0.0 111.275 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.585 HG13 ' HZ ' ' A' ' 53' ' ' PHE . 14.1 mm -60.32 -48.04 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.207 1.003 . . . . 0.0 110.528 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -57.66 -38.32 74.87 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -61.66 -44.09 97.61 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 124.435 1.085 . . . . 0.0 110.879 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -61.83 -33.47 74.2 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.29 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 mt -88.68 4.92 45.52 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.291 1.436 . . . . 0.0 114.67 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.85 19.76 77.11 Favored Glycine 0 CA--C 1.543 1.842 0 C-N-CA 124.193 0.902 . . . . 0.0 114.116 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 68.0 mtt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 116.873 -1.537 . . . . 0.0 112.064 179.348 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.6 p -71.35 81.64 0.76 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.212 1.005 . . . . 0.0 112.678 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.572 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 40.2 t0 -73.23 86.88 1.44 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.258 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -53.41 -33.14 52.72 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -74.87 5.54 4.96 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.822 1.249 . . . . 0.0 114.342 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.572 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 0.8 OUTLIER -66.31 126.91 30.24 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.256 1.423 . . . . 0.0 113.032 -177.424 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -84.25 108.73 17.28 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 112.983 -1.917 . . . . 0.0 112.282 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -99.73 127.87 45.85 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.757 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.544 HD13 HG22 ' A' ' 11' ' ' VAL . 1.4 tm? -107.65 95.84 5.97 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.71 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 45.6 t -79.43 104.71 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 111.148 -2.751 . . . . 0.0 108.931 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.544 HG22 HD13 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -104.44 72.56 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 123.553 1.644 . . . . 0.0 107.921 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -129.11 80.23 1.96 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 112.885 -1.961 . . . . 0.0 110.7 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -13.01 -30.61 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 1 N-CA-C 124.421 4.971 . . . . 0.0 124.421 -178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -101.12 124.01 46.17 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.418 ' HA ' HH11 ' A' ' 18' ' ' ARG . 11.9 m -41.95 -43.54 3.15 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 114.68 -1.145 . . . . 0.0 113.392 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.525 ' O ' HG12 ' A' ' 20' ' ' ILE . 2.1 m -58.21 -55.95 28.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.932 1.293 . . . . 0.0 110.835 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.449 ' O ' HG23 ' A' ' 21' ' ' VAL . 1.1 tmm? -59.88 -42.61 94.15 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.487 ' HB3' ' OE1' ' A' ' 35' ' ' GLU . 12.9 mtp180 -55.72 -47.81 76.23 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.766 0.666 . . . . 0.0 111.229 176.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 15.0 ttp180 -67.14 -39.92 86.67 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.078 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 16' ' ' THR . 37.2 mm -56.55 -47.76 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 123.307 0.38 . . . . 0.0 110.086 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 17' ' ' MET . 18.7 t -60.59 -42.06 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.617 ' HG3' HG11 ' A' ' 33' ' ' VAL . 24.5 ttt85 -53.31 -52.54 58.81 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.582 0.753 . . . . 0.0 110.155 176.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -53.51 -44.46 69.13 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.325 1.05 . . . . 0.0 112.279 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.0 -51.13 69.3 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.963 1.305 . . . . 0.0 112.048 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.0 mt -56.15 -44.31 79.15 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.041 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -57.78 -47.64 81.95 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.927 176.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.19 -39.15 78.18 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.109 1.364 . . . . 0.0 111.733 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.8 mt -73.21 -26.9 61.33 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.86 21.18 7.95 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.567 1.08 . . . . 0.0 114.399 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -92.97 116.44 29.05 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 122.456 1.122 . . . . 0.0 112.645 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -67.52 -48.27 67.52 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 111.411 -2.631 . . . . 0.0 116.15 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -111.57 122.36 47.62 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 -174.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG11 ' HG3' ' A' ' 22' ' ' ARG . 7.9 p -138.31 112.92 8.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 111.154 -2.748 . . . . 0.0 110.781 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.632 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 31.9 mt-10 -109.44 140.75 42.79 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.71 ' HG2' ' HB ' ' A' ' 10' ' ' VAL . 45.0 mt-10 -123.36 131.64 53.72 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 -174.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.407 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -117.09 157.03 26.56 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 111.493 -2.594 . . . . 0.0 110.271 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -92.23 -55.46 3.42 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -130.34 173.05 11.19 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.703 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -40.57 -54.64 3.35 Favored Glycine 0 CA--C 1.536 1.346 0 O-C-N 124.977 1.423 . . . . 0.0 115.44 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.8 t -57.25 -56.78 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.984 0.914 . . . . 0.0 112.076 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -56.82 -36.72 70.29 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.421 0.688 . . . . 0.0 111.579 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.536 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -64.14 -51.05 65.77 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.126 0.97 . . . . 0.0 111.028 177.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.2 mt -54.13 -49.27 69.59 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.501 0.72 . . . . 0.0 110.711 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -52.16 -55.45 20.9 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.301 1.041 . . . . 0.0 111.661 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.489 ' HD3' HD21 ' A' ' 9' ' ' LEU . 41.3 mttm -58.23 -52.78 64.13 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.537 177.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.7 mt -56.34 -39.22 72.48 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.984 1.314 . . . . 0.0 114.092 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -58.79 -23.93 61.06 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.46 -19.25 62.24 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.09 -165.5 29.2 Favored Glycine 0 N--CA 1.481 1.645 0 C-N-CA 124.884 1.23 . . . . 0.0 112.097 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.33 -34.95 1.53 Allowed Glycine 0 CA--C 1.544 1.865 0 N-CA-C 116.0 1.16 . . . . 0.0 116.0 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.632 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 80.9 m-85 -66.5 118.38 10.05 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.08 7.36 56.94 Favored Glycine 0 N--CA 1.476 1.316 0 CA-C-N 112.654 -2.067 . . . . 0.0 111.803 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.511 ' HA ' ' HG2' ' A' ' 82' ' ' PRO . 2.4 t80 -163.97 138.18 5.69 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.7 t -122.16 110.94 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.581 HG23 ' HA ' ' A' ' 10' ' ' VAL . 12.5 tt -114.93 97.84 6.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.5 t -118.67 136.01 54.15 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 60' ' ' MET . 53.6 t0 -71.72 132.67 44.86 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 113.2 -1.818 . . . . 0.0 110.745 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.441 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 17.6 t-105 -56.39 -46.5 80.09 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.306 177.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -93.29 105.42 17.5 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.883 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.41 ' HE2' ' HA2' ' A' ' 65' ' ' GLY . 29.5 mtm -140.25 134.39 15.5 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.627 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -58.43 142.25 97.72 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 C-N-CA 123.717 2.945 . . . . 0.0 111.054 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.7 m120 63.75 -67.32 0.1 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.857 1.663 . . . . 0.0 114.304 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.401 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 57.4 ttm -115.73 97.74 6.3 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 4.0 p30 -60.94 165.74 3.91 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 112.122 -2.308 . . . . 0.0 112.541 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.41 ' HA2' ' HE2' ' A' ' 60' ' ' MET . . . -49.33 -55.92 11.86 Favored Glycine 0 N--CA 1.484 1.886 0 C-N-CA 124.711 1.148 . . . . 0.0 114.432 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.455 HD12 HD23 ' A' ' 69' ' ' LEU . 41.1 tp -57.26 -43.23 82.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.141 0.576 . . . . 0.0 112.47 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.54 -41.74 92.72 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.875 0.87 . . . . 0.0 111.365 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.53 -46.46 83.81 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.328 1.051 . . . . 0.0 110.225 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.455 HD23 HD12 ' A' ' 66' ' ' LEU . 18.4 tp -55.07 -47.81 74.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.386 1.475 . . . . 0.0 110.737 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -60.0 -47.47 85.71 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.218 0.607 . . . . 0.0 112.125 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.267 16.4 p -57.19 -29.21 63.49 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.019 0.928 . . . . 0.0 112.634 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mt -81.55 -58.01 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.157 0.983 . . . . 0.0 108.891 177.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 81.8 mmt-85 -48.08 -47.78 33.86 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.467 1.907 . . . . 0.0 112.855 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.98 61.66 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -84.33 96.43 9.03 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -17.96 -69.46 0.01 OUTLIER Glycine 0 N--CA 1.488 2.114 0 C-N-CA 126.27 1.891 . . . . 0.0 116.56 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.57 95.33 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 98.7 mtp -75.51 -22.43 57.15 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.1 t -38.03 -36.07 0.19 Allowed 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 117.405 2.372 . . . . 0.0 117.405 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.39 -1.86 51.23 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 117.23 2.308 . . . . 0.0 117.23 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.4 mt -69.42 110.28 6.04 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.561 ' HB3' HD11 ' A' ' 127' ' ' LEU . 39.5 Cg_endo -54.99 124.33 16.01 Favored 'Trans proline' 0 N--CA 1.483 0.888 0 C-N-CA 123.435 2.757 . . . . 0.0 113.437 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.9 t -112.68 119.27 59.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 114.078 -1.419 . . . . 0.0 114.521 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 66.6 tp -109.09 101.18 10.26 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 111.919 -2.4 . . . . 0.0 107.859 176.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.4 mmt -76.02 104.51 6.59 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.42 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 t -83.94 98.57 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.3 p -90.6 132.13 35.91 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 112.958 -1.928 . . . . 0.0 112.387 -176.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.11 -46.14 89.09 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.959 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -147.11 115.18 6.55 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.97 98.52 5.71 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.657 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -114.64 142.21 46.76 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.114 -1.857 . . . . 0.0 108.69 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' A' ' 93' ' ' GLU 0.264 0.0 OUTLIER -38.36 -45.17 0.98 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 179.677 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.403 ' H ' ' HD2' ' A' ' 92' ' ' LYS . 0.8 OUTLIER -55.59 -53.21 59.3 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.631 0.772 . . . . 0.0 112.959 178.584 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.01 -37.66 84.57 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.598 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.97 -51.27 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.775 0.83 . . . . 0.0 110.4 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.0 mt -57.84 -51.65 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.38 0.672 . . . . 0.0 109.244 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.02 -44.6 74.74 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.04 0.936 . . . . 0.0 113.369 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.441 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -58.48 -47.77 82.96 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.155 0.982 . . . . 0.0 112.31 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.79 -44.75 96.26 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.886 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -59.06 -31.58 68.99 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.16 -5.8 49.32 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.13 4.4 27.43 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 118.317 2.087 . . . . 0.0 118.317 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.7 121.03 8.84 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.402 ' HB3' HG23 ' A' ' 123' ' ' ILE . 13.6 m -66.87 -30.67 70.9 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 113.271 -1.786 . . . . 0.0 113.404 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.78 167.42 38.81 Favored Glycine 0 N--CA 1.479 1.556 0 C-N-CA 124.458 1.028 . . . . 0.0 110.819 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -141.92 137.63 31.43 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.31 126.55 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 124.617 1.198 . . . . 0.0 111.66 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.2 p -88.99 135.62 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.706 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.2 pttt -92.75 142.36 25.54 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-O 117.709 -1.138 . . . . 0.0 112.392 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.08 129.81 18.55 Favored 'Cis proline' 0 N--CA 1.481 0.769 0 N-CA-C 116.568 1.718 . . . . 0.0 116.568 0.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -120.38 139.29 53.01 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 112.814 -1.994 . . . . 0.0 107.966 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.5 p -97.82 174.94 6.35 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.876 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.88 -36.39 67.58 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.38 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.02 -47.29 71.89 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.185 0.994 . . . . 0.0 111.44 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 m -59.59 -45.96 90.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.285 0.634 . . . . 0.0 109.623 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 42.4 tp -56.89 -51.64 68.28 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.602 1.161 . . . . 0.0 110.277 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.55 ' HA ' HD12 ' A' ' 120' ' ' LEU . 15.2 tm-20 -54.3 -46.85 72.87 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.646 1.178 . . . . 0.0 111.91 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -58.96 -43.76 91.36 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.099 0.874 . . . . 0.0 112.655 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -65.61 -42.26 91.82 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.853 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 117' ' ' GLU . 89.2 mt -53.69 -47.69 70.22 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.337 1.023 . . . . 0.0 111.33 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -52.59 -54.98 25.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.592 1.557 . . . . 0.0 111.867 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -52.45 -49.88 63.74 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 113.859 -1.519 . . . . 0.0 112.51 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.463 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 58.7 mt -60.14 -45.54 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.852 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.5 m-30 -61.78 -33.8 74.74 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -61.26 -45.23 95.36 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.41 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -61.39 -34.08 74.74 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.121 0.968 . . . . 0.0 112.166 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 82' ' ' PRO . 39.9 mt -77.79 5.66 9.06 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.88 11.37 65.51 Favored Glycine 0 CA--C 1.542 1.721 0 C-N-CA 124.641 1.115 . . . . 0.0 115.684 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 76.0 mtm . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 179.657 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.456 ' HB3' ' OE1' ' A' ' 5' ' ' GLU . 58.1 m -85.04 71.37 10.94 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 -176.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -92.77 66.27 4.33 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.427 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -151.88 -69.34 0.17 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 113.502 -1.681 . . . . 0.0 113.058 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.456 ' OE1' ' HB3' ' A' ' 2' ' ' SER . 0.0 OUTLIER -82.31 62.5 6.04 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 123.127 1.441 . . . . 0.0 111.4 179.483 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 tt -106.34 123.64 48.36 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 113.24 -1.8 . . . . 0.0 111.068 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -76.34 103.27 6.27 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.895 1.372 . . . . 0.0 113.976 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -98.47 130.47 45.08 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 112.621 -2.081 . . . . 0.0 112.014 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.535 HD12 ' HG ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -108.64 102.54 11.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 122.748 1.261 . . . . 0.0 108.695 174.42 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.3 t -88.13 107.16 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.501 HG12 ' SD ' ' A' ' 60' ' ' MET . 4.3 t -105.45 101.99 13.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 111.391 -2.641 . . . . 0.0 108.339 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -138.85 133.57 32.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.968 -1.469 . . . . 0.0 112.33 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -63.52 -23.18 67.28 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 113.965 -1.47 . . . . 0.0 112.396 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.49 102.06 11.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.789 177.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.9 p -49.06 -34.09 12.9 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.767 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.65 -41.57 95.22 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.131 1.772 . . . . 0.0 110.726 176.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.422 ' O ' HG23 ' A' ' 21' ' ' VAL . 10.3 tpt -66.67 -42.21 86.94 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.3 0.64 . . . . 0.0 110.536 177.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.667 ' HG3' ' HG3' ' A' ' 35' ' ' GLU . 1.8 tmm_? -56.51 -42.79 78.97 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 124.285 0.991 . . . . 0.0 109.735 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.714 ' HD3' HH22 ' A' ' 22' ' ' ARG . 1.8 tpp180 -56.02 -48.6 75.64 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.147 1.379 . . . . 0.0 110.576 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.3 mm -58.47 -55.85 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.046 0.939 . . . . 0.0 110.382 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 17' ' ' MET . 4.5 t -53.04 -44.79 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.817 0.847 . . . . 0.0 111.566 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.714 HH22 ' HD3' ' A' ' 19' ' ' ARG . 26.0 ttm180 -52.62 -54.12 37.52 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.054 0.942 . . . . 0.0 111.452 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -60.19 -39.75 87.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.99 0.916 . . . . 0.0 113.299 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.91 -53.13 61.49 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.48 1.112 . . . . 0.0 110.745 177.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.2 mt -57.48 -44.51 84.94 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.835 0.854 . . . . 0.0 112.112 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -53.37 -48.7 68.36 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.486 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -57.45 -38.88 75.15 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.035 1.334 . . . . 0.0 111.985 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.2 mt -74.83 -15.13 60.74 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.37 6.49 29.25 Favored Glycine 0 CA--C 1.545 1.947 0 C-N-CA 125.104 1.335 . . . . 0.0 114.78 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -98.44 91.88 5.4 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 122.758 1.265 . . . . 0.0 112.666 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -79.35 -10.22 59.76 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 119.604 3.187 . . . . 0.0 119.604 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -107.4 99.23 8.77 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 119.404 1.002 . . . . 0.0 112.511 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -130.12 125.04 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.066 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -111.84 163.75 13.84 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.596 0.758 . . . . 0.0 109.851 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.667 ' HG3' ' HG3' ' A' ' 18' ' ' ARG . 44.1 tt0 -120.67 131.05 54.38 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 -176.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.452 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -137.03 149.49 47.49 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 112.104 -2.316 . . . . 0.0 108.095 173.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -101.45 -41.65 6.56 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -130.85 159.84 36.19 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.629 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -39.51 -51.71 3.03 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.984 1.754 . . . . 0.0 115.03 177.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.45 -56.19 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 114.852 -0.674 . . . . 0.0 111.23 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.8 -37.58 68.81 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.933 0.893 . . . . 0.0 111.458 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.436 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -60.18 -49.52 77.32 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 117.462 -1.256 . . . . 0.0 111.42 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.7 mt -58.5 -44.77 89.56 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.104 0.562 . . . . 0.0 111.385 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -54.8 -53.02 60.68 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.971 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -59.9 -50.92 71.87 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.681 1.593 . . . . 0.0 111.88 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.535 ' HG ' HD12 ' A' ' 9' ' ' LEU . 16.4 mt -54.81 -49.28 71.39 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.451 1.9 . . . . 0.0 114.73 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.91 -17.63 10.27 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.64 -19.65 65.81 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.224 0.61 . . . . 0.0 112.499 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.3 -177.88 38.19 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.924 1.249 . . . . 0.0 114.146 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.56 -24.57 2.62 Favored Glycine 0 CA--C 1.541 1.703 0 N-CA-C 116.432 1.333 . . . . 0.0 116.432 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -69.0 113.22 6.19 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.27 5.65 61.07 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 112.725 -2.034 . . . . 0.0 112.01 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -164.24 143.86 7.73 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.469 HG22 HD21 ' A' ' 46' ' ' LEU . 21.3 t -127.88 120.0 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.086 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 84' ' ' LEU . 71.2 mt -113.07 102.59 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.7 t -119.23 131.78 55.85 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 118.016 2.598 . . . . 0.0 118.016 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -71.98 124.84 25.78 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 112.066 -2.334 . . . . 0.0 109.808 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.498 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 18.3 t-105 -55.4 -39.34 70.06 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.232 178.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -91.41 94.05 9.31 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.797 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.501 ' SD ' HG12 ' A' ' 11' ' ' VAL . 29.6 mtm -139.58 122.52 10.43 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-N 112.83 -1.986 . . . . 0.0 109.589 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -60.82 127.62 23.06 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.893 3.062 . . . . 0.0 113.335 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 m120 81.32 -65.8 0.13 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.02 1.728 . . . . 0.0 113.283 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.2 ttm -115.57 87.72 2.73 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.625 0.726 . . . . 0.0 109.363 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.5 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.1 p30 -61.43 168.87 2.52 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 111.863 -2.426 . . . . 0.0 112.224 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 58' ' ' TRP . . . -47.29 -53.43 11.69 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 124.932 1.253 . . . . 0.0 114.223 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.42 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 62.3 tp -57.38 -44.59 84.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.883 0.873 . . . . 0.0 111.997 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.522 ' HA ' ' HD3' ' A' ' 70' ' ' LYS . 32.5 mm-40 -66.23 -40.72 90.48 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.2 tp -61.57 -42.79 99.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.368 0.667 . . . . 0.0 111.27 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.605 HD12 ' HD3' ' A' ' 73' ' ' ARG . 5.4 tp -53.25 -45.21 68.67 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.831 1.252 . . . . 0.0 110.868 177.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.522 ' HD3' ' HA ' ' A' ' 67' ' ' GLU . 13.8 mtpp -64.76 -44.86 88.68 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.488 1.115 . . . . 0.0 111.209 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.2 p -61.0 -25.12 66.66 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.773 1.229 . . . . 0.0 113.219 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.9 mt -84.04 -59.64 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.613 1.165 . . . . 0.0 108.072 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.605 ' HD3' HD12 ' A' ' 69' ' ' LEU . 2.9 mpt_? -49.05 -43.39 40.7 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.253 1.821 . . . . 0.0 113.447 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.46 -14.64 52.05 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.83 91.98 7.17 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -7.52 -79.53 0.01 OUTLIER Glycine 0 N--CA 1.488 2.141 0 C-N-CA 126.936 2.208 . . . . 0.0 117.161 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.57 -45.62 88.63 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.8 mtp -80.16 -11.45 59.75 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 117.36 2.355 . . . . 0.0 117.36 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.3 t -30.47 -61.37 0.17 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 118.761 2.874 . . . . 0.0 118.761 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.22 12.82 2.65 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 119.9 3.296 . . . . 0.0 119.9 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.1 mt -76.62 106.37 3.29 Favored Pre-proline 0 N--CA 1.479 0.989 0 O-C-N 121.251 -0.906 . . . . 0.0 112.117 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.402 ' HG3' HD11 ' A' ' 127' ' ' LEU . 14.7 Cg_endo -40.13 133.86 1.95 Allowed 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 124.567 3.511 . . . . 0.0 117.149 -175.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.4 t -119.28 117.96 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 111.068 -2.787 . . . . 0.0 112.817 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.402 ' HB3' HG12 ' A' ' 55' ' ' ILE . 47.8 tp -108.98 105.64 15.25 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 113.34 -1.754 . . . . 0.0 107.706 177.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.7 mmt -80.53 114.84 19.7 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 113.597 -1.638 . . . . 0.0 111.686 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.54 HG12 ' HG3' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -98.91 110.57 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 179.497 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.6 p -111.53 153.89 25.58 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 117.846 2.536 . . . . 0.0 117.846 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.12 -31.8 73.18 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 112.018 -2.356 . . . . 0.0 113.641 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.03 124.56 3.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.535 1.134 . . . . 0.0 108.518 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.42 90.39 6.71 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 122.529 1.157 . . . . 0.0 110.403 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -121.48 133.28 55.04 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.721 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -25.5 -61.63 0.07 Allowed 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 117.692 2.478 . . . . 0.0 117.692 -177.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -53.58 -46.75 70.42 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -70.27 -34.44 72.79 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.3 mt -60.03 -53.33 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.47 0.708 . . . . 0.0 109.906 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.434 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 33.8 mt -58.56 -46.85 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.707 0.803 . . . . 0.0 109.783 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.08 -47.99 64.9 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.86 0.864 . . . . 0.0 112.294 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.498 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -63.05 -47.38 83.25 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.574 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.79 84.13 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.353 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 96' ' ' ILE . 24.6 mm100 -60.19 -36.82 78.49 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.035 0.934 . . . . 0.0 112.73 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.71 -5.07 52.17 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.561 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 113.86 -5.23 24.15 Favored Glycine 0 CA--C 1.542 1.761 0 N-CA-C 117.367 1.707 . . . . 0.0 117.367 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.51 115.46 2.53 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.417 1.608 . . . . 0.0 115.314 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.2 p -67.95 -18.65 64.81 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 113.568 -1.651 . . . . 0.0 114.217 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.416 ' HA3' HD11 ' A' ' 123' ' ' ILE . . . -165.87 162.05 35.56 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.505 1.05 . . . . 0.0 112.304 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -146.14 126.18 13.71 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.665 0.786 . . . . 0.0 111.117 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 1.4 p -131.27 136.43 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 124.849 1.343 . . . . 0.0 110.864 176.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -93.22 145.37 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.499 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.54 ' HG3' HG12 ' A' ' 86' ' ' VAL . 10.1 mtmp? -89.3 128.91 49.55 Favored Pre-proline 0 N--CA 1.476 0.825 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.68 155.66 80.58 Favored 'Cis proline' 0 CA--C 1.54 0.778 0 O-C-N 123.055 1.029 . . . . 0.0 114.371 0.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -146.53 155.72 42.73 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.067 1.747 . . . . 0.0 107.967 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.5 t -117.13 177.18 4.81 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.919 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.48 -41.86 61.22 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.823 0.849 . . . . 0.0 111.563 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.81 -53.02 60.69 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.184 0.994 . . . . 0.0 111.986 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.73 -46.76 84.0 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.757 0.823 . . . . 0.0 110.62 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.65 -52.56 63.41 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.069 1.348 . . . . 0.0 108.551 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -56.11 -46.94 78.93 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.859 1.264 . . . . 0.0 111.981 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.19 -45.86 65.33 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -68.39 -45.17 73.42 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.85 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.3 mt -55.97 -50.84 69.71 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.2 1.0 . . . . 0.0 112.169 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -51.61 -50.17 60.75 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.604 1.561 . . . . 0.0 111.995 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -54.89 -47.7 73.96 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.721 1.208 . . . . 0.0 110.997 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.416 HD11 ' HA3' ' A' ' 105' ' ' GLY . 96.4 mt -62.78 -44.42 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.849 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -61.01 -33.36 73.15 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -62.87 -44.65 95.54 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.033 176.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -62.82 -39.66 95.0 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.08 1.352 . . . . 0.0 110.741 177.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.402 HD11 ' HG3' ' A' ' 82' ' ' PRO . 85.7 mt -77.48 0.04 24.26 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.24 28.31 72.84 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 123.687 0.661 . . . . 0.0 114.563 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 117.556 -1.211 . . . . 0.0 112.75 179.731 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.3 m 61.66 -30.78 0.07 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 118.805 2.891 . . . . 0.0 118.805 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -113.34 139.36 48.92 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 126.343 1.857 . . . . 0.0 111.984 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 62.1 mttm -133.18 -51.97 0.89 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 113.53 -1.668 . . . . 0.0 112.235 176.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -84.64 60.76 6.3 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 122.388 1.09 . . . . 0.0 109.488 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 tt -108.94 133.04 53.48 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.341 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -79.84 106.75 12.1 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 125.079 1.487 . . . . 0.0 113.588 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -104.09 139.31 39.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 112.672 -2.058 . . . . 0.0 112.704 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -115.92 107.79 15.45 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.572 174.055 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.51 99.04 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 112.585 -2.098 . . . . 0.0 107.53 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.432 HG12 ' SD ' ' A' ' 60' ' ' MET . 3.5 t -101.75 91.0 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.375 -178.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.44 ' OD1' ' HB2' ' A' ' 57' ' ' ASP . 12.0 m-20 -136.48 114.11 11.06 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 113.809 -1.541 . . . . 0.0 113.137 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -52.82 -28.1 21.18 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.628 ' HB3' ' HB2' ' A' ' 17' ' ' MET . 5.4 t80 -94.29 113.48 25.39 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.5 p -45.76 -46.69 15.33 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.709 1.204 . . . . 0.0 113.644 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -47.97 83.68 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.78 177.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.628 ' HB2' ' HB3' ' A' ' 14' ' ' PHE . 2.1 mmm -61.68 -39.92 93.13 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -55.76 -53.86 51.43 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 124.38 1.05 . . . . 0.0 110.421 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.12 -40.14 92.66 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.852 177.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 74.9 mt -56.03 -56.52 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.958 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.487 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 3.3 t -57.76 -45.09 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.041 0.537 . . . . 0.0 111.447 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -51.74 -56.66 12.48 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.151 0.98 . . . . 0.0 111.534 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -59.81 -41.98 92.45 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.576 0.75 . . . . 0.0 112.793 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 71.8 mt -56.96 -53.64 55.72 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.76 0.824 . . . . 0.0 111.405 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.5 mt -54.4 -47.6 72.55 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.143 0.977 . . . . 0.0 112.029 177.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 31' ' ' ASN . 97.7 mttt -57.83 -44.25 86.34 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.871 177.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 28.4 mt-10 -58.71 -38.29 77.97 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.482 1.513 . . . . 0.0 112.174 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.0 mt -75.73 -16.98 60.07 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 124.705 1.253 . . . . 0.0 113.426 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.77 -6.84 20.04 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.738 1.161 . . . . 0.0 114.263 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 68.0 m-85 -90.95 80.82 5.72 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 123.277 1.513 . . . . 0.0 110.46 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.47 ' HA ' ' HG2' ' A' ' 26' ' ' LYS . 9.2 p30 -76.62 -17.26 59.28 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 -177.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -94.47 88.57 5.53 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 122.386 1.088 . . . . 0.0 109.954 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.91 129.04 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 113.991 -1.458 . . . . 0.0 112.213 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.485 ' OE1' ' HB3' ' A' ' 45' ' ' LYS . 29.7 tt0 -109.93 153.92 23.83 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 175.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -125.62 120.77 31.68 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.35 162.33 19.65 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.37 -1.741 . . . . 0.0 109.848 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.42 -43.27 5.01 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -132.51 170.06 15.68 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.21 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.485 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -47.32 -53.15 12.24 Favored Glycine 0 CA--C 1.541 1.707 0 O-C-N 124.675 1.234 . . . . 0.0 114.944 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.8 t -56.3 -54.52 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.542 0.337 . . . . 0.0 111.524 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -56.61 -36.27 69.24 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.559 0.744 . . . . 0.0 111.621 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.32 -49.9 62.29 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.496 1.118 . . . . 0.0 112.507 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.4 mt -53.8 -43.12 69.07 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.339 0.656 . . . . 0.0 111.665 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.14 -59.36 5.42 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 125.059 1.474 . . . . 0.0 110.304 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.485 ' HB3' ' OE1' ' A' ' 34' ' ' GLU . 62.1 mttm -57.79 -40.57 80.17 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.624 HD21 HG22 ' A' ' 54' ' ' VAL . 19.1 mt -56.29 -48.55 76.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.535 0.734 . . . . 0.0 112.026 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -71.6 -5.71 35.44 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.9 -7.71 42.58 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.71 147.71 13.59 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 116.813 1.485 . . . . 0.0 116.813 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.96 -12.46 3.01 Favored Glycine 0 CA--C 1.542 1.778 0 N-CA-C 121.934 3.534 . . . . 0.0 121.934 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -66.0 105.2 1.28 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 121.035 2.418 . . . . 0.0 115.79 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.685 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -101.11 20.24 48.31 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 112.44 -2.163 . . . . 0.0 112.372 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.409 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -171.05 137.03 1.13 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.861 0.865 . . . . 0.0 112.401 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.624 HG22 HD21 ' A' ' 46' ' ' LEU . 22.0 t -124.59 119.54 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.684 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.424 HG21 HG11 ' A' ' 21' ' ' VAL . 87.2 mt -111.69 102.71 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 104.192 -2.521 . . . . 0.0 104.192 176.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 t -121.29 132.39 54.77 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 -176.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.44 ' HB2' ' OD1' ' A' ' 12' ' ' ASP . 13.6 t0 -68.15 131.89 46.22 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 111.815 -2.448 . . . . 0.0 109.536 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 -56.22 -50.99 69.71 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -91.81 89.74 7.19 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 122.527 1.156 . . . . 0.0 113.778 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.539 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 25.2 mtm -124.44 136.01 27.23 Favored Pre-proline 0 N--CA 1.484 1.239 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.373 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -54.16 148.62 39.51 Favored 'Trans proline' 0 N--CA 1.48 0.7 0 C-N-CA 124.172 3.248 . . . . 0.0 110.771 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.313 11.5 p30 60.06 -67.6 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 126.547 1.939 . . . . 0.0 114.534 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.485 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 52.0 ttm -122.16 102.09 7.93 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.229 1.012 . . . . 0.0 108.61 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 8.7 m-20 -66.17 167.35 10.27 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 113.01 -1.905 . . . . 0.0 112.428 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.01 -53.44 18.49 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 124.453 1.025 . . . . 0.0 112.875 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.429 HD12 HD23 ' A' ' 69' ' ' LEU . 60.0 tp -57.93 -38.98 76.91 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.4 ' OE1' ' HB2' ' A' ' 64' ' ' ASP . 12.1 mp0 -72.06 -37.96 69.54 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.768 0.427 . . . . 0.0 111.686 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.8 tp -60.56 -42.52 96.76 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.788 0.835 . . . . 0.0 110.345 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.429 HD23 HD12 ' A' ' 66' ' ' LEU . 10.1 tp -55.06 -46.58 75.38 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.726 1.21 . . . . 0.0 109.909 176.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -60.63 -45.48 93.9 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.915 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.271 38.8 p -60.9 -35.18 75.99 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 124.238 1.015 . . . . 0.0 111.8 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.479 HG23 ' HB3' ' A' ' 78' ' ' MET . 41.2 mt -72.53 -56.73 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.647 1.179 . . . . 0.0 108.664 177.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 73' ' ' ARG . 76.5 mmt-85 -53.39 -42.65 67.15 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.89 1.676 . . . . 0.0 114.048 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.25 -30.08 69.88 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -88.18 100.01 12.64 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.113 0.565 . . . . 0.0 111.309 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -11.37 -74.18 0.01 OUTLIER Glycine 0 N--CA 1.489 2.175 0 C-N-CA 127.662 2.554 . . . . 0.0 118.266 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.51 84.37 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.479 ' HB3' HG23 ' A' ' 72' ' ' ILE . 96.1 mtp -72.31 -24.06 61.26 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.089 1.356 . . . . 0.0 113.847 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.3 m -51.57 -28.48 14.06 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.321 1.449 . . . . 0.0 114.438 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.85 -11.09 42.99 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.685 HD22 ' HA2' ' A' ' 52' ' ' GLY . 83.2 mt -77.49 114.72 43.26 Favored Pre-proline 0 N--CA 1.475 0.807 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 11.3 Cg_endo -49.41 132.7 29.96 Favored 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 124.189 3.259 . . . . 0.0 115.695 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.4 t -120.74 120.53 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 112.739 -2.028 . . . . 0.0 111.955 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.409 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 47.8 tp -112.18 107.05 15.81 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 113.313 -1.767 . . . . 0.0 109.323 178.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 30.9 mmt -81.24 121.97 26.82 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 113.744 -1.571 . . . . 0.0 112.353 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.76 101.52 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.05 145.83 37.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 111.772 -2.467 . . . . 0.0 113.567 -176.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.74 -38.2 72.07 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -156.53 147.28 21.79 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.674 0.789 . . . . 0.0 110.389 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.36 86.78 6.22 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -123.42 134.19 53.98 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 112.667 -2.06 . . . . 0.0 110.351 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -27.19 -60.6 0.09 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.235 1.814 . . . . 0.0 115.481 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -53.58 -52.44 59.77 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -66.69 -38.92 87.75 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.2 mt -59.05 -55.03 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.279 1.032 . . . . 0.0 110.002 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.3 mt -54.84 -54.57 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.301 1.04 . . . . 0.0 109.602 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.18 -49.43 63.87 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.192 0.997 . . . . 0.0 113.308 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.11 -51.02 68.22 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.058 0.943 . . . . 0.0 113.503 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.3 -51.06 71.38 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.047 0.939 . . . . 0.0 112.895 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -64.39 -25.66 68.12 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.44 -5.91 59.04 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.23 2.32 26.39 Favored Glycine 0 CA--C 1.54 1.635 0 N-CA-C 117.408 1.723 . . . . 0.0 117.408 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.92 119.47 8.32 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.4 m -64.93 -30.58 71.59 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.412 -1.722 . . . . 0.0 112.933 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -174.2 170.79 43.95 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.687 1.137 . . . . 0.0 110.587 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.49 ' O ' ' HE2' ' A' ' 119' ' ' LYS . 50.5 p90 -143.21 129.05 19.43 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.462 -0.869 . . . . 0.0 112.458 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.39 124.66 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.743 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.14 123.38 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 112.1 -2.318 . . . . 0.0 111.199 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -90.95 134.79 29.6 Favored Pre-proline 0 N--CA 1.483 1.193 0 CA-C-N 113.65 -1.614 . . . . 0.0 111.284 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -75.45 141.59 71.71 Favored 'Cis proline' 0 CA--C 1.542 0.893 0 O-C-N 123.273 1.144 . . . . 0.0 112.988 0.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.487 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 37.9 p90 -126.69 147.27 49.96 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 113.12 -1.855 . . . . 0.0 109.515 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 52.5 p -97.46 171.03 8.64 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.753 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.22 67.87 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.296 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.99 -49.81 66.51 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.091 0.956 . . . . 0.0 111.533 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.6 m -58.09 -46.12 86.04 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.916 0.886 . . . . 0.0 109.324 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 48.2 tp -58.77 -55.47 34.65 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.438 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . 0.26 1.3 pp20? -59.15 -36.52 75.4 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -55.61 -49.55 72.5 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 123.952 0.783 . . . . 0.0 111.112 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.49 ' HE2' ' O ' ' A' ' 106' ' ' TYR . 32.8 mmmt -65.39 -45.41 84.14 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.901 178.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.0 mt -54.44 -46.91 73.35 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 124.093 0.87 . . . . 0.0 112.222 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -55.0 -52.94 61.58 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.486 1.114 . . . . 0.0 112.308 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -55.36 -42.75 74.31 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.244 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.12 -46.87 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.863 0.865 . . . . 0.0 110.633 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -59.5 -35.12 73.52 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -62.97 -48.82 77.22 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.267 1.027 . . . . 0.0 110.18 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -60.44 -40.1 89.88 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.83 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.9 16.88 6.26 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.065 1.346 . . . . 0.0 113.7 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.72 -68.98 2.14 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 124.644 1.116 . . . . 0.0 111.667 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 C--O 1.254 1.342 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 -179.923 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 t -79.14 93.14 5.14 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 113.275 -1.784 . . . . 0.0 111.038 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.449 ' HB2' HD12 ' A' ' 6' ' ' LEU . 51.2 p30 -81.56 52.09 1.81 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -65.41 -45.24 84.71 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 115.058 -0.973 . . . . 0.0 112.885 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -89.29 60.33 5.24 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 123.426 1.584 . . . . 0.0 110.471 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.449 HD12 ' HB2' ' A' ' 3' ' ' ASP . 3.9 tt -106.56 131.03 54.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.004 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' N ' HD23 ' A' ' 6' ' ' LEU . 14.8 mmtp -78.32 102.2 7.58 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 113.448 -1.706 . . . . 0.0 111.414 177.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -102.35 138.6 39.06 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 112.884 -1.962 . . . . 0.0 113.404 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.16 111.41 19.43 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.815 174.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.1 t -87.02 97.11 6.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 123.899 1.809 . . . . 0.0 107.466 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.552 HG12 ' SD ' ' A' ' 60' ' ' MET . 5.2 t -101.65 74.0 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 112.72 -2.037 . . . . 0.0 106.808 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 8.3 m-20 -127.25 87.06 2.58 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 112.915 -1.948 . . . . 0.0 113.396 -176.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -11.25 -55.85 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 121.62 3.933 . . . . 0.0 121.62 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.545 ' HB3' ' HB2' ' A' ' 17' ' ' MET . 6.2 t80 -81.72 133.5 35.36 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.75 0.656 . . . . 0.0 109.278 -177.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 p -46.33 -50.83 15.82 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.067 0.947 . . . . 0.0 112.908 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.562 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -60.13 -49.73 76.49 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.81 177.488 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.545 ' HB2' ' HB3' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -57.62 -45.34 85.51 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.959 0.904 . . . . 0.0 111.26 -179.717 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 12' ' ' ASP . 9.0 mtm180 -57.66 -52.74 64.2 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.114 0.966 . . . . 0.0 111.496 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.757 HH21 ' HD3' ' A' ' 22' ' ' ARG . 2.1 mmp_? -56.78 -43.49 80.91 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.435 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.562 HG12 ' O ' ' A' ' 16' ' ' THR . 34.5 mm -54.23 -61.44 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.257 0.623 . . . . 0.0 110.939 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.637 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 3.5 t -57.47 -45.16 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.261 0.624 . . . . 0.0 111.63 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.757 ' HD3' HH21 ' A' ' 19' ' ' ARG . 58.7 ttt180 -54.44 -53.54 52.75 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.9 0.88 . . . . 0.0 112.13 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.493 ' HA ' ' HD2' ' A' ' 26' ' ' LYS . 22.4 m120 -63.55 -37.82 88.77 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.499 HD22 ' HB2' ' A' ' 113' ' ' ALA . 57.0 mt -56.95 -51.31 69.68 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.877 0.471 . . . . 0.0 111.874 176.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.416 HD11 HD12 ' A' ' 55' ' ' ILE . 49.1 mt -53.36 -47.04 69.75 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.564 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.493 ' HD2' ' HA ' ' A' ' 23' ' ' ASN . 87.8 mttt -56.85 -47.5 80.23 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.113 177.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 35.2 mt-10 -59.65 -38.87 82.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.49 1.516 . . . . 0.0 112.64 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.63 -16.14 62.27 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.698 1.599 . . . . 0.0 114.085 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.86 9.7 25.96 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 124.462 1.029 . . . . 0.0 114.759 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -92.11 98.16 11.37 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 123.874 1.797 . . . . 0.0 111.53 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -57.76 -42.62 84.41 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 110.39 -3.096 . . . . 0.0 119.236 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -111.55 106.68 15.61 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 t -133.53 126.63 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -110.85 158.0 19.19 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.433 ' OE1' ' HB3' ' A' ' 18' ' ' ARG . 14.9 pt-20 -130.13 119.52 23.15 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -114.67 149.38 36.83 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.921 1.288 . . . . 0.0 110.687 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -76.1 -60.83 2.16 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -133.62 -178.22 4.9 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 119.092 -0.48 . . . . 0.0 111.522 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -43.1 -55.7 4.84 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 125.564 1.554 . . . . 0.0 114.652 177.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.9 t -57.11 -56.69 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 114.335 -0.932 . . . . 0.0 111.947 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -57.26 -38.6 74.12 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.427 0.691 . . . . 0.0 111.631 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.34 -50.25 70.7 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.564 1.146 . . . . 0.0 112.414 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' A' ' 46' ' ' LEU . 78.9 mt -53.85 -40.71 66.71 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.64 0.776 . . . . 0.0 112.862 179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -67.55 -55.18 14.48 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 124.325 1.016 . . . . 0.0 110.927 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -57.78 -30.92 66.04 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.496 HD21 HG22 ' A' ' 54' ' ' VAL . 22.4 mt -55.67 -38.21 69.3 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -71.49 -9.25 57.9 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.65 34.84 0.12 Allowed 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 116.258 1.948 . . . . 0.0 116.258 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.1 115.54 2.63 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 117.939 1.936 . . . . 0.0 117.939 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 27.01 47.77 0.05 OUTLIER Glycine 0 CA--C 1.545 1.925 0 N-CA-C 122.249 3.66 . . . . 0.0 122.249 176.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.477 ' O ' HD22 ' A' ' 81' ' ' LEU . 97.7 m-85 -74.84 87.58 2.26 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 118.547 1.173 . . . . 0.0 113.069 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.6 29.91 5.16 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 113.357 -1.747 . . . . 0.0 111.617 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.408 ' HZ ' HD13 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -175.2 131.86 0.3 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.84 1.305 . . . . 0.0 112.927 178.136 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.496 HG22 HD21 ' A' ' 46' ' ' LEU . 10.7 t -126.99 119.83 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-N 112.436 -2.165 . . . . 0.0 108.88 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.613 HG21 HG11 ' A' ' 21' ' ' VAL . 96.2 mt -110.48 105.89 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.9 t -124.98 132.75 53.22 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 118.128 2.64 . . . . 0.0 118.128 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.555 ' O ' ' HG3' ' A' ' 60' ' ' MET . 20.3 t0 -73.63 133.08 43.39 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 111.71 -2.495 . . . . 0.0 109.512 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.495 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 15.5 t-105 -55.01 -49.28 71.92 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.221 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -90.86 82.09 5.69 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.555 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 39.4 mtm -116.77 137.99 24.21 Favored Pre-proline 0 N--CA 1.482 1.15 0 CA-C-N 114.222 -1.354 . . . . 0.0 112.101 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -57.72 139.5 90.47 Favored 'Trans proline' 0 N--CA 1.476 0.478 0 C-N-CA 124.034 3.156 . . . . 0.0 111.903 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 64.42 -73.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.306 1.842 . . . . 0.0 112.487 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.453 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 51.5 ttm -110.2 98.7 7.9 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 2.6 p30 -64.64 168.08 6.49 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 112.312 -2.222 . . . . 0.0 112.901 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.2 -52.74 21.83 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.028 1.299 . . . . 0.0 114.38 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.459 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 59.8 tp -59.01 -40.45 84.97 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -66.83 -43.43 83.74 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.555 0.342 . . . . 0.0 111.515 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.447 HD11 HG11 ' A' ' 54' ' ' VAL . 1.5 tm? -56.13 -47.49 78.06 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.018 0.927 . . . . 0.0 110.993 177.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 103' ' ' ALA . 4.5 tt -49.22 -55.64 11.89 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.982 1.713 . . . . 0.0 109.412 175.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -61.0 -44.49 97.34 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.909 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.259 29.7 p -59.21 -21.77 60.01 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 124.643 1.177 . . . . 0.0 113.186 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.8 mt -89.99 -58.42 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.573 ' HG2' ' HA3' ' A' ' 102' ' ' GLY . 2.7 mpt_? -47.77 -45.18 28.97 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.953 2.101 . . . . 0.0 114.217 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.73 -11.53 50.86 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -84.01 93.35 8.06 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.199 0.6 . . . . 0.0 110.274 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -12.73 -70.59 0.01 OUTLIER Glycine 0 N--CA 1.495 2.584 0 C-N-CA 126.351 1.929 . . . . 0.0 116.47 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.64 -49.43 75.19 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.43 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 90.4 mtp -75.84 -26.68 57.39 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 m -11.0 -61.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 120.585 3.55 . . . . 0.0 120.585 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.56 28.95 0.45 Allowed 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 120.64 3.57 . . . . 0.0 120.64 -174.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.477 HD22 ' O ' ' A' ' 51' ' ' TYR . 61.2 mt -89.75 106.79 15.36 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.877 -1.139 . . . . 0.0 110.074 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -47.56 133.06 20.96 Favored 'Trans proline' 0 N--CA 1.48 0.735 0 C-N-CA 123.432 2.755 . . . . 0.0 114.756 -177.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.468 HG11 ' HG ' ' A' ' 69' ' ' LEU . 39.3 t -118.19 128.31 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 112.891 -1.958 . . . . 0.0 114.202 -176.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.5 tp -116.48 108.71 16.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 113.199 -1.819 . . . . 0.0 109.562 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.0 mmt -83.19 114.55 21.43 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.595 1.188 . . . . 0.0 114.006 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.75 98.6 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.8 t -106.91 144.57 33.36 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 111.861 -2.427 . . . . 0.0 113.993 -175.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.58 -41.2 41.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 113.471 -1.695 . . . . 0.0 115.236 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -161.9 144.19 11.51 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.076 1.35 . . . . 0.0 109.948 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.22 86.87 3.66 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.364 1.078 . . . . 0.0 109.967 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -118.75 122.48 42.54 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.582 -1.644 . . . . 0.0 109.585 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -21.44 -59.34 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 117.414 2.376 . . . . 0.0 117.414 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -46.12 72.61 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -70.97 -38.31 72.78 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.02 -53.77 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.801 1.24 . . . . 0.0 109.012 176.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.0 mt -54.01 -54.95 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.377 1.071 . . . . 0.0 110.24 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.19 -50.5 64.54 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.267 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.495 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -61.24 -55.37 32.78 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.48 -51.51 69.15 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.877 0.871 . . . . 0.0 112.312 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -30.34 71.39 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.02 -13.84 60.22 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 177.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.573 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 121.75 -0.97 11.07 Favored Glycine 0 CA--C 1.545 1.96 0 N-CA-C 116.208 1.243 . . . . 0.0 116.208 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.666 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -59.63 123.99 18.65 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 119.051 1.426 . . . . 0.0 113.744 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.5 m -64.53 -30.51 71.54 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 113.07 -1.877 . . . . 0.0 112.88 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.72 172.84 45.82 Favored Glycine 0 CA--C 1.542 1.727 0 C-N-CA 124.818 1.199 . . . . 0.0 110.697 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -144.14 139.99 29.14 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.1 p -124.41 129.69 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 124.457 1.098 . . . . 0.0 110.459 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.36 127.45 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 113.217 -1.811 . . . . 0.0 111.24 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -92.94 132.39 31.12 Favored Pre-proline 0 N--CA 1.479 1.002 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.055 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -74.25 142.85 76.0 Favored 'Cis proline' 0 CA--C 1.548 1.189 0 O-C-N 123.017 1.009 . . . . 0.0 114.277 0.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.637 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 33.0 p90 -134.1 155.28 50.33 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 112.282 -2.236 . . . . 0.0 107.986 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 44.9 p -106.62 172.42 6.83 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.335 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.499 ' HB2' HD22 ' A' ' 24' ' ' LEU . . . -54.93 -38.96 68.33 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 123.612 0.57 . . . . 0.0 111.736 176.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.32 -46.78 75.7 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.356 1.062 . . . . 0.0 111.37 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.1 m -60.13 -47.02 87.68 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 52.8 tp -57.19 -52.11 66.64 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.525 1.13 . . . . 0.0 109.851 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -54.03 -48.21 70.75 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 124.12 0.888 . . . . 0.0 112.152 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -52.61 -47.42 66.99 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.58 -46.54 82.28 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.329 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 82.5 mt -56.96 -47.91 79.6 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 124.141 0.901 . . . . 0.0 111.212 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -53.74 -53.54 50.78 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.541 1.536 . . . . 0.0 111.669 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -52.11 -46.04 65.14 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.499 1.52 . . . . 0.0 111.566 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.408 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 63.7 mt -62.37 -51.78 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.341 1.056 . . . . 0.0 110.447 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -57.84 -39.25 77.26 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -58.58 -42.63 88.49 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.735 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -60.98 -39.04 88.09 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.966 0.907 . . . . 0.0 111.264 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.2 mt -83.96 8.87 13.79 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.051 1.341 . . . . 0.0 114.001 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.58 13.98 77.73 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 115.744 1.057 . . . . 0.0 115.744 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.5 mtm . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 117.091 -1.433 . . . . 0.0 113.043 179.544 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.521 ' NH2' ' HB3' ' A' ' 124' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 m -55.84 82.05 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 116.828 2.159 . . . . 0.0 116.828 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -62.11 -30.66 71.17 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . 0.263 63.3 mttp 75.02 -37.18 0.34 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 128.655 2.782 . . . . 0.0 118.089 178.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -90.3 51.34 2.01 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.988 1.375 . . . . 0.0 111.861 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 1.9 tt -112.94 130.85 55.97 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.881 -177.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -86.49 111.21 20.35 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.899 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -105.86 145.32 31.38 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.021 1.728 . . . . 0.0 115.287 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.447 ' CD1' HG22 ' A' ' 11' ' ' VAL . 1.9 tm? -121.5 105.09 10.15 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 112.488 -2.142 . . . . 0.0 110.047 174.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.3 t -82.89 112.52 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 112.87 -1.968 . . . . 0.0 107.763 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.496 ' CG1' ' HB2' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -111.66 96.0 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.697 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -138.44 130.36 28.21 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.166 0.916 . . . . 0.0 112.46 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -72.03 -16.39 62.05 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.529 ' HB3' ' HB2' ' A' ' 17' ' ' MET . 5.5 t80 -101.01 114.68 28.84 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.509 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 35.3 p -40.75 -57.61 1.87 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 125.177 1.548 . . . . 0.0 113.2 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -48.05 80.18 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.529 ' HB2' ' HB3' ' A' ' 14' ' ' PHE . 1.2 tmm? -60.83 -37.58 82.52 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.443 ' NH1' ' HG2' ' A' ' 37' ' ' GLU . 36.9 ttp-105 -59.29 -50.52 73.67 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.437 1.095 . . . . 0.0 110.996 177.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 15' ' ' SER . 9.0 mmt180 -60.82 -42.81 98.42 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.655 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.407 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 71.7 mt -55.63 -52.66 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.266 1.026 . . . . 0.0 111.113 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 17' ' ' MET . 6.3 t -56.11 -48.29 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 122.501 0.32 . . . . 0.0 110.752 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.443 ' HD2' ' OE1' ' A' ' 35' ' ' GLU . 56.4 ttt180 -55.35 -50.49 69.53 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.649 1.18 . . . . 0.0 110.827 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -59.08 -45.68 90.21 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.99 0.916 . . . . 0.0 112.082 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 78.1 mt -54.21 -50.96 65.9 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.334 1.054 . . . . 0.0 111.793 177.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.3 mt -56.03 -46.56 78.82 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.968 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -55.74 -46.73 77.76 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.567 1.167 . . . . 0.0 111.303 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 44.5 mt-10 -59.45 -39.67 84.34 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.381 1.473 . . . . 0.0 112.381 177.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.1 mt -74.01 -12.66 60.69 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.15 -13.28 33.97 Favored Glycine 0 N--CA 1.479 1.522 0 C-N-CA 124.216 0.912 . . . . 0.0 113.386 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -84.72 62.73 7.56 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 123.42 1.581 . . . . 0.0 111.453 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -68.7 -13.72 62.55 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 6.6 m120 -86.42 70.83 10.51 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.81 126.35 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.623 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 16.4 mt-10 -120.42 160.57 22.82 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.044 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.443 ' OE1' ' HD2' ' A' ' 22' ' ' ARG . 7.9 pt-20 -133.69 140.99 47.37 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 119.439 3.125 . . . . 0.0 119.439 -175.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.524 ' HB2' ' HD2' ' A' ' 45' ' ' LYS . . . -124.44 160.75 27.53 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 112.234 -2.257 . . . . 0.0 109.506 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.443 ' HG2' ' NH1' ' A' ' 18' ' ' ARG . 38.1 mt-10 -97.47 -39.43 9.16 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 -177.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -137.59 170.32 16.27 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.468 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.434 ' HA2' HD22 ' A' ' 68' ' ' LEU . . . -45.71 -54.08 8.09 Favored Glycine 0 N--CA 1.482 1.736 0 O-C-N 124.651 1.219 . . . . 0.0 115.671 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.1 t -57.7 -54.42 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.665 0.786 . . . . 0.0 111.783 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -55.21 -36.5 66.03 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.935 0.894 . . . . 0.0 112.167 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.496 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . . . -66.69 -50.78 61.77 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.326 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.2 mt -54.17 -46.1 72.25 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 124.541 1.15 . . . . 0.0 110.482 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -57.05 -53.0 63.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.832 0.853 . . . . 0.0 111.506 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.524 ' HD2' ' HB2' ' A' ' 36' ' ' ALA . 51.2 mttm -56.94 -45.74 82.58 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.207 175.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.552 HD23 ' HB2' ' A' ' 51' ' ' TYR . 19.4 mt -59.2 -42.68 91.48 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.149 0.98 . . . . 0.0 111.653 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -60.57 -30.18 69.63 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 125.102 1.361 . . . . 0.0 112.089 177.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.83 -19.5 65.91 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.81 0.844 . . . . 0.0 112.154 175.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.64 175.09 28.33 Favored Glycine 0 N--CA 1.479 1.53 0 N-CA-C 117.508 1.763 . . . . 0.0 117.508 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.62 -33.1 1.63 Allowed Glycine 0 N--CA 1.483 1.781 0 N-CA-C 121.304 3.282 . . . . 0.0 121.304 176.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.623 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 37.4 m-85 -65.85 113.37 4.31 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -176.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.45 16.87 57.5 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-N 113.761 -1.563 . . . . 0.0 113.124 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -166.23 138.55 3.85 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.229 1.412 . . . . 0.0 110.483 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.449 HG22 HD21 ' A' ' 46' ' ' LEU . 26.5 t -125.31 126.41 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.491 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 91.0 mt -112.13 99.61 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.9 t -109.06 123.68 49.54 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -73.56 127.25 32.22 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 112.572 -2.104 . . . . 0.0 109.565 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.52 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 5.2 t-105 -52.65 -49.14 65.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.032 0.933 . . . . 0.0 111.4 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -88.45 96.77 10.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.971 0.908 . . . . 0.0 110.94 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.4 mtm -138.3 132.3 16.7 Favored Pre-proline 0 N--CA 1.48 1.03 0 CA-C-N 113.742 -1.572 . . . . 0.0 112.589 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -65.87 150.41 85.79 Favored 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 123.933 3.089 . . . . 0.0 111.795 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.3 m120 68.33 -64.01 0.32 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 125.794 1.934 . . . . 0.0 112.694 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.405 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 57.7 ttm -126.44 101.95 6.92 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.277 1.031 . . . . 0.0 108.277 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.36 169.11 6.19 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 113.394 -1.73 . . . . 0.0 111.866 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.0 -52.76 29.65 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.15 0.881 . . . . 0.0 115.156 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.446 HD12 HD13 ' A' ' 69' ' ' LEU . 36.3 tp -60.04 -38.6 83.24 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.48 0.712 . . . . 0.0 112.343 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -66.63 -42.75 86.25 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.664 0.386 . . . . 0.0 110.469 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.434 HD22 ' HA2' ' A' ' 39' ' ' GLY . 58.9 tp -59.7 -45.17 92.95 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.987 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 103' ' ' ALA . 5.6 tt -50.32 -51.71 43.04 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.75 1.62 . . . . 0.0 109.054 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -59.68 -47.24 86.42 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.984 0.914 . . . . 0.0 113.143 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.268 21.7 p -56.55 -35.38 68.06 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.551 1.14 . . . . 0.0 111.994 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.671 HG23 ' HB3' ' A' ' 78' ' ' MET . 42.6 mt -76.29 -54.42 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.152 0.981 . . . . 0.0 109.396 177.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HD3' HD23 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -53.0 -40.79 64.07 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.678 1.991 . . . . 0.0 113.749 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.42 -31.83 65.83 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -87.23 94.91 9.79 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.825 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -13.68 -71.34 0.01 OUTLIER Glycine 0 N--CA 1.487 2.06 0 C-N-CA 127.345 2.402 . . . . 0.0 118.207 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.98 -41.89 71.77 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.671 ' HB3' HG23 ' A' ' 72' ' ' ILE . 35.0 mtm -74.61 -30.8 61.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.25 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.7 m -53.77 -29.08 38.54 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.321 1.048 . . . . 0.0 112.585 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.61 -34.63 58.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.305 1.042 . . . . 0.0 113.264 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.505 ' HA ' ' HD2' ' A' ' 82' ' ' PRO 0.273 2.5 pp -84.45 120.55 74.44 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.505 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 18.8 Cg_endo -47.74 146.9 7.64 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 125.123 3.882 . . . . 0.0 120.65 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.8 t -122.02 107.18 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 111.549 -2.568 . . . . 0.0 110.751 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 56.4 tp -101.07 110.97 23.06 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.643 -1.162 . . . . 0.0 107.931 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 90.0 mmm -81.77 133.9 35.39 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.178 -1.374 . . . . 0.0 112.182 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.427 HG12 ' HB2' ' A' ' 109' ' ' LYS . 3.5 t -112.58 109.47 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 177.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.8 p -103.85 134.33 47.33 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.968 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.97 -24.31 52.13 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -165.13 130.51 2.61 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.624 1.97 . . . . 0.0 107.554 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.621 ' HB2' HG22 ' A' ' 108' ' ' VAL . . . -79.94 98.23 7.07 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 122.474 1.131 . . . . 0.0 111.106 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -121.87 144.53 48.79 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.746 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -35.1 -50.47 0.51 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.759 1.223 . . . . 0.0 114.121 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -50.79 -58.15 6.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.523 1.129 . . . . 0.0 112.759 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -69.06 -39.91 78.85 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 93.5 mt -57.01 -55.49 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.634 0.774 . . . . 0.0 111.767 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.441 HG22 ' OE1' ' A' ' 100' ' ' GLN . 59.0 mt -59.06 -51.26 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 124.052 0.845 . . . . 0.0 111.143 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.51 -45.1 73.26 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 115.248 -0.887 . . . . 0.0 113.286 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.52 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -60.92 -52.38 65.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.566 1.146 . . . . 0.0 113.014 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.29 -47.49 83.5 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.723 0.809 . . . . 0.0 111.702 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.441 ' OE1' HG22 ' A' ' 96' ' ' ILE . 61.1 mt-30 -58.62 -36.46 74.09 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.6 -13.57 57.82 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.446 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 119.43 3.22 12.92 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.679 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -57.93 125.28 22.4 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.737 1.269 . . . . 0.0 112.807 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.2 m -65.52 -31.97 73.31 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 113.447 -1.706 . . . . 0.0 113.166 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.79 174.99 46.48 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 125.01 1.291 . . . . 0.0 110.333 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -145.81 139.72 26.58 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 p -119.11 130.49 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 125.462 1.726 . . . . 0.0 110.853 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.621 HG22 ' HB2' ' A' ' 90' ' ' ALA . 3.3 t -75.7 130.53 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.894 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.427 ' HB2' HG12 ' A' ' 86' ' ' VAL . 1.8 ttmp? -91.84 123.01 64.43 Favored Pre-proline 0 N--CA 1.479 0.997 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -81.42 156.21 81.98 Favored 'Cis proline' 0 N--CA 1.486 1.069 0 N-CA-C 114.323 0.855 . . . . 0.0 114.323 -0.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -140.67 163.84 31.81 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 112.898 -1.955 . . . . 0.0 109.401 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.3 p -112.53 175.4 5.45 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.271 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.84 81.06 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.156 176.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.21 -48.75 76.99 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.821 0.848 . . . . 0.0 110.97 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.0 m -57.07 -45.94 82.88 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.817 0.847 . . . . 0.0 110.494 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.434 HD22 HD11 ' A' ' 120' ' ' LEU . 1.1 tt -59.67 -53.16 61.26 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 124.446 1.091 . . . . 0.0 108.824 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.611 ' HA ' HD12 ' A' ' 120' ' ' LEU . 51.5 tt0 -57.5 -41.86 81.58 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.27 -48.43 65.28 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.845 0.716 . . . . 0.0 111.608 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -63.72 -48.89 75.24 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.965 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 117' ' ' GLU . 96.8 mt -49.93 -47.38 52.41 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.822 1.249 . . . . 0.0 113.716 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -63.87 -49.18 73.76 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -53.99 -48.44 70.39 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 124.649 1.218 . . . . 0.0 110.152 176.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 81.1 mt -55.01 -54.72 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.139 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.521 ' HB3' ' NH2' ' A' ' 1' ' ' ARG . 21.6 m-30 -53.6 -39.34 64.81 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.46 -29.75 69.29 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.67 -45.15 7.15 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.689 1.196 . . . . 0.0 113.508 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 46.5 tp -132.73 88.46 2.52 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.868 1.667 . . . . 0.0 108.932 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.23 89.81 0.01 OUTLIER Glycine 0 CA--C 1.546 1.971 0 CA-C-N 110.579 -3.009 . . . . 0.0 112.746 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.17 0 N-CA-C 119.117 3.006 . . . . 0.0 119.117 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 . . . . . 0 CA--C 1.551 0.992 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.404 ' HA ' HD22 ' A' ' 6' ' ' LEU . 19.1 p -72.15 14.25 0.24 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 116.609 2.077 . . . . 0.0 116.609 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -120.41 72.36 0.95 Allowed 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -176.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 69.58 -37.64 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 127.312 2.245 . . . . 0.0 116.981 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.79 39.07 0.78 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.862 -1.517 . . . . 0.0 110.895 177.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.455 HD21 ' HD2' ' A' ' 53' ' ' PHE . 28.6 tp -95.91 128.05 42.46 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 112.644 -2.071 . . . . 0.0 111.244 -177.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.433 ' NZ ' ' HA3' ' A' ' 49' ' ' GLY . 49.2 mtpt -80.9 106.18 12.7 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 112.874 -1.967 . . . . 0.0 112.107 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -101.73 136.89 40.8 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 113.6 -1.636 . . . . 0.0 113.629 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -115.5 103.24 10.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.575 -1.648 . . . . 0.0 109.902 172.767 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.9 t -81.63 91.99 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 112.074 -2.33 . . . . 0.0 107.156 178.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.511 HG12 ' SD ' ' A' ' 60' ' ' MET . 3.2 t -99.53 94.92 3.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 112.753 -2.021 . . . . 0.0 107.983 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.424 ' OD1' ' HB2' ' A' ' 57' ' ' ASP . 18.2 m-20 -135.47 140.39 44.8 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.258 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -67.08 -27.84 67.69 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 117.017 2.229 . . . . 0.0 117.017 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -107.65 132.15 53.63 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.448 0.299 . . . . 0.0 111.224 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.5 p -51.36 -52.08 48.85 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.754 1.222 . . . . 0.0 113.231 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 m -60.45 -48.82 80.1 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.258 0.974 . . . . 0.0 111.441 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.4 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -59.89 -44.58 94.15 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.224 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -55.39 -58.52 7.39 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.054 1.341 . . . . 0.0 111.039 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 30.4 ptt180 -58.9 -36.37 74.58 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.5 mt -58.23 -49.7 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 122.946 0.498 . . . . 0.0 110.09 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 17' ' ' MET . 9.7 t -55.71 -47.35 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 123.525 0.73 . . . . 0.0 110.27 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.526 ' HA ' HG11 ' A' ' 33' ' ' VAL . 7.0 ttp180 -51.51 -51.73 52.7 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.059 1.344 . . . . 0.0 110.843 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.488 HD22 HH21 ' A' ' 22' ' ' ARG . 66.4 m-20 -62.28 -40.4 96.13 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.206 1.002 . . . . 0.0 112.48 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 84.8 mt -58.5 -51.71 68.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.785 0.834 . . . . 0.0 110.69 177.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.1 mt -55.01 -46.27 75.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.125 0.97 . . . . 0.0 112.548 177.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.8 -43.24 90.5 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.661 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 25.0 mt-10 -58.78 -39.04 79.89 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.887 1.275 . . . . 0.0 111.995 177.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.0 mt -74.23 -17.49 60.88 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.003 1.321 . . . . 0.0 114.068 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.17 9.71 25.37 Favored Glycine 0 N--CA 1.478 1.477 0 N-CA-C 115.639 1.015 . . . . 0.0 115.639 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -92.6 101.78 14.21 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.753 1.263 . . . . 0.0 112.009 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -64.13 -51.41 64.04 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 118.705 2.854 . . . . 0.0 118.705 -175.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -94.08 101.72 13.76 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.239 1.199 . . . . 0.0 114.239 -174.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.526 HG11 ' HA ' ' A' ' 22' ' ' ARG . 32.1 t -130.61 118.35 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.002 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.697 ' HB2' ' HE2' ' A' ' 51' ' ' TYR . 12.5 mp0 -110.79 157.56 19.65 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -127.24 127.93 45.22 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -174.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.03 154.81 32.51 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.501 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -86.93 -48.61 8.0 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -142.74 173.74 11.28 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.245 0.618 . . . . 0.0 109.426 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -43.03 -55.64 4.82 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.071 1.319 . . . . 0.0 116.332 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.87 -54.85 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.366 0.666 . . . . 0.0 111.675 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -56.55 -33.85 66.52 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.665 0.786 . . . . 0.0 111.996 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.86 -48.21 72.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.481 1.112 . . . . 0.0 111.958 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.5 mt -57.62 -40.46 79.2 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.439 0.695 . . . . 0.0 111.464 177.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -59.18 -59.74 4.97 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.402 1.081 . . . . 0.0 109.305 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -58.25 -39.57 79.5 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.414 ' HG ' HD12 ' A' ' 9' ' ' LEU . 16.3 mt -52.8 -38.47 61.24 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.739 1.216 . . . . 0.0 113.905 177.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -59.47 -26.17 65.02 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.52 56.89 1.48 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.786 1.234 . . . . 0.0 114.313 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.433 ' HA3' ' NZ ' ' A' ' 7' ' ' LYS . . . 125.32 -15.14 7.28 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 117.822 1.889 . . . . 0.0 117.822 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.91 67.24 2.04 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.697 ' HE2' ' HB2' ' A' ' 34' ' ' GLU . 1.7 m-85 -58.16 129.64 42.93 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.671 1.989 . . . . 0.0 113.114 -177.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.685 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -83.64 19.06 16.55 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-N 113.915 -1.493 . . . . 0.0 116.564 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.49 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -172.29 128.81 0.57 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 122.551 1.167 . . . . 0.0 112.046 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.3 t -121.8 119.14 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-N 113.521 -1.672 . . . . 0.0 108.182 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.8 mt -108.81 101.77 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 177.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.6 t -119.0 125.87 50.39 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 118.185 2.661 . . . . 0.0 118.185 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.424 ' HB2' ' OD1' ' A' ' 12' ' ' ASP . 54.7 t0 -67.38 128.21 35.55 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 112.374 -2.194 . . . . 0.0 109.892 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.411 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 17.1 t-105 -53.92 -50.15 67.04 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.003 0.921 . . . . 0.0 109.934 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -89.19 95.07 10.15 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.548 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.511 ' SD ' HG12 ' A' ' 11' ' ' VAL . 18.4 mtm -134.83 131.66 20.15 Favored Pre-proline 0 N--CA 1.477 0.887 0 CA-C-N 113.08 -1.873 . . . . 0.0 110.882 177.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -56.65 139.14 87.5 Favored 'Trans proline' 0 N--CA 1.48 0.715 0 C-N-CA 123.945 3.097 . . . . 0.0 111.549 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 m120 64.73 -65.0 0.15 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 126.759 2.024 . . . . 0.0 114.115 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.434 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 57.9 ttm -115.83 92.17 3.82 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.7 p30 -62.16 167.89 3.71 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 111.263 -2.699 . . . . 0.0 112.592 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.28 -55.29 10.73 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 124.298 0.951 . . . . 0.0 113.796 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.425 HD12 HD13 ' A' ' 69' ' ' LEU . 53.3 tp -59.42 -38.14 79.87 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.154 0.981 . . . . 0.0 112.786 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -71.62 -40.05 70.04 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 119.613 -0.232 . . . . 0.0 111.235 177.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.4 tp -60.41 -40.39 90.78 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.679 0.752 . . . . 0.0 110.529 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 103' ' ' ALA . 4.2 tt -51.0 -49.85 59.62 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.089 1.356 . . . . 0.0 108.632 176.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -61.56 -44.96 96.08 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.84 1.256 . . . . 0.0 113.372 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.4 p -61.03 -27.53 68.4 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.625 0.77 . . . . 0.0 111.662 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.0 mt -80.65 -56.9 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.47 1.108 . . . . 0.0 108.78 176.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.416 ' HD3' ' HA ' ' A' ' 73' ' ' ARG . 58.0 mmt-85 -51.87 -42.91 63.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.994 1.717 . . . . 0.0 113.346 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.47 -23.69 50.36 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -86.79 95.45 9.84 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.17 0.588 . . . . 0.0 111.807 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -3.5 -83.63 0.0 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 127.106 2.289 . . . . 0.0 118.412 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.94 -39.86 82.89 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 82.3 mtp -71.84 -23.56 61.56 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.573 1.549 . . . . 0.0 113.778 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.6 m -50.8 -26.17 5.36 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.841 1.657 . . . . 0.0 115.147 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.49 -7.43 50.5 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.685 HD22 ' HA2' ' A' ' 52' ' ' GLY . 54.3 mt -83.42 119.48 73.99 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 123.284 0.633 . . . . 0.0 111.829 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.455 ' HG3' HD11 ' A' ' 127' ' ' LEU . 14.6 Cg_endo -54.18 138.44 71.69 Favored 'Trans proline' 0 N--CA 1.482 0.812 0 C-N-CA 123.984 3.123 . . . . 0.0 114.892 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.46 HG11 ' HG ' ' A' ' 69' ' ' LEU . 13.0 t -120.26 114.47 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-N 112.366 -2.197 . . . . 0.0 111.427 -178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.49 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 30.9 tp -106.64 110.37 22.54 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.969 -1.469 . . . . 0.0 109.36 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.3 mmt -81.11 112.29 18.34 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.911 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.63 102.82 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.4 t -110.18 138.63 46.3 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.13 -1.85 . . . . 0.0 113.78 -176.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -48.0 -31.41 5.31 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -161.5 152.73 18.54 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.709 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.438 ' HB2' HG21 ' A' ' 108' ' ' VAL . . . -77.24 82.29 3.72 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 123.187 1.47 . . . . 0.0 107.552 176.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -100.94 121.42 41.71 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 111.343 -2.662 . . . . 0.0 108.362 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.531 ' O ' HG12 ' A' ' 96' ' ' ILE . 33.0 ttmt -38.48 -53.07 1.58 Allowed 'General case' 0 N--CA 1.483 1.178 0 O-C-N 125.018 1.449 . . . . 0.0 113.892 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -53.17 -53.29 52.74 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.171 0.588 . . . . 0.0 111.188 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -56.79 -49.36 75.57 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.3 1.0 . . . . 0.0 111.833 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.8 mt -55.25 -51.92 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.188 0.995 . . . . 0.0 111.969 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 92' ' ' LYS . 32.2 mm -58.98 -54.89 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.606 0.762 . . . . 0.0 110.8 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.63 -47.05 70.65 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.191 0.996 . . . . 0.0 113.234 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -57.06 -51.72 68.14 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.451 1.1 . . . . 0.0 112.168 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.1 -47.75 84.83 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.284 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.455 ' OE1' HG22 ' A' ' 96' ' ' ILE . 65.9 mt-30 -56.3 -40.38 74.23 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.85 1.26 . . . . 0.0 113.489 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.28 -14.41 59.44 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.92 3.11 12.35 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.631 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -65.24 123.02 18.45 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.192 1.496 . . . . 0.0 112.319 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.1 p -69.78 -17.57 63.43 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 113.161 -1.836 . . . . 0.0 114.314 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.54 173.47 43.93 Favored Glycine 0 N--CA 1.481 1.658 0 C-N-CA 124.043 0.83 . . . . 0.0 111.844 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -144.4 136.63 26.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 114.999 -0.601 . . . . 0.0 112.387 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.258 1.0 OUTLIER -118.03 126.9 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 124.413 1.07 . . . . 0.0 110.419 178.363 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 25.4 t -80.37 114.64 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 112.159 -2.292 . . . . 0.0 111.229 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -90.36 132.28 36.03 Favored Pre-proline 0 N--CA 1.472 0.627 0 CA-C-O 117.725 -1.131 . . . . 0.0 110.611 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.18 132.87 26.91 Favored 'Cis proline' 0 N--CA 1.489 1.228 0 N-CA-C 115.173 1.182 . . . . 0.0 115.173 1.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.442 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 35.0 p90 -124.74 151.62 44.84 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 112.462 -2.154 . . . . 0.0 108.69 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.2 p -102.53 171.63 7.33 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.014 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.71 -39.85 68.6 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.576 0.548 . . . . 0.0 111.396 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.0 -44.41 80.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.427 1.091 . . . . 0.0 111.983 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.4 m -60.15 -49.32 78.09 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 60.3 tp -56.14 -50.45 71.08 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.24 1.416 . . . . 0.0 109.715 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -56.45 -46.86 80.12 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.328 1.051 . . . . 0.0 112.473 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -53.41 -44.08 68.44 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -65.88 -48.43 71.55 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.392 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.7 mt -56.66 -48.94 76.48 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.535 1.134 . . . . 0.0 111.504 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -50.09 -53.24 28.57 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 126.021 1.728 . . . . 0.0 112.056 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -54.15 -45.91 72.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.654 1.182 . . . . 0.0 111.466 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.74 -39.8 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.338 1.055 . . . . 0.0 112.038 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -61.3 -25.46 67.13 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -57.91 -44.62 86.95 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 124.004 0.815 . . . . 0.0 109.542 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -68.18 -35.83 78.64 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.28 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.455 HD11 ' HG3' ' A' ' 82' ' ' PRO . 82.7 mt -86.85 44.23 1.15 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.672 1.589 . . . . 0.0 112.468 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 61.04 15.26 42.59 Favored Glycine 0 CA--C 1.55 2.276 0 C-N-CA 127.081 2.277 . . . . 0.0 118.35 177.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 116.984 -1.484 . . . . 0.0 113.083 179.176 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 . . . . . 0 CA--C 1.554 1.132 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.4 p -82.91 81.22 8.71 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 122.969 1.366 . . . . 0.0 112.011 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -65.34 105.23 1.09 Allowed 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.761 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 57.6 mmtt -51.19 -39.9 57.49 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -105.68 45.33 0.98 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.6 tp -83.11 122.78 28.81 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 112.029 -2.351 . . . . 0.0 107.349 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 51' ' ' TYR . 69.1 tttt -78.26 115.88 18.3 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.931 -1.486 . . . . 0.0 113.446 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.509 ' HB2' HG22 ' A' ' 33' ' ' VAL . 65.1 m-85 -105.72 138.15 42.4 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.745 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.661 HD23 ' HB3' ' A' ' 34' ' ' GLU . 1.6 tm? -116.16 99.53 7.3 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.616 1.198 . . . . 0.0 108.822 175.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.71 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 94.9 t -79.68 104.36 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 111.61 -2.541 . . . . 0.0 108.958 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.56 HG22 HD13 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -104.89 102.54 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 113.605 -1.634 . . . . 0.0 110.02 -178.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.75 135.05 22.96 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.986 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -66.1 -16.99 64.41 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -106.59 110.36 22.54 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.2 p -46.93 -49.63 20.19 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.691 -1.14 . . . . 0.0 113.273 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -38.93 85.94 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.297 1.039 . . . . 0.0 112.741 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.2 tpt -62.19 -38.98 91.18 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.515 ' HD2' ' HB3' ' A' ' 35' ' ' GLU . 77.4 mtm180 -56.39 -47.89 78.02 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.196 0.522 . . . . 0.0 110.907 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.56 -41.61 73.51 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 114.133 -1.394 . . . . 0.0 112.399 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.5 mt -57.69 -50.99 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.244 0.617 . . . . 0.0 110.23 177.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 t -58.57 -42.47 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.273 0.629 . . . . 0.0 109.97 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 56.0 ttm-85 -53.8 -54.14 42.51 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 123.938 0.774 . . . . 0.0 110.737 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -58.81 -39.78 82.17 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 81.1 mt -62.59 -53.88 48.05 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.482 0.713 . . . . 0.0 111.492 177.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.9 mt -54.87 -44.3 73.9 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.988 0.915 . . . . 0.0 111.882 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -56.75 -49.08 76.32 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 113.343 -1.753 . . . . 0.0 110.175 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 28.5 mt-10 -56.42 -38.0 70.97 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.05 1.74 . . . . 0.0 112.914 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.4 mt -73.76 -19.17 60.86 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.787 1.235 . . . . 0.0 114.287 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.41 -5.22 23.21 Favored Glycine 0 CA--C 1.551 2.295 0 C-N-CA 124.296 0.951 . . . . 0.0 112.919 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 22.3 m-85 -92.54 86.03 5.49 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 122.557 1.17 . . . . 0.0 109.773 -178.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -85.28 -7.52 58.96 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -98.29 93.37 6.18 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 122.387 1.089 . . . . 0.0 110.343 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.509 HG22 ' HB2' ' A' ' 8' ' ' PHE . 54.6 t -129.11 136.32 59.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 113.525 -1.67 . . . . 0.0 111.403 -178.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.661 ' HB3' HD23 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -126.16 149.85 48.7 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 176.387 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.71 ' HG2' ' HB ' ' A' ' 10' ' ' VAL . 87.8 mt-10 -127.99 141.27 51.57 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 118.637 2.828 . . . . 0.0 118.637 -176.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -131.51 152.44 50.73 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 112.072 -2.331 . . . . 0.0 110.531 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . 0.374 0.0 OUTLIER -100.08 -27.71 13.41 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 -179.057 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.7 p30 -142.7 166.59 24.24 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.476 -0.765 . . . . 0.0 110.831 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -45.08 -49.25 9.7 Favored Glycine 0 N--CA 1.479 1.543 0 C-N-CA 124.6 1.095 . . . . 0.0 115.582 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -58.65 -56.68 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 114.616 -0.792 . . . . 0.0 110.585 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -55.36 -35.38 65.17 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.802 0.841 . . . . 0.0 111.662 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.01 -51.52 57.57 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 117.91 -1.043 . . . . 0.0 111.834 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 50.6 mt -54.82 -45.77 74.48 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 124.211 0.944 . . . . 0.0 111.068 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -54.96 -54.41 43.17 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 125.166 1.541 . . . . 0.0 111.43 177.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.8 mttt -62.61 -45.14 94.22 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.027 1.331 . . . . 0.0 114.271 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.8 mt -54.09 -28.71 41.02 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 98.3 mm-40 -57.88 -25.51 60.87 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.39 -18.89 62.69 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.72 -179.8 50.63 Favored Glycine 0 N--CA 1.48 1.593 0 CA-C-O 122.165 0.869 . . . . 0.0 112.541 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.46 -31.02 3.29 Favored Glycine 0 N--CA 1.485 1.953 0 CA-C-N 113.959 -1.121 . . . . 0.0 114.142 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.546 ' HA ' ' HB3' ' A' ' 7' ' ' LYS . 65.3 m-85 -60.69 113.29 2.39 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.094 0.558 . . . . 0.0 110.772 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.62 15.3 45.64 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 125.815 1.947 . . . . 0.0 112.222 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.529 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.6 OUTLIER -171.3 134.19 0.88 Allowed 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 122.381 1.086 . . . . 0.0 112.348 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.32 121.49 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.538 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 89.8 mt -112.33 98.99 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.5 t -113.46 122.06 46.17 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.02 127.26 32.22 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 111.456 -2.611 . . . . 0.0 110.259 177.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -51.93 -45.04 64.14 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.237 0.961 . . . . 0.0 112.871 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -87.06 103.15 15.11 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.013 0.925 . . . . 0.0 109.438 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.9 mtp -147.23 131.46 8.58 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 123.999 0.92 . . . . 0.0 111.815 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.21 149.42 81.62 Favored 'Trans proline' 0 N--CA 1.48 0.734 0 C-N-CA 123.484 2.789 . . . . 0.0 110.968 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.5 m120 70.94 -71.7 0.13 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.911 1.684 . . . . 0.0 111.05 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.4 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 58.8 ttm -119.84 99.71 6.8 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -61.1 166.59 3.51 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.688 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.91 -56.64 7.45 Favored Glycine 0 N--CA 1.485 1.939 0 O-C-N 124.188 0.93 . . . . 0.0 114.868 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.627 HD12 HD23 ' A' ' 69' ' ' LEU . 50.8 tp -58.59 -37.26 75.43 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -68.31 -39.81 81.89 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.773 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.7 tp -58.99 -42.37 89.87 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.904 0.753 . . . . 0.0 110.372 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.627 HD23 HD12 ' A' ' 66' ' ' LEU . 12.9 tp -54.06 -47.27 71.82 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.059 1.344 . . . . 0.0 111.178 176.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.36 -47.11 85.62 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.235 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.257 11.4 p -59.15 -32.38 69.83 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.658 1.183 . . . . 0.0 112.943 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.452 HG23 ' HB3' ' A' ' 78' ' ' MET . 53.3 mt -74.65 -55.7 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.248 1.019 . . . . 0.0 108.311 176.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.439 ' HD3' ' HA ' ' A' ' 73' ' ' ARG . 71.1 mmt-85 -51.03 -48.01 61.57 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.584 1.554 . . . . 0.0 111.769 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.83 -22.32 65.15 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -83.66 110.71 18.5 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.599 0.76 . . . . 0.0 109.411 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -26.28 -69.14 0.05 OUTLIER Glycine 0 CA--C 1.541 1.71 0 C-N-CA 125.981 1.753 . . . . 0.0 115.306 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.02 -35.28 80.68 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.452 ' HB3' HG23 ' A' ' 72' ' ' ILE . 42.7 mtm -85.35 -11.38 54.72 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 64.8 p -42.67 -43.17 3.74 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.456 1.903 . . . . 0.0 116.099 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.64 -3.95 57.01 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 90.5 mt -73.95 111.07 10.86 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 11.8 Cg_endo -52.1 131.14 38.0 Favored 'Trans proline' 0 N--CA 1.481 0.749 0 C-N-CA 123.166 2.577 . . . . 0.0 114.249 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 63.3 t -116.86 124.72 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 112.865 -1.97 . . . . 0.0 113.224 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.529 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 50.4 tp -111.97 108.13 17.35 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 112.659 -2.064 . . . . 0.0 108.771 178.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.0 mmt -81.8 106.13 13.48 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 113.383 -1.735 . . . . 0.0 113.637 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -91.28 98.61 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 123.921 1.819 . . . . 0.0 108.504 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 t -108.9 139.23 44.04 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 111.813 -2.449 . . . . 0.0 112.6 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.19 -41.79 65.63 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 114.213 -1.358 . . . . 0.0 113.495 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -137.32 151.17 48.34 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.472 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.565 ' HB2' HG21 ' A' ' 108' ' ' VAL . . . -91.73 78.14 5.51 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.352 177.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.8 135.99 37.98 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.259 -1.791 . . . . 0.0 108.7 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -41.07 -49.46 3.4 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.077 1.351 . . . . 0.0 113.193 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -58.59 -51.2 70.9 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -56.93 -45.39 82.76 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.343 1.027 . . . . 0.0 111.312 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 78.9 mt -56.87 -55.16 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 124.716 1.206 . . . . 0.0 110.892 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.448 HG22 ' OE1' ' A' ' 100' ' ' GLN . 44.5 mt -59.32 -50.92 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.021 0.928 . . . . 0.0 110.674 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.58 74.11 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.834 0.854 . . . . 0.0 111.865 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.08 -49.05 79.35 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.507 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.53 88.29 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.305 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.448 ' OE1' HG22 ' A' ' 96' ' ' ILE . 78.5 mt-30 -60.12 -38.87 84.31 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.0 -0.66 45.22 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.54 -0.81 29.23 Favored Glycine 0 CA--C 1.545 1.908 0 N-CA-C 117.391 1.716 . . . . 0.0 117.391 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.03 121.65 14.11 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.099 1.449 . . . . 0.0 114.357 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.0 m -65.44 -30.02 70.77 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 111.913 -2.403 . . . . 0.0 113.08 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -173.68 177.23 46.09 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.308 1.432 . . . . 0.0 111.121 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -147.32 131.54 17.42 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.053 -1.073 . . . . 0.0 111.186 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.8 p -120.83 123.85 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 123.988 0.805 . . . . 0.0 110.364 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.565 HG21 ' HB2' ' A' ' 90' ' ' ALA . 93.8 t -76.41 128.56 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 112.796 -2.002 . . . . 0.0 111.456 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -92.78 138.26 23.67 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.859 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.51 133.75 31.92 Favored 'Cis proline' 0 CA--C 1.54 0.788 0 N-CA-C 115.866 1.449 . . . . 0.0 115.866 0.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -116.95 147.72 42.02 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 112.832 -1.985 . . . . 0.0 108.458 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 59.9 p -105.56 178.48 4.55 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.983 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.11 -42.93 69.99 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.912 0.758 . . . . 0.0 111.97 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.09 72.93 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.738 0.815 . . . . 0.0 111.723 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -60.57 -46.3 90.73 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.475 0.71 . . . . 0.0 110.786 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.3 tp -56.47 -51.2 69.35 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.323 1.049 . . . . 0.0 109.553 177.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.436 ' HA ' HD12 ' A' ' 120' ' ' LEU . 8.3 tt0 -58.67 -47.67 83.71 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.531 0.732 . . . . 0.0 111.752 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -50.42 -45.5 55.82 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 124.195 0.934 . . . . 0.0 110.653 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -68.47 -46.59 69.34 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.159 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 117' ' ' GLU . 46.5 mt -55.87 -48.67 75.15 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.503 0.721 . . . . 0.0 111.218 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -55.15 -52.53 63.0 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.502 1.521 . . . . 0.0 112.004 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -52.85 -46.96 68.05 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.357 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.92 -46.88 93.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.276 1.03 . . . . 0.0 111.528 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -61.33 -40.89 95.88 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.582 0.353 . . . . 0.0 111.722 178.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.58 -48.9 77.41 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.581 1.152 . . . . 0.0 110.346 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -54.9 -39.83 69.17 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.033 1.333 . . . . 0.0 111.563 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.9 33.4 0.59 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.308 1.443 . . . . 0.0 113.919 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.38 -5.41 2.2 Favored Glycine 0 CA--C 1.546 1.995 0 N-CA-C 117.122 1.609 . . . . 0.0 117.122 178.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 71.1 mtm . . . . . 0 C--O 1.255 1.374 0 CA-C-O 118.606 -0.712 . . . . 0.0 112.815 179.977 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.6 p -66.73 90.36 0.17 Allowed 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.43 124.6 22.69 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 111.983 -2.371 . . . . 0.0 112.111 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 33.5 mmtp -59.83 -31.51 69.81 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -99.94 46.8 0.95 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.497 1.142 . . . . 0.0 113.802 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.424 HD23 ' CZ ' ' A' ' 8' ' ' PHE . 38.2 tp -79.77 127.68 32.51 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 111.405 -2.634 . . . . 0.0 107.318 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 51' ' ' TYR . 76.8 tttt -81.77 110.43 17.08 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.558 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 30' ' ' PHE . 89.4 m-85 -99.33 141.65 31.84 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.933 -1.94 . . . . 0.0 113.135 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.745 HD23 ' HB3' ' A' ' 34' ' ' GLU . 1.3 tm? -121.82 98.76 6.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.368 174.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -80.11 109.68 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 111.955 -2.384 . . . . 0.0 108.419 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.6 HG22 HD13 ' A' ' 9' ' ' LEU . 1.4 t -108.53 100.64 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.597 -179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -141.21 133.73 28.44 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.844 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -65.06 -28.37 69.42 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 112.976 -1.92 . . . . 0.0 114.025 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -94.54 102.02 13.94 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.0 p -39.12 -50.09 1.85 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 113.024 -1.898 . . . . 0.0 113.27 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -38.82 92.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.04 1.336 . . . . 0.0 112.61 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 12.4 tpt -63.51 -34.27 77.4 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.473 ' HD2' ' HB3' ' A' ' 35' ' ' GLU . 72.0 mtm180 -56.47 -42.58 78.45 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.507 0.504 . . . . 0.0 111.441 178.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -60.37 -43.88 96.16 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.114 -1.403 . . . . 0.0 112.533 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.6 mt -59.97 -51.46 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 122.993 0.517 . . . . 0.0 110.231 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.8 t -58.04 -44.41 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 123.806 0.691 . . . . 0.0 109.172 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 37.5 ttm-85 -55.42 -52.49 63.42 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.953 0.901 . . . . 0.0 111.469 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -55.9 -44.87 78.63 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 123.916 0.76 . . . . 0.0 113.04 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 68.4 mt -59.36 -52.82 64.01 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.506 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.5 mt -54.29 -48.75 70.93 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.541 176.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -52.25 -48.51 65.18 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.64 1.576 . . . . 0.0 111.198 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 35.3 mt-10 -58.33 -39.03 78.36 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.014 1.725 . . . . 0.0 114.017 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.2 mt -73.84 -16.25 61.14 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.962 1.305 . . . . 0.0 114.163 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.62 -8.31 19.8 Favored Glycine 0 N--CA 1.482 1.743 0 C-N-CA 124.696 1.141 . . . . 0.0 112.824 -177.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 51.9 m-85 -90.11 74.07 7.19 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 123.871 1.795 . . . . 0.0 111.675 -178.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -76.18 -14.73 60.15 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 112.256 -2.247 . . . . 0.0 116.167 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -91.79 93.51 8.89 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.465 1.126 . . . . 0.0 110.218 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.8 t -132.63 140.53 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.591 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.745 ' HB3' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -126.93 152.44 47.12 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 175.388 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 36.8 mt-10 -126.67 141.95 51.69 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -178.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.458 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -131.54 158.15 41.7 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 112.01 -2.359 . . . . 0.0 108.951 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . 0.314 0.0 OUTLIER -105.37 -17.37 14.46 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 -178.05 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -157.17 169.01 25.75 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 122.009 -0.432 . . . . 0.0 109.924 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -44.82 -54.99 6.48 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 124.743 1.164 . . . . 0.0 114.684 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.3 t -56.67 -56.54 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 122.612 0.365 . . . . 0.0 111.096 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -52.29 -35.91 51.63 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.113 0.965 . . . . 0.0 112.748 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . . . -68.9 -52.92 24.35 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.551 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.3 mt -52.89 -42.5 65.36 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.801 0.688 . . . . 0.0 111.412 178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -55.71 -57.29 12.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.601 1.56 . . . . 0.0 110.592 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -58.65 -42.2 87.81 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.536 1.535 . . . . 0.0 113.252 177.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.3 mt -59.98 -32.33 70.75 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -55.27 -26.66 41.44 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.83 -15.0 61.25 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.82 -177.43 47.57 Favored Glycine 0 CA--C 1.542 1.73 0 C-N-CA 124.033 0.825 . . . . 0.0 112.566 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.93 -33.2 4.06 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 114.753 -0.723 . . . . 0.0 113.495 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.547 ' O ' HD22 ' A' ' 81' ' ' LEU . 50.9 m-85 -69.16 122.56 19.04 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.944 0.897 . . . . 0.0 111.827 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.46 23.97 8.27 Favored Glycine 0 N--CA 1.478 1.49 0 O-C-N 126.17 2.169 . . . . 0.0 112.322 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.504 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -173.94 133.32 0.44 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.779 1.232 . . . . 0.0 111.398 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.6 t -122.77 122.95 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.823 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.5 mt -110.93 100.04 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 105.861 -1.904 . . . . 0.0 105.861 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.401 ' OG ' ' HA2' ' A' ' 65' ' ' GLY . 29.8 t -118.0 130.02 55.93 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -68.5 127.65 33.76 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 111.624 -2.535 . . . . 0.0 110.828 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.495 ' O ' ' HB2' ' A' ' 64' ' ' ASP . 32.1 t-105 -48.11 -54.62 12.61 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.515 1.126 . . . . 0.0 112.54 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -104.43 114.35 28.53 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 122.323 1.058 . . . . 0.0 111.167 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.455 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 32.8 mtm -139.73 137.28 18.33 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 111.916 -2.402 . . . . 0.0 109.383 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -57.04 145.54 85.27 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.645 2.897 . . . . 0.0 112.23 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.7 m120 69.41 -59.22 0.49 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.49 1.916 . . . . 0.0 115.009 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 59.3 ttm -133.02 101.4 5.21 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 58' ' ' TRP . 3.0 p30 -68.81 164.24 22.37 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 113.634 -1.621 . . . . 0.0 112.323 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.401 ' HA2' ' OG ' ' A' ' 56' ' ' SER . . . -43.91 -50.36 7.41 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 124.857 1.217 . . . . 0.0 114.453 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 61.9 tp -61.19 -42.6 98.87 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.743 -0.729 . . . . 0.0 112.84 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -65.63 -38.86 90.6 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.631 0.373 . . . . 0.0 111.198 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.14 -43.94 95.34 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.046 0.841 . . . . 0.0 110.345 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 66' ' ' LEU . 19.4 tp -55.15 -46.28 75.69 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.697 1.199 . . . . 0.0 110.685 176.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.63 -46.4 89.1 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.254 0.622 . . . . 0.0 112.366 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.25 12.8 p -62.55 -16.61 56.98 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.954 1.302 . . . . 0.0 114.069 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.9 mt -92.68 -59.76 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.111 1.364 . . . . 0.0 108.08 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 101' ' ' ALA . 77.2 mmt-85 -53.32 -46.48 69.46 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 126.386 1.874 . . . . 0.0 113.873 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.74 -29.92 65.04 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' A' ' 78' ' ' MET . 37.1 t0 -86.37 103.27 14.78 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -23.0 -71.19 0.01 OUTLIER Glycine 0 N--CA 1.483 1.818 0 C-N-CA 126.188 1.852 . . . . 0.0 115.692 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.01 -43.46 77.73 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.421 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 75.5 mmm -68.11 -27.02 66.11 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 -179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 96.1 p -47.36 -27.87 1.81 Allowed 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.73 -12.23 44.81 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 51' ' ' TYR . 2.6 mt -95.86 115.2 65.37 Favored Pre-proline 0 N--CA 1.485 1.312 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -59.42 142.98 99.81 Favored 'Trans proline' 0 N--CA 1.483 0.903 0 C-N-CA 123.439 2.759 . . . . 0.0 111.329 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.0 t -121.3 126.97 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-O 122.681 1.229 . . . . 0.0 113.234 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.504 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 54.4 tp -112.96 112.11 23.34 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 112.336 -2.211 . . . . 0.0 109.932 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 31.5 mmt -85.85 108.36 18.1 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.955 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.1 t -86.85 98.69 7.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-O 123.234 1.492 . . . . 0.0 107.692 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 1.8 t -113.26 140.57 47.87 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 112.03 -2.35 . . . . 0.0 109.947 -177.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.12 -50.57 58.57 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.542 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.405 ' HA ' HG13 ' A' ' 108' ' ' VAL . 39.1 mt-10 -138.92 153.6 48.27 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.974 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.14 83.74 7.74 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 122.83 1.3 . . . . 0.0 109.209 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -108.89 141.41 41.0 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 112.592 -2.095 . . . . 0.0 111.6 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -40.96 -52.77 3.07 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.621 1.568 . . . . 0.0 113.443 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -55.73 -50.19 71.05 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -62.98 -47.14 84.45 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.184 0.994 . . . . 0.0 111.323 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.8 mt -55.97 -54.57 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.783 1.233 . . . . 0.0 112.585 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.542 HG22 ' OE1' ' A' ' 100' ' ' GLN . 24.3 mt -55.83 -53.88 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.184 0.594 . . . . 0.0 109.9 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.71 -45.57 74.05 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.481 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.77 -48.7 79.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.23 1.012 . . . . 0.0 113.041 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.59 -43.17 97.74 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.983 0.913 . . . . 0.0 111.633 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.542 ' OE1' HG22 ' A' ' 96' ' ' ILE . 54.0 mt-30 -57.86 -33.73 68.99 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.314 1.046 . . . . 0.0 113.541 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.52 ' O ' ' HG3' ' A' ' 73' ' ' ARG . . . -90.9 -1.62 57.82 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 100.33 13.32 36.21 Favored Glycine 0 CA--C 1.547 2.088 0 N-CA-C 117.676 1.83 . . . . 0.0 117.676 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.04 129.9 43.75 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 118.921 1.36 . . . . 0.0 114.57 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.443 ' HB3' HG23 ' A' ' 123' ' ' ILE . 28.3 m -73.82 -29.29 62.06 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 113.085 -1.87 . . . . 0.0 112.439 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.12 174.99 47.22 Favored Glycine 0 N--CA 1.481 1.672 0 C-N-CA 124.898 1.237 . . . . 0.0 110.466 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.548 ' O ' ' HE2' ' A' ' 119' ' ' LYS . 37.0 p90 -144.88 130.51 18.96 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 113.924 -1.138 . . . . 0.0 111.304 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.292 1.4 p -114.68 121.19 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.205 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.405 HG13 ' HA ' ' A' ' 89' ' ' GLU . 94.0 t -74.69 115.41 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 111.479 -2.6 . . . . 0.0 111.316 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -91.65 135.57 27.58 Favored Pre-proline 0 C--O 1.24 0.567 0 O-C-N 124.421 1.075 . . . . 0.0 112.298 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -72.75 130.66 20.32 Favored 'Cis proline' 0 N--CA 1.475 0.423 0 N-CA-C 116.725 1.779 . . . . 0.0 116.725 0.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -120.63 137.83 54.23 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 112.073 -2.331 . . . . 0.0 108.213 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 54.3 p -96.48 179.52 4.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 123.85 0.719 . . . . 0.0 110.079 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.26 -36.53 68.67 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 119.504 -0.284 . . . . 0.0 111.324 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.45 -49.54 66.34 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.82 0.848 . . . . 0.0 110.839 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.99 -43.14 99.47 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.146 0.579 . . . . 0.0 110.123 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 40.2 tp -60.66 -53.72 54.03 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.695 0.798 . . . . 0.0 110.492 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -55.16 -45.87 75.71 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.459 0.704 . . . . 0.0 111.083 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -54.79 -47.36 74.08 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.337 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.548 ' HE2' ' O ' ' A' ' 106' ' ' TYR . 31.9 mmmt -66.8 -41.92 86.77 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 55.9 mt -57.76 -47.73 81.66 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.722 0.809 . . . . 0.0 109.621 177.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -54.64 -54.02 47.11 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.761 1.624 . . . . 0.0 112.074 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -52.74 -43.65 65.88 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.955 0.902 . . . . 0.0 112.331 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.443 HG23 ' HB3' ' A' ' 104' ' ' SER . 68.8 mt -60.65 -49.82 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.509 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -59.44 -40.97 88.5 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.218 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -56.75 -50.65 71.62 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 125.083 1.489 . . . . 0.0 110.691 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -60.94 -40.75 94.48 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.278 1.031 . . . . 0.0 111.385 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.7 1.44 26.47 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.14 -35.81 4.35 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 116.24 1.256 . . . . 0.0 116.24 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 75.4 mtm . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 -178.747 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 119.826 3.269 . . . . 0.0 119.826 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.9 p -87.12 119.29 27.2 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.8 1.286 . . . . 0.0 110.788 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -98.44 109.39 22.16 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.097 -1.865 . . . . 0.0 111.188 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 4' ' ' LYS . 55.3 mmtt -61.43 -17.83 56.07 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -109.71 61.26 0.6 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 123.347 1.546 . . . . 0.0 109.541 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.401 HD11 ' HA3' ' A' ' 52' ' ' GLY . 59.1 tp -86.71 136.19 33.11 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 110.846 -2.888 . . . . 0.0 110.212 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -86.96 118.57 26.43 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 125.674 1.859 . . . . 0.0 111.89 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.565 ' HB2' HG22 ' A' ' 33' ' ' VAL . 61.1 m-85 -108.2 148.93 29.24 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 112.826 -1.988 . . . . 0.0 112.868 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.649 HD23 ' HB3' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -127.23 104.01 7.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.639 175.484 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.451 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 95.4 t -84.1 105.3 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 112.526 -2.125 . . . . 0.0 109.197 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.534 HG22 HD13 ' A' ' 9' ' ' LEU . 1.4 t -104.08 92.45 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.817 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -135.62 127.54 29.49 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.36 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -60.36 -21.41 62.08 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -101.89 131.22 48.38 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.429 0.633 . . . . 0.0 110.995 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.5 p -50.44 -58.55 5.46 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.006 -1.907 . . . . 0.0 112.568 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -45.24 93.77 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.471 1.108 . . . . 0.0 112.614 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 11.9 tpt -59.87 -37.29 78.89 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.523 ' HD2' ' HB3' ' A' ' 35' ' ' GLU . 64.4 mtm-85 -58.21 -47.35 83.75 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -59.61 -43.44 93.77 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.396 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.403 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 83.2 mt -56.35 -48.26 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.537 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.423 HG11 HG21 ' A' ' 55' ' ' ILE . 4.6 t -63.07 -41.56 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 CA-C-O 118.943 -0.551 . . . . 0.0 109.982 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 57.7 ttm-85 -54.67 -52.47 62.25 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.378 0.671 . . . . 0.0 110.047 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -59.57 -38.43 81.13 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.415 1.086 . . . . 0.0 113.624 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 20' ' ' ILE . 83.1 mt -63.36 -54.39 37.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.753 0.821 . . . . 0.0 110.91 177.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.8 mt -55.66 -43.29 76.15 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.139 0.976 . . . . 0.0 111.743 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -56.68 -47.59 79.52 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.103 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -59.95 -37.43 79.55 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.038 1.735 . . . . 0.0 112.684 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.9 mt -72.66 -20.33 61.27 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.639 1.176 . . . . 0.0 113.21 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.81 -15.31 11.31 Favored Glycine 0 CA--C 1.546 2.028 0 C-N-CA 124.591 1.091 . . . . 0.0 114.336 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -89.71 82.23 6.32 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 123.408 1.575 . . . . 0.0 110.578 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -76.65 -7.97 56.33 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -96.98 97.95 9.68 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.071 0.939 . . . . 0.0 110.067 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.565 HG22 ' HB2' ' A' ' 8' ' ' PHE . 83.1 t -134.16 141.45 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.904 -178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.649 ' HB3' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -125.49 153.2 43.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 174.759 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.523 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 89.3 mt-10 -126.07 142.54 51.48 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 116.143 1.905 . . . . 0.0 116.143 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.62 157.25 46.22 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 112.53 -2.123 . . . . 0.0 108.097 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.6 -33.15 9.1 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -138.91 173.09 11.93 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.98 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.67 -56.85 7.08 Favored Glycine 0 N--CA 1.474 1.23 0 CA-C-N 114.254 -1.339 . . . . 0.0 115.551 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.9 t -58.07 -53.84 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 122.922 0.489 . . . . 0.0 111.496 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -51.83 -40.62 60.81 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.939 0.895 . . . . 0.0 111.969 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.8 -51.27 65.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.414 1.086 . . . . 0.0 112.728 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.6 mt -54.47 -47.32 73.09 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.776 0.831 . . . . 0.0 112.104 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -56.77 -55.35 35.38 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.777 1.298 . . . . 0.0 110.256 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -58.19 -39.34 78.71 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.008 -1.451 . . . . 0.0 114.597 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 34.0 mt -58.43 -31.0 67.33 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.962 1.468 . . . . 0.0 114.962 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -58.41 -22.37 53.85 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.534 1.134 . . . . 0.0 114.018 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.86 -26.36 67.32 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.55 175.97 48.48 Favored Glycine 0 N--CA 1.479 1.533 0 C-N-CA 124.211 0.91 . . . . 0.0 113.445 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.19 -27.79 3.49 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 113.539 -1.33 . . . . 0.0 114.933 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -61.44 108.64 0.98 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.959 0.904 . . . . 0.0 112.499 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.401 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -99.42 15.92 59.55 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-N 113.634 -1.621 . . . . 0.0 111.837 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.728 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -173.61 141.21 0.84 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.257 1.023 . . . . 0.0 113.757 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.6 t -123.18 111.82 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 113.318 -1.765 . . . . 0.0 108.267 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.423 HG21 HG11 ' A' ' 21' ' ' VAL . 76.5 mt -100.9 101.8 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.5 t -119.44 128.21 53.81 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -74.14 132.34 42.15 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.052 -1.886 . . . . 0.0 110.426 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -54.01 -44.02 70.57 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.388 1.055 . . . . 0.0 113.098 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -93.7 99.52 11.92 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.673 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.468 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 9.7 mtm -139.88 137.3 18.17 Favored Pre-proline 0 N--CA 1.478 0.967 0 CA-C-N 114.511 -1.222 . . . . 0.0 112.127 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.1 145.13 93.67 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.789 2.993 . . . . 0.0 113.177 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 65.05 -69.09 0.1 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.316 1.847 . . . . 0.0 112.415 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.6 ttm -116.81 100.27 7.67 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.468 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 2.3 p30 -65.32 173.35 2.61 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 113.476 -1.693 . . . . 0.0 113.24 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -52.23 -54.97 24.04 Favored Glycine 0 N--CA 1.478 1.474 0 C-N-CA 124.703 1.144 . . . . 0.0 115.051 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 57.8 tp -59.4 -39.85 84.75 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.599 0.76 . . . . 0.0 111.925 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -66.87 -39.8 87.64 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.354 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.24 -45.34 93.59 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.878 0.871 . . . . 0.0 110.089 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.514 HD13 HG11 ' A' ' 83' ' ' VAL . 9.7 tp -52.32 -45.62 65.69 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.517 1.127 . . . . 0.0 111.77 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -60.31 -47.69 84.93 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.998 0.919 . . . . 0.0 113.082 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.32 -38.24 86.17 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.247 1.019 . . . . 0.0 111.335 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' A' ' 78' ' ' MET . 47.8 mt -67.91 -54.67 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 123.893 0.877 . . . . 0.0 109.467 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.451 ' HD3' ' HA ' ' A' ' 73' ' ' ARG . 62.1 mmt-85 -54.1 -41.11 67.9 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 125.61 1.564 . . . . 0.0 111.918 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.44 -30.73 68.72 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.963 1.305 . . . . 0.0 113.982 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.535 ' OD2' ' HG3' ' A' ' 78' ' ' MET . 27.0 t70 -83.84 93.98 8.11 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.553 0.741 . . . . 0.0 110.36 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -8.86 -80.15 0.01 OUTLIER Glycine 0 N--CA 1.482 1.729 0 C-N-CA 126.85 2.167 . . . . 0.0 117.254 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.18 -42.81 86.88 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.535 ' HG3' ' OD2' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -63.61 -25.28 68.16 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -179.179 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.5 p -53.64 -25.78 19.3 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.22 -22.51 61.25 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.413 1.485 . . . . 0.0 114.439 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.472 ' HA ' ' HD2' ' A' ' 82' ' ' PRO 0.355 1.5 pp -94.02 111.62 53.87 Favored Pre-proline 0 N--CA 1.479 0.997 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 179.463 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 11.4 Cg_endo -47.46 143.97 10.82 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 125.086 3.857 . . . . 0.0 117.453 -177.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.514 HG11 HD13 ' A' ' 69' ' ' LEU . 87.7 t -117.44 121.29 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 112.248 -2.251 . . . . 0.0 111.575 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.728 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 46.8 tp -112.55 115.5 28.73 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.343 -1.753 . . . . 0.0 108.992 178.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.9 mmt -88.21 112.25 22.55 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.533 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -92.23 96.84 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 123.377 1.56 . . . . 0.0 108.155 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 1.3 t -109.22 128.6 55.18 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 111.457 -2.611 . . . . 0.0 111.494 -178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.12 -38.7 25.77 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -143.37 138.6 29.53 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.24 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.23 84.89 5.13 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.265 -1.334 . . . . 0.0 107.912 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -100.38 133.69 44.43 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 112.055 -2.338 . . . . 0.0 107.253 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -39.12 -49.46 1.8 Allowed 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.941 1.401 . . . . 0.0 113.593 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -58.5 -52.76 64.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.159 0.984 . . . . 0.0 112.079 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -56.33 -44.69 80.24 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.906 0.882 . . . . 0.0 110.928 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 83.4 mt -58.7 -56.15 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.856 0.863 . . . . 0.0 111.195 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.422 HG22 ' OE1' ' A' ' 100' ' ' GLN . 52.4 mt -57.41 -50.82 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.231 0.612 . . . . 0.0 110.511 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.72 -48.32 72.67 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.891 0.876 . . . . 0.0 113.248 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.21 -48.88 79.98 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.687 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.0 -48.25 82.27 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.27 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.422 ' OE1' HG22 ' A' ' 96' ' ' ILE . 62.6 mt-30 -55.6 -42.8 75.36 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.391 1.076 . . . . 0.0 113.897 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.05 -1.37 43.82 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.417 ' C ' HD11 ' A' ' 69' ' ' LEU . . . 107.41 11.47 25.3 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 117.823 1.889 . . . . 0.0 117.823 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.41 125.65 24.89 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.198 1.499 . . . . 0.0 114.86 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.0 m -70.47 -23.15 62.64 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 112.445 -2.161 . . . . 0.0 112.684 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.01 -179.68 45.21 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.541 1.544 . . . . 0.0 110.348 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -147.27 130.45 16.47 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.216 -0.992 . . . . 0.0 111.715 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.7 p -115.36 123.54 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.852 0.834 . . . . 0.0 110.393 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 87' ' ' THR . 67.9 t -77.8 125.44 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 113.231 -1.804 . . . . 0.0 110.679 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -92.66 139.19 23.52 Favored Pre-proline 0 N--CA 1.478 0.934 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.914 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.64 125.36 11.68 Favored 'Cis proline' 0 CA--C 1.54 0.812 0 CA-C-O 122.734 1.056 . . . . 0.0 114.629 0.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.421 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 15.6 p90 -110.01 145.16 37.48 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.039 -1.891 . . . . 0.0 109.015 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 49.9 p -97.89 171.14 8.48 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.35 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.24 -39.07 63.52 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.934 176.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.43 -46.18 84.28 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.88 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.8 m -64.2 -45.98 85.92 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.084 0.954 . . . . 0.0 109.489 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 30.4 tp -56.59 -51.32 69.08 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.099 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -58.22 -47.77 82.47 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.51 0.724 . . . . 0.0 112.372 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -46.08 -47.41 17.2 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.106 0.879 . . . . 0.0 112.291 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -71.54 -47.57 54.32 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.472 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 116' ' ' LEU . 37.5 mt -55.86 -45.24 78.54 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.858 0.863 . . . . 0.0 112.27 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -53.66 -55.86 22.33 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.786 1.234 . . . . 0.0 113.295 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -53.17 -47.47 68.8 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.783 -1.553 . . . . 0.0 112.088 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.407 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 65.5 mt -57.1 -44.41 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 114.2 -1.364 . . . . 0.0 113.238 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -59.55 -36.71 76.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -76.03 -46.18 30.67 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 113.732 -1.576 . . . . 0.0 110.279 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -61.37 -29.05 69.67 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.898 1.279 . . . . 0.0 112.527 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 mp -91.73 1.85 56.88 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 64.94 23.57 69.49 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 115.957 1.143 . . . . 0.0 115.957 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 27.0 mtt . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 116.329 -1.796 . . . . 0.0 114.417 179.596 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 t -85.52 72.71 10.59 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 112.79 -2.005 . . . . 0.0 105.616 177.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.548 ' OD1' HD12 ' A' ' 6' ' ' LEU 0.269 0.0 OUTLIER -71.25 45.24 0.1 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 111.072 -2.786 . . . . 0.0 115.282 -177.647 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HG2' ' H ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -64.06 -27.1 68.87 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 113.682 -1.599 . . . . 0.0 114.638 178.16 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -84.57 27.46 0.72 Allowed 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.508 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.548 HD12 ' OD1' ' A' ' 3' ' ' ASP . 3.9 tt -82.9 130.53 35.15 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.409 1.084 . . . . 0.0 109.898 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.728 ' HG3' ' HB3' ' A' ' 32' ' ' ASN . 0.4 OUTLIER -87.45 102.01 14.14 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.764 176.687 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -92.85 133.68 35.83 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.183 -1.826 . . . . 0.0 111.638 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.455 HD12 ' HG ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -109.46 104.23 13.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.754 174.845 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.514 ' HA ' HG23 ' A' ' 55' ' ' ILE . 54.8 t -80.73 98.27 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.519 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.526 HG12 ' SD ' ' A' ' 60' ' ' MET . 2.7 t -101.7 78.61 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 112.69 -2.05 . . . . 0.0 108.42 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 3.7 m-20 -128.47 100.12 5.66 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 113.044 -1.889 . . . . 0.0 112.313 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -27.69 -41.44 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -92.34 124.76 36.64 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.8 p -47.86 -50.5 26.2 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.143 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.523 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -57.91 -46.24 85.26 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.264 0.626 . . . . 0.0 111.456 177.929 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.06 -45.8 91.95 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.393 0.677 . . . . 0.0 111.373 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.74 ' HD2' ' HB3' ' A' ' 35' ' ' GLU . 6.6 mtm180 -53.67 -46.78 70.73 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.727 0.811 . . . . 0.0 111.133 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 10.5 mtp180 -61.92 -43.02 99.71 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 112.993 -1.912 . . . . 0.0 113.735 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 16' ' ' THR . 40.1 mm -57.83 -54.74 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.376 0.671 . . . . 0.0 110.311 178.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.535 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 20.7 t -55.05 -44.49 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.67 0.788 . . . . 0.0 110.855 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.415 ' HB3' ' O ' ' A' ' 19' ' ' ARG . 52.4 ttt180 -53.67 -54.83 32.23 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.475 1.11 . . . . 0.0 110.936 177.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -55.74 -39.71 71.51 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.311 1.044 . . . . 0.0 112.743 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.02 -53.55 53.91 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.559 1.144 . . . . 0.0 111.393 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.1 mt -53.98 -41.86 68.34 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.329 1.052 . . . . 0.0 111.832 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -56.94 -51.43 69.18 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.128 -1.397 . . . . 0.0 109.982 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -56.82 -37.68 71.54 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.654 1.581 . . . . 0.0 112.55 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.2 mt -74.03 -18.08 60.89 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.91 15.5 19.99 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.868 1.223 . . . . 0.0 114.356 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -96.27 101.0 12.58 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 123.347 1.546 . . . . 0.0 112.152 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -60.44 -45.33 94.04 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 111.494 -2.594 . . . . 0.0 117.689 -178.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.728 ' HB3' ' HG3' ' A' ' 7' ' ' LYS . 69.8 m-80 -100.16 108.55 20.7 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -173.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.1 t -133.24 120.17 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 112.291 -2.231 . . . . 0.0 109.433 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.436 ' O ' HD23 ' A' ' 9' ' ' LEU . 7.7 tt0 -111.47 154.89 24.05 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 175.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.74 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 33.0 mt-10 -122.46 125.32 45.57 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -120.5 148.25 44.09 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.073 -1.876 . . . . 0.0 109.844 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.58 -61.08 1.98 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -129.67 179.41 5.84 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.799 -176.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -45.45 -52.79 8.59 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-N 114.594 -1.184 . . . . 0.0 115.182 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.7 t -57.79 -57.86 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.027 0.931 . . . . 0.0 111.471 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -55.68 -36.98 67.71 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.07 0.948 . . . . 0.0 111.335 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.441 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -63.78 -51.36 65.2 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.868 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.8 mt -55.05 -45.95 75.31 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.321 0.648 . . . . 0.0 110.936 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -56.46 -58.01 9.86 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.188 0.995 . . . . 0.0 110.933 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -58.18 -40.92 82.73 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.643 1.577 . . . . 0.0 114.569 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 54' ' ' VAL . 25.4 mt -53.57 -41.01 66.08 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -65.04 -15.83 62.77 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.75 14.32 0.21 Allowed 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.28 160.09 6.91 Favored Glycine 0 N--CA 1.483 1.784 0 C-N-CA 126.024 1.773 . . . . 0.0 116.788 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.92 -13.48 3.2 Favored Glycine 0 CA--C 1.546 1.987 0 N-CA-C 120.461 2.944 . . . . 0.0 120.461 176.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.562 ' O ' HD22 ' A' ' 81' ' ' LEU . 76.0 m-85 -65.76 99.97 0.5 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.923 1.861 . . . . 0.0 115.52 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.4 15.77 62.59 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-N 112.55 -2.114 . . . . 0.0 111.797 177.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.468 ' HB2' HD21 ' A' ' 6' ' ' LEU . 0.6 OUTLIER -168.31 136.48 2.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 122.577 1.179 . . . . 0.0 113.756 178.634 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.505 HG22 HD21 ' A' ' 46' ' ' LEU . 13.4 t -124.23 112.86 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.106 177.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.514 HG23 ' HA ' ' A' ' 10' ' ' VAL . 18.0 tt -115.96 97.89 6.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 113.714 -1.585 . . . . 0.0 107.055 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.3 t -118.37 139.67 51.01 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 119.523 3.157 . . . . 0.0 119.523 -174.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 60' ' ' MET . 15.1 t0 -73.45 129.64 38.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.324 -2.217 . . . . 0.0 110.662 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.493 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 25.0 t-105 -56.15 -39.69 72.67 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.648 0.779 . . . . 0.0 112.401 178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -99.35 93.55 5.98 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.497 1.519 . . . . 0.0 110.334 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.526 ' SD ' HG12 ' A' ' 11' ' ' VAL . 20.0 mtm -132.95 134.88 25.01 Favored Pre-proline 0 N--CA 1.479 1.023 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.79 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -57.11 144.58 89.74 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.729 2.953 . . . . 0.0 111.162 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.7 m120 65.69 -73.62 0.06 Allowed 'General case' 0 N--CA 1.483 1.205 0 O-C-N 125.182 1.551 . . . . 0.0 112.659 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.468 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 55.0 ttm -115.12 98.4 6.76 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.1 p30 -61.84 168.56 3.02 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 112.34 -2.209 . . . . 0.0 112.691 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.46 -52.91 26.76 Favored Glycine 0 N--CA 1.481 1.653 0 C-N-CA 124.632 1.11 . . . . 0.0 114.247 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 60.5 tp -59.81 -40.99 90.25 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.645 0.778 . . . . 0.0 112.247 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -66.03 -43.64 87.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.703 0.801 . . . . 0.0 111.159 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -58.42 -45.66 88.03 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.499 1.12 . . . . 0.0 110.821 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 103' ' ' ALA . 7.4 tt -52.32 -50.07 62.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.205 1.402 . . . . 0.0 109.818 176.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -59.28 -47.01 86.99 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.678 1.191 . . . . 0.0 112.836 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.263 27.6 p -61.24 -23.7 65.83 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.585 1.154 . . . . 0.0 112.291 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.3 mt -84.32 -58.88 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.959 0.904 . . . . 0.0 108.65 174.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.5 mmt-85 -48.67 -51.34 28.94 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.909 2.083 . . . . 0.0 113.968 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.1 -21.4 59.91 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.06 97.64 8.87 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -22.25 -61.45 0.03 OUTLIER Glycine 0 N--CA 1.486 2.033 0 C-N-CA 125.976 1.751 . . . . 0.0 116.37 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.11 91.55 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 97.7 mtp -78.44 -24.27 46.18 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.899 1.815 . . . . 0.0 115.899 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 t -27.94 -33.15 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 118.609 2.818 . . . . 0.0 118.609 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.69 -1.52 58.12 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.562 HD22 ' O ' ' A' ' 51' ' ' TYR . 59.6 mt -75.23 113.25 23.58 Favored Pre-proline 0 N--CA 1.489 1.491 0 CA-C-N 119.248 0.931 . . . . 0.0 113.119 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.509 ' HB3' HD11 ' A' ' 127' ' ' LEU . 27.5 Cg_endo -56.62 134.46 64.56 Favored 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.436 2.757 . . . . 0.0 113.245 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.3 t -118.9 120.09 62.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 113.971 -1.468 . . . . 0.0 113.413 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.509 HD23 HD12 ' A' ' 55' ' ' ILE . 59.4 tp -112.22 105.4 13.72 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.815 -1.993 . . . . 0.0 109.361 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.2 mmt -78.25 107.53 10.91 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.815 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -87.18 96.22 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 t -100.15 136.78 39.53 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 111.422 -2.627 . . . . 0.0 114.898 -176.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.88 -24.41 66.86 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 112.691 -2.049 . . . . 0.0 113.487 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.503 ' HB3' ' HG3' ' A' ' 91' ' ' LYS . 12.6 mt-10 -155.91 126.23 6.68 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.173 1.389 . . . . 0.0 111.911 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.0 81.07 7.56 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 122.096 0.951 . . . . 0.0 108.897 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.503 ' HG3' ' HB3' ' A' ' 89' ' ' GLU . 43.3 mtmt -110.32 136.38 49.59 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.775 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' A' ' 93' ' ' GLU 0.29 0.0 OUTLIER -33.4 -52.26 0.37 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 117.049 2.241 . . . . 0.0 117.049 -178.993 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.485 ' N ' ' HD2' ' A' ' 92' ' ' LYS 0.334 0.8 OUTLIER -63.91 -42.41 97.41 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -179.458 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.301 32.1 p-10 -73.94 -30.68 62.68 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.868 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.3 mt -61.05 -50.85 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.3 mt -53.42 -54.22 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.349 1.46 . . . . 0.0 110.132 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.72 -48.84 72.0 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.484 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.493 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -57.9 -55.54 33.58 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.831 1.252 . . . . 0.0 112.976 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.83 85.28 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.593 0.757 . . . . 0.0 112.283 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -64.36 -34.12 77.42 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.041 1.496 . . . . 0.0 115.041 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.56 -13.18 59.95 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.12 1.01 8.08 Favored Glycine 0 CA--C 1.547 2.058 0 N-CA-C 117.391 1.716 . . . . 0.0 117.391 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.674 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -55.5 120.43 7.17 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 119.707 1.753 . . . . 0.0 115.116 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.7 m -64.31 -32.95 74.75 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.355 -1.748 . . . . 0.0 112.327 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.72 172.85 45.56 Favored Glycine 0 N--CA 1.477 1.378 0 C-N-CA 125.162 1.363 . . . . 0.0 110.061 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -144.01 140.32 29.51 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.4 p -122.63 127.1 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 124.942 1.401 . . . . 0.0 109.959 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.7 p -86.62 132.76 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.829 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.32 137.61 24.64 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.549 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -77.29 139.35 58.13 Favored 'Cis proline' 0 N--CA 1.482 0.799 0 N-CA-C 115.112 1.158 . . . . 0.0 115.112 -0.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.535 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 25.8 p90 -126.92 147.73 50.07 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 112.424 -2.171 . . . . 0.0 107.953 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.4 p -100.3 174.35 6.17 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.298 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.38 -37.93 62.9 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.178 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.26 -47.71 66.99 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.287 1.035 . . . . 0.0 111.89 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 m -58.25 -47.88 82.17 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.3 tp -56.27 -52.12 65.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.757 1.223 . . . . 0.0 111.412 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.486 ' HA ' HD12 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -55.81 -44.15 77.57 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.991 0.917 . . . . 0.0 112.449 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -57.72 -43.91 85.6 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -64.55 -45.19 88.14 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.273 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 117' ' ' GLU . 94.3 mt -54.08 -49.39 69.19 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.188 0.995 . . . . 0.0 111.468 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -53.94 -55.05 30.56 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.488 1.115 . . . . 0.0 111.945 178.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -51.78 -46.95 64.37 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.147 1.379 . . . . 0.0 111.607 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.4 mt -60.91 -52.15 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.485 1.114 . . . . 0.0 110.646 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -55.78 -44.29 77.59 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.383 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -56.93 -41.46 78.24 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 124.319 1.012 . . . . 0.0 111.952 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -64.44 -50.2 68.49 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.742 0.817 . . . . 0.0 111.242 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 82' ' ' PRO . 53.7 mt -69.2 -7.71 39.02 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.112 1.765 . . . . 0.0 115.404 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 102.88 -28.33 16.32 Favored Glycine 0 N--CA 1.478 1.457 0 C-N-CA 123.753 0.692 . . . . 0.0 112.766 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 59.9 mtm . . . . . 0 C--O 1.257 1.458 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 179.598 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 91.4 mttt . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 117.367 2.358 . . . . 0.0 117.367 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.414 ' HG3' ' OD1' ' A' ' 32' ' ' ASN . 0.5 OUTLIER -120.92 89.86 3.21 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.548 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 tt -144.26 128.57 17.83 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 112.28 -2.236 . . . . 0.0 107.687 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.485 ' HG2' ' HB3' ' A' ' 32' ' ' ASN . 65.1 mttm -82.06 112.86 19.5 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -104.32 132.97 50.0 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.47 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.476 ' CD1' HG22 ' A' ' 11' ' ' VAL . 2.0 tm? -111.95 99.76 8.35 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.103 0.954 . . . . 0.0 110.06 176.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.469 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 53.9 t -78.94 103.61 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 112.03 -2.35 . . . . 0.0 108.467 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.495 ' CG1' ' HB2' ' A' ' 42' ' ' ALA . 1.3 t -100.85 90.05 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 113.555 -1.657 . . . . 0.0 107.785 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -132.34 121.59 23.75 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.818 1.294 . . . . 0.0 112.275 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.84 -29.9 70.48 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 111.979 -2.373 . . . . 0.0 115.345 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -98.4 121.31 40.18 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.7 0.625 . . . . 0.0 109.452 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.1 p -50.04 -50.67 46.91 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 m -59.45 -50.12 75.16 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.046 0.538 . . . . 0.0 111.137 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -40.35 94.58 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.135 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.528 HH21 ' NH1' ' A' ' 19' ' ' ARG . 37.1 ttp180 -58.88 -48.33 81.78 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.315 1.046 . . . . 0.0 111.147 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.528 ' NH1' HH21 ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.74 -46.47 89.04 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.387 1.054 . . . . 0.0 111.994 177.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.424 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 61.2 mt -53.97 -50.92 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.828 0.851 . . . . 0.0 110.932 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.428 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 5.8 t -57.23 -48.45 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 122.506 0.323 . . . . 0.0 110.732 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -56.39 -50.77 70.63 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.86 0.725 . . . . 0.0 110.946 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -55.83 -43.33 76.89 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.268 1.027 . . . . 0.0 110.769 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 20' ' ' ILE . 67.9 mt -59.97 -51.82 68.03 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.718 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.7 mt -57.11 -43.19 82.06 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.718 0.807 . . . . 0.0 112.81 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -58.2 -48.9 78.88 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.383 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -60.69 -33.99 73.68 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.748 1.619 . . . . 0.0 113.008 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.5 mt -76.2 -13.7 60.17 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.06 -14.44 26.17 Favored Glycine 0 N--CA 1.482 1.755 0 C-N-CA 124.359 0.98 . . . . 0.0 113.741 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -81.23 85.41 6.38 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 122.384 1.088 . . . . 0.0 111.999 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -81.37 13.55 2.91 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.485 ' HB3' ' HG2' ' A' ' 7' ' ' LYS . 20.8 m120 -121.83 85.9 2.49 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 123.461 1.601 . . . . 0.0 110.756 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p -136.78 127.63 41.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 113.562 -1.653 . . . . 0.0 111.374 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.594 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 23.3 mp0 -119.43 155.29 32.29 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.469 ' HG2' ' HB ' ' A' ' 10' ' ' VAL . 29.9 mt-10 -127.8 139.7 52.49 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -177.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.79 167.15 17.72 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 111.175 -2.738 . . . . 0.0 109.748 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -104.35 -53.78 2.65 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -125.0 171.33 10.32 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.199 0.599 . . . . 0.0 110.989 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.475 ' HA2' HD22 ' A' ' 68' ' ' LEU . . . -45.58 -53.77 8.12 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.992 1.282 . . . . 0.0 115.662 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.5 t -58.25 -55.06 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.671 0.788 . . . . 0.0 111.27 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -54.49 -41.51 69.67 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.672 1.189 . . . . 0.0 111.318 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.495 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . . . -63.1 -49.45 74.41 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.501 1.121 . . . . 0.0 112.146 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.518 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 18.0 mt -52.25 -53.91 37.83 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 124.332 1.02 . . . . 0.0 110.706 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -52.11 -52.2 52.99 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.39 1.056 . . . . 0.0 112.426 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -57.93 -52.8 63.99 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.634 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.1 mt -59.56 -33.09 70.98 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 83.3 mt-30 -62.29 -26.27 68.32 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.87 -25.84 68.07 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.79 -168.37 15.96 Favored Glycine 0 N--CA 1.478 1.449 0 O-C-N 124.585 1.178 . . . . 0.0 110.588 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.61 -41.73 2.15 Favored Glycine 0 CA--C 1.541 1.71 0 N-CA-C 116.17 1.228 . . . . 0.0 116.17 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.594 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 76.8 m-85 -66.77 135.42 53.95 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.83 19.87 7.34 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 113.801 -1.545 . . . . 0.0 113.62 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -174.29 144.06 0.91 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.762 1.225 . . . . 0.0 111.776 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 t -125.64 124.66 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.886 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.0 mt -115.92 99.99 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.8 t -116.93 137.5 52.17 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 -176.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -77.37 129.49 35.87 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 113.456 -1.702 . . . . 0.0 110.236 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -56.58 -50.4 72.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.101 0.96 . . . . 0.0 112.534 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.437 ' OD1' ' HB2' ' A' ' 88' ' ' ALA . 4.4 p-10 -87.92 77.28 8.52 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.146 1.379 . . . . 0.0 113.338 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.436 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 3.4 mtm -117.66 133.23 23.32 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-N 113.576 -1.647 . . . . 0.0 113.706 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 60' ' ' MET . 71.5 Cg_exo -61.68 147.02 96.28 Favored 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 123.982 3.122 . . . . 0.0 112.505 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 68.9 -64.08 0.34 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.565 1.946 . . . . 0.0 112.208 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 60.4 ttm -126.69 104.31 8.02 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 124.779 1.231 . . . . 0.0 107.887 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -69.71 168.61 14.57 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 113.614 -1.63 . . . . 0.0 113.178 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.3 -54.57 12.37 Favored Glycine 0 N--CA 1.476 1.314 0 C-N-CA 125.046 1.308 . . . . 0.0 114.393 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.645 HD12 HD23 ' A' ' 69' ' ' LEU . 41.8 tp -59.99 -41.5 92.21 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.66 0.784 . . . . 0.0 112.846 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.5 -43.91 88.65 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.627 0.371 . . . . 0.0 111.228 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.475 HD22 ' HA2' ' A' ' 39' ' ' GLY . 61.1 tp -58.73 -40.82 84.87 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.091 0.956 . . . . 0.0 110.736 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.645 HD23 HD12 ' A' ' 66' ' ' LEU . 13.0 tp -56.0 -45.64 78.99 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.178 0.991 . . . . 0.0 110.675 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.75 -45.42 89.94 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.018 0.927 . . . . 0.0 112.083 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 75' ' ' ASP 0.251 67.8 p -59.84 -38.31 81.71 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.109 0.964 . . . . 0.0 110.54 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.8 mt -68.98 -54.28 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.637 0.775 . . . . 0.0 109.473 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.543 ' HD3' HD12 ' A' ' 69' ' ' LEU . 2.2 mpt_? -52.92 -28.59 24.07 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 126.925 2.09 . . . . 0.0 114.231 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.5 -12.75 15.86 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 78' ' ' MET . 30.8 t0 -80.37 60.39 3.78 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.992 0.917 . . . . 0.0 113.437 -177.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 32.98 -89.5 0.01 OUTLIER Glycine 0 N--CA 1.485 1.964 0 C-N-CA 127.856 2.646 . . . . 0.0 115.036 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.36 -38.58 80.78 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.072 0.949 . . . . 0.0 113.137 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.505 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 87.0 mtp -78.17 -11.17 59.9 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.6 m -57.68 -17.6 15.91 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.64 8.31 41.77 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 86.1 mt -85.11 112.42 43.3 Favored Pre-proline 0 N--CA 1.484 1.247 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 10.9 Cg_endo -51.86 139.52 49.95 Favored 'Trans proline' 0 N--CA 1.477 0.547 0 C-N-CA 123.872 3.048 . . . . 0.0 113.365 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.0 t -122.53 127.42 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.457 -1.247 . . . . 0.0 113.684 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.2 tp -114.66 102.2 9.81 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.534 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.4 mmt -78.96 108.31 12.35 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.361 -1.745 . . . . 0.0 113.162 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 3.9 t -85.93 104.89 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.5 p -94.64 139.74 30.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.703 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.437 ' HB2' ' OD1' ' A' ' 59' ' ' ASN . . . -67.93 -45.39 74.47 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.13 -1.396 . . . . 0.0 110.72 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -136.45 128.39 29.39 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.649 -1.614 . . . . 0.0 107.226 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.16 113.46 26.75 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.715 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.4 153.01 51.22 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 113.171 -1.832 . . . . 0.0 108.277 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -41.25 -43.54 2.42 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -53.37 -61.14 2.49 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.463 1.105 . . . . 0.0 112.933 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -69.94 -28.94 65.98 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 88.1 mt -61.55 -52.7 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.739 0.816 . . . . 0.0 110.102 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.6 mt -62.56 -44.33 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.98 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.54 -47.54 69.89 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.187 0.995 . . . . 0.0 112.104 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.71 -53.4 58.65 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.782 1.233 . . . . 0.0 111.75 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.67 90.72 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.204 1.002 . . . . 0.0 112.279 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -57.61 -38.37 74.81 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.64 1.176 . . . . 0.0 113.325 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.96 5.57 32.59 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.446 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 110.06 -5.56 30.5 Favored Glycine 0 CA--C 1.541 1.718 0 N-CA-C 116.825 1.49 . . . . 0.0 116.825 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.55 117.13 5.81 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 119.454 1.627 . . . . 0.0 113.906 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.3 m -62.59 -28.58 69.98 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 112.109 -2.314 . . . . 0.0 113.142 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.1 170.8 43.14 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.982 1.277 . . . . 0.0 110.706 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -143.81 142.16 30.73 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.18 -1.01 . . . . 0.0 111.738 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 2.0 p -128.92 126.97 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.198 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.4 p -84.47 142.56 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.755 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -90.4 137.85 27.3 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.692 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -86.87 135.63 17.02 Favored 'Cis proline' 0 CA--C 1.539 0.729 0 CA-C-O 122.722 1.051 . . . . 0.0 113.624 -0.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.428 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 28.0 p90 -116.09 151.29 35.88 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 113.467 -1.697 . . . . 0.0 109.558 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.5 p -105.7 177.9 4.72 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.35 0.595 . . . . 0.0 111.384 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.6 -45.1 69.93 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.027 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.33 -48.72 76.85 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.624 0.77 . . . . 0.0 111.221 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.65 -47.97 78.6 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.43 0.692 . . . . 0.0 110.291 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -51.44 70.02 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.445 1.098 . . . . 0.0 109.095 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -55.7 -46.28 77.7 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.644 1.178 . . . . 0.0 112.685 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.03 -48.09 70.88 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.249 0.62 . . . . 0.0 111.352 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -61.94 -47.28 85.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.817 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.5 mt -55.3 -51.1 67.78 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.037 0.835 . . . . 0.0 112.534 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -53.34 -50.51 64.86 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.558 1.143 . . . . 0.0 111.882 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -56.07 -49.01 74.99 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.817 1.647 . . . . 0.0 112.035 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.4 mt -59.47 -48.64 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.278 1.031 . . . . 0.0 110.53 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 . . . . . 0 N--CA 1.479 0.987 0 O-C-N 124.03 0.831 . . . . 0.0 112.83 179.653 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.4 tptt . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -118.8 73.29 0.92 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.899 0.857 . . . . 0.0 108.884 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.3 tp -102.27 128.6 48.74 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 112.534 -2.121 . . . . 0.0 109.572 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HG2' ' HB3' ' A' ' 32' ' ' ASN . 43.2 mtpt -74.48 113.42 11.71 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.53 -1.214 . . . . 0.0 114.017 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -107.84 142.53 37.75 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.106 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.415 ' CD1' HG22 ' A' ' 11' ' ' VAL . 1.5 tm? -123.23 103.76 8.73 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.221 175.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 77.1 t -81.28 101.15 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 111.889 -2.414 . . . . 0.0 109.333 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.415 HG22 ' CD1' ' A' ' 9' ' ' LEU . 1.7 t -100.39 94.65 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 113.685 -1.598 . . . . 0.0 107.149 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -139.23 124.75 19.33 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.779 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.6 p-10 -61.92 -30.7 71.07 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.16 121.56 38.06 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.092 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.3 p -47.0 -50.6 18.88 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 113.2 -1.818 . . . . 0.0 113.025 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.407 ' O ' HG12 ' A' ' 20' ' ' ILE . 2.8 m -60.56 -55.27 35.43 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.1 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.441 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -62.69 -35.8 80.85 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -58.55 -47.59 83.69 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.3 1.04 . . . . 0.0 110.395 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.767 ' CZ ' HD21 ' A' ' 23' ' ' ASN . 28.4 tpt180 -60.71 -45.53 93.89 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.286 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.462 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 45.5 mm -52.98 -54.73 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.274 1.03 . . . . 0.0 110.41 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.473 HG11 HG21 ' A' ' 55' ' ' ILE . 2.9 t -59.94 -49.05 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 123.562 0.539 . . . . 0.0 111.345 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.675 HH11 HH12 ' A' ' 19' ' ' ARG . 3.3 tmt_? -54.69 -46.3 74.09 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 124.088 0.867 . . . . 0.0 110.592 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.767 HD21 ' CZ ' ' A' ' 19' ' ' ARG . 12.0 m120 -63.81 -47.49 80.62 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.56 1.144 . . . . 0.0 112.158 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 20' ' ' ILE . 72.0 mt -52.97 -53.77 45.02 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.284 1.034 . . . . 0.0 112.313 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.7 mt -55.61 -48.0 75.6 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.192 0.997 . . . . 0.0 113.372 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -55.89 -46.56 78.29 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 113.215 -1.811 . . . . 0.0 110.476 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -62.4 -31.1 71.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.073 1.749 . . . . 0.0 113.706 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 73.4 mt -77.15 -10.06 59.15 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.835 1.254 . . . . 0.0 113.904 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.76 -12.83 20.43 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 125.302 1.43 . . . . 0.0 114.53 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -85.57 81.29 8.73 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 122.48 1.133 . . . . 0.0 113.629 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -85.42 29.24 0.69 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 113.168 -1.833 . . . . 0.0 114.431 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.575 ' HB3' ' HG2' ' A' ' 7' ' ' LYS . 4.4 m120 -127.62 53.38 1.76 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 123.789 1.757 . . . . 0.0 109.788 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.95 126.19 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.602 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.58 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 72.5 mm-40 -117.49 165.03 14.01 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.33 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -127.41 141.4 51.69 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 119.508 3.151 . . . . 0.0 119.508 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -132.46 148.96 52.41 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 111.301 -2.681 . . . . 0.0 109.098 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -85.81 -53.77 4.92 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.526 -1.215 . . . . 0.0 112.777 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -130.72 171.06 13.52 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.899 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.427 ' HA2' HD22 ' A' ' 68' ' ' LEU . . . -45.14 -44.11 9.45 Favored Glycine 0 N--CA 1.477 1.426 0 O-C-N 125.11 1.506 . . . . 0.0 116.524 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.3 t -61.76 -55.76 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 118.18 -0.914 . . . . 0.0 109.908 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -54.54 -40.01 68.25 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 123.596 0.56 . . . . 0.0 110.726 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.41 -54.46 45.37 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.453 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.529 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 32.3 mt -54.65 -51.26 66.01 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.31 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -46.08 -48.65 17.0 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.961 0.904 . . . . 0.0 112.733 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -69.0 -49.83 54.25 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.917 2.087 . . . . 0.0 113.591 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.4 mt -59.44 -36.66 76.34 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 10.2 mm100 -55.43 -25.66 37.44 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.26 -28.1 68.45 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.95 -170.42 23.82 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.538 1.065 . . . . 0.0 111.405 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.05 -46.06 3.1 Favored Glycine 0 N--CA 1.483 1.817 0 CA-C-N 113.814 -1.193 . . . . 0.0 113.748 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.58 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 74.3 m-85 -62.21 109.57 1.36 Allowed 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.134 0.969 . . . . 0.0 111.961 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.534 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -105.3 29.56 11.36 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-N 113.2 -1.818 . . . . 0.0 113.363 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.569 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -178.72 129.49 0.12 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.053 1.341 . . . . 0.0 112.404 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 t -116.35 116.4 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 113.536 -1.665 . . . . 0.0 107.384 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.473 HG21 HG11 ' A' ' 21' ' ' VAL . 77.4 mt -107.2 98.77 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.5 t -118.28 127.11 53.4 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 117.895 2.554 . . . . 0.0 117.895 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.88 128.55 35.83 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.228 -2.26 . . . . 0.0 111.0 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -49.33 -47.32 47.31 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -92.8 106.76 18.68 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.972 0.891 . . . . 0.0 109.125 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.459 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 2.9 mtp -145.98 133.53 10.33 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.687 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.08 146.8 78.08 Favored 'Trans proline' 0 N--CA 1.48 0.691 0 C-N-CA 123.299 2.666 . . . . 0.0 111.969 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 m120 70.31 -72.92 0.1 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.106 1.762 . . . . 0.0 111.069 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.418 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 56.1 ttm -116.88 97.74 6.12 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.1 p30 -64.48 168.75 5.47 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 113.006 -1.906 . . . . 0.0 113.64 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.22 -56.6 10.25 Favored Glycine 0 N--CA 1.479 1.563 0 C-N-CA 124.664 1.126 . . . . 0.0 114.242 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.473 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 60.7 tp -61.03 -37.85 84.05 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.099 0.959 . . . . 0.0 112.96 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -68.53 -38.85 81.2 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.368 0.667 . . . . 0.0 111.151 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.427 HD22 ' HA2' ' A' ' 39' ' ' GLY . 65.4 tp -64.9 -38.93 92.62 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.861 0.864 . . . . 0.0 110.648 177.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.664 HD23 ' HD3' ' A' ' 73' ' ' ARG . 5.8 tt -50.63 -49.44 56.79 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.027 0.931 . . . . 0.0 109.254 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -60.43 -42.86 96.93 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.936 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.514 ' HB ' HD11 ' A' ' 43' ' ' LEU . 47.8 p -69.22 -14.92 63.24 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.4 1.08 . . . . 0.0 113.014 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.5 mt -92.51 -54.34 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.156 1.382 . . . . 0.0 107.679 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.664 ' HD3' HD23 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -50.8 -52.81 37.51 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.688 1.995 . . . . 0.0 112.761 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.0 -14.7 59.42 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 71' ' ' THR . 7.9 t70 -86.85 75.75 9.55 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.664 0.745 . . . . 0.0 111.847 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 30.99 -100.0 0.01 OUTLIER Glycine 0 N--CA 1.483 1.818 0 C-N-CA 126.828 2.156 . . . . 0.0 115.151 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.84 -31.19 72.15 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 95.5 mtp -62.98 -18.0 62.75 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.7 p -53.17 -26.85 18.62 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.82 -16.43 36.21 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.534 HD22 ' HA2' ' A' ' 52' ' ' GLY . 94.6 mt -76.56 111.41 15.63 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 123.153 0.581 . . . . 0.0 111.51 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -52.49 130.57 36.94 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.389 2.726 . . . . 0.0 115.367 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.418 HG11 ' HG ' ' A' ' 69' ' ' LEU . 47.0 t -113.61 117.78 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 112.462 -2.154 . . . . 0.0 110.754 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.569 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 48.0 tp -110.37 114.77 28.48 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 113.207 -1.815 . . . . 0.0 108.863 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 28.4 mmt -87.92 104.42 16.59 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 122.91 1.338 . . . . 0.0 114.441 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.02 99.38 7.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 122.91 1.338 . . . . 0.0 107.82 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 4.2 t -123.1 129.1 51.02 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 113.256 -1.793 . . . . 0.0 112.546 -177.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.75 -32.02 73.33 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.109 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -107.47 106.5 16.93 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.128 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.434 ' HB2' HG22 ' A' ' 108' ' ' VAL . . . -92.05 66.15 4.91 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 123.767 1.746 . . . . 0.0 107.098 177.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -115.99 150.88 36.49 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 111.868 -2.424 . . . . 0.0 111.056 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -33.61 -57.91 0.43 Allowed 'General case' 0 N--CA 1.476 0.826 0 O-C-N 125.488 1.743 . . . . 0.0 114.725 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -51.69 -52.34 48.95 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -61.72 -49.05 77.99 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.317 0.647 . . . . 0.0 111.53 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.0 mt -56.47 -54.89 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.539 1.136 . . . . 0.0 111.629 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.0 mm -57.86 -54.77 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.548 1.139 . . . . 0.0 111.056 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.83 -45.22 67.21 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.05 0.94 . . . . 0.0 112.47 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.17 -53.14 49.35 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.973 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.97 -46.16 85.6 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -57.72 -39.68 77.84 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.371 1.068 . . . . 0.0 113.579 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.51 -26.93 46.02 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 129.22 13.78 2.32 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 116.651 1.42 . . . . 0.0 116.651 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.629 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -63.43 121.37 13.64 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 118.79 1.295 . . . . 0.0 112.295 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.502 ' HB3' HG23 ' A' ' 123' ' ' ILE . 7.9 m -67.29 -25.78 66.22 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 112.988 -1.914 . . . . 0.0 112.482 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.0 173.11 40.52 Favored Glycine 0 N--CA 1.482 1.705 0 C-N-CA 125.686 1.613 . . . . 0.0 109.66 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -143.35 130.97 21.24 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.25 1.8 p -113.09 123.57 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 122.195 0.998 . . . . 0.0 111.97 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 87' ' ' THR . 8.2 t -72.41 128.36 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 111.609 -2.541 . . . . 0.0 108.963 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -99.93 134.89 20.63 Favored Pre-proline 0 N--CA 1.472 0.638 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.431 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.68 144.28 79.64 Favored 'Cis proline' 0 N--CA 1.482 0.815 0 N-CA-C 115.123 1.163 . . . . 0.0 115.123 0.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -129.77 150.88 50.88 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 112.384 -2.189 . . . . 0.0 107.517 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.414 HG22 ' OG1' ' A' ' 115' ' ' THR . 14.3 t -102.34 172.05 7.11 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.773 0.671 . . . . 0.0 110.29 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.34 -43.9 61.89 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.93 0.892 . . . . 0.0 111.698 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.32 -46.64 87.84 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.134 0.974 . . . . 0.0 112.412 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.414 ' OG1' HG22 ' A' ' 112' ' ' THR . 1.0 OUTLIER -58.79 -48.31 81.7 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.456 1.103 . . . . 0.0 109.181 178.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.416 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 48.8 tp -57.67 -51.32 70.01 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.201 1.4 . . . . 0.0 110.329 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.451 ' HA ' HD12 ' A' ' 120' ' ' LEU . 17.6 tp10 -55.53 -47.36 76.42 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.685 0.794 . . . . 0.0 111.54 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.79 -46.43 74.46 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.429 0.692 . . . . 0.0 112.025 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.9 mmmt -63.95 -48.4 76.66 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 124.2 0.937 . . . . 0.0 112.328 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 117' ' ' GLU . 48.5 mt -53.18 -48.41 68.04 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.498 1.119 . . . . 0.0 110.961 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -55.95 -58.46 7.79 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.534 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -51.32 -44.06 61.86 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.894 1.278 . . . . 0.0 112.37 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.502 HG23 ' HB3' ' A' ' 104' ' ' SER . 79.3 mt -57.2 -52.06 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.164 1.386 . . . . 0.0 112.307 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 . . . . . 0 N--CA 1.49 1.562 0 O-C-N 123.885 0.74 . . . . 0.0 112.19 -179.667 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 85.2 mttt . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.83 71.15 10.69 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.591 0.71 . . . . 0.0 109.172 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 tt -121.28 132.77 55.0 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.154 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -77.06 105.51 8.18 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.162 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -109.43 144.9 37.02 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.139 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.71 110.91 16.52 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.64 -1.163 . . . . 0.0 112.012 174.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.5 t -89.84 106.03 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.501 HG11 ' HB2' ' A' ' 42' ' ' ALA . 4.4 t -106.22 90.06 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 112.864 -1.971 . . . . 0.0 108.888 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -137.88 124.17 20.55 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.184 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -59.88 -25.85 65.41 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -97.88 119.45 36.51 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.248 0.546 . . . . 0.0 110.347 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.9 p -46.05 -48.39 16.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 113.926 -1.488 . . . . 0.0 113.517 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.532 ' O ' HG12 ' A' ' 20' ' ' ILE . 2.9 m -60.85 -55.06 37.52 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.682 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.481 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.2 mmm -59.95 -38.95 83.95 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.507 ' NH1' HH22 ' A' ' 19' ' ' ARG . 15.5 ttm180 -57.1 -53.08 62.16 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.813 0.845 . . . . 0.0 110.153 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.507 HH22 ' NH1' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -58.64 -41.72 86.68 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.142 1.377 . . . . 0.0 113.477 177.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 16' ' ' THR . 39.9 mm -57.1 -58.63 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.261 1.024 . . . . 0.0 110.724 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.58 HG11 HG21 ' A' ' 55' ' ' ILE . 3.4 t -55.99 -44.56 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.231 0.613 . . . . 0.0 111.537 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.592 ' HD2' ' HB3' ' A' ' 35' ' ' GLU . 28.6 mtp-105 -54.25 -55.45 28.04 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.96 0.904 . . . . 0.0 112.376 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -59.92 -39.83 86.79 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 75.9 mt -55.38 -52.38 63.74 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.553 0.692 . . . . 0.0 111.358 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.0 mt -54.66 -48.97 71.71 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.47 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -56.45 -44.89 80.94 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.287 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 29.6 mt-10 -58.06 -40.48 81.12 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.434 1.894 . . . . 0.0 112.308 177.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.2 mt -73.47 -13.95 61.15 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.069 1.347 . . . . 0.0 113.605 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.34 -11.4 24.04 Favored Glycine 0 CA--C 1.544 1.901 0 C-N-CA 124.816 1.198 . . . . 0.0 113.757 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 57.1 m-85 -85.7 76.5 9.95 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 123.23 1.49 . . . . 0.0 111.537 -177.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -72.32 -24.72 61.35 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 118.04 2.607 . . . . 0.0 118.04 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.22 71.68 10.02 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.505 1.145 . . . . 0.0 112.178 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.2 p -120.04 128.6 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HB2' ' HE2' ' A' ' 51' ' ' TYR . 80.7 mm-40 -110.79 167.18 10.43 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.573 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.592 ' HB3' ' HD2' ' A' ' 22' ' ' ARG . 1.2 pp20? -126.75 126.15 42.96 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 -176.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.403 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -122.29 150.97 41.61 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.093 -1.867 . . . . 0.0 108.893 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -92.05 -43.67 9.27 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -141.49 173.34 11.59 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.241 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -43.15 -56.6 4.54 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.065 1.317 . . . . 0.0 115.852 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.1 t -56.16 -54.61 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 123.429 0.691 . . . . 0.0 110.997 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -56.94 -34.27 67.85 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.941 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.501 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -65.41 -48.89 71.24 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.347 1.059 . . . . 0.0 110.971 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.441 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 99.5 mt -57.46 -45.47 84.71 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -55.42 -54.79 39.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.541 1.136 . . . . 0.0 110.927 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -59.66 -45.03 93.27 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 114.399 -1.273 . . . . 0.0 113.641 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.497 HD21 HG22 ' A' ' 54' ' ' VAL . 25.2 mt -55.42 -42.83 74.66 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.327 1.051 . . . . 0.0 112.433 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 53.0 mt-30 -52.92 -35.57 58.47 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.758 1.223 . . . . 0.0 111.493 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.73 59.17 3.55 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.07 -19.63 4.61 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 118.466 2.147 . . . . 0.0 118.466 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.86 56.37 21.39 Favored Glycine 0 CA--C 1.548 2.138 0 CA-C-N 118.23 1.015 . . . . 0.0 112.296 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.579 ' H ' ' HD1' ' A' ' 51' ' ' TYR . 1.4 m-85 -50.71 135.63 23.14 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.063 2.145 . . . . 0.0 113.427 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.486 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -84.47 22.18 9.29 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 -177.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.669 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -178.13 129.26 0.13 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.698 1.237 . . . . 0.0 112.237 177.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.497 HG22 HD21 ' A' ' 46' ' ' LEU . 38.4 t -117.82 113.58 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 112.907 -1.951 . . . . 0.0 107.537 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.58 HG21 HG11 ' A' ' 21' ' ' VAL . 96.5 mt -107.94 97.52 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 t -119.04 136.62 54.04 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -71.13 130.18 40.83 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 112.258 -2.246 . . . . 0.0 109.195 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.447 ' O ' ' HB3' ' A' ' 64' ' ' ASP . 38.7 t-105 -58.29 -44.7 88.62 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.706 0.802 . . . . 0.0 111.428 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -94.53 96.17 9.29 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.747 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.493 ' SD ' HG12 ' A' ' 11' ' ' VAL . 33.6 mtm -134.71 132.76 20.78 Favored Pre-proline 0 N--CA 1.486 1.33 0 CA-C-N 113.651 -1.613 . . . . 0.0 110.362 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -59.34 144.06 99.52 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.763 2.975 . . . . 0.0 112.517 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.8 m120 69.69 -65.02 0.32 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.543 1.937 . . . . 0.0 113.062 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.0 ttm -123.3 96.77 5.12 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.489 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 6.0 m-20 -68.34 167.12 15.18 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.034 -1.894 . . . . 0.0 112.548 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -47.0 -55.04 8.8 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.645 1.593 . . . . 0.0 116.152 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.48 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 48.9 tp -56.71 -48.88 76.71 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . 0.268 7.1 pm0 -67.98 -33.76 75.25 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 177.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.11 -43.96 95.22 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.855 0.722 . . . . 0.0 110.079 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.48 ' HB3' ' O ' ' A' ' 66' ' ' LEU . 12.2 tp -54.09 -44.41 71.17 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.416 1.086 . . . . 0.0 110.865 175.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -64.15 -43.68 94.48 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.55 0.74 . . . . 0.0 111.785 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.263 33.0 p -58.6 -29.86 66.78 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 123.682 0.793 . . . . 0.0 111.99 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.552 HG23 ' HB3' ' A' ' 78' ' ' MET . 45.6 mt -80.02 -56.61 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.855 1.262 . . . . 0.0 109.217 177.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.47 ' HG3' ' HA3' ' A' ' 102' ' ' GLY . 77.4 mmt-85 -53.94 -47.48 71.23 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.539 1.536 . . . . 0.0 114.076 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.31 -26.32 67.72 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.284 1.033 . . . . 0.0 113.557 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -85.11 108.17 17.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.294 1.038 . . . . 0.0 108.827 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -29.14 -61.78 0.15 Allowed Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.046 1.784 . . . . 0.0 114.95 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.38 -47.9 80.12 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.552 ' HB3' HG23 ' A' ' 72' ' ' ILE . 55.4 mtm -68.31 -22.19 64.73 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.8 p -46.45 -35.73 5.9 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.31 -13.11 59.45 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.486 HD22 ' HA2' ' A' ' 52' ' ' GLY . 77.4 mt -79.31 111.87 23.96 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 122.857 0.463 . . . . 0.0 111.388 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 11.6 Cg_endo -51.31 136.42 46.99 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.685 2.923 . . . . 0.0 115.919 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.474 HG11 HD13 ' A' ' 69' ' ' LEU . 67.2 t -120.08 123.34 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 112.843 -1.98 . . . . 0.0 112.686 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.669 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -112.45 110.15 20.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 112.887 -1.96 . . . . 0.0 107.864 177.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 30.1 mmt -85.22 105.3 15.81 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 113.628 -1.624 . . . . 0.0 111.991 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.52 103.51 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.34 138.38 42.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 112.068 -2.333 . . . . 0.0 115.851 -174.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.17 -27.92 69.4 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.045 -1.889 . . . . 0.0 113.157 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -151.97 110.99 3.86 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 124.171 0.92 . . . . 0.0 110.21 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.43 86.42 4.48 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.494 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -118.85 147.22 44.19 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.956 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -33.53 -55.66 0.44 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -53.24 -49.5 66.7 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.613 0.765 . . . . 0.0 112.33 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.68 -49.07 79.0 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.006 1.323 . . . . 0.0 110.811 177.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 79.4 mt -58.73 -53.21 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 124.508 1.13 . . . . 0.0 111.411 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.528 HG23 ' OE1' ' A' ' 100' ' ' GLN . 57.0 mt -55.39 -54.49 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.642 1.177 . . . . 0.0 110.537 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.58 -47.2 73.6 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.812 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.404 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -59.52 -58.0 10.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.3 1.04 . . . . 0.0 112.84 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.16 -49.01 78.49 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.518 0.727 . . . . 0.0 112.619 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.528 ' OE1' HG23 ' A' ' 96' ' ' ILE . 29.2 mt-30 -65.91 -25.37 67.12 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.4 1.45 54.67 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.47 ' HA3' ' HG3' ' A' ' 73' ' ' ARG . . . 113.75 -4.84 24.38 Favored Glycine 0 CA--C 1.545 1.95 0 N-CA-C 116.829 1.492 . . . . 0.0 116.829 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.63 119.81 9.96 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.098 1.449 . . . . 0.0 114.686 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.479 ' HB3' HG23 ' A' ' 123' ' ' ILE . 14.5 m -63.48 -30.45 71.57 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 110.823 -2.899 . . . . 0.0 113.691 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -174.58 167.07 39.21 Favored Glycine 0 N--CA 1.476 1.32 0 C-N-CA 124.501 1.048 . . . . 0.0 110.761 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -142.5 138.42 30.93 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.625 -0.788 . . . . 0.0 112.065 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.98 131.17 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 124.243 0.964 . . . . 0.0 112.277 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.5 p -79.26 134.79 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 113.417 -1.72 . . . . 0.0 110.803 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.435 ' HB3' ' HZ3' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -85.13 136.73 37.84 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.022 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -87.22 153.34 42.85 Favored 'Cis proline' 0 CA--C 1.541 0.873 0 CA-C-O 122.451 0.938 . . . . 0.0 112.771 -1.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -131.42 150.61 52.08 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 113.468 -1.696 . . . . 0.0 108.949 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.7 t -101.92 169.71 8.6 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 123.776 0.673 . . . . 0.0 111.829 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.33 37.38 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.427 1.091 . . . . 0.0 112.187 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.22 -52.02 66.54 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.877 0.871 . . . . 0.0 112.31 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -57.09 -48.96 77.32 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.249 1.02 . . . . 0.0 110.081 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.1 tp -56.49 -52.82 63.3 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.919 1.387 . . . . 0.0 110.349 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -55.24 -48.97 73.17 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.497 1.119 . . . . 0.0 112.573 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -50.91 -46.68 60.8 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.978 0.911 . . . . 0.0 112.107 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.634 ' O ' HG12 ' A' ' 123' ' ' ILE . 35.6 mttp -67.78 -52.38 37.85 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.233 177.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.2 mt -48.04 -51.36 24.53 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.68 0.792 . . . . 0.0 112.238 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -52.25 -55.92 18.1 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.846 1.258 . . . . 0.0 112.32 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -61.57 -39.71 92.13 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.193 1.397 . . . . 0.0 113.096 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.634 HG12 ' O ' ' A' ' 119' ' ' LYS . 31.6 mm -57.56 -49.18 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.962 0.905 . . . . 0.0 111.045 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 . . . . . 0 N--CA 1.478 0.942 0 C-N-CA 123.357 0.663 . . . . 0.0 112.364 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.13 27.82 0.65 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 tt -77.91 132.59 37.99 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.618 0.767 . . . . 0.0 109.932 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 51' ' ' TYR . 4.8 ttmm -84.04 104.51 14.17 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 125.032 1.458 . . . . 0.0 112.762 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -104.28 142.29 34.81 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 113.081 -1.872 . . . . 0.0 114.165 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 45' ' ' LYS . 0.3 OUTLIER -119.71 112.14 18.91 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.447 173.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 83.1 t -84.26 94.0 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.495 HG12 ' SD ' ' A' ' 60' ' ' MET . 4.2 t -98.21 85.8 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 123.832 1.777 . . . . 0.0 106.284 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -126.97 121.08 30.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 111.908 -2.405 . . . . 0.0 113.488 -175.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.442 ' HB3' ' HG2' ' A' ' 60' ' ' MET . 11.8 p-10 -60.04 -28.15 67.52 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 112.233 -2.258 . . . . 0.0 115.702 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -99.03 103.88 15.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.211 -1.404 . . . . 0.0 107.211 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -41.79 -42.82 2.76 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.975 1.31 . . . . 0.0 113.735 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -51.75 62.98 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.801 1.24 . . . . 0.0 111.41 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.443 ' O ' HG23 ' A' ' 21' ' ' VAL . 13.4 ttt -64.27 -36.19 83.28 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.87 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -52.71 -50.27 63.7 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.633 1.173 . . . . 0.0 110.533 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -58.6 -51.08 71.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.771 1.228 . . . . 0.0 110.211 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.43 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 51.0 mt -55.11 -51.8 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.047 0.939 . . . . 0.0 112.162 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 17' ' ' MET . 16.4 t -57.09 -44.48 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 118.461 0.573 . . . . 0.0 110.992 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -50.26 71.73 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.205 1.402 . . . . 0.0 109.615 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -60.3 -41.59 93.73 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.6 1.16 . . . . 0.0 112.302 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.45 HD22 ' HB2' ' A' ' 113' ' ' ALA . 78.2 mt -56.87 -51.13 70.28 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.252 1.021 . . . . 0.0 110.685 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.8 mt -55.88 -45.71 78.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.018 0.927 . . . . 0.0 111.857 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -56.36 -46.73 79.89 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.678 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -59.83 -38.7 82.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.358 1.463 . . . . 0.0 112.602 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.8 mt -71.2 -13.17 61.83 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.507 1.123 . . . . 0.0 113.836 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.3 -1.17 32.95 Favored Glycine 0 CA--C 1.541 1.676 0 C-N-CA 124.808 1.194 . . . . 0.0 114.806 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -79.2 108.93 13.06 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 123.322 1.534 . . . . 0.0 114.385 -177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -67.87 -51.34 49.32 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 110.726 -2.943 . . . . 0.0 117.42 -176.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.424 ' HB3' ' HG3' ' A' ' 7' ' ' LYS . 78.0 m-20 -97.45 97.24 8.93 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -174.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -133.21 118.39 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.971 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.692 ' HB2' ' HE2' ' A' ' 51' ' ' TYR . 4.1 mp0 -106.28 161.49 14.5 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.31 178.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.89 119.37 21.07 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.61 165.45 16.44 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 113.299 -1.773 . . . . 0.0 109.597 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -109.69 -38.71 5.33 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 118.017 2.599 . . . . 0.0 118.017 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -128.67 167.62 16.94 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.867 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.506 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -44.24 -57.71 4.81 Favored Glycine 0 N--CA 1.478 1.477 0 C-N-CA 125.831 1.681 . . . . 0.0 114.529 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.7 t -55.3 -58.45 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.549 0.739 . . . . 0.0 111.702 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.38 -32.83 57.93 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.462 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . . . -65.74 -50.57 64.31 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.51 1.124 . . . . 0.0 111.249 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.4 mt -58.55 -43.38 89.27 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.873 0.733 . . . . 0.0 110.679 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -54.3 -58.49 7.21 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.492 0.717 . . . . 0.0 110.641 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.598 ' HB3' HD11 ' A' ' 9' ' ' LEU . 16.0 tttt -61.69 -39.66 92.22 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.427 HD11 HG22 ' A' ' 54' ' ' VAL . 3.4 tp -54.66 -37.26 65.51 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.914 1.286 . . . . 0.0 113.669 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -68.63 -10.17 54.39 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.81 15.85 0.34 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.82 94.3 1.98 Allowed Glycine 0 N--CA 1.481 1.661 0 N-CA-C 115.443 0.937 . . . . 0.0 115.443 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 17.84 88.46 0.01 OUTLIER Glycine 0 CA--C 1.546 2.021 0 C-N-CA 128.683 3.039 . . . . 0.0 120.248 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.692 ' HE2' ' HB2' ' A' ' 34' ' ' GLU . 37.6 m-85 -88.63 104.32 16.75 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.894 -1.153 . . . . 0.0 109.89 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.64 27.22 1.9 Allowed Glycine 0 N--CA 1.478 1.458 0 CA-C-N 114.039 -1.437 . . . . 0.0 114.919 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.583 ' HZ ' HD13 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -178.71 131.52 0.12 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.49 1.516 . . . . 0.0 113.062 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.427 HG22 HD11 ' A' ' 46' ' ' LEU . 59.1 t -126.55 115.0 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 113.188 -1.823 . . . . 0.0 107.744 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 94.9 mt -106.2 101.17 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.6 t -120.0 133.42 55.55 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 117.623 2.453 . . . . 0.0 117.623 -175.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 60' ' ' MET . 6.3 m-20 -73.67 136.39 43.8 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.185 -1.371 . . . . 0.0 111.059 176.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -56.73 -49.31 75.59 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.016 0.822 . . . . 0.0 111.324 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -92.29 101.38 13.86 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.11 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.495 ' SD ' HG12 ' A' ' 11' ' ' VAL . 30.0 mtm -133.85 125.28 18.19 Favored Pre-proline 0 N--CA 1.482 1.131 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.363 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -55.52 150.55 42.37 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 124.009 3.139 . . . . 0.0 111.635 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 70.47 -69.51 0.17 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.461 1.904 . . . . 0.0 111.5 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.506 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 18.6 ttp -127.04 109.21 11.65 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -64.94 167.29 7.93 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.327 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.56 -48.82 63.54 Favored Glycine 0 N--CA 1.48 1.619 0 C-N-CA 124.273 0.939 . . . . 0.0 114.602 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.45 -40.07 93.13 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.826 0.45 . . . . 0.0 112.183 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -63.37 -41.82 98.84 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.83 -49.83 75.89 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.949 0.9 . . . . 0.0 110.964 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.715 HD11 ' HB2' ' A' ' 103' ' ' ALA . 4.0 tt -46.75 -50.79 17.56 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.28 1.432 . . . . 0.0 109.274 176.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.69 -46.57 84.92 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.266 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 47.2 p -59.24 -25.31 63.92 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.094 0.958 . . . . 0.0 112.982 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.4 mt -84.02 -58.04 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 73' ' ' ARG . 25.8 mmt180 -49.74 -46.77 50.74 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.875 1.67 . . . . 0.0 113.122 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.37 -18.79 57.05 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -82.57 94.82 7.58 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.736 -0.602 . . . . 0.0 110.178 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -21.18 -62.48 0.02 OUTLIER Glycine 0 CA--C 1.547 2.062 0 C-N-CA 126.88 2.181 . . . . 0.0 116.232 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.16 89.07 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.523 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 49.1 mtm -87.26 -34.67 18.85 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.4 t 2.57 -61.03 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 121.385 3.846 . . . . 0.0 121.385 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.24 25.03 0.62 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 118.855 2.909 . . . . 0.0 118.855 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 78' ' ' MET . 86.2 mt -83.05 118.94 73.25 Favored Pre-proline 0 N--CA 1.483 1.19 0 O-C-N 121.306 -0.872 . . . . 0.0 112.794 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.36 128.34 28.85 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 123.53 2.82 . . . . 0.0 113.675 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.468 HG11 ' HG ' ' A' ' 69' ' ' LEU . 3.4 t -116.57 119.89 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 113.13 -1.85 . . . . 0.0 112.645 -177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.53 HD13 HD11 ' A' ' 123' ' ' ILE . 45.2 tp -108.55 109.45 20.69 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.384 -1.734 . . . . 0.0 108.766 176.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 82.9 mmm -87.32 112.44 22.08 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 113.89 -1.505 . . . . 0.0 114.597 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.56 102.62 13.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 123.901 1.81 . . . . 0.0 108.319 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.9 t -115.71 130.26 56.79 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 111.593 -2.549 . . . . 0.0 109.426 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -46.42 -40.99 13.07 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -141.78 148.55 39.1 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.41 83.3 3.85 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 122.97 1.366 . . . . 0.0 107.718 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.48 ' O ' HG12 ' A' ' 95' ' ' ILE . 87.8 mttt -92.68 112.36 24.29 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 111.011 -2.813 . . . . 0.0 109.139 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 92' ' ' LYS . 71.6 mmtt -34.57 -56.03 0.54 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 117.431 2.382 . . . . 0.0 117.431 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . 0.258 0.0 OUTLIER -55.58 -42.86 75.35 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 177.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -62.63 -47.59 83.07 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.672 1.189 . . . . 0.0 110.335 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 91' ' ' LYS . 18.1 mm -58.08 -49.71 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.1 1.36 . . . . 0.0 112.537 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.439 HG22 ' OE1' ' A' ' 100' ' ' GLN . 31.7 mt -60.1 -50.66 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.284 0.634 . . . . 0.0 110.271 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.89 -46.43 81.92 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.777 0.831 . . . . 0.0 111.908 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.71 -56.24 19.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.427 1.491 . . . . 0.0 112.241 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.38 -48.35 82.13 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.071 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.439 ' OE1' HG22 ' A' ' 96' ' ' ILE . 72.8 mt-30 -56.53 -37.72 70.88 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.84 -16.45 55.41 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.65 12.65 7.15 Favored Glycine 0 CA--C 1.545 1.916 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.715 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -70.34 106.1 3.25 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.981 1.372 . . . . 0.0 111.36 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.473 ' HB3' HG23 ' A' ' 123' ' ' ILE . 6.9 m -56.89 -27.22 60.33 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 112.234 -2.257 . . . . 0.0 113.25 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -173.6 169.08 42.14 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.209 0.909 . . . . 0.0 111.406 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -142.62 142.27 32.08 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.643 -0.778 . . . . 0.0 110.948 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.61 131.47 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 124.742 1.276 . . . . 0.0 111.491 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -79.79 126.0 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 112.34 -2.209 . . . . 0.0 110.301 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 110' ' ' PRO . 34.5 ttpt -91.52 130.6 38.76 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 112.843 -1.98 . . . . 0.0 110.511 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 92.8 Cg_endo -80.41 148.39 77.07 Favored 'Cis proline' 0 N--CA 1.484 0.937 0 O-C-N 123.233 1.123 . . . . 0.0 114.953 0.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -130.31 156.53 44.51 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.002 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 69.9 p -108.96 174.83 5.69 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.693 0.797 . . . . 0.0 111.013 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.45 ' HB2' HD22 ' A' ' 24' ' ' LEU . . . -54.99 -39.0 68.56 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.142 175.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.71 -47.39 72.5 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.039 0.936 . . . . 0.0 111.263 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.0 m -61.32 -46.0 92.12 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 50.6 tp -56.24 -50.67 70.65 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.925 1.29 . . . . 0.0 109.529 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.483 ' HA ' HD12 ' A' ' 120' ' ' LEU . 40.5 tt0 -55.42 -48.77 73.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.293 1.037 . . . . 0.0 111.488 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -55.93 -46.89 78.37 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.361 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.3 mptp? -63.92 -42.18 97.45 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.114 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 117' ' ' GLU . 86.8 mt -53.87 -51.02 64.97 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.219 0.608 . . . . 0.0 111.101 177.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -50.05 -52.29 35.59 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.333 1.053 . . . . 0.0 113.137 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -53.59 -47.05 70.52 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.478 1.511 . . . . 0.0 112.386 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.583 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 57.8 mt -57.46 -51.52 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.872 1.269 . . . . 0.0 111.925 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 179.244 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.9 mttt . . . . . 0 CA--C 1.544 0.745 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -100.07 41.1 1.18 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 123.206 1.479 . . . . 0.0 113.791 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 tt -86.25 124.72 32.94 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.277 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.61 ' HE3' HD22 ' A' ' 32' ' ' ASN . 12.9 mptt -75.96 107.92 8.5 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 125.095 1.497 . . . . 0.0 113.393 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -102.88 132.83 48.82 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 112.402 -2.181 . . . . 0.0 111.8 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.529 HD21 ' HD3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -108.46 102.7 11.77 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.069 -1.053 . . . . 0.0 109.288 173.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.526 ' HA ' HG23 ' A' ' 55' ' ' ILE . 46.6 t -79.14 98.72 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 113.481 -1.69 . . . . 0.0 106.777 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.754 HG11 ' HB2' ' A' ' 42' ' ' ALA . 3.3 t -108.24 60.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 112.241 -2.254 . . . . 0.0 107.138 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.612 ' HA ' ' HB2' ' A' ' 57' ' ' ASP . 11.6 t70 -109.56 90.38 3.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 113.359 -1.746 . . . . 0.0 108.638 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -13.58 -42.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 121.58 3.919 . . . . 0.0 121.58 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.523 ' C ' ' H ' ' A' ' 16' ' ' THR . 2.6 t80 -87.57 109.6 19.76 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 t -65.98 27.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 124.167 1.937 . . . . 0.0 115.697 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.523 ' H ' ' C ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -123.72 -58.52 1.58 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.062 2.545 . . . . 0.0 105.448 177.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.528 ' HA ' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -60.05 -35.82 75.96 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.696 177.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 36' ' ' ALA . 8.8 ttp180 -53.76 -50.93 64.94 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.521 1.529 . . . . 0.0 112.139 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.632 ' CZ ' HD21 ' A' ' 23' ' ' ASN . 3.0 tmt_? -65.24 -38.37 90.15 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.809 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 17' ' ' MET . 71.6 mt -57.73 -46.3 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 17' ' ' MET . 12.7 t -58.26 -42.52 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.462 0.705 . . . . 0.0 110.049 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.459 ' NH2' ' HE ' ' A' ' 19' ' ' ARG . 46.9 ttp180 -53.01 -52.57 57.97 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.187 0.995 . . . . 0.0 110.575 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.632 HD21 ' CZ ' ' A' ' 19' ' ' ARG . 80.9 m-20 -57.71 -41.02 80.88 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.355 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -59.62 -51.44 69.79 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.135 0.974 . . . . 0.0 110.774 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.9 mt -56.56 -44.51 81.01 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.015 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -58.59 -42.26 87.69 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.981 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -59.78 -38.55 82.16 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.627 1.171 . . . . 0.0 110.48 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 mp -74.94 -11.9 60.22 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.29 2.236 . . . . 0.0 115.17 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.82 -0.61 41.91 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.035 1.302 . . . . 0.0 114.648 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -89.13 97.95 11.49 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 123.266 1.508 . . . . 0.0 112.459 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -72.46 -37.33 68.55 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 110.858 -2.883 . . . . 0.0 116.056 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.61 HD22 ' HE3' ' A' ' 7' ' ' LYS . 3.6 m120 -95.91 96.4 8.89 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.749 1.262 . . . . 0.0 113.895 -173.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.2 t -129.66 131.96 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.407 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -117.72 154.8 31.07 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -126.96 120.19 28.52 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -122.31 152.99 39.54 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 113.611 -1.631 . . . . 0.0 109.863 177.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -78.37 -66.13 0.89 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -129.44 -176.61 3.95 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 117.972 -1.013 . . . . 0.0 112.16 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 42' ' ' ALA . . . -45.39 -53.55 7.98 Favored Glycine 0 N--CA 1.482 1.766 0 O-C-N 125.048 1.467 . . . . 0.0 114.112 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -57.32 -57.87 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.348 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -55.52 -34.65 64.84 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.754 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -58.26 -53.56 56.85 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.753 1.221 . . . . 0.0 110.385 177.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.4 mt -60.27 -41.87 94.2 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.928 0.891 . . . . 0.0 111.313 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.418 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 24.8 m120 -53.35 -52.14 60.18 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.811 0.844 . . . . 0.0 111.233 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HD3' HD21 ' A' ' 9' ' ' LEU . 12.7 tttp -70.36 -41.2 73.43 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 124.212 0.945 . . . . 0.0 113.141 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.9 mt -54.42 -36.42 63.98 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 10.6 pt20 -52.33 -26.46 12.29 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.4 -19.16 64.44 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.44 -170.42 52.17 Favored Glycine 0 N--CA 1.474 1.224 0 C-N-CA 124.427 1.013 . . . . 0.0 111.113 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.75 -29.7 1.52 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 115.504 0.962 . . . . 0.0 115.504 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -67.85 107.99 2.83 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.52 -22.86 52.74 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-N 112.587 -2.097 . . . . 0.0 110.028 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.514 ' HZ ' HD13 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -133.35 141.65 48.02 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -174.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.5 t -127.16 110.68 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 113.765 -1.562 . . . . 0.0 107.343 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.526 HG23 ' HA ' ' A' ' 10' ' ' VAL . 13.1 tt -110.22 93.3 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 124.094 1.902 . . . . 0.0 106.607 177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.1 t -117.27 147.76 42.27 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 111.887 -2.415 . . . . 0.0 115.433 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.612 ' HB2' ' HA ' ' A' ' 12' ' ' ASP . 4.8 t70 -79.63 144.29 33.92 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.733 -1.122 . . . . 0.0 112.834 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.482 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 20.3 t-105 -61.23 -47.2 87.16 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.077 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -95.59 103.38 15.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.673 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 54.0 mtm -134.99 134.24 21.58 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-N 113.243 -1.799 . . . . 0.0 110.531 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -60.42 143.62 99.48 Favored 'Trans proline' 0 N--CA 1.482 0.827 0 C-N-CA 123.186 2.59 . . . . 0.0 112.089 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 m120 67.89 -69.81 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.902 1.681 . . . . 0.0 113.763 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.1 ttm -114.86 98.75 7.01 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -61.56 165.87 4.59 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 112.605 -2.088 . . . . 0.0 111.932 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.44 -52.08 29.73 Favored Glycine 0 N--CA 1.476 1.353 0 C-N-CA 124.692 1.139 . . . . 0.0 115.081 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 42.2 tp -58.84 -38.46 78.74 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.225 1.01 . . . . 0.0 113.222 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -72.44 -36.27 68.51 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.57 0.748 . . . . 0.0 111.014 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -59.03 -38.22 78.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.804 0.841 . . . . 0.0 111.016 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' A' ' 103' ' ' ALA . 9.1 mp -50.92 -52.24 44.1 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.76 1.224 . . . . 0.0 109.832 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -56.38 -48.76 76.21 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.042 -1.435 . . . . 0.0 112.505 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.3 p -58.17 -33.42 69.22 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.8 mt -80.8 -57.35 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.5 ' HG3' ' HA3' ' A' ' 102' ' ' GLY . 24.9 mmt180 -49.23 -45.82 45.09 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.344 1.858 . . . . 0.0 114.11 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.74 -25.52 61.23 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -81.34 93.9 6.65 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.187 0.595 . . . . 0.0 109.514 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -25.71 -58.76 0.07 OUTLIER Glycine 0 CA--C 1.542 1.753 0 C-N-CA 127.078 2.275 . . . . 0.0 116.756 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.77 -38.91 83.12 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.47 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 91.3 mtp -89.52 -45.38 9.45 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.412 1.485 . . . . 0.0 114.608 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.2 t 8.82 -78.21 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 120.091 3.367 . . . . 0.0 120.091 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.03 29.25 0.13 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 118.655 2.835 . . . . 0.0 118.655 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 78' ' ' MET . 82.4 mt -76.62 133.81 70.12 Favored Pre-proline 0 N--CA 1.479 0.981 0 O-C-N 121.184 -0.947 . . . . 0.0 111.876 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -56.81 114.23 1.83 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.816 2.344 . . . . 0.0 112.806 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 81' ' ' LEU . 37.0 t -109.94 110.97 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 111.704 -2.498 . . . . 0.0 109.245 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.51 HD23 HD12 ' A' ' 55' ' ' ILE . 41.1 tp -106.56 104.08 13.68 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 112.805 -1.998 . . . . 0.0 109.363 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.5 mmt -78.57 118.13 20.4 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 113.053 -1.885 . . . . 0.0 112.678 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.674 HG12 ' HB2' ' A' ' 109' ' ' LYS . 1.5 t -91.18 96.72 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.7 p -94.38 114.97 27.11 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.256 -1.793 . . . . 0.0 112.886 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.05 -22.01 5.37 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -166.74 118.79 0.97 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.61 92.96 4.77 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.578 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 95' ' ' ILE . 78.0 mttt -101.68 132.19 47.51 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.395 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -41.17 -46.78 3.14 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.734 1.213 . . . . 0.0 114.134 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -52.74 -55.32 23.62 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.708 1.603 . . . . 0.0 110.973 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -58.91 -42.91 90.73 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.352 1.461 . . . . 0.0 111.241 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 91' ' ' LYS . 14.7 mm -60.39 -49.09 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.52 1.128 . . . . 0.0 111.547 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 37.4 mt -57.73 -50.95 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.81 -45.84 74.43 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.087 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.482 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -57.42 -54.89 41.71 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.693 1.197 . . . . 0.0 112.418 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.38 -41.99 81.27 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.334 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -66.14 -40.04 90.31 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.73 0.55 52.49 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 117.674 2.472 . . . . 0.0 117.674 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.5 ' HA3' ' HG3' ' A' ' 73' ' ' ARG . . . 110.34 21.6 6.85 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 117.702 1.841 . . . . 0.0 117.702 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.599 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -82.62 110.32 17.58 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.416 1.108 . . . . 0.0 112.029 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.9 m -59.99 -30.26 69.01 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 113.219 -1.81 . . . . 0.0 113.519 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.25 173.45 46.28 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.198 1.38 . . . . 0.0 110.055 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -148.83 139.08 22.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.052 -0.574 . . . . 0.0 112.527 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.9 p -115.2 117.93 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 124.2 0.937 . . . . 0.0 109.505 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.0 p -71.33 109.45 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 113.076 -1.874 . . . . 0.0 114.261 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.674 ' HB2' HG12 ' A' ' 86' ' ' VAL . 68.1 tttt -83.13 130.11 58.43 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 111.079 -2.782 . . . . 0.0 107.681 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.6 133.34 26.6 Favored 'Cis proline' 0 CA--C 1.54 0.78 0 O-C-N 123.962 1.506 . . . . 0.0 114.854 0.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.441 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 17.9 p90 -130.58 157.25 43.23 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 112.653 -2.067 . . . . 0.0 109.01 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.2 t -116.61 176.02 5.3 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.063 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.45 -41.78 61.08 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.203 1.001 . . . . 0.0 111.82 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.99 -50.07 73.55 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.568 0.747 . . . . 0.0 112.819 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.32 -45.04 94.81 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.623 1.169 . . . . 0.0 109.982 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 58.1 tp -56.99 -50.54 72.38 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.305 1.042 . . . . 0.0 109.888 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -58.13 -47.65 82.66 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.61 0.764 . . . . 0.0 111.376 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -51.22 -43.36 61.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.484 0.714 . . . . 0.0 112.278 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -72.78 -41.7 64.74 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.187 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.1 mt -56.96 -46.31 82.23 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.398 0.679 . . . . 0.0 111.157 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -52.14 -48.18 65.01 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.089 1.356 . . . . 0.0 111.935 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -52.93 -48.81 67.02 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.129 1.372 . . . . 0.0 111.595 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.514 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 9.1 mt -60.47 -49.43 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.267 1.027 . . . . 0.0 111.68 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 . . . . . 0 N--CA 1.493 1.679 0 C-N-CA 123.686 0.794 . . . . 0.0 112.064 177.991 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HA ' ' HD1' ' A' ' 30' ' ' PHE . 42.8 mmtm . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.27 50.93 1.82 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.756 1.265 . . . . 0.0 114.042 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 53' ' ' PHE . 5.1 tt -109.76 122.96 48.69 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.768 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -81.76 109.28 16.01 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.108 0.956 . . . . 0.0 112.495 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -96.24 139.24 32.67 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 111.802 -2.454 . . . . 0.0 111.783 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.462 ' CD1' HG22 ' A' ' 11' ' ' VAL . 2.1 tm? -118.19 104.87 11.22 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.437 176.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.2 t -83.7 111.19 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 112.095 -2.321 . . . . 0.0 108.775 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -114.02 91.13 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.544 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 57' ' ' ASP . 8.5 m-20 -137.19 115.27 11.59 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.745 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.418 ' OD1' ' HB3' ' A' ' 37' ' ' GLU . 3.5 t70 -80.12 77.12 6.85 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.966 -178.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.435 ' HD2' ' HB2' ' A' ' 17' ' ' MET . 11.5 t80 172.25 115.09 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 111.816 -2.447 . . . . 0.0 106.127 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.2 t -42.25 -55.67 3.22 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.228 1.011 . . . . 0.0 113.338 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.69 -47.5 85.38 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.708 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.435 ' HB2' ' HD2' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -62.43 -45.55 92.59 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.165 0.586 . . . . 0.0 111.829 -179.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.417 ' HD2' ' HB2' ' A' ' 35' ' ' GLU . 38.1 ttp180 -59.26 -45.2 91.83 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.759 1.224 . . . . 0.0 110.472 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -43.89 96.01 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.121 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.0 mt -56.17 -57.26 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-O 118.589 -0.719 . . . . 0.0 111.084 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.519 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 13.6 t -54.1 -44.53 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 123.512 0.507 . . . . 0.0 111.19 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.59 ' HG2' ' NZ ' ' A' ' 26' ' ' LYS . 34.9 ttt180 -55.92 -53.45 56.73 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.065 1.346 . . . . 0.0 111.735 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -62.87 -38.8 92.3 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.127 0.971 . . . . 0.0 113.331 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 75.7 mt -56.92 -48.88 77.22 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.175 0.99 . . . . 0.0 111.114 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.9 mt -60.27 -44.81 94.99 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.783 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.59 ' NZ ' ' HG2' ' A' ' 22' ' ' ARG . 63.5 mttp -56.44 -45.13 80.95 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.0 176.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 36.3 mt-10 -60.32 -35.99 76.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.479 1.512 . . . . 0.0 113.032 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.0 mt -74.44 -2.03 23.71 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.306 1.443 . . . . 0.0 114.372 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.8 -9.89 60.38 Favored Glycine 0 CA--C 1.542 1.76 0 C-N-CA 124.566 1.079 . . . . 0.0 112.752 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.432 ' HD1' ' HA ' ' A' ' 4' ' ' LYS . 6.5 m-85 -93.15 76.71 4.63 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 123.126 1.441 . . . . 0.0 110.078 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -66.29 -24.04 66.49 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.594 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -78.7 80.83 5.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.653 1.581 . . . . 0.0 112.062 -178.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.5 130.35 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.929 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.609 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 6.8 mp0 -120.61 160.91 22.29 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.417 ' HB2' ' HD2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -132.57 147.87 52.36 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 120.398 3.481 . . . . 0.0 120.398 -176.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.469 ' HB2' ' HD2' ' A' ' 45' ' ' LYS . . . -140.54 163.88 31.64 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 110.94 -2.845 . . . . 0.0 108.307 177.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . 22.5 mt-10 -112.04 -35.51 5.64 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -129.07 158.57 38.55 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.875 0.735 . . . . 0.0 111.148 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -39.27 -52.89 2.79 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 125.528 1.767 . . . . 0.0 116.064 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.476 HG21 HD21 ' A' ' 62' ' ' ASN . 74.3 t -59.77 -50.12 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 118.481 -0.771 . . . . 0.0 112.582 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -56.04 -44.05 78.41 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.045 0.926 . . . . 0.0 109.672 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.27 -52.15 65.92 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.398 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.4 mt -51.08 -51.25 55.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.406 1.066 . . . . 0.0 111.022 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -53.29 -54.79 31.28 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.447 1.099 . . . . 0.0 112.475 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HD2' ' HB2' ' A' ' 36' ' ' ALA . 29.4 mttp -57.6 -48.9 78.12 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 113.808 -1.542 . . . . 0.0 113.043 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 31.2 mt -59.79 -41.74 91.83 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.536 1.134 . . . . 0.0 112.479 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -57.24 -25.43 59.12 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.16 -19.77 63.18 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.41 -166.31 19.68 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.854 1.216 . . . . 0.0 111.434 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.38 -41.43 1.84 Allowed Glycine 0 N--CA 1.483 1.775 0 C-N-CA 124.3 0.952 . . . . 0.0 115.241 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.609 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 78.9 m-85 -70.91 136.1 48.36 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.69 16.51 7.87 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 112.656 -2.065 . . . . 0.0 113.397 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.653 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -172.41 140.08 1.06 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.367 1.067 . . . . 0.0 111.975 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 t -122.37 114.1 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.045 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.7 mt -108.44 98.96 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.0 t -120.87 137.09 54.75 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.445 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 31.0 t0 -73.18 133.82 44.17 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 112.348 -2.205 . . . . 0.0 110.197 177.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.447 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 30.9 t-105 -59.26 -49.77 76.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.027 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -88.78 99.86 12.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.391 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.524 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 8.7 mtm -141.95 121.77 8.17 Favored Pre-proline 0 N--CA 1.478 0.931 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.106 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -62.28 164.42 17.57 Favored 'Trans proline' 0 N--CA 1.479 0.627 0 C-N-CA 123.208 2.605 . . . . 0.0 109.006 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.476 HD21 HG21 ' A' ' 40' ' ' VAL . 0.6 OUTLIER 70.82 -79.68 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.09 0.956 . . . . 0.0 109.633 -176.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.5 ttm -130.36 107.31 9.16 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.854 0.862 . . . . 0.0 108.948 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.524 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.7 p30 -62.85 162.08 11.65 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.029 -1.441 . . . . 0.0 112.895 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.21 -53.41 15.41 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 124.975 1.274 . . . . 0.0 114.793 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.67 -44.98 93.38 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.172 0.589 . . . . 0.0 111.887 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.71 -40.81 98.34 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -44.52 88.7 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.722 1.209 . . . . 0.0 110.328 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tp -58.97 -47.09 86.38 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.515 1.126 . . . . 0.0 111.012 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.13 -43.41 91.97 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.536 0.735 . . . . 0.0 112.76 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.268 4.7 p -64.29 -33.93 76.96 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.114 0.966 . . . . 0.0 111.811 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.5 mt -69.32 -56.49 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 73' ' ' ARG . 71.0 mmt-85 -53.53 -43.37 68.32 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.476 1.51 . . . . 0.0 113.065 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.77 -30.13 65.22 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -87.84 95.56 10.14 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.136 0.574 . . . . 0.0 112.088 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -13.65 -72.51 0.01 OUTLIER Glycine 0 N--CA 1.489 2.169 0 C-N-CA 127.821 2.629 . . . . 0.0 117.478 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.46 -40.54 68.51 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 50.9 mtm -88.53 -14.16 38.4 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.2 m -48.12 -25.14 1.34 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 117.365 2.358 . . . . 0.0 117.365 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.98 -7.81 50.99 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.426 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 96.4 mt -70.2 111.56 9.71 Favored Pre-proline 0 N--CA 1.485 1.283 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 11.5 Cg_endo -51.96 133.9 47.4 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 123.181 2.587 . . . . 0.0 113.921 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.2 t -120.53 126.82 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 122.812 1.292 . . . . 0.0 113.304 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.653 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 1.7 tm? -113.01 116.89 30.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 111.656 -2.52 . . . . 0.0 107.389 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 28.6 mmt -95.39 109.89 22.0 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 122.734 1.254 . . . . 0.0 113.437 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.31 96.02 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 123.178 1.466 . . . . 0.0 107.428 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -108.17 141.29 40.12 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 112.357 -2.201 . . . . 0.0 114.241 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.3 -29.59 70.88 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.404 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -134.1 129.33 35.81 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.299 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -94.1 55.83 2.13 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 123.997 1.856 . . . . 0.0 108.489 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -98.81 139.91 33.78 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 112.887 -1.961 . . . . 0.0 107.542 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 25.3 mmtp -34.52 -48.47 0.36 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -51.62 -49.83 61.47 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.736 0.647 . . . . 0.0 112.556 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -64.06 -47.81 78.67 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.504 1.122 . . . . 0.0 111.507 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 68.9 mt -57.94 -57.26 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.809 1.244 . . . . 0.0 111.83 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.9 mt -54.56 -52.75 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.878 0.871 . . . . 0.0 110.307 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.21 -52.71 58.01 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.151 0.981 . . . . 0.0 112.194 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.447 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -57.15 -52.58 64.75 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.677 1.191 . . . . 0.0 113.095 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.36 -48.84 80.11 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.64 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -60.07 -36.19 76.8 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 73' ' ' ARG . . . -78.12 -6.58 55.15 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.01 4.14 27.75 Favored Glycine 0 CA--C 1.548 2.148 0 N-CA-C 116.151 1.22 . . . . 0.0 116.151 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.02 119.73 10.67 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.906 1.353 . . . . 0.0 112.099 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.2 m -64.12 -36.32 83.64 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 112.362 -2.199 . . . . 0.0 112.448 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -169.79 178.67 42.61 Favored Glycine 0 CA--C 1.541 1.659 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.749 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -152.96 143.01 22.31 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.4 p -122.39 125.41 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 124.623 1.202 . . . . 0.0 109.972 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.1 p -85.54 122.64 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 113.937 -1.483 . . . . 0.0 111.073 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -83.83 138.12 40.63 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 113.764 -1.562 . . . . 0.0 113.249 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.41 143.01 75.0 Favored 'Cis proline' 0 CA--C 1.546 1.1 0 O-C-N 123.072 1.038 . . . . 0.0 114.787 0.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.519 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 33.8 p90 -134.91 151.12 50.6 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 112.31 -2.223 . . . . 0.0 108.642 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.2 t -107.16 175.61 5.44 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.189 0.931 . . . . 0.0 109.928 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.64 -42.46 56.34 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.936 0.894 . . . . 0.0 111.993 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.3 -44.45 95.0 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.294 1.038 . . . . 0.0 112.886 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.24 -48.66 77.28 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.466 0.707 . . . . 0.0 109.333 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.3 tp -55.94 -46.96 78.35 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.935 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.485 ' HG2' ' OD1' ' A' ' 121' ' ' ASN . 7.0 tt0 -58.36 -50.9 72.0 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.891 0.876 . . . . 0.0 110.975 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -49.19 -45.25 43.87 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.719 0.808 . . . . 0.0 112.618 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -66.24 -48.09 71.66 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.741 1.216 . . . . 0.0 111.807 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.401 ' HB3' ' CE2' ' A' ' 124' ' ' PHE . 96.3 mt -57.61 -46.73 83.72 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.064 0.946 . . . . 0.0 111.902 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.485 ' OD1' ' HG2' ' A' ' 117' ' ' GLU . 31.5 m-20 -48.14 -53.48 16.56 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.478 1.511 . . . . 0.0 112.079 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.1 tttt -51.68 -47.91 63.68 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 113.841 -1.527 . . . . 0.0 112.161 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.606 HG13 ' HZ ' ' A' ' 53' ' ' PHE . 8.3 mm -58.49 -57.47 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.693 1.197 . . . . 0.0 109.644 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' A' ' 120' ' ' LEU . 22.3 m-85 . . . . . 0 N--CA 1.475 0.799 0 C-N-CA 124.597 1.159 . . . . 0.0 113.334 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 54.0 mtmt . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -86.5 66.03 9.31 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 123.42 1.581 . . . . 0.0 110.911 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.2 tt -102.38 135.87 43.23 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.049 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -77.87 110.29 12.63 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -110.07 142.65 41.24 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.824 1.649 . . . . 0.0 112.698 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.589 HD12 ' HG ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -117.89 110.34 17.63 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 122.22 1.01 . . . . 0.0 109.932 173.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.7 t -85.92 107.87 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 113.862 -1.517 . . . . 0.0 107.495 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' A' ' 42' ' ' ALA . 2.8 t -112.74 94.36 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.745 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -135.27 131.92 37.14 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.702 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -60.63 -25.01 65.97 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -101.07 105.34 16.51 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 44.3 p -41.21 -45.61 2.9 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.417 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -62.64 -52.79 61.95 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.404 1.082 . . . . 0.0 112.188 176.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -39.05 87.74 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.561 0.344 . . . . 0.0 110.222 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -55.45 -51.58 66.44 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.495 1.118 . . . . 0.0 110.683 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.641 ' CZ ' HD21 ' A' ' 23' ' ' ASN . 10.3 ttt180 -63.92 -36.53 84.25 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.47 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 42.3 mm -55.73 -47.5 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 122.625 0.37 . . . . 0.0 110.474 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -60.1 -44.44 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 122.849 0.459 . . . . 0.0 110.092 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.466 ' NH1' HH21 ' A' ' 19' ' ' ARG . 0.0 OUTLIER -54.19 -50.03 67.98 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.457 1.103 . . . . 0.0 110.575 176.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.641 HD21 ' CZ ' ' A' ' 19' ' ' ARG . 23.2 m120 -59.69 -44.65 93.57 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.495 0.718 . . . . 0.0 111.814 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.536 HD22 ' HB2' ' A' ' 113' ' ' ALA . 77.7 mt -56.06 -52.62 63.61 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.293 1.037 . . . . 0.0 111.442 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 73.9 mt -54.91 -45.51 74.74 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.759 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 27.3 mtpp -56.88 -46.39 81.91 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.285 177.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 28.5 mt-10 -59.5 -40.61 87.6 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.879 1.672 . . . . 0.0 111.746 177.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.4 mp -70.8 -16.14 62.71 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.892 1.677 . . . . 0.0 114.755 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.55 -5.81 33.33 Favored Glycine 0 CA--C 1.543 1.832 0 C-N-CA 125.342 1.448 . . . . 0.0 114.05 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 65.1 m-85 -92.94 67.66 4.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 123.506 1.622 . . . . 0.0 111.022 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -69.48 -14.09 62.69 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 116.974 2.213 . . . . 0.0 116.974 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -92.84 78.2 4.76 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 122.924 1.345 . . . . 0.0 108.987 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 p -126.87 130.87 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 113.757 -1.565 . . . . 0.0 114.189 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.435 ' O ' HD23 ' A' ' 9' ' ' LEU . 4.5 tm-20 -106.64 156.29 18.77 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 113.615 -1.629 . . . . 0.0 107.885 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -123.85 121.92 36.65 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -130.06 157.47 42.28 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 113.547 -1.661 . . . . 0.0 108.433 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -105.24 -40.63 5.78 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -130.71 162.3 29.75 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.289 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -42.63 -50.58 5.78 Favored Glycine 0 N--CA 1.484 1.855 0 O-C-N 125.531 1.769 . . . . 0.0 115.943 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.4 t -58.69 -53.58 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 119.091 -0.48 . . . . 0.0 111.541 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.51 -37.14 74.96 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.471 0.709 . . . . 0.0 110.995 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.555 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -61.45 -54.08 48.08 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.044 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.46 -38.13 86.1 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 123.862 0.727 . . . . 0.0 112.853 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 20.7 m120 -57.55 -50.33 73.45 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.126 0.891 . . . . 0.0 111.099 175.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -67.67 -42.97 81.3 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.828 1.251 . . . . 0.0 112.63 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.589 ' HG ' HD12 ' A' ' 9' ' ' LEU . 16.5 mt -59.87 -45.09 93.58 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.535 1.934 . . . . 0.0 114.563 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 19.0 pt20 -57.8 -14.62 6.23 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.67 -23.64 66.17 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.902 0.881 . . . . 0.0 112.337 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.15 -178.51 43.4 Favored Glycine 0 N--CA 1.48 1.609 0 C-N-CA 125.107 1.337 . . . . 0.0 113.757 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.4 -26.12 3.58 Favored Glycine 0 N--CA 1.482 1.705 0 CA-C-N 113.662 -1.269 . . . . 0.0 116.154 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -64.51 111.03 2.51 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.73 12.57 65.94 Favored Glycine 0 CA--C 1.541 1.665 0 O-C-N 125.103 1.502 . . . . 0.0 112.472 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.529 ' HZ ' HD13 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -168.73 141.06 2.75 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.016 0.926 . . . . 0.0 112.071 179.118 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.6 t -129.39 122.58 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.543 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.8 mt -111.68 102.53 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.2 t -122.27 133.84 54.68 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 116.909 2.188 . . . . 0.0 116.909 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -73.82 127.99 34.31 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 111.335 -2.666 . . . . 0.0 110.767 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.46 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 13.6 t-105 -56.04 -43.57 77.96 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.778 1.231 . . . . 0.0 110.73 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -91.13 94.49 9.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.202 1.401 . . . . 0.0 109.062 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.503 ' SD ' HG12 ' A' ' 11' ' ' VAL . 15.2 mtm -141.24 121.87 8.72 Favored Pre-proline 0 N--CA 1.476 0.83 0 CA-C-N 114.179 -1.373 . . . . 0.0 113.516 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -55.25 158.74 11.48 Favored 'Trans proline' 0 N--CA 1.479 0.652 0 C-N-CA 123.139 2.56 . . . . 0.0 110.945 175.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.349 21.3 p30 66.84 -72.36 0.09 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.226 2.21 . . . . 0.0 112.024 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.496 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 43.4 ttp -128.86 108.18 10.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.508 0.723 . . . . 0.0 109.728 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -62.43 164.6 7.12 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.474 -1.694 . . . . 0.0 113.033 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.78 -54.76 23.7 Favored Glycine 0 N--CA 1.479 1.555 0 C-N-CA 125.132 1.349 . . . . 0.0 114.24 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.3 tp -57.01 -40.95 77.61 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.7 -40.43 84.32 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.553 0.341 . . . . 0.0 111.562 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.01 -41.03 95.75 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.778 1.231 . . . . 0.0 110.784 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 103' ' ' ALA . 2.9 tt -51.76 -51.2 58.04 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.286 1.434 . . . . 0.0 108.718 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -59.41 -43.19 93.07 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.429 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.7 p -69.25 -0.61 6.37 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.5 mt -109.64 -62.02 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.647 ' HG2' ' HA3' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -51.2 -44.52 61.61 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.16 1.784 . . . . 0.0 113.83 -179.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.83 -3.35 49.1 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -85.69 99.85 11.59 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -10.25 -77.87 0.01 OUTLIER Glycine 0 N--CA 1.488 2.165 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.96 -41.23 99.46 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 76.6 mtp -85.93 -6.71 59.02 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.6 t -34.06 -61.99 0.34 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 118.972 2.953 . . . . 0.0 118.972 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.41 18.05 0.45 Allowed 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 119.248 3.055 . . . . 0.0 119.248 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 69.9 mt -84.9 120.14 73.4 Favored Pre-proline 0 CA--C 1.543 0.708 0 O-C-N 121.215 -0.928 . . . . 0.0 112.689 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 9.5 Cg_endo -52.22 132.96 45.97 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.812 3.008 . . . . 0.0 113.901 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.506 HG11 ' HG ' ' A' ' 69' ' ' LEU . 11.3 t -118.96 115.58 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 112.61 -2.086 . . . . 0.0 112.314 -176.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.556 HD13 HD11 ' A' ' 123' ' ' ILE . 62.5 tp -107.43 105.59 15.58 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 113.858 -1.519 . . . . 0.0 107.635 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.5 mmt -79.35 138.19 37.6 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 113.284 -1.78 . . . . 0.0 111.708 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.7 t -112.43 104.66 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 p -102.47 152.56 20.98 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.439 -1.255 . . . . 0.0 113.587 -175.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.62 -40.12 95.96 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.361 -1.745 . . . . 0.0 111.705 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -159.95 148.36 17.18 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.693 1.597 . . . . 0.0 112.211 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.48 94.68 8.59 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.149 0.906 . . . . 0.0 109.813 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -125.38 130.36 51.76 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.418 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -25.95 -61.11 0.07 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 116.42 2.008 . . . . 0.0 116.42 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -57.19 -46.17 83.08 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -68.62 -37.41 79.72 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 91.5 mt -59.41 -50.02 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.386 1.075 . . . . 0.0 109.051 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.4 mm -55.67 -55.46 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.468 1.107 . . . . 0.0 110.241 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.54 -49.3 62.24 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.237 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.46 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -59.96 -57.28 13.52 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.451 1.1 . . . . 0.0 113.646 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.78 -51.03 71.25 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.244 1.017 . . . . 0.0 111.995 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.19 -30.23 70.92 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.12 -13.19 58.93 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.647 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 120.61 -3.21 12.18 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 116.895 1.518 . . . . 0.0 116.895 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.566 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -57.78 114.09 2.14 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 118.918 1.359 . . . . 0.0 112.878 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.481 ' HB3' HG23 ' A' ' 123' ' ' ILE . 5.0 m -63.56 -26.79 68.86 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 112.007 -2.36 . . . . 0.0 113.76 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.7 166.25 35.89 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.742 1.163 . . . . 0.0 110.353 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -142.25 137.63 30.83 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 p -121.51 131.95 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.89 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.98 139.63 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.598 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.08 140.42 28.98 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.617 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.62 135.86 20.28 Favored 'Cis proline' 0 C--N 1.352 0.715 0 O-C-N 122.47 0.721 . . . . 0.0 110.983 -2.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -113.43 154.71 26.53 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.293 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.8 t -110.27 178.24 4.45 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.15 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.536 ' HB2' HD22 ' A' ' 24' ' ' LEU . . . -51.27 -44.19 61.76 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.664 1.185 . . . . 0.0 111.893 178.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.24 -51.72 67.78 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.245 1.018 . . . . 0.0 111.888 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.44 -47.21 82.39 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.191 0.996 . . . . 0.0 110.389 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 47.7 tp -56.58 -53.51 56.69 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.11 1.364 . . . . 0.0 109.506 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -53.89 -47.19 71.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.77 1.228 . . . . 0.0 112.354 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.38 -50.25 70.21 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -62.54 -43.15 99.52 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 61.7 mt -52.84 -46.23 67.71 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -55.4 -51.64 66.18 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.584 0.754 . . . . 0.0 112.843 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -56.5 -43.36 79.64 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.35 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.556 HD11 HD13 ' A' ' 84' ' ' LEU . 62.2 mt -58.44 -53.56 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.038 0.935 . . . . 0.0 110.58 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 N--CA 1.479 0.992 0 C-N-CA 123.736 0.814 . . . . 0.0 113.144 179.292 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -66.77 9.03 0.2 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.821 2.048 . . . . 0.0 115.574 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.52 97.04 3.61 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -175.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.4 ' HG3' ' HB2' ' A' ' 32' ' ' ASN . 34.0 tttt -79.53 111.27 15.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.724 -1.58 . . . . 0.0 111.692 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -92.26 136.58 33.08 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 112.141 -2.3 . . . . 0.0 112.107 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.561 HD12 HD13 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -111.16 104.04 12.52 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 118.698 -1.201 . . . . 0.0 109.145 173.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.552 ' HA ' HG23 ' A' ' 55' ' ' ILE . 48.2 t -80.29 97.54 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 112.968 -1.923 . . . . 0.0 105.848 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.506 HG11 ' HB2' ' A' ' 42' ' ' ALA . 5.0 t -101.04 84.6 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 112.702 -2.044 . . . . 0.0 107.808 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.611 ' HB3' ' HG3' ' A' ' 18' ' ' ARG . 7.0 t70 -133.94 121.14 21.25 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.105 -1.861 . . . . 0.0 111.752 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -54.9 -28.23 49.02 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 112.264 -2.244 . . . . 0.0 115.55 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -97.34 119.71 36.37 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.559 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.3 p -50.39 -50.93 50.24 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 125.028 1.455 . . . . 0.0 112.929 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -43.78 98.35 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.188 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 13.2 tpt -62.64 -40.89 98.45 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.611 ' HG3' ' HB3' ' A' ' 12' ' ' ASP . 10.1 mtm180 -56.14 -49.23 74.52 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.695 0.798 . . . . 0.0 111.578 175.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -60.18 -43.3 95.96 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.523 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.2 mt -56.18 -50.43 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.097 0.559 . . . . 0.0 110.583 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.85 -43.13 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.218 0.607 . . . . 0.0 111.524 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -51.99 -52.0 53.44 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.531 0.732 . . . . 0.0 111.273 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -57.72 -40.84 80.51 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.737 0.815 . . . . 0.0 112.839 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.03 -52.01 67.18 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.445 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.7 mt -58.54 -42.11 87.08 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.083 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -59.1 -47.49 85.06 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.353 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -54.98 -39.44 68.99 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 125.327 1.451 . . . . 0.0 112.293 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.4 mt -73.21 -17.28 61.37 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.21 17.72 19.32 Favored Glycine 0 CA--C 1.543 1.807 0 C-N-CA 124.567 1.08 . . . . 0.0 113.349 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -110.14 89.68 3.09 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 122.943 1.354 . . . . 0.0 112.126 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -68.54 -29.11 67.61 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 112.557 -2.11 . . . . 0.0 115.058 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.4 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -84.24 91.32 7.7 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 123.049 1.405 . . . . 0.0 113.481 -175.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.0 t -133.89 125.89 49.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 112.884 -1.962 . . . . 0.0 110.867 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.45 ' OE1' ' HB3' ' A' ' 45' ' ' LYS . 5.5 tt0 -110.26 153.59 24.62 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 175.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 36.9 mt-10 -125.92 124.8 41.62 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.49 153.87 36.06 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.552 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -4.0 19.85 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -165.84 157.4 14.06 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.452 0.701 . . . . 0.0 110.64 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 42' ' ' ALA . . . -39.9 -53.78 3.09 Favored Glycine 0 CA--C 1.544 1.856 0 O-C-N 125.04 1.463 . . . . 0.0 115.517 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.01 -52.84 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 122.414 0.286 . . . . 0.0 111.439 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -55.71 -38.76 70.15 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.568 1.147 . . . . 0.0 110.16 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.506 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -61.98 -58.57 7.39 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.233 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.17 -39.51 56.56 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.985 0.803 . . . . 0.0 112.531 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -63.69 -64.2 0.96 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.561 1.144 . . . . 0.0 109.92 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.45 ' HB3' ' OE1' ' A' ' 34' ' ' GLU . 46.1 mttm -55.38 -37.65 67.84 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 126.91 2.084 . . . . 0.0 115.319 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.581 HD11 HG22 ' A' ' 54' ' ' VAL . 5.9 tp -54.47 -25.86 27.8 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -90.94 -17.79 25.8 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.95 69.54 7.56 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.73 81.47 1.52 Allowed Glycine 0 CA--C 1.541 1.665 0 N-CA-C 118.496 2.158 . . . . 0.0 118.496 174.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 18.81 76.99 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 C-N-CA 128.012 2.72 . . . . 0.0 119.366 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -83.94 127.69 34.03 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.239 -0.981 . . . . 0.0 110.301 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.78 8.21 50.45 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.201 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.518 ' HA ' ' HG2' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -166.64 144.5 5.15 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 -179.201 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.581 HG22 HD11 ' A' ' 46' ' ' LEU . 21.4 t -123.85 110.87 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 175.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.552 HG23 ' HA ' ' A' ' 10' ' ' VAL . 14.8 tt -115.08 98.05 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 t -120.73 142.07 49.86 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 120.485 3.513 . . . . 0.0 120.485 -174.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -72.4 129.2 37.81 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 113.039 -1.892 . . . . 0.0 109.879 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.411 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 37.7 t-105 -53.71 -38.73 64.57 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.742 0.817 . . . . 0.0 112.544 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -105.6 108.46 19.99 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.584 0.754 . . . . 0.0 110.139 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.489 ' SD ' HG12 ' A' ' 11' ' ' VAL . 50.7 mtm -139.71 126.39 12.41 Favored Pre-proline 0 N--CA 1.478 0.966 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.78 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.76 118.48 5.41 Favored 'Trans proline' 0 N--CA 1.482 0.829 0 C-N-CA 124.048 3.165 . . . . 0.0 111.837 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 99.17 -76.25 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 129.224 3.01 . . . . 0.0 110.119 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.8 ttm -112.28 93.92 4.68 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.253 0.549 . . . . 0.0 109.744 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.6 p30 -59.74 162.28 5.42 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 112.133 -2.303 . . . . 0.0 112.068 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.88 -53.63 25.59 Favored Glycine 0 N--CA 1.477 1.433 0 C-N-CA 124.516 1.055 . . . . 0.0 114.296 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.488 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 60.8 tp -59.64 -37.87 79.85 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -70.69 -40.96 72.6 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.157 0.583 . . . . 0.0 110.369 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.9 tp -56.62 -44.86 81.6 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.111 0.964 . . . . 0.0 110.188 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' A' ' 103' ' ' ALA . 4.8 tt -48.79 -51.22 30.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.212 1.405 . . . . 0.0 109.363 175.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.37 -45.86 92.04 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.651 1.18 . . . . 0.0 112.538 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 p -61.9 -15.36 42.26 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.6 mt -96.31 -65.46 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.762 ' HG2' ' HA3' ' A' ' 102' ' ' GLY . 6.5 tpp180 -53.17 -43.35 67.0 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.163 2.185 . . . . 0.0 115.195 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.49 -10.41 49.1 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 78' ' ' MET . 12.6 t70 -89.4 112.32 23.41 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -42.79 -18.64 0.05 OUTLIER Glycine 0 CA--C 1.547 2.092 0 C-N-CA 127.601 2.524 . . . . 0.0 118.978 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.27 -50.77 3.84 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.64 0.776 . . . . 0.0 111.576 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.406 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 88.9 mmm -70.08 -25.15 63.39 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 118.718 2.859 . . . . 0.0 118.718 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.6 t -58.64 39.19 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 118.255 2.687 . . . . 0.0 118.255 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -123.55 -37.05 2.69 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.77 2.028 . . . . 0.0 111.073 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.447 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 6.1 mt -66.1 117.6 44.39 Favored Pre-proline 0 N--CA 1.472 0.657 0 C-N-CA 126.158 1.783 . . . . 0.0 115.299 -178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.518 ' HG2' ' HA ' ' A' ' 53' ' ' PHE . 35.4 Cg_endo -63.35 137.91 63.1 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.631 2.221 . . . . 0.0 111.121 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.94 110.26 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 113.812 -1.54 . . . . 0.0 112.668 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.421 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 33.1 tp -106.7 107.43 18.44 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.142 -1.845 . . . . 0.0 109.46 178.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.8 mmt -81.71 111.56 18.08 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 113.581 -1.645 . . . . 0.0 113.438 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.0 97.36 7.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 177.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 2.5 t -107.14 134.57 50.06 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 112.032 -2.349 . . . . 0.0 115.646 -174.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.21 -8.28 56.16 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 113.151 -1.841 . . . . 0.0 112.639 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -144.82 95.92 2.77 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.124 0.964 . . . . 0.0 113.09 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.03 64.17 8.31 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 123.429 1.585 . . . . 0.0 109.766 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -116.21 150.24 37.84 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.963 -1.926 . . . . 0.0 111.123 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -34.48 -51.95 0.48 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 115.329 1.604 . . . . 0.0 115.329 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -52.32 -57.57 9.35 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.494 0.718 . . . . 0.0 112.161 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -61.19 -41.04 96.11 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 85.2 mt -58.09 -51.13 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 124.125 0.891 . . . . 0.0 109.753 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 80.4 mt -54.91 -55.81 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.412 1.085 . . . . 0.0 109.892 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.21 -50.55 64.48 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.146 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -62.37 -52.42 63.68 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.88 -47.7 84.68 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -63.2 -36.78 84.79 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.52 -21.74 61.87 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.762 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 116.34 20.97 4.95 Favored Glycine 0 N--CA 1.48 1.568 0 N-CA-C 116.445 1.338 . . . . 0.0 116.445 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.61 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -68.77 118.91 12.34 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.456 1.128 . . . . 0.0 112.029 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.8 m -64.05 -28.3 69.7 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 113.52 -1.673 . . . . 0.0 111.992 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.61 172.26 45.23 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 124.149 0.88 . . . . 0.0 110.979 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -148.82 137.4 21.22 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.288 -0.956 . . . . 0.0 111.865 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.43 127.73 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 124.642 1.214 . . . . 0.0 109.438 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 87' ' ' THR . 11.0 p -81.04 139.97 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.782 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -94.6 131.63 30.42 Favored Pre-proline 0 CA--C 1.55 0.976 0 O-C-N 123.883 0.74 . . . . 0.0 111.255 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.3 151.88 69.33 Favored 'Cis proline' 0 N--CA 1.48 0.723 0 O-C-N 123.069 1.036 . . . . 0.0 113.46 -0.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -134.17 152.23 51.73 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 113.316 -1.765 . . . . 0.0 107.724 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.7 p -98.74 172.85 7.2 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.803 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.36 -41.62 72.79 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.822 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.11 -44.35 89.05 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.065 0.946 . . . . 0.0 111.702 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.2 m -61.25 -44.93 96.44 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.319 0.647 . . . . 0.0 110.041 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.449 HD21 HD12 ' A' ' 55' ' ' ILE . 2.0 tm? -60.44 -47.57 85.54 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.59 177.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -56.61 -43.06 79.81 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.496 1.118 . . . . 0.0 112.283 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -52.55 -45.51 66.41 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.124 0.57 . . . . 0.0 111.758 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -68.14 -42.32 80.3 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.196 0.998 . . . . 0.0 112.176 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 59.2 mt -53.88 -53.45 52.36 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.926 0.89 . . . . 0.0 111.433 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -50.54 -53.7 28.2 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.714 1.606 . . . . 0.0 111.957 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -49.27 -48.48 45.91 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.358 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 26.9 mt -63.01 -50.02 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 125.026 1.33 . . . . 0.0 112.284 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 . . . . . 0 N--CA 1.481 1.089 0 C-N-CA 124.396 1.078 . . . . 0.0 111.875 -179.473 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.7 pttt . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.95 54.41 1.26 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 1.2 tt -111.41 118.83 36.9 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 113.673 -1.603 . . . . 0.0 112.064 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -75.74 108.83 8.86 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.513 ' HE2' HD22 ' A' ' 120' ' ' LEU . 74.4 m-85 -97.53 140.71 31.56 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.522 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.44 HD12 ' HG ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -114.38 109.6 18.58 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.604 ' HA ' HG23 ' A' ' 55' ' ' ILE . 9.9 p -81.23 101.37 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 124.972 1.42 . . . . 0.0 107.169 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.524 HG12 ' SD ' ' A' ' 60' ' ' MET . 4.0 t -100.17 85.4 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -123.48 124.6 43.24 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 110.765 -2.925 . . . . 0.0 113.039 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -65.65 -19.22 65.82 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 110.955 -2.839 . . . . 0.0 116.23 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -110.09 127.79 55.07 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.303 0.377 . . . . 0.0 110.436 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.1 p -47.4 -59.31 3.3 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 113.683 -1.598 . . . . 0.0 113.721 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.454 ' O ' HG12 ' A' ' 20' ' ' ILE . 1.8 p -66.75 -42.3 86.39 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.439 ' O ' HG23 ' A' ' 21' ' ' VAL . 9.6 ttt -60.36 -38.32 83.48 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.058 0.39 . . . . 0.0 111.309 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -54.97 -50.91 67.76 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.62 1.168 . . . . 0.0 110.392 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.635 ' NH2' HD21 ' A' ' 23' ' ' ASN . 4.9 mtp-105 -65.03 -39.35 93.23 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.924 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 16' ' ' THR . 43.7 mm -55.95 -51.24 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 17' ' ' MET . 6.1 t -58.78 -45.98 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 123.596 0.56 . . . . 0.0 109.991 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -49.24 -53.92 19.22 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.888 0.875 . . . . 0.0 111.838 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.635 HD21 ' NH2' ' A' ' 19' ' ' ARG . 48.0 m-80 -62.98 -39.01 93.43 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.495 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.8 mt -58.95 -52.41 65.85 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.632 0.773 . . . . 0.0 110.564 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.7 mt -54.98 -47.18 74.93 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.065 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.425 ' HG3' ' OD1' ' A' ' 31' ' ' ASN . 36.4 ttpt -54.03 -50.15 67.3 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.416 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -58.71 -40.14 82.84 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.601 1.561 . . . . 0.0 112.288 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.7 mt -71.96 -10.35 59.65 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.543 1.137 . . . . 0.0 113.135 177.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.31 -16.39 24.66 Favored Glycine 0 CA--C 1.546 2.002 0 C-N-CA 125.226 1.393 . . . . 0.0 113.677 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -87.69 72.7 9.47 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 123.366 1.555 . . . . 0.0 113.015 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.425 ' OD1' ' HG3' ' A' ' 26' ' ' LYS . 4.8 m-80 -69.2 -8.42 45.5 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.705 -1.589 . . . . 0.0 113.891 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.447 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -94.17 83.9 4.35 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.483 1.513 . . . . 0.0 110.53 -178.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.35 137.8 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.775 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.582 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -111.59 159.15 18.42 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.888 1.275 . . . . 0.0 108.922 176.352 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -126.5 108.9 11.6 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.47 158.36 20.8 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.967 1.307 . . . . 0.0 110.287 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -101.87 -39.03 7.56 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -138.94 170.44 15.97 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.349 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -47.1 -51.93 13.29 Favored Glycine 0 N--CA 1.474 1.227 0 C-N-CA 124.646 1.117 . . . . 0.0 115.552 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.6 t -57.73 -54.43 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.409 0.683 . . . . 0.0 110.683 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -57.56 -33.61 68.32 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.583 0.753 . . . . 0.0 111.694 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . . . -64.09 -50.71 67.25 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 117.172 -1.394 . . . . 0.0 110.971 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.462 HD11 ' OG1' ' A' ' 71' ' ' THR . 61.8 mt -57.06 -45.99 82.8 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 123.752 0.658 . . . . 0.0 111.131 178.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -52.62 -54.32 34.73 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.199 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -63.16 -42.45 99.42 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.725 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.44 ' HG ' HD12 ' A' ' 9' ' ' LEU . 26.4 mt -56.7 -35.98 69.13 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.726 1.21 . . . . 0.0 113.139 177.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.19 -24.36 17.93 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.86 -23.64 67.43 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.251 1.02 . . . . 0.0 113.053 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.74 179.83 50.19 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 124.805 1.193 . . . . 0.0 113.922 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.73 -14.94 8.61 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 116.544 1.377 . . . . 0.0 116.544 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.582 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 84.1 m-85 -68.19 121.58 16.5 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.263 1.03 . . . . 0.0 113.64 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -106.23 10.1 43.03 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 112.505 -2.134 . . . . 0.0 111.959 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.732 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.6 OUTLIER -168.94 145.43 3.54 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.5 t -128.75 111.15 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 113.389 -1.732 . . . . 0.0 107.663 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.604 HG23 ' HA ' ' A' ' 10' ' ' VAL . 12.1 tt -107.34 96.64 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.3 t -118.33 134.47 55.01 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 60' ' ' MET . 12.3 m-20 -72.08 134.36 45.76 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.883 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.459 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 14.7 t-105 -55.63 -48.58 74.7 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.828 0.851 . . . . 0.0 111.498 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -96.52 97.77 9.69 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.224 0.952 . . . . 0.0 111.271 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.524 ' SD ' HG12 ' A' ' 11' ' ' VAL . 29.6 mtm -131.15 138.67 33.43 Favored Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 113.782 -1.553 . . . . 0.0 111.826 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -58.87 143.93 99.06 Favored 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.144 2.562 . . . . 0.0 111.518 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.345 27.9 p30 65.12 -66.64 0.14 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 127.313 2.245 . . . . 0.0 114.295 -177.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.8 ttm -122.36 100.43 6.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.881 0.872 . . . . 0.0 108.691 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 7.3 m-20 -65.27 167.18 8.71 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 112.413 -2.176 . . . . 0.0 112.875 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.4 -56.18 9.72 Favored Glycine 0 N--CA 1.482 1.717 0 C-N-CA 125.177 1.37 . . . . 0.0 114.123 -178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.463 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 43.7 tp -57.57 -39.89 77.73 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -70.63 -40.45 73.12 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.99 -0.444 . . . . 0.0 110.547 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.428 ' HA ' HG22 ' A' ' 71' ' ' THR . 1.4 tm? -57.87 -42.27 84.21 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.071 0.548 . . . . 0.0 110.668 176.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 103' ' ' ALA . 4.8 tt -51.1 -49.93 59.75 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.842 1.657 . . . . 0.0 109.705 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -56.89 -47.33 80.77 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.392 1.077 . . . . 0.0 113.66 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.462 ' OG1' HD11 ' A' ' 43' ' ' LEU 0.359 13.7 t -70.69 5.58 1.84 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 mt -115.18 -64.68 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 174.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.405 ' HG3' ' HA3' ' A' ' 102' ' ' GLY . 24.9 mmt180 -51.12 -45.59 61.64 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.811 1.644 . . . . 0.0 113.752 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.69 -10.72 42.06 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -83.03 89.94 6.97 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -11.67 -72.06 0.01 OUTLIER Glycine 0 N--CA 1.485 1.929 0 C-N-CA 127.091 2.281 . . . . 0.0 116.641 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.4 -38.64 77.76 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 82.5 mtp -92.51 -14.17 28.79 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.0 t -30.0 -35.92 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 121.681 3.956 . . . . 0.0 121.681 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.71 -8.58 58.15 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 120.849 3.648 . . . . 0.0 120.849 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 2.3 mp -68.08 119.16 65.29 Favored Pre-proline 0 N--CA 1.477 0.903 0 N-CA-C 118.049 2.611 . . . . 0.0 118.049 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 7.5 Cg_endo -57.86 142.24 96.25 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.686 2.924 . . . . 0.0 110.949 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 103' ' ' ALA . 1.3 t -123.29 121.82 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 113.538 -1.665 . . . . 0.0 113.121 -175.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.732 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 28.3 tp -111.6 102.58 10.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.699 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 31.4 mmt -80.04 105.98 11.72 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 113.416 -1.72 . . . . 0.0 112.845 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.59 98.06 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 113.492 -1.686 . . . . 0.0 107.722 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 1.7 t -114.05 121.74 44.77 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 -176.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.757 ' HB2' ' HE3' ' A' ' 109' ' ' LYS . . . -70.0 -18.8 63.34 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.002 -1.454 . . . . 0.0 112.928 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.78 84.45 1.94 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.218 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.48 100.12 6.74 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.794 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -119.04 137.68 53.37 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 112.951 -1.931 . . . . 0.0 107.876 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.479 ' O ' HG12 ' A' ' 96' ' ' ILE . 64.4 tttp -31.14 -57.27 0.24 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -57.51 -47.52 81.74 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.264 30.1 p30 -69.3 -33.99 74.02 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.0 mt -59.72 -49.87 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 124.136 0.974 . . . . 0.0 109.186 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 92' ' ' LYS . 42.4 mm -57.83 -50.41 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.228 1.011 . . . . 0.0 110.195 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.32 -50.11 60.03 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.339 1.055 . . . . 0.0 111.272 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.459 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -58.06 -56.4 22.54 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.892 1.277 . . . . 0.0 112.504 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.23 -49.24 74.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.986 0.914 . . . . 0.0 112.623 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -63.43 -37.48 87.45 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.04 -16.99 62.05 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.405 ' HA3' ' HG3' ' A' ' 73' ' ' ARG . . . 121.98 -0.02 10.76 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.618 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -67.07 110.67 3.5 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.404 1.102 . . . . 0.0 111.478 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.9 p -66.85 -18.29 65.31 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 113.681 -1.6 . . . . 0.0 114.644 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.16 168.3 40.02 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.76 1.171 . . . . 0.0 111.866 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -144.73 140.5 28.6 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.423 -0.888 . . . . 0.0 111.793 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.9 p -126.34 134.75 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 124.504 1.127 . . . . 0.0 111.845 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 87' ' ' THR . 47.8 t -81.03 128.79 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.983 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.757 ' HE3' ' HB2' ' A' ' 88' ' ' ALA . 42.1 pttt -94.03 132.86 28.55 Favored Pre-proline 0 N--CA 1.486 1.333 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.332 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.91 146.88 76.2 Favored 'Cis proline' 0 N--CA 1.478 0.617 0 O-C-N 123.437 1.23 . . . . 0.0 114.497 0.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -126.08 154.07 43.59 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 112.941 -1.936 . . . . 0.0 109.034 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.4 p -99.01 172.07 7.63 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.523 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.97 -39.71 72.2 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.87 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.89 -47.34 69.11 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.637 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.3 m -59.56 -46.91 87.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.584 0.754 . . . . 0.0 109.816 178.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.0 tp -56.76 -54.26 48.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.424 1.49 . . . . 0.0 110.198 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.24 -46.51 76.02 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.857 0.863 . . . . 0.0 112.682 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.28 -44.88 65.24 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.198 0.936 . . . . 0.0 112.134 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -66.54 -49.61 65.9 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.717 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.513 HD22 ' HE2' ' A' ' 8' ' ' PHE . 55.6 mt -55.92 -49.29 73.88 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.15 0.98 . . . . 0.0 111.849 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -55.78 -48.67 74.92 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.369 1.468 . . . . 0.0 112.692 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -54.22 -48.72 70.76 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.632 1.173 . . . . 0.0 110.784 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.21 -47.37 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.262 1.025 . . . . 0.0 110.585 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 179.103 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 65.1 mttm . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.59 60.89 5.82 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 123.209 1.48 . . . . 0.0 108.565 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.435 HD21 ' HB2' ' A' ' 53' ' ' PHE . 5.5 tt -98.11 123.75 42.31 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.049 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 46.4 tttp -80.33 105.46 11.61 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.685 1.241 . . . . 0.0 112.657 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -97.47 145.22 26.42 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.005 -1.452 . . . . 0.0 112.615 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.838 HD12 HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -113.15 107.23 15.64 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 173.592 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.52 98.85 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.931 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.674 HG11 ' HB2' ' A' ' 42' ' ' ALA . 2.2 t -105.77 89.88 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 113.304 -1.771 . . . . 0.0 109.257 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -134.14 125.68 28.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 112.643 -2.071 . . . . 0.0 111.019 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -55.37 -24.86 31.91 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 110.93 -2.85 . . . . 0.0 116.738 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -106.66 120.69 42.64 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.2 p -42.96 -57.67 2.75 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.937 -1.483 . . . . 0.0 114.305 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.44 ' O ' HG12 ' A' ' 20' ' ' ILE . 11.0 p -68.06 -43.37 78.8 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 118.223 -0.894 . . . . 0.0 113.29 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -39.3 90.4 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.249 0.477 . . . . 0.0 110.896 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -56.63 -49.45 74.96 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.386 1.074 . . . . 0.0 109.971 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -61.0 -42.33 98.23 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.71 177.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 16' ' ' THR . 42.8 mm -56.17 -48.59 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 118.888 -0.577 . . . . 0.0 110.002 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.464 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 4.1 t -59.5 -49.97 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 19' ' ' ARG . 42.5 ttt180 -49.62 -49.08 48.33 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.207 1.403 . . . . 0.0 111.092 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -64.5 -43.32 94.48 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.548 1.139 . . . . 0.0 112.286 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.496 HD22 ' HB2' ' A' ' 113' ' ' ALA . 57.3 mt -55.72 -50.97 68.92 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.385 1.074 . . . . 0.0 111.31 177.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 mt -51.01 -48.6 61.38 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.757 1.286 . . . . 0.0 112.187 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.406 ' NZ ' ' HG2' ' A' ' 22' ' ' ARG . 32.0 mtmm -58.96 -44.8 91.56 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.982 -1.463 . . . . 0.0 112.247 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 32.5 mt-10 -59.18 -38.47 79.88 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.095 1.358 . . . . 0.0 112.733 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.543 HD22 ' HB2' ' A' ' 117' ' ' GLU . 60.2 mt -71.14 -18.21 62.52 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.098 1.359 . . . . 0.0 114.239 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.79 9.96 19.81 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 124.476 1.036 . . . . 0.0 113.5 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -96.76 95.39 7.86 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 123.405 1.574 . . . . 0.0 110.199 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -61.95 -34.62 76.46 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 110.501 -3.045 . . . . 0.0 118.746 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 7' ' ' LYS . 9.1 t-20 -112.3 125.81 54.58 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 -174.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.4 p -147.96 135.79 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.77 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 12.9 mm-40 -113.78 161.42 17.56 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.869 175.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -123.38 130.51 52.82 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -139.12 156.7 46.96 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.377 1.471 . . . . 0.0 109.699 175.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -113.86 -38.79 4.14 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 61' ' ' PRO . 6.6 p-10 -123.38 159.79 28.17 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 118.719 -0.658 . . . . 0.0 109.774 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.575 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -44.67 -45.68 8.8 Favored Glycine 0 N--CA 1.478 1.445 0 N-CA-C 116.74 1.456 . . . . 0.0 116.74 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.57 -54.77 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 122.559 0.344 . . . . 0.0 110.196 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -57.51 -34.13 68.77 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.446 0.699 . . . . 0.0 110.777 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.674 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -62.94 -55.23 27.76 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.653 1.181 . . . . 0.0 110.32 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.0 mt -56.52 -43.54 79.92 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.66 0.784 . . . . 0.0 110.324 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -53.86 -56.16 20.13 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.318 1.047 . . . . 0.0 110.744 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -59.38 -52.97 63.32 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.213 1.405 . . . . 0.0 111.896 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.838 HD13 HD12 ' A' ' 9' ' ' LEU . 4.0 tp -56.49 -37.21 70.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.933 2.093 . . . . 0.0 114.61 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -54.64 -30.26 54.62 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.472 1.509 . . . . 0.0 113.589 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.77 -22.47 66.99 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.21 -173.13 46.12 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.25 0.928 . . . . 0.0 112.093 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.63 -26.41 3.14 Favored Glycine 0 CA--C 1.543 1.833 0 N-CA-C 114.78 0.672 . . . . 0.0 114.78 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.77 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 91.3 m-85 -68.12 108.94 3.31 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.879 0.872 . . . . 0.0 111.799 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.59 3.11 86.41 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.441 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.646 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -166.04 143.52 5.45 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.105 0.962 . . . . 0.0 113.441 179.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.543 HG22 HD11 ' A' ' 46' ' ' LEU . 31.3 t -122.14 113.84 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 113.918 -1.492 . . . . 0.0 107.608 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.549 HD12 HD23 ' A' ' 84' ' ' LEU . 18.8 tt -113.43 97.28 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 178.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.7 t -119.53 136.03 54.52 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -175.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.408 ' O ' ' HG3' ' A' ' 60' ' ' MET . 8.0 t0 -71.98 132.88 44.91 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 112.415 -2.175 . . . . 0.0 110.944 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.479 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 26.6 t-105 -56.29 -41.23 75.58 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.41 1.084 . . . . 0.0 111.719 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -99.5 104.44 16.27 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.481 ' SD ' HG12 ' A' ' 11' ' ' VAL . 29.4 mtm -138.83 130.45 15.39 Favored Pre-proline 0 N--CA 1.473 0.689 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.713 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.508 ' O ' ' HB2' ' A' ' 38' ' ' ASP . 99.0 Cg_exo -57.42 149.6 64.76 Favored 'Trans proline' 0 N--CA 1.481 0.766 0 C-N-CA 123.448 2.765 . . . . 0.0 110.944 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 71.19 -61.2 0.49 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 126.119 1.767 . . . . 0.0 112.516 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.575 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 55.6 ttm -135.31 108.33 7.64 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.154 1.381 . . . . 0.0 108.101 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 10.7 m-20 -68.88 167.39 15.76 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.457 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.26 -57.01 9.55 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 125.508 1.528 . . . . 0.0 114.527 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.455 HD12 HD23 ' A' ' 69' ' ' LEU . 56.9 tp -57.44 -37.84 73.45 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -71.61 -42.95 67.04 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.668 0.787 . . . . 0.0 111.167 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.07 -41.53 83.59 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.328 1.051 . . . . 0.0 110.246 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.577 HD13 HG11 ' A' ' 83' ' ' VAL . 8.4 tp -57.23 -46.53 82.88 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.005 176.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -60.43 -44.0 96.21 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.38 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.26 24.9 p -62.0 -35.44 78.53 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.268 1.027 . . . . 0.0 111.993 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.4 mt -69.33 -56.95 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.499 ' HG3' ' HA3' ' A' ' 102' ' ' GLY . 30.1 mmt180 -53.34 -47.98 68.89 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.718 1.261 . . . . 0.0 113.043 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.14 -33.85 75.26 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.165 0.986 . . . . 0.0 113.097 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -84.68 83.25 8.09 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.794 0.838 . . . . 0.0 108.777 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -4.58 -80.6 0.01 OUTLIER Glycine 0 N--CA 1.484 1.849 0 C-N-CA 127.521 2.486 . . . . 0.0 118.221 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.89 -35.27 57.7 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 94.0 mtp -73.37 -27.11 61.3 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.072 0.949 . . . . 0.0 113.241 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.3 t -53.83 -26.51 24.65 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.43 -14.61 61.74 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.516 HD22 ' O ' ' A' ' 51' ' ' TYR . 16.0 mt -86.53 116.19 65.01 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 123.784 0.833 . . . . 0.0 109.876 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 9.4 Cg_endo -52.58 143.66 45.03 Favored 'Trans proline' 0 N--CA 1.476 0.488 0 C-N-CA 123.53 2.82 . . . . 0.0 113.71 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.577 HG11 HD13 ' A' ' 69' ' ' LEU . 13.5 t -121.23 117.86 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.801 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.646 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 29.5 tp -110.64 107.32 16.86 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 113.044 -1.889 . . . . 0.0 109.573 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.4 mmt -82.27 119.23 23.84 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 113.862 -1.517 . . . . 0.0 112.825 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 2.2 t -94.13 96.29 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 t -105.24 138.52 41.31 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 112.162 -2.29 . . . . 0.0 116.084 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.79 -22.11 66.03 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 113.565 -1.652 . . . . 0.0 113.167 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -142.09 135.4 29.07 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 1.006 ' HB2' HG21 ' A' ' 108' ' ' VAL . . . -97.99 60.29 1.46 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 113.344 -1.753 . . . . 0.0 109.492 176.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -112.28 148.17 34.75 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.652 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -37.17 -45.13 0.61 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 116.32 1.971 . . . . 0.0 116.32 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.12 -60.53 3.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.961 0.904 . . . . 0.0 110.738 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -59.39 -46.75 87.81 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.788 1.235 . . . . 0.0 112.594 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 73.3 mt -57.31 -57.2 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 124.207 0.942 . . . . 0.0 111.598 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.7 mt -60.06 -50.48 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.175 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.96 -49.69 68.17 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.771 0.669 . . . . 0.0 112.228 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.479 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -60.78 -54.94 39.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.348 1.059 . . . . 0.0 111.633 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.42 -48.59 76.65 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.077 0.951 . . . . 0.0 112.408 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -61.18 -31.35 71.1 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.55 1.87 55.37 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.499 ' HA3' ' HG3' ' A' ' 73' ' ' ARG . . . 110.18 -0.28 29.82 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 116.892 1.517 . . . . 0.0 116.892 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.452 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -70.55 109.55 4.91 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.2 1.0 . . . . 0.0 111.856 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.2 p -63.64 -21.48 66.39 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.54 -1.664 . . . . 0.0 114.246 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -170.45 171.07 43.47 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.897 1.237 . . . . 0.0 112.357 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.494 ' O ' ' HE2' ' A' ' 119' ' ' LYS . 31.2 p90 -146.45 127.29 14.42 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.643 -0.778 . . . . 0.0 113.024 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 1.5 p -111.2 119.54 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.006 HG21 ' HB2' ' A' ' 90' ' ' ALA . 63.2 t -82.05 125.36 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 113.607 -1.633 . . . . 0.0 112.88 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -87.09 133.95 37.86 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 112.77 -2.014 . . . . 0.0 110.214 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.27 126.71 13.77 Favored 'Cis proline' 0 C--N 1.351 0.663 0 CA-C-O 123.192 1.247 . . . . 0.0 115.223 0.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.464 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 21.6 p90 -115.83 147.81 40.61 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 112.424 -2.171 . . . . 0.0 108.269 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 48.7 p -104.07 171.93 7.08 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.764 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.496 ' HB2' HD22 ' A' ' 24' ' ' LEU . . . -54.85 -37.52 66.32 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.99 176.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.06 -50.33 64.52 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.196 0.998 . . . . 0.0 110.741 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.8 m -58.81 -44.74 90.9 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.701 0.801 . . . . 0.0 110.211 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 36.6 tp -58.18 -55.83 29.95 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.147 1.379 . . . . 0.0 109.844 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.543 ' HB2' HD22 ' A' ' 28' ' ' LEU . 23.5 tt0 -59.3 -41.65 89.52 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.76 0.424 . . . . 0.0 111.72 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -52.52 -46.89 66.88 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.694 0.797 . . . . 0.0 110.868 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 106' ' ' TYR . 31.3 mmmt -70.4 -42.58 71.5 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.032 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.1 mt -56.76 -46.65 81.31 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -53.2 -49.54 66.54 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.806 1.242 . . . . 0.0 111.681 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 119' ' ' LYS . 59.0 tttm -52.51 -47.86 66.38 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.75 1.62 . . . . 0.0 111.275 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.585 HG13 ' HZ ' ' A' ' 53' ' ' PHE . 14.1 mm -60.32 -48.04 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.207 1.003 . . . . 0.0 110.528 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -179.284 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.3 mttt . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -74.87 5.54 4.96 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.822 1.249 . . . . 0.0 114.342 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.31 126.91 30.24 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.256 1.423 . . . . 0.0 113.032 -177.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -84.25 108.73 17.28 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 112.983 -1.917 . . . . 0.0 112.282 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -99.73 127.87 45.85 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.757 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.544 HD13 HG22 ' A' ' 11' ' ' VAL . 1.4 tm? -107.65 95.84 5.97 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.71 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 45.6 t -79.43 104.71 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 111.148 -2.751 . . . . 0.0 108.931 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.544 HG22 HD13 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -104.44 72.56 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 123.553 1.644 . . . . 0.0 107.921 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -129.11 80.23 1.96 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 112.885 -1.961 . . . . 0.0 110.7 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -13.01 -30.61 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 1 N-CA-C 124.421 4.971 . . . . 0.0 124.421 -178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -101.12 124.01 46.17 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.418 ' HA ' HH11 ' A' ' 18' ' ' ARG . 11.9 m -41.95 -43.54 3.15 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 114.68 -1.145 . . . . 0.0 113.392 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.525 ' O ' HG12 ' A' ' 20' ' ' ILE . 2.1 m -58.21 -55.95 28.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.932 1.293 . . . . 0.0 110.835 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.449 ' O ' HG23 ' A' ' 21' ' ' VAL . 1.1 tmm? -59.88 -42.61 94.15 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.487 ' HB3' ' OE1' ' A' ' 35' ' ' GLU . 12.9 mtp180 -55.72 -47.81 76.23 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.766 0.666 . . . . 0.0 111.229 176.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 15.0 ttp180 -67.14 -39.92 86.67 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.078 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 16' ' ' THR . 37.2 mm -56.55 -47.76 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 123.307 0.38 . . . . 0.0 110.086 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 17' ' ' MET . 18.7 t -60.59 -42.06 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.617 ' HG3' HG11 ' A' ' 33' ' ' VAL . 24.5 ttt85 -53.31 -52.54 58.81 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.582 0.753 . . . . 0.0 110.155 176.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -53.51 -44.46 69.13 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.325 1.05 . . . . 0.0 112.279 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.0 -51.13 69.3 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.963 1.305 . . . . 0.0 112.048 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.0 mt -56.15 -44.31 79.15 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.041 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -57.78 -47.64 81.95 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.927 176.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.19 -39.15 78.18 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.109 1.364 . . . . 0.0 111.733 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.8 mt -73.21 -26.9 61.33 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.86 21.18 7.95 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.567 1.08 . . . . 0.0 114.399 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -92.97 116.44 29.05 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 122.456 1.122 . . . . 0.0 112.645 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.52 -48.27 67.52 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 111.411 -2.631 . . . . 0.0 116.15 -177.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -111.57 122.36 47.62 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 -174.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG11 ' HG3' ' A' ' 22' ' ' ARG . 7.9 p -138.31 112.92 8.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 111.154 -2.748 . . . . 0.0 110.781 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.632 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 31.9 mt-10 -109.44 140.75 42.79 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.71 ' HG2' ' HB ' ' A' ' 10' ' ' VAL . 45.0 mt-10 -123.36 131.64 53.72 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 -174.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.407 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -117.09 157.03 26.56 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 111.493 -2.594 . . . . 0.0 110.271 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -92.23 -55.46 3.42 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -130.34 173.05 11.19 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.703 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -40.57 -54.64 3.35 Favored Glycine 0 CA--C 1.536 1.346 0 O-C-N 124.977 1.423 . . . . 0.0 115.44 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.8 t -57.25 -56.78 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.984 0.914 . . . . 0.0 112.076 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -56.82 -36.72 70.29 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.421 0.688 . . . . 0.0 111.579 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.536 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -64.14 -51.05 65.77 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.126 0.97 . . . . 0.0 111.028 177.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.2 mt -54.13 -49.27 69.59 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.501 0.72 . . . . 0.0 110.711 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -52.16 -55.45 20.9 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.301 1.041 . . . . 0.0 111.661 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.489 ' HD3' HD21 ' A' ' 9' ' ' LEU . 41.3 mttm -58.23 -52.78 64.13 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.537 177.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.7 mt -56.34 -39.22 72.48 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.984 1.314 . . . . 0.0 114.092 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -58.79 -23.93 61.06 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.46 -19.25 62.24 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.09 -165.5 29.2 Favored Glycine 0 N--CA 1.481 1.645 0 C-N-CA 124.884 1.23 . . . . 0.0 112.097 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.33 -34.95 1.53 Allowed Glycine 0 CA--C 1.544 1.865 0 N-CA-C 116.0 1.16 . . . . 0.0 116.0 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.632 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 80.9 m-85 -66.5 118.38 10.05 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.08 7.36 56.94 Favored Glycine 0 N--CA 1.476 1.316 0 CA-C-N 112.654 -2.067 . . . . 0.0 111.803 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.511 ' HA ' ' HG2' ' A' ' 82' ' ' PRO . 2.4 t80 -163.97 138.18 5.69 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.7 t -122.16 110.94 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.581 HG23 ' HA ' ' A' ' 10' ' ' VAL . 12.5 tt -114.93 97.84 6.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.5 t -118.67 136.01 54.15 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 60' ' ' MET . 53.6 t0 -71.72 132.67 44.86 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 113.2 -1.818 . . . . 0.0 110.745 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.441 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 17.6 t-105 -56.39 -46.5 80.09 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.306 177.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -93.29 105.42 17.5 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.883 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.41 ' HE2' ' HA2' ' A' ' 65' ' ' GLY . 29.5 mtm -140.25 134.39 15.5 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.627 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -58.43 142.25 97.72 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 C-N-CA 123.717 2.945 . . . . 0.0 111.054 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.7 m120 63.75 -67.32 0.1 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.857 1.663 . . . . 0.0 114.304 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.401 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 57.4 ttm -115.73 97.74 6.3 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 4.0 p30 -60.94 165.74 3.91 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 112.122 -2.308 . . . . 0.0 112.541 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.41 ' HA2' ' HE2' ' A' ' 60' ' ' MET . . . -49.33 -55.92 11.86 Favored Glycine 0 N--CA 1.484 1.886 0 C-N-CA 124.711 1.148 . . . . 0.0 114.432 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.455 HD12 HD23 ' A' ' 69' ' ' LEU . 41.1 tp -57.26 -43.23 82.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.141 0.576 . . . . 0.0 112.47 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.54 -41.74 92.72 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.875 0.87 . . . . 0.0 111.365 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.53 -46.46 83.81 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.328 1.051 . . . . 0.0 110.225 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.455 HD23 HD12 ' A' ' 66' ' ' LEU . 18.4 tp -55.07 -47.81 74.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.386 1.475 . . . . 0.0 110.737 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -60.0 -47.47 85.71 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.218 0.607 . . . . 0.0 112.125 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.267 16.4 p -57.19 -29.21 63.49 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.019 0.928 . . . . 0.0 112.634 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mt -81.55 -58.01 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.157 0.983 . . . . 0.0 108.891 177.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 81.8 mmt-85 -48.08 -47.78 33.86 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.467 1.907 . . . . 0.0 112.855 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.98 61.66 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -84.33 96.43 9.03 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -17.96 -69.46 0.01 OUTLIER Glycine 0 N--CA 1.488 2.114 0 C-N-CA 126.27 1.891 . . . . 0.0 116.56 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.57 95.33 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 98.7 mtp -75.51 -22.43 57.15 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.1 t -38.03 -36.07 0.19 Allowed 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 117.405 2.372 . . . . 0.0 117.405 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.39 -1.86 51.23 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 117.23 2.308 . . . . 0.0 117.23 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.4 mt -69.42 110.28 6.04 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.511 ' HG2' ' HA ' ' A' ' 53' ' ' PHE . 39.5 Cg_endo -54.99 124.33 16.01 Favored 'Trans proline' 0 N--CA 1.483 0.888 0 C-N-CA 123.435 2.757 . . . . 0.0 113.437 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.9 t -112.68 119.27 59.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 114.078 -1.419 . . . . 0.0 114.521 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 66.6 tp -109.09 101.18 10.26 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 111.919 -2.4 . . . . 0.0 107.859 176.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.4 mmt -76.02 104.51 6.59 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.42 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 t -83.94 98.57 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.3 p -90.6 132.13 35.91 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 112.958 -1.928 . . . . 0.0 112.387 -176.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.11 -46.14 89.09 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.959 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -147.11 115.18 6.55 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.97 98.52 5.71 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.657 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -114.64 142.21 46.76 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.114 -1.857 . . . . 0.0 108.69 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' A' ' 93' ' ' GLU 0.264 0.0 OUTLIER -38.36 -45.17 0.98 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 179.677 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.403 ' H ' ' HD2' ' A' ' 92' ' ' LYS . 0.8 OUTLIER -55.59 -53.21 59.3 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.631 0.772 . . . . 0.0 112.959 178.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.01 -37.66 84.57 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.598 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.97 -51.27 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.775 0.83 . . . . 0.0 110.4 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.0 mt -57.84 -51.65 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.38 0.672 . . . . 0.0 109.244 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.02 -44.6 74.74 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.04 0.936 . . . . 0.0 113.369 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.441 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -58.48 -47.77 82.96 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.155 0.982 . . . . 0.0 112.31 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.79 -44.75 96.26 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.886 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -59.06 -31.58 68.99 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.16 -5.8 49.32 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.13 4.4 27.43 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 118.317 2.087 . . . . 0.0 118.317 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.7 121.03 8.84 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.402 ' HB3' HG23 ' A' ' 123' ' ' ILE . 13.6 m -66.87 -30.67 70.9 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 113.271 -1.786 . . . . 0.0 113.404 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.78 167.42 38.81 Favored Glycine 0 N--CA 1.479 1.556 0 C-N-CA 124.458 1.028 . . . . 0.0 110.819 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -141.92 137.63 31.43 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.31 126.55 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 124.617 1.198 . . . . 0.0 111.66 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.2 p -88.99 135.62 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.706 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.2 pttt -92.75 142.36 25.54 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-O 117.709 -1.138 . . . . 0.0 112.392 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.08 129.81 18.55 Favored 'Cis proline' 0 N--CA 1.481 0.769 0 N-CA-C 116.568 1.718 . . . . 0.0 116.568 0.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -120.38 139.29 53.01 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 112.814 -1.994 . . . . 0.0 107.966 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.5 p -97.82 174.94 6.35 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.876 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.88 -36.39 67.58 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.38 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.02 -47.29 71.89 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.185 0.994 . . . . 0.0 111.44 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 m -59.59 -45.96 90.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.285 0.634 . . . . 0.0 109.623 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 42.4 tp -56.89 -51.64 68.28 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.602 1.161 . . . . 0.0 110.277 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.55 ' HA ' HD12 ' A' ' 120' ' ' LEU . 15.2 tm-20 -54.3 -46.85 72.87 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.646 1.178 . . . . 0.0 111.91 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -58.96 -43.76 91.36 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.099 0.874 . . . . 0.0 112.655 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -65.61 -42.26 91.82 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.853 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 117' ' ' GLU . 89.2 mt -53.69 -47.69 70.22 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.337 1.023 . . . . 0.0 111.33 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -52.59 -54.98 25.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.592 1.557 . . . . 0.0 111.867 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -52.45 -49.88 63.74 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 113.859 -1.519 . . . . 0.0 112.51 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.463 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 58.7 mt -60.14 -45.54 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.852 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.5 m-30 . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 179.035 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.31 62.5 6.04 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 123.127 1.441 . . . . 0.0 111.4 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 tt -106.34 123.64 48.36 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 113.24 -1.8 . . . . 0.0 111.068 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -76.34 103.27 6.27 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.895 1.372 . . . . 0.0 113.976 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -98.47 130.47 45.08 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 112.621 -2.081 . . . . 0.0 112.014 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.535 HD12 ' HG ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -108.64 102.54 11.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 122.748 1.261 . . . . 0.0 108.695 174.42 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.3 t -88.13 107.16 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.501 HG12 ' SD ' ' A' ' 60' ' ' MET . 4.3 t -105.45 101.99 13.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 111.391 -2.641 . . . . 0.0 108.339 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -138.85 133.57 32.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.968 -1.469 . . . . 0.0 112.33 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -63.52 -23.18 67.28 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 113.965 -1.47 . . . . 0.0 112.396 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.49 102.06 11.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.789 177.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.9 p -49.06 -34.09 12.9 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.767 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.65 -41.57 95.22 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.131 1.772 . . . . 0.0 110.726 176.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.422 ' O ' HG23 ' A' ' 21' ' ' VAL . 10.3 tpt -66.67 -42.21 86.94 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.3 0.64 . . . . 0.0 110.536 177.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.667 ' HG3' ' HG3' ' A' ' 35' ' ' GLU . 1.8 tmm_? -56.51 -42.79 78.97 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 124.285 0.991 . . . . 0.0 109.735 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.714 ' HD3' HH22 ' A' ' 22' ' ' ARG . 1.8 tpp180 -56.02 -48.6 75.64 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.147 1.379 . . . . 0.0 110.576 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.3 mm -58.47 -55.85 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.046 0.939 . . . . 0.0 110.382 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 17' ' ' MET . 4.5 t -53.04 -44.79 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.817 0.847 . . . . 0.0 111.566 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.714 HH22 ' HD3' ' A' ' 19' ' ' ARG . 26.0 ttm180 -52.62 -54.12 37.52 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.054 0.942 . . . . 0.0 111.452 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -60.19 -39.75 87.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.99 0.916 . . . . 0.0 113.299 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.91 -53.13 61.49 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.48 1.112 . . . . 0.0 110.745 177.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.2 mt -57.48 -44.51 84.94 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.835 0.854 . . . . 0.0 112.112 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -53.37 -48.7 68.36 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.486 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -57.45 -38.88 75.15 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.035 1.334 . . . . 0.0 111.985 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.2 mt -74.83 -15.13 60.74 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.37 6.49 29.25 Favored Glycine 0 CA--C 1.545 1.947 0 C-N-CA 125.104 1.335 . . . . 0.0 114.78 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -98.44 91.88 5.4 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 122.758 1.265 . . . . 0.0 112.666 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -79.35 -10.22 59.76 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 119.604 3.187 . . . . 0.0 119.604 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -107.4 99.23 8.77 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 119.404 1.002 . . . . 0.0 112.511 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -130.12 125.04 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.066 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -111.84 163.75 13.84 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.596 0.758 . . . . 0.0 109.851 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.667 ' HG3' ' HG3' ' A' ' 18' ' ' ARG . 44.1 tt0 -120.67 131.05 54.38 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 -176.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.452 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -137.03 149.49 47.49 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 112.104 -2.316 . . . . 0.0 108.095 173.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -101.45 -41.65 6.56 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -130.85 159.84 36.19 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.629 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -39.51 -51.71 3.03 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.984 1.754 . . . . 0.0 115.03 177.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.45 -56.19 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 114.852 -0.674 . . . . 0.0 111.23 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.8 -37.58 68.81 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.933 0.893 . . . . 0.0 111.458 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.436 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -60.18 -49.52 77.32 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 117.462 -1.256 . . . . 0.0 111.42 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.7 mt -58.5 -44.77 89.56 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.104 0.562 . . . . 0.0 111.385 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -54.8 -53.02 60.68 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.971 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -59.9 -50.92 71.87 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.681 1.593 . . . . 0.0 111.88 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.535 ' HG ' HD12 ' A' ' 9' ' ' LEU . 16.4 mt -54.81 -49.28 71.39 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.451 1.9 . . . . 0.0 114.73 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.91 -17.63 10.27 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.64 -19.65 65.81 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.224 0.61 . . . . 0.0 112.499 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.3 -177.88 38.19 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.924 1.249 . . . . 0.0 114.146 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.56 -24.57 2.62 Favored Glycine 0 CA--C 1.541 1.703 0 N-CA-C 116.432 1.333 . . . . 0.0 116.432 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -69.0 113.22 6.19 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.27 5.65 61.07 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 112.725 -2.034 . . . . 0.0 112.01 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -164.24 143.86 7.73 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.469 HG22 HD21 ' A' ' 46' ' ' LEU . 21.3 t -127.88 120.0 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.086 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 84' ' ' LEU . 71.2 mt -113.07 102.59 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.7 t -119.23 131.78 55.85 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 118.016 2.598 . . . . 0.0 118.016 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -71.98 124.84 25.78 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 112.066 -2.334 . . . . 0.0 109.808 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.498 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 18.3 t-105 -55.4 -39.34 70.06 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.232 178.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -91.41 94.05 9.31 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.797 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.501 ' SD ' HG12 ' A' ' 11' ' ' VAL . 29.6 mtm -139.58 122.52 10.43 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-N 112.83 -1.986 . . . . 0.0 109.589 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -60.82 127.62 23.06 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.893 3.062 . . . . 0.0 113.335 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 m120 81.32 -65.8 0.13 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.02 1.728 . . . . 0.0 113.283 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.2 ttm -115.57 87.72 2.73 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.625 0.726 . . . . 0.0 109.363 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.5 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.1 p30 -61.43 168.87 2.52 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 111.863 -2.426 . . . . 0.0 112.224 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 58' ' ' TRP . . . -47.29 -53.43 11.69 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 124.932 1.253 . . . . 0.0 114.223 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.42 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 62.3 tp -57.38 -44.59 84.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.883 0.873 . . . . 0.0 111.997 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.522 ' HA ' ' HD3' ' A' ' 70' ' ' LYS . 32.5 mm-40 -66.23 -40.72 90.48 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.2 tp -61.57 -42.79 99.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.368 0.667 . . . . 0.0 111.27 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.605 HD12 ' HD3' ' A' ' 73' ' ' ARG . 5.4 tp -53.25 -45.21 68.67 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.831 1.252 . . . . 0.0 110.868 177.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.522 ' HD3' ' HA ' ' A' ' 67' ' ' GLU . 13.8 mtpp -64.76 -44.86 88.68 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.488 1.115 . . . . 0.0 111.209 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.2 p -61.0 -25.12 66.66 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.773 1.229 . . . . 0.0 113.219 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.9 mt -84.04 -59.64 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.613 1.165 . . . . 0.0 108.072 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.605 ' HD3' HD12 ' A' ' 69' ' ' LEU . 2.9 mpt_? -49.05 -43.39 40.7 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.253 1.821 . . . . 0.0 113.447 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.46 -14.64 52.05 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.83 91.98 7.17 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -7.52 -79.53 0.01 OUTLIER Glycine 0 N--CA 1.488 2.141 0 C-N-CA 126.936 2.208 . . . . 0.0 117.161 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.57 -45.62 88.63 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.8 mtp -80.16 -11.45 59.75 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 117.36 2.355 . . . . 0.0 117.36 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.3 t -30.47 -61.37 0.17 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 118.761 2.874 . . . . 0.0 118.761 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.22 12.82 2.65 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 119.9 3.296 . . . . 0.0 119.9 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.1 mt -76.62 106.37 3.29 Favored Pre-proline 0 N--CA 1.479 0.989 0 O-C-N 121.251 -0.906 . . . . 0.0 112.117 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -40.13 133.86 1.95 Allowed 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 124.567 3.511 . . . . 0.0 117.149 -175.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.4 t -119.28 117.96 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 111.068 -2.787 . . . . 0.0 112.817 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.402 ' HB3' HG12 ' A' ' 55' ' ' ILE . 47.8 tp -108.98 105.64 15.25 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 113.34 -1.754 . . . . 0.0 107.706 177.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.7 mmt -80.53 114.84 19.7 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 113.597 -1.638 . . . . 0.0 111.686 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.54 HG12 ' HG3' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -98.91 110.57 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 179.497 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.6 p -111.53 153.89 25.58 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 117.846 2.536 . . . . 0.0 117.846 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.12 -31.8 73.18 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 112.018 -2.356 . . . . 0.0 113.641 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.03 124.56 3.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.535 1.134 . . . . 0.0 108.518 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.42 90.39 6.71 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 122.529 1.157 . . . . 0.0 110.403 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -121.48 133.28 55.04 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.721 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -25.5 -61.63 0.07 Allowed 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 117.692 2.478 . . . . 0.0 117.692 -177.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -53.58 -46.75 70.42 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -70.27 -34.44 72.79 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.3 mt -60.03 -53.33 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.47 0.708 . . . . 0.0 109.906 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.434 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 33.8 mt -58.56 -46.85 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.707 0.803 . . . . 0.0 109.783 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.08 -47.99 64.9 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.86 0.864 . . . . 0.0 112.294 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.498 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -63.05 -47.38 83.25 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.574 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.79 84.13 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.353 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 96' ' ' ILE . 24.6 mm100 -60.19 -36.82 78.49 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.035 0.934 . . . . 0.0 112.73 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.71 -5.07 52.17 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.561 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 113.86 -5.23 24.15 Favored Glycine 0 CA--C 1.542 1.761 0 N-CA-C 117.367 1.707 . . . . 0.0 117.367 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.51 115.46 2.53 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.417 1.608 . . . . 0.0 115.314 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.2 p -67.95 -18.65 64.81 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 113.568 -1.651 . . . . 0.0 114.217 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.416 ' HA3' HD11 ' A' ' 123' ' ' ILE . . . -165.87 162.05 35.56 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.505 1.05 . . . . 0.0 112.304 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -146.14 126.18 13.71 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.665 0.786 . . . . 0.0 111.117 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 1.4 p -131.27 136.43 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 124.849 1.343 . . . . 0.0 110.864 176.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -93.22 145.37 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.499 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.54 ' HG3' HG12 ' A' ' 86' ' ' VAL . 10.1 mtmp? -89.3 128.91 49.55 Favored Pre-proline 0 N--CA 1.476 0.825 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.68 155.66 80.58 Favored 'Cis proline' 0 CA--C 1.54 0.778 0 O-C-N 123.055 1.029 . . . . 0.0 114.371 0.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -146.53 155.72 42.73 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.067 1.747 . . . . 0.0 107.967 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.5 t -117.13 177.18 4.81 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.919 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.48 -41.86 61.22 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.823 0.849 . . . . 0.0 111.563 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.81 -53.02 60.69 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.184 0.994 . . . . 0.0 111.986 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.73 -46.76 84.0 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.757 0.823 . . . . 0.0 110.62 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.65 -52.56 63.41 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.069 1.348 . . . . 0.0 108.551 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -56.11 -46.94 78.93 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.859 1.264 . . . . 0.0 111.981 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.19 -45.86 65.33 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -68.39 -45.17 73.42 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.85 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.3 mt -55.97 -50.84 69.71 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.2 1.0 . . . . 0.0 112.169 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -51.61 -50.17 60.75 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.604 1.561 . . . . 0.0 111.995 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -54.89 -47.7 73.96 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.721 1.208 . . . . 0.0 110.997 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.416 HD11 ' HA3' ' A' ' 105' ' ' GLY . 96.4 mt -62.78 -44.42 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.849 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.322 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 62.1 mttm . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 121.126 0.488 . . . . 0.0 112.235 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -84.64 60.76 6.3 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 122.388 1.09 . . . . 0.0 109.488 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 tt -108.94 133.04 53.48 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.341 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -79.84 106.75 12.1 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 125.079 1.487 . . . . 0.0 113.588 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -104.09 139.31 39.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 112.672 -2.058 . . . . 0.0 112.704 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -115.92 107.79 15.45 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.572 174.055 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.51 99.04 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 112.585 -2.098 . . . . 0.0 107.53 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.432 HG12 ' SD ' ' A' ' 60' ' ' MET . 3.5 t -101.75 91.0 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.375 -178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.44 ' OD1' ' HB2' ' A' ' 57' ' ' ASP . 12.0 m-20 -136.48 114.11 11.06 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 113.809 -1.541 . . . . 0.0 113.137 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -52.82 -28.1 21.18 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.628 ' HB3' ' HB2' ' A' ' 17' ' ' MET . 5.4 t80 -94.29 113.48 25.39 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.5 p -45.76 -46.69 15.33 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.709 1.204 . . . . 0.0 113.644 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -47.97 83.68 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.78 177.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.628 ' HB2' ' HB3' ' A' ' 14' ' ' PHE . 2.1 mmm -61.68 -39.92 93.13 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -55.76 -53.86 51.43 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 124.38 1.05 . . . . 0.0 110.421 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.12 -40.14 92.66 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.852 177.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 74.9 mt -56.03 -56.52 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.958 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.487 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 3.3 t -57.76 -45.09 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.041 0.537 . . . . 0.0 111.447 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -51.74 -56.66 12.48 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.151 0.98 . . . . 0.0 111.534 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -59.81 -41.98 92.45 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.576 0.75 . . . . 0.0 112.793 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 71.8 mt -56.96 -53.64 55.72 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.76 0.824 . . . . 0.0 111.405 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.5 mt -54.4 -47.6 72.55 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.143 0.977 . . . . 0.0 112.029 177.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 31' ' ' ASN . 97.7 mttt -57.83 -44.25 86.34 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.871 177.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 28.4 mt-10 -58.71 -38.29 77.97 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.482 1.513 . . . . 0.0 112.174 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.0 mt -75.73 -16.98 60.07 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 124.705 1.253 . . . . 0.0 113.426 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.77 -6.84 20.04 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.738 1.161 . . . . 0.0 114.263 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 68.0 m-85 -90.95 80.82 5.72 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 123.277 1.513 . . . . 0.0 110.46 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.47 ' HA ' ' HG2' ' A' ' 26' ' ' LYS . 9.2 p30 -76.62 -17.26 59.28 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 -177.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -94.47 88.57 5.53 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 122.386 1.088 . . . . 0.0 109.954 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.91 129.04 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 113.991 -1.458 . . . . 0.0 112.213 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.485 ' OE1' ' HB3' ' A' ' 45' ' ' LYS . 29.7 tt0 -109.93 153.92 23.83 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 175.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -125.62 120.77 31.68 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.35 162.33 19.65 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.37 -1.741 . . . . 0.0 109.848 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.42 -43.27 5.01 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -132.51 170.06 15.68 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.21 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.485 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -47.32 -53.15 12.24 Favored Glycine 0 CA--C 1.541 1.707 0 O-C-N 124.675 1.234 . . . . 0.0 114.944 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.8 t -56.3 -54.52 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.542 0.337 . . . . 0.0 111.524 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -56.61 -36.27 69.24 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.559 0.744 . . . . 0.0 111.621 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.32 -49.9 62.29 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.496 1.118 . . . . 0.0 112.507 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.4 mt -53.8 -43.12 69.07 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.339 0.656 . . . . 0.0 111.665 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.14 -59.36 5.42 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 125.059 1.474 . . . . 0.0 110.304 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.485 ' HB3' ' OE1' ' A' ' 34' ' ' GLU . 62.1 mttm -57.79 -40.57 80.17 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.624 HD21 HG22 ' A' ' 54' ' ' VAL . 19.1 mt -56.29 -48.55 76.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.535 0.734 . . . . 0.0 112.026 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -71.6 -5.71 35.44 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.9 -7.71 42.58 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.71 147.71 13.59 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 116.813 1.485 . . . . 0.0 116.813 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.96 -12.46 3.01 Favored Glycine 0 CA--C 1.542 1.778 0 N-CA-C 121.934 3.534 . . . . 0.0 121.934 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -66.0 105.2 1.28 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 121.035 2.418 . . . . 0.0 115.79 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.685 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -101.11 20.24 48.31 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 112.44 -2.163 . . . . 0.0 112.372 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.409 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -171.05 137.03 1.13 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.861 0.865 . . . . 0.0 112.401 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.624 HG22 HD21 ' A' ' 46' ' ' LEU . 22.0 t -124.59 119.54 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.684 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.424 HG21 HG11 ' A' ' 21' ' ' VAL . 87.2 mt -111.69 102.71 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 104.192 -2.521 . . . . 0.0 104.192 176.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 t -121.29 132.39 54.77 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 -176.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.44 ' HB2' ' OD1' ' A' ' 12' ' ' ASP . 13.6 t0 -68.15 131.89 46.22 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 111.815 -2.448 . . . . 0.0 109.536 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 -56.22 -50.99 69.71 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -91.81 89.74 7.19 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 122.527 1.156 . . . . 0.0 113.778 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.539 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 25.2 mtm -124.44 136.01 27.23 Favored Pre-proline 0 N--CA 1.484 1.239 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.373 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -54.16 148.62 39.51 Favored 'Trans proline' 0 N--CA 1.48 0.7 0 C-N-CA 124.172 3.248 . . . . 0.0 110.771 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.313 11.5 p30 60.06 -67.6 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 126.547 1.939 . . . . 0.0 114.534 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.485 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 52.0 ttm -122.16 102.09 7.93 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.229 1.012 . . . . 0.0 108.61 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 8.7 m-20 -66.17 167.35 10.27 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 113.01 -1.905 . . . . 0.0 112.428 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.01 -53.44 18.49 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 124.453 1.025 . . . . 0.0 112.875 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.429 HD12 HD23 ' A' ' 69' ' ' LEU . 60.0 tp -57.93 -38.98 76.91 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.4 ' OE1' ' HB2' ' A' ' 64' ' ' ASP . 12.1 mp0 -72.06 -37.96 69.54 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.768 0.427 . . . . 0.0 111.686 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.8 tp -60.56 -42.52 96.76 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.788 0.835 . . . . 0.0 110.345 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.429 HD23 HD12 ' A' ' 66' ' ' LEU . 10.1 tp -55.06 -46.58 75.38 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.726 1.21 . . . . 0.0 109.909 176.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -60.63 -45.48 93.9 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.915 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.271 38.8 p -60.9 -35.18 75.99 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 124.238 1.015 . . . . 0.0 111.8 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.479 HG23 ' HB3' ' A' ' 78' ' ' MET . 41.2 mt -72.53 -56.73 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.647 1.179 . . . . 0.0 108.664 177.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 73' ' ' ARG . 76.5 mmt-85 -53.39 -42.65 67.15 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.89 1.676 . . . . 0.0 114.048 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.25 -30.08 69.88 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -88.18 100.01 12.64 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.113 0.565 . . . . 0.0 111.309 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -11.37 -74.18 0.01 OUTLIER Glycine 0 N--CA 1.489 2.175 0 C-N-CA 127.662 2.554 . . . . 0.0 118.266 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.51 84.37 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.479 ' HB3' HG23 ' A' ' 72' ' ' ILE . 96.1 mtp -72.31 -24.06 61.26 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.089 1.356 . . . . 0.0 113.847 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.3 m -51.57 -28.48 14.06 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.321 1.449 . . . . 0.0 114.438 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.85 -11.09 42.99 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.685 HD22 ' HA2' ' A' ' 52' ' ' GLY . 83.2 mt -77.49 114.72 43.26 Favored Pre-proline 0 N--CA 1.475 0.807 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 11.3 Cg_endo -49.41 132.7 29.96 Favored 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 124.189 3.259 . . . . 0.0 115.695 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.4 t -120.74 120.53 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 112.739 -2.028 . . . . 0.0 111.955 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.409 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 47.8 tp -112.18 107.05 15.81 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 113.313 -1.767 . . . . 0.0 109.323 178.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 30.9 mmt -81.24 121.97 26.82 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 113.744 -1.571 . . . . 0.0 112.353 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.76 101.52 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.05 145.83 37.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 111.772 -2.467 . . . . 0.0 113.567 -176.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.74 -38.2 72.07 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -156.53 147.28 21.79 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.674 0.789 . . . . 0.0 110.389 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.36 86.78 6.22 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -123.42 134.19 53.98 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 112.667 -2.06 . . . . 0.0 110.351 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -27.19 -60.6 0.09 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.235 1.814 . . . . 0.0 115.481 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -53.58 -52.44 59.77 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -66.69 -38.92 87.75 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.2 mt -59.05 -55.03 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.279 1.032 . . . . 0.0 110.002 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.3 mt -54.84 -54.57 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.301 1.04 . . . . 0.0 109.602 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.18 -49.43 63.87 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.192 0.997 . . . . 0.0 113.308 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.11 -51.02 68.22 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.058 0.943 . . . . 0.0 113.503 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.3 -51.06 71.38 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.047 0.939 . . . . 0.0 112.895 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -64.39 -25.66 68.12 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.44 -5.91 59.04 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.23 2.32 26.39 Favored Glycine 0 CA--C 1.54 1.635 0 N-CA-C 117.408 1.723 . . . . 0.0 117.408 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.92 119.47 8.32 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.4 m -64.93 -30.58 71.59 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.412 -1.722 . . . . 0.0 112.933 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -174.2 170.79 43.95 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.687 1.137 . . . . 0.0 110.587 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.49 ' O ' ' HE2' ' A' ' 119' ' ' LYS . 50.5 p90 -143.21 129.05 19.43 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.462 -0.869 . . . . 0.0 112.458 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.39 124.66 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.743 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.14 123.38 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 112.1 -2.318 . . . . 0.0 111.199 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -90.95 134.79 29.6 Favored Pre-proline 0 N--CA 1.483 1.193 0 CA-C-N 113.65 -1.614 . . . . 0.0 111.284 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -75.45 141.59 71.71 Favored 'Cis proline' 0 CA--C 1.542 0.893 0 O-C-N 123.273 1.144 . . . . 0.0 112.988 0.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.487 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 37.9 p90 -126.69 147.27 49.96 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 113.12 -1.855 . . . . 0.0 109.515 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 52.5 p -97.46 171.03 8.64 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.753 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.22 67.87 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.296 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.99 -49.81 66.51 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.091 0.956 . . . . 0.0 111.533 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.6 m -58.09 -46.12 86.04 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.916 0.886 . . . . 0.0 109.324 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 48.2 tp -58.77 -55.47 34.65 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.438 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . 0.26 1.3 pp20? -59.15 -36.52 75.4 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -55.61 -49.55 72.5 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 123.952 0.783 . . . . 0.0 111.112 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.49 ' HE2' ' O ' ' A' ' 106' ' ' TYR . 32.8 mmmt -65.39 -45.41 84.14 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.901 178.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.0 mt -54.44 -46.91 73.35 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 124.093 0.87 . . . . 0.0 112.222 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -55.0 -52.94 61.58 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.486 1.114 . . . . 0.0 112.308 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -55.36 -42.75 74.31 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.244 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.12 -46.87 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.863 0.865 . . . . 0.0 110.633 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 177.462 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -89.29 60.33 5.24 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 123.426 1.584 . . . . 0.0 110.471 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.408 HD23 ' N ' ' A' ' 7' ' ' LYS . 3.9 tt -106.56 131.03 54.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.004 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.408 ' N ' HD23 ' A' ' 6' ' ' LEU . 14.8 mmtp -78.32 102.2 7.58 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 113.448 -1.706 . . . . 0.0 111.414 177.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -102.35 138.6 39.06 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 112.884 -1.962 . . . . 0.0 113.404 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.16 111.41 19.43 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.815 174.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.1 t -87.02 97.11 6.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 123.899 1.809 . . . . 0.0 107.466 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.552 HG12 ' SD ' ' A' ' 60' ' ' MET . 5.2 t -101.65 74.0 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 112.72 -2.037 . . . . 0.0 106.808 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 8.3 m-20 -127.25 87.06 2.58 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 112.915 -1.948 . . . . 0.0 113.396 -176.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -11.25 -55.85 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 121.62 3.933 . . . . 0.0 121.62 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.545 ' HB3' ' HB2' ' A' ' 17' ' ' MET . 6.2 t80 -81.72 133.5 35.36 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.75 0.656 . . . . 0.0 109.278 -177.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 p -46.33 -50.83 15.82 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.067 0.947 . . . . 0.0 112.908 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.562 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -60.13 -49.73 76.49 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.81 177.488 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.545 ' HB2' ' HB3' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -57.62 -45.34 85.51 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.959 0.904 . . . . 0.0 111.26 -179.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 12' ' ' ASP . 9.0 mtm180 -57.66 -52.74 64.2 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.114 0.966 . . . . 0.0 111.496 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.757 HH21 ' HD3' ' A' ' 22' ' ' ARG . 2.1 mmp_? -56.78 -43.49 80.91 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.435 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.562 HG12 ' O ' ' A' ' 16' ' ' THR . 34.5 mm -54.23 -61.44 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.257 0.623 . . . . 0.0 110.939 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.637 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 3.5 t -57.47 -45.16 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.261 0.624 . . . . 0.0 111.63 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.757 ' HD3' HH21 ' A' ' 19' ' ' ARG . 58.7 ttt180 -54.44 -53.54 52.75 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.9 0.88 . . . . 0.0 112.13 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.697 HD21 ' NH1' ' A' ' 19' ' ' ARG . 66.2 m-80 -63.55 -37.82 88.77 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.499 HD22 ' HB2' ' A' ' 113' ' ' ALA . 57.0 mt -56.95 -51.31 69.68 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.877 0.471 . . . . 0.0 111.874 176.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.416 HD11 HD12 ' A' ' 55' ' ' ILE . 49.1 mt -53.36 -47.04 69.75 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.564 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.493 ' HD2' ' HA ' ' A' ' 23' ' ' ASN . 87.8 mttt -56.85 -47.5 80.23 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.113 177.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 35.2 mt-10 -59.65 -38.87 82.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.49 1.516 . . . . 0.0 112.64 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.63 -16.14 62.27 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.698 1.599 . . . . 0.0 114.085 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.86 9.7 25.96 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 124.462 1.029 . . . . 0.0 114.759 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -92.11 98.16 11.37 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 123.874 1.797 . . . . 0.0 111.53 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -57.76 -42.62 84.41 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 110.39 -3.096 . . . . 0.0 119.236 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -111.55 106.68 15.61 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 t -133.53 126.63 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -110.85 158.0 19.19 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.433 ' OE1' ' HB3' ' A' ' 18' ' ' ARG . 14.9 pt-20 -130.13 119.52 23.15 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -114.67 149.38 36.83 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.921 1.288 . . . . 0.0 110.687 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -76.1 -60.83 2.16 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -133.62 -178.22 4.9 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 119.092 -0.48 . . . . 0.0 111.522 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -43.1 -55.7 4.84 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 125.564 1.554 . . . . 0.0 114.652 177.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.9 t -57.11 -56.69 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 114.335 -0.932 . . . . 0.0 111.947 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -57.26 -38.6 74.12 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.427 0.691 . . . . 0.0 111.631 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.34 -50.25 70.7 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.564 1.146 . . . . 0.0 112.414 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' A' ' 46' ' ' LEU . 78.9 mt -53.85 -40.71 66.71 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.64 0.776 . . . . 0.0 112.862 179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -67.55 -55.18 14.48 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 124.325 1.016 . . . . 0.0 110.927 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -57.78 -30.92 66.04 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.496 HD21 HG22 ' A' ' 54' ' ' VAL . 22.4 mt -55.67 -38.21 69.3 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -71.49 -9.25 57.9 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.65 34.84 0.12 Allowed 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 116.258 1.948 . . . . 0.0 116.258 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.1 115.54 2.63 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 117.939 1.936 . . . . 0.0 117.939 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 27.01 47.77 0.05 OUTLIER Glycine 0 CA--C 1.545 1.925 0 N-CA-C 122.249 3.66 . . . . 0.0 122.249 176.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.477 ' O ' HD22 ' A' ' 81' ' ' LEU . 97.7 m-85 -74.84 87.58 2.26 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 118.547 1.173 . . . . 0.0 113.069 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.6 29.91 5.16 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 113.357 -1.747 . . . . 0.0 111.617 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.408 ' HZ ' HD13 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -175.2 131.86 0.3 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.84 1.305 . . . . 0.0 112.927 178.136 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.496 HG22 HD21 ' A' ' 46' ' ' LEU . 10.7 t -126.99 119.83 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-N 112.436 -2.165 . . . . 0.0 108.88 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.613 HG21 HG11 ' A' ' 21' ' ' VAL . 96.2 mt -110.48 105.89 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.9 t -124.98 132.75 53.22 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 118.128 2.64 . . . . 0.0 118.128 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.555 ' O ' ' HG3' ' A' ' 60' ' ' MET . 20.3 t0 -73.63 133.08 43.39 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 111.71 -2.495 . . . . 0.0 109.512 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.495 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 15.5 t-105 -55.01 -49.28 71.92 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.221 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -90.86 82.09 5.69 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.555 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 39.4 mtm -116.77 137.99 24.21 Favored Pre-proline 0 N--CA 1.482 1.15 0 CA-C-N 114.222 -1.354 . . . . 0.0 112.101 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -57.72 139.5 90.47 Favored 'Trans proline' 0 N--CA 1.476 0.478 0 C-N-CA 124.034 3.156 . . . . 0.0 111.903 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 64.42 -73.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.306 1.842 . . . . 0.0 112.487 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.453 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 51.5 ttm -110.2 98.7 7.9 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 2.6 p30 -64.64 168.08 6.49 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 112.312 -2.222 . . . . 0.0 112.901 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.2 -52.74 21.83 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.028 1.299 . . . . 0.0 114.38 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.459 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 59.8 tp -59.01 -40.45 84.97 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -66.83 -43.43 83.74 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.555 0.342 . . . . 0.0 111.515 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.447 HD11 HG11 ' A' ' 54' ' ' VAL . 1.5 tm? -56.13 -47.49 78.06 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.018 0.927 . . . . 0.0 110.993 177.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 103' ' ' ALA . 4.5 tt -49.22 -55.64 11.89 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.982 1.713 . . . . 0.0 109.412 175.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -61.0 -44.49 97.34 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.909 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.259 29.7 p -59.21 -21.77 60.01 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 124.643 1.177 . . . . 0.0 113.186 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.8 mt -89.99 -58.42 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.573 ' HG2' ' HA3' ' A' ' 102' ' ' GLY . 2.7 mpt_? -47.77 -45.18 28.97 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.953 2.101 . . . . 0.0 114.217 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.73 -11.53 50.86 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -84.01 93.35 8.06 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.199 0.6 . . . . 0.0 110.274 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -12.73 -70.59 0.01 OUTLIER Glycine 0 N--CA 1.495 2.584 0 C-N-CA 126.351 1.929 . . . . 0.0 116.47 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.64 -49.43 75.19 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.43 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 90.4 mtp -75.84 -26.68 57.39 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 m -11.0 -61.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 120.585 3.55 . . . . 0.0 120.585 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.56 28.95 0.45 Allowed 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 120.64 3.57 . . . . 0.0 120.64 -174.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.477 HD22 ' O ' ' A' ' 51' ' ' TYR . 61.2 mt -89.75 106.79 15.36 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.877 -1.139 . . . . 0.0 110.074 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -47.56 133.06 20.96 Favored 'Trans proline' 0 N--CA 1.48 0.735 0 C-N-CA 123.432 2.755 . . . . 0.0 114.756 -177.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.468 HG11 ' HG ' ' A' ' 69' ' ' LEU . 39.3 t -118.19 128.31 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 112.891 -1.958 . . . . 0.0 114.202 -176.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.5 tp -116.48 108.71 16.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 113.199 -1.819 . . . . 0.0 109.562 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.0 mmt -83.19 114.55 21.43 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.595 1.188 . . . . 0.0 114.006 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.75 98.6 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.8 t -106.91 144.57 33.36 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 111.861 -2.427 . . . . 0.0 113.993 -175.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.58 -41.2 41.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 113.471 -1.695 . . . . 0.0 115.236 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -161.9 144.19 11.51 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.076 1.35 . . . . 0.0 109.948 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.22 86.87 3.66 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.364 1.078 . . . . 0.0 109.967 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -118.75 122.48 42.54 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.582 -1.644 . . . . 0.0 109.585 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -21.44 -59.34 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 117.414 2.376 . . . . 0.0 117.414 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -46.12 72.61 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -70.97 -38.31 72.78 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.02 -53.77 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.801 1.24 . . . . 0.0 109.012 176.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.0 mt -54.01 -54.95 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.377 1.071 . . . . 0.0 110.24 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.19 -50.5 64.54 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.267 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.495 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -61.24 -55.37 32.78 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.48 -51.51 69.15 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.877 0.871 . . . . 0.0 112.312 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -30.34 71.39 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.02 -13.84 60.22 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 177.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.573 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 121.75 -0.97 11.07 Favored Glycine 0 CA--C 1.545 1.96 0 N-CA-C 116.208 1.243 . . . . 0.0 116.208 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.666 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -59.63 123.99 18.65 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 119.051 1.426 . . . . 0.0 113.744 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.5 m -64.53 -30.51 71.54 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 113.07 -1.877 . . . . 0.0 112.88 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.72 172.84 45.82 Favored Glycine 0 CA--C 1.542 1.727 0 C-N-CA 124.818 1.199 . . . . 0.0 110.697 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -144.14 139.99 29.14 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.1 p -124.41 129.69 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 124.457 1.098 . . . . 0.0 110.459 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.36 127.45 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 113.217 -1.811 . . . . 0.0 111.24 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -92.94 132.39 31.12 Favored Pre-proline 0 N--CA 1.479 1.002 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.055 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -74.25 142.85 76.0 Favored 'Cis proline' 0 CA--C 1.548 1.189 0 O-C-N 123.017 1.009 . . . . 0.0 114.277 0.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.637 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 33.0 p90 -134.1 155.28 50.33 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 112.282 -2.236 . . . . 0.0 107.986 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 44.9 p -106.62 172.42 6.83 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.335 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.499 ' HB2' HD22 ' A' ' 24' ' ' LEU . . . -54.93 -38.96 68.33 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 123.612 0.57 . . . . 0.0 111.736 176.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.32 -46.78 75.7 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.356 1.062 . . . . 0.0 111.37 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.1 m -60.13 -47.02 87.68 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 52.8 tp -57.19 -52.11 66.64 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.525 1.13 . . . . 0.0 109.851 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -54.03 -48.21 70.75 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 124.12 0.888 . . . . 0.0 112.152 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -52.61 -47.42 66.99 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.58 -46.54 82.28 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.329 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 82.5 mt -56.96 -47.91 79.6 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 124.141 0.901 . . . . 0.0 111.212 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -53.74 -53.54 50.78 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.541 1.536 . . . . 0.0 111.669 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -52.11 -46.04 65.14 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.499 1.52 . . . . 0.0 111.566 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.408 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 63.7 mt -62.37 -51.78 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.341 1.056 . . . . 0.0 110.447 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 179.475 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . 0.263 63.3 mttp . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 118.089 2.625 . . . . 0.0 118.089 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -90.3 51.34 2.01 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.988 1.375 . . . . 0.0 111.861 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 1.9 tt -112.94 130.85 55.97 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.881 -177.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -86.49 111.21 20.35 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.899 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -105.86 145.32 31.38 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.021 1.728 . . . . 0.0 115.287 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.447 ' CD1' HG22 ' A' ' 11' ' ' VAL . 1.9 tm? -121.5 105.09 10.15 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 112.488 -2.142 . . . . 0.0 110.047 174.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.3 t -82.89 112.52 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 112.87 -1.968 . . . . 0.0 107.763 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.496 ' CG1' ' HB2' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -111.66 96.0 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.697 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -138.44 130.36 28.21 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.166 0.916 . . . . 0.0 112.46 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -72.03 -16.39 62.05 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.529 ' HB3' ' HB2' ' A' ' 17' ' ' MET . 5.5 t80 -101.01 114.68 28.84 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.509 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 35.3 p -40.75 -57.61 1.87 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 125.177 1.548 . . . . 0.0 113.2 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -48.05 80.18 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.529 ' HB2' ' HB3' ' A' ' 14' ' ' PHE . 1.2 tmm? -60.83 -37.58 82.52 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.443 ' NH1' ' HG2' ' A' ' 37' ' ' GLU . 36.9 ttp-105 -59.29 -50.52 73.67 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.437 1.095 . . . . 0.0 110.996 177.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 15' ' ' SER . 9.0 mmt180 -60.82 -42.81 98.42 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.655 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.407 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 71.7 mt -55.63 -52.66 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.266 1.026 . . . . 0.0 111.113 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 17' ' ' MET . 6.3 t -56.11 -48.29 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 122.501 0.32 . . . . 0.0 110.752 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.443 ' HD2' ' OE1' ' A' ' 35' ' ' GLU . 56.4 ttt180 -55.35 -50.49 69.53 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.649 1.18 . . . . 0.0 110.827 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -59.08 -45.68 90.21 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.99 0.916 . . . . 0.0 112.082 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 78.1 mt -54.21 -50.96 65.9 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.334 1.054 . . . . 0.0 111.793 177.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.3 mt -56.03 -46.56 78.82 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.968 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -55.74 -46.73 77.76 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.567 1.167 . . . . 0.0 111.303 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 44.5 mt-10 -59.45 -39.67 84.34 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.381 1.473 . . . . 0.0 112.381 177.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.1 mt -74.01 -12.66 60.69 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.15 -13.28 33.97 Favored Glycine 0 N--CA 1.479 1.522 0 C-N-CA 124.216 0.912 . . . . 0.0 113.386 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -84.72 62.73 7.56 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 123.42 1.581 . . . . 0.0 111.453 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -68.7 -13.72 62.55 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 6.6 m120 -86.42 70.83 10.51 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.81 126.35 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.623 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 16.4 mt-10 -120.42 160.57 22.82 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.044 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.443 ' OE1' ' HD2' ' A' ' 22' ' ' ARG . 7.9 pt-20 -133.69 140.99 47.37 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 119.439 3.125 . . . . 0.0 119.439 -175.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.524 ' HB2' ' HD2' ' A' ' 45' ' ' LYS . . . -124.44 160.75 27.53 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 112.234 -2.257 . . . . 0.0 109.506 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.443 ' HG2' ' NH1' ' A' ' 18' ' ' ARG . 38.1 mt-10 -97.47 -39.43 9.16 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 -177.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -137.59 170.32 16.27 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.468 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.434 ' HA2' HD22 ' A' ' 68' ' ' LEU . . . -45.71 -54.08 8.09 Favored Glycine 0 N--CA 1.482 1.736 0 O-C-N 124.651 1.219 . . . . 0.0 115.671 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.1 t -57.7 -54.42 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.665 0.786 . . . . 0.0 111.783 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -55.21 -36.5 66.03 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.935 0.894 . . . . 0.0 112.167 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.496 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . . . -66.69 -50.78 61.77 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.326 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.2 mt -54.17 -46.1 72.25 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 124.541 1.15 . . . . 0.0 110.482 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -57.05 -53.0 63.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.832 0.853 . . . . 0.0 111.506 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.524 ' HD2' ' HB2' ' A' ' 36' ' ' ALA . 51.2 mttm -56.94 -45.74 82.58 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.207 175.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.552 HD23 ' HB2' ' A' ' 51' ' ' TYR . 19.4 mt -59.2 -42.68 91.48 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.149 0.98 . . . . 0.0 111.653 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -60.57 -30.18 69.63 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 125.102 1.361 . . . . 0.0 112.089 177.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.83 -19.5 65.91 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.81 0.844 . . . . 0.0 112.154 175.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.64 175.09 28.33 Favored Glycine 0 N--CA 1.479 1.53 0 N-CA-C 117.508 1.763 . . . . 0.0 117.508 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.62 -33.1 1.63 Allowed Glycine 0 N--CA 1.483 1.781 0 N-CA-C 121.304 3.282 . . . . 0.0 121.304 176.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.623 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 37.4 m-85 -65.85 113.37 4.31 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -176.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.45 16.87 57.5 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-N 113.761 -1.563 . . . . 0.0 113.124 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -166.23 138.55 3.85 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.229 1.412 . . . . 0.0 110.483 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.449 HG22 HD21 ' A' ' 46' ' ' LEU . 26.5 t -125.31 126.41 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.491 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 91.0 mt -112.13 99.61 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.9 t -109.06 123.68 49.54 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -73.56 127.25 32.22 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 112.572 -2.104 . . . . 0.0 109.565 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.52 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 5.2 t-105 -52.65 -49.14 65.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.032 0.933 . . . . 0.0 111.4 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -88.45 96.77 10.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.971 0.908 . . . . 0.0 110.94 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.4 mtm -138.3 132.3 16.7 Favored Pre-proline 0 N--CA 1.48 1.03 0 CA-C-N 113.742 -1.572 . . . . 0.0 112.589 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -65.87 150.41 85.79 Favored 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 123.933 3.089 . . . . 0.0 111.795 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.3 m120 68.33 -64.01 0.32 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 125.794 1.934 . . . . 0.0 112.694 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.405 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 57.7 ttm -126.44 101.95 6.92 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.277 1.031 . . . . 0.0 108.277 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.36 169.11 6.19 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 113.394 -1.73 . . . . 0.0 111.866 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.0 -52.76 29.65 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.15 0.881 . . . . 0.0 115.156 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.446 HD12 HD13 ' A' ' 69' ' ' LEU . 36.3 tp -60.04 -38.6 83.24 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.48 0.712 . . . . 0.0 112.343 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -66.63 -42.75 86.25 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.664 0.386 . . . . 0.0 110.469 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.434 HD22 ' HA2' ' A' ' 39' ' ' GLY . 58.9 tp -59.7 -45.17 92.95 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.987 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 103' ' ' ALA . 5.6 tt -50.32 -51.71 43.04 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.75 1.62 . . . . 0.0 109.054 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -59.68 -47.24 86.42 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.984 0.914 . . . . 0.0 113.143 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.268 21.7 p -56.55 -35.38 68.06 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.551 1.14 . . . . 0.0 111.994 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.671 HG23 ' HB3' ' A' ' 78' ' ' MET . 42.6 mt -76.29 -54.42 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.152 0.981 . . . . 0.0 109.396 177.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HD3' HD23 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -53.0 -40.79 64.07 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.678 1.991 . . . . 0.0 113.749 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.42 -31.83 65.83 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -87.23 94.91 9.79 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.825 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -13.68 -71.34 0.01 OUTLIER Glycine 0 N--CA 1.487 2.06 0 C-N-CA 127.345 2.402 . . . . 0.0 118.207 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.98 -41.89 71.77 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.671 ' HB3' HG23 ' A' ' 72' ' ' ILE . 35.0 mtm -74.61 -30.8 61.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.25 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.7 m -53.77 -29.08 38.54 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.321 1.048 . . . . 0.0 112.585 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.61 -34.63 58.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.305 1.042 . . . . 0.0 113.264 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.505 ' HA ' ' HD2' ' A' ' 82' ' ' PRO 0.273 2.5 pp -84.45 120.55 74.44 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.505 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 18.8 Cg_endo -47.74 146.9 7.64 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 125.123 3.882 . . . . 0.0 120.65 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.8 t -122.02 107.18 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 111.549 -2.568 . . . . 0.0 110.751 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 56.4 tp -101.07 110.97 23.06 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.643 -1.162 . . . . 0.0 107.931 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 90.0 mmm -81.77 133.9 35.39 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.178 -1.374 . . . . 0.0 112.182 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.427 HG12 ' HB2' ' A' ' 109' ' ' LYS . 3.5 t -112.58 109.47 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 177.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.8 p -103.85 134.33 47.33 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.968 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.97 -24.31 52.13 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -165.13 130.51 2.61 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.624 1.97 . . . . 0.0 107.554 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.621 ' HB2' HG22 ' A' ' 108' ' ' VAL . . . -79.94 98.23 7.07 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 122.474 1.131 . . . . 0.0 111.106 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -121.87 144.53 48.79 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.746 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -35.1 -50.47 0.51 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.759 1.223 . . . . 0.0 114.121 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -50.79 -58.15 6.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.523 1.129 . . . . 0.0 112.759 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -69.06 -39.91 78.85 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 93.5 mt -57.01 -55.49 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.634 0.774 . . . . 0.0 111.767 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.441 HG22 ' OE1' ' A' ' 100' ' ' GLN . 59.0 mt -59.06 -51.26 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 124.052 0.845 . . . . 0.0 111.143 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.51 -45.1 73.26 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 115.248 -0.887 . . . . 0.0 113.286 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.52 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -60.92 -52.38 65.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.566 1.146 . . . . 0.0 113.014 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.29 -47.49 83.5 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.723 0.809 . . . . 0.0 111.702 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.441 ' OE1' HG22 ' A' ' 96' ' ' ILE . 61.1 mt-30 -58.62 -36.46 74.09 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.6 -13.57 57.82 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.446 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 119.43 3.22 12.92 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.679 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -57.93 125.28 22.4 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.737 1.269 . . . . 0.0 112.807 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.2 m -65.52 -31.97 73.31 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 113.447 -1.706 . . . . 0.0 113.166 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.79 174.99 46.48 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 125.01 1.291 . . . . 0.0 110.333 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -145.81 139.72 26.58 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 p -119.11 130.49 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 125.462 1.726 . . . . 0.0 110.853 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.621 HG22 ' HB2' ' A' ' 90' ' ' ALA . 3.3 t -75.7 130.53 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.894 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.427 ' HB2' HG12 ' A' ' 86' ' ' VAL . 1.8 ttmp? -91.84 123.01 64.43 Favored Pre-proline 0 N--CA 1.479 0.997 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -81.42 156.21 81.98 Favored 'Cis proline' 0 N--CA 1.486 1.069 0 N-CA-C 114.323 0.855 . . . . 0.0 114.323 -0.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -140.67 163.84 31.81 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 112.898 -1.955 . . . . 0.0 109.401 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.3 p -112.53 175.4 5.45 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.271 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.84 81.06 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.156 176.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.21 -48.75 76.99 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.821 0.848 . . . . 0.0 110.97 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.0 m -57.07 -45.94 82.88 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.817 0.847 . . . . 0.0 110.494 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.434 HD22 HD11 ' A' ' 120' ' ' LEU . 1.1 tt -59.67 -53.16 61.26 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 124.446 1.091 . . . . 0.0 108.824 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.611 ' HA ' HD12 ' A' ' 120' ' ' LEU . 51.5 tt0 -57.5 -41.86 81.58 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.27 -48.43 65.28 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.845 0.716 . . . . 0.0 111.608 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -63.72 -48.89 75.24 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.965 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 117' ' ' GLU . 96.8 mt -49.93 -47.38 52.41 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.822 1.249 . . . . 0.0 113.716 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -63.87 -49.18 73.76 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -53.99 -48.44 70.39 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 124.649 1.218 . . . . 0.0 110.152 176.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 81.1 mt -55.01 -54.72 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.139 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -179.63 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 116.981 2.215 . . . . 0.0 116.981 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.79 39.07 0.78 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.862 -1.517 . . . . 0.0 110.895 177.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.455 HD21 ' HD2' ' A' ' 53' ' ' PHE . 28.6 tp -95.91 128.05 42.46 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 112.644 -2.071 . . . . 0.0 111.244 -177.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.433 ' NZ ' ' HA3' ' A' ' 49' ' ' GLY . 49.2 mtpt -80.9 106.18 12.7 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 112.874 -1.967 . . . . 0.0 112.107 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -101.73 136.89 40.8 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 113.6 -1.636 . . . . 0.0 113.629 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -115.5 103.24 10.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.575 -1.648 . . . . 0.0 109.902 172.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.9 t -81.63 91.99 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 112.074 -2.33 . . . . 0.0 107.156 178.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.511 HG12 ' SD ' ' A' ' 60' ' ' MET . 3.2 t -99.53 94.92 3.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 112.753 -2.021 . . . . 0.0 107.983 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.424 ' OD1' ' HB2' ' A' ' 57' ' ' ASP . 18.2 m-20 -135.47 140.39 44.8 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.258 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -67.08 -27.84 67.69 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 117.017 2.229 . . . . 0.0 117.017 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -107.65 132.15 53.63 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.448 0.299 . . . . 0.0 111.224 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.5 p -51.36 -52.08 48.85 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.754 1.222 . . . . 0.0 113.231 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 m -60.45 -48.82 80.1 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.258 0.974 . . . . 0.0 111.441 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.4 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -59.89 -44.58 94.15 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.224 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -55.39 -58.52 7.39 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.054 1.341 . . . . 0.0 111.039 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 30.4 ptt180 -58.9 -36.37 74.58 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.5 mt -58.23 -49.7 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 122.946 0.498 . . . . 0.0 110.09 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 17' ' ' MET . 9.7 t -55.71 -47.35 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 123.525 0.73 . . . . 0.0 110.27 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.692 ' NH2' HD21 ' A' ' 23' ' ' ASN . 7.0 ttp180 -51.51 -51.73 52.7 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.059 1.344 . . . . 0.0 110.843 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.692 HD21 ' NH2' ' A' ' 22' ' ' ARG . 16.1 m120 -62.28 -40.4 96.13 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.206 1.002 . . . . 0.0 112.48 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 84.8 mt -58.5 -51.71 68.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.785 0.834 . . . . 0.0 110.69 177.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.1 mt -55.01 -46.27 75.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.125 0.97 . . . . 0.0 112.548 177.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.8 -43.24 90.5 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.661 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 25.0 mt-10 -58.78 -39.04 79.89 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.887 1.275 . . . . 0.0 111.995 177.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.0 mt -74.23 -17.49 60.88 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.003 1.321 . . . . 0.0 114.068 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.17 9.71 25.37 Favored Glycine 0 N--CA 1.478 1.477 0 N-CA-C 115.639 1.015 . . . . 0.0 115.639 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -92.6 101.78 14.21 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.753 1.263 . . . . 0.0 112.009 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -64.13 -51.41 64.04 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 118.705 2.854 . . . . 0.0 118.705 -175.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -94.08 101.72 13.76 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.239 1.199 . . . . 0.0 114.239 -174.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.526 HG11 ' HA ' ' A' ' 22' ' ' ARG . 32.1 t -130.61 118.35 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.002 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.697 ' HB2' ' HE2' ' A' ' 51' ' ' TYR . 12.5 mp0 -110.79 157.56 19.65 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -127.24 127.93 45.22 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -174.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.03 154.81 32.51 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.501 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -86.93 -48.61 8.0 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -142.74 173.74 11.28 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.245 0.618 . . . . 0.0 109.426 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -43.03 -55.64 4.82 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.071 1.319 . . . . 0.0 116.332 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.87 -54.85 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.366 0.666 . . . . 0.0 111.675 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -56.55 -33.85 66.52 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.665 0.786 . . . . 0.0 111.996 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.86 -48.21 72.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.481 1.112 . . . . 0.0 111.958 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.5 mt -57.62 -40.46 79.2 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.439 0.695 . . . . 0.0 111.464 177.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -59.18 -59.74 4.97 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.402 1.081 . . . . 0.0 109.305 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -58.25 -39.57 79.5 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.414 ' HG ' HD12 ' A' ' 9' ' ' LEU . 16.3 mt -52.8 -38.47 61.24 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.739 1.216 . . . . 0.0 113.905 177.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -59.47 -26.17 65.02 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.52 56.89 1.48 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.786 1.234 . . . . 0.0 114.313 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.433 ' HA3' ' NZ ' ' A' ' 7' ' ' LYS . . . 125.32 -15.14 7.28 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 117.822 1.889 . . . . 0.0 117.822 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.91 67.24 2.04 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.697 ' HE2' ' HB2' ' A' ' 34' ' ' GLU . 1.7 m-85 -58.16 129.64 42.93 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.671 1.989 . . . . 0.0 113.114 -177.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.685 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -83.64 19.06 16.55 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-N 113.915 -1.493 . . . . 0.0 116.564 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.49 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -172.29 128.81 0.57 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 122.551 1.167 . . . . 0.0 112.046 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.3 t -121.8 119.14 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-N 113.521 -1.672 . . . . 0.0 108.182 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.8 mt -108.81 101.77 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 177.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.6 t -119.0 125.87 50.39 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 118.185 2.661 . . . . 0.0 118.185 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.424 ' HB2' ' OD1' ' A' ' 12' ' ' ASP . 54.7 t0 -67.38 128.21 35.55 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 112.374 -2.194 . . . . 0.0 109.892 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.411 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 17.1 t-105 -53.92 -50.15 67.04 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.003 0.921 . . . . 0.0 109.934 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -89.19 95.07 10.15 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.548 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.511 ' SD ' HG12 ' A' ' 11' ' ' VAL . 18.4 mtm -134.83 131.66 20.15 Favored Pre-proline 0 N--CA 1.477 0.887 0 CA-C-N 113.08 -1.873 . . . . 0.0 110.882 177.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -56.65 139.14 87.5 Favored 'Trans proline' 0 N--CA 1.48 0.715 0 C-N-CA 123.945 3.097 . . . . 0.0 111.549 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 m120 64.73 -65.0 0.15 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 126.759 2.024 . . . . 0.0 114.115 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.434 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 57.9 ttm -115.83 92.17 3.82 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.7 p30 -62.16 167.89 3.71 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 111.263 -2.699 . . . . 0.0 112.592 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.28 -55.29 10.73 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 124.298 0.951 . . . . 0.0 113.796 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.425 HD12 HD13 ' A' ' 69' ' ' LEU . 53.3 tp -59.42 -38.14 79.87 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.154 0.981 . . . . 0.0 112.786 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -71.62 -40.05 70.04 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 119.613 -0.232 . . . . 0.0 111.235 177.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.4 tp -60.41 -40.39 90.78 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.679 0.752 . . . . 0.0 110.529 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 103' ' ' ALA . 4.2 tt -51.0 -49.85 59.62 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.089 1.356 . . . . 0.0 108.632 176.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -61.56 -44.96 96.08 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.84 1.256 . . . . 0.0 113.372 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.4 p -61.03 -27.53 68.4 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.625 0.77 . . . . 0.0 111.662 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.0 mt -80.65 -56.9 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.47 1.108 . . . . 0.0 108.78 176.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.416 ' HD3' ' HA ' ' A' ' 73' ' ' ARG . 58.0 mmt-85 -51.87 -42.91 63.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.994 1.717 . . . . 0.0 113.346 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.47 -23.69 50.36 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -86.79 95.45 9.84 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.17 0.588 . . . . 0.0 111.807 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -3.5 -83.63 0.0 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 127.106 2.289 . . . . 0.0 118.412 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.94 -39.86 82.89 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 82.3 mtp -71.84 -23.56 61.56 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.573 1.549 . . . . 0.0 113.778 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.6 m -50.8 -26.17 5.36 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.841 1.657 . . . . 0.0 115.147 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.49 -7.43 50.5 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.685 HD22 ' HA2' ' A' ' 52' ' ' GLY . 54.3 mt -83.42 119.48 73.99 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 123.284 0.633 . . . . 0.0 111.829 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 14.6 Cg_endo -54.18 138.44 71.69 Favored 'Trans proline' 0 N--CA 1.482 0.812 0 C-N-CA 123.984 3.123 . . . . 0.0 114.892 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.46 HG11 ' HG ' ' A' ' 69' ' ' LEU . 13.0 t -120.26 114.47 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-N 112.366 -2.197 . . . . 0.0 111.427 -178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.49 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 30.9 tp -106.64 110.37 22.54 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.969 -1.469 . . . . 0.0 109.36 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.3 mmt -81.11 112.29 18.34 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.911 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.63 102.82 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.4 t -110.18 138.63 46.3 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.13 -1.85 . . . . 0.0 113.78 -176.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -48.0 -31.41 5.31 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -161.5 152.73 18.54 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.709 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.438 ' HB2' HG21 ' A' ' 108' ' ' VAL . . . -77.24 82.29 3.72 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 123.187 1.47 . . . . 0.0 107.552 176.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -100.94 121.42 41.71 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 111.343 -2.662 . . . . 0.0 108.362 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.531 ' O ' HG12 ' A' ' 96' ' ' ILE . 33.0 ttmt -38.48 -53.07 1.58 Allowed 'General case' 0 N--CA 1.483 1.178 0 O-C-N 125.018 1.449 . . . . 0.0 113.892 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -53.17 -53.29 52.74 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.171 0.588 . . . . 0.0 111.188 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -56.79 -49.36 75.57 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.3 1.0 . . . . 0.0 111.833 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.8 mt -55.25 -51.92 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.188 0.995 . . . . 0.0 111.969 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 92' ' ' LYS . 32.2 mm -58.98 -54.89 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.606 0.762 . . . . 0.0 110.8 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.63 -47.05 70.65 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.191 0.996 . . . . 0.0 113.234 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -57.06 -51.72 68.14 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.451 1.1 . . . . 0.0 112.168 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.1 -47.75 84.83 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.284 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.455 ' OE1' HG22 ' A' ' 96' ' ' ILE . 65.9 mt-30 -56.3 -40.38 74.23 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.85 1.26 . . . . 0.0 113.489 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.28 -14.41 59.44 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.92 3.11 12.35 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.631 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -65.24 123.02 18.45 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.192 1.496 . . . . 0.0 112.319 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.1 p -69.78 -17.57 63.43 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 113.161 -1.836 . . . . 0.0 114.314 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.54 173.47 43.93 Favored Glycine 0 N--CA 1.481 1.658 0 C-N-CA 124.043 0.83 . . . . 0.0 111.844 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -144.4 136.63 26.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 114.999 -0.601 . . . . 0.0 112.387 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.258 1.0 OUTLIER -118.03 126.9 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 124.413 1.07 . . . . 0.0 110.419 178.363 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 25.4 t -80.37 114.64 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 112.159 -2.292 . . . . 0.0 111.229 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -90.36 132.28 36.03 Favored Pre-proline 0 N--CA 1.472 0.627 0 CA-C-O 117.725 -1.131 . . . . 0.0 110.611 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.18 132.87 26.91 Favored 'Cis proline' 0 N--CA 1.489 1.228 0 N-CA-C 115.173 1.182 . . . . 0.0 115.173 1.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.442 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 35.0 p90 -124.74 151.62 44.84 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 112.462 -2.154 . . . . 0.0 108.69 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.2 p -102.53 171.63 7.33 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.014 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.71 -39.85 68.6 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.576 0.548 . . . . 0.0 111.396 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.0 -44.41 80.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.427 1.091 . . . . 0.0 111.983 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.4 m -60.15 -49.32 78.09 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 60.3 tp -56.14 -50.45 71.08 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.24 1.416 . . . . 0.0 109.715 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -56.45 -46.86 80.12 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.328 1.051 . . . . 0.0 112.473 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -53.41 -44.08 68.44 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -65.88 -48.43 71.55 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.392 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.7 mt -56.66 -48.94 76.48 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.535 1.134 . . . . 0.0 111.504 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -50.09 -53.24 28.57 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 126.021 1.728 . . . . 0.0 112.056 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -54.15 -45.91 72.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.654 1.182 . . . . 0.0 111.466 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.74 -39.8 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.338 1.055 . . . . 0.0 112.038 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 179.061 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 57.6 mmtt . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -105.68 45.33 0.98 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.6 tp -83.11 122.78 28.81 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 112.029 -2.351 . . . . 0.0 107.349 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 51' ' ' TYR . 69.1 tttt -78.26 115.88 18.3 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.931 -1.486 . . . . 0.0 113.446 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.509 ' HB2' HG22 ' A' ' 33' ' ' VAL . 65.1 m-85 -105.72 138.15 42.4 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.745 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.661 HD23 ' HB3' ' A' ' 34' ' ' GLU . 1.6 tm? -116.16 99.53 7.3 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.616 1.198 . . . . 0.0 108.822 175.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.71 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 94.9 t -79.68 104.36 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 111.61 -2.541 . . . . 0.0 108.958 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.56 HG22 HD13 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -104.89 102.54 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 113.605 -1.634 . . . . 0.0 110.02 -178.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.75 135.05 22.96 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.986 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -66.1 -16.99 64.41 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -106.59 110.36 22.54 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.2 p -46.93 -49.63 20.19 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.691 -1.14 . . . . 0.0 113.273 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -38.93 85.94 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.297 1.039 . . . . 0.0 112.741 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.2 tpt -62.19 -38.98 91.18 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.515 ' HD2' ' HB3' ' A' ' 35' ' ' GLU . 77.4 mtm180 -56.39 -47.89 78.02 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.196 0.522 . . . . 0.0 110.907 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.56 -41.61 73.51 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 114.133 -1.394 . . . . 0.0 112.399 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.5 mt -57.69 -50.99 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.244 0.617 . . . . 0.0 110.23 177.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 t -58.57 -42.47 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.273 0.629 . . . . 0.0 109.97 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 56.0 ttm-85 -53.8 -54.14 42.51 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 123.938 0.774 . . . . 0.0 110.737 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -58.81 -39.78 82.17 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 81.1 mt -62.59 -53.88 48.05 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.482 0.713 . . . . 0.0 111.492 177.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.9 mt -54.87 -44.3 73.9 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.988 0.915 . . . . 0.0 111.882 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -56.75 -49.08 76.32 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 113.343 -1.753 . . . . 0.0 110.175 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 28.5 mt-10 -56.42 -38.0 70.97 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.05 1.74 . . . . 0.0 112.914 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.4 mt -73.76 -19.17 60.86 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.787 1.235 . . . . 0.0 114.287 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.41 -5.22 23.21 Favored Glycine 0 CA--C 1.551 2.295 0 C-N-CA 124.296 0.951 . . . . 0.0 112.919 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 22.3 m-85 -92.54 86.03 5.49 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 122.557 1.17 . . . . 0.0 109.773 -178.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -85.28 -7.52 58.96 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -98.29 93.37 6.18 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 122.387 1.089 . . . . 0.0 110.343 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.509 HG22 ' HB2' ' A' ' 8' ' ' PHE . 54.6 t -129.11 136.32 59.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 113.525 -1.67 . . . . 0.0 111.403 -178.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.661 ' HB3' HD23 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -126.16 149.85 48.7 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 176.387 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.71 ' HG2' ' HB ' ' A' ' 10' ' ' VAL . 87.8 mt-10 -127.99 141.27 51.57 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 118.637 2.828 . . . . 0.0 118.637 -176.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -131.51 152.44 50.73 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 112.072 -2.331 . . . . 0.0 110.531 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . 0.374 0.0 OUTLIER -100.08 -27.71 13.41 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 -179.057 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.7 p30 -142.7 166.59 24.24 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.476 -0.765 . . . . 0.0 110.831 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -45.08 -49.25 9.7 Favored Glycine 0 N--CA 1.479 1.543 0 C-N-CA 124.6 1.095 . . . . 0.0 115.582 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -58.65 -56.68 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 114.616 -0.792 . . . . 0.0 110.585 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -55.36 -35.38 65.17 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.802 0.841 . . . . 0.0 111.662 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.01 -51.52 57.57 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 117.91 -1.043 . . . . 0.0 111.834 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 50.6 mt -54.82 -45.77 74.48 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 124.211 0.944 . . . . 0.0 111.068 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -54.96 -54.41 43.17 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 125.166 1.541 . . . . 0.0 111.43 177.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.8 mttt -62.61 -45.14 94.22 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.027 1.331 . . . . 0.0 114.271 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.8 mt -54.09 -28.71 41.02 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 98.3 mm-40 -57.88 -25.51 60.87 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.39 -18.89 62.69 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.72 -179.8 50.63 Favored Glycine 0 N--CA 1.48 1.593 0 CA-C-O 122.165 0.869 . . . . 0.0 112.541 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.46 -31.02 3.29 Favored Glycine 0 N--CA 1.485 1.953 0 CA-C-N 113.959 -1.121 . . . . 0.0 114.142 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.546 ' HA ' ' HB3' ' A' ' 7' ' ' LYS . 65.3 m-85 -60.69 113.29 2.39 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.094 0.558 . . . . 0.0 110.772 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.62 15.3 45.64 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 125.815 1.947 . . . . 0.0 112.222 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.529 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.6 OUTLIER -171.3 134.19 0.88 Allowed 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 122.381 1.086 . . . . 0.0 112.348 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.32 121.49 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.538 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 89.8 mt -112.33 98.99 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.5 t -113.46 122.06 46.17 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.02 127.26 32.22 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 111.456 -2.611 . . . . 0.0 110.259 177.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -51.93 -45.04 64.14 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.237 0.961 . . . . 0.0 112.871 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -87.06 103.15 15.11 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.013 0.925 . . . . 0.0 109.438 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.9 mtp -147.23 131.46 8.58 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 123.999 0.92 . . . . 0.0 111.815 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.21 149.42 81.62 Favored 'Trans proline' 0 N--CA 1.48 0.734 0 C-N-CA 123.484 2.789 . . . . 0.0 110.968 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.5 m120 70.94 -71.7 0.13 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.911 1.684 . . . . 0.0 111.05 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.4 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 58.8 ttm -119.84 99.71 6.8 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -61.1 166.59 3.51 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.688 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.91 -56.64 7.45 Favored Glycine 0 N--CA 1.485 1.939 0 O-C-N 124.188 0.93 . . . . 0.0 114.868 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.627 HD12 HD23 ' A' ' 69' ' ' LEU . 50.8 tp -58.59 -37.26 75.43 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -68.31 -39.81 81.89 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.773 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.7 tp -58.99 -42.37 89.87 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.904 0.753 . . . . 0.0 110.372 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.627 HD23 HD12 ' A' ' 66' ' ' LEU . 12.9 tp -54.06 -47.27 71.82 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.059 1.344 . . . . 0.0 111.178 176.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.36 -47.11 85.62 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.235 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.257 11.4 p -59.15 -32.38 69.83 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.658 1.183 . . . . 0.0 112.943 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.452 HG23 ' HB3' ' A' ' 78' ' ' MET . 53.3 mt -74.65 -55.7 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.248 1.019 . . . . 0.0 108.311 176.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.439 ' HD3' ' HA ' ' A' ' 73' ' ' ARG . 71.1 mmt-85 -51.03 -48.01 61.57 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.584 1.554 . . . . 0.0 111.769 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.83 -22.32 65.15 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -83.66 110.71 18.5 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.599 0.76 . . . . 0.0 109.411 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -26.28 -69.14 0.05 OUTLIER Glycine 0 CA--C 1.541 1.71 0 C-N-CA 125.981 1.753 . . . . 0.0 115.306 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.02 -35.28 80.68 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.452 ' HB3' HG23 ' A' ' 72' ' ' ILE . 42.7 mtm -85.35 -11.38 54.72 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 64.8 p -42.67 -43.17 3.74 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.456 1.903 . . . . 0.0 116.099 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.64 -3.95 57.01 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 90.5 mt -73.95 111.07 10.86 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 11.8 Cg_endo -52.1 131.14 38.0 Favored 'Trans proline' 0 N--CA 1.481 0.749 0 C-N-CA 123.166 2.577 . . . . 0.0 114.249 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 63.3 t -116.86 124.72 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 112.865 -1.97 . . . . 0.0 113.224 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.529 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 50.4 tp -111.97 108.13 17.35 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 112.659 -2.064 . . . . 0.0 108.771 178.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.0 mmt -81.8 106.13 13.48 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 113.383 -1.735 . . . . 0.0 113.637 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -91.28 98.61 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 123.921 1.819 . . . . 0.0 108.504 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 t -108.9 139.23 44.04 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 111.813 -2.449 . . . . 0.0 112.6 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.19 -41.79 65.63 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 114.213 -1.358 . . . . 0.0 113.495 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -137.32 151.17 48.34 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.472 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.565 ' HB2' HG21 ' A' ' 108' ' ' VAL . . . -91.73 78.14 5.51 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.352 177.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.8 135.99 37.98 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.259 -1.791 . . . . 0.0 108.7 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -41.07 -49.46 3.4 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.077 1.351 . . . . 0.0 113.193 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -58.59 -51.2 70.9 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -56.93 -45.39 82.76 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.343 1.027 . . . . 0.0 111.312 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 78.9 mt -56.87 -55.16 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 124.716 1.206 . . . . 0.0 110.892 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.448 HG22 ' OE1' ' A' ' 100' ' ' GLN . 44.5 mt -59.32 -50.92 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.021 0.928 . . . . 0.0 110.674 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.58 74.11 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.834 0.854 . . . . 0.0 111.865 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.08 -49.05 79.35 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.507 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.53 88.29 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.305 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.448 ' OE1' HG22 ' A' ' 96' ' ' ILE . 78.5 mt-30 -60.12 -38.87 84.31 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.0 -0.66 45.22 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.54 -0.81 29.23 Favored Glycine 0 CA--C 1.545 1.908 0 N-CA-C 117.391 1.716 . . . . 0.0 117.391 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.03 121.65 14.11 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.099 1.449 . . . . 0.0 114.357 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.0 m -65.44 -30.02 70.77 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 111.913 -2.403 . . . . 0.0 113.08 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -173.68 177.23 46.09 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.308 1.432 . . . . 0.0 111.121 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -147.32 131.54 17.42 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.053 -1.073 . . . . 0.0 111.186 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.8 p -120.83 123.85 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 123.988 0.805 . . . . 0.0 110.364 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.565 HG21 ' HB2' ' A' ' 90' ' ' ALA . 93.8 t -76.41 128.56 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 112.796 -2.002 . . . . 0.0 111.456 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -92.78 138.26 23.67 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.859 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.51 133.75 31.92 Favored 'Cis proline' 0 CA--C 1.54 0.788 0 N-CA-C 115.866 1.449 . . . . 0.0 115.866 0.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -116.95 147.72 42.02 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 112.832 -1.985 . . . . 0.0 108.458 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 59.9 p -105.56 178.48 4.55 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.983 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.11 -42.93 69.99 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.912 0.758 . . . . 0.0 111.97 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.09 72.93 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.738 0.815 . . . . 0.0 111.723 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -60.57 -46.3 90.73 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.475 0.71 . . . . 0.0 110.786 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.3 tp -56.47 -51.2 69.35 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.323 1.049 . . . . 0.0 109.553 177.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.436 ' HA ' HD12 ' A' ' 120' ' ' LEU . 8.3 tt0 -58.67 -47.67 83.71 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.531 0.732 . . . . 0.0 111.752 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -50.42 -45.5 55.82 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 124.195 0.934 . . . . 0.0 110.653 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -68.47 -46.59 69.34 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.159 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 117' ' ' GLU . 46.5 mt -55.87 -48.67 75.15 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.503 0.721 . . . . 0.0 111.218 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -55.15 -52.53 63.0 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.502 1.521 . . . . 0.0 112.004 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -52.85 -46.96 68.05 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.357 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.92 -46.88 93.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.276 1.03 . . . . 0.0 111.528 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 N--CA 1.476 0.858 0 C-N-CA 122.582 0.353 . . . . 0.0 111.722 178.078 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 33.5 mmtp . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -99.94 46.8 0.95 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.497 1.142 . . . . 0.0 113.802 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.424 HD23 ' CZ ' ' A' ' 8' ' ' PHE . 38.2 tp -79.77 127.68 32.51 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 111.405 -2.634 . . . . 0.0 107.318 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 51' ' ' TYR . 76.8 tttt -81.77 110.43 17.08 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.558 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 30' ' ' PHE . 89.4 m-85 -99.33 141.65 31.84 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.933 -1.94 . . . . 0.0 113.135 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.745 HD23 ' HB3' ' A' ' 34' ' ' GLU . 1.3 tm? -121.82 98.76 6.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.368 174.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -80.11 109.68 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 111.955 -2.384 . . . . 0.0 108.419 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.6 HG22 HD13 ' A' ' 9' ' ' LEU . 1.4 t -108.53 100.64 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.597 -179.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -141.21 133.73 28.44 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.844 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -65.06 -28.37 69.42 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 112.976 -1.92 . . . . 0.0 114.025 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -94.54 102.02 13.94 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.0 p -39.12 -50.09 1.85 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 113.024 -1.898 . . . . 0.0 113.27 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -38.82 92.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.04 1.336 . . . . 0.0 112.61 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 12.4 tpt -63.51 -34.27 77.4 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.473 ' HD2' ' HB3' ' A' ' 35' ' ' GLU . 72.0 mtm180 -56.47 -42.58 78.45 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.507 0.504 . . . . 0.0 111.441 178.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -60.37 -43.88 96.16 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.114 -1.403 . . . . 0.0 112.533 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.6 mt -59.97 -51.46 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 122.993 0.517 . . . . 0.0 110.231 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.8 t -58.04 -44.41 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 123.806 0.691 . . . . 0.0 109.172 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 37.5 ttm-85 -55.42 -52.49 63.42 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.953 0.901 . . . . 0.0 111.469 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -55.9 -44.87 78.63 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 123.916 0.76 . . . . 0.0 113.04 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 68.4 mt -59.36 -52.82 64.01 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.506 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.5 mt -54.29 -48.75 70.93 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.541 176.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -52.25 -48.51 65.18 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.64 1.576 . . . . 0.0 111.198 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 35.3 mt-10 -58.33 -39.03 78.36 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.014 1.725 . . . . 0.0 114.017 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.2 mt -73.84 -16.25 61.14 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.962 1.305 . . . . 0.0 114.163 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.62 -8.31 19.8 Favored Glycine 0 N--CA 1.482 1.743 0 C-N-CA 124.696 1.141 . . . . 0.0 112.824 -177.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 51.9 m-85 -90.11 74.07 7.19 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 123.871 1.795 . . . . 0.0 111.675 -178.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -76.18 -14.73 60.15 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 112.256 -2.247 . . . . 0.0 116.167 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -91.79 93.51 8.89 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.465 1.126 . . . . 0.0 110.218 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.8 t -132.63 140.53 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.591 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.745 ' HB3' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -126.93 152.44 47.12 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 175.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 36.8 mt-10 -126.67 141.95 51.69 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -178.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.458 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -131.54 158.15 41.7 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 112.01 -2.359 . . . . 0.0 108.951 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . 0.314 0.0 OUTLIER -105.37 -17.37 14.46 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 -178.05 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -157.17 169.01 25.75 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 122.009 -0.432 . . . . 0.0 109.924 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -44.82 -54.99 6.48 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 124.743 1.164 . . . . 0.0 114.684 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.3 t -56.67 -56.54 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 122.612 0.365 . . . . 0.0 111.096 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -52.29 -35.91 51.63 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.113 0.965 . . . . 0.0 112.748 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . . . -68.9 -52.92 24.35 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.551 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.3 mt -52.89 -42.5 65.36 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.801 0.688 . . . . 0.0 111.412 178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -55.71 -57.29 12.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.601 1.56 . . . . 0.0 110.592 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -58.65 -42.2 87.81 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.536 1.535 . . . . 0.0 113.252 177.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.3 mt -59.98 -32.33 70.75 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -55.27 -26.66 41.44 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.83 -15.0 61.25 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.82 -177.43 47.57 Favored Glycine 0 CA--C 1.542 1.73 0 C-N-CA 124.033 0.825 . . . . 0.0 112.566 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.93 -33.2 4.06 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 114.753 -0.723 . . . . 0.0 113.495 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.547 ' O ' HD22 ' A' ' 81' ' ' LEU . 50.9 m-85 -69.16 122.56 19.04 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.944 0.897 . . . . 0.0 111.827 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.46 23.97 8.27 Favored Glycine 0 N--CA 1.478 1.49 0 O-C-N 126.17 2.169 . . . . 0.0 112.322 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.504 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -173.94 133.32 0.44 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.779 1.232 . . . . 0.0 111.398 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.6 t -122.77 122.95 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.823 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.5 mt -110.93 100.04 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 105.861 -1.904 . . . . 0.0 105.861 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.401 ' OG ' ' HA2' ' A' ' 65' ' ' GLY . 29.8 t -118.0 130.02 55.93 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -68.5 127.65 33.76 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 111.624 -2.535 . . . . 0.0 110.828 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.495 ' O ' ' HB2' ' A' ' 64' ' ' ASP . 32.1 t-105 -48.11 -54.62 12.61 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.515 1.126 . . . . 0.0 112.54 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -104.43 114.35 28.53 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 122.323 1.058 . . . . 0.0 111.167 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.455 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 32.8 mtm -139.73 137.28 18.33 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 111.916 -2.402 . . . . 0.0 109.383 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -57.04 145.54 85.27 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.645 2.897 . . . . 0.0 112.23 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.7 m120 69.41 -59.22 0.49 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.49 1.916 . . . . 0.0 115.009 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 59.3 ttm -133.02 101.4 5.21 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 58' ' ' TRP . 3.0 p30 -68.81 164.24 22.37 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 113.634 -1.621 . . . . 0.0 112.323 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.401 ' HA2' ' OG ' ' A' ' 56' ' ' SER . . . -43.91 -50.36 7.41 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 124.857 1.217 . . . . 0.0 114.453 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 61.9 tp -61.19 -42.6 98.87 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.743 -0.729 . . . . 0.0 112.84 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -65.63 -38.86 90.6 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.631 0.373 . . . . 0.0 111.198 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.14 -43.94 95.34 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.046 0.841 . . . . 0.0 110.345 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 66' ' ' LEU . 19.4 tp -55.15 -46.28 75.69 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.697 1.199 . . . . 0.0 110.685 176.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.63 -46.4 89.1 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.254 0.622 . . . . 0.0 112.366 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.25 12.8 p -62.55 -16.61 56.98 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.954 1.302 . . . . 0.0 114.069 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.9 mt -92.68 -59.76 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.111 1.364 . . . . 0.0 108.08 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 101' ' ' ALA . 77.2 mmt-85 -53.32 -46.48 69.46 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 126.386 1.874 . . . . 0.0 113.873 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.74 -29.92 65.04 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' A' ' 78' ' ' MET . 37.1 t0 -86.37 103.27 14.78 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -23.0 -71.19 0.01 OUTLIER Glycine 0 N--CA 1.483 1.818 0 C-N-CA 126.188 1.852 . . . . 0.0 115.692 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.01 -43.46 77.73 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.421 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 75.5 mmm -68.11 -27.02 66.11 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 -179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 96.1 p -47.36 -27.87 1.81 Allowed 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.73 -12.23 44.81 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 51' ' ' TYR . 2.6 mt -95.86 115.2 65.37 Favored Pre-proline 0 N--CA 1.485 1.312 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -59.42 142.98 99.81 Favored 'Trans proline' 0 N--CA 1.483 0.903 0 C-N-CA 123.439 2.759 . . . . 0.0 111.329 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.0 t -121.3 126.97 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-O 122.681 1.229 . . . . 0.0 113.234 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.504 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 54.4 tp -112.96 112.11 23.34 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 112.336 -2.211 . . . . 0.0 109.932 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 31.5 mmt -85.85 108.36 18.1 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.955 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.1 t -86.85 98.69 7.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-O 123.234 1.492 . . . . 0.0 107.692 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 1.8 t -113.26 140.57 47.87 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 112.03 -2.35 . . . . 0.0 109.947 -177.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.12 -50.57 58.57 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.542 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.405 ' HA ' HG13 ' A' ' 108' ' ' VAL . 39.1 mt-10 -138.92 153.6 48.27 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.974 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.14 83.74 7.74 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 122.83 1.3 . . . . 0.0 109.209 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -108.89 141.41 41.0 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 112.592 -2.095 . . . . 0.0 111.6 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -40.96 -52.77 3.07 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.621 1.568 . . . . 0.0 113.443 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -55.73 -50.19 71.05 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -62.98 -47.14 84.45 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.184 0.994 . . . . 0.0 111.323 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.8 mt -55.97 -54.57 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.783 1.233 . . . . 0.0 112.585 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.542 HG22 ' OE1' ' A' ' 100' ' ' GLN . 24.3 mt -55.83 -53.88 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.184 0.594 . . . . 0.0 109.9 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.71 -45.57 74.05 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.481 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.77 -48.7 79.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.23 1.012 . . . . 0.0 113.041 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.59 -43.17 97.74 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.983 0.913 . . . . 0.0 111.633 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.542 ' OE1' HG22 ' A' ' 96' ' ' ILE . 54.0 mt-30 -57.86 -33.73 68.99 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.314 1.046 . . . . 0.0 113.541 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.52 ' O ' ' HG3' ' A' ' 73' ' ' ARG . . . -90.9 -1.62 57.82 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 100.33 13.32 36.21 Favored Glycine 0 CA--C 1.547 2.088 0 N-CA-C 117.676 1.83 . . . . 0.0 117.676 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.04 129.9 43.75 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 118.921 1.36 . . . . 0.0 114.57 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.443 ' HB3' HG23 ' A' ' 123' ' ' ILE . 28.3 m -73.82 -29.29 62.06 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 113.085 -1.87 . . . . 0.0 112.439 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.12 174.99 47.22 Favored Glycine 0 N--CA 1.481 1.672 0 C-N-CA 124.898 1.237 . . . . 0.0 110.466 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.548 ' O ' ' HE2' ' A' ' 119' ' ' LYS . 37.0 p90 -144.88 130.51 18.96 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 113.924 -1.138 . . . . 0.0 111.304 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.292 1.4 p -114.68 121.19 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.205 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.405 HG13 ' HA ' ' A' ' 89' ' ' GLU . 94.0 t -74.69 115.41 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 111.479 -2.6 . . . . 0.0 111.316 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -91.65 135.57 27.58 Favored Pre-proline 0 C--O 1.24 0.567 0 O-C-N 124.421 1.075 . . . . 0.0 112.298 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -72.75 130.66 20.32 Favored 'Cis proline' 0 N--CA 1.475 0.423 0 N-CA-C 116.725 1.779 . . . . 0.0 116.725 0.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -120.63 137.83 54.23 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 112.073 -2.331 . . . . 0.0 108.213 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 54.3 p -96.48 179.52 4.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 123.85 0.719 . . . . 0.0 110.079 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.26 -36.53 68.67 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 119.504 -0.284 . . . . 0.0 111.324 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.45 -49.54 66.34 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.82 0.848 . . . . 0.0 110.839 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.99 -43.14 99.47 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.146 0.579 . . . . 0.0 110.123 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 40.2 tp -60.66 -53.72 54.03 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.695 0.798 . . . . 0.0 110.492 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -55.16 -45.87 75.71 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.459 0.704 . . . . 0.0 111.083 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -54.79 -47.36 74.08 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.337 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.548 ' HE2' ' O ' ' A' ' 106' ' ' TYR . 31.9 mmmt -66.8 -41.92 86.77 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 55.9 mt -57.76 -47.73 81.66 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.722 0.809 . . . . 0.0 109.621 177.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -54.64 -54.02 47.11 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.761 1.624 . . . . 0.0 112.074 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -52.74 -43.65 65.88 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.955 0.902 . . . . 0.0 112.331 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.443 HG23 ' HB3' ' A' ' 104' ' ' SER . 68.8 mt -60.65 -49.82 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.509 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 N--CA 1.482 1.125 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.218 179.802 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 4' ' ' LYS . 55.3 mmtt . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -109.71 61.26 0.6 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 123.347 1.546 . . . . 0.0 109.541 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.401 HD11 ' HA3' ' A' ' 52' ' ' GLY . 59.1 tp -86.71 136.19 33.11 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 110.846 -2.888 . . . . 0.0 110.212 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -86.96 118.57 26.43 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 125.674 1.859 . . . . 0.0 111.89 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.565 ' HB2' HG22 ' A' ' 33' ' ' VAL . 61.1 m-85 -108.2 148.93 29.24 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 112.826 -1.988 . . . . 0.0 112.868 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.649 HD23 ' HB3' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -127.23 104.01 7.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.639 175.484 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.451 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 95.4 t -84.1 105.3 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 112.526 -2.125 . . . . 0.0 109.197 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.534 HG22 HD13 ' A' ' 9' ' ' LEU . 1.4 t -104.08 92.45 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.817 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -135.62 127.54 29.49 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.36 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -60.36 -21.41 62.08 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -101.89 131.22 48.38 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.429 0.633 . . . . 0.0 110.995 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.5 p -50.44 -58.55 5.46 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.006 -1.907 . . . . 0.0 112.568 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -45.24 93.77 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.471 1.108 . . . . 0.0 112.614 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 11.9 tpt -59.87 -37.29 78.89 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.523 ' HD2' ' HB3' ' A' ' 35' ' ' GLU . 64.4 mtm-85 -58.21 -47.35 83.75 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -59.61 -43.44 93.77 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.396 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.403 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 83.2 mt -56.35 -48.26 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.537 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.423 HG11 HG21 ' A' ' 55' ' ' ILE . 4.6 t -63.07 -41.56 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 CA-C-O 118.943 -0.551 . . . . 0.0 109.982 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 57.7 ttm-85 -54.67 -52.47 62.25 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.378 0.671 . . . . 0.0 110.047 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -59.57 -38.43 81.13 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.415 1.086 . . . . 0.0 113.624 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 20' ' ' ILE . 83.1 mt -63.36 -54.39 37.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.753 0.821 . . . . 0.0 110.91 177.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.8 mt -55.66 -43.29 76.15 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.139 0.976 . . . . 0.0 111.743 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -56.68 -47.59 79.52 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.103 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -59.95 -37.43 79.55 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.038 1.735 . . . . 0.0 112.684 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.9 mt -72.66 -20.33 61.27 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.639 1.176 . . . . 0.0 113.21 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.81 -15.31 11.31 Favored Glycine 0 CA--C 1.546 2.028 0 C-N-CA 124.591 1.091 . . . . 0.0 114.336 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -89.71 82.23 6.32 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 123.408 1.575 . . . . 0.0 110.578 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -76.65 -7.97 56.33 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -96.98 97.95 9.68 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.071 0.939 . . . . 0.0 110.067 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.565 HG22 ' HB2' ' A' ' 8' ' ' PHE . 83.1 t -134.16 141.45 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.904 -178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.649 ' HB3' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -125.49 153.2 43.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 174.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.523 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 89.3 mt-10 -126.07 142.54 51.48 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 116.143 1.905 . . . . 0.0 116.143 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.62 157.25 46.22 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 112.53 -2.123 . . . . 0.0 108.097 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.6 -33.15 9.1 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -138.91 173.09 11.93 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.98 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.67 -56.85 7.08 Favored Glycine 0 N--CA 1.474 1.23 0 CA-C-N 114.254 -1.339 . . . . 0.0 115.551 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.9 t -58.07 -53.84 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 122.922 0.489 . . . . 0.0 111.496 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -51.83 -40.62 60.81 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.939 0.895 . . . . 0.0 111.969 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.8 -51.27 65.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.414 1.086 . . . . 0.0 112.728 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.6 mt -54.47 -47.32 73.09 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.776 0.831 . . . . 0.0 112.104 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -56.77 -55.35 35.38 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.777 1.298 . . . . 0.0 110.256 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -58.19 -39.34 78.71 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.008 -1.451 . . . . 0.0 114.597 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 34.0 mt -58.43 -31.0 67.33 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.962 1.468 . . . . 0.0 114.962 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -58.41 -22.37 53.85 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.534 1.134 . . . . 0.0 114.018 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.86 -26.36 67.32 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.55 175.97 48.48 Favored Glycine 0 N--CA 1.479 1.533 0 C-N-CA 124.211 0.91 . . . . 0.0 113.445 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.19 -27.79 3.49 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 113.539 -1.33 . . . . 0.0 114.933 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -61.44 108.64 0.98 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.959 0.904 . . . . 0.0 112.499 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.401 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -99.42 15.92 59.55 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-N 113.634 -1.621 . . . . 0.0 111.837 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.728 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -173.61 141.21 0.84 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.257 1.023 . . . . 0.0 113.757 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.6 t -123.18 111.82 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 113.318 -1.765 . . . . 0.0 108.267 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.423 HG21 HG11 ' A' ' 21' ' ' VAL . 76.5 mt -100.9 101.8 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.5 t -119.44 128.21 53.81 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -74.14 132.34 42.15 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.052 -1.886 . . . . 0.0 110.426 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -54.01 -44.02 70.57 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.388 1.055 . . . . 0.0 113.098 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -93.7 99.52 11.92 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.673 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.468 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 9.7 mtm -139.88 137.3 18.17 Favored Pre-proline 0 N--CA 1.478 0.967 0 CA-C-N 114.511 -1.222 . . . . 0.0 112.127 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.1 145.13 93.67 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.789 2.993 . . . . 0.0 113.177 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 65.05 -69.09 0.1 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.316 1.847 . . . . 0.0 112.415 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.6 ttm -116.81 100.27 7.67 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.468 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 2.3 p30 -65.32 173.35 2.61 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 113.476 -1.693 . . . . 0.0 113.24 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -52.23 -54.97 24.04 Favored Glycine 0 N--CA 1.478 1.474 0 C-N-CA 124.703 1.144 . . . . 0.0 115.051 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 57.8 tp -59.4 -39.85 84.75 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.599 0.76 . . . . 0.0 111.925 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -66.87 -39.8 87.64 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.354 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.24 -45.34 93.59 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.878 0.871 . . . . 0.0 110.089 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.514 HD13 HG11 ' A' ' 83' ' ' VAL . 9.7 tp -52.32 -45.62 65.69 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.517 1.127 . . . . 0.0 111.77 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -60.31 -47.69 84.93 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.998 0.919 . . . . 0.0 113.082 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.32 -38.24 86.17 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.247 1.019 . . . . 0.0 111.335 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' A' ' 78' ' ' MET . 47.8 mt -67.91 -54.67 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 123.893 0.877 . . . . 0.0 109.467 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.451 ' HD3' ' HA ' ' A' ' 73' ' ' ARG . 62.1 mmt-85 -54.1 -41.11 67.9 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 125.61 1.564 . . . . 0.0 111.918 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.44 -30.73 68.72 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.963 1.305 . . . . 0.0 113.982 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.535 ' OD2' ' HG3' ' A' ' 78' ' ' MET . 27.0 t70 -83.84 93.98 8.11 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.553 0.741 . . . . 0.0 110.36 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -8.86 -80.15 0.01 OUTLIER Glycine 0 N--CA 1.482 1.729 0 C-N-CA 126.85 2.167 . . . . 0.0 117.254 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.18 -42.81 86.88 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.535 ' HG3' ' OD2' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -63.61 -25.28 68.16 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -179.179 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.5 p -53.64 -25.78 19.3 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.22 -22.51 61.25 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.413 1.485 . . . . 0.0 114.439 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.472 ' HA ' ' HD2' ' A' ' 82' ' ' PRO 0.355 1.5 pp -94.02 111.62 53.87 Favored Pre-proline 0 N--CA 1.479 0.997 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 179.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 11.4 Cg_endo -47.46 143.97 10.82 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 125.086 3.857 . . . . 0.0 117.453 -177.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.514 HG11 HD13 ' A' ' 69' ' ' LEU . 87.7 t -117.44 121.29 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 112.248 -2.251 . . . . 0.0 111.575 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.728 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 46.8 tp -112.55 115.5 28.73 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.343 -1.753 . . . . 0.0 108.992 178.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.9 mmt -88.21 112.25 22.55 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.533 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -92.23 96.84 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 123.377 1.56 . . . . 0.0 108.155 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 1.3 t -109.22 128.6 55.18 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 111.457 -2.611 . . . . 0.0 111.494 -178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.12 -38.7 25.77 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -143.37 138.6 29.53 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.24 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.23 84.89 5.13 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.265 -1.334 . . . . 0.0 107.912 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -100.38 133.69 44.43 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 112.055 -2.338 . . . . 0.0 107.253 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -39.12 -49.46 1.8 Allowed 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.941 1.401 . . . . 0.0 113.593 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -58.5 -52.76 64.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.159 0.984 . . . . 0.0 112.079 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -56.33 -44.69 80.24 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.906 0.882 . . . . 0.0 110.928 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 83.4 mt -58.7 -56.15 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.856 0.863 . . . . 0.0 111.195 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.422 HG22 ' OE1' ' A' ' 100' ' ' GLN . 52.4 mt -57.41 -50.82 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.231 0.612 . . . . 0.0 110.511 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.72 -48.32 72.67 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.891 0.876 . . . . 0.0 113.248 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.21 -48.88 79.98 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.687 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.0 -48.25 82.27 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.27 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.422 ' OE1' HG22 ' A' ' 96' ' ' ILE . 62.6 mt-30 -55.6 -42.8 75.36 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.391 1.076 . . . . 0.0 113.897 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.05 -1.37 43.82 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.417 ' C ' HD11 ' A' ' 69' ' ' LEU . . . 107.41 11.47 25.3 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 117.823 1.889 . . . . 0.0 117.823 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.41 125.65 24.89 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.198 1.499 . . . . 0.0 114.86 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.0 m -70.47 -23.15 62.64 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 112.445 -2.161 . . . . 0.0 112.684 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.01 -179.68 45.21 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.541 1.544 . . . . 0.0 110.348 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -147.27 130.45 16.47 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.216 -0.992 . . . . 0.0 111.715 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.7 p -115.36 123.54 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.852 0.834 . . . . 0.0 110.393 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 87' ' ' THR . 67.9 t -77.8 125.44 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 113.231 -1.804 . . . . 0.0 110.679 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -92.66 139.19 23.52 Favored Pre-proline 0 N--CA 1.478 0.934 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.914 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.64 125.36 11.68 Favored 'Cis proline' 0 CA--C 1.54 0.812 0 CA-C-O 122.734 1.056 . . . . 0.0 114.629 0.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.421 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 15.6 p90 -110.01 145.16 37.48 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.039 -1.891 . . . . 0.0 109.015 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 49.9 p -97.89 171.14 8.48 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.35 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.24 -39.07 63.52 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.934 176.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.43 -46.18 84.28 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.88 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.8 m -64.2 -45.98 85.92 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.084 0.954 . . . . 0.0 109.489 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 30.4 tp -56.59 -51.32 69.08 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.099 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -58.22 -47.77 82.47 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.51 0.724 . . . . 0.0 112.372 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -46.08 -47.41 17.2 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.106 0.879 . . . . 0.0 112.291 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -71.54 -47.57 54.32 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.472 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 116' ' ' LEU . 37.5 mt -55.86 -45.24 78.54 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.858 0.863 . . . . 0.0 112.27 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -53.66 -55.86 22.33 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.786 1.234 . . . . 0.0 113.295 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -53.17 -47.47 68.8 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.783 -1.553 . . . . 0.0 112.088 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.407 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 65.5 mt -57.1 -44.41 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 114.2 -1.364 . . . . 0.0 113.238 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.835 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.549 0.941 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -84.57 27.46 0.72 Allowed 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.508 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 7' ' ' LYS . 3.9 tt -82.9 130.53 35.15 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.409 1.084 . . . . 0.0 109.898 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.728 ' HG3' ' HB3' ' A' ' 32' ' ' ASN . 0.4 OUTLIER -87.45 102.01 14.14 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.764 176.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -92.85 133.68 35.83 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.183 -1.826 . . . . 0.0 111.638 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.455 HD12 ' HG ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -109.46 104.23 13.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.754 174.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.514 ' HA ' HG23 ' A' ' 55' ' ' ILE . 54.8 t -80.73 98.27 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.519 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.526 HG12 ' SD ' ' A' ' 60' ' ' MET . 2.7 t -101.7 78.61 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 112.69 -2.05 . . . . 0.0 108.42 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 3.7 m-20 -128.47 100.12 5.66 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 113.044 -1.889 . . . . 0.0 112.313 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -27.69 -41.44 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -92.34 124.76 36.64 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.8 p -47.86 -50.5 26.2 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.143 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.523 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -57.91 -46.24 85.26 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.264 0.626 . . . . 0.0 111.456 177.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.06 -45.8 91.95 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.393 0.677 . . . . 0.0 111.373 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.74 ' HD2' ' HB3' ' A' ' 35' ' ' GLU . 6.6 mtm180 -53.67 -46.78 70.73 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.727 0.811 . . . . 0.0 111.133 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 10.5 mtp180 -61.92 -43.02 99.71 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 112.993 -1.912 . . . . 0.0 113.735 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 16' ' ' THR . 40.1 mm -57.83 -54.74 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.376 0.671 . . . . 0.0 110.311 178.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.535 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 20.7 t -55.05 -44.49 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.67 0.788 . . . . 0.0 110.855 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.415 ' HB3' ' O ' ' A' ' 19' ' ' ARG . 52.4 ttt180 -53.67 -54.83 32.23 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.475 1.11 . . . . 0.0 110.936 177.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -55.74 -39.71 71.51 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.311 1.044 . . . . 0.0 112.743 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.02 -53.55 53.91 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.559 1.144 . . . . 0.0 111.393 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.1 mt -53.98 -41.86 68.34 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.329 1.052 . . . . 0.0 111.832 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -56.94 -51.43 69.18 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.128 -1.397 . . . . 0.0 109.982 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -56.82 -37.68 71.54 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.654 1.581 . . . . 0.0 112.55 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.2 mt -74.03 -18.08 60.89 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.91 15.5 19.99 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.868 1.223 . . . . 0.0 114.356 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -96.27 101.0 12.58 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 123.347 1.546 . . . . 0.0 112.152 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -60.44 -45.33 94.04 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 111.494 -2.594 . . . . 0.0 117.689 -178.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.728 ' HB3' ' HG3' ' A' ' 7' ' ' LYS . 69.8 m-80 -100.16 108.55 20.7 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -173.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.1 t -133.24 120.17 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 112.291 -2.231 . . . . 0.0 109.433 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.436 ' O ' HD23 ' A' ' 9' ' ' LEU . 7.7 tt0 -111.47 154.89 24.05 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 175.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.74 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 33.0 mt-10 -122.46 125.32 45.57 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -120.5 148.25 44.09 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.073 -1.876 . . . . 0.0 109.844 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.58 -61.08 1.98 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -129.67 179.41 5.84 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.799 -176.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -45.45 -52.79 8.59 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-N 114.594 -1.184 . . . . 0.0 115.182 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.7 t -57.79 -57.86 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.027 0.931 . . . . 0.0 111.471 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -55.68 -36.98 67.71 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.07 0.948 . . . . 0.0 111.335 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.441 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -63.78 -51.36 65.2 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.868 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.8 mt -55.05 -45.95 75.31 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.321 0.648 . . . . 0.0 110.936 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -56.46 -58.01 9.86 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.188 0.995 . . . . 0.0 110.933 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -58.18 -40.92 82.73 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.643 1.577 . . . . 0.0 114.569 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 54' ' ' VAL . 25.4 mt -53.57 -41.01 66.08 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -65.04 -15.83 62.77 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.75 14.32 0.21 Allowed 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.28 160.09 6.91 Favored Glycine 0 N--CA 1.483 1.784 0 C-N-CA 126.024 1.773 . . . . 0.0 116.788 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.92 -13.48 3.2 Favored Glycine 0 CA--C 1.546 1.987 0 N-CA-C 120.461 2.944 . . . . 0.0 120.461 176.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.562 ' O ' HD22 ' A' ' 81' ' ' LEU . 76.0 m-85 -65.76 99.97 0.5 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.923 1.861 . . . . 0.0 115.52 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.4 15.77 62.59 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-N 112.55 -2.114 . . . . 0.0 111.797 177.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.468 ' HB2' HD21 ' A' ' 6' ' ' LEU . 0.6 OUTLIER -168.31 136.48 2.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 122.577 1.179 . . . . 0.0 113.756 178.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.505 HG22 HD21 ' A' ' 46' ' ' LEU . 13.4 t -124.23 112.86 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.106 177.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.514 HG23 ' HA ' ' A' ' 10' ' ' VAL . 18.0 tt -115.96 97.89 6.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 113.714 -1.585 . . . . 0.0 107.055 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.3 t -118.37 139.67 51.01 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 119.523 3.157 . . . . 0.0 119.523 -174.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 60' ' ' MET . 15.1 t0 -73.45 129.64 38.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.324 -2.217 . . . . 0.0 110.662 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.493 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 25.0 t-105 -56.15 -39.69 72.67 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.648 0.779 . . . . 0.0 112.401 178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -99.35 93.55 5.98 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.497 1.519 . . . . 0.0 110.334 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.526 ' SD ' HG12 ' A' ' 11' ' ' VAL . 20.0 mtm -132.95 134.88 25.01 Favored Pre-proline 0 N--CA 1.479 1.023 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.79 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -57.11 144.58 89.74 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.729 2.953 . . . . 0.0 111.162 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.7 m120 65.69 -73.62 0.06 Allowed 'General case' 0 N--CA 1.483 1.205 0 O-C-N 125.182 1.551 . . . . 0.0 112.659 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.468 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 55.0 ttm -115.12 98.4 6.76 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.1 p30 -61.84 168.56 3.02 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 112.34 -2.209 . . . . 0.0 112.691 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.46 -52.91 26.76 Favored Glycine 0 N--CA 1.481 1.653 0 C-N-CA 124.632 1.11 . . . . 0.0 114.247 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 60.5 tp -59.81 -40.99 90.25 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.645 0.778 . . . . 0.0 112.247 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -66.03 -43.64 87.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.703 0.801 . . . . 0.0 111.159 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -58.42 -45.66 88.03 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.499 1.12 . . . . 0.0 110.821 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 103' ' ' ALA . 7.4 tt -52.32 -50.07 62.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.205 1.402 . . . . 0.0 109.818 176.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -59.28 -47.01 86.99 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.678 1.191 . . . . 0.0 112.836 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.263 27.6 p -61.24 -23.7 65.83 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.585 1.154 . . . . 0.0 112.291 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.3 mt -84.32 -58.88 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.959 0.904 . . . . 0.0 108.65 174.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.5 mmt-85 -48.67 -51.34 28.94 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.909 2.083 . . . . 0.0 113.968 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.1 -21.4 59.91 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.06 97.64 8.87 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -22.25 -61.45 0.03 OUTLIER Glycine 0 N--CA 1.486 2.033 0 C-N-CA 125.976 1.751 . . . . 0.0 116.37 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.11 91.55 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 97.7 mtp -78.44 -24.27 46.18 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.899 1.815 . . . . 0.0 115.899 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 t -27.94 -33.15 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 118.609 2.818 . . . . 0.0 118.609 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.69 -1.52 58.12 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.562 HD22 ' O ' ' A' ' 51' ' ' TYR . 59.6 mt -75.23 113.25 23.58 Favored Pre-proline 0 N--CA 1.489 1.491 0 CA-C-N 119.248 0.931 . . . . 0.0 113.119 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -56.62 134.46 64.56 Favored 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.436 2.757 . . . . 0.0 113.245 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.3 t -118.9 120.09 62.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 113.971 -1.468 . . . . 0.0 113.413 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.509 HD23 HD12 ' A' ' 55' ' ' ILE . 59.4 tp -112.22 105.4 13.72 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.815 -1.993 . . . . 0.0 109.361 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.2 mmt -78.25 107.53 10.91 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.815 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -87.18 96.22 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 t -100.15 136.78 39.53 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 111.422 -2.627 . . . . 0.0 114.898 -176.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.88 -24.41 66.86 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 112.691 -2.049 . . . . 0.0 113.487 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.503 ' HB3' ' HG3' ' A' ' 91' ' ' LYS . 12.6 mt-10 -155.91 126.23 6.68 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.173 1.389 . . . . 0.0 111.911 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.0 81.07 7.56 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 122.096 0.951 . . . . 0.0 108.897 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.503 ' HG3' ' HB3' ' A' ' 89' ' ' GLU . 43.3 mtmt -110.32 136.38 49.59 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.775 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' A' ' 93' ' ' GLU 0.29 0.0 OUTLIER -33.4 -52.26 0.37 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 117.049 2.241 . . . . 0.0 117.049 -178.993 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.485 ' N ' ' HD2' ' A' ' 92' ' ' LYS 0.334 0.8 OUTLIER -63.91 -42.41 97.41 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -179.458 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.301 32.1 p-10 -73.94 -30.68 62.68 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.868 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.3 mt -61.05 -50.85 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.3 mt -53.42 -54.22 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.349 1.46 . . . . 0.0 110.132 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.72 -48.84 72.0 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.484 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.493 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -57.9 -55.54 33.58 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.831 1.252 . . . . 0.0 112.976 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.83 85.28 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.593 0.757 . . . . 0.0 112.283 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -64.36 -34.12 77.42 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.041 1.496 . . . . 0.0 115.041 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.56 -13.18 59.95 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.12 1.01 8.08 Favored Glycine 0 CA--C 1.547 2.058 0 N-CA-C 117.391 1.716 . . . . 0.0 117.391 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.674 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -55.5 120.43 7.17 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 119.707 1.753 . . . . 0.0 115.116 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.7 m -64.31 -32.95 74.75 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.355 -1.748 . . . . 0.0 112.327 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.72 172.85 45.56 Favored Glycine 0 N--CA 1.477 1.378 0 C-N-CA 125.162 1.363 . . . . 0.0 110.061 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -144.01 140.32 29.51 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.4 p -122.63 127.1 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 124.942 1.401 . . . . 0.0 109.959 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.7 p -86.62 132.76 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.829 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.32 137.61 24.64 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.549 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -77.29 139.35 58.13 Favored 'Cis proline' 0 N--CA 1.482 0.799 0 N-CA-C 115.112 1.158 . . . . 0.0 115.112 -0.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.535 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 25.8 p90 -126.92 147.73 50.07 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 112.424 -2.171 . . . . 0.0 107.953 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.4 p -100.3 174.35 6.17 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.298 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.38 -37.93 62.9 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.178 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.26 -47.71 66.99 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.287 1.035 . . . . 0.0 111.89 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 m -58.25 -47.88 82.17 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.3 tp -56.27 -52.12 65.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.757 1.223 . . . . 0.0 111.412 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.486 ' HA ' HD12 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -55.81 -44.15 77.57 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.991 0.917 . . . . 0.0 112.449 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -57.72 -43.91 85.6 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -64.55 -45.19 88.14 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.273 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 117' ' ' GLU . 94.3 mt -54.08 -49.39 69.19 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.188 0.995 . . . . 0.0 111.468 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -53.94 -55.05 30.56 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.488 1.115 . . . . 0.0 111.945 178.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -51.78 -46.95 64.37 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.147 1.379 . . . . 0.0 111.607 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.4 mt -60.91 -52.15 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.485 1.114 . . . . 0.0 110.646 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 . . . . . 0 N--CA 1.48 1.051 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.383 179.365 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 16.7 ptt-85 . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 p -70.92 79.75 0.64 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 113.166 -1.834 . . . . 0.0 114.831 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.489 ' OD1' ' HB2' ' A' ' 6' ' ' LEU . 2.2 p30 -68.75 -26.43 65.23 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 113.659 -1.61 . . . . 0.0 114.325 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 70.55 -32.73 0.25 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 129.323 3.049 . . . . 0.0 117.367 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.414 ' HG3' ' OD1' ' A' ' 32' ' ' ASN . 0.5 OUTLIER -120.92 89.86 3.21 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.548 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.489 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 5.2 tt -144.26 128.57 17.83 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 112.28 -2.236 . . . . 0.0 107.687 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.485 ' HG2' ' HB3' ' A' ' 32' ' ' ASN . 65.1 mttm -82.06 112.86 19.5 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -104.32 132.97 50.0 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.47 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.476 ' CD1' HG22 ' A' ' 11' ' ' VAL . 2.0 tm? -111.95 99.76 8.35 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.103 0.954 . . . . 0.0 110.06 176.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.469 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 53.9 t -78.94 103.61 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 112.03 -2.35 . . . . 0.0 108.467 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.495 ' CG1' ' HB2' ' A' ' 42' ' ' ALA . 1.3 t -100.85 90.05 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 113.555 -1.657 . . . . 0.0 107.785 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -132.34 121.59 23.75 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.818 1.294 . . . . 0.0 112.275 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.84 -29.9 70.48 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 111.979 -2.373 . . . . 0.0 115.345 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -98.4 121.31 40.18 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.7 0.625 . . . . 0.0 109.452 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.1 p -50.04 -50.67 46.91 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 m -59.45 -50.12 75.16 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.046 0.538 . . . . 0.0 111.137 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -40.35 94.58 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.135 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.528 HH21 ' NH1' ' A' ' 19' ' ' ARG . 37.1 ttp180 -58.88 -48.33 81.78 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.315 1.046 . . . . 0.0 111.147 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.528 ' NH1' HH21 ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.74 -46.47 89.04 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.387 1.054 . . . . 0.0 111.994 177.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.424 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 61.2 mt -53.97 -50.92 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.828 0.851 . . . . 0.0 110.932 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.428 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 5.8 t -57.23 -48.45 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 122.506 0.323 . . . . 0.0 110.732 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -56.39 -50.77 70.63 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.86 0.725 . . . . 0.0 110.946 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -55.83 -43.33 76.89 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.268 1.027 . . . . 0.0 110.769 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 20' ' ' ILE . 67.9 mt -59.97 -51.82 68.03 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.718 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.7 mt -57.11 -43.19 82.06 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.718 0.807 . . . . 0.0 112.81 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -58.2 -48.9 78.88 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.383 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -60.69 -33.99 73.68 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.748 1.619 . . . . 0.0 113.008 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.5 mt -76.2 -13.7 60.17 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.06 -14.44 26.17 Favored Glycine 0 N--CA 1.482 1.755 0 C-N-CA 124.359 0.98 . . . . 0.0 113.741 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -81.23 85.41 6.38 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 122.384 1.088 . . . . 0.0 111.999 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -81.37 13.55 2.91 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.485 ' HB3' ' HG2' ' A' ' 7' ' ' LYS . 20.8 m120 -121.83 85.9 2.49 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 123.461 1.601 . . . . 0.0 110.756 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p -136.78 127.63 41.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 113.562 -1.653 . . . . 0.0 111.374 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.594 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 23.3 mp0 -119.43 155.29 32.29 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.469 ' HG2' ' HB ' ' A' ' 10' ' ' VAL . 29.9 mt-10 -127.8 139.7 52.49 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -177.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.79 167.15 17.72 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 111.175 -2.738 . . . . 0.0 109.748 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -104.35 -53.78 2.65 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -125.0 171.33 10.32 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.199 0.599 . . . . 0.0 110.989 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.475 ' HA2' HD22 ' A' ' 68' ' ' LEU . . . -45.58 -53.77 8.12 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.992 1.282 . . . . 0.0 115.662 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.5 t -58.25 -55.06 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.671 0.788 . . . . 0.0 111.27 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -54.49 -41.51 69.67 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.672 1.189 . . . . 0.0 111.318 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.495 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . . . -63.1 -49.45 74.41 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.501 1.121 . . . . 0.0 112.146 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.518 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 18.0 mt -52.25 -53.91 37.83 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 124.332 1.02 . . . . 0.0 110.706 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -52.11 -52.2 52.99 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.39 1.056 . . . . 0.0 112.426 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -57.93 -52.8 63.99 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.634 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.1 mt -59.56 -33.09 70.98 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 83.3 mt-30 -62.29 -26.27 68.32 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.87 -25.84 68.07 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.79 -168.37 15.96 Favored Glycine 0 N--CA 1.478 1.449 0 O-C-N 124.585 1.178 . . . . 0.0 110.588 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.61 -41.73 2.15 Favored Glycine 0 CA--C 1.541 1.71 0 N-CA-C 116.17 1.228 . . . . 0.0 116.17 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.594 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 76.8 m-85 -66.77 135.42 53.95 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.83 19.87 7.34 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 113.801 -1.545 . . . . 0.0 113.62 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -174.29 144.06 0.91 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.762 1.225 . . . . 0.0 111.776 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 t -125.64 124.66 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.886 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.0 mt -115.92 99.99 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.8 t -116.93 137.5 52.17 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 -176.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -77.37 129.49 35.87 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 113.456 -1.702 . . . . 0.0 110.236 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -56.58 -50.4 72.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.101 0.96 . . . . 0.0 112.534 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.437 ' OD1' ' HB2' ' A' ' 88' ' ' ALA . 4.4 p-10 -87.92 77.28 8.52 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.146 1.379 . . . . 0.0 113.338 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.436 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 3.4 mtm -117.66 133.23 23.32 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-N 113.576 -1.647 . . . . 0.0 113.706 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 60' ' ' MET . 71.5 Cg_exo -61.68 147.02 96.28 Favored 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 123.982 3.122 . . . . 0.0 112.505 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 68.9 -64.08 0.34 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.565 1.946 . . . . 0.0 112.208 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 60.4 ttm -126.69 104.31 8.02 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 124.779 1.231 . . . . 0.0 107.887 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -69.71 168.61 14.57 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 113.614 -1.63 . . . . 0.0 113.178 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.3 -54.57 12.37 Favored Glycine 0 N--CA 1.476 1.314 0 C-N-CA 125.046 1.308 . . . . 0.0 114.393 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.645 HD12 HD23 ' A' ' 69' ' ' LEU . 41.8 tp -59.99 -41.5 92.21 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.66 0.784 . . . . 0.0 112.846 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.5 -43.91 88.65 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.627 0.371 . . . . 0.0 111.228 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.475 HD22 ' HA2' ' A' ' 39' ' ' GLY . 61.1 tp -58.73 -40.82 84.87 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.091 0.956 . . . . 0.0 110.736 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.645 HD23 HD12 ' A' ' 66' ' ' LEU . 13.0 tp -56.0 -45.64 78.99 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.178 0.991 . . . . 0.0 110.675 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.75 -45.42 89.94 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.018 0.927 . . . . 0.0 112.083 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 75' ' ' ASP 0.251 67.8 p -59.84 -38.31 81.71 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.109 0.964 . . . . 0.0 110.54 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.8 mt -68.98 -54.28 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.637 0.775 . . . . 0.0 109.473 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.543 ' HD3' HD12 ' A' ' 69' ' ' LEU . 2.2 mpt_? -52.92 -28.59 24.07 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 126.925 2.09 . . . . 0.0 114.231 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.5 -12.75 15.86 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 78' ' ' MET . 30.8 t0 -80.37 60.39 3.78 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.992 0.917 . . . . 0.0 113.437 -177.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 32.98 -89.5 0.01 OUTLIER Glycine 0 N--CA 1.485 1.964 0 C-N-CA 127.856 2.646 . . . . 0.0 115.036 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.36 -38.58 80.78 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.072 0.949 . . . . 0.0 113.137 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.505 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 87.0 mtp -78.17 -11.17 59.9 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.6 m -57.68 -17.6 15.91 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.64 8.31 41.77 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 86.1 mt -85.11 112.42 43.3 Favored Pre-proline 0 N--CA 1.484 1.247 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 10.9 Cg_endo -51.86 139.52 49.95 Favored 'Trans proline' 0 N--CA 1.477 0.547 0 C-N-CA 123.872 3.048 . . . . 0.0 113.365 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.0 t -122.53 127.42 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.457 -1.247 . . . . 0.0 113.684 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.2 tp -114.66 102.2 9.81 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.534 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.4 mmt -78.96 108.31 12.35 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.361 -1.745 . . . . 0.0 113.162 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 3.9 t -85.93 104.89 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.5 p -94.64 139.74 30.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.703 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.437 ' HB2' ' OD1' ' A' ' 59' ' ' ASN . . . -67.93 -45.39 74.47 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.13 -1.396 . . . . 0.0 110.72 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -136.45 128.39 29.39 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.649 -1.614 . . . . 0.0 107.226 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.16 113.46 26.75 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.715 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.4 153.01 51.22 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 113.171 -1.832 . . . . 0.0 108.277 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -41.25 -43.54 2.42 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -53.37 -61.14 2.49 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.463 1.105 . . . . 0.0 112.933 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -69.94 -28.94 65.98 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 88.1 mt -61.55 -52.7 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.739 0.816 . . . . 0.0 110.102 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.6 mt -62.56 -44.33 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.98 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.54 -47.54 69.89 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.187 0.995 . . . . 0.0 112.104 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.71 -53.4 58.65 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.782 1.233 . . . . 0.0 111.75 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.67 90.72 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.204 1.002 . . . . 0.0 112.279 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -57.61 -38.37 74.81 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.64 1.176 . . . . 0.0 113.325 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.96 5.57 32.59 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.446 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 110.06 -5.56 30.5 Favored Glycine 0 CA--C 1.541 1.718 0 N-CA-C 116.825 1.49 . . . . 0.0 116.825 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.55 117.13 5.81 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 119.454 1.627 . . . . 0.0 113.906 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.3 m -62.59 -28.58 69.98 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 112.109 -2.314 . . . . 0.0 113.142 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.1 170.8 43.14 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.982 1.277 . . . . 0.0 110.706 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -143.81 142.16 30.73 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.18 -1.01 . . . . 0.0 111.738 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 2.0 p -128.92 126.97 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.198 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.4 p -84.47 142.56 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.755 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -90.4 137.85 27.3 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.692 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -86.87 135.63 17.02 Favored 'Cis proline' 0 CA--C 1.539 0.729 0 CA-C-O 122.722 1.051 . . . . 0.0 113.624 -0.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.428 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 28.0 p90 -116.09 151.29 35.88 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 113.467 -1.697 . . . . 0.0 109.558 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.5 p -105.7 177.9 4.72 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.35 0.595 . . . . 0.0 111.384 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.6 -45.1 69.93 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.027 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.33 -48.72 76.85 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.624 0.77 . . . . 0.0 111.221 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.65 -47.97 78.6 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.43 0.692 . . . . 0.0 110.291 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -51.44 70.02 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.445 1.098 . . . . 0.0 109.095 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -55.7 -46.28 77.7 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.644 1.178 . . . . 0.0 112.685 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.03 -48.09 70.88 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.249 0.62 . . . . 0.0 111.352 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -61.94 -47.28 85.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.817 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.5 mt -55.3 -51.1 67.78 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.037 0.835 . . . . 0.0 112.534 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -53.34 -50.51 64.86 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.558 1.143 . . . . 0.0 111.882 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -56.07 -49.01 74.99 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.817 1.647 . . . . 0.0 112.035 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.4 mt -59.47 -48.64 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.278 1.031 . . . . 0.0 110.53 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -58.51 -41.15 84.76 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.03 0.831 . . . . 0.0 112.83 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -62.11 -49.6 75.24 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 124.725 1.266 . . . . 0.0 111.68 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -58.46 -45.88 87.72 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 124.095 0.872 . . . . 0.0 112.462 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.32 -32.14 72.9 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.21 31.99 72.2 Favored Glycine 0 N--CA 1.488 2.128 0 O-C-N 124.406 1.066 . . . . 0.0 111.479 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 4.4 ppp? . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -178.727 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.44 ' O ' HD22 ' A' ' 6' ' ' LEU . 16.5 ptp180 . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 p -78.54 75.11 5.07 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 112.412 -2.176 . . . . 0.0 111.195 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -129.29 130.38 46.09 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.004 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.4 tptt -54.51 -30.2 52.82 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -118.8 73.29 0.92 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.899 0.857 . . . . 0.0 108.884 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.44 HD22 ' O ' ' A' ' 1' ' ' ARG . 50.3 tp -102.27 128.6 48.74 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 112.534 -2.121 . . . . 0.0 109.572 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HG2' ' HB3' ' A' ' 32' ' ' ASN . 43.2 mtpt -74.48 113.42 11.71 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.53 -1.214 . . . . 0.0 114.017 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -107.84 142.53 37.75 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.106 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.415 ' CD1' HG22 ' A' ' 11' ' ' VAL . 1.5 tm? -123.23 103.76 8.73 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.221 175.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 77.1 t -81.28 101.15 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 111.889 -2.414 . . . . 0.0 109.333 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.415 HG22 ' CD1' ' A' ' 9' ' ' LEU . 1.7 t -100.39 94.65 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 113.685 -1.598 . . . . 0.0 107.149 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -139.23 124.75 19.33 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.779 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.6 p-10 -61.92 -30.7 71.07 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.16 121.56 38.06 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.092 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.3 p -47.0 -50.6 18.88 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 113.2 -1.818 . . . . 0.0 113.025 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.407 ' O ' HG12 ' A' ' 20' ' ' ILE . 2.8 m -60.56 -55.27 35.43 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.1 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.441 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -62.69 -35.8 80.85 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -58.55 -47.59 83.69 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.3 1.04 . . . . 0.0 110.395 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.767 ' CZ ' HD21 ' A' ' 23' ' ' ASN . 28.4 tpt180 -60.71 -45.53 93.89 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.286 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.462 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 45.5 mm -52.98 -54.73 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.274 1.03 . . . . 0.0 110.41 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.473 HG11 HG21 ' A' ' 55' ' ' ILE . 2.9 t -59.94 -49.05 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 123.562 0.539 . . . . 0.0 111.345 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.675 HH11 HH12 ' A' ' 19' ' ' ARG . 3.3 tmt_? -54.69 -46.3 74.09 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 124.088 0.867 . . . . 0.0 110.592 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.767 HD21 ' CZ ' ' A' ' 19' ' ' ARG . 12.0 m120 -63.81 -47.49 80.62 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.56 1.144 . . . . 0.0 112.158 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 20' ' ' ILE . 72.0 mt -52.97 -53.77 45.02 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.284 1.034 . . . . 0.0 112.313 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.7 mt -55.61 -48.0 75.6 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.192 0.997 . . . . 0.0 113.372 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -55.89 -46.56 78.29 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 113.215 -1.811 . . . . 0.0 110.476 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -62.4 -31.1 71.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.073 1.749 . . . . 0.0 113.706 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 73.4 mt -77.15 -10.06 59.15 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.835 1.254 . . . . 0.0 113.904 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.76 -12.83 20.43 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 125.302 1.43 . . . . 0.0 114.53 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -85.57 81.29 8.73 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 122.48 1.133 . . . . 0.0 113.629 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -85.42 29.24 0.69 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 113.168 -1.833 . . . . 0.0 114.431 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.575 ' HB3' ' HG2' ' A' ' 7' ' ' LYS . 4.4 m120 -127.62 53.38 1.76 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 123.789 1.757 . . . . 0.0 109.788 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.95 126.19 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.602 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.58 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 72.5 mm-40 -117.49 165.03 14.01 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.33 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -127.41 141.4 51.69 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 119.508 3.151 . . . . 0.0 119.508 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -132.46 148.96 52.41 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 111.301 -2.681 . . . . 0.0 109.098 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -85.81 -53.77 4.92 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.526 -1.215 . . . . 0.0 112.777 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -130.72 171.06 13.52 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.899 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.427 ' HA2' HD22 ' A' ' 68' ' ' LEU . . . -45.14 -44.11 9.45 Favored Glycine 0 N--CA 1.477 1.426 0 O-C-N 125.11 1.506 . . . . 0.0 116.524 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.3 t -61.76 -55.76 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 118.18 -0.914 . . . . 0.0 109.908 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -54.54 -40.01 68.25 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 123.596 0.56 . . . . 0.0 110.726 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.41 -54.46 45.37 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.453 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.529 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 32.3 mt -54.65 -51.26 66.01 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.31 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -46.08 -48.65 17.0 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.961 0.904 . . . . 0.0 112.733 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -69.0 -49.83 54.25 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.917 2.087 . . . . 0.0 113.591 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.4 mt -59.44 -36.66 76.34 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 10.2 mm100 -55.43 -25.66 37.44 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.26 -28.1 68.45 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.95 -170.42 23.82 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.538 1.065 . . . . 0.0 111.405 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.05 -46.06 3.1 Favored Glycine 0 N--CA 1.483 1.817 0 CA-C-N 113.814 -1.193 . . . . 0.0 113.748 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.58 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 74.3 m-85 -62.21 109.57 1.36 Allowed 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.134 0.969 . . . . 0.0 111.961 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.534 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -105.3 29.56 11.36 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-N 113.2 -1.818 . . . . 0.0 113.363 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.569 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -178.72 129.49 0.12 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.053 1.341 . . . . 0.0 112.404 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 t -116.35 116.4 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 113.536 -1.665 . . . . 0.0 107.384 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.473 HG21 HG11 ' A' ' 21' ' ' VAL . 77.4 mt -107.2 98.77 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.5 t -118.28 127.11 53.4 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 117.895 2.554 . . . . 0.0 117.895 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.88 128.55 35.83 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.228 -2.26 . . . . 0.0 111.0 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -49.33 -47.32 47.31 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -92.8 106.76 18.68 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.972 0.891 . . . . 0.0 109.125 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.459 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 2.9 mtp -145.98 133.53 10.33 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.687 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.08 146.8 78.08 Favored 'Trans proline' 0 N--CA 1.48 0.691 0 C-N-CA 123.299 2.666 . . . . 0.0 111.969 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 m120 70.31 -72.92 0.1 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.106 1.762 . . . . 0.0 111.069 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.418 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 56.1 ttm -116.88 97.74 6.12 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.1 p30 -64.48 168.75 5.47 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 113.006 -1.906 . . . . 0.0 113.64 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.22 -56.6 10.25 Favored Glycine 0 N--CA 1.479 1.563 0 C-N-CA 124.664 1.126 . . . . 0.0 114.242 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.473 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 60.7 tp -61.03 -37.85 84.05 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.099 0.959 . . . . 0.0 112.96 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -68.53 -38.85 81.2 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.368 0.667 . . . . 0.0 111.151 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.427 HD22 ' HA2' ' A' ' 39' ' ' GLY . 65.4 tp -64.9 -38.93 92.62 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.861 0.864 . . . . 0.0 110.648 177.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.664 HD23 ' HD3' ' A' ' 73' ' ' ARG . 5.8 tt -50.63 -49.44 56.79 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.027 0.931 . . . . 0.0 109.254 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -60.43 -42.86 96.93 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.936 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.514 ' HB ' HD11 ' A' ' 43' ' ' LEU . 47.8 p -69.22 -14.92 63.24 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.4 1.08 . . . . 0.0 113.014 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.5 mt -92.51 -54.34 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.156 1.382 . . . . 0.0 107.679 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.664 ' HD3' HD23 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -50.8 -52.81 37.51 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.688 1.995 . . . . 0.0 112.761 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.0 -14.7 59.42 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 71' ' ' THR . 7.9 t70 -86.85 75.75 9.55 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.664 0.745 . . . . 0.0 111.847 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 30.99 -100.0 0.01 OUTLIER Glycine 0 N--CA 1.483 1.818 0 C-N-CA 126.828 2.156 . . . . 0.0 115.151 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.84 -31.19 72.15 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 95.5 mtp -62.98 -18.0 62.75 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.7 p -53.17 -26.85 18.62 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.82 -16.43 36.21 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.534 HD22 ' HA2' ' A' ' 52' ' ' GLY . 94.6 mt -76.56 111.41 15.63 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 123.153 0.581 . . . . 0.0 111.51 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -52.49 130.57 36.94 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.389 2.726 . . . . 0.0 115.367 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.418 HG11 ' HG ' ' A' ' 69' ' ' LEU . 47.0 t -113.61 117.78 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 112.462 -2.154 . . . . 0.0 110.754 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.569 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 48.0 tp -110.37 114.77 28.48 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 113.207 -1.815 . . . . 0.0 108.863 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 28.4 mmt -87.92 104.42 16.59 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 122.91 1.338 . . . . 0.0 114.441 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.02 99.38 7.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 122.91 1.338 . . . . 0.0 107.82 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 4.2 t -123.1 129.1 51.02 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 113.256 -1.793 . . . . 0.0 112.546 -177.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.75 -32.02 73.33 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.109 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -107.47 106.5 16.93 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.128 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.434 ' HB2' HG22 ' A' ' 108' ' ' VAL . . . -92.05 66.15 4.91 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 123.767 1.746 . . . . 0.0 107.098 177.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -115.99 150.88 36.49 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 111.868 -2.424 . . . . 0.0 111.056 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -33.61 -57.91 0.43 Allowed 'General case' 0 N--CA 1.476 0.826 0 O-C-N 125.488 1.743 . . . . 0.0 114.725 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -51.69 -52.34 48.95 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -61.72 -49.05 77.99 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.317 0.647 . . . . 0.0 111.53 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.0 mt -56.47 -54.89 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.539 1.136 . . . . 0.0 111.629 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.0 mm -57.86 -54.77 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.548 1.139 . . . . 0.0 111.056 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.83 -45.22 67.21 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.05 0.94 . . . . 0.0 112.47 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.17 -53.14 49.35 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.973 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.97 -46.16 85.6 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -57.72 -39.68 77.84 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.371 1.068 . . . . 0.0 113.579 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.51 -26.93 46.02 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 129.22 13.78 2.32 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 116.651 1.42 . . . . 0.0 116.651 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.629 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -63.43 121.37 13.64 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 118.79 1.295 . . . . 0.0 112.295 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.502 ' HB3' HG23 ' A' ' 123' ' ' ILE . 7.9 m -67.29 -25.78 66.22 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 112.988 -1.914 . . . . 0.0 112.482 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.0 173.11 40.52 Favored Glycine 0 N--CA 1.482 1.705 0 C-N-CA 125.686 1.613 . . . . 0.0 109.66 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -143.35 130.97 21.24 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.25 1.8 p -113.09 123.57 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 122.195 0.998 . . . . 0.0 111.97 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 87' ' ' THR . 8.2 t -72.41 128.36 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 111.609 -2.541 . . . . 0.0 108.963 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -99.93 134.89 20.63 Favored Pre-proline 0 N--CA 1.472 0.638 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.431 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.68 144.28 79.64 Favored 'Cis proline' 0 N--CA 1.482 0.815 0 N-CA-C 115.123 1.163 . . . . 0.0 115.123 0.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -129.77 150.88 50.88 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 112.384 -2.189 . . . . 0.0 107.517 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.414 HG22 ' OG1' ' A' ' 115' ' ' THR . 14.3 t -102.34 172.05 7.11 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.773 0.671 . . . . 0.0 110.29 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.34 -43.9 61.89 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.93 0.892 . . . . 0.0 111.698 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.32 -46.64 87.84 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.134 0.974 . . . . 0.0 112.412 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.414 ' OG1' HG22 ' A' ' 112' ' ' THR . 1.0 OUTLIER -58.79 -48.31 81.7 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.456 1.103 . . . . 0.0 109.181 178.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.416 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 48.8 tp -57.67 -51.32 70.01 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.201 1.4 . . . . 0.0 110.329 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.451 ' HA ' HD12 ' A' ' 120' ' ' LEU . 17.6 tp10 -55.53 -47.36 76.42 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.685 0.794 . . . . 0.0 111.54 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.79 -46.43 74.46 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.429 0.692 . . . . 0.0 112.025 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.9 mmmt -63.95 -48.4 76.66 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 124.2 0.937 . . . . 0.0 112.328 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 117' ' ' GLU . 48.5 mt -53.18 -48.41 68.04 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.498 1.119 . . . . 0.0 110.961 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -55.95 -58.46 7.79 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.534 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -51.32 -44.06 61.86 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.894 1.278 . . . . 0.0 112.37 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.502 HG23 ' HB3' ' A' ' 104' ' ' SER . 79.3 mt -57.2 -52.06 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.164 1.386 . . . . 0.0 112.307 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -56.64 -42.24 78.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 123.885 0.74 . . . . 0.0 112.19 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -57.13 -52.12 66.57 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 125.237 1.586 . . . . 0.0 111.378 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -65.15 -43.07 93.03 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.15 4.53 17.08 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 58.48 41.5 95.4 Favored Glycine 0 CA--C 1.546 2.007 0 C-N-CA 124.549 1.071 . . . . 0.0 113.05 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 73.2 mtp . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 117.31 -1.328 . . . . 0.0 112.755 -178.669 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.724 ' HG3' ' H ' ' A' ' 2' ' ' SER . 13.9 ptt-85 . . . . . 0 CA--C 1.555 1.154 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.724 ' H ' ' HG3' ' A' ' 1' ' ' ARG . 15.2 m -81.27 65.43 6.4 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.056 1.342 . . . . 0.0 110.068 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 54.2 t0 -86.13 121.76 29.18 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 113.737 -1.574 . . . . 0.0 111.452 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 85.2 mttt -51.46 -39.14 56.85 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.282 1.433 . . . . 0.0 113.513 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.83 71.15 10.69 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.591 0.71 . . . . 0.0 109.172 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 4.3 tt -121.28 132.77 55.0 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.154 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -77.06 105.51 8.18 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.162 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -109.43 144.9 37.02 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.139 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.71 110.91 16.52 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.64 -1.163 . . . . 0.0 112.012 174.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.5 t -89.84 106.03 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.501 HG11 ' HB2' ' A' ' 42' ' ' ALA . 4.4 t -106.22 90.06 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 112.864 -1.971 . . . . 0.0 108.888 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -137.88 124.17 20.55 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.184 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -59.88 -25.85 65.41 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -97.88 119.45 36.51 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.248 0.546 . . . . 0.0 110.347 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.9 p -46.05 -48.39 16.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 113.926 -1.488 . . . . 0.0 113.517 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.532 ' O ' HG12 ' A' ' 20' ' ' ILE . 2.9 m -60.85 -55.06 37.52 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.682 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.481 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.2 mmm -59.95 -38.95 83.95 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.507 ' NH1' HH22 ' A' ' 19' ' ' ARG . 15.5 ttm180 -57.1 -53.08 62.16 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.813 0.845 . . . . 0.0 110.153 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.507 HH22 ' NH1' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -58.64 -41.72 86.68 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.142 1.377 . . . . 0.0 113.477 177.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 16' ' ' THR . 39.9 mm -57.1 -58.63 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.261 1.024 . . . . 0.0 110.724 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.58 HG11 HG21 ' A' ' 55' ' ' ILE . 3.4 t -55.99 -44.56 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.231 0.613 . . . . 0.0 111.537 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.592 ' HD2' ' HB3' ' A' ' 35' ' ' GLU . 28.6 mtp-105 -54.25 -55.45 28.04 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.96 0.904 . . . . 0.0 112.376 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -59.92 -39.83 86.79 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 75.9 mt -55.38 -52.38 63.74 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.553 0.692 . . . . 0.0 111.358 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.0 mt -54.66 -48.97 71.71 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.47 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -56.45 -44.89 80.94 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.287 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 29.6 mt-10 -58.06 -40.48 81.12 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.434 1.894 . . . . 0.0 112.308 177.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.2 mt -73.47 -13.95 61.15 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.069 1.347 . . . . 0.0 113.605 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.34 -11.4 24.04 Favored Glycine 0 CA--C 1.544 1.901 0 C-N-CA 124.816 1.198 . . . . 0.0 113.757 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 57.1 m-85 -85.7 76.5 9.95 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 123.23 1.49 . . . . 0.0 111.537 -177.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -72.32 -24.72 61.35 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 118.04 2.607 . . . . 0.0 118.04 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.22 71.68 10.02 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.505 1.145 . . . . 0.0 112.178 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.2 p -120.04 128.6 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HB2' ' HE2' ' A' ' 51' ' ' TYR . 80.7 mm-40 -110.79 167.18 10.43 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.573 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.592 ' HB3' ' HD2' ' A' ' 22' ' ' ARG . 1.2 pp20? -126.75 126.15 42.96 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 -176.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.403 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -122.29 150.97 41.61 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.093 -1.867 . . . . 0.0 108.893 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -92.05 -43.67 9.27 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -141.49 173.34 11.59 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.241 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -43.15 -56.6 4.54 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.065 1.317 . . . . 0.0 115.852 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.1 t -56.16 -54.61 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 123.429 0.691 . . . . 0.0 110.997 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -56.94 -34.27 67.85 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.941 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.501 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -65.41 -48.89 71.24 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.347 1.059 . . . . 0.0 110.971 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.441 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 99.5 mt -57.46 -45.47 84.71 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -55.42 -54.79 39.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.541 1.136 . . . . 0.0 110.927 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -59.66 -45.03 93.27 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 114.399 -1.273 . . . . 0.0 113.641 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.497 HD21 HG22 ' A' ' 54' ' ' VAL . 25.2 mt -55.42 -42.83 74.66 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.327 1.051 . . . . 0.0 112.433 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 53.0 mt-30 -52.92 -35.57 58.47 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.758 1.223 . . . . 0.0 111.493 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.73 59.17 3.55 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.07 -19.63 4.61 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 118.466 2.147 . . . . 0.0 118.466 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.86 56.37 21.39 Favored Glycine 0 CA--C 1.548 2.138 0 CA-C-N 118.23 1.015 . . . . 0.0 112.296 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.579 ' H ' ' HD1' ' A' ' 51' ' ' TYR . 1.4 m-85 -50.71 135.63 23.14 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.063 2.145 . . . . 0.0 113.427 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.486 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -84.47 22.18 9.29 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 -177.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.669 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -178.13 129.26 0.13 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.698 1.237 . . . . 0.0 112.237 177.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.497 HG22 HD21 ' A' ' 46' ' ' LEU . 38.4 t -117.82 113.58 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 112.907 -1.951 . . . . 0.0 107.537 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.58 HG21 HG11 ' A' ' 21' ' ' VAL . 96.5 mt -107.94 97.52 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 t -119.04 136.62 54.04 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -71.13 130.18 40.83 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 112.258 -2.246 . . . . 0.0 109.195 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.447 ' O ' ' HB3' ' A' ' 64' ' ' ASP . 38.7 t-105 -58.29 -44.7 88.62 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.706 0.802 . . . . 0.0 111.428 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -94.53 96.17 9.29 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.747 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.493 ' SD ' HG12 ' A' ' 11' ' ' VAL . 33.6 mtm -134.71 132.76 20.78 Favored Pre-proline 0 N--CA 1.486 1.33 0 CA-C-N 113.651 -1.613 . . . . 0.0 110.362 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -59.34 144.06 99.52 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.763 2.975 . . . . 0.0 112.517 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.8 m120 69.69 -65.02 0.32 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.543 1.937 . . . . 0.0 113.062 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.0 ttm -123.3 96.77 5.12 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.489 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 6.0 m-20 -68.34 167.12 15.18 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.034 -1.894 . . . . 0.0 112.548 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -47.0 -55.04 8.8 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.645 1.593 . . . . 0.0 116.152 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.48 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 48.9 tp -56.71 -48.88 76.71 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . 0.268 7.1 pm0 -67.98 -33.76 75.25 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 177.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.11 -43.96 95.22 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.855 0.722 . . . . 0.0 110.079 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.48 ' HB3' ' O ' ' A' ' 66' ' ' LEU . 12.2 tp -54.09 -44.41 71.17 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.416 1.086 . . . . 0.0 110.865 175.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -64.15 -43.68 94.48 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.55 0.74 . . . . 0.0 111.785 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.263 33.0 p -58.6 -29.86 66.78 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 123.682 0.793 . . . . 0.0 111.99 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.552 HG23 ' HB3' ' A' ' 78' ' ' MET . 45.6 mt -80.02 -56.61 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.855 1.262 . . . . 0.0 109.217 177.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.47 ' HG3' ' HA3' ' A' ' 102' ' ' GLY . 77.4 mmt-85 -53.94 -47.48 71.23 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.539 1.536 . . . . 0.0 114.076 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.31 -26.32 67.72 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.284 1.033 . . . . 0.0 113.557 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -85.11 108.17 17.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.294 1.038 . . . . 0.0 108.827 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -29.14 -61.78 0.15 Allowed Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.046 1.784 . . . . 0.0 114.95 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.38 -47.9 80.12 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.552 ' HB3' HG23 ' A' ' 72' ' ' ILE . 55.4 mtm -68.31 -22.19 64.73 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.8 p -46.45 -35.73 5.9 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.31 -13.11 59.45 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.486 HD22 ' HA2' ' A' ' 52' ' ' GLY . 77.4 mt -79.31 111.87 23.96 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 122.857 0.463 . . . . 0.0 111.388 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 11.6 Cg_endo -51.31 136.42 46.99 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.685 2.923 . . . . 0.0 115.919 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.474 HG11 HD13 ' A' ' 69' ' ' LEU . 67.2 t -120.08 123.34 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 112.843 -1.98 . . . . 0.0 112.686 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.669 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -112.45 110.15 20.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 112.887 -1.96 . . . . 0.0 107.864 177.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 30.1 mmt -85.22 105.3 15.81 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 113.628 -1.624 . . . . 0.0 111.991 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.52 103.51 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.34 138.38 42.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 112.068 -2.333 . . . . 0.0 115.851 -174.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.17 -27.92 69.4 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.045 -1.889 . . . . 0.0 113.157 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -151.97 110.99 3.86 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 124.171 0.92 . . . . 0.0 110.21 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.43 86.42 4.48 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.494 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -118.85 147.22 44.19 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.956 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -33.53 -55.66 0.44 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -53.24 -49.5 66.7 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.613 0.765 . . . . 0.0 112.33 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.68 -49.07 79.0 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.006 1.323 . . . . 0.0 110.811 177.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 79.4 mt -58.73 -53.21 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 124.508 1.13 . . . . 0.0 111.411 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.528 HG23 ' OE1' ' A' ' 100' ' ' GLN . 57.0 mt -55.39 -54.49 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.642 1.177 . . . . 0.0 110.537 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.58 -47.2 73.6 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.812 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.404 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -59.52 -58.0 10.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.3 1.04 . . . . 0.0 112.84 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.16 -49.01 78.49 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.518 0.727 . . . . 0.0 112.619 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.528 ' OE1' HG23 ' A' ' 96' ' ' ILE . 29.2 mt-30 -65.91 -25.37 67.12 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.4 1.45 54.67 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.47 ' HA3' ' HG3' ' A' ' 73' ' ' ARG . . . 113.75 -4.84 24.38 Favored Glycine 0 CA--C 1.545 1.95 0 N-CA-C 116.829 1.492 . . . . 0.0 116.829 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.63 119.81 9.96 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.098 1.449 . . . . 0.0 114.686 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.479 ' HB3' HG23 ' A' ' 123' ' ' ILE . 14.5 m -63.48 -30.45 71.57 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 110.823 -2.899 . . . . 0.0 113.691 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -174.58 167.07 39.21 Favored Glycine 0 N--CA 1.476 1.32 0 C-N-CA 124.501 1.048 . . . . 0.0 110.761 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -142.5 138.42 30.93 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.625 -0.788 . . . . 0.0 112.065 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.98 131.17 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 124.243 0.964 . . . . 0.0 112.277 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.5 p -79.26 134.79 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 113.417 -1.72 . . . . 0.0 110.803 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.435 ' HB3' ' HZ3' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -85.13 136.73 37.84 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.022 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -87.22 153.34 42.85 Favored 'Cis proline' 0 CA--C 1.541 0.873 0 CA-C-O 122.451 0.938 . . . . 0.0 112.771 -1.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -131.42 150.61 52.08 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 113.468 -1.696 . . . . 0.0 108.949 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.7 t -101.92 169.71 8.6 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 123.776 0.673 . . . . 0.0 111.829 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.33 37.38 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.427 1.091 . . . . 0.0 112.187 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.22 -52.02 66.54 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.877 0.871 . . . . 0.0 112.31 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -57.09 -48.96 77.32 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.249 1.02 . . . . 0.0 110.081 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.1 tp -56.49 -52.82 63.3 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.919 1.387 . . . . 0.0 110.349 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -55.24 -48.97 73.17 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.497 1.119 . . . . 0.0 112.573 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -50.91 -46.68 60.8 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.978 0.911 . . . . 0.0 112.107 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.634 ' O ' HG12 ' A' ' 123' ' ' ILE . 35.6 mttp -67.78 -52.38 37.85 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.233 177.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.2 mt -48.04 -51.36 24.53 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.68 0.792 . . . . 0.0 112.238 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -52.25 -55.92 18.1 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.846 1.258 . . . . 0.0 112.32 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -61.57 -39.71 92.13 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.193 1.397 . . . . 0.0 113.096 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.634 HG12 ' O ' ' A' ' 119' ' ' LYS . 31.6 mm -57.56 -49.18 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.962 0.905 . . . . 0.0 111.045 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -52.12 -45.42 64.91 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.357 0.663 . . . . 0.0 112.364 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -59.38 -53.55 56.94 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.092 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -59.28 -42.91 92.35 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.51 6.14 7.64 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.54 -7.68 46.36 Favored Glycine 0 CA--C 1.545 1.946 0 C-N-CA 124.59 1.09 . . . . 0.0 114.922 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 89.7 mtp . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.023 -1.465 . . . . 0.0 113.122 -178.827 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 . . . . . 0 CA--C 1.559 1.291 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.1 p -74.14 20.01 0.11 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.205 1.402 . . . . 0.0 114.378 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -117.25 77.65 1.15 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 123.105 1.431 . . . . 0.0 111.684 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -55.43 -31.88 62.26 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 112.341 -2.209 . . . . 0.0 116.409 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.13 27.82 0.65 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 tt -77.91 132.59 37.99 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.618 0.767 . . . . 0.0 109.932 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 51' ' ' TYR . 4.8 ttmm -84.04 104.51 14.17 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 125.032 1.458 . . . . 0.0 112.762 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -104.28 142.29 34.81 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 113.081 -1.872 . . . . 0.0 114.165 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 45' ' ' LYS . 0.3 OUTLIER -119.71 112.14 18.91 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.447 173.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 83.1 t -84.26 94.0 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.495 HG12 ' SD ' ' A' ' 60' ' ' MET . 4.2 t -98.21 85.8 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 123.832 1.777 . . . . 0.0 106.284 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -126.97 121.08 30.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 111.908 -2.405 . . . . 0.0 113.488 -175.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.442 ' HB3' ' HG2' ' A' ' 60' ' ' MET . 11.8 p-10 -60.04 -28.15 67.52 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 112.233 -2.258 . . . . 0.0 115.702 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -99.03 103.88 15.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.211 -1.404 . . . . 0.0 107.211 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -41.79 -42.82 2.76 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.975 1.31 . . . . 0.0 113.735 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -51.75 62.98 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.801 1.24 . . . . 0.0 111.41 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.443 ' O ' HG23 ' A' ' 21' ' ' VAL . 13.4 ttt -64.27 -36.19 83.28 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.87 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -52.71 -50.27 63.7 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.633 1.173 . . . . 0.0 110.533 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -58.6 -51.08 71.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.771 1.228 . . . . 0.0 110.211 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.43 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 51.0 mt -55.11 -51.8 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.047 0.939 . . . . 0.0 112.162 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 17' ' ' MET . 16.4 t -57.09 -44.48 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 118.461 0.573 . . . . 0.0 110.992 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -50.26 71.73 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.205 1.402 . . . . 0.0 109.615 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -60.3 -41.59 93.73 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.6 1.16 . . . . 0.0 112.302 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.45 HD22 ' HB2' ' A' ' 113' ' ' ALA . 78.2 mt -56.87 -51.13 70.28 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.252 1.021 . . . . 0.0 110.685 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.8 mt -55.88 -45.71 78.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.018 0.927 . . . . 0.0 111.857 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -56.36 -46.73 79.89 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.678 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -59.83 -38.7 82.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.358 1.463 . . . . 0.0 112.602 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.8 mt -71.2 -13.17 61.83 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.507 1.123 . . . . 0.0 113.836 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.3 -1.17 32.95 Favored Glycine 0 CA--C 1.541 1.676 0 C-N-CA 124.808 1.194 . . . . 0.0 114.806 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -79.2 108.93 13.06 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 123.322 1.534 . . . . 0.0 114.385 -177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -67.87 -51.34 49.32 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 110.726 -2.943 . . . . 0.0 117.42 -176.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.424 ' HB3' ' HG3' ' A' ' 7' ' ' LYS . 78.0 m-20 -97.45 97.24 8.93 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -174.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -133.21 118.39 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.971 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.692 ' HB2' ' HE2' ' A' ' 51' ' ' TYR . 4.1 mp0 -106.28 161.49 14.5 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.31 178.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.89 119.37 21.07 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.61 165.45 16.44 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 113.299 -1.773 . . . . 0.0 109.597 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -109.69 -38.71 5.33 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 118.017 2.599 . . . . 0.0 118.017 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -128.67 167.62 16.94 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.867 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.506 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -44.24 -57.71 4.81 Favored Glycine 0 N--CA 1.478 1.477 0 C-N-CA 125.831 1.681 . . . . 0.0 114.529 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.7 t -55.3 -58.45 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.549 0.739 . . . . 0.0 111.702 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.38 -32.83 57.93 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.462 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . . . -65.74 -50.57 64.31 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.51 1.124 . . . . 0.0 111.249 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.4 mt -58.55 -43.38 89.27 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.873 0.733 . . . . 0.0 110.679 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -54.3 -58.49 7.21 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.492 0.717 . . . . 0.0 110.641 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.598 ' HB3' HD11 ' A' ' 9' ' ' LEU . 16.0 tttt -61.69 -39.66 92.22 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.427 HD11 HG22 ' A' ' 54' ' ' VAL . 3.4 tp -54.66 -37.26 65.51 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.914 1.286 . . . . 0.0 113.669 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -68.63 -10.17 54.39 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.81 15.85 0.34 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.82 94.3 1.98 Allowed Glycine 0 N--CA 1.481 1.661 0 N-CA-C 115.443 0.937 . . . . 0.0 115.443 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 17.84 88.46 0.01 OUTLIER Glycine 0 CA--C 1.546 2.021 0 C-N-CA 128.683 3.039 . . . . 0.0 120.248 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.692 ' HE2' ' HB2' ' A' ' 34' ' ' GLU . 37.6 m-85 -88.63 104.32 16.75 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.894 -1.153 . . . . 0.0 109.89 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.64 27.22 1.9 Allowed Glycine 0 N--CA 1.478 1.458 0 CA-C-N 114.039 -1.437 . . . . 0.0 114.919 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.583 ' HZ ' HD13 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -178.71 131.52 0.12 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.49 1.516 . . . . 0.0 113.062 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.427 HG22 HD11 ' A' ' 46' ' ' LEU . 59.1 t -126.55 115.0 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 113.188 -1.823 . . . . 0.0 107.744 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 94.9 mt -106.2 101.17 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.6 t -120.0 133.42 55.55 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 117.623 2.453 . . . . 0.0 117.623 -175.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 60' ' ' MET . 6.3 m-20 -73.67 136.39 43.8 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.185 -1.371 . . . . 0.0 111.059 176.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -56.73 -49.31 75.59 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.016 0.822 . . . . 0.0 111.324 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -92.29 101.38 13.86 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.11 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.495 ' SD ' HG12 ' A' ' 11' ' ' VAL . 30.0 mtm -133.85 125.28 18.19 Favored Pre-proline 0 N--CA 1.482 1.131 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.363 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -55.52 150.55 42.37 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 124.009 3.139 . . . . 0.0 111.635 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 70.47 -69.51 0.17 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.461 1.904 . . . . 0.0 111.5 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.506 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 18.6 ttp -127.04 109.21 11.65 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -64.94 167.29 7.93 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.327 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.56 -48.82 63.54 Favored Glycine 0 N--CA 1.48 1.619 0 C-N-CA 124.273 0.939 . . . . 0.0 114.602 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.45 -40.07 93.13 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.826 0.45 . . . . 0.0 112.183 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -63.37 -41.82 98.84 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.83 -49.83 75.89 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.949 0.9 . . . . 0.0 110.964 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.715 HD11 ' HB2' ' A' ' 103' ' ' ALA . 4.0 tt -46.75 -50.79 17.56 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.28 1.432 . . . . 0.0 109.274 176.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.69 -46.57 84.92 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.266 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 47.2 p -59.24 -25.31 63.92 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.094 0.958 . . . . 0.0 112.982 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.4 mt -84.02 -58.04 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 73' ' ' ARG . 25.8 mmt180 -49.74 -46.77 50.74 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.875 1.67 . . . . 0.0 113.122 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.37 -18.79 57.05 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -82.57 94.82 7.58 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.736 -0.602 . . . . 0.0 110.178 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -21.18 -62.48 0.02 OUTLIER Glycine 0 CA--C 1.547 2.062 0 C-N-CA 126.88 2.181 . . . . 0.0 116.232 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.16 89.07 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.523 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 49.1 mtm -87.26 -34.67 18.85 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.4 t 2.57 -61.03 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 121.385 3.846 . . . . 0.0 121.385 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.24 25.03 0.62 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 118.855 2.909 . . . . 0.0 118.855 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 78' ' ' MET . 86.2 mt -83.05 118.94 73.25 Favored Pre-proline 0 N--CA 1.483 1.19 0 O-C-N 121.306 -0.872 . . . . 0.0 112.794 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.36 128.34 28.85 Favored 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 123.53 2.82 . . . . 0.0 113.675 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.468 HG11 ' HG ' ' A' ' 69' ' ' LEU . 3.4 t -116.57 119.89 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 113.13 -1.85 . . . . 0.0 112.645 -177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.53 HD13 HD11 ' A' ' 123' ' ' ILE . 45.2 tp -108.55 109.45 20.69 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.384 -1.734 . . . . 0.0 108.766 176.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 82.9 mmm -87.32 112.44 22.08 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 113.89 -1.505 . . . . 0.0 114.597 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.56 102.62 13.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 123.901 1.81 . . . . 0.0 108.319 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.9 t -115.71 130.26 56.79 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 111.593 -2.549 . . . . 0.0 109.426 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -46.42 -40.99 13.07 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -141.78 148.55 39.1 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.41 83.3 3.85 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 122.97 1.366 . . . . 0.0 107.718 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.48 ' O ' HG12 ' A' ' 95' ' ' ILE . 87.8 mttt -92.68 112.36 24.29 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 111.011 -2.813 . . . . 0.0 109.139 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 92' ' ' LYS . 71.6 mmtt -34.57 -56.03 0.54 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 117.431 2.382 . . . . 0.0 117.431 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . 0.258 0.0 OUTLIER -55.58 -42.86 75.35 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 177.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -62.63 -47.59 83.07 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.672 1.189 . . . . 0.0 110.335 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 91' ' ' LYS . 18.1 mm -58.08 -49.71 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.1 1.36 . . . . 0.0 112.537 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.439 HG22 ' OE1' ' A' ' 100' ' ' GLN . 31.7 mt -60.1 -50.66 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.284 0.634 . . . . 0.0 110.271 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.89 -46.43 81.92 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.777 0.831 . . . . 0.0 111.908 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.71 -56.24 19.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.427 1.491 . . . . 0.0 112.241 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.38 -48.35 82.13 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.071 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.439 ' OE1' HG22 ' A' ' 96' ' ' ILE . 72.8 mt-30 -56.53 -37.72 70.88 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.84 -16.45 55.41 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.65 12.65 7.15 Favored Glycine 0 CA--C 1.545 1.916 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.715 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -70.34 106.1 3.25 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.981 1.372 . . . . 0.0 111.36 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.473 ' HB3' HG23 ' A' ' 123' ' ' ILE . 6.9 m -56.89 -27.22 60.33 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 112.234 -2.257 . . . . 0.0 113.25 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -173.6 169.08 42.14 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.209 0.909 . . . . 0.0 111.406 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -142.62 142.27 32.08 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.643 -0.778 . . . . 0.0 110.948 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.61 131.47 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 124.742 1.276 . . . . 0.0 111.491 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -79.79 126.0 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 112.34 -2.209 . . . . 0.0 110.301 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 110' ' ' PRO . 34.5 ttpt -91.52 130.6 38.76 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 112.843 -1.98 . . . . 0.0 110.511 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 92.8 Cg_endo -80.41 148.39 77.07 Favored 'Cis proline' 0 N--CA 1.484 0.937 0 O-C-N 123.233 1.123 . . . . 0.0 114.953 0.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -130.31 156.53 44.51 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.002 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 69.9 p -108.96 174.83 5.69 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.693 0.797 . . . . 0.0 111.013 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.45 ' HB2' HD22 ' A' ' 24' ' ' LEU . . . -54.99 -39.0 68.56 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.142 175.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.71 -47.39 72.5 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.039 0.936 . . . . 0.0 111.263 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.0 m -61.32 -46.0 92.12 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 50.6 tp -56.24 -50.67 70.65 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.925 1.29 . . . . 0.0 109.529 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.483 ' HA ' HD12 ' A' ' 120' ' ' LEU . 40.5 tt0 -55.42 -48.77 73.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.293 1.037 . . . . 0.0 111.488 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -55.93 -46.89 78.37 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.361 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.3 mptp? -63.92 -42.18 97.45 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.114 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 117' ' ' GLU . 86.8 mt -53.87 -51.02 64.97 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.219 0.608 . . . . 0.0 111.101 177.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -50.05 -52.29 35.59 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.333 1.053 . . . . 0.0 113.137 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -53.59 -47.05 70.52 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.478 1.511 . . . . 0.0 112.386 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.583 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 57.8 mt -57.46 -51.52 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.872 1.269 . . . . 0.0 111.925 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -56.51 -38.83 72.33 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -61.86 -48.06 82.22 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.817 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -58.25 -41.12 83.53 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.364 1.066 . . . . 0.0 112.175 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -73.4 13.29 0.47 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.66 23.41 73.87 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 125.374 1.464 . . . . 0.0 114.508 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 76.2 mtp . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 116.704 -1.617 . . . . 0.0 112.219 -179.061 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.081 0 N-CA-C 116.048 1.869 . . . . 0.0 116.048 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.6 t -52.26 112.27 0.77 Allowed 'General case' 0 C--O 1.241 0.628 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 43.9 t0 -76.06 85.74 2.95 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -54.71 -28.79 50.46 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -100.07 41.1 1.18 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 123.206 1.479 . . . . 0.0 113.791 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 4.6 tt -86.25 124.72 32.94 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.277 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.61 ' HE3' HD22 ' A' ' 32' ' ' ASN . 12.9 mptt -75.96 107.92 8.5 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 125.095 1.497 . . . . 0.0 113.393 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -102.88 132.83 48.82 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 112.402 -2.181 . . . . 0.0 111.8 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.529 HD21 ' HD3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -108.46 102.7 11.77 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.069 -1.053 . . . . 0.0 109.288 173.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.526 ' HA ' HG23 ' A' ' 55' ' ' ILE . 46.6 t -79.14 98.72 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 113.481 -1.69 . . . . 0.0 106.777 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.754 HG11 ' HB2' ' A' ' 42' ' ' ALA . 3.3 t -108.24 60.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 112.241 -2.254 . . . . 0.0 107.138 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.612 ' HA ' ' HB2' ' A' ' 57' ' ' ASP . 11.6 t70 -109.56 90.38 3.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 113.359 -1.746 . . . . 0.0 108.638 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -13.58 -42.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 121.58 3.919 . . . . 0.0 121.58 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.523 ' C ' ' H ' ' A' ' 16' ' ' THR . 2.6 t80 -87.57 109.6 19.76 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 t -65.98 27.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 124.167 1.937 . . . . 0.0 115.697 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.523 ' H ' ' C ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -123.72 -58.52 1.58 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.062 2.545 . . . . 0.0 105.448 177.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.528 ' HA ' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -60.05 -35.82 75.96 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.696 177.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 36' ' ' ALA . 8.8 ttp180 -53.76 -50.93 64.94 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.521 1.529 . . . . 0.0 112.139 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.632 ' CZ ' HD21 ' A' ' 23' ' ' ASN . 3.0 tmt_? -65.24 -38.37 90.15 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.809 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 17' ' ' MET . 71.6 mt -57.73 -46.3 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 17' ' ' MET . 12.7 t -58.26 -42.52 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.462 0.705 . . . . 0.0 110.049 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.459 ' NH2' ' HE ' ' A' ' 19' ' ' ARG . 46.9 ttp180 -53.01 -52.57 57.97 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.187 0.995 . . . . 0.0 110.575 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.632 HD21 ' CZ ' ' A' ' 19' ' ' ARG . 80.9 m-20 -57.71 -41.02 80.88 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.355 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -59.62 -51.44 69.79 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.135 0.974 . . . . 0.0 110.774 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.9 mt -56.56 -44.51 81.01 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.015 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -58.59 -42.26 87.69 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.981 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -59.78 -38.55 82.16 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.627 1.171 . . . . 0.0 110.48 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 mp -74.94 -11.9 60.22 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.29 2.236 . . . . 0.0 115.17 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.82 -0.61 41.91 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.035 1.302 . . . . 0.0 114.648 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -89.13 97.95 11.49 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 123.266 1.508 . . . . 0.0 112.459 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -72.46 -37.33 68.55 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 110.858 -2.883 . . . . 0.0 116.056 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.61 HD22 ' HE3' ' A' ' 7' ' ' LYS . 3.6 m120 -95.91 96.4 8.89 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.749 1.262 . . . . 0.0 113.895 -173.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.2 t -129.66 131.96 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.407 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -117.72 154.8 31.07 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -126.96 120.19 28.52 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -122.31 152.99 39.54 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 113.611 -1.631 . . . . 0.0 109.863 177.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -78.37 -66.13 0.89 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -129.44 -176.61 3.95 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 117.972 -1.013 . . . . 0.0 112.16 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 42' ' ' ALA . . . -45.39 -53.55 7.98 Favored Glycine 0 N--CA 1.482 1.766 0 O-C-N 125.048 1.467 . . . . 0.0 114.112 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -57.32 -57.87 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.348 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -55.52 -34.65 64.84 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.754 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -58.26 -53.56 56.85 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.753 1.221 . . . . 0.0 110.385 177.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.4 mt -60.27 -41.87 94.2 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.928 0.891 . . . . 0.0 111.313 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.418 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 24.8 m120 -53.35 -52.14 60.18 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.811 0.844 . . . . 0.0 111.233 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HD3' HD21 ' A' ' 9' ' ' LEU . 12.7 tttp -70.36 -41.2 73.43 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 124.212 0.945 . . . . 0.0 113.141 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.9 mt -54.42 -36.42 63.98 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 10.6 pt20 -52.33 -26.46 12.29 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.4 -19.16 64.44 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.44 -170.42 52.17 Favored Glycine 0 N--CA 1.474 1.224 0 C-N-CA 124.427 1.013 . . . . 0.0 111.113 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.75 -29.7 1.52 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 115.504 0.962 . . . . 0.0 115.504 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -67.85 107.99 2.83 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.52 -22.86 52.74 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-N 112.587 -2.097 . . . . 0.0 110.028 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.514 ' HZ ' HD13 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -133.35 141.65 48.02 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -174.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.5 t -127.16 110.68 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 113.765 -1.562 . . . . 0.0 107.343 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.526 HG23 ' HA ' ' A' ' 10' ' ' VAL . 13.1 tt -110.22 93.3 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 124.094 1.902 . . . . 0.0 106.607 177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.1 t -117.27 147.76 42.27 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 111.887 -2.415 . . . . 0.0 115.433 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.612 ' HB2' ' HA ' ' A' ' 12' ' ' ASP . 4.8 t70 -79.63 144.29 33.92 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.733 -1.122 . . . . 0.0 112.834 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.482 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 20.3 t-105 -61.23 -47.2 87.16 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.077 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -95.59 103.38 15.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.673 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 54.0 mtm -134.99 134.24 21.58 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-N 113.243 -1.799 . . . . 0.0 110.531 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -60.42 143.62 99.48 Favored 'Trans proline' 0 N--CA 1.482 0.827 0 C-N-CA 123.186 2.59 . . . . 0.0 112.089 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 m120 67.89 -69.81 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.902 1.681 . . . . 0.0 113.763 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.1 ttm -114.86 98.75 7.01 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -61.56 165.87 4.59 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 112.605 -2.088 . . . . 0.0 111.932 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.44 -52.08 29.73 Favored Glycine 0 N--CA 1.476 1.353 0 C-N-CA 124.692 1.139 . . . . 0.0 115.081 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 42.2 tp -58.84 -38.46 78.74 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.225 1.01 . . . . 0.0 113.222 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -72.44 -36.27 68.51 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.57 0.748 . . . . 0.0 111.014 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -59.03 -38.22 78.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.804 0.841 . . . . 0.0 111.016 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' A' ' 103' ' ' ALA . 9.1 mp -50.92 -52.24 44.1 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.76 1.224 . . . . 0.0 109.832 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -56.38 -48.76 76.21 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.042 -1.435 . . . . 0.0 112.505 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.3 p -58.17 -33.42 69.22 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.8 mt -80.8 -57.35 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.5 ' HG3' ' HA3' ' A' ' 102' ' ' GLY . 24.9 mmt180 -49.23 -45.82 45.09 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.344 1.858 . . . . 0.0 114.11 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.74 -25.52 61.23 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -81.34 93.9 6.65 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.187 0.595 . . . . 0.0 109.514 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -25.71 -58.76 0.07 OUTLIER Glycine 0 CA--C 1.542 1.753 0 C-N-CA 127.078 2.275 . . . . 0.0 116.756 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.77 -38.91 83.12 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.47 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 91.3 mtp -89.52 -45.38 9.45 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.412 1.485 . . . . 0.0 114.608 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.2 t 8.82 -78.21 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 120.091 3.367 . . . . 0.0 120.091 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.03 29.25 0.13 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 118.655 2.835 . . . . 0.0 118.655 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 78' ' ' MET . 82.4 mt -76.62 133.81 70.12 Favored Pre-proline 0 N--CA 1.479 0.981 0 O-C-N 121.184 -0.947 . . . . 0.0 111.876 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -56.81 114.23 1.83 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.816 2.344 . . . . 0.0 112.806 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 81' ' ' LEU . 37.0 t -109.94 110.97 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 111.704 -2.498 . . . . 0.0 109.245 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.51 HD23 HD12 ' A' ' 55' ' ' ILE . 41.1 tp -106.56 104.08 13.68 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 112.805 -1.998 . . . . 0.0 109.363 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.5 mmt -78.57 118.13 20.4 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 113.053 -1.885 . . . . 0.0 112.678 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.674 HG12 ' HB2' ' A' ' 109' ' ' LYS . 1.5 t -91.18 96.72 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.7 p -94.38 114.97 27.11 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.256 -1.793 . . . . 0.0 112.886 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.05 -22.01 5.37 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -166.74 118.79 0.97 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.61 92.96 4.77 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.578 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 95' ' ' ILE . 78.0 mttt -101.68 132.19 47.51 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.395 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -41.17 -46.78 3.14 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.734 1.213 . . . . 0.0 114.134 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -52.74 -55.32 23.62 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.708 1.603 . . . . 0.0 110.973 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -58.91 -42.91 90.73 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.352 1.461 . . . . 0.0 111.241 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 91' ' ' LYS . 14.7 mm -60.39 -49.09 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.52 1.128 . . . . 0.0 111.547 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 37.4 mt -57.73 -50.95 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.81 -45.84 74.43 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.087 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.482 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -57.42 -54.89 41.71 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.693 1.197 . . . . 0.0 112.418 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.38 -41.99 81.27 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.334 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -66.14 -40.04 90.31 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.73 0.55 52.49 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 117.674 2.472 . . . . 0.0 117.674 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.5 ' HA3' ' HG3' ' A' ' 73' ' ' ARG . . . 110.34 21.6 6.85 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 117.702 1.841 . . . . 0.0 117.702 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.599 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -82.62 110.32 17.58 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.416 1.108 . . . . 0.0 112.029 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.9 m -59.99 -30.26 69.01 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 113.219 -1.81 . . . . 0.0 113.519 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.25 173.45 46.28 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.198 1.38 . . . . 0.0 110.055 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -148.83 139.08 22.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.052 -0.574 . . . . 0.0 112.527 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.9 p -115.2 117.93 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 124.2 0.937 . . . . 0.0 109.505 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.0 p -71.33 109.45 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 113.076 -1.874 . . . . 0.0 114.261 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.674 ' HB2' HG12 ' A' ' 86' ' ' VAL . 68.1 tttt -83.13 130.11 58.43 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 111.079 -2.782 . . . . 0.0 107.681 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.6 133.34 26.6 Favored 'Cis proline' 0 CA--C 1.54 0.78 0 O-C-N 123.962 1.506 . . . . 0.0 114.854 0.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.441 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 17.9 p90 -130.58 157.25 43.23 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 112.653 -2.067 . . . . 0.0 109.01 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.2 t -116.61 176.02 5.3 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.063 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.45 -41.78 61.08 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.203 1.001 . . . . 0.0 111.82 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.99 -50.07 73.55 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.568 0.747 . . . . 0.0 112.819 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.32 -45.04 94.81 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.623 1.169 . . . . 0.0 109.982 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 58.1 tp -56.99 -50.54 72.38 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.305 1.042 . . . . 0.0 109.888 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -58.13 -47.65 82.66 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.61 0.764 . . . . 0.0 111.376 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -51.22 -43.36 61.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.484 0.714 . . . . 0.0 112.278 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -72.78 -41.7 64.74 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.187 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.1 mt -56.96 -46.31 82.23 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.398 0.679 . . . . 0.0 111.157 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -52.14 -48.18 65.01 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.089 1.356 . . . . 0.0 111.935 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -52.93 -48.81 67.02 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.129 1.372 . . . . 0.0 111.595 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.514 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 9.1 mt -60.47 -49.43 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.267 1.027 . . . . 0.0 111.68 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -57.01 -38.96 73.83 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.686 0.794 . . . . 0.0 112.064 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -63.21 -43.04 99.25 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 123.773 0.671 . . . . 0.0 112.153 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -73.14 -54.18 9.14 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.275 1.03 . . . . 0.0 113.32 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.3 mt -90.65 36.43 0.9 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 32.28 51.64 0.4 Allowed Glycine 0 N--CA 1.489 2.204 0 C-N-CA 126.202 1.858 . . . . 0.0 116.519 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 7.2 mmt . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 115.041 -2.409 . . . . 0.0 116.221 -178.947 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -73.67 79.81 1.52 Allowed 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 122.598 1.19 . . . . 0.0 113.41 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -79.12 80.17 5.48 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.045 0.926 . . . . 0.0 112.178 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HA ' ' HD1' ' A' ' 30' ' ' PHE . 42.8 mmtm -50.63 -49.49 56.73 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.27 50.93 1.82 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.756 1.265 . . . . 0.0 114.042 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 53' ' ' PHE . 5.1 tt -109.76 122.96 48.69 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.768 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -81.76 109.28 16.01 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.108 0.956 . . . . 0.0 112.495 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -96.24 139.24 32.67 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 111.802 -2.454 . . . . 0.0 111.783 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.462 ' CD1' HG22 ' A' ' 11' ' ' VAL . 2.1 tm? -118.19 104.87 11.22 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.437 176.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.2 t -83.7 111.19 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 112.095 -2.321 . . . . 0.0 108.775 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -114.02 91.13 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.544 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 57' ' ' ASP . 8.5 m-20 -137.19 115.27 11.59 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.745 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.418 ' OD1' ' HB3' ' A' ' 37' ' ' GLU . 3.5 t70 -80.12 77.12 6.85 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.966 -178.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.435 ' HD2' ' HB2' ' A' ' 17' ' ' MET . 11.5 t80 172.25 115.09 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 111.816 -2.447 . . . . 0.0 106.127 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.2 t -42.25 -55.67 3.22 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.228 1.011 . . . . 0.0 113.338 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.69 -47.5 85.38 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.708 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.435 ' HB2' ' HD2' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -62.43 -45.55 92.59 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.165 0.586 . . . . 0.0 111.829 -179.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.417 ' HD2' ' HB2' ' A' ' 35' ' ' GLU . 38.1 ttp180 -59.26 -45.2 91.83 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.759 1.224 . . . . 0.0 110.472 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -43.89 96.01 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.121 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.0 mt -56.17 -57.26 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-O 118.589 -0.719 . . . . 0.0 111.084 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.519 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 13.6 t -54.1 -44.53 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 123.512 0.507 . . . . 0.0 111.19 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.59 ' HG2' ' NZ ' ' A' ' 26' ' ' LYS . 34.9 ttt180 -55.92 -53.45 56.73 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.065 1.346 . . . . 0.0 111.735 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -62.87 -38.8 92.3 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.127 0.971 . . . . 0.0 113.331 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 75.7 mt -56.92 -48.88 77.22 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.175 0.99 . . . . 0.0 111.114 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.9 mt -60.27 -44.81 94.99 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.783 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.59 ' NZ ' ' HG2' ' A' ' 22' ' ' ARG . 63.5 mttp -56.44 -45.13 80.95 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.0 176.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 36.3 mt-10 -60.32 -35.99 76.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.479 1.512 . . . . 0.0 113.032 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.0 mt -74.44 -2.03 23.71 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.306 1.443 . . . . 0.0 114.372 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.8 -9.89 60.38 Favored Glycine 0 CA--C 1.542 1.76 0 C-N-CA 124.566 1.079 . . . . 0.0 112.752 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.432 ' HD1' ' HA ' ' A' ' 4' ' ' LYS . 6.5 m-85 -93.15 76.71 4.63 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 123.126 1.441 . . . . 0.0 110.078 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -66.29 -24.04 66.49 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.594 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -78.7 80.83 5.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.653 1.581 . . . . 0.0 112.062 -178.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.5 130.35 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.929 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.609 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 6.8 mp0 -120.61 160.91 22.29 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.417 ' HB2' ' HD2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -132.57 147.87 52.36 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 120.398 3.481 . . . . 0.0 120.398 -176.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.469 ' HB2' ' HD2' ' A' ' 45' ' ' LYS . . . -140.54 163.88 31.64 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 110.94 -2.845 . . . . 0.0 108.307 177.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . 22.5 mt-10 -112.04 -35.51 5.64 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -129.07 158.57 38.55 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.875 0.735 . . . . 0.0 111.148 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -39.27 -52.89 2.79 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 125.528 1.767 . . . . 0.0 116.064 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.476 HG21 HD21 ' A' ' 62' ' ' ASN . 74.3 t -59.77 -50.12 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 118.481 -0.771 . . . . 0.0 112.582 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -56.04 -44.05 78.41 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.045 0.926 . . . . 0.0 109.672 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.27 -52.15 65.92 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.398 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.4 mt -51.08 -51.25 55.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.406 1.066 . . . . 0.0 111.022 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -53.29 -54.79 31.28 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.447 1.099 . . . . 0.0 112.475 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HD2' ' HB2' ' A' ' 36' ' ' ALA . 29.4 mttp -57.6 -48.9 78.12 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 113.808 -1.542 . . . . 0.0 113.043 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 31.2 mt -59.79 -41.74 91.83 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.536 1.134 . . . . 0.0 112.479 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -57.24 -25.43 59.12 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.16 -19.77 63.18 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.41 -166.31 19.68 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.854 1.216 . . . . 0.0 111.434 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.38 -41.43 1.84 Allowed Glycine 0 N--CA 1.483 1.775 0 C-N-CA 124.3 0.952 . . . . 0.0 115.241 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.609 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 78.9 m-85 -70.91 136.1 48.36 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.69 16.51 7.87 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 112.656 -2.065 . . . . 0.0 113.397 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.653 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -172.41 140.08 1.06 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.367 1.067 . . . . 0.0 111.975 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 t -122.37 114.1 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.045 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.7 mt -108.44 98.96 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.0 t -120.87 137.09 54.75 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.445 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 31.0 t0 -73.18 133.82 44.17 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 112.348 -2.205 . . . . 0.0 110.197 177.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.447 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 30.9 t-105 -59.26 -49.77 76.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.027 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -88.78 99.86 12.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.391 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.524 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 8.7 mtm -141.95 121.77 8.17 Favored Pre-proline 0 N--CA 1.478 0.931 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.106 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -62.28 164.42 17.57 Favored 'Trans proline' 0 N--CA 1.479 0.627 0 C-N-CA 123.208 2.605 . . . . 0.0 109.006 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.476 HD21 HG21 ' A' ' 40' ' ' VAL . 0.6 OUTLIER 70.82 -79.68 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.09 0.956 . . . . 0.0 109.633 -176.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.5 ttm -130.36 107.31 9.16 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.854 0.862 . . . . 0.0 108.948 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.524 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.7 p30 -62.85 162.08 11.65 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.029 -1.441 . . . . 0.0 112.895 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.21 -53.41 15.41 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 124.975 1.274 . . . . 0.0 114.793 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.67 -44.98 93.38 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.172 0.589 . . . . 0.0 111.887 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.71 -40.81 98.34 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -44.52 88.7 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.722 1.209 . . . . 0.0 110.328 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tp -58.97 -47.09 86.38 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.515 1.126 . . . . 0.0 111.012 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.13 -43.41 91.97 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.536 0.735 . . . . 0.0 112.76 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.268 4.7 p -64.29 -33.93 76.96 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.114 0.966 . . . . 0.0 111.811 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.5 mt -69.32 -56.49 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 73' ' ' ARG . 71.0 mmt-85 -53.53 -43.37 68.32 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.476 1.51 . . . . 0.0 113.065 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.77 -30.13 65.22 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -87.84 95.56 10.14 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.136 0.574 . . . . 0.0 112.088 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -13.65 -72.51 0.01 OUTLIER Glycine 0 N--CA 1.489 2.169 0 C-N-CA 127.821 2.629 . . . . 0.0 117.478 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.46 -40.54 68.51 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 50.9 mtm -88.53 -14.16 38.4 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.2 m -48.12 -25.14 1.34 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 117.365 2.358 . . . . 0.0 117.365 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.98 -7.81 50.99 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.426 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 96.4 mt -70.2 111.56 9.71 Favored Pre-proline 0 N--CA 1.485 1.283 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 11.5 Cg_endo -51.96 133.9 47.4 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 123.181 2.587 . . . . 0.0 113.921 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.2 t -120.53 126.82 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 122.812 1.292 . . . . 0.0 113.304 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.653 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 1.7 tm? -113.01 116.89 30.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 111.656 -2.52 . . . . 0.0 107.389 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 28.6 mmt -95.39 109.89 22.0 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 122.734 1.254 . . . . 0.0 113.437 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.31 96.02 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 123.178 1.466 . . . . 0.0 107.428 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -108.17 141.29 40.12 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 112.357 -2.201 . . . . 0.0 114.241 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.3 -29.59 70.88 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.404 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -134.1 129.33 35.81 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.299 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -94.1 55.83 2.13 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 123.997 1.856 . . . . 0.0 108.489 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -98.81 139.91 33.78 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 112.887 -1.961 . . . . 0.0 107.542 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 25.3 mmtp -34.52 -48.47 0.36 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -51.62 -49.83 61.47 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.736 0.647 . . . . 0.0 112.556 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -64.06 -47.81 78.67 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.504 1.122 . . . . 0.0 111.507 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 68.9 mt -57.94 -57.26 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.809 1.244 . . . . 0.0 111.83 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.9 mt -54.56 -52.75 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.878 0.871 . . . . 0.0 110.307 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.21 -52.71 58.01 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.151 0.981 . . . . 0.0 112.194 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.447 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -57.15 -52.58 64.75 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.677 1.191 . . . . 0.0 113.095 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.36 -48.84 80.11 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.64 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -60.07 -36.19 76.8 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 73' ' ' ARG . . . -78.12 -6.58 55.15 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.01 4.14 27.75 Favored Glycine 0 CA--C 1.548 2.148 0 N-CA-C 116.151 1.22 . . . . 0.0 116.151 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.02 119.73 10.67 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.906 1.353 . . . . 0.0 112.099 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.2 m -64.12 -36.32 83.64 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 112.362 -2.199 . . . . 0.0 112.448 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -169.79 178.67 42.61 Favored Glycine 0 CA--C 1.541 1.659 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.749 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -152.96 143.01 22.31 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.4 p -122.39 125.41 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 124.623 1.202 . . . . 0.0 109.972 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.1 p -85.54 122.64 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 113.937 -1.483 . . . . 0.0 111.073 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -83.83 138.12 40.63 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 113.764 -1.562 . . . . 0.0 113.249 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.41 143.01 75.0 Favored 'Cis proline' 0 CA--C 1.546 1.1 0 O-C-N 123.072 1.038 . . . . 0.0 114.787 0.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.519 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 33.8 p90 -134.91 151.12 50.6 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 112.31 -2.223 . . . . 0.0 108.642 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.2 t -107.16 175.61 5.44 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.189 0.931 . . . . 0.0 109.928 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.64 -42.46 56.34 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.936 0.894 . . . . 0.0 111.993 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.3 -44.45 95.0 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.294 1.038 . . . . 0.0 112.886 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.24 -48.66 77.28 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.466 0.707 . . . . 0.0 109.333 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.3 tp -55.94 -46.96 78.35 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.935 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.485 ' HG2' ' OD1' ' A' ' 121' ' ' ASN . 7.0 tt0 -58.36 -50.9 72.0 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.891 0.876 . . . . 0.0 110.975 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -49.19 -45.25 43.87 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.719 0.808 . . . . 0.0 112.618 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -66.24 -48.09 71.66 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.741 1.216 . . . . 0.0 111.807 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.401 ' HB3' ' CE2' ' A' ' 124' ' ' PHE . 96.3 mt -57.61 -46.73 83.72 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.064 0.946 . . . . 0.0 111.902 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.485 ' OD1' ' HG2' ' A' ' 117' ' ' GLU . 31.5 m-20 -48.14 -53.48 16.56 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.478 1.511 . . . . 0.0 112.079 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.1 tttt -51.68 -47.91 63.68 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 113.841 -1.527 . . . . 0.0 112.161 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.606 HG13 ' HZ ' ' A' ' 53' ' ' PHE . 8.3 mm -58.49 -57.47 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.693 1.197 . . . . 0.0 109.644 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' A' ' 120' ' ' LEU . 22.3 m-85 -52.47 -49.31 64.92 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.597 1.159 . . . . 0.0 113.334 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.52 -46.73 89.08 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.71 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.96 -41.52 96.52 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.926 1.291 . . . . 0.0 111.792 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.6 mp -93.6 15.45 16.13 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.74 -46.79 2.07 Favored Glycine 0 N--CA 1.48 1.599 0 C-N-CA 125.053 1.311 . . . . 0.0 114.397 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 21.0 ptt? . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -179.445 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t -124.14 145.21 49.44 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.36 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -81.74 92.93 6.71 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.197 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 54.0 mtmt -56.39 -24.15 42.74 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -86.5 66.03 9.31 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 123.42 1.581 . . . . 0.0 110.911 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.2 tt -102.38 135.87 43.23 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.049 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -77.87 110.29 12.63 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -110.07 142.65 41.24 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.824 1.649 . . . . 0.0 112.698 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.589 HD12 ' HG ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -117.89 110.34 17.63 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 122.22 1.01 . . . . 0.0 109.932 173.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.7 t -85.92 107.87 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 113.862 -1.517 . . . . 0.0 107.495 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' A' ' 42' ' ' ALA . 2.8 t -112.74 94.36 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.745 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -135.27 131.92 37.14 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.702 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -60.63 -25.01 65.97 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -101.07 105.34 16.51 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 44.3 p -41.21 -45.61 2.9 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.417 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -62.64 -52.79 61.95 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.404 1.082 . . . . 0.0 112.188 176.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -39.05 87.74 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.561 0.344 . . . . 0.0 110.222 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -55.45 -51.58 66.44 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.495 1.118 . . . . 0.0 110.683 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.641 ' CZ ' HD21 ' A' ' 23' ' ' ASN . 10.3 ttt180 -63.92 -36.53 84.25 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.47 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 42.3 mm -55.73 -47.5 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 122.625 0.37 . . . . 0.0 110.474 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -60.1 -44.44 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 122.849 0.459 . . . . 0.0 110.092 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.466 ' NH1' HH21 ' A' ' 19' ' ' ARG . 0.0 OUTLIER -54.19 -50.03 67.98 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.457 1.103 . . . . 0.0 110.575 176.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.641 HD21 ' CZ ' ' A' ' 19' ' ' ARG . 23.2 m120 -59.69 -44.65 93.57 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.495 0.718 . . . . 0.0 111.814 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.536 HD22 ' HB2' ' A' ' 113' ' ' ALA . 77.7 mt -56.06 -52.62 63.61 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.293 1.037 . . . . 0.0 111.442 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 73.9 mt -54.91 -45.51 74.74 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.759 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 27.3 mtpp -56.88 -46.39 81.91 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.285 177.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 28.5 mt-10 -59.5 -40.61 87.6 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.879 1.672 . . . . 0.0 111.746 177.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.4 mp -70.8 -16.14 62.71 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.892 1.677 . . . . 0.0 114.755 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.55 -5.81 33.33 Favored Glycine 0 CA--C 1.543 1.832 0 C-N-CA 125.342 1.448 . . . . 0.0 114.05 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 65.1 m-85 -92.94 67.66 4.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 123.506 1.622 . . . . 0.0 111.022 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -69.48 -14.09 62.69 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 116.974 2.213 . . . . 0.0 116.974 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -92.84 78.2 4.76 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 122.924 1.345 . . . . 0.0 108.987 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 p -126.87 130.87 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 113.757 -1.565 . . . . 0.0 114.189 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' O ' HD23 ' A' ' 9' ' ' LEU . 4.5 tm-20 -106.64 156.29 18.77 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 113.615 -1.629 . . . . 0.0 107.885 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -123.85 121.92 36.65 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -130.06 157.47 42.28 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 113.547 -1.661 . . . . 0.0 108.433 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -105.24 -40.63 5.78 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -130.71 162.3 29.75 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.289 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -42.63 -50.58 5.78 Favored Glycine 0 N--CA 1.484 1.855 0 O-C-N 125.531 1.769 . . . . 0.0 115.943 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.4 t -58.69 -53.58 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 119.091 -0.48 . . . . 0.0 111.541 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.51 -37.14 74.96 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.471 0.709 . . . . 0.0 110.995 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.555 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -61.45 -54.08 48.08 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.044 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.46 -38.13 86.1 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 123.862 0.727 . . . . 0.0 112.853 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 20.7 m120 -57.55 -50.33 73.45 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.126 0.891 . . . . 0.0 111.099 175.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -67.67 -42.97 81.3 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.828 1.251 . . . . 0.0 112.63 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.589 ' HG ' HD12 ' A' ' 9' ' ' LEU . 16.5 mt -59.87 -45.09 93.58 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.535 1.934 . . . . 0.0 114.563 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 19.0 pt20 -57.8 -14.62 6.23 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.67 -23.64 66.17 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.902 0.881 . . . . 0.0 112.337 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.15 -178.51 43.4 Favored Glycine 0 N--CA 1.48 1.609 0 C-N-CA 125.107 1.337 . . . . 0.0 113.757 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.4 -26.12 3.58 Favored Glycine 0 N--CA 1.482 1.705 0 CA-C-N 113.662 -1.269 . . . . 0.0 116.154 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -64.51 111.03 2.51 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.73 12.57 65.94 Favored Glycine 0 CA--C 1.541 1.665 0 O-C-N 125.103 1.502 . . . . 0.0 112.472 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.529 ' HZ ' HD13 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -168.73 141.06 2.75 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.016 0.926 . . . . 0.0 112.071 179.118 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.6 t -129.39 122.58 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.543 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.8 mt -111.68 102.53 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.2 t -122.27 133.84 54.68 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 116.909 2.188 . . . . 0.0 116.909 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -73.82 127.99 34.31 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 111.335 -2.666 . . . . 0.0 110.767 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.46 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 13.6 t-105 -56.04 -43.57 77.96 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.778 1.231 . . . . 0.0 110.73 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -91.13 94.49 9.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.202 1.401 . . . . 0.0 109.062 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.503 ' SD ' HG12 ' A' ' 11' ' ' VAL . 15.2 mtm -141.24 121.87 8.72 Favored Pre-proline 0 N--CA 1.476 0.83 0 CA-C-N 114.179 -1.373 . . . . 0.0 113.516 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -55.25 158.74 11.48 Favored 'Trans proline' 0 N--CA 1.479 0.652 0 C-N-CA 123.139 2.56 . . . . 0.0 110.945 175.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.349 21.3 p30 66.84 -72.36 0.09 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.226 2.21 . . . . 0.0 112.024 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.496 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 43.4 ttp -128.86 108.18 10.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.508 0.723 . . . . 0.0 109.728 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -62.43 164.6 7.12 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.474 -1.694 . . . . 0.0 113.033 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.78 -54.76 23.7 Favored Glycine 0 N--CA 1.479 1.555 0 C-N-CA 125.132 1.349 . . . . 0.0 114.24 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.3 tp -57.01 -40.95 77.61 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.7 -40.43 84.32 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.553 0.341 . . . . 0.0 111.562 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.01 -41.03 95.75 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.778 1.231 . . . . 0.0 110.784 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 103' ' ' ALA . 2.9 tt -51.76 -51.2 58.04 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.286 1.434 . . . . 0.0 108.718 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -59.41 -43.19 93.07 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.429 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.7 p -69.25 -0.61 6.37 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.5 mt -109.64 -62.02 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.647 ' HG2' ' HA3' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -51.2 -44.52 61.61 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.16 1.784 . . . . 0.0 113.83 -179.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.83 -3.35 49.1 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -85.69 99.85 11.59 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -10.25 -77.87 0.01 OUTLIER Glycine 0 N--CA 1.488 2.165 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.96 -41.23 99.46 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 76.6 mtp -85.93 -6.71 59.02 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.6 t -34.06 -61.99 0.34 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 118.972 2.953 . . . . 0.0 118.972 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.41 18.05 0.45 Allowed 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 119.248 3.055 . . . . 0.0 119.248 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 69.9 mt -84.9 120.14 73.4 Favored Pre-proline 0 CA--C 1.543 0.708 0 O-C-N 121.215 -0.928 . . . . 0.0 112.689 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 9.5 Cg_endo -52.22 132.96 45.97 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.812 3.008 . . . . 0.0 113.901 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.506 HG11 ' HG ' ' A' ' 69' ' ' LEU . 11.3 t -118.96 115.58 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 112.61 -2.086 . . . . 0.0 112.314 -176.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.556 HD13 HD11 ' A' ' 123' ' ' ILE . 62.5 tp -107.43 105.59 15.58 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 113.858 -1.519 . . . . 0.0 107.635 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.5 mmt -79.35 138.19 37.6 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 113.284 -1.78 . . . . 0.0 111.708 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.7 t -112.43 104.66 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 p -102.47 152.56 20.98 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.439 -1.255 . . . . 0.0 113.587 -175.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.62 -40.12 95.96 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.361 -1.745 . . . . 0.0 111.705 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -159.95 148.36 17.18 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.693 1.597 . . . . 0.0 112.211 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.48 94.68 8.59 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.149 0.906 . . . . 0.0 109.813 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -125.38 130.36 51.76 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.418 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -25.95 -61.11 0.07 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 116.42 2.008 . . . . 0.0 116.42 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -57.19 -46.17 83.08 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -68.62 -37.41 79.72 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 91.5 mt -59.41 -50.02 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.386 1.075 . . . . 0.0 109.051 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.4 mm -55.67 -55.46 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.468 1.107 . . . . 0.0 110.241 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.54 -49.3 62.24 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.237 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.46 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -59.96 -57.28 13.52 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.451 1.1 . . . . 0.0 113.646 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.78 -51.03 71.25 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.244 1.017 . . . . 0.0 111.995 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.19 -30.23 70.92 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.12 -13.19 58.93 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.647 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 120.61 -3.21 12.18 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 116.895 1.518 . . . . 0.0 116.895 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.566 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -57.78 114.09 2.14 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 118.918 1.359 . . . . 0.0 112.878 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.481 ' HB3' HG23 ' A' ' 123' ' ' ILE . 5.0 m -63.56 -26.79 68.86 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 112.007 -2.36 . . . . 0.0 113.76 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.7 166.25 35.89 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.742 1.163 . . . . 0.0 110.353 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -142.25 137.63 30.83 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 p -121.51 131.95 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.89 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.98 139.63 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.598 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.08 140.42 28.98 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.617 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.62 135.86 20.28 Favored 'Cis proline' 0 C--N 1.352 0.715 0 O-C-N 122.47 0.721 . . . . 0.0 110.983 -2.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -113.43 154.71 26.53 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.293 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.8 t -110.27 178.24 4.45 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.15 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.536 ' HB2' HD22 ' A' ' 24' ' ' LEU . . . -51.27 -44.19 61.76 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.664 1.185 . . . . 0.0 111.893 178.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.24 -51.72 67.78 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.245 1.018 . . . . 0.0 111.888 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.44 -47.21 82.39 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.191 0.996 . . . . 0.0 110.389 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 47.7 tp -56.58 -53.51 56.69 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.11 1.364 . . . . 0.0 109.506 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -53.89 -47.19 71.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.77 1.228 . . . . 0.0 112.354 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.38 -50.25 70.21 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -62.54 -43.15 99.52 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 61.7 mt -52.84 -46.23 67.71 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -55.4 -51.64 66.18 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.584 0.754 . . . . 0.0 112.843 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -56.5 -43.36 79.64 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.35 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.556 HD11 HD13 ' A' ' 84' ' ' LEU . 62.2 mt -58.44 -53.56 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.038 0.935 . . . . 0.0 110.58 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.454 ' HB3' ' SD ' ' A' ' 129' ' ' MET . 21.5 m-85 -56.45 -39.87 73.87 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.736 0.814 . . . . 0.0 113.144 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.43 -52.83 62.95 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.098 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -57.6 -41.23 80.78 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.777 0.831 . . . . 0.0 112.006 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.8 mp -60.79 -22.8 64.49 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.041 1.336 . . . . 0.0 114.428 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 61.9 39.37 97.43 Favored Glycine 0 CA--C 1.542 1.75 0 C-N-CA 124.04 0.829 . . . . 0.0 111.963 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.454 ' SD ' ' HB3' ' A' ' 124' ' ' PHE . 26.1 ptm . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.1 t -84.05 76.66 10.04 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -38.26 -31.22 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -176.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -26.14 24.68 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 177.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -66.77 9.03 0.2 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.821 2.048 . . . . 0.0 115.574 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.52 97.04 3.61 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -175.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.4 ' HG3' ' HB2' ' A' ' 32' ' ' ASN . 34.0 tttt -79.53 111.27 15.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.724 -1.58 . . . . 0.0 111.692 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -92.26 136.58 33.08 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 112.141 -2.3 . . . . 0.0 112.107 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.561 HD12 HD13 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -111.16 104.04 12.52 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 118.698 -1.201 . . . . 0.0 109.145 173.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.552 ' HA ' HG23 ' A' ' 55' ' ' ILE . 48.2 t -80.29 97.54 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 112.968 -1.923 . . . . 0.0 105.848 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.506 HG11 ' HB2' ' A' ' 42' ' ' ALA . 5.0 t -101.04 84.6 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 112.702 -2.044 . . . . 0.0 107.808 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.611 ' HB3' ' HG3' ' A' ' 18' ' ' ARG . 7.0 t70 -133.94 121.14 21.25 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.105 -1.861 . . . . 0.0 111.752 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -54.9 -28.23 49.02 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 112.264 -2.244 . . . . 0.0 115.55 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -97.34 119.71 36.37 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.559 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.3 p -50.39 -50.93 50.24 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 125.028 1.455 . . . . 0.0 112.929 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -43.78 98.35 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.188 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 13.2 tpt -62.64 -40.89 98.45 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.611 ' HG3' ' HB3' ' A' ' 12' ' ' ASP . 10.1 mtm180 -56.14 -49.23 74.52 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.695 0.798 . . . . 0.0 111.578 175.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -60.18 -43.3 95.96 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.523 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.2 mt -56.18 -50.43 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.097 0.559 . . . . 0.0 110.583 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.85 -43.13 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.218 0.607 . . . . 0.0 111.524 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -51.99 -52.0 53.44 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.531 0.732 . . . . 0.0 111.273 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -57.72 -40.84 80.51 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.737 0.815 . . . . 0.0 112.839 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.03 -52.01 67.18 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.445 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.7 mt -58.54 -42.11 87.08 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.083 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -59.1 -47.49 85.06 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.353 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -54.98 -39.44 68.99 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 125.327 1.451 . . . . 0.0 112.293 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.4 mt -73.21 -17.28 61.37 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.21 17.72 19.32 Favored Glycine 0 CA--C 1.543 1.807 0 C-N-CA 124.567 1.08 . . . . 0.0 113.349 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -110.14 89.68 3.09 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 122.943 1.354 . . . . 0.0 112.126 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -68.54 -29.11 67.61 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 112.557 -2.11 . . . . 0.0 115.058 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.4 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -84.24 91.32 7.7 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 123.049 1.405 . . . . 0.0 113.481 -175.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.0 t -133.89 125.89 49.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 112.884 -1.962 . . . . 0.0 110.867 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.45 ' OE1' ' HB3' ' A' ' 45' ' ' LYS . 5.5 tt0 -110.26 153.59 24.62 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 175.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 36.9 mt-10 -125.92 124.8 41.62 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.49 153.87 36.06 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.552 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -4.0 19.85 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -165.84 157.4 14.06 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.452 0.701 . . . . 0.0 110.64 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 42' ' ' ALA . . . -39.9 -53.78 3.09 Favored Glycine 0 CA--C 1.544 1.856 0 O-C-N 125.04 1.463 . . . . 0.0 115.517 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.01 -52.84 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 122.414 0.286 . . . . 0.0 111.439 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -55.71 -38.76 70.15 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.568 1.147 . . . . 0.0 110.16 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.506 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -61.98 -58.57 7.39 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.233 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.17 -39.51 56.56 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.985 0.803 . . . . 0.0 112.531 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -63.69 -64.2 0.96 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.561 1.144 . . . . 0.0 109.92 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.45 ' HB3' ' OE1' ' A' ' 34' ' ' GLU . 46.1 mttm -55.38 -37.65 67.84 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 126.91 2.084 . . . . 0.0 115.319 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.581 HD11 HG22 ' A' ' 54' ' ' VAL . 5.9 tp -54.47 -25.86 27.8 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -90.94 -17.79 25.8 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.95 69.54 7.56 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.73 81.47 1.52 Allowed Glycine 0 CA--C 1.541 1.665 0 N-CA-C 118.496 2.158 . . . . 0.0 118.496 174.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 18.81 76.99 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 C-N-CA 128.012 2.72 . . . . 0.0 119.366 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -83.94 127.69 34.03 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.239 -0.981 . . . . 0.0 110.301 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.78 8.21 50.45 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.201 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.518 ' HA ' ' HG2' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -166.64 144.5 5.15 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 -179.201 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.581 HG22 HD11 ' A' ' 46' ' ' LEU . 21.4 t -123.85 110.87 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 175.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.552 HG23 ' HA ' ' A' ' 10' ' ' VAL . 14.8 tt -115.08 98.05 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 t -120.73 142.07 49.86 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 120.485 3.513 . . . . 0.0 120.485 -174.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -72.4 129.2 37.81 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 113.039 -1.892 . . . . 0.0 109.879 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.411 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 37.7 t-105 -53.71 -38.73 64.57 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.742 0.817 . . . . 0.0 112.544 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -105.6 108.46 19.99 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.584 0.754 . . . . 0.0 110.139 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.489 ' SD ' HG12 ' A' ' 11' ' ' VAL . 50.7 mtm -139.71 126.39 12.41 Favored Pre-proline 0 N--CA 1.478 0.966 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.78 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.76 118.48 5.41 Favored 'Trans proline' 0 N--CA 1.482 0.829 0 C-N-CA 124.048 3.165 . . . . 0.0 111.837 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 99.17 -76.25 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 129.224 3.01 . . . . 0.0 110.119 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.8 ttm -112.28 93.92 4.68 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.253 0.549 . . . . 0.0 109.744 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.6 p30 -59.74 162.28 5.42 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 112.133 -2.303 . . . . 0.0 112.068 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.88 -53.63 25.59 Favored Glycine 0 N--CA 1.477 1.433 0 C-N-CA 124.516 1.055 . . . . 0.0 114.296 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.488 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 60.8 tp -59.64 -37.87 79.85 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -70.69 -40.96 72.6 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.157 0.583 . . . . 0.0 110.369 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.9 tp -56.62 -44.86 81.6 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.111 0.964 . . . . 0.0 110.188 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' A' ' 103' ' ' ALA . 4.8 tt -48.79 -51.22 30.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.212 1.405 . . . . 0.0 109.363 175.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.37 -45.86 92.04 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.651 1.18 . . . . 0.0 112.538 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 p -61.9 -15.36 42.26 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.6 mt -96.31 -65.46 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.762 ' HG2' ' HA3' ' A' ' 102' ' ' GLY . 6.5 tpp180 -53.17 -43.35 67.0 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.163 2.185 . . . . 0.0 115.195 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.49 -10.41 49.1 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 78' ' ' MET . 12.6 t70 -89.4 112.32 23.41 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -42.79 -18.64 0.05 OUTLIER Glycine 0 CA--C 1.547 2.092 0 C-N-CA 127.601 2.524 . . . . 0.0 118.978 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.27 -50.77 3.84 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.64 0.776 . . . . 0.0 111.576 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.406 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 88.9 mmm -70.08 -25.15 63.39 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 118.718 2.859 . . . . 0.0 118.718 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.6 t -58.64 39.19 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 118.255 2.687 . . . . 0.0 118.255 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -123.55 -37.05 2.69 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.77 2.028 . . . . 0.0 111.073 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.447 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 6.1 mt -66.1 117.6 44.39 Favored Pre-proline 0 N--CA 1.472 0.657 0 C-N-CA 126.158 1.783 . . . . 0.0 115.299 -178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.518 ' HG2' ' HA ' ' A' ' 53' ' ' PHE . 35.4 Cg_endo -63.35 137.91 63.1 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.631 2.221 . . . . 0.0 111.121 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.94 110.26 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 113.812 -1.54 . . . . 0.0 112.668 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.421 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 33.1 tp -106.7 107.43 18.44 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.142 -1.845 . . . . 0.0 109.46 178.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.8 mmt -81.71 111.56 18.08 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 113.581 -1.645 . . . . 0.0 113.438 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.0 97.36 7.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 177.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 2.5 t -107.14 134.57 50.06 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 112.032 -2.349 . . . . 0.0 115.646 -174.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.21 -8.28 56.16 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 113.151 -1.841 . . . . 0.0 112.639 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -144.82 95.92 2.77 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.124 0.964 . . . . 0.0 113.09 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.03 64.17 8.31 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 123.429 1.585 . . . . 0.0 109.766 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -116.21 150.24 37.84 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.963 -1.926 . . . . 0.0 111.123 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -34.48 -51.95 0.48 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 115.329 1.604 . . . . 0.0 115.329 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -52.32 -57.57 9.35 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.494 0.718 . . . . 0.0 112.161 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -61.19 -41.04 96.11 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 85.2 mt -58.09 -51.13 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 124.125 0.891 . . . . 0.0 109.753 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 80.4 mt -54.91 -55.81 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.412 1.085 . . . . 0.0 109.892 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.21 -50.55 64.48 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.146 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -62.37 -52.42 63.68 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.88 -47.7 84.68 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -63.2 -36.78 84.79 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.52 -21.74 61.87 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.762 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 116.34 20.97 4.95 Favored Glycine 0 N--CA 1.48 1.568 0 N-CA-C 116.445 1.338 . . . . 0.0 116.445 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.61 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -68.77 118.91 12.34 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.456 1.128 . . . . 0.0 112.029 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.8 m -64.05 -28.3 69.7 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 113.52 -1.673 . . . . 0.0 111.992 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.61 172.26 45.23 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 124.149 0.88 . . . . 0.0 110.979 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -148.82 137.4 21.22 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.288 -0.956 . . . . 0.0 111.865 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.43 127.73 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 124.642 1.214 . . . . 0.0 109.438 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 87' ' ' THR . 11.0 p -81.04 139.97 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.782 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -94.6 131.63 30.42 Favored Pre-proline 0 CA--C 1.55 0.976 0 O-C-N 123.883 0.74 . . . . 0.0 111.255 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.3 151.88 69.33 Favored 'Cis proline' 0 N--CA 1.48 0.723 0 O-C-N 123.069 1.036 . . . . 0.0 113.46 -0.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -134.17 152.23 51.73 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 113.316 -1.765 . . . . 0.0 107.724 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.7 p -98.74 172.85 7.2 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.803 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.36 -41.62 72.79 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.822 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.11 -44.35 89.05 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.065 0.946 . . . . 0.0 111.702 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.2 m -61.25 -44.93 96.44 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.319 0.647 . . . . 0.0 110.041 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.449 HD21 HD12 ' A' ' 55' ' ' ILE . 2.0 tm? -60.44 -47.57 85.54 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.59 177.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -56.61 -43.06 79.81 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.496 1.118 . . . . 0.0 112.283 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -52.55 -45.51 66.41 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.124 0.57 . . . . 0.0 111.758 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -68.14 -42.32 80.3 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.196 0.998 . . . . 0.0 112.176 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 59.2 mt -53.88 -53.45 52.36 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.926 0.89 . . . . 0.0 111.433 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -50.54 -53.7 28.2 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.714 1.606 . . . . 0.0 111.957 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -49.27 -48.48 45.91 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.358 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 26.9 mt -63.01 -50.02 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 125.026 1.33 . . . . 0.0 112.284 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -58.72 -43.02 90.04 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.396 1.078 . . . . 0.0 111.875 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.69 -27.99 68.08 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -102.1 -53.45 2.92 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 117.755 2.502 . . . . 0.0 117.755 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 pp -111.61 -3.72 14.99 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.07 -160.39 18.62 Favored Glycine 0 N--CA 1.475 1.287 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.464 ' OXT' ' HG3' ' A' ' 82' ' ' PRO 0.307 14.3 ptp . . . . . 0 C--O 1.256 1.416 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.793 ' CZ ' HD22 ' A' ' 121' ' ' ASN . 18.7 ptt180 . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.5 p -73.68 87.58 1.69 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.728 1.252 . . . . 0.0 113.698 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -73.33 98.52 2.71 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.277 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -49.6 -38.85 33.35 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.95 54.41 1.26 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 1.2 tt -111.41 118.83 36.9 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 113.673 -1.603 . . . . 0.0 112.064 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -75.74 108.83 8.86 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.513 ' HE2' HD22 ' A' ' 120' ' ' LEU . 74.4 m-85 -97.53 140.71 31.56 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.522 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.44 HD12 ' HG ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -114.38 109.6 18.58 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.604 ' HA ' HG23 ' A' ' 55' ' ' ILE . 9.9 p -81.23 101.37 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 124.972 1.42 . . . . 0.0 107.169 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.524 HG12 ' SD ' ' A' ' 60' ' ' MET . 4.0 t -100.17 85.4 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -123.48 124.6 43.24 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 110.765 -2.925 . . . . 0.0 113.039 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -65.65 -19.22 65.82 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 110.955 -2.839 . . . . 0.0 116.23 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -110.09 127.79 55.07 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.303 0.377 . . . . 0.0 110.436 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.1 p -47.4 -59.31 3.3 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 113.683 -1.598 . . . . 0.0 113.721 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.454 ' O ' HG12 ' A' ' 20' ' ' ILE . 1.8 p -66.75 -42.3 86.39 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.439 ' O ' HG23 ' A' ' 21' ' ' VAL . 9.6 ttt -60.36 -38.32 83.48 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.058 0.39 . . . . 0.0 111.309 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -54.97 -50.91 67.76 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.62 1.168 . . . . 0.0 110.392 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.635 ' NH2' HD21 ' A' ' 23' ' ' ASN . 4.9 mtp-105 -65.03 -39.35 93.23 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.924 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 16' ' ' THR . 43.7 mm -55.95 -51.24 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 17' ' ' MET . 6.1 t -58.78 -45.98 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 123.596 0.56 . . . . 0.0 109.991 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -49.24 -53.92 19.22 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.888 0.875 . . . . 0.0 111.838 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.635 HD21 ' NH2' ' A' ' 19' ' ' ARG . 48.0 m-80 -62.98 -39.01 93.43 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.495 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.8 mt -58.95 -52.41 65.85 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.632 0.773 . . . . 0.0 110.564 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.7 mt -54.98 -47.18 74.93 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.065 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.425 ' HG3' ' OD1' ' A' ' 31' ' ' ASN . 36.4 ttpt -54.03 -50.15 67.3 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.416 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -58.71 -40.14 82.84 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.601 1.561 . . . . 0.0 112.288 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.7 mt -71.96 -10.35 59.65 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.543 1.137 . . . . 0.0 113.135 177.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.31 -16.39 24.66 Favored Glycine 0 CA--C 1.546 2.002 0 C-N-CA 125.226 1.393 . . . . 0.0 113.677 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -87.69 72.7 9.47 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 123.366 1.555 . . . . 0.0 113.015 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.425 ' OD1' ' HG3' ' A' ' 26' ' ' LYS . 4.8 m-80 -69.2 -8.42 45.5 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.705 -1.589 . . . . 0.0 113.891 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.447 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -94.17 83.9 4.35 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.483 1.513 . . . . 0.0 110.53 -178.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.35 137.8 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.775 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.582 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -111.59 159.15 18.42 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.888 1.275 . . . . 0.0 108.922 176.352 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -126.5 108.9 11.6 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.47 158.36 20.8 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.967 1.307 . . . . 0.0 110.287 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -101.87 -39.03 7.56 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -138.94 170.44 15.97 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.349 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -47.1 -51.93 13.29 Favored Glycine 0 N--CA 1.474 1.227 0 C-N-CA 124.646 1.117 . . . . 0.0 115.552 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.6 t -57.73 -54.43 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.409 0.683 . . . . 0.0 110.683 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -57.56 -33.61 68.32 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.583 0.753 . . . . 0.0 111.694 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . . . -64.09 -50.71 67.25 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 117.172 -1.394 . . . . 0.0 110.971 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.462 HD11 ' OG1' ' A' ' 71' ' ' THR . 61.8 mt -57.06 -45.99 82.8 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 123.752 0.658 . . . . 0.0 111.131 178.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -52.62 -54.32 34.73 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.199 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -63.16 -42.45 99.42 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.725 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.44 ' HG ' HD12 ' A' ' 9' ' ' LEU . 26.4 mt -56.7 -35.98 69.13 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.726 1.21 . . . . 0.0 113.139 177.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.19 -24.36 17.93 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.86 -23.64 67.43 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.251 1.02 . . . . 0.0 113.053 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.74 179.83 50.19 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 124.805 1.193 . . . . 0.0 113.922 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.73 -14.94 8.61 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 116.544 1.377 . . . . 0.0 116.544 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.582 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 84.1 m-85 -68.19 121.58 16.5 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.263 1.03 . . . . 0.0 113.64 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -106.23 10.1 43.03 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 112.505 -2.134 . . . . 0.0 111.959 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.732 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.6 OUTLIER -168.94 145.43 3.54 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.5 t -128.75 111.15 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 113.389 -1.732 . . . . 0.0 107.663 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.604 HG23 ' HA ' ' A' ' 10' ' ' VAL . 12.1 tt -107.34 96.64 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.3 t -118.33 134.47 55.01 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 60' ' ' MET . 12.3 m-20 -72.08 134.36 45.76 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.883 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.459 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 14.7 t-105 -55.63 -48.58 74.7 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.828 0.851 . . . . 0.0 111.498 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -96.52 97.77 9.69 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.224 0.952 . . . . 0.0 111.271 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.524 ' SD ' HG12 ' A' ' 11' ' ' VAL . 29.6 mtm -131.15 138.67 33.43 Favored Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 113.782 -1.553 . . . . 0.0 111.826 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -58.87 143.93 99.06 Favored 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.144 2.562 . . . . 0.0 111.518 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.345 27.9 p30 65.12 -66.64 0.14 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 127.313 2.245 . . . . 0.0 114.295 -177.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 57.8 ttm -122.36 100.43 6.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.881 0.872 . . . . 0.0 108.691 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 7.3 m-20 -65.27 167.18 8.71 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 112.413 -2.176 . . . . 0.0 112.875 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.4 -56.18 9.72 Favored Glycine 0 N--CA 1.482 1.717 0 C-N-CA 125.177 1.37 . . . . 0.0 114.123 -178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.463 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 43.7 tp -57.57 -39.89 77.73 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -70.63 -40.45 73.12 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.99 -0.444 . . . . 0.0 110.547 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.428 ' HA ' HG22 ' A' ' 71' ' ' THR . 1.4 tm? -57.87 -42.27 84.21 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.071 0.548 . . . . 0.0 110.668 176.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 103' ' ' ALA . 4.8 tt -51.1 -49.93 59.75 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.842 1.657 . . . . 0.0 109.705 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -56.89 -47.33 80.77 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.392 1.077 . . . . 0.0 113.66 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.462 ' OG1' HD11 ' A' ' 43' ' ' LEU 0.359 13.7 t -70.69 5.58 1.84 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 mt -115.18 -64.68 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 174.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.405 ' HG3' ' HA3' ' A' ' 102' ' ' GLY . 24.9 mmt180 -51.12 -45.59 61.64 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.811 1.644 . . . . 0.0 113.752 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.69 -10.72 42.06 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -83.03 89.94 6.97 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -11.67 -72.06 0.01 OUTLIER Glycine 0 N--CA 1.485 1.929 0 C-N-CA 127.091 2.281 . . . . 0.0 116.641 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.4 -38.64 77.76 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 82.5 mtp -92.51 -14.17 28.79 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.0 t -30.0 -35.92 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 121.681 3.956 . . . . 0.0 121.681 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.71 -8.58 58.15 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 120.849 3.648 . . . . 0.0 120.849 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 2.3 mp -68.08 119.16 65.29 Favored Pre-proline 0 N--CA 1.477 0.903 0 N-CA-C 118.049 2.611 . . . . 0.0 118.049 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 7.5 Cg_endo -57.86 142.24 96.25 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.686 2.924 . . . . 0.0 110.949 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 103' ' ' ALA . 1.3 t -123.29 121.82 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 113.538 -1.665 . . . . 0.0 113.121 -175.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.732 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 28.3 tp -111.6 102.58 10.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.699 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 31.4 mmt -80.04 105.98 11.72 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 113.416 -1.72 . . . . 0.0 112.845 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.59 98.06 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 113.492 -1.686 . . . . 0.0 107.722 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 1.7 t -114.05 121.74 44.77 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 -176.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.757 ' HB2' ' HE3' ' A' ' 109' ' ' LYS . . . -70.0 -18.8 63.34 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.002 -1.454 . . . . 0.0 112.928 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.78 84.45 1.94 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.218 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.48 100.12 6.74 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.794 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -119.04 137.68 53.37 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 112.951 -1.931 . . . . 0.0 107.876 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.479 ' O ' HG12 ' A' ' 96' ' ' ILE . 64.4 tttp -31.14 -57.27 0.24 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -57.51 -47.52 81.74 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.264 30.1 p30 -69.3 -33.99 74.02 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.0 mt -59.72 -49.87 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 124.136 0.974 . . . . 0.0 109.186 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 92' ' ' LYS . 42.4 mm -57.83 -50.41 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.228 1.011 . . . . 0.0 110.195 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.32 -50.11 60.03 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.339 1.055 . . . . 0.0 111.272 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.459 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -58.06 -56.4 22.54 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.892 1.277 . . . . 0.0 112.504 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.23 -49.24 74.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.986 0.914 . . . . 0.0 112.623 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -63.43 -37.48 87.45 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.04 -16.99 62.05 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.405 ' HA3' ' HG3' ' A' ' 73' ' ' ARG . . . 121.98 -0.02 10.76 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.618 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -67.07 110.67 3.5 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.404 1.102 . . . . 0.0 111.478 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.9 p -66.85 -18.29 65.31 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 113.681 -1.6 . . . . 0.0 114.644 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.16 168.3 40.02 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.76 1.171 . . . . 0.0 111.866 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -144.73 140.5 28.6 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.423 -0.888 . . . . 0.0 111.793 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.9 p -126.34 134.75 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 124.504 1.127 . . . . 0.0 111.845 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 87' ' ' THR . 47.8 t -81.03 128.79 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.983 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.757 ' HE3' ' HB2' ' A' ' 88' ' ' ALA . 42.1 pttt -94.03 132.86 28.55 Favored Pre-proline 0 N--CA 1.486 1.333 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.332 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.91 146.88 76.2 Favored 'Cis proline' 0 N--CA 1.478 0.617 0 O-C-N 123.437 1.23 . . . . 0.0 114.497 0.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -126.08 154.07 43.59 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 112.941 -1.936 . . . . 0.0 109.034 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.4 p -99.01 172.07 7.63 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.523 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.97 -39.71 72.2 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.87 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.89 -47.34 69.11 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.637 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.3 m -59.56 -46.91 87.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.584 0.754 . . . . 0.0 109.816 178.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.0 tp -56.76 -54.26 48.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.424 1.49 . . . . 0.0 110.198 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.24 -46.51 76.02 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.857 0.863 . . . . 0.0 112.682 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.28 -44.88 65.24 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.198 0.936 . . . . 0.0 112.134 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -66.54 -49.61 65.9 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.717 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.513 HD22 ' HE2' ' A' ' 8' ' ' PHE . 55.6 mt -55.92 -49.29 73.88 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.15 0.98 . . . . 0.0 111.849 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.793 HD22 ' CZ ' ' A' ' 1' ' ' ARG . 3.7 m-20 -55.78 -48.67 74.92 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.369 1.468 . . . . 0.0 112.692 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -54.22 -48.72 70.76 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.632 1.173 . . . . 0.0 110.784 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.21 -47.37 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.262 1.025 . . . . 0.0 110.585 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' A' ' 129' ' ' MET . 22.2 m-30 -57.79 -36.6 72.4 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -61.79 -44.65 96.44 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.636 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -62.15 -43.14 99.49 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.687 1.195 . . . . 0.0 110.777 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -74.92 4.63 6.21 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.08 30.97 74.22 Favored Glycine 0 N--CA 1.484 1.838 0 C-N-CA 125.351 1.453 . . . . 0.0 116.266 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.458 ' HB2' ' HB3' ' A' ' 124' ' ' PHE . 20.8 mmt . . . . . 0 C--O 1.255 1.345 0 CA-C-O 116.753 -1.594 . . . . 0.0 114.092 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.9 p -81.56 74.59 8.54 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 123.647 1.689 . . . . 0.0 110.151 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -71.48 81.84 0.8 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -88.96 -37.47 15.2 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.22 -1.355 . . . . 0.0 113.352 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.59 60.89 5.82 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 123.209 1.48 . . . . 0.0 108.565 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.435 HD21 ' HB2' ' A' ' 53' ' ' PHE . 5.5 tt -98.11 123.75 42.31 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.049 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 32' ' ' ASN . 46.4 tttp -80.33 105.46 11.61 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.685 1.241 . . . . 0.0 112.657 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -97.47 145.22 26.42 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.005 -1.452 . . . . 0.0 112.615 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.838 HD12 HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -113.15 107.23 15.64 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 173.592 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.52 98.85 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.931 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.674 HG11 ' HB2' ' A' ' 42' ' ' ALA . 2.2 t -105.77 89.88 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 113.304 -1.771 . . . . 0.0 109.257 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -134.14 125.68 28.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 112.643 -2.071 . . . . 0.0 111.019 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -55.37 -24.86 31.91 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 110.93 -2.85 . . . . 0.0 116.738 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -106.66 120.69 42.64 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.2 p -42.96 -57.67 2.75 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.937 -1.483 . . . . 0.0 114.305 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.44 ' O ' HG12 ' A' ' 20' ' ' ILE . 11.0 p -68.06 -43.37 78.8 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 118.223 -0.894 . . . . 0.0 113.29 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -39.3 90.4 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.249 0.477 . . . . 0.0 110.896 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -56.63 -49.45 74.96 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.386 1.074 . . . . 0.0 109.971 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -61.0 -42.33 98.23 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.71 177.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 16' ' ' THR . 42.8 mm -56.17 -48.59 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 118.888 -0.577 . . . . 0.0 110.002 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.464 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 4.1 t -59.5 -49.97 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 19' ' ' ARG . 42.5 ttt180 -49.62 -49.08 48.33 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.207 1.403 . . . . 0.0 111.092 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -64.5 -43.32 94.48 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.548 1.139 . . . . 0.0 112.286 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.496 HD22 ' HB2' ' A' ' 113' ' ' ALA . 57.3 mt -55.72 -50.97 68.92 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.385 1.074 . . . . 0.0 111.31 177.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 mt -51.01 -48.6 61.38 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.757 1.286 . . . . 0.0 112.187 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.406 ' NZ ' ' HG2' ' A' ' 22' ' ' ARG . 32.0 mtmm -58.96 -44.8 91.56 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.982 -1.463 . . . . 0.0 112.247 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 32.5 mt-10 -59.18 -38.47 79.88 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.095 1.358 . . . . 0.0 112.733 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.543 HD22 ' HB2' ' A' ' 117' ' ' GLU . 60.2 mt -71.14 -18.21 62.52 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.098 1.359 . . . . 0.0 114.239 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.79 9.96 19.81 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 124.476 1.036 . . . . 0.0 113.5 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -96.76 95.39 7.86 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 123.405 1.574 . . . . 0.0 110.199 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -61.95 -34.62 76.46 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 110.501 -3.045 . . . . 0.0 118.746 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 7' ' ' LYS . 9.1 t-20 -112.3 125.81 54.58 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 -174.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.4 p -147.96 135.79 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.77 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 12.9 mm-40 -113.78 161.42 17.56 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.869 175.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -123.38 130.51 52.82 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -139.12 156.7 46.96 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.377 1.471 . . . . 0.0 109.699 175.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -113.86 -38.79 4.14 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 61' ' ' PRO . 6.6 p-10 -123.38 159.79 28.17 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 118.719 -0.658 . . . . 0.0 109.774 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.575 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -44.67 -45.68 8.8 Favored Glycine 0 N--CA 1.478 1.445 0 N-CA-C 116.74 1.456 . . . . 0.0 116.74 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.57 -54.77 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 122.559 0.344 . . . . 0.0 110.196 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -57.51 -34.13 68.77 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.446 0.699 . . . . 0.0 110.777 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.674 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -62.94 -55.23 27.76 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.653 1.181 . . . . 0.0 110.32 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.0 mt -56.52 -43.54 79.92 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.66 0.784 . . . . 0.0 110.324 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -53.86 -56.16 20.13 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.318 1.047 . . . . 0.0 110.744 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -59.38 -52.97 63.32 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.213 1.405 . . . . 0.0 111.896 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.838 HD13 HD12 ' A' ' 9' ' ' LEU . 4.0 tp -56.49 -37.21 70.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.933 2.093 . . . . 0.0 114.61 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -54.64 -30.26 54.62 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.472 1.509 . . . . 0.0 113.589 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.77 -22.47 66.99 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.21 -173.13 46.12 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.25 0.928 . . . . 0.0 112.093 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.63 -26.41 3.14 Favored Glycine 0 CA--C 1.543 1.833 0 N-CA-C 114.78 0.672 . . . . 0.0 114.78 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.77 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 91.3 m-85 -68.12 108.94 3.31 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.879 0.872 . . . . 0.0 111.799 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.59 3.11 86.41 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.441 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.646 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -166.04 143.52 5.45 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.105 0.962 . . . . 0.0 113.441 179.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.543 HG22 HD11 ' A' ' 46' ' ' LEU . 31.3 t -122.14 113.84 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 113.918 -1.492 . . . . 0.0 107.608 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.549 HD12 HD23 ' A' ' 84' ' ' LEU . 18.8 tt -113.43 97.28 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 178.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.7 t -119.53 136.03 54.52 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -175.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.408 ' O ' ' HG3' ' A' ' 60' ' ' MET . 8.0 t0 -71.98 132.88 44.91 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 112.415 -2.175 . . . . 0.0 110.944 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.479 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 26.6 t-105 -56.29 -41.23 75.58 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.41 1.084 . . . . 0.0 111.719 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -99.5 104.44 16.27 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.481 ' SD ' HG12 ' A' ' 11' ' ' VAL . 29.4 mtm -138.83 130.45 15.39 Favored Pre-proline 0 N--CA 1.473 0.689 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.713 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.508 ' O ' ' HB2' ' A' ' 38' ' ' ASP . 99.0 Cg_exo -57.42 149.6 64.76 Favored 'Trans proline' 0 N--CA 1.481 0.766 0 C-N-CA 123.448 2.765 . . . . 0.0 110.944 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 71.19 -61.2 0.49 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 126.119 1.767 . . . . 0.0 112.516 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.575 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 55.6 ttm -135.31 108.33 7.64 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.154 1.381 . . . . 0.0 108.101 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 10.7 m-20 -68.88 167.39 15.76 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.457 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.26 -57.01 9.55 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 125.508 1.528 . . . . 0.0 114.527 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.455 HD12 HD23 ' A' ' 69' ' ' LEU . 56.9 tp -57.44 -37.84 73.45 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -71.61 -42.95 67.04 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.668 0.787 . . . . 0.0 111.167 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.07 -41.53 83.59 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.328 1.051 . . . . 0.0 110.246 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.577 HD13 HG11 ' A' ' 83' ' ' VAL . 8.4 tp -57.23 -46.53 82.88 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.005 176.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -60.43 -44.0 96.21 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.38 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.26 24.9 p -62.0 -35.44 78.53 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.268 1.027 . . . . 0.0 111.993 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.4 mt -69.33 -56.95 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.499 ' HG3' ' HA3' ' A' ' 102' ' ' GLY . 30.1 mmt180 -53.34 -47.98 68.89 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.718 1.261 . . . . 0.0 113.043 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.14 -33.85 75.26 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.165 0.986 . . . . 0.0 113.097 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -84.68 83.25 8.09 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.794 0.838 . . . . 0.0 108.777 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -4.58 -80.6 0.01 OUTLIER Glycine 0 N--CA 1.484 1.849 0 C-N-CA 127.521 2.486 . . . . 0.0 118.221 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.89 -35.27 57.7 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 94.0 mtp -73.37 -27.11 61.3 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.072 0.949 . . . . 0.0 113.241 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.3 t -53.83 -26.51 24.65 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.43 -14.61 61.74 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.516 HD22 ' O ' ' A' ' 51' ' ' TYR . 16.0 mt -86.53 116.19 65.01 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 123.784 0.833 . . . . 0.0 109.876 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 9.4 Cg_endo -52.58 143.66 45.03 Favored 'Trans proline' 0 N--CA 1.476 0.488 0 C-N-CA 123.53 2.82 . . . . 0.0 113.71 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.577 HG11 HD13 ' A' ' 69' ' ' LEU . 13.5 t -121.23 117.86 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.801 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.646 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 29.5 tp -110.64 107.32 16.86 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 113.044 -1.889 . . . . 0.0 109.573 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.4 mmt -82.27 119.23 23.84 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 113.862 -1.517 . . . . 0.0 112.825 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 2.2 t -94.13 96.29 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 t -105.24 138.52 41.31 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 112.162 -2.29 . . . . 0.0 116.084 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.79 -22.11 66.03 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 113.565 -1.652 . . . . 0.0 113.167 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -142.09 135.4 29.07 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 1.006 ' HB2' HG21 ' A' ' 108' ' ' VAL . . . -97.99 60.29 1.46 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 113.344 -1.753 . . . . 0.0 109.492 176.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -112.28 148.17 34.75 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.652 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -37.17 -45.13 0.61 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 116.32 1.971 . . . . 0.0 116.32 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.12 -60.53 3.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.961 0.904 . . . . 0.0 110.738 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -59.39 -46.75 87.81 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.788 1.235 . . . . 0.0 112.594 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 73.3 mt -57.31 -57.2 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 124.207 0.942 . . . . 0.0 111.598 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.7 mt -60.06 -50.48 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.175 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.96 -49.69 68.17 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.771 0.669 . . . . 0.0 112.228 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.479 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -60.78 -54.94 39.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.348 1.059 . . . . 0.0 111.633 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.42 -48.59 76.65 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.077 0.951 . . . . 0.0 112.408 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -61.18 -31.35 71.1 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.55 1.87 55.37 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.499 ' HA3' ' HG3' ' A' ' 73' ' ' ARG . . . 110.18 -0.28 29.82 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 116.892 1.517 . . . . 0.0 116.892 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.452 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -70.55 109.55 4.91 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.2 1.0 . . . . 0.0 111.856 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.2 p -63.64 -21.48 66.39 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.54 -1.664 . . . . 0.0 114.246 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -170.45 171.07 43.47 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.897 1.237 . . . . 0.0 112.357 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.494 ' O ' ' HE2' ' A' ' 119' ' ' LYS . 31.2 p90 -146.45 127.29 14.42 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.643 -0.778 . . . . 0.0 113.024 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 1.5 p -111.2 119.54 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.006 HG21 ' HB2' ' A' ' 90' ' ' ALA . 63.2 t -82.05 125.36 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 113.607 -1.633 . . . . 0.0 112.88 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -87.09 133.95 37.86 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 112.77 -2.014 . . . . 0.0 110.214 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.27 126.71 13.77 Favored 'Cis proline' 0 C--N 1.351 0.663 0 CA-C-O 123.192 1.247 . . . . 0.0 115.223 0.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.464 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 21.6 p90 -115.83 147.81 40.61 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 112.424 -2.171 . . . . 0.0 108.269 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 48.7 p -104.07 171.93 7.08 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.764 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.496 ' HB2' HD22 ' A' ' 24' ' ' LEU . . . -54.85 -37.52 66.32 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.99 176.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.06 -50.33 64.52 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.196 0.998 . . . . 0.0 110.741 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.8 m -58.81 -44.74 90.9 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.701 0.801 . . . . 0.0 110.211 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 36.6 tp -58.18 -55.83 29.95 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.147 1.379 . . . . 0.0 109.844 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.543 ' HB2' HD22 ' A' ' 28' ' ' LEU . 23.5 tt0 -59.3 -41.65 89.52 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.76 0.424 . . . . 0.0 111.72 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -52.52 -46.89 66.88 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.694 0.797 . . . . 0.0 110.868 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 106' ' ' TYR . 31.3 mmmt -70.4 -42.58 71.5 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.032 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.1 mt -56.76 -46.65 81.31 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -53.2 -49.54 66.54 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.806 1.242 . . . . 0.0 111.681 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 119' ' ' LYS . 59.0 tttm -52.51 -47.86 66.38 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.75 1.62 . . . . 0.0 111.275 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.585 HG13 ' HZ ' ' A' ' 53' ' ' PHE . 14.1 mm -60.32 -48.04 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.207 1.003 . . . . 0.0 110.528 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -57.66 -38.32 74.87 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -61.66 -44.09 97.61 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 124.435 1.085 . . . . 0.0 110.879 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -61.83 -33.47 74.2 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.29 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 mt -88.68 4.92 45.52 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.291 1.436 . . . . 0.0 114.67 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.85 19.76 77.11 Favored Glycine 0 CA--C 1.543 1.842 0 C-N-CA 124.193 0.902 . . . . 0.0 114.116 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 68.0 mtt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 116.873 -1.537 . . . . 0.0 112.064 179.348 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.6 p -71.35 81.64 0.76 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.212 1.005 . . . . 0.0 112.678 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.572 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 40.2 t0 -73.23 86.88 1.44 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.258 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -53.41 -33.14 52.72 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -74.87 5.54 4.96 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.822 1.249 . . . . 0.0 114.342 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.572 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 0.8 OUTLIER -66.31 126.91 30.24 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.256 1.423 . . . . 0.0 113.032 -177.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -84.25 108.73 17.28 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 112.983 -1.917 . . . . 0.0 112.282 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -99.73 127.87 45.85 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.757 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.544 HD13 HG22 ' A' ' 11' ' ' VAL . 1.4 tm? -107.65 95.84 5.97 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.71 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 45.6 t -79.43 104.71 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 111.148 -2.751 . . . . 0.0 108.931 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.544 HG22 HD13 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -104.44 72.56 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 123.553 1.644 . . . . 0.0 107.921 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -129.11 80.23 1.96 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 112.885 -1.961 . . . . 0.0 110.7 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -13.01 -30.61 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 1 N-CA-C 124.421 4.971 . . . . 0.0 124.421 -178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -101.12 124.01 46.17 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.418 ' HA ' HH11 ' A' ' 18' ' ' ARG . 11.9 m -41.95 -43.54 3.15 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 114.68 -1.145 . . . . 0.0 113.392 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.525 ' O ' HG12 ' A' ' 20' ' ' ILE . 2.1 m -58.21 -55.95 28.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.932 1.293 . . . . 0.0 110.835 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.449 ' O ' HG23 ' A' ' 21' ' ' VAL . 1.1 tmm? -59.88 -42.61 94.15 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.487 ' HB3' ' OE1' ' A' ' 35' ' ' GLU . 12.9 mtp180 -55.72 -47.81 76.23 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.766 0.666 . . . . 0.0 111.229 176.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 15.0 ttp180 -67.14 -39.92 86.67 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.078 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 16' ' ' THR . 37.2 mm -56.55 -47.76 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 123.307 0.38 . . . . 0.0 110.086 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 17' ' ' MET . 18.7 t -60.59 -42.06 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.617 ' HG3' HG11 ' A' ' 33' ' ' VAL . 24.5 ttt85 -53.31 -52.54 58.81 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.582 0.753 . . . . 0.0 110.155 176.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -53.51 -44.46 69.13 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.325 1.05 . . . . 0.0 112.279 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.0 -51.13 69.3 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.963 1.305 . . . . 0.0 112.048 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.0 mt -56.15 -44.31 79.15 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.041 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -57.78 -47.64 81.95 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.927 176.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.19 -39.15 78.18 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.109 1.364 . . . . 0.0 111.733 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.8 mt -73.21 -26.9 61.33 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.86 21.18 7.95 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.567 1.08 . . . . 0.0 114.399 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -92.97 116.44 29.05 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 122.456 1.122 . . . . 0.0 112.645 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.52 -48.27 67.52 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 111.411 -2.631 . . . . 0.0 116.15 -177.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -111.57 122.36 47.62 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 -174.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG11 ' HG3' ' A' ' 22' ' ' ARG . 7.9 p -138.31 112.92 8.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 111.154 -2.748 . . . . 0.0 110.781 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.632 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 31.9 mt-10 -109.44 140.75 42.79 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.71 ' HG2' ' HB ' ' A' ' 10' ' ' VAL . 45.0 mt-10 -123.36 131.64 53.72 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 -174.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.407 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -117.09 157.03 26.56 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 111.493 -2.594 . . . . 0.0 110.271 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -92.23 -55.46 3.42 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -130.34 173.05 11.19 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.703 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -40.57 -54.64 3.35 Favored Glycine 0 CA--C 1.536 1.346 0 O-C-N 124.977 1.423 . . . . 0.0 115.44 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.8 t -57.25 -56.78 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.984 0.914 . . . . 0.0 112.076 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -56.82 -36.72 70.29 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.421 0.688 . . . . 0.0 111.579 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.536 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -64.14 -51.05 65.77 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.126 0.97 . . . . 0.0 111.028 177.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.2 mt -54.13 -49.27 69.59 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.501 0.72 . . . . 0.0 110.711 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -52.16 -55.45 20.9 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.301 1.041 . . . . 0.0 111.661 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.489 ' HD3' HD21 ' A' ' 9' ' ' LEU . 41.3 mttm -58.23 -52.78 64.13 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.537 177.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.7 mt -56.34 -39.22 72.48 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.984 1.314 . . . . 0.0 114.092 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -58.79 -23.93 61.06 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.46 -19.25 62.24 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.09 -165.5 29.2 Favored Glycine 0 N--CA 1.481 1.645 0 C-N-CA 124.884 1.23 . . . . 0.0 112.097 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.33 -34.95 1.53 Allowed Glycine 0 CA--C 1.544 1.865 0 N-CA-C 116.0 1.16 . . . . 0.0 116.0 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.632 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 80.9 m-85 -66.5 118.38 10.05 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.08 7.36 56.94 Favored Glycine 0 N--CA 1.476 1.316 0 CA-C-N 112.654 -2.067 . . . . 0.0 111.803 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.511 ' HA ' ' HG2' ' A' ' 82' ' ' PRO . 2.4 t80 -163.97 138.18 5.69 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.7 t -122.16 110.94 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.581 HG23 ' HA ' ' A' ' 10' ' ' VAL . 12.5 tt -114.93 97.84 6.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.5 t -118.67 136.01 54.15 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 60' ' ' MET . 53.6 t0 -71.72 132.67 44.86 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 113.2 -1.818 . . . . 0.0 110.745 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.441 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 17.6 t-105 -56.39 -46.5 80.09 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.306 177.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -93.29 105.42 17.5 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.883 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.41 ' HE2' ' HA2' ' A' ' 65' ' ' GLY . 29.5 mtm -140.25 134.39 15.5 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.627 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -58.43 142.25 97.72 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 C-N-CA 123.717 2.945 . . . . 0.0 111.054 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.7 m120 63.75 -67.32 0.1 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.857 1.663 . . . . 0.0 114.304 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.401 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 57.4 ttm -115.73 97.74 6.3 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 4.0 p30 -60.94 165.74 3.91 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 112.122 -2.308 . . . . 0.0 112.541 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.41 ' HA2' ' HE2' ' A' ' 60' ' ' MET . . . -49.33 -55.92 11.86 Favored Glycine 0 N--CA 1.484 1.886 0 C-N-CA 124.711 1.148 . . . . 0.0 114.432 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.455 HD12 HD23 ' A' ' 69' ' ' LEU . 41.1 tp -57.26 -43.23 82.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.141 0.576 . . . . 0.0 112.47 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.54 -41.74 92.72 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.875 0.87 . . . . 0.0 111.365 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.53 -46.46 83.81 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.328 1.051 . . . . 0.0 110.225 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.455 HD23 HD12 ' A' ' 66' ' ' LEU . 18.4 tp -55.07 -47.81 74.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.386 1.475 . . . . 0.0 110.737 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -60.0 -47.47 85.71 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.218 0.607 . . . . 0.0 112.125 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.267 16.4 p -57.19 -29.21 63.49 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.019 0.928 . . . . 0.0 112.634 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mt -81.55 -58.01 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.157 0.983 . . . . 0.0 108.891 177.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 81.8 mmt-85 -48.08 -47.78 33.86 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.467 1.907 . . . . 0.0 112.855 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.98 61.66 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -84.33 96.43 9.03 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -17.96 -69.46 0.01 OUTLIER Glycine 0 N--CA 1.488 2.114 0 C-N-CA 126.27 1.891 . . . . 0.0 116.56 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.57 95.33 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 98.7 mtp -75.51 -22.43 57.15 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.1 t -38.03 -36.07 0.19 Allowed 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 117.405 2.372 . . . . 0.0 117.405 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.39 -1.86 51.23 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 117.23 2.308 . . . . 0.0 117.23 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.4 mt -69.42 110.28 6.04 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.561 ' HB3' HD11 ' A' ' 127' ' ' LEU . 39.5 Cg_endo -54.99 124.33 16.01 Favored 'Trans proline' 0 N--CA 1.483 0.888 0 C-N-CA 123.435 2.757 . . . . 0.0 113.437 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.9 t -112.68 119.27 59.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 114.078 -1.419 . . . . 0.0 114.521 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 66.6 tp -109.09 101.18 10.26 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 111.919 -2.4 . . . . 0.0 107.859 176.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.4 mmt -76.02 104.51 6.59 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.42 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 t -83.94 98.57 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.3 p -90.6 132.13 35.91 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 112.958 -1.928 . . . . 0.0 112.387 -176.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.11 -46.14 89.09 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.959 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -147.11 115.18 6.55 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.97 98.52 5.71 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.657 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -114.64 142.21 46.76 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.114 -1.857 . . . . 0.0 108.69 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' A' ' 93' ' ' GLU 0.264 0.0 OUTLIER -38.36 -45.17 0.98 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 179.677 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.403 ' H ' ' HD2' ' A' ' 92' ' ' LYS . 0.8 OUTLIER -55.59 -53.21 59.3 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.631 0.772 . . . . 0.0 112.959 178.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.01 -37.66 84.57 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.598 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.97 -51.27 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.775 0.83 . . . . 0.0 110.4 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.0 mt -57.84 -51.65 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.38 0.672 . . . . 0.0 109.244 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.02 -44.6 74.74 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.04 0.936 . . . . 0.0 113.369 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.441 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -58.48 -47.77 82.96 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.155 0.982 . . . . 0.0 112.31 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.79 -44.75 96.26 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.886 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -59.06 -31.58 68.99 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.16 -5.8 49.32 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.13 4.4 27.43 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 118.317 2.087 . . . . 0.0 118.317 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.7 121.03 8.84 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.402 ' HB3' HG23 ' A' ' 123' ' ' ILE . 13.6 m -66.87 -30.67 70.9 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 113.271 -1.786 . . . . 0.0 113.404 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.78 167.42 38.81 Favored Glycine 0 N--CA 1.479 1.556 0 C-N-CA 124.458 1.028 . . . . 0.0 110.819 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -141.92 137.63 31.43 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.31 126.55 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 124.617 1.198 . . . . 0.0 111.66 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.2 p -88.99 135.62 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.706 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.2 pttt -92.75 142.36 25.54 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-O 117.709 -1.138 . . . . 0.0 112.392 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.08 129.81 18.55 Favored 'Cis proline' 0 N--CA 1.481 0.769 0 N-CA-C 116.568 1.718 . . . . 0.0 116.568 0.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -120.38 139.29 53.01 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 112.814 -1.994 . . . . 0.0 107.966 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.5 p -97.82 174.94 6.35 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.876 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.88 -36.39 67.58 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.38 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.02 -47.29 71.89 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.185 0.994 . . . . 0.0 111.44 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 m -59.59 -45.96 90.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.285 0.634 . . . . 0.0 109.623 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 42.4 tp -56.89 -51.64 68.28 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.602 1.161 . . . . 0.0 110.277 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.55 ' HA ' HD12 ' A' ' 120' ' ' LEU . 15.2 tm-20 -54.3 -46.85 72.87 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.646 1.178 . . . . 0.0 111.91 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -58.96 -43.76 91.36 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.099 0.874 . . . . 0.0 112.655 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -65.61 -42.26 91.82 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.853 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 117' ' ' GLU . 89.2 mt -53.69 -47.69 70.22 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.337 1.023 . . . . 0.0 111.33 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -52.59 -54.98 25.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.592 1.557 . . . . 0.0 111.867 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -52.45 -49.88 63.74 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 113.859 -1.519 . . . . 0.0 112.51 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.463 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 58.7 mt -60.14 -45.54 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.852 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.5 m-30 -61.78 -33.8 74.74 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -61.26 -45.23 95.36 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.41 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -61.39 -34.08 74.74 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.121 0.968 . . . . 0.0 112.166 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 82' ' ' PRO . 39.9 mt -77.79 5.66 9.06 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.88 11.37 65.51 Favored Glycine 0 CA--C 1.542 1.721 0 C-N-CA 124.641 1.115 . . . . 0.0 115.684 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 76.0 mtm . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 179.657 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.456 ' HB3' ' OE1' ' A' ' 5' ' ' GLU . 58.1 m -85.04 71.37 10.94 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 -176.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -92.77 66.27 4.33 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.427 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -151.88 -69.34 0.17 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 113.502 -1.681 . . . . 0.0 113.058 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.456 ' OE1' ' HB3' ' A' ' 2' ' ' SER . 0.0 OUTLIER -82.31 62.5 6.04 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 123.127 1.441 . . . . 0.0 111.4 179.483 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 tt -106.34 123.64 48.36 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 113.24 -1.8 . . . . 0.0 111.068 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -76.34 103.27 6.27 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.895 1.372 . . . . 0.0 113.976 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -98.47 130.47 45.08 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 112.621 -2.081 . . . . 0.0 112.014 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.535 HD12 ' HG ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -108.64 102.54 11.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 122.748 1.261 . . . . 0.0 108.695 174.42 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.3 t -88.13 107.16 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.501 HG12 ' SD ' ' A' ' 60' ' ' MET . 4.3 t -105.45 101.99 13.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 111.391 -2.641 . . . . 0.0 108.339 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -138.85 133.57 32.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.968 -1.469 . . . . 0.0 112.33 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -63.52 -23.18 67.28 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 113.965 -1.47 . . . . 0.0 112.396 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.49 102.06 11.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.789 177.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.9 p -49.06 -34.09 12.9 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.767 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.65 -41.57 95.22 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.131 1.772 . . . . 0.0 110.726 176.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.422 ' O ' HG23 ' A' ' 21' ' ' VAL . 10.3 tpt -66.67 -42.21 86.94 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.3 0.64 . . . . 0.0 110.536 177.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.667 ' HG3' ' HG3' ' A' ' 35' ' ' GLU . 1.8 tmm_? -56.51 -42.79 78.97 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 124.285 0.991 . . . . 0.0 109.735 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.714 ' HD3' HH22 ' A' ' 22' ' ' ARG . 1.8 tpp180 -56.02 -48.6 75.64 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.147 1.379 . . . . 0.0 110.576 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.3 mm -58.47 -55.85 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.046 0.939 . . . . 0.0 110.382 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 17' ' ' MET . 4.5 t -53.04 -44.79 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.817 0.847 . . . . 0.0 111.566 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.714 HH22 ' HD3' ' A' ' 19' ' ' ARG . 26.0 ttm180 -52.62 -54.12 37.52 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.054 0.942 . . . . 0.0 111.452 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -60.19 -39.75 87.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.99 0.916 . . . . 0.0 113.299 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.91 -53.13 61.49 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.48 1.112 . . . . 0.0 110.745 177.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.2 mt -57.48 -44.51 84.94 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.835 0.854 . . . . 0.0 112.112 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -53.37 -48.7 68.36 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.486 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -57.45 -38.88 75.15 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.035 1.334 . . . . 0.0 111.985 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.2 mt -74.83 -15.13 60.74 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.37 6.49 29.25 Favored Glycine 0 CA--C 1.545 1.947 0 C-N-CA 125.104 1.335 . . . . 0.0 114.78 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -98.44 91.88 5.4 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 122.758 1.265 . . . . 0.0 112.666 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -79.35 -10.22 59.76 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 119.604 3.187 . . . . 0.0 119.604 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -107.4 99.23 8.77 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 119.404 1.002 . . . . 0.0 112.511 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -130.12 125.04 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.066 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -111.84 163.75 13.84 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.596 0.758 . . . . 0.0 109.851 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.667 ' HG3' ' HG3' ' A' ' 18' ' ' ARG . 44.1 tt0 -120.67 131.05 54.38 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 -176.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.452 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -137.03 149.49 47.49 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 112.104 -2.316 . . . . 0.0 108.095 173.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -101.45 -41.65 6.56 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -130.85 159.84 36.19 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.629 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -39.51 -51.71 3.03 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.984 1.754 . . . . 0.0 115.03 177.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.45 -56.19 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 114.852 -0.674 . . . . 0.0 111.23 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.8 -37.58 68.81 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.933 0.893 . . . . 0.0 111.458 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.436 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -60.18 -49.52 77.32 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 117.462 -1.256 . . . . 0.0 111.42 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.7 mt -58.5 -44.77 89.56 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.104 0.562 . . . . 0.0 111.385 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -54.8 -53.02 60.68 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.971 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -59.9 -50.92 71.87 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.681 1.593 . . . . 0.0 111.88 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.535 ' HG ' HD12 ' A' ' 9' ' ' LEU . 16.4 mt -54.81 -49.28 71.39 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.451 1.9 . . . . 0.0 114.73 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.91 -17.63 10.27 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.64 -19.65 65.81 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.224 0.61 . . . . 0.0 112.499 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.3 -177.88 38.19 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.924 1.249 . . . . 0.0 114.146 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.56 -24.57 2.62 Favored Glycine 0 CA--C 1.541 1.703 0 N-CA-C 116.432 1.333 . . . . 0.0 116.432 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -69.0 113.22 6.19 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.27 5.65 61.07 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 112.725 -2.034 . . . . 0.0 112.01 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -164.24 143.86 7.73 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.469 HG22 HD21 ' A' ' 46' ' ' LEU . 21.3 t -127.88 120.0 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.086 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 84' ' ' LEU . 71.2 mt -113.07 102.59 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.7 t -119.23 131.78 55.85 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 118.016 2.598 . . . . 0.0 118.016 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -71.98 124.84 25.78 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 112.066 -2.334 . . . . 0.0 109.808 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.498 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 18.3 t-105 -55.4 -39.34 70.06 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.232 178.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -91.41 94.05 9.31 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.797 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.501 ' SD ' HG12 ' A' ' 11' ' ' VAL . 29.6 mtm -139.58 122.52 10.43 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-N 112.83 -1.986 . . . . 0.0 109.589 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -60.82 127.62 23.06 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.893 3.062 . . . . 0.0 113.335 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 m120 81.32 -65.8 0.13 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.02 1.728 . . . . 0.0 113.283 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.2 ttm -115.57 87.72 2.73 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.625 0.726 . . . . 0.0 109.363 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.5 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.1 p30 -61.43 168.87 2.52 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 111.863 -2.426 . . . . 0.0 112.224 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 58' ' ' TRP . . . -47.29 -53.43 11.69 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 124.932 1.253 . . . . 0.0 114.223 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.42 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 62.3 tp -57.38 -44.59 84.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.883 0.873 . . . . 0.0 111.997 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.522 ' HA ' ' HD3' ' A' ' 70' ' ' LYS . 32.5 mm-40 -66.23 -40.72 90.48 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.2 tp -61.57 -42.79 99.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.368 0.667 . . . . 0.0 111.27 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.605 HD12 ' HD3' ' A' ' 73' ' ' ARG . 5.4 tp -53.25 -45.21 68.67 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.831 1.252 . . . . 0.0 110.868 177.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.522 ' HD3' ' HA ' ' A' ' 67' ' ' GLU . 13.8 mtpp -64.76 -44.86 88.68 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.488 1.115 . . . . 0.0 111.209 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.2 p -61.0 -25.12 66.66 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.773 1.229 . . . . 0.0 113.219 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.9 mt -84.04 -59.64 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.613 1.165 . . . . 0.0 108.072 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.605 ' HD3' HD12 ' A' ' 69' ' ' LEU . 2.9 mpt_? -49.05 -43.39 40.7 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.253 1.821 . . . . 0.0 113.447 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.46 -14.64 52.05 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.83 91.98 7.17 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -7.52 -79.53 0.01 OUTLIER Glycine 0 N--CA 1.488 2.141 0 C-N-CA 126.936 2.208 . . . . 0.0 117.161 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.57 -45.62 88.63 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.8 mtp -80.16 -11.45 59.75 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 117.36 2.355 . . . . 0.0 117.36 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.3 t -30.47 -61.37 0.17 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 118.761 2.874 . . . . 0.0 118.761 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.22 12.82 2.65 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 119.9 3.296 . . . . 0.0 119.9 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.1 mt -76.62 106.37 3.29 Favored Pre-proline 0 N--CA 1.479 0.989 0 O-C-N 121.251 -0.906 . . . . 0.0 112.117 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.402 ' HG3' HD11 ' A' ' 127' ' ' LEU . 14.7 Cg_endo -40.13 133.86 1.95 Allowed 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 124.567 3.511 . . . . 0.0 117.149 -175.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.4 t -119.28 117.96 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 111.068 -2.787 . . . . 0.0 112.817 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.402 ' HB3' HG12 ' A' ' 55' ' ' ILE . 47.8 tp -108.98 105.64 15.25 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 113.34 -1.754 . . . . 0.0 107.706 177.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.7 mmt -80.53 114.84 19.7 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 113.597 -1.638 . . . . 0.0 111.686 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.54 HG12 ' HG3' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -98.91 110.57 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 179.497 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.6 p -111.53 153.89 25.58 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 117.846 2.536 . . . . 0.0 117.846 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.12 -31.8 73.18 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 112.018 -2.356 . . . . 0.0 113.641 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.03 124.56 3.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.535 1.134 . . . . 0.0 108.518 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.42 90.39 6.71 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 122.529 1.157 . . . . 0.0 110.403 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -121.48 133.28 55.04 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.721 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -25.5 -61.63 0.07 Allowed 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 117.692 2.478 . . . . 0.0 117.692 -177.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -53.58 -46.75 70.42 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -70.27 -34.44 72.79 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.3 mt -60.03 -53.33 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.47 0.708 . . . . 0.0 109.906 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.434 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 33.8 mt -58.56 -46.85 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.707 0.803 . . . . 0.0 109.783 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.08 -47.99 64.9 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.86 0.864 . . . . 0.0 112.294 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.498 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -63.05 -47.38 83.25 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.574 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.79 84.13 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.353 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 96' ' ' ILE . 24.6 mm100 -60.19 -36.82 78.49 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.035 0.934 . . . . 0.0 112.73 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.71 -5.07 52.17 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.561 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 113.86 -5.23 24.15 Favored Glycine 0 CA--C 1.542 1.761 0 N-CA-C 117.367 1.707 . . . . 0.0 117.367 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.51 115.46 2.53 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.417 1.608 . . . . 0.0 115.314 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.2 p -67.95 -18.65 64.81 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 113.568 -1.651 . . . . 0.0 114.217 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.416 ' HA3' HD11 ' A' ' 123' ' ' ILE . . . -165.87 162.05 35.56 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.505 1.05 . . . . 0.0 112.304 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -146.14 126.18 13.71 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.665 0.786 . . . . 0.0 111.117 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 1.4 p -131.27 136.43 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 124.849 1.343 . . . . 0.0 110.864 176.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -93.22 145.37 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.499 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.54 ' HG3' HG12 ' A' ' 86' ' ' VAL . 10.1 mtmp? -89.3 128.91 49.55 Favored Pre-proline 0 N--CA 1.476 0.825 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.68 155.66 80.58 Favored 'Cis proline' 0 CA--C 1.54 0.778 0 O-C-N 123.055 1.029 . . . . 0.0 114.371 0.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -146.53 155.72 42.73 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.067 1.747 . . . . 0.0 107.967 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.5 t -117.13 177.18 4.81 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.919 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.48 -41.86 61.22 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.823 0.849 . . . . 0.0 111.563 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.81 -53.02 60.69 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.184 0.994 . . . . 0.0 111.986 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.73 -46.76 84.0 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.757 0.823 . . . . 0.0 110.62 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.65 -52.56 63.41 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.069 1.348 . . . . 0.0 108.551 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -56.11 -46.94 78.93 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.859 1.264 . . . . 0.0 111.981 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.19 -45.86 65.33 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -68.39 -45.17 73.42 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.85 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.3 mt -55.97 -50.84 69.71 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.2 1.0 . . . . 0.0 112.169 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -51.61 -50.17 60.75 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.604 1.561 . . . . 0.0 111.995 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -54.89 -47.7 73.96 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.721 1.208 . . . . 0.0 110.997 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.416 HD11 ' HA3' ' A' ' 105' ' ' GLY . 96.4 mt -62.78 -44.42 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.849 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -61.01 -33.36 73.15 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -62.87 -44.65 95.54 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.033 176.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -62.82 -39.66 95.0 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.08 1.352 . . . . 0.0 110.741 177.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.402 HD11 ' HG3' ' A' ' 82' ' ' PRO . 85.7 mt -77.48 0.04 24.26 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.24 28.31 72.84 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 123.687 0.661 . . . . 0.0 114.563 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 117.556 -1.211 . . . . 0.0 112.75 179.731 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.3 m 61.66 -30.78 0.07 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 118.805 2.891 . . . . 0.0 118.805 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -113.34 139.36 48.92 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 126.343 1.857 . . . . 0.0 111.984 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 62.1 mttm -133.18 -51.97 0.89 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 113.53 -1.668 . . . . 0.0 112.235 176.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -84.64 60.76 6.3 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 122.388 1.09 . . . . 0.0 109.488 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 tt -108.94 133.04 53.48 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.341 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -79.84 106.75 12.1 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 125.079 1.487 . . . . 0.0 113.588 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -104.09 139.31 39.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 112.672 -2.058 . . . . 0.0 112.704 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -115.92 107.79 15.45 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.572 174.055 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.51 99.04 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 112.585 -2.098 . . . . 0.0 107.53 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.432 HG12 ' SD ' ' A' ' 60' ' ' MET . 3.5 t -101.75 91.0 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.375 -178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.44 ' OD1' ' HB2' ' A' ' 57' ' ' ASP . 12.0 m-20 -136.48 114.11 11.06 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 113.809 -1.541 . . . . 0.0 113.137 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -52.82 -28.1 21.18 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.628 ' HB3' ' HB2' ' A' ' 17' ' ' MET . 5.4 t80 -94.29 113.48 25.39 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.5 p -45.76 -46.69 15.33 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.709 1.204 . . . . 0.0 113.644 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -47.97 83.68 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.78 177.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.628 ' HB2' ' HB3' ' A' ' 14' ' ' PHE . 2.1 mmm -61.68 -39.92 93.13 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -55.76 -53.86 51.43 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 124.38 1.05 . . . . 0.0 110.421 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.12 -40.14 92.66 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.852 177.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 74.9 mt -56.03 -56.52 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.958 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.487 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 3.3 t -57.76 -45.09 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.041 0.537 . . . . 0.0 111.447 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -51.74 -56.66 12.48 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.151 0.98 . . . . 0.0 111.534 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -59.81 -41.98 92.45 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.576 0.75 . . . . 0.0 112.793 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 71.8 mt -56.96 -53.64 55.72 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.76 0.824 . . . . 0.0 111.405 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.5 mt -54.4 -47.6 72.55 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.143 0.977 . . . . 0.0 112.029 177.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 31' ' ' ASN . 97.7 mttt -57.83 -44.25 86.34 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.871 177.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 28.4 mt-10 -58.71 -38.29 77.97 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.482 1.513 . . . . 0.0 112.174 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.0 mt -75.73 -16.98 60.07 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 124.705 1.253 . . . . 0.0 113.426 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.77 -6.84 20.04 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.738 1.161 . . . . 0.0 114.263 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 68.0 m-85 -90.95 80.82 5.72 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 123.277 1.513 . . . . 0.0 110.46 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.47 ' HA ' ' HG2' ' A' ' 26' ' ' LYS . 9.2 p30 -76.62 -17.26 59.28 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 -177.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -94.47 88.57 5.53 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 122.386 1.088 . . . . 0.0 109.954 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.91 129.04 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 113.991 -1.458 . . . . 0.0 112.213 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.485 ' OE1' ' HB3' ' A' ' 45' ' ' LYS . 29.7 tt0 -109.93 153.92 23.83 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 175.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -125.62 120.77 31.68 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.35 162.33 19.65 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.37 -1.741 . . . . 0.0 109.848 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.42 -43.27 5.01 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -132.51 170.06 15.68 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.21 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.485 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -47.32 -53.15 12.24 Favored Glycine 0 CA--C 1.541 1.707 0 O-C-N 124.675 1.234 . . . . 0.0 114.944 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.8 t -56.3 -54.52 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.542 0.337 . . . . 0.0 111.524 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -56.61 -36.27 69.24 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.559 0.744 . . . . 0.0 111.621 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.32 -49.9 62.29 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.496 1.118 . . . . 0.0 112.507 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.4 mt -53.8 -43.12 69.07 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.339 0.656 . . . . 0.0 111.665 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.14 -59.36 5.42 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 125.059 1.474 . . . . 0.0 110.304 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.485 ' HB3' ' OE1' ' A' ' 34' ' ' GLU . 62.1 mttm -57.79 -40.57 80.17 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.624 HD21 HG22 ' A' ' 54' ' ' VAL . 19.1 mt -56.29 -48.55 76.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.535 0.734 . . . . 0.0 112.026 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -71.6 -5.71 35.44 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.9 -7.71 42.58 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.71 147.71 13.59 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 116.813 1.485 . . . . 0.0 116.813 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.96 -12.46 3.01 Favored Glycine 0 CA--C 1.542 1.778 0 N-CA-C 121.934 3.534 . . . . 0.0 121.934 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -66.0 105.2 1.28 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 121.035 2.418 . . . . 0.0 115.79 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.685 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -101.11 20.24 48.31 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 112.44 -2.163 . . . . 0.0 112.372 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.409 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -171.05 137.03 1.13 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.861 0.865 . . . . 0.0 112.401 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.624 HG22 HD21 ' A' ' 46' ' ' LEU . 22.0 t -124.59 119.54 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.684 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.424 HG21 HG11 ' A' ' 21' ' ' VAL . 87.2 mt -111.69 102.71 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 104.192 -2.521 . . . . 0.0 104.192 176.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 t -121.29 132.39 54.77 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 -176.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.44 ' HB2' ' OD1' ' A' ' 12' ' ' ASP . 13.6 t0 -68.15 131.89 46.22 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 111.815 -2.448 . . . . 0.0 109.536 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 -56.22 -50.99 69.71 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -91.81 89.74 7.19 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 122.527 1.156 . . . . 0.0 113.778 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.539 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 25.2 mtm -124.44 136.01 27.23 Favored Pre-proline 0 N--CA 1.484 1.239 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.373 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -54.16 148.62 39.51 Favored 'Trans proline' 0 N--CA 1.48 0.7 0 C-N-CA 124.172 3.248 . . . . 0.0 110.771 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.313 11.5 p30 60.06 -67.6 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 126.547 1.939 . . . . 0.0 114.534 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.485 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 52.0 ttm -122.16 102.09 7.93 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.229 1.012 . . . . 0.0 108.61 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 8.7 m-20 -66.17 167.35 10.27 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 113.01 -1.905 . . . . 0.0 112.428 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.01 -53.44 18.49 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 124.453 1.025 . . . . 0.0 112.875 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.429 HD12 HD23 ' A' ' 69' ' ' LEU . 60.0 tp -57.93 -38.98 76.91 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.4 ' OE1' ' HB2' ' A' ' 64' ' ' ASP . 12.1 mp0 -72.06 -37.96 69.54 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.768 0.427 . . . . 0.0 111.686 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.8 tp -60.56 -42.52 96.76 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.788 0.835 . . . . 0.0 110.345 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.429 HD23 HD12 ' A' ' 66' ' ' LEU . 10.1 tp -55.06 -46.58 75.38 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.726 1.21 . . . . 0.0 109.909 176.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -60.63 -45.48 93.9 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.915 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.271 38.8 p -60.9 -35.18 75.99 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 124.238 1.015 . . . . 0.0 111.8 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.479 HG23 ' HB3' ' A' ' 78' ' ' MET . 41.2 mt -72.53 -56.73 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.647 1.179 . . . . 0.0 108.664 177.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 73' ' ' ARG . 76.5 mmt-85 -53.39 -42.65 67.15 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.89 1.676 . . . . 0.0 114.048 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.25 -30.08 69.88 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -88.18 100.01 12.64 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.113 0.565 . . . . 0.0 111.309 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -11.37 -74.18 0.01 OUTLIER Glycine 0 N--CA 1.489 2.175 0 C-N-CA 127.662 2.554 . . . . 0.0 118.266 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.51 84.37 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.479 ' HB3' HG23 ' A' ' 72' ' ' ILE . 96.1 mtp -72.31 -24.06 61.26 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.089 1.356 . . . . 0.0 113.847 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.3 m -51.57 -28.48 14.06 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.321 1.449 . . . . 0.0 114.438 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.85 -11.09 42.99 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.685 HD22 ' HA2' ' A' ' 52' ' ' GLY . 83.2 mt -77.49 114.72 43.26 Favored Pre-proline 0 N--CA 1.475 0.807 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 11.3 Cg_endo -49.41 132.7 29.96 Favored 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 124.189 3.259 . . . . 0.0 115.695 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.4 t -120.74 120.53 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 112.739 -2.028 . . . . 0.0 111.955 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.409 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 47.8 tp -112.18 107.05 15.81 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 113.313 -1.767 . . . . 0.0 109.323 178.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 30.9 mmt -81.24 121.97 26.82 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 113.744 -1.571 . . . . 0.0 112.353 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.76 101.52 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.05 145.83 37.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 111.772 -2.467 . . . . 0.0 113.567 -176.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.74 -38.2 72.07 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -156.53 147.28 21.79 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.674 0.789 . . . . 0.0 110.389 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.36 86.78 6.22 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -123.42 134.19 53.98 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 112.667 -2.06 . . . . 0.0 110.351 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -27.19 -60.6 0.09 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.235 1.814 . . . . 0.0 115.481 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -53.58 -52.44 59.77 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -66.69 -38.92 87.75 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.2 mt -59.05 -55.03 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.279 1.032 . . . . 0.0 110.002 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.3 mt -54.84 -54.57 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.301 1.04 . . . . 0.0 109.602 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.18 -49.43 63.87 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.192 0.997 . . . . 0.0 113.308 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.11 -51.02 68.22 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.058 0.943 . . . . 0.0 113.503 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.3 -51.06 71.38 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.047 0.939 . . . . 0.0 112.895 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -64.39 -25.66 68.12 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.44 -5.91 59.04 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.23 2.32 26.39 Favored Glycine 0 CA--C 1.54 1.635 0 N-CA-C 117.408 1.723 . . . . 0.0 117.408 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.92 119.47 8.32 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.4 m -64.93 -30.58 71.59 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.412 -1.722 . . . . 0.0 112.933 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -174.2 170.79 43.95 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.687 1.137 . . . . 0.0 110.587 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.49 ' O ' ' HE2' ' A' ' 119' ' ' LYS . 50.5 p90 -143.21 129.05 19.43 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.462 -0.869 . . . . 0.0 112.458 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.39 124.66 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.743 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.14 123.38 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 112.1 -2.318 . . . . 0.0 111.199 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -90.95 134.79 29.6 Favored Pre-proline 0 N--CA 1.483 1.193 0 CA-C-N 113.65 -1.614 . . . . 0.0 111.284 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -75.45 141.59 71.71 Favored 'Cis proline' 0 CA--C 1.542 0.893 0 O-C-N 123.273 1.144 . . . . 0.0 112.988 0.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.487 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 37.9 p90 -126.69 147.27 49.96 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 113.12 -1.855 . . . . 0.0 109.515 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 52.5 p -97.46 171.03 8.64 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.753 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.22 67.87 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.296 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.99 -49.81 66.51 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.091 0.956 . . . . 0.0 111.533 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.6 m -58.09 -46.12 86.04 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.916 0.886 . . . . 0.0 109.324 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 48.2 tp -58.77 -55.47 34.65 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.438 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . 0.26 1.3 pp20? -59.15 -36.52 75.4 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -55.61 -49.55 72.5 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 123.952 0.783 . . . . 0.0 111.112 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.49 ' HE2' ' O ' ' A' ' 106' ' ' TYR . 32.8 mmmt -65.39 -45.41 84.14 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.901 178.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.0 mt -54.44 -46.91 73.35 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 124.093 0.87 . . . . 0.0 112.222 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -55.0 -52.94 61.58 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.486 1.114 . . . . 0.0 112.308 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -55.36 -42.75 74.31 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.244 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.12 -46.87 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.863 0.865 . . . . 0.0 110.633 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -59.5 -35.12 73.52 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -62.97 -48.82 77.22 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.267 1.027 . . . . 0.0 110.18 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -60.44 -40.1 89.88 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.83 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.9 16.88 6.26 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.065 1.346 . . . . 0.0 113.7 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.72 -68.98 2.14 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 124.644 1.116 . . . . 0.0 111.667 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 C--O 1.254 1.342 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 -179.923 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 t -79.14 93.14 5.14 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 113.275 -1.784 . . . . 0.0 111.038 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.449 ' HB2' HD12 ' A' ' 6' ' ' LEU . 51.2 p30 -81.56 52.09 1.81 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -65.41 -45.24 84.71 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 115.058 -0.973 . . . . 0.0 112.885 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -89.29 60.33 5.24 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 123.426 1.584 . . . . 0.0 110.471 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.449 HD12 ' HB2' ' A' ' 3' ' ' ASP . 3.9 tt -106.56 131.03 54.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.004 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' N ' HD23 ' A' ' 6' ' ' LEU . 14.8 mmtp -78.32 102.2 7.58 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 113.448 -1.706 . . . . 0.0 111.414 177.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -102.35 138.6 39.06 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 112.884 -1.962 . . . . 0.0 113.404 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.16 111.41 19.43 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.815 174.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.1 t -87.02 97.11 6.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 123.899 1.809 . . . . 0.0 107.466 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.552 HG12 ' SD ' ' A' ' 60' ' ' MET . 5.2 t -101.65 74.0 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 112.72 -2.037 . . . . 0.0 106.808 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 8.3 m-20 -127.25 87.06 2.58 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 112.915 -1.948 . . . . 0.0 113.396 -176.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -11.25 -55.85 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 121.62 3.933 . . . . 0.0 121.62 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.545 ' HB3' ' HB2' ' A' ' 17' ' ' MET . 6.2 t80 -81.72 133.5 35.36 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.75 0.656 . . . . 0.0 109.278 -177.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 p -46.33 -50.83 15.82 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.067 0.947 . . . . 0.0 112.908 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.562 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -60.13 -49.73 76.49 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.81 177.488 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.545 ' HB2' ' HB3' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -57.62 -45.34 85.51 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.959 0.904 . . . . 0.0 111.26 -179.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 12' ' ' ASP . 9.0 mtm180 -57.66 -52.74 64.2 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.114 0.966 . . . . 0.0 111.496 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.757 HH21 ' HD3' ' A' ' 22' ' ' ARG . 2.1 mmp_? -56.78 -43.49 80.91 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.435 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.562 HG12 ' O ' ' A' ' 16' ' ' THR . 34.5 mm -54.23 -61.44 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.257 0.623 . . . . 0.0 110.939 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.637 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 3.5 t -57.47 -45.16 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.261 0.624 . . . . 0.0 111.63 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.757 ' HD3' HH21 ' A' ' 19' ' ' ARG . 58.7 ttt180 -54.44 -53.54 52.75 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.9 0.88 . . . . 0.0 112.13 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.697 HD21 ' NH1' ' A' ' 19' ' ' ARG . 66.2 m-80 -63.55 -37.82 88.77 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.499 HD22 ' HB2' ' A' ' 113' ' ' ALA . 57.0 mt -56.95 -51.31 69.68 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.877 0.471 . . . . 0.0 111.874 176.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.416 HD11 HD12 ' A' ' 55' ' ' ILE . 49.1 mt -53.36 -47.04 69.75 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.564 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.493 ' HD2' ' HA ' ' A' ' 23' ' ' ASN . 87.8 mttt -56.85 -47.5 80.23 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.113 177.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 35.2 mt-10 -59.65 -38.87 82.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.49 1.516 . . . . 0.0 112.64 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.63 -16.14 62.27 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.698 1.599 . . . . 0.0 114.085 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.86 9.7 25.96 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 124.462 1.029 . . . . 0.0 114.759 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -92.11 98.16 11.37 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 123.874 1.797 . . . . 0.0 111.53 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -57.76 -42.62 84.41 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 110.39 -3.096 . . . . 0.0 119.236 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -111.55 106.68 15.61 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 t -133.53 126.63 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -110.85 158.0 19.19 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.433 ' OE1' ' HB3' ' A' ' 18' ' ' ARG . 14.9 pt-20 -130.13 119.52 23.15 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -114.67 149.38 36.83 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.921 1.288 . . . . 0.0 110.687 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -76.1 -60.83 2.16 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -133.62 -178.22 4.9 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 119.092 -0.48 . . . . 0.0 111.522 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -43.1 -55.7 4.84 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 125.564 1.554 . . . . 0.0 114.652 177.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.9 t -57.11 -56.69 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 114.335 -0.932 . . . . 0.0 111.947 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -57.26 -38.6 74.12 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.427 0.691 . . . . 0.0 111.631 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.34 -50.25 70.7 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.564 1.146 . . . . 0.0 112.414 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' A' ' 46' ' ' LEU . 78.9 mt -53.85 -40.71 66.71 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.64 0.776 . . . . 0.0 112.862 179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -67.55 -55.18 14.48 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 124.325 1.016 . . . . 0.0 110.927 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -57.78 -30.92 66.04 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.496 HD21 HG22 ' A' ' 54' ' ' VAL . 22.4 mt -55.67 -38.21 69.3 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -71.49 -9.25 57.9 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.65 34.84 0.12 Allowed 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 116.258 1.948 . . . . 0.0 116.258 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.1 115.54 2.63 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 117.939 1.936 . . . . 0.0 117.939 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 27.01 47.77 0.05 OUTLIER Glycine 0 CA--C 1.545 1.925 0 N-CA-C 122.249 3.66 . . . . 0.0 122.249 176.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.477 ' O ' HD22 ' A' ' 81' ' ' LEU . 97.7 m-85 -74.84 87.58 2.26 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 118.547 1.173 . . . . 0.0 113.069 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.6 29.91 5.16 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 113.357 -1.747 . . . . 0.0 111.617 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.408 ' HZ ' HD13 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -175.2 131.86 0.3 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.84 1.305 . . . . 0.0 112.927 178.136 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.496 HG22 HD21 ' A' ' 46' ' ' LEU . 10.7 t -126.99 119.83 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-N 112.436 -2.165 . . . . 0.0 108.88 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.613 HG21 HG11 ' A' ' 21' ' ' VAL . 96.2 mt -110.48 105.89 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.9 t -124.98 132.75 53.22 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 118.128 2.64 . . . . 0.0 118.128 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.555 ' O ' ' HG3' ' A' ' 60' ' ' MET . 20.3 t0 -73.63 133.08 43.39 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 111.71 -2.495 . . . . 0.0 109.512 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.495 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 15.5 t-105 -55.01 -49.28 71.92 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.221 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -90.86 82.09 5.69 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.555 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 39.4 mtm -116.77 137.99 24.21 Favored Pre-proline 0 N--CA 1.482 1.15 0 CA-C-N 114.222 -1.354 . . . . 0.0 112.101 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -57.72 139.5 90.47 Favored 'Trans proline' 0 N--CA 1.476 0.478 0 C-N-CA 124.034 3.156 . . . . 0.0 111.903 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 64.42 -73.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.306 1.842 . . . . 0.0 112.487 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.453 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 51.5 ttm -110.2 98.7 7.9 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 2.6 p30 -64.64 168.08 6.49 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 112.312 -2.222 . . . . 0.0 112.901 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.2 -52.74 21.83 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.028 1.299 . . . . 0.0 114.38 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.459 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 59.8 tp -59.01 -40.45 84.97 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -66.83 -43.43 83.74 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.555 0.342 . . . . 0.0 111.515 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.447 HD11 HG11 ' A' ' 54' ' ' VAL . 1.5 tm? -56.13 -47.49 78.06 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.018 0.927 . . . . 0.0 110.993 177.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 103' ' ' ALA . 4.5 tt -49.22 -55.64 11.89 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.982 1.713 . . . . 0.0 109.412 175.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -61.0 -44.49 97.34 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.909 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.259 29.7 p -59.21 -21.77 60.01 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 124.643 1.177 . . . . 0.0 113.186 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.8 mt -89.99 -58.42 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.573 ' HG2' ' HA3' ' A' ' 102' ' ' GLY . 2.7 mpt_? -47.77 -45.18 28.97 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.953 2.101 . . . . 0.0 114.217 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.73 -11.53 50.86 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -84.01 93.35 8.06 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.199 0.6 . . . . 0.0 110.274 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -12.73 -70.59 0.01 OUTLIER Glycine 0 N--CA 1.495 2.584 0 C-N-CA 126.351 1.929 . . . . 0.0 116.47 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.64 -49.43 75.19 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.43 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 90.4 mtp -75.84 -26.68 57.39 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 m -11.0 -61.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 120.585 3.55 . . . . 0.0 120.585 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.56 28.95 0.45 Allowed 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 120.64 3.57 . . . . 0.0 120.64 -174.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.477 HD22 ' O ' ' A' ' 51' ' ' TYR . 61.2 mt -89.75 106.79 15.36 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.877 -1.139 . . . . 0.0 110.074 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -47.56 133.06 20.96 Favored 'Trans proline' 0 N--CA 1.48 0.735 0 C-N-CA 123.432 2.755 . . . . 0.0 114.756 -177.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.468 HG11 ' HG ' ' A' ' 69' ' ' LEU . 39.3 t -118.19 128.31 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 112.891 -1.958 . . . . 0.0 114.202 -176.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.5 tp -116.48 108.71 16.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 113.199 -1.819 . . . . 0.0 109.562 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.0 mmt -83.19 114.55 21.43 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.595 1.188 . . . . 0.0 114.006 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.75 98.6 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.8 t -106.91 144.57 33.36 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 111.861 -2.427 . . . . 0.0 113.993 -175.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.58 -41.2 41.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 113.471 -1.695 . . . . 0.0 115.236 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -161.9 144.19 11.51 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.076 1.35 . . . . 0.0 109.948 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.22 86.87 3.66 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.364 1.078 . . . . 0.0 109.967 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -118.75 122.48 42.54 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.582 -1.644 . . . . 0.0 109.585 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -21.44 -59.34 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 117.414 2.376 . . . . 0.0 117.414 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -46.12 72.61 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -70.97 -38.31 72.78 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.02 -53.77 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.801 1.24 . . . . 0.0 109.012 176.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.0 mt -54.01 -54.95 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.377 1.071 . . . . 0.0 110.24 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.19 -50.5 64.54 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.267 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.495 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -61.24 -55.37 32.78 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.48 -51.51 69.15 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.877 0.871 . . . . 0.0 112.312 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -30.34 71.39 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.02 -13.84 60.22 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 177.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.573 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 121.75 -0.97 11.07 Favored Glycine 0 CA--C 1.545 1.96 0 N-CA-C 116.208 1.243 . . . . 0.0 116.208 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.666 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -59.63 123.99 18.65 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 119.051 1.426 . . . . 0.0 113.744 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.5 m -64.53 -30.51 71.54 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 113.07 -1.877 . . . . 0.0 112.88 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.72 172.84 45.82 Favored Glycine 0 CA--C 1.542 1.727 0 C-N-CA 124.818 1.199 . . . . 0.0 110.697 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -144.14 139.99 29.14 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.1 p -124.41 129.69 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 124.457 1.098 . . . . 0.0 110.459 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.36 127.45 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 113.217 -1.811 . . . . 0.0 111.24 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -92.94 132.39 31.12 Favored Pre-proline 0 N--CA 1.479 1.002 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.055 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -74.25 142.85 76.0 Favored 'Cis proline' 0 CA--C 1.548 1.189 0 O-C-N 123.017 1.009 . . . . 0.0 114.277 0.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.637 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 33.0 p90 -134.1 155.28 50.33 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 112.282 -2.236 . . . . 0.0 107.986 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 44.9 p -106.62 172.42 6.83 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.335 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.499 ' HB2' HD22 ' A' ' 24' ' ' LEU . . . -54.93 -38.96 68.33 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 123.612 0.57 . . . . 0.0 111.736 176.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.32 -46.78 75.7 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.356 1.062 . . . . 0.0 111.37 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.1 m -60.13 -47.02 87.68 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 52.8 tp -57.19 -52.11 66.64 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.525 1.13 . . . . 0.0 109.851 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -54.03 -48.21 70.75 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 124.12 0.888 . . . . 0.0 112.152 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -52.61 -47.42 66.99 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.58 -46.54 82.28 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.329 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 82.5 mt -56.96 -47.91 79.6 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 124.141 0.901 . . . . 0.0 111.212 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -53.74 -53.54 50.78 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.541 1.536 . . . . 0.0 111.669 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -52.11 -46.04 65.14 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.499 1.52 . . . . 0.0 111.566 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.408 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 63.7 mt -62.37 -51.78 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.341 1.056 . . . . 0.0 110.447 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -57.84 -39.25 77.26 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -58.58 -42.63 88.49 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.735 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -60.98 -39.04 88.09 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.966 0.907 . . . . 0.0 111.264 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.2 mt -83.96 8.87 13.79 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.051 1.341 . . . . 0.0 114.001 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.58 13.98 77.73 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 115.744 1.057 . . . . 0.0 115.744 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.5 mtm . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 117.091 -1.433 . . . . 0.0 113.043 179.544 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.521 ' NH2' ' HB3' ' A' ' 124' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 m -55.84 82.05 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 116.828 2.159 . . . . 0.0 116.828 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -62.11 -30.66 71.17 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . 0.263 63.3 mttp 75.02 -37.18 0.34 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 128.655 2.782 . . . . 0.0 118.089 178.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -90.3 51.34 2.01 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.988 1.375 . . . . 0.0 111.861 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 1.9 tt -112.94 130.85 55.97 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.881 -177.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -86.49 111.21 20.35 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.899 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -105.86 145.32 31.38 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.021 1.728 . . . . 0.0 115.287 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.447 ' CD1' HG22 ' A' ' 11' ' ' VAL . 1.9 tm? -121.5 105.09 10.15 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 112.488 -2.142 . . . . 0.0 110.047 174.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.3 t -82.89 112.52 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 112.87 -1.968 . . . . 0.0 107.763 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.496 ' CG1' ' HB2' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -111.66 96.0 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.697 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -138.44 130.36 28.21 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.166 0.916 . . . . 0.0 112.46 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -72.03 -16.39 62.05 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.529 ' HB3' ' HB2' ' A' ' 17' ' ' MET . 5.5 t80 -101.01 114.68 28.84 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.509 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 35.3 p -40.75 -57.61 1.87 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 125.177 1.548 . . . . 0.0 113.2 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -48.05 80.18 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.529 ' HB2' ' HB3' ' A' ' 14' ' ' PHE . 1.2 tmm? -60.83 -37.58 82.52 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.443 ' NH1' ' HG2' ' A' ' 37' ' ' GLU . 36.9 ttp-105 -59.29 -50.52 73.67 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.437 1.095 . . . . 0.0 110.996 177.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 15' ' ' SER . 9.0 mmt180 -60.82 -42.81 98.42 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.655 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.407 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 71.7 mt -55.63 -52.66 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.266 1.026 . . . . 0.0 111.113 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 17' ' ' MET . 6.3 t -56.11 -48.29 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 122.501 0.32 . . . . 0.0 110.752 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.443 ' HD2' ' OE1' ' A' ' 35' ' ' GLU . 56.4 ttt180 -55.35 -50.49 69.53 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.649 1.18 . . . . 0.0 110.827 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -59.08 -45.68 90.21 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.99 0.916 . . . . 0.0 112.082 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 78.1 mt -54.21 -50.96 65.9 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.334 1.054 . . . . 0.0 111.793 177.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.3 mt -56.03 -46.56 78.82 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.968 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -55.74 -46.73 77.76 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.567 1.167 . . . . 0.0 111.303 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 44.5 mt-10 -59.45 -39.67 84.34 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.381 1.473 . . . . 0.0 112.381 177.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.1 mt -74.01 -12.66 60.69 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.15 -13.28 33.97 Favored Glycine 0 N--CA 1.479 1.522 0 C-N-CA 124.216 0.912 . . . . 0.0 113.386 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -84.72 62.73 7.56 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 123.42 1.581 . . . . 0.0 111.453 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -68.7 -13.72 62.55 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 6.6 m120 -86.42 70.83 10.51 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.81 126.35 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.623 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 16.4 mt-10 -120.42 160.57 22.82 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.044 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.443 ' OE1' ' HD2' ' A' ' 22' ' ' ARG . 7.9 pt-20 -133.69 140.99 47.37 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 119.439 3.125 . . . . 0.0 119.439 -175.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.524 ' HB2' ' HD2' ' A' ' 45' ' ' LYS . . . -124.44 160.75 27.53 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 112.234 -2.257 . . . . 0.0 109.506 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.443 ' HG2' ' NH1' ' A' ' 18' ' ' ARG . 38.1 mt-10 -97.47 -39.43 9.16 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 -177.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -137.59 170.32 16.27 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.468 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.434 ' HA2' HD22 ' A' ' 68' ' ' LEU . . . -45.71 -54.08 8.09 Favored Glycine 0 N--CA 1.482 1.736 0 O-C-N 124.651 1.219 . . . . 0.0 115.671 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.1 t -57.7 -54.42 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.665 0.786 . . . . 0.0 111.783 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -55.21 -36.5 66.03 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.935 0.894 . . . . 0.0 112.167 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.496 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . . . -66.69 -50.78 61.77 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.326 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.2 mt -54.17 -46.1 72.25 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 124.541 1.15 . . . . 0.0 110.482 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -57.05 -53.0 63.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.832 0.853 . . . . 0.0 111.506 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.524 ' HD2' ' HB2' ' A' ' 36' ' ' ALA . 51.2 mttm -56.94 -45.74 82.58 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.207 175.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.552 HD23 ' HB2' ' A' ' 51' ' ' TYR . 19.4 mt -59.2 -42.68 91.48 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.149 0.98 . . . . 0.0 111.653 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -60.57 -30.18 69.63 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 125.102 1.361 . . . . 0.0 112.089 177.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.83 -19.5 65.91 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.81 0.844 . . . . 0.0 112.154 175.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.64 175.09 28.33 Favored Glycine 0 N--CA 1.479 1.53 0 N-CA-C 117.508 1.763 . . . . 0.0 117.508 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.62 -33.1 1.63 Allowed Glycine 0 N--CA 1.483 1.781 0 N-CA-C 121.304 3.282 . . . . 0.0 121.304 176.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.623 ' HE1' ' HB2' ' A' ' 34' ' ' GLU . 37.4 m-85 -65.85 113.37 4.31 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -176.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.45 16.87 57.5 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-N 113.761 -1.563 . . . . 0.0 113.124 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -166.23 138.55 3.85 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.229 1.412 . . . . 0.0 110.483 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.449 HG22 HD21 ' A' ' 46' ' ' LEU . 26.5 t -125.31 126.41 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.491 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 91.0 mt -112.13 99.61 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.9 t -109.06 123.68 49.54 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -73.56 127.25 32.22 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 112.572 -2.104 . . . . 0.0 109.565 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.52 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 5.2 t-105 -52.65 -49.14 65.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.032 0.933 . . . . 0.0 111.4 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -88.45 96.77 10.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.971 0.908 . . . . 0.0 110.94 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.4 mtm -138.3 132.3 16.7 Favored Pre-proline 0 N--CA 1.48 1.03 0 CA-C-N 113.742 -1.572 . . . . 0.0 112.589 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -65.87 150.41 85.79 Favored 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 123.933 3.089 . . . . 0.0 111.795 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.3 m120 68.33 -64.01 0.32 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 125.794 1.934 . . . . 0.0 112.694 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.405 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 57.7 ttm -126.44 101.95 6.92 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.277 1.031 . . . . 0.0 108.277 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.36 169.11 6.19 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 113.394 -1.73 . . . . 0.0 111.866 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.0 -52.76 29.65 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.15 0.881 . . . . 0.0 115.156 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.446 HD12 HD13 ' A' ' 69' ' ' LEU . 36.3 tp -60.04 -38.6 83.24 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.48 0.712 . . . . 0.0 112.343 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -66.63 -42.75 86.25 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.664 0.386 . . . . 0.0 110.469 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.434 HD22 ' HA2' ' A' ' 39' ' ' GLY . 58.9 tp -59.7 -45.17 92.95 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.987 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 103' ' ' ALA . 5.6 tt -50.32 -51.71 43.04 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.75 1.62 . . . . 0.0 109.054 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -59.68 -47.24 86.42 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.984 0.914 . . . . 0.0 113.143 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.268 21.7 p -56.55 -35.38 68.06 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.551 1.14 . . . . 0.0 111.994 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.671 HG23 ' HB3' ' A' ' 78' ' ' MET . 42.6 mt -76.29 -54.42 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.152 0.981 . . . . 0.0 109.396 177.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HD3' HD23 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -53.0 -40.79 64.07 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.678 1.991 . . . . 0.0 113.749 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.42 -31.83 65.83 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -87.23 94.91 9.79 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.825 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -13.68 -71.34 0.01 OUTLIER Glycine 0 N--CA 1.487 2.06 0 C-N-CA 127.345 2.402 . . . . 0.0 118.207 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.98 -41.89 71.77 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.671 ' HB3' HG23 ' A' ' 72' ' ' ILE . 35.0 mtm -74.61 -30.8 61.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.25 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.7 m -53.77 -29.08 38.54 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.321 1.048 . . . . 0.0 112.585 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.61 -34.63 58.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.305 1.042 . . . . 0.0 113.264 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.505 ' HA ' ' HD2' ' A' ' 82' ' ' PRO 0.273 2.5 pp -84.45 120.55 74.44 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.505 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 18.8 Cg_endo -47.74 146.9 7.64 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 125.123 3.882 . . . . 0.0 120.65 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.8 t -122.02 107.18 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 111.549 -2.568 . . . . 0.0 110.751 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 56.4 tp -101.07 110.97 23.06 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.643 -1.162 . . . . 0.0 107.931 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 90.0 mmm -81.77 133.9 35.39 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.178 -1.374 . . . . 0.0 112.182 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.427 HG12 ' HB2' ' A' ' 109' ' ' LYS . 3.5 t -112.58 109.47 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 177.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.8 p -103.85 134.33 47.33 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.968 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.97 -24.31 52.13 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -165.13 130.51 2.61 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.624 1.97 . . . . 0.0 107.554 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.621 ' HB2' HG22 ' A' ' 108' ' ' VAL . . . -79.94 98.23 7.07 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 122.474 1.131 . . . . 0.0 111.106 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -121.87 144.53 48.79 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.746 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -35.1 -50.47 0.51 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.759 1.223 . . . . 0.0 114.121 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -50.79 -58.15 6.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.523 1.129 . . . . 0.0 112.759 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -69.06 -39.91 78.85 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 93.5 mt -57.01 -55.49 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.634 0.774 . . . . 0.0 111.767 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.441 HG22 ' OE1' ' A' ' 100' ' ' GLN . 59.0 mt -59.06 -51.26 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 124.052 0.845 . . . . 0.0 111.143 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.51 -45.1 73.26 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 115.248 -0.887 . . . . 0.0 113.286 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.52 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -60.92 -52.38 65.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.566 1.146 . . . . 0.0 113.014 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.29 -47.49 83.5 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.723 0.809 . . . . 0.0 111.702 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.441 ' OE1' HG22 ' A' ' 96' ' ' ILE . 61.1 mt-30 -58.62 -36.46 74.09 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.6 -13.57 57.82 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.446 ' HA3' ' HG2' ' A' ' 73' ' ' ARG . . . 119.43 3.22 12.92 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.679 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -57.93 125.28 22.4 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.737 1.269 . . . . 0.0 112.807 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.2 m -65.52 -31.97 73.31 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 113.447 -1.706 . . . . 0.0 113.166 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.79 174.99 46.48 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 125.01 1.291 . . . . 0.0 110.333 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -145.81 139.72 26.58 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 p -119.11 130.49 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 125.462 1.726 . . . . 0.0 110.853 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.621 HG22 ' HB2' ' A' ' 90' ' ' ALA . 3.3 t -75.7 130.53 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.894 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.427 ' HB2' HG12 ' A' ' 86' ' ' VAL . 1.8 ttmp? -91.84 123.01 64.43 Favored Pre-proline 0 N--CA 1.479 0.997 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -81.42 156.21 81.98 Favored 'Cis proline' 0 N--CA 1.486 1.069 0 N-CA-C 114.323 0.855 . . . . 0.0 114.323 -0.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -140.67 163.84 31.81 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 112.898 -1.955 . . . . 0.0 109.401 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.3 p -112.53 175.4 5.45 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.271 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.84 81.06 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.156 176.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.21 -48.75 76.99 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.821 0.848 . . . . 0.0 110.97 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.0 m -57.07 -45.94 82.88 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.817 0.847 . . . . 0.0 110.494 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.434 HD22 HD11 ' A' ' 120' ' ' LEU . 1.1 tt -59.67 -53.16 61.26 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 124.446 1.091 . . . . 0.0 108.824 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.611 ' HA ' HD12 ' A' ' 120' ' ' LEU . 51.5 tt0 -57.5 -41.86 81.58 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.27 -48.43 65.28 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.845 0.716 . . . . 0.0 111.608 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -63.72 -48.89 75.24 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.965 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 117' ' ' GLU . 96.8 mt -49.93 -47.38 52.41 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.822 1.249 . . . . 0.0 113.716 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -63.87 -49.18 73.76 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -53.99 -48.44 70.39 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 124.649 1.218 . . . . 0.0 110.152 176.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 81.1 mt -55.01 -54.72 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.139 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.521 ' HB3' ' NH2' ' A' ' 1' ' ' ARG . 21.6 m-30 -53.6 -39.34 64.81 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.46 -29.75 69.29 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.67 -45.15 7.15 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.689 1.196 . . . . 0.0 113.508 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 46.5 tp -132.73 88.46 2.52 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.868 1.667 . . . . 0.0 108.932 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.23 89.81 0.01 OUTLIER Glycine 0 CA--C 1.546 1.971 0 CA-C-N 110.579 -3.009 . . . . 0.0 112.746 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.17 0 N-CA-C 119.117 3.006 . . . . 0.0 119.117 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 . . . . . 0 CA--C 1.551 0.992 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.404 ' HA ' HD22 ' A' ' 6' ' ' LEU . 19.1 p -72.15 14.25 0.24 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 116.609 2.077 . . . . 0.0 116.609 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -120.41 72.36 0.95 Allowed 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -176.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 69.58 -37.64 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 127.312 2.245 . . . . 0.0 116.981 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.79 39.07 0.78 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.862 -1.517 . . . . 0.0 110.895 177.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.455 HD21 ' HD2' ' A' ' 53' ' ' PHE . 28.6 tp -95.91 128.05 42.46 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 112.644 -2.071 . . . . 0.0 111.244 -177.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.433 ' NZ ' ' HA3' ' A' ' 49' ' ' GLY . 49.2 mtpt -80.9 106.18 12.7 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 112.874 -1.967 . . . . 0.0 112.107 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -101.73 136.89 40.8 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 113.6 -1.636 . . . . 0.0 113.629 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -115.5 103.24 10.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.575 -1.648 . . . . 0.0 109.902 172.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.9 t -81.63 91.99 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 112.074 -2.33 . . . . 0.0 107.156 178.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.511 HG12 ' SD ' ' A' ' 60' ' ' MET . 3.2 t -99.53 94.92 3.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 112.753 -2.021 . . . . 0.0 107.983 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.424 ' OD1' ' HB2' ' A' ' 57' ' ' ASP . 18.2 m-20 -135.47 140.39 44.8 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.258 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -67.08 -27.84 67.69 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 117.017 2.229 . . . . 0.0 117.017 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -107.65 132.15 53.63 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.448 0.299 . . . . 0.0 111.224 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.5 p -51.36 -52.08 48.85 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.754 1.222 . . . . 0.0 113.231 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 m -60.45 -48.82 80.1 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.258 0.974 . . . . 0.0 111.441 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.4 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -59.89 -44.58 94.15 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.224 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -55.39 -58.52 7.39 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.054 1.341 . . . . 0.0 111.039 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 30.4 ptt180 -58.9 -36.37 74.58 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.5 mt -58.23 -49.7 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 122.946 0.498 . . . . 0.0 110.09 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 17' ' ' MET . 9.7 t -55.71 -47.35 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 123.525 0.73 . . . . 0.0 110.27 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.692 ' NH2' HD21 ' A' ' 23' ' ' ASN . 7.0 ttp180 -51.51 -51.73 52.7 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.059 1.344 . . . . 0.0 110.843 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.692 HD21 ' NH2' ' A' ' 22' ' ' ARG . 16.1 m120 -62.28 -40.4 96.13 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.206 1.002 . . . . 0.0 112.48 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 84.8 mt -58.5 -51.71 68.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.785 0.834 . . . . 0.0 110.69 177.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.1 mt -55.01 -46.27 75.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.125 0.97 . . . . 0.0 112.548 177.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.8 -43.24 90.5 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.661 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 25.0 mt-10 -58.78 -39.04 79.89 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.887 1.275 . . . . 0.0 111.995 177.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.0 mt -74.23 -17.49 60.88 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.003 1.321 . . . . 0.0 114.068 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.17 9.71 25.37 Favored Glycine 0 N--CA 1.478 1.477 0 N-CA-C 115.639 1.015 . . . . 0.0 115.639 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -92.6 101.78 14.21 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.753 1.263 . . . . 0.0 112.009 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -64.13 -51.41 64.04 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 118.705 2.854 . . . . 0.0 118.705 -175.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -94.08 101.72 13.76 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.239 1.199 . . . . 0.0 114.239 -174.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.526 HG11 ' HA ' ' A' ' 22' ' ' ARG . 32.1 t -130.61 118.35 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.002 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.697 ' HB2' ' HE2' ' A' ' 51' ' ' TYR . 12.5 mp0 -110.79 157.56 19.65 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -127.24 127.93 45.22 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -174.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.03 154.81 32.51 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.501 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -86.93 -48.61 8.0 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -142.74 173.74 11.28 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.245 0.618 . . . . 0.0 109.426 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -43.03 -55.64 4.82 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.071 1.319 . . . . 0.0 116.332 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.87 -54.85 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.366 0.666 . . . . 0.0 111.675 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -56.55 -33.85 66.52 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.665 0.786 . . . . 0.0 111.996 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.86 -48.21 72.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.481 1.112 . . . . 0.0 111.958 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.5 mt -57.62 -40.46 79.2 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.439 0.695 . . . . 0.0 111.464 177.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -59.18 -59.74 4.97 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.402 1.081 . . . . 0.0 109.305 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -58.25 -39.57 79.5 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.414 ' HG ' HD12 ' A' ' 9' ' ' LEU . 16.3 mt -52.8 -38.47 61.24 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.739 1.216 . . . . 0.0 113.905 177.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -59.47 -26.17 65.02 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.52 56.89 1.48 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.786 1.234 . . . . 0.0 114.313 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.433 ' HA3' ' NZ ' ' A' ' 7' ' ' LYS . . . 125.32 -15.14 7.28 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 117.822 1.889 . . . . 0.0 117.822 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.91 67.24 2.04 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.697 ' HE2' ' HB2' ' A' ' 34' ' ' GLU . 1.7 m-85 -58.16 129.64 42.93 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.671 1.989 . . . . 0.0 113.114 -177.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.685 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -83.64 19.06 16.55 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-N 113.915 -1.493 . . . . 0.0 116.564 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.49 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -172.29 128.81 0.57 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 122.551 1.167 . . . . 0.0 112.046 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.3 t -121.8 119.14 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-N 113.521 -1.672 . . . . 0.0 108.182 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.8 mt -108.81 101.77 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 177.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.6 t -119.0 125.87 50.39 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 118.185 2.661 . . . . 0.0 118.185 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.424 ' HB2' ' OD1' ' A' ' 12' ' ' ASP . 54.7 t0 -67.38 128.21 35.55 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 112.374 -2.194 . . . . 0.0 109.892 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.411 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 17.1 t-105 -53.92 -50.15 67.04 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.003 0.921 . . . . 0.0 109.934 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -89.19 95.07 10.15 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.548 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.511 ' SD ' HG12 ' A' ' 11' ' ' VAL . 18.4 mtm -134.83 131.66 20.15 Favored Pre-proline 0 N--CA 1.477 0.887 0 CA-C-N 113.08 -1.873 . . . . 0.0 110.882 177.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -56.65 139.14 87.5 Favored 'Trans proline' 0 N--CA 1.48 0.715 0 C-N-CA 123.945 3.097 . . . . 0.0 111.549 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 m120 64.73 -65.0 0.15 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 126.759 2.024 . . . . 0.0 114.115 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.434 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 57.9 ttm -115.83 92.17 3.82 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.7 p30 -62.16 167.89 3.71 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 111.263 -2.699 . . . . 0.0 112.592 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.28 -55.29 10.73 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 124.298 0.951 . . . . 0.0 113.796 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.425 HD12 HD13 ' A' ' 69' ' ' LEU . 53.3 tp -59.42 -38.14 79.87 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.154 0.981 . . . . 0.0 112.786 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -71.62 -40.05 70.04 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 119.613 -0.232 . . . . 0.0 111.235 177.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.4 tp -60.41 -40.39 90.78 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.679 0.752 . . . . 0.0 110.529 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 103' ' ' ALA . 4.2 tt -51.0 -49.85 59.62 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.089 1.356 . . . . 0.0 108.632 176.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -61.56 -44.96 96.08 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.84 1.256 . . . . 0.0 113.372 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.4 p -61.03 -27.53 68.4 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.625 0.77 . . . . 0.0 111.662 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.0 mt -80.65 -56.9 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.47 1.108 . . . . 0.0 108.78 176.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.416 ' HD3' ' HA ' ' A' ' 73' ' ' ARG . 58.0 mmt-85 -51.87 -42.91 63.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.994 1.717 . . . . 0.0 113.346 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.47 -23.69 50.36 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -86.79 95.45 9.84 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.17 0.588 . . . . 0.0 111.807 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -3.5 -83.63 0.0 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 127.106 2.289 . . . . 0.0 118.412 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.94 -39.86 82.89 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 82.3 mtp -71.84 -23.56 61.56 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.573 1.549 . . . . 0.0 113.778 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.6 m -50.8 -26.17 5.36 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.841 1.657 . . . . 0.0 115.147 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.49 -7.43 50.5 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.685 HD22 ' HA2' ' A' ' 52' ' ' GLY . 54.3 mt -83.42 119.48 73.99 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 123.284 0.633 . . . . 0.0 111.829 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.455 ' HG3' HD11 ' A' ' 127' ' ' LEU . 14.6 Cg_endo -54.18 138.44 71.69 Favored 'Trans proline' 0 N--CA 1.482 0.812 0 C-N-CA 123.984 3.123 . . . . 0.0 114.892 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.46 HG11 ' HG ' ' A' ' 69' ' ' LEU . 13.0 t -120.26 114.47 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-N 112.366 -2.197 . . . . 0.0 111.427 -178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.49 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 30.9 tp -106.64 110.37 22.54 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.969 -1.469 . . . . 0.0 109.36 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.3 mmt -81.11 112.29 18.34 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.911 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.63 102.82 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.4 t -110.18 138.63 46.3 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.13 -1.85 . . . . 0.0 113.78 -176.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -48.0 -31.41 5.31 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -161.5 152.73 18.54 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.709 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.438 ' HB2' HG21 ' A' ' 108' ' ' VAL . . . -77.24 82.29 3.72 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 123.187 1.47 . . . . 0.0 107.552 176.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -100.94 121.42 41.71 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 111.343 -2.662 . . . . 0.0 108.362 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.531 ' O ' HG12 ' A' ' 96' ' ' ILE . 33.0 ttmt -38.48 -53.07 1.58 Allowed 'General case' 0 N--CA 1.483 1.178 0 O-C-N 125.018 1.449 . . . . 0.0 113.892 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -53.17 -53.29 52.74 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.171 0.588 . . . . 0.0 111.188 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -56.79 -49.36 75.57 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.3 1.0 . . . . 0.0 111.833 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.8 mt -55.25 -51.92 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.188 0.995 . . . . 0.0 111.969 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 92' ' ' LYS . 32.2 mm -58.98 -54.89 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.606 0.762 . . . . 0.0 110.8 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.63 -47.05 70.65 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.191 0.996 . . . . 0.0 113.234 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -57.06 -51.72 68.14 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.451 1.1 . . . . 0.0 112.168 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.1 -47.75 84.83 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.284 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.455 ' OE1' HG22 ' A' ' 96' ' ' ILE . 65.9 mt-30 -56.3 -40.38 74.23 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.85 1.26 . . . . 0.0 113.489 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.28 -14.41 59.44 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.92 3.11 12.35 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.631 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -65.24 123.02 18.45 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.192 1.496 . . . . 0.0 112.319 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.1 p -69.78 -17.57 63.43 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 113.161 -1.836 . . . . 0.0 114.314 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.54 173.47 43.93 Favored Glycine 0 N--CA 1.481 1.658 0 C-N-CA 124.043 0.83 . . . . 0.0 111.844 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -144.4 136.63 26.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 114.999 -0.601 . . . . 0.0 112.387 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.258 1.0 OUTLIER -118.03 126.9 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 124.413 1.07 . . . . 0.0 110.419 178.363 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 25.4 t -80.37 114.64 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 112.159 -2.292 . . . . 0.0 111.229 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -90.36 132.28 36.03 Favored Pre-proline 0 N--CA 1.472 0.627 0 CA-C-O 117.725 -1.131 . . . . 0.0 110.611 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.18 132.87 26.91 Favored 'Cis proline' 0 N--CA 1.489 1.228 0 N-CA-C 115.173 1.182 . . . . 0.0 115.173 1.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.442 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 35.0 p90 -124.74 151.62 44.84 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 112.462 -2.154 . . . . 0.0 108.69 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.2 p -102.53 171.63 7.33 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.014 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.71 -39.85 68.6 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.576 0.548 . . . . 0.0 111.396 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.0 -44.41 80.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.427 1.091 . . . . 0.0 111.983 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.4 m -60.15 -49.32 78.09 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 60.3 tp -56.14 -50.45 71.08 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.24 1.416 . . . . 0.0 109.715 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -56.45 -46.86 80.12 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.328 1.051 . . . . 0.0 112.473 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -53.41 -44.08 68.44 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -65.88 -48.43 71.55 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.392 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.7 mt -56.66 -48.94 76.48 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.535 1.134 . . . . 0.0 111.504 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -50.09 -53.24 28.57 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 126.021 1.728 . . . . 0.0 112.056 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -54.15 -45.91 72.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.654 1.182 . . . . 0.0 111.466 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.74 -39.8 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.338 1.055 . . . . 0.0 112.038 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -61.3 -25.46 67.13 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -57.91 -44.62 86.95 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 124.004 0.815 . . . . 0.0 109.542 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -68.18 -35.83 78.64 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.28 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.455 HD11 ' HG3' ' A' ' 82' ' ' PRO . 82.7 mt -86.85 44.23 1.15 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.672 1.589 . . . . 0.0 112.468 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 61.04 15.26 42.59 Favored Glycine 0 CA--C 1.55 2.276 0 C-N-CA 127.081 2.277 . . . . 0.0 118.35 177.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 116.984 -1.484 . . . . 0.0 113.083 179.176 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 . . . . . 0 CA--C 1.554 1.132 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.4 p -82.91 81.22 8.71 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 122.969 1.366 . . . . 0.0 112.011 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -65.34 105.23 1.09 Allowed 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.761 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 57.6 mmtt -51.19 -39.9 57.49 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -105.68 45.33 0.98 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.6 tp -83.11 122.78 28.81 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 112.029 -2.351 . . . . 0.0 107.349 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 51' ' ' TYR . 69.1 tttt -78.26 115.88 18.3 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.931 -1.486 . . . . 0.0 113.446 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.509 ' HB2' HG22 ' A' ' 33' ' ' VAL . 65.1 m-85 -105.72 138.15 42.4 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.745 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.661 HD23 ' HB3' ' A' ' 34' ' ' GLU . 1.6 tm? -116.16 99.53 7.3 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.616 1.198 . . . . 0.0 108.822 175.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.71 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 94.9 t -79.68 104.36 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 111.61 -2.541 . . . . 0.0 108.958 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.56 HG22 HD13 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -104.89 102.54 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 113.605 -1.634 . . . . 0.0 110.02 -178.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.75 135.05 22.96 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.986 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -66.1 -16.99 64.41 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -106.59 110.36 22.54 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.2 p -46.93 -49.63 20.19 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.691 -1.14 . . . . 0.0 113.273 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -38.93 85.94 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.297 1.039 . . . . 0.0 112.741 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.2 tpt -62.19 -38.98 91.18 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.515 ' HD2' ' HB3' ' A' ' 35' ' ' GLU . 77.4 mtm180 -56.39 -47.89 78.02 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.196 0.522 . . . . 0.0 110.907 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.56 -41.61 73.51 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 114.133 -1.394 . . . . 0.0 112.399 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.5 mt -57.69 -50.99 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.244 0.617 . . . . 0.0 110.23 177.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 t -58.57 -42.47 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.273 0.629 . . . . 0.0 109.97 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 56.0 ttm-85 -53.8 -54.14 42.51 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 123.938 0.774 . . . . 0.0 110.737 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -58.81 -39.78 82.17 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 81.1 mt -62.59 -53.88 48.05 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.482 0.713 . . . . 0.0 111.492 177.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.9 mt -54.87 -44.3 73.9 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.988 0.915 . . . . 0.0 111.882 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -56.75 -49.08 76.32 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 113.343 -1.753 . . . . 0.0 110.175 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 28.5 mt-10 -56.42 -38.0 70.97 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.05 1.74 . . . . 0.0 112.914 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.4 mt -73.76 -19.17 60.86 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.787 1.235 . . . . 0.0 114.287 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.41 -5.22 23.21 Favored Glycine 0 CA--C 1.551 2.295 0 C-N-CA 124.296 0.951 . . . . 0.0 112.919 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 22.3 m-85 -92.54 86.03 5.49 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 122.557 1.17 . . . . 0.0 109.773 -178.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -85.28 -7.52 58.96 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -98.29 93.37 6.18 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 122.387 1.089 . . . . 0.0 110.343 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.509 HG22 ' HB2' ' A' ' 8' ' ' PHE . 54.6 t -129.11 136.32 59.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 113.525 -1.67 . . . . 0.0 111.403 -178.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.661 ' HB3' HD23 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -126.16 149.85 48.7 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 176.387 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.71 ' HG2' ' HB ' ' A' ' 10' ' ' VAL . 87.8 mt-10 -127.99 141.27 51.57 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 118.637 2.828 . . . . 0.0 118.637 -176.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -131.51 152.44 50.73 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 112.072 -2.331 . . . . 0.0 110.531 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . 0.374 0.0 OUTLIER -100.08 -27.71 13.41 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 -179.057 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.7 p30 -142.7 166.59 24.24 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.476 -0.765 . . . . 0.0 110.831 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -45.08 -49.25 9.7 Favored Glycine 0 N--CA 1.479 1.543 0 C-N-CA 124.6 1.095 . . . . 0.0 115.582 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.0 t -58.65 -56.68 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 114.616 -0.792 . . . . 0.0 110.585 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -55.36 -35.38 65.17 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.802 0.841 . . . . 0.0 111.662 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.01 -51.52 57.57 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 117.91 -1.043 . . . . 0.0 111.834 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 50.6 mt -54.82 -45.77 74.48 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 124.211 0.944 . . . . 0.0 111.068 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -54.96 -54.41 43.17 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 125.166 1.541 . . . . 0.0 111.43 177.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.8 mttt -62.61 -45.14 94.22 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.027 1.331 . . . . 0.0 114.271 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.8 mt -54.09 -28.71 41.02 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 98.3 mm-40 -57.88 -25.51 60.87 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.39 -18.89 62.69 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.72 -179.8 50.63 Favored Glycine 0 N--CA 1.48 1.593 0 CA-C-O 122.165 0.869 . . . . 0.0 112.541 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.46 -31.02 3.29 Favored Glycine 0 N--CA 1.485 1.953 0 CA-C-N 113.959 -1.121 . . . . 0.0 114.142 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.546 ' HA ' ' HB3' ' A' ' 7' ' ' LYS . 65.3 m-85 -60.69 113.29 2.39 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.094 0.558 . . . . 0.0 110.772 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.62 15.3 45.64 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 125.815 1.947 . . . . 0.0 112.222 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.529 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.6 OUTLIER -171.3 134.19 0.88 Allowed 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 122.381 1.086 . . . . 0.0 112.348 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.32 121.49 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.538 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 89.8 mt -112.33 98.99 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.5 t -113.46 122.06 46.17 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.02 127.26 32.22 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 111.456 -2.611 . . . . 0.0 110.259 177.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -51.93 -45.04 64.14 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.237 0.961 . . . . 0.0 112.871 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -87.06 103.15 15.11 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.013 0.925 . . . . 0.0 109.438 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.9 mtp -147.23 131.46 8.58 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 123.999 0.92 . . . . 0.0 111.815 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.21 149.42 81.62 Favored 'Trans proline' 0 N--CA 1.48 0.734 0 C-N-CA 123.484 2.789 . . . . 0.0 110.968 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.5 m120 70.94 -71.7 0.13 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.911 1.684 . . . . 0.0 111.05 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.4 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 58.8 ttm -119.84 99.71 6.8 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -61.1 166.59 3.51 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.688 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.91 -56.64 7.45 Favored Glycine 0 N--CA 1.485 1.939 0 O-C-N 124.188 0.93 . . . . 0.0 114.868 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.627 HD12 HD23 ' A' ' 69' ' ' LEU . 50.8 tp -58.59 -37.26 75.43 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -68.31 -39.81 81.89 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.773 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.7 tp -58.99 -42.37 89.87 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.904 0.753 . . . . 0.0 110.372 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.627 HD23 HD12 ' A' ' 66' ' ' LEU . 12.9 tp -54.06 -47.27 71.82 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.059 1.344 . . . . 0.0 111.178 176.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.36 -47.11 85.62 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.235 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.257 11.4 p -59.15 -32.38 69.83 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.658 1.183 . . . . 0.0 112.943 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.452 HG23 ' HB3' ' A' ' 78' ' ' MET . 53.3 mt -74.65 -55.7 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.248 1.019 . . . . 0.0 108.311 176.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.439 ' HD3' ' HA ' ' A' ' 73' ' ' ARG . 71.1 mmt-85 -51.03 -48.01 61.57 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.584 1.554 . . . . 0.0 111.769 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.83 -22.32 65.15 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -83.66 110.71 18.5 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.599 0.76 . . . . 0.0 109.411 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -26.28 -69.14 0.05 OUTLIER Glycine 0 CA--C 1.541 1.71 0 C-N-CA 125.981 1.753 . . . . 0.0 115.306 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.02 -35.28 80.68 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.452 ' HB3' HG23 ' A' ' 72' ' ' ILE . 42.7 mtm -85.35 -11.38 54.72 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 64.8 p -42.67 -43.17 3.74 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.456 1.903 . . . . 0.0 116.099 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.64 -3.95 57.01 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 90.5 mt -73.95 111.07 10.86 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 11.8 Cg_endo -52.1 131.14 38.0 Favored 'Trans proline' 0 N--CA 1.481 0.749 0 C-N-CA 123.166 2.577 . . . . 0.0 114.249 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 63.3 t -116.86 124.72 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 112.865 -1.97 . . . . 0.0 113.224 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.529 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 50.4 tp -111.97 108.13 17.35 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 112.659 -2.064 . . . . 0.0 108.771 178.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.0 mmt -81.8 106.13 13.48 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 113.383 -1.735 . . . . 0.0 113.637 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -91.28 98.61 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 123.921 1.819 . . . . 0.0 108.504 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 t -108.9 139.23 44.04 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 111.813 -2.449 . . . . 0.0 112.6 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.19 -41.79 65.63 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 114.213 -1.358 . . . . 0.0 113.495 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -137.32 151.17 48.34 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.472 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.565 ' HB2' HG21 ' A' ' 108' ' ' VAL . . . -91.73 78.14 5.51 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.352 177.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.8 135.99 37.98 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.259 -1.791 . . . . 0.0 108.7 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -41.07 -49.46 3.4 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.077 1.351 . . . . 0.0 113.193 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -58.59 -51.2 70.9 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -56.93 -45.39 82.76 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.343 1.027 . . . . 0.0 111.312 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 78.9 mt -56.87 -55.16 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 124.716 1.206 . . . . 0.0 110.892 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.448 HG22 ' OE1' ' A' ' 100' ' ' GLN . 44.5 mt -59.32 -50.92 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.021 0.928 . . . . 0.0 110.674 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.58 74.11 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.834 0.854 . . . . 0.0 111.865 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.08 -49.05 79.35 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.507 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.53 88.29 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.305 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.448 ' OE1' HG22 ' A' ' 96' ' ' ILE . 78.5 mt-30 -60.12 -38.87 84.31 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.0 -0.66 45.22 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.54 -0.81 29.23 Favored Glycine 0 CA--C 1.545 1.908 0 N-CA-C 117.391 1.716 . . . . 0.0 117.391 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.03 121.65 14.11 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.099 1.449 . . . . 0.0 114.357 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.0 m -65.44 -30.02 70.77 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 111.913 -2.403 . . . . 0.0 113.08 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -173.68 177.23 46.09 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.308 1.432 . . . . 0.0 111.121 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -147.32 131.54 17.42 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.053 -1.073 . . . . 0.0 111.186 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.8 p -120.83 123.85 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 123.988 0.805 . . . . 0.0 110.364 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.565 HG21 ' HB2' ' A' ' 90' ' ' ALA . 93.8 t -76.41 128.56 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 112.796 -2.002 . . . . 0.0 111.456 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -92.78 138.26 23.67 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.859 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.51 133.75 31.92 Favored 'Cis proline' 0 CA--C 1.54 0.788 0 N-CA-C 115.866 1.449 . . . . 0.0 115.866 0.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -116.95 147.72 42.02 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 112.832 -1.985 . . . . 0.0 108.458 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 59.9 p -105.56 178.48 4.55 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.983 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.11 -42.93 69.99 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.912 0.758 . . . . 0.0 111.97 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.09 72.93 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.738 0.815 . . . . 0.0 111.723 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -60.57 -46.3 90.73 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.475 0.71 . . . . 0.0 110.786 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.3 tp -56.47 -51.2 69.35 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.323 1.049 . . . . 0.0 109.553 177.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.436 ' HA ' HD12 ' A' ' 120' ' ' LEU . 8.3 tt0 -58.67 -47.67 83.71 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.531 0.732 . . . . 0.0 111.752 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -50.42 -45.5 55.82 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 124.195 0.934 . . . . 0.0 110.653 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -68.47 -46.59 69.34 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.159 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 117' ' ' GLU . 46.5 mt -55.87 -48.67 75.15 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.503 0.721 . . . . 0.0 111.218 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -55.15 -52.53 63.0 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.502 1.521 . . . . 0.0 112.004 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -52.85 -46.96 68.05 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.357 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.92 -46.88 93.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.276 1.03 . . . . 0.0 111.528 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -61.33 -40.89 95.88 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.582 0.353 . . . . 0.0 111.722 178.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.58 -48.9 77.41 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.581 1.152 . . . . 0.0 110.346 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -54.9 -39.83 69.17 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.033 1.333 . . . . 0.0 111.563 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.9 33.4 0.59 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.308 1.443 . . . . 0.0 113.919 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.38 -5.41 2.2 Favored Glycine 0 CA--C 1.546 1.995 0 N-CA-C 117.122 1.609 . . . . 0.0 117.122 178.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 71.1 mtm . . . . . 0 C--O 1.255 1.374 0 CA-C-O 118.606 -0.712 . . . . 0.0 112.815 179.977 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.6 p -66.73 90.36 0.17 Allowed 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.43 124.6 22.69 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 111.983 -2.371 . . . . 0.0 112.111 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 33.5 mmtp -59.83 -31.51 69.81 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -99.94 46.8 0.95 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.497 1.142 . . . . 0.0 113.802 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.424 HD23 ' CZ ' ' A' ' 8' ' ' PHE . 38.2 tp -79.77 127.68 32.51 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 111.405 -2.634 . . . . 0.0 107.318 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 51' ' ' TYR . 76.8 tttt -81.77 110.43 17.08 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.558 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 30' ' ' PHE . 89.4 m-85 -99.33 141.65 31.84 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.933 -1.94 . . . . 0.0 113.135 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.745 HD23 ' HB3' ' A' ' 34' ' ' GLU . 1.3 tm? -121.82 98.76 6.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.368 174.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -80.11 109.68 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 111.955 -2.384 . . . . 0.0 108.419 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.6 HG22 HD13 ' A' ' 9' ' ' LEU . 1.4 t -108.53 100.64 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.597 -179.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -141.21 133.73 28.44 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.844 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -65.06 -28.37 69.42 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 112.976 -1.92 . . . . 0.0 114.025 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -94.54 102.02 13.94 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.0 p -39.12 -50.09 1.85 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 113.024 -1.898 . . . . 0.0 113.27 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -38.82 92.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.04 1.336 . . . . 0.0 112.61 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 12.4 tpt -63.51 -34.27 77.4 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.473 ' HD2' ' HB3' ' A' ' 35' ' ' GLU . 72.0 mtm180 -56.47 -42.58 78.45 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.507 0.504 . . . . 0.0 111.441 178.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -60.37 -43.88 96.16 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.114 -1.403 . . . . 0.0 112.533 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.6 mt -59.97 -51.46 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 122.993 0.517 . . . . 0.0 110.231 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.8 t -58.04 -44.41 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 123.806 0.691 . . . . 0.0 109.172 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 37.5 ttm-85 -55.42 -52.49 63.42 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.953 0.901 . . . . 0.0 111.469 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -55.9 -44.87 78.63 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 123.916 0.76 . . . . 0.0 113.04 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 68.4 mt -59.36 -52.82 64.01 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.506 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.5 mt -54.29 -48.75 70.93 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.541 176.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -52.25 -48.51 65.18 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.64 1.576 . . . . 0.0 111.198 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 35.3 mt-10 -58.33 -39.03 78.36 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.014 1.725 . . . . 0.0 114.017 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.2 mt -73.84 -16.25 61.14 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.962 1.305 . . . . 0.0 114.163 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.62 -8.31 19.8 Favored Glycine 0 N--CA 1.482 1.743 0 C-N-CA 124.696 1.141 . . . . 0.0 112.824 -177.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 51.9 m-85 -90.11 74.07 7.19 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 123.871 1.795 . . . . 0.0 111.675 -178.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -76.18 -14.73 60.15 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 112.256 -2.247 . . . . 0.0 116.167 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -91.79 93.51 8.89 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.465 1.126 . . . . 0.0 110.218 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.8 t -132.63 140.53 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.591 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.745 ' HB3' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -126.93 152.44 47.12 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 175.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 36.8 mt-10 -126.67 141.95 51.69 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -178.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.458 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -131.54 158.15 41.7 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 112.01 -2.359 . . . . 0.0 108.951 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . 0.314 0.0 OUTLIER -105.37 -17.37 14.46 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 -178.05 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -157.17 169.01 25.75 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 122.009 -0.432 . . . . 0.0 109.924 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -44.82 -54.99 6.48 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 124.743 1.164 . . . . 0.0 114.684 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.3 t -56.67 -56.54 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 122.612 0.365 . . . . 0.0 111.096 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -52.29 -35.91 51.63 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.113 0.965 . . . . 0.0 112.748 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . . . -68.9 -52.92 24.35 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.551 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.3 mt -52.89 -42.5 65.36 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.801 0.688 . . . . 0.0 111.412 178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -55.71 -57.29 12.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.601 1.56 . . . . 0.0 110.592 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -58.65 -42.2 87.81 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.536 1.535 . . . . 0.0 113.252 177.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.3 mt -59.98 -32.33 70.75 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -55.27 -26.66 41.44 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.83 -15.0 61.25 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.82 -177.43 47.57 Favored Glycine 0 CA--C 1.542 1.73 0 C-N-CA 124.033 0.825 . . . . 0.0 112.566 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.93 -33.2 4.06 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 114.753 -0.723 . . . . 0.0 113.495 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.547 ' O ' HD22 ' A' ' 81' ' ' LEU . 50.9 m-85 -69.16 122.56 19.04 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.944 0.897 . . . . 0.0 111.827 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.46 23.97 8.27 Favored Glycine 0 N--CA 1.478 1.49 0 O-C-N 126.17 2.169 . . . . 0.0 112.322 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.504 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -173.94 133.32 0.44 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.779 1.232 . . . . 0.0 111.398 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.6 t -122.77 122.95 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.823 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.5 mt -110.93 100.04 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 105.861 -1.904 . . . . 0.0 105.861 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.401 ' OG ' ' HA2' ' A' ' 65' ' ' GLY . 29.8 t -118.0 130.02 55.93 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -68.5 127.65 33.76 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 111.624 -2.535 . . . . 0.0 110.828 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.495 ' O ' ' HB2' ' A' ' 64' ' ' ASP . 32.1 t-105 -48.11 -54.62 12.61 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.515 1.126 . . . . 0.0 112.54 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -104.43 114.35 28.53 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 122.323 1.058 . . . . 0.0 111.167 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.455 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 32.8 mtm -139.73 137.28 18.33 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 111.916 -2.402 . . . . 0.0 109.383 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -57.04 145.54 85.27 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.645 2.897 . . . . 0.0 112.23 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.7 m120 69.41 -59.22 0.49 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.49 1.916 . . . . 0.0 115.009 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 59.3 ttm -133.02 101.4 5.21 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 58' ' ' TRP . 3.0 p30 -68.81 164.24 22.37 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 113.634 -1.621 . . . . 0.0 112.323 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.401 ' HA2' ' OG ' ' A' ' 56' ' ' SER . . . -43.91 -50.36 7.41 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 124.857 1.217 . . . . 0.0 114.453 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 61.9 tp -61.19 -42.6 98.87 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.743 -0.729 . . . . 0.0 112.84 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -65.63 -38.86 90.6 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.631 0.373 . . . . 0.0 111.198 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.14 -43.94 95.34 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.046 0.841 . . . . 0.0 110.345 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 66' ' ' LEU . 19.4 tp -55.15 -46.28 75.69 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.697 1.199 . . . . 0.0 110.685 176.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.63 -46.4 89.1 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.254 0.622 . . . . 0.0 112.366 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.25 12.8 p -62.55 -16.61 56.98 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.954 1.302 . . . . 0.0 114.069 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.9 mt -92.68 -59.76 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.111 1.364 . . . . 0.0 108.08 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 101' ' ' ALA . 77.2 mmt-85 -53.32 -46.48 69.46 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 126.386 1.874 . . . . 0.0 113.873 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.74 -29.92 65.04 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' A' ' 78' ' ' MET . 37.1 t0 -86.37 103.27 14.78 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -23.0 -71.19 0.01 OUTLIER Glycine 0 N--CA 1.483 1.818 0 C-N-CA 126.188 1.852 . . . . 0.0 115.692 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.01 -43.46 77.73 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.421 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 75.5 mmm -68.11 -27.02 66.11 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 -179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 96.1 p -47.36 -27.87 1.81 Allowed 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.73 -12.23 44.81 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 51' ' ' TYR . 2.6 mt -95.86 115.2 65.37 Favored Pre-proline 0 N--CA 1.485 1.312 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -59.42 142.98 99.81 Favored 'Trans proline' 0 N--CA 1.483 0.903 0 C-N-CA 123.439 2.759 . . . . 0.0 111.329 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.0 t -121.3 126.97 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-O 122.681 1.229 . . . . 0.0 113.234 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.504 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 54.4 tp -112.96 112.11 23.34 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 112.336 -2.211 . . . . 0.0 109.932 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 31.5 mmt -85.85 108.36 18.1 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.955 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.1 t -86.85 98.69 7.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-O 123.234 1.492 . . . . 0.0 107.692 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 1.8 t -113.26 140.57 47.87 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 112.03 -2.35 . . . . 0.0 109.947 -177.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.12 -50.57 58.57 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.542 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.405 ' HA ' HG13 ' A' ' 108' ' ' VAL . 39.1 mt-10 -138.92 153.6 48.27 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.974 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.14 83.74 7.74 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 122.83 1.3 . . . . 0.0 109.209 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -108.89 141.41 41.0 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 112.592 -2.095 . . . . 0.0 111.6 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -40.96 -52.77 3.07 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.621 1.568 . . . . 0.0 113.443 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -55.73 -50.19 71.05 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -62.98 -47.14 84.45 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.184 0.994 . . . . 0.0 111.323 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.8 mt -55.97 -54.57 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.783 1.233 . . . . 0.0 112.585 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.542 HG22 ' OE1' ' A' ' 100' ' ' GLN . 24.3 mt -55.83 -53.88 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.184 0.594 . . . . 0.0 109.9 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.71 -45.57 74.05 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.481 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.77 -48.7 79.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.23 1.012 . . . . 0.0 113.041 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.59 -43.17 97.74 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.983 0.913 . . . . 0.0 111.633 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.542 ' OE1' HG22 ' A' ' 96' ' ' ILE . 54.0 mt-30 -57.86 -33.73 68.99 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.314 1.046 . . . . 0.0 113.541 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.52 ' O ' ' HG3' ' A' ' 73' ' ' ARG . . . -90.9 -1.62 57.82 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 100.33 13.32 36.21 Favored Glycine 0 CA--C 1.547 2.088 0 N-CA-C 117.676 1.83 . . . . 0.0 117.676 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.04 129.9 43.75 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 118.921 1.36 . . . . 0.0 114.57 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.443 ' HB3' HG23 ' A' ' 123' ' ' ILE . 28.3 m -73.82 -29.29 62.06 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 113.085 -1.87 . . . . 0.0 112.439 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.12 174.99 47.22 Favored Glycine 0 N--CA 1.481 1.672 0 C-N-CA 124.898 1.237 . . . . 0.0 110.466 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.548 ' O ' ' HE2' ' A' ' 119' ' ' LYS . 37.0 p90 -144.88 130.51 18.96 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 113.924 -1.138 . . . . 0.0 111.304 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.292 1.4 p -114.68 121.19 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.205 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.405 HG13 ' HA ' ' A' ' 89' ' ' GLU . 94.0 t -74.69 115.41 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 111.479 -2.6 . . . . 0.0 111.316 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -91.65 135.57 27.58 Favored Pre-proline 0 C--O 1.24 0.567 0 O-C-N 124.421 1.075 . . . . 0.0 112.298 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -72.75 130.66 20.32 Favored 'Cis proline' 0 N--CA 1.475 0.423 0 N-CA-C 116.725 1.779 . . . . 0.0 116.725 0.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -120.63 137.83 54.23 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 112.073 -2.331 . . . . 0.0 108.213 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 54.3 p -96.48 179.52 4.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 123.85 0.719 . . . . 0.0 110.079 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.26 -36.53 68.67 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 119.504 -0.284 . . . . 0.0 111.324 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.45 -49.54 66.34 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.82 0.848 . . . . 0.0 110.839 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.99 -43.14 99.47 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.146 0.579 . . . . 0.0 110.123 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 40.2 tp -60.66 -53.72 54.03 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.695 0.798 . . . . 0.0 110.492 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -55.16 -45.87 75.71 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.459 0.704 . . . . 0.0 111.083 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -54.79 -47.36 74.08 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.337 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.548 ' HE2' ' O ' ' A' ' 106' ' ' TYR . 31.9 mmmt -66.8 -41.92 86.77 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 55.9 mt -57.76 -47.73 81.66 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.722 0.809 . . . . 0.0 109.621 177.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -54.64 -54.02 47.11 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.761 1.624 . . . . 0.0 112.074 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -52.74 -43.65 65.88 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.955 0.902 . . . . 0.0 112.331 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.443 HG23 ' HB3' ' A' ' 104' ' ' SER . 68.8 mt -60.65 -49.82 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.509 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -59.44 -40.97 88.5 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.218 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -56.75 -50.65 71.62 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 125.083 1.489 . . . . 0.0 110.691 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -60.94 -40.75 94.48 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.278 1.031 . . . . 0.0 111.385 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.7 1.44 26.47 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.14 -35.81 4.35 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 116.24 1.256 . . . . 0.0 116.24 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 75.4 mtm . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 -178.747 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 119.826 3.269 . . . . 0.0 119.826 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.9 p -87.12 119.29 27.2 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.8 1.286 . . . . 0.0 110.788 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -98.44 109.39 22.16 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.097 -1.865 . . . . 0.0 111.188 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 4' ' ' LYS . 55.3 mmtt -61.43 -17.83 56.07 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -109.71 61.26 0.6 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 123.347 1.546 . . . . 0.0 109.541 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.401 HD11 ' HA3' ' A' ' 52' ' ' GLY . 59.1 tp -86.71 136.19 33.11 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 110.846 -2.888 . . . . 0.0 110.212 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -86.96 118.57 26.43 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 125.674 1.859 . . . . 0.0 111.89 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.565 ' HB2' HG22 ' A' ' 33' ' ' VAL . 61.1 m-85 -108.2 148.93 29.24 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 112.826 -1.988 . . . . 0.0 112.868 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.649 HD23 ' HB3' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -127.23 104.01 7.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.639 175.484 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.451 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 95.4 t -84.1 105.3 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 112.526 -2.125 . . . . 0.0 109.197 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.534 HG22 HD13 ' A' ' 9' ' ' LEU . 1.4 t -104.08 92.45 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.817 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -135.62 127.54 29.49 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.36 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -60.36 -21.41 62.08 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -101.89 131.22 48.38 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.429 0.633 . . . . 0.0 110.995 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.5 p -50.44 -58.55 5.46 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.006 -1.907 . . . . 0.0 112.568 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -45.24 93.77 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.471 1.108 . . . . 0.0 112.614 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 11.9 tpt -59.87 -37.29 78.89 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.523 ' HD2' ' HB3' ' A' ' 35' ' ' GLU . 64.4 mtm-85 -58.21 -47.35 83.75 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -59.61 -43.44 93.77 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.396 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.403 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 83.2 mt -56.35 -48.26 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.537 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.423 HG11 HG21 ' A' ' 55' ' ' ILE . 4.6 t -63.07 -41.56 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 CA-C-O 118.943 -0.551 . . . . 0.0 109.982 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 57.7 ttm-85 -54.67 -52.47 62.25 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.378 0.671 . . . . 0.0 110.047 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -59.57 -38.43 81.13 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.415 1.086 . . . . 0.0 113.624 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 20' ' ' ILE . 83.1 mt -63.36 -54.39 37.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.753 0.821 . . . . 0.0 110.91 177.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.8 mt -55.66 -43.29 76.15 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.139 0.976 . . . . 0.0 111.743 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -56.68 -47.59 79.52 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.103 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -59.95 -37.43 79.55 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.038 1.735 . . . . 0.0 112.684 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.9 mt -72.66 -20.33 61.27 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.639 1.176 . . . . 0.0 113.21 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.81 -15.31 11.31 Favored Glycine 0 CA--C 1.546 2.028 0 C-N-CA 124.591 1.091 . . . . 0.0 114.336 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -89.71 82.23 6.32 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 123.408 1.575 . . . . 0.0 110.578 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -76.65 -7.97 56.33 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -96.98 97.95 9.68 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.071 0.939 . . . . 0.0 110.067 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.565 HG22 ' HB2' ' A' ' 8' ' ' PHE . 83.1 t -134.16 141.45 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.904 -178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.649 ' HB3' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -125.49 153.2 43.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 174.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.523 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 89.3 mt-10 -126.07 142.54 51.48 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 116.143 1.905 . . . . 0.0 116.143 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.62 157.25 46.22 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 112.53 -2.123 . . . . 0.0 108.097 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.6 -33.15 9.1 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -138.91 173.09 11.93 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.98 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.67 -56.85 7.08 Favored Glycine 0 N--CA 1.474 1.23 0 CA-C-N 114.254 -1.339 . . . . 0.0 115.551 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.9 t -58.07 -53.84 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 122.922 0.489 . . . . 0.0 111.496 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -51.83 -40.62 60.81 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.939 0.895 . . . . 0.0 111.969 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.8 -51.27 65.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.414 1.086 . . . . 0.0 112.728 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.6 mt -54.47 -47.32 73.09 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.776 0.831 . . . . 0.0 112.104 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -56.77 -55.35 35.38 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.777 1.298 . . . . 0.0 110.256 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -58.19 -39.34 78.71 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.008 -1.451 . . . . 0.0 114.597 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 34.0 mt -58.43 -31.0 67.33 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.962 1.468 . . . . 0.0 114.962 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -58.41 -22.37 53.85 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.534 1.134 . . . . 0.0 114.018 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.86 -26.36 67.32 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.55 175.97 48.48 Favored Glycine 0 N--CA 1.479 1.533 0 C-N-CA 124.211 0.91 . . . . 0.0 113.445 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.19 -27.79 3.49 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 113.539 -1.33 . . . . 0.0 114.933 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -61.44 108.64 0.98 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.959 0.904 . . . . 0.0 112.499 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.401 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -99.42 15.92 59.55 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-N 113.634 -1.621 . . . . 0.0 111.837 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.728 ' HE1' ' HB2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -173.61 141.21 0.84 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.257 1.023 . . . . 0.0 113.757 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.6 t -123.18 111.82 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 113.318 -1.765 . . . . 0.0 108.267 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.423 HG21 HG11 ' A' ' 21' ' ' VAL . 76.5 mt -100.9 101.8 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.5 t -119.44 128.21 53.81 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -74.14 132.34 42.15 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.052 -1.886 . . . . 0.0 110.426 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -54.01 -44.02 70.57 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.388 1.055 . . . . 0.0 113.098 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -93.7 99.52 11.92 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.673 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.468 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 9.7 mtm -139.88 137.3 18.17 Favored Pre-proline 0 N--CA 1.478 0.967 0 CA-C-N 114.511 -1.222 . . . . 0.0 112.127 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.1 145.13 93.67 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.789 2.993 . . . . 0.0 113.177 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 65.05 -69.09 0.1 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.316 1.847 . . . . 0.0 112.415 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.6 ttm -116.81 100.27 7.67 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.468 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 2.3 p30 -65.32 173.35 2.61 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 113.476 -1.693 . . . . 0.0 113.24 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -52.23 -54.97 24.04 Favored Glycine 0 N--CA 1.478 1.474 0 C-N-CA 124.703 1.144 . . . . 0.0 115.051 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 57.8 tp -59.4 -39.85 84.75 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.599 0.76 . . . . 0.0 111.925 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -66.87 -39.8 87.64 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.354 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.24 -45.34 93.59 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.878 0.871 . . . . 0.0 110.089 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.514 HD13 HG11 ' A' ' 83' ' ' VAL . 9.7 tp -52.32 -45.62 65.69 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.517 1.127 . . . . 0.0 111.77 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -60.31 -47.69 84.93 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.998 0.919 . . . . 0.0 113.082 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.32 -38.24 86.17 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.247 1.019 . . . . 0.0 111.335 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' A' ' 78' ' ' MET . 47.8 mt -67.91 -54.67 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 123.893 0.877 . . . . 0.0 109.467 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.451 ' HD3' ' HA ' ' A' ' 73' ' ' ARG . 62.1 mmt-85 -54.1 -41.11 67.9 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 125.61 1.564 . . . . 0.0 111.918 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.44 -30.73 68.72 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.963 1.305 . . . . 0.0 113.982 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.535 ' OD2' ' HG3' ' A' ' 78' ' ' MET . 27.0 t70 -83.84 93.98 8.11 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.553 0.741 . . . . 0.0 110.36 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -8.86 -80.15 0.01 OUTLIER Glycine 0 N--CA 1.482 1.729 0 C-N-CA 126.85 2.167 . . . . 0.0 117.254 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.18 -42.81 86.88 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.535 ' HG3' ' OD2' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -63.61 -25.28 68.16 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -179.179 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.5 p -53.64 -25.78 19.3 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.22 -22.51 61.25 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.413 1.485 . . . . 0.0 114.439 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.472 ' HA ' ' HD2' ' A' ' 82' ' ' PRO 0.355 1.5 pp -94.02 111.62 53.87 Favored Pre-proline 0 N--CA 1.479 0.997 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 179.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 11.4 Cg_endo -47.46 143.97 10.82 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 125.086 3.857 . . . . 0.0 117.453 -177.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.514 HG11 HD13 ' A' ' 69' ' ' LEU . 87.7 t -117.44 121.29 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 112.248 -2.251 . . . . 0.0 111.575 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.728 ' HB2' ' HE1' ' A' ' 53' ' ' PHE . 46.8 tp -112.55 115.5 28.73 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.343 -1.753 . . . . 0.0 108.992 178.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.9 mmt -88.21 112.25 22.55 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.533 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -92.23 96.84 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 123.377 1.56 . . . . 0.0 108.155 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 1.3 t -109.22 128.6 55.18 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 111.457 -2.611 . . . . 0.0 111.494 -178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.12 -38.7 25.77 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -143.37 138.6 29.53 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.24 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.23 84.89 5.13 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.265 -1.334 . . . . 0.0 107.912 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -100.38 133.69 44.43 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 112.055 -2.338 . . . . 0.0 107.253 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -39.12 -49.46 1.8 Allowed 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.941 1.401 . . . . 0.0 113.593 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -58.5 -52.76 64.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.159 0.984 . . . . 0.0 112.079 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -56.33 -44.69 80.24 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.906 0.882 . . . . 0.0 110.928 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 83.4 mt -58.7 -56.15 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.856 0.863 . . . . 0.0 111.195 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.422 HG22 ' OE1' ' A' ' 100' ' ' GLN . 52.4 mt -57.41 -50.82 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.231 0.612 . . . . 0.0 110.511 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.72 -48.32 72.67 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.891 0.876 . . . . 0.0 113.248 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.21 -48.88 79.98 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.687 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.0 -48.25 82.27 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.27 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.422 ' OE1' HG22 ' A' ' 96' ' ' ILE . 62.6 mt-30 -55.6 -42.8 75.36 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.391 1.076 . . . . 0.0 113.897 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.05 -1.37 43.82 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.417 ' C ' HD11 ' A' ' 69' ' ' LEU . . . 107.41 11.47 25.3 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 117.823 1.889 . . . . 0.0 117.823 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.41 125.65 24.89 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.198 1.499 . . . . 0.0 114.86 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.0 m -70.47 -23.15 62.64 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 112.445 -2.161 . . . . 0.0 112.684 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.01 -179.68 45.21 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.541 1.544 . . . . 0.0 110.348 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -147.27 130.45 16.47 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.216 -0.992 . . . . 0.0 111.715 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.7 p -115.36 123.54 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.852 0.834 . . . . 0.0 110.393 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 87' ' ' THR . 67.9 t -77.8 125.44 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 113.231 -1.804 . . . . 0.0 110.679 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -92.66 139.19 23.52 Favored Pre-proline 0 N--CA 1.478 0.934 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.914 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.64 125.36 11.68 Favored 'Cis proline' 0 CA--C 1.54 0.812 0 CA-C-O 122.734 1.056 . . . . 0.0 114.629 0.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.421 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 15.6 p90 -110.01 145.16 37.48 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.039 -1.891 . . . . 0.0 109.015 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 49.9 p -97.89 171.14 8.48 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.35 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.24 -39.07 63.52 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.934 176.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.43 -46.18 84.28 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.88 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.8 m -64.2 -45.98 85.92 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.084 0.954 . . . . 0.0 109.489 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 120' ' ' LEU . 30.4 tp -56.59 -51.32 69.08 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.099 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -58.22 -47.77 82.47 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.51 0.724 . . . . 0.0 112.372 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -46.08 -47.41 17.2 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.106 0.879 . . . . 0.0 112.291 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -71.54 -47.57 54.32 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.472 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 116' ' ' LEU . 37.5 mt -55.86 -45.24 78.54 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.858 0.863 . . . . 0.0 112.27 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -53.66 -55.86 22.33 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.786 1.234 . . . . 0.0 113.295 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -53.17 -47.47 68.8 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.783 -1.553 . . . . 0.0 112.088 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.407 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 65.5 mt -57.1 -44.41 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 114.2 -1.364 . . . . 0.0 113.238 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -59.55 -36.71 76.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -76.03 -46.18 30.67 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 113.732 -1.576 . . . . 0.0 110.279 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -61.37 -29.05 69.67 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.898 1.279 . . . . 0.0 112.527 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 mp -91.73 1.85 56.88 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 64.94 23.57 69.49 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 115.957 1.143 . . . . 0.0 115.957 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 27.0 mtt . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 116.329 -1.796 . . . . 0.0 114.417 179.596 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 t -85.52 72.71 10.59 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 112.79 -2.005 . . . . 0.0 105.616 177.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.548 ' OD1' HD12 ' A' ' 6' ' ' LEU 0.269 0.0 OUTLIER -71.25 45.24 0.1 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 111.072 -2.786 . . . . 0.0 115.282 -177.647 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HG2' ' H ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -64.06 -27.1 68.87 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 113.682 -1.599 . . . . 0.0 114.638 178.16 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -84.57 27.46 0.72 Allowed 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.508 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.548 HD12 ' OD1' ' A' ' 3' ' ' ASP . 3.9 tt -82.9 130.53 35.15 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.409 1.084 . . . . 0.0 109.898 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.728 ' HG3' ' HB3' ' A' ' 32' ' ' ASN . 0.4 OUTLIER -87.45 102.01 14.14 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.764 176.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -92.85 133.68 35.83 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.183 -1.826 . . . . 0.0 111.638 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.455 HD12 ' HG ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -109.46 104.23 13.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.754 174.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.514 ' HA ' HG23 ' A' ' 55' ' ' ILE . 54.8 t -80.73 98.27 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.519 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.526 HG12 ' SD ' ' A' ' 60' ' ' MET . 2.7 t -101.7 78.61 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 112.69 -2.05 . . . . 0.0 108.42 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 3.7 m-20 -128.47 100.12 5.66 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 113.044 -1.889 . . . . 0.0 112.313 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -27.69 -41.44 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -92.34 124.76 36.64 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.8 p -47.86 -50.5 26.2 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.143 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.523 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -57.91 -46.24 85.26 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.264 0.626 . . . . 0.0 111.456 177.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.06 -45.8 91.95 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.393 0.677 . . . . 0.0 111.373 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.74 ' HD2' ' HB3' ' A' ' 35' ' ' GLU . 6.6 mtm180 -53.67 -46.78 70.73 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.727 0.811 . . . . 0.0 111.133 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 10.5 mtp180 -61.92 -43.02 99.71 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 112.993 -1.912 . . . . 0.0 113.735 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 16' ' ' THR . 40.1 mm -57.83 -54.74 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.376 0.671 . . . . 0.0 110.311 178.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.535 HG22 ' HZ ' ' A' ' 111' ' ' PHE . 20.7 t -55.05 -44.49 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.67 0.788 . . . . 0.0 110.855 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.415 ' HB3' ' O ' ' A' ' 19' ' ' ARG . 52.4 ttt180 -53.67 -54.83 32.23 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.475 1.11 . . . . 0.0 110.936 177.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -55.74 -39.71 71.51 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.311 1.044 . . . . 0.0 112.743 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.02 -53.55 53.91 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.559 1.144 . . . . 0.0 111.393 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.1 mt -53.98 -41.86 68.34 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.329 1.052 . . . . 0.0 111.832 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -56.94 -51.43 69.18 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.128 -1.397 . . . . 0.0 109.982 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -56.82 -37.68 71.54 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.654 1.581 . . . . 0.0 112.55 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.2 mt -74.03 -18.08 60.89 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.91 15.5 19.99 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.868 1.223 . . . . 0.0 114.356 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -96.27 101.0 12.58 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 123.347 1.546 . . . . 0.0 112.152 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -60.44 -45.33 94.04 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 111.494 -2.594 . . . . 0.0 117.689 -178.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.728 ' HB3' ' HG3' ' A' ' 7' ' ' LYS . 69.8 m-80 -100.16 108.55 20.7 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -173.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.1 t -133.24 120.17 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 112.291 -2.231 . . . . 0.0 109.433 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.436 ' O ' HD23 ' A' ' 9' ' ' LEU . 7.7 tt0 -111.47 154.89 24.05 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 175.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.74 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 33.0 mt-10 -122.46 125.32 45.57 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -120.5 148.25 44.09 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.073 -1.876 . . . . 0.0 109.844 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.58 -61.08 1.98 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -129.67 179.41 5.84 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.799 -176.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA3' ' HB3' ' A' ' 63' ' ' MET . . . -45.45 -52.79 8.59 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-N 114.594 -1.184 . . . . 0.0 115.182 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.7 t -57.79 -57.86 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.027 0.931 . . . . 0.0 111.471 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -55.68 -36.98 67.71 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.07 0.948 . . . . 0.0 111.335 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.441 ' HB2' HG11 ' A' ' 11' ' ' VAL . . . -63.78 -51.36 65.2 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.868 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.8 mt -55.05 -45.95 75.31 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.321 0.648 . . . . 0.0 110.936 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -56.46 -58.01 9.86 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.188 0.995 . . . . 0.0 110.933 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -58.18 -40.92 82.73 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.643 1.577 . . . . 0.0 114.569 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 54' ' ' VAL . 25.4 mt -53.57 -41.01 66.08 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -65.04 -15.83 62.77 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.75 14.32 0.21 Allowed 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.28 160.09 6.91 Favored Glycine 0 N--CA 1.483 1.784 0 C-N-CA 126.024 1.773 . . . . 0.0 116.788 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.92 -13.48 3.2 Favored Glycine 0 CA--C 1.546 1.987 0 N-CA-C 120.461 2.944 . . . . 0.0 120.461 176.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.562 ' O ' HD22 ' A' ' 81' ' ' LEU . 76.0 m-85 -65.76 99.97 0.5 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.923 1.861 . . . . 0.0 115.52 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.4 15.77 62.59 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-N 112.55 -2.114 . . . . 0.0 111.797 177.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.468 ' HB2' HD21 ' A' ' 6' ' ' LEU . 0.6 OUTLIER -168.31 136.48 2.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 122.577 1.179 . . . . 0.0 113.756 178.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.505 HG22 HD21 ' A' ' 46' ' ' LEU . 13.4 t -124.23 112.86 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.106 177.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.514 HG23 ' HA ' ' A' ' 10' ' ' VAL . 18.0 tt -115.96 97.89 6.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 113.714 -1.585 . . . . 0.0 107.055 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.3 t -118.37 139.67 51.01 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 119.523 3.157 . . . . 0.0 119.523 -174.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 60' ' ' MET . 15.1 t0 -73.45 129.64 38.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.324 -2.217 . . . . 0.0 110.662 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.493 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 25.0 t-105 -56.15 -39.69 72.67 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.648 0.779 . . . . 0.0 112.401 178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -99.35 93.55 5.98 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.497 1.519 . . . . 0.0 110.334 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.526 ' SD ' HG12 ' A' ' 11' ' ' VAL . 20.0 mtm -132.95 134.88 25.01 Favored Pre-proline 0 N--CA 1.479 1.023 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.79 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -57.11 144.58 89.74 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.729 2.953 . . . . 0.0 111.162 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.7 m120 65.69 -73.62 0.06 Allowed 'General case' 0 N--CA 1.483 1.205 0 O-C-N 125.182 1.551 . . . . 0.0 112.659 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.468 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 55.0 ttm -115.12 98.4 6.76 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 3.1 p30 -61.84 168.56 3.02 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 112.34 -2.209 . . . . 0.0 112.691 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.46 -52.91 26.76 Favored Glycine 0 N--CA 1.481 1.653 0 C-N-CA 124.632 1.11 . . . . 0.0 114.247 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 60.5 tp -59.81 -40.99 90.25 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.645 0.778 . . . . 0.0 112.247 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -66.03 -43.64 87.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.703 0.801 . . . . 0.0 111.159 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -58.42 -45.66 88.03 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.499 1.12 . . . . 0.0 110.821 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 103' ' ' ALA . 7.4 tt -52.32 -50.07 62.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.205 1.402 . . . . 0.0 109.818 176.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -59.28 -47.01 86.99 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.678 1.191 . . . . 0.0 112.836 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.263 27.6 p -61.24 -23.7 65.83 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.585 1.154 . . . . 0.0 112.291 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.3 mt -84.32 -58.88 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.959 0.904 . . . . 0.0 108.65 174.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.5 mmt-85 -48.67 -51.34 28.94 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.909 2.083 . . . . 0.0 113.968 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.1 -21.4 59.91 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.06 97.64 8.87 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -22.25 -61.45 0.03 OUTLIER Glycine 0 N--CA 1.486 2.033 0 C-N-CA 125.976 1.751 . . . . 0.0 116.37 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.11 91.55 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 97.7 mtp -78.44 -24.27 46.18 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.899 1.815 . . . . 0.0 115.899 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 t -27.94 -33.15 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 118.609 2.818 . . . . 0.0 118.609 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.69 -1.52 58.12 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.562 HD22 ' O ' ' A' ' 51' ' ' TYR . 59.6 mt -75.23 113.25 23.58 Favored Pre-proline 0 N--CA 1.489 1.491 0 CA-C-N 119.248 0.931 . . . . 0.0 113.119 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.509 ' HB3' HD11 ' A' ' 127' ' ' LEU . 27.5 Cg_endo -56.62 134.46 64.56 Favored 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.436 2.757 . . . . 0.0 113.245 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.3 t -118.9 120.09 62.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 113.971 -1.468 . . . . 0.0 113.413 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.509 HD23 HD12 ' A' ' 55' ' ' ILE . 59.4 tp -112.22 105.4 13.72 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.815 -1.993 . . . . 0.0 109.361 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.2 mmt -78.25 107.53 10.91 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.815 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -87.18 96.22 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 t -100.15 136.78 39.53 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 111.422 -2.627 . . . . 0.0 114.898 -176.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.88 -24.41 66.86 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 112.691 -2.049 . . . . 0.0 113.487 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.503 ' HB3' ' HG3' ' A' ' 91' ' ' LYS . 12.6 mt-10 -155.91 126.23 6.68 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.173 1.389 . . . . 0.0 111.911 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.0 81.07 7.56 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 122.096 0.951 . . . . 0.0 108.897 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.503 ' HG3' ' HB3' ' A' ' 89' ' ' GLU . 43.3 mtmt -110.32 136.38 49.59 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.775 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' A' ' 93' ' ' GLU 0.29 0.0 OUTLIER -33.4 -52.26 0.37 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 117.049 2.241 . . . . 0.0 117.049 -178.993 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.485 ' N ' ' HD2' ' A' ' 92' ' ' LYS 0.334 0.8 OUTLIER -63.91 -42.41 97.41 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -179.458 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.301 32.1 p-10 -73.94 -30.68 62.68 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.868 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.3 mt -61.05 -50.85 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.3 mt -53.42 -54.22 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.349 1.46 . . . . 0.0 110.132 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.72 -48.84 72.0 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.484 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.493 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -57.9 -55.54 33.58 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.831 1.252 . . . . 0.0 112.976 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.83 85.28 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.593 0.757 . . . . 0.0 112.283 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -64.36 -34.12 77.42 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.041 1.496 . . . . 0.0 115.041 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.56 -13.18 59.95 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.12 1.01 8.08 Favored Glycine 0 CA--C 1.547 2.058 0 N-CA-C 117.391 1.716 . . . . 0.0 117.391 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.674 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -55.5 120.43 7.17 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 119.707 1.753 . . . . 0.0 115.116 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.7 m -64.31 -32.95 74.75 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.355 -1.748 . . . . 0.0 112.327 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.72 172.85 45.56 Favored Glycine 0 N--CA 1.477 1.378 0 C-N-CA 125.162 1.363 . . . . 0.0 110.061 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -144.01 140.32 29.51 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.4 p -122.63 127.1 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 124.942 1.401 . . . . 0.0 109.959 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.7 p -86.62 132.76 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.829 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.32 137.61 24.64 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.549 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -77.29 139.35 58.13 Favored 'Cis proline' 0 N--CA 1.482 0.799 0 N-CA-C 115.112 1.158 . . . . 0.0 115.112 -0.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.535 ' HZ ' HG22 ' A' ' 21' ' ' VAL . 25.8 p90 -126.92 147.73 50.07 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 112.424 -2.171 . . . . 0.0 107.953 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.4 p -100.3 174.35 6.17 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.298 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.38 -37.93 62.9 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.178 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.26 -47.71 66.99 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.287 1.035 . . . . 0.0 111.89 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 m -58.25 -47.88 82.17 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.3 tp -56.27 -52.12 65.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.757 1.223 . . . . 0.0 111.412 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.486 ' HA ' HD12 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -55.81 -44.15 77.57 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.991 0.917 . . . . 0.0 112.449 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -57.72 -43.91 85.6 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -64.55 -45.19 88.14 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.273 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 117' ' ' GLU . 94.3 mt -54.08 -49.39 69.19 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.188 0.995 . . . . 0.0 111.468 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -53.94 -55.05 30.56 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.488 1.115 . . . . 0.0 111.945 178.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -51.78 -46.95 64.37 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.147 1.379 . . . . 0.0 111.607 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.4 mt -60.91 -52.15 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.485 1.114 . . . . 0.0 110.646 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -55.78 -44.29 77.59 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.383 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -56.93 -41.46 78.24 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 124.319 1.012 . . . . 0.0 111.952 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -64.44 -50.2 68.49 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.742 0.817 . . . . 0.0 111.242 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 82' ' ' PRO . 53.7 mt -69.2 -7.71 39.02 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.112 1.765 . . . . 0.0 115.404 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 102.88 -28.33 16.32 Favored Glycine 0 N--CA 1.478 1.457 0 C-N-CA 123.753 0.692 . . . . 0.0 112.766 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 59.9 mtm . . . . . 0 C--O 1.257 1.458 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 179.598 . . . . . . . . 0 0 . 1 stop_ save_